Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,protein targeting to ER (GO:0045047),-0.7512854281475719,-2.857781475146319,0.0,0.0,0.0,71/99,15.60%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;SRP9;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;RPL29;RPLP2;RPLP0;RPL35A;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;SEC62;SRPRB;RPS26;SEC61G;RPS16;RPS5;UBA52;RPL13A;ZFAND2B
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7652854892335148,-2.855256424487856,0.0,0.0,0.0,68/87,15.60%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;SRP9;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;RPL29;RPLP2;RPLP0;RPL35A;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;RPS26;RPS16;RPS5;UBA52;RPL13A;ZFAND2B
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7567009248913117,-2.8393632326734615,0.0,0.0,0.0,72/91,17.48%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;SRP9;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;RPL29;SIL1;RPLP2;RPLP0;RPL35A;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;SEC62;RPS26;RPS16;RPS5;UBA52;RPL13A;RPL36A;ARL6IP1;RPL12
prerank,cytoplasmic translation (GO:0002181),-0.7487010949361301,-2.818832919957045,0.0,0.0,0.0,67/91,15.49%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;EIF3I;RPL27;RPL31;RPS27;RPL29;RPLP0;RPL35A;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;GSPT2;RPS26;RPS16;RPS5;UBA52;RPL13A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.709141507092588,-2.7738028681378832,0.0,0.0,0.0,72/110,15.49%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;PABPC1;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;RPL29;PYM1;RPLP2;RPLP0;RPL35A;EIF4G1;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;RBM8A;GSPT2;RNPS1;RPS26;RPS16;RPS5;UBA52;RPL13A
prerank,peptide biosynthetic process (GO:0043043),-0.628087804739465,-2.6419768242586534,0.0,0.0,0.0,79/153,15.49%,EEF1A1;RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;WARS1;MRRF;RPS25;RPS18;RPL3;SARS1;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;MRPL32;RPL31;RPS27;RPL29;RPLP2;RPLP0;RPL35A;EIF4G1;FURIN;MRPS14;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;GSPT2;RRBP1;MRPS16;RSL24D1;RPS26;RPS16;MRPS5;RPS5;MRPL23;RPL13A
prerank,translation (GO:0006412),-0.5853557590330427,-2.554231144218704,0.0,0.0,0.0,95/208,17.48%,EEF1A1;RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;EEF2;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;WARS2;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;LARS2;RPS20;WARS1;MRRF;EEF1D;RPS25;RPS18;RPL3;SARS1;RPL32;RPL36;RPS27A;RPL14;RPL5;NDUFA7;RPS2;RPL27;MRPL32;RPL31;RPS27;RPL29;RPLP2;RPLP0;APEH;RPL35A;EIF4G1;MRPS14;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;GSPT2;YARS1;EEF1G;RRBP1;MRPS16;RSL24D1;RPS26;RPS16;MRPS5;RPS5;IARS1;MRPL23;UBA52;RPL13A;NARS1;EEF1E1;MRPL24;EEFSEC;RPL36A;EEF1B2;RPL12
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5726920796528495,-2.4190591359336437,0.0,0.0,0.0,86/168,18.21%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;PAN2;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;PABPC1;RPS25;RPS18;RPL3;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;RPL31;RPS27;PATL1;RPL29;CNOT6L;DDX5;PYM1;RPLP2;RPLP0;RPL35A;EIF4G1;ZFP36L1;RPL7A;RPS28;RPL7;RPS17;RPS10;RPL30;RPS4X;RBM8A;GSPT2;RNPS1;RPS26;RPS16;TNKS1BP1;RPS5;UBA52;RPL13A;POLR2G;PPP2R2A;RPL36A;DCPS;RPL12;ZC3H12A;PELO;SMG5
prerank,rRNA metabolic process (GO:0016072),-0.5359149819437914,-2.214587005931368,0.0,0.0002482970084839526,0.002,82/160,21.81%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS14;RPL18;RPS6;RPL23A;RPS25;RPL3;RPL32;RPL36;RPL14;RPL5;DCAF13;RPS2;RPL27;RPL31;RPS27;RPL29;DDX52;TEX10;RPLP2;IMP3;RPLP0;RPL35A;TRIR;PDCD11;BMS1;RPL7A;RPS28;RPL7;POP5;PIH1D1;RPS17;DDX54;RPL30;DHX37;WDR3;FBL;POP4;RPF1;RPS16;UBA52;RPL13A;RPL36A;RPL12;TBL3;UTP18;MRM2;UTP15;MTREX;RPL9;EBNA1BP2;NOLC1;EXOSC10;NOP53;RPL35;RPL22;PWP2;WDR74
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.6663822499846628,-2.177649489719093,0.0,0.0005586682690888933,0.005,22/39,15.08%,EFNA5;ACTN4;ACER2;THBS1;JAG1;ADAM15;CORO2B;NOTCH1;SEMA3E;FZD4;KANK1;CORO1C;AP1AR;NEXMIF;MYOC;AJAP1;RHOA;GCNT2;CASK;SPRY4;SPOCK1;RCC2
prerank,ribosome biogenesis (GO:0042254),-0.49762645503661107,-2.115122473351265,0.0,0.0015236407338788001,0.013,87/187,21.81%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS14;RPL18;RPS6;RPL23A;RPS25;RPL3;RPL32;RPL36;RPL14;RPL5;DCAF13;RPS2;RPL27;RPL31;RPS27;RPL29;DDX52;TEX10;RPLP2;IMP3;RPLP0;RPL35A;PDCD11;BMS1;RPL7A;RPS28;RPL7;POP5;PIH1D1;RPS17;DDX54;RPL30;DHX37;RBIS;WDR3;FBL;POP4;RPF1;RPS16;UBA52;RPL13A;DHX29;RPL36A;EIF2A;RPL12;TBL3;UTP18;MRM2;HEATR3;UTP15;MTREX;RPL9;EBNA1BP2;NOLC1;EXOSC10;NOP53;RPL35;NOC2L;RPL22;EIF6;PWP2;WDR74
prerank,ncRNA processing (GO:0034470),-0.49117760346974415,-2.1094735409322456,0.0,0.0014897820509037157,0.014,93/200,21.81%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS14;RPL18;RPS6;RPL23A;RPS25;RPL3;SARS1;RPL32;RPL36;RPL14;RPL5;DCAF13;RPS2;RPL27;RPL31;RPS27;RPL29;DDX52;TEX10;RPLP2;IMP3;RPLP0;RPL35A;PDCD11;BMS1;ADAR;SSB;RPL7A;RPS28;RPL7;POP5;PIH1D1;RPS17;DGCR8;DDX54;RPL30;INTS11;DHX37;WDR3;FBL;POP4;RPP21;RPF1;INTS6;RPS16;UBA52;RPL13A;LIN28B;INTS1;RPL36A;RPL12;RPP30;TBL3;UTP18;MRM2;UTP15;MTREX;RPL9;EBNA1BP2;NOLC1;EXOSC10;NOP53;AGO3;RPL35;METTL3;RPL22;PWP2;WDR74
prerank,rRNA processing (GO:0006364),-0.4969708787253651,-2.089323147896453,0.0,0.0024065710053060023,0.024,88/172,21.81%,RPL37A;RPL41;RPL11;RPL13;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS14;RPL18;RPS6;RPL23A;RPS25;RPL3;RPL32;RPL36;RPL14;RPL5;DCAF13;RPS2;RPL27;RPL31;MAK16;RPS27;RPL29;DDX52;TEX10;RPLP2;IMP3;RPLP0;RPL35A;PDCD11;BMS1;RPL7A;RPS28;RPL7;POP5;RSL1D1;PIH1D1;RPS17;DDX54;RPL30;DHX37;WDR3;FBL;POP4;RPF1;RPS16;UBA52;RPL13A;TSR3;RPL36A;RPL12;TBL3;UTP18;MRM2;UTP15;MTREX;RPL9;EBNA1BP2;NOLC1;EXOSC10;THUMPD1;NOP53;RRP15;RPL35;NHP2;RPL22;EIF6;PWP2;WDR74
prerank,regulation of glucose import (GO:0046324),0.7305244809171543,2.071901433746091,0.0,0.061216568615538404,0.061,7/30,3.96%,IGF1;PRKAG2;OSBPL8;APPL2;PID1;SORBS1;GRB10
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.7827389052491849,2.0544014838321036,0.0,0.04546230463359837,0.086,6/23,2.80%,TGFBR3;ADAMTS9;FGFR2;TPM1;TNNC1;TNNT2
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.8107837506259512,2.041516571703858,0.0,0.04111112696239589,0.109,4/18,3.44%,IGF1;IGFBP2;IL18;IGF2
prerank,cellular response to copper ion (GO:0071280),-0.791065980663311,-2.0312255857405934,0.0,0.0055068729381619495,0.057,9/16,6.77%,MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;MT2A
prerank,epithelial tube morphogenesis (GO:0060562),-0.6413400209168896,-2.028082797793247,0.0,0.00528872628070819,0.059,14/32,8.40%,MEF2C;SLIT2;PODXL;COL4A1;ACVRL1;RASIP1;HES1;PKD1;SOX17;RHOB;CTNNB1;MET;RYR2;PAK1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.44373785159501034,-2.0185408613647393,0.0,0.005935850359069492,0.071,123/306,21.28%,ST3GAL4;EEF1A1;PTMA;RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL6;RPS15;RPL38;RPL37;EEF2;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;PTMS;RPS11;RPL34;RPL28;RPL18A;RPL26;RPL24;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;B4GALT5;RPS20;WARS1;EXT1;MRRF;EEF1D;RPS25;RPS18;RPL3;SARS1;RPL32;RPL36;RPS27A;RPL14;RPL5;RPS2;RPL27;MRPL32;RPL31;RPS27;RPL29;SET;ING4;RPLP2;RPLP0;RPL35A;EIF4G1;MRPS14;RPL7A;BCL3;RPS28;RPL7;KIN;RPS17;RPS10;RPA1;RPL30;RPS4X;GSPT2;EEF1G;RRBP1;POLR2C;DONSON;XAB2;RAD17;RNPS1;MCM4;MRPS16;RSL24D1;RPS26;TOPBP1;RPS16;MRPS5;RPS5;MRPL23;RPL13A;POLR2G;TOP3A;FAM111A;NR4A2;MRPL24;EEFSEC;RPL36A;EEF1B2;MCM8;POLA1;RPL12;RAD9A;CDK2;ATR;RPL9;INHA;MRPL13;MRPL35;POLE;RPL35;POLD3;RBBP8;GTPBP2;PAX8;RPL22
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.7899171052055386,-2.0130070326344667,0.0,0.005981036763186977,0.077,8/14,9.24%,THBS1;KLF4;MEOX2;NOTCH1;HDAC5;CARD10;PDCD10;RHOA
prerank,response to copper ion (GO:0046688),-0.736365136138395,-2.0103482284738794,0.0,0.00602120245573585,0.081,10/20,6.77%,MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;ATP5F1D;MT2A
prerank,cellular response to zinc ion (GO:0071294),-0.7809446184243152,-2.0079347117177258,0.0,0.005998332994428117,0.085,9/15,6.77%,MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;MT2A
prerank,retinoid metabolic process (GO:0001523),0.6133145588922452,2.004513065078166,0.0,0.06661803055220356,0.231,12/71,6.18%,CYP26B1;ALDH1A1;ALDH1A2;RBP4;ABCA4;SDC2;GPC6;RBP1;GPC3;LRP2;SCPEP1;NAPEPLD
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.7131882654718262,-2.003950921524836,0.0,0.006257084613795605,0.094,11/22,9.59%,SLIT2;TMSB4X;KANK3;GSN;TMSB10;KANK1;HIP1R;CYRIB;SSH2;SSH1;KANK4
prerank,retinoic acid metabolic process (GO:0042573),0.8440228051486168,1.9952122790256086,0.0,0.06463749450875966,0.266,3/14,6.14%,CYP26B1;ALDH1A2;SCPEP1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.6253858792388951,-1.994829278234317,0.0,0.007395703752700588,0.111,18/39,10.79%,SLIT2;COL4A1;TIE1;KDR;RASIP1;ENG;PKD1;SEMA3E;TGFBR2;CTNNB1;LRP5;MET;SIX1;VEGFA;NOTCH4;NPNT;PAK1;BMP2
prerank,response to progesterone (GO:0032570),-0.7252892475186927,-1.967147640354194,0.0,0.011681245626404133,0.179,7/18,8.78%,ABHD2;CAV1;THBS1;TGFB2;UBE3A;TGFB1;WBP2
prerank,response to zinc ion (GO:0010043),-0.6668235822464089,-1.95944356974431,0.0,0.012387861618927635,0.198,11/25,6.77%,MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;SLC30A5;CRIP1;MT2A
prerank,ribosome assembly (GO:0042255),-0.5739940389955367,-1.9471261800644897,0.0,0.014711597752674192,0.245,27/47,23.47%,RPL11;RPL6;RPS15;RPSA;RPS19;RPL24;RPS14;RPL23A;RPL3;RPL5;RPS27;RPLP0;RPS28;DHX37;ERAL1;RPS27L;RSL24D1;RPS5;DHX29;EIF2A;NOP53;NLE1;EIF6;PWP2;PPAN;MRPS2;MRPS11
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.7927682680873832,-1.9466046680512508,0.0,0.01430190768867567,0.248,4/12,2.20%,PODXL;PROM1;IQGAP1;JAG1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6537813937087081,-1.9370872805880621,0.0,0.01572866049896423,0.273,17/26,16.19%,SLC39A10;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;SLC30A5;MT2A;SLC39A8;SLC30A1;SLC39A7;SLC39A14;MT3;ATP13A2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.6086242556389906,-1.934950771172054,0.0,0.01576686003873099,0.285,20/33,27.77%,MEF2C;THBS1;ACVRL1;KLF4;MEOX2;NOTCH1;TGFB1;HDAC5;CARD10;PDCD10;RHOA;JUP;CSNK2B;DLL4;ATP2B4;GADD45A;RGCC;ANGPT4;FGF2;VASH1
prerank,skeletal system morphogenesis (GO:0048705),0.6452055027166324,1.9334335007001613,0.0,0.1618938174906028,0.575,11/42,6.20%,CYP26B1;FGFR2;HOXC4;WWOX;FBN2;HOXB4;LTF;HOXB3;HOXA3;PDGFRA;ANKRD11
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.5697013168593541,-1.9315580900764808,0.0,0.016201379803577907,0.298,20/47,15.08%,EFNA5;ACTN4;LIMS2;RAC1;CARMIL1;PTK2;DOCK1;LIMS1;FLNA;KANK1;CORO1C;AP1AR;CALR;FERMT2;MYOC;CRK;S100A10;SPRY4;NEDD9;RCC2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.6119651467435313,1.9246999337320587,0.0,0.16140082691701826,0.619,4/49,1.24%,IL31RA;IGF1;IL18;KIT
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.6862384280043954,-1.9093377694306433,0.0,0.021999971148259176,0.387,10/19,12.24%,TEK;PTPRJ;KDR;RAC1;LIMS1;FERMT2;MYOC;VEGFA;COL16A1;S100A10
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.7701247736680097,-1.9090269687007924,0.0,0.021415616981740913,0.389,8/13,8.08%,COL4A1;KDR;ENG;SEMA3E;TGFBR2;CTNNB1;VEGFA;NOTCH4
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5926953280609379,-1.906192922885213,0.0,0.021733997823264694,0.403,18/39,16.22%,RPS24;RPS15;RPSA;RPS7;RPS19;RPS14;RPS6;RPS25;RPS27;DDX52;RPS28;RPS17;ERAL1;WDR3;RPS27L;RPS16;RPS5;TSR3
prerank,organic anion transport (GO:0015711),-0.5081009084303453,-1.906082347958954,0.0,0.021089727158105726,0.404,24/76,16.21%,ABCC4;SLC4A10;ABCG2;SLC26A7;LRRC8C;SLCO1C1;LRRC8D;SLCO2A1;SLCO2B1;CA4;SLC39A8;SLC4A8;SLCO3A1;LRRC8A;CA2;SLC4A2;SLC26A6;SLC52A3;CYB5R1;SLC25A42;SLC35B2;SLC16A2;CFTR;SLC17A9
prerank,branched-chain amino acid catabolic process (GO:0009083),0.7370834355917277,1.895234458503688,0.0,0.20875650114481803,0.798,10/20,14.25%,ACADSB;MCCC2;IVD;DBT;HSD17B10;BCKDHA;ALDH6A1;BCKDHB;AUH;HIBCH
prerank,branched-chain amino acid metabolic process (GO:0009081),0.7370834355917277,1.895234458503688,0.0,0.20875650114481803,0.798,10/20,14.25%,ACADSB;MCCC2;IVD;DBT;HSD17B10;BCKDHA;ALDH6A1;BCKDHB;AUH;HIBCH
prerank,regulation of activated T cell proliferation (GO:0046006),0.6933200678124224,1.8935886499728434,0.0018484288354898336,0.1946326784511677,0.803,4/30,3.44%,IGF1;IGFBP2;IL18;IGF2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.5111800070281792,-1.8675467762345392,0.0,0.03883590937242186,0.614,31/71,22.88%,ELMO1;ACTB;ACTG1;MYO10;RAC1;HSP90AA1;HSP90AB1;PTK2;DOCK1;PLCG2;FYN;NCKAP1;WIPF1;ARPC1B;NCK1;ARPC3;WIPF3;PAK1;CRK;ACTR2;PRKCE;YES1;ARPC4;ARPC1A;CYFIP2;PRKCD;NCKAP1L;ABI1;MAPK3;ACTR3;FCGR2B
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.5127495873854488,-1.8637999300766608,0.0,0.039468270069162405,0.63,31/70,22.88%,ELMO1;ACTB;ACTG1;MYO10;RAC1;HSP90AA1;HSP90AB1;PTK2;DOCK1;PLCG2;FYN;NCKAP1;WIPF1;ARPC1B;NCK1;ARPC3;WIPF3;PAK1;CRK;ACTR2;PRKCE;YES1;ARPC4;ARPC1A;CYFIP2;PRKCD;NCKAP1L;ABI1;MAPK3;ACTR3;FCGR2B
prerank,neurotransmitter biosynthetic process (GO:0042136),0.7637887892589124,1.8613196073960723,0.0,0.2776024074116394,0.919,2/14,0.70%,MOXD1;SLC22A2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.7233328520891986,1.861108863221449,0.007858546168958742,0.23572533887702796,0.919,4/21,2.18%,EYA4;EYA1;EYA2;BCL2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.7233328520891986,1.861108863221449,0.007858546168958742,0.23572533887702796,0.919,4/21,2.18%,EYA4;EYA1;EYA2;BCL2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6195299336585444,-1.857423997028105,0.0,0.042331092846392714,0.671,12/24,12.24%,TEK;PTPRJ;KDR;RAC1;IQSEC1;LIMS1;FERMT2;MYOC;VEGFA;COL16A1;DUSP3;S100A10
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5042082205118987,-1.855737856729598,0.0024937655860349127,0.04224152856833243,0.681,30/69,18.29%,COX4I1;COX6C;NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;UQCRH;COX6A1;NDUFA13;COX7C;NDUFS1;UQCR11;NDUFB11;SDHAF2;COX8A;NDUFB10;COX5A;NDUFA1;UQCRQ;UQCC3;NDUFB4;COA6;NDUFS7;UQCRC2;UQCRC1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.7927262903248665,-1.854926506845985,0.0,0.04143204676702495,0.684,6/10,9.97%,FAP;CST3;NOTCH1;TGFB1;TNFRSF1B;DPP4
prerank,neuron projection organization (GO:0106027),-0.7165910350046226,-1.8520532017361833,0.0,0.04234117407831613,0.702,11/15,23.28%,LGMN;GSK3B;ARF1;APP;ATP1A3;PICK1;ABCD2;PSEN1;INSR;DCTN1;MAP1A
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6040823918626785,1.8504937312850582,0.0016611295681063123,0.2526469517756832,0.941,17/50,11.24%,DCDC2;RORA;ZIC1;FGFR2;TULP3;INTU;MGRN1;TEDC2;TTC23;GPC3;GLI3;ARMC9;SUFU;HERC4;FBXL17;WDR11;IFT122
prerank,energy reserve metabolic process (GO:0006112),0.7375348522750301,1.8469323137809026,0.006085192697768763,0.24690682674933823,0.945,4/19,1.70%,PRKAG2;LEPR;PID1;PHKB
prerank,entry into host (GO:0044409),-0.7271931852777045,-1.84166061147695,0.0,0.04744382839031833,0.752,5/13,6.69%,CDH1;CBL;PPIA;CTNNB1;MET
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5725348480114778,1.8409822043158024,0.0017094017094017094,0.2507178582268742,0.955,4/57,1.24%,IL31RA;IGF1;IL18;KIT
prerank,sodium ion transport (GO:0006814),0.5432846665734604,1.8396485284063122,0.0,0.24078870025506324,0.957,12/85,3.73%,SCN7A;ATP1A2;SLC6A13;SLC24A3;SLC8A3;SLC5A5;SLC6A12;SLC6A9;NALCN;ATP1B3;SLC8A1;SLC6A1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.5010621161922624,-1.8357679605929376,0.0,0.05011254373727373,0.775,30/73,21.78%,ELMO1;ACTB;ACTG1;MYO10;RAC1;HSP90AA1;HSP90AB1;PTK2;DOCK1;PLCG2;FYN;NCKAP1;WIPF1;ARPC1B;NCK1;ARPC3;WIPF3;PAK1;CRK;ACTR2;PRKCE;YES1;ARPC4;ARPC1A;CYFIP2;PRKCD;NCKAP1L;ABI1;MAPK3;ACTR3
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.7928319595459463,1.835258356566654,0.0021008403361344537,0.24151536751996316,0.96,3/12,3.44%,IGF1;SORBS1;IGF2
prerank,aerobic electron transport chain (GO:0019646),-0.4984639635495404,-1.8327428526293172,0.0024813895781637717,0.05109770753861829,0.791,29/68,18.29%,COX4I1;COX6C;NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;UQCRH;COX6A1;NDUFA13;COX7C;NDUFS1;UQCR11;NDUFB11;SDHAF2;COX8A;NDUFB10;COX5A;NDUFA1;UQCRQ;UQCC3;NDUFB4;NDUFS7;UQCRC2;UQCRC1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6746973607358828,1.832319803465063,0.0036101083032490976,0.23643241284174663,0.967,4/26,2.18%,EYA4;EYA1;EYA2;BCL2
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.7800438902257067,1.8322420468188423,0.0020876826722338203,0.22474582874807592,0.967,3/13,3.44%,IGF1;SORBS1;IGF2
prerank,gene expression (GO:0010467),-0.39784059503842556,-1.8291738857822624,0.0,0.052780849803445926,0.803,126/348,19.63%,EEF1A1;PTMA;RPL37A;RPL41;RPL11;RPL13;RPL27A;RPS21;RPLP1;RPL17;RPL23;RPS24;HNRNPK;RPL19;RPL21;RPS9;ADARB1;RPL6;RPS15;RPL38;RPL37;RPL4;RPSA;RPS7;RPS8;RPS3;RPL8;RPS23;RPS19;RPS11;ADARB2;RPL34;RPL28;RPL18A;RPL26;RPL24;SRSF2;RPS29;RPS14;RPL18;RPS6;RPL23A;RPS12;RPS20;WARS1;MRRF;RPS25;RPS18;SRSF1;RPL3;SARS1;RPL32;RPL36;RPS27A;GALNT2;RPL14;RPL5;RPS2;HNRNPU;RPL27;MRPL32;RPL31;RPS27;RPL29;DDX20;TSPAN17;SRSF5;RPLP2;RPLP0;RPL35A;DDX39B;EIF4G1;ADAR;MRPS14;RPL7A;BCL3;RPS28;RPL7;CPSF3;HHEX;RPS17;SRSF9;RPS10;DDX54;RPL30;RPS4X;RBM8A;GSPT2;HSPD1;RRBP1;POLR2C;XAB2;DNAJB11;RNPS1;SRSF6;MRPS16;NUP37;RSL24D1;RPS26;AGFG1;RPS16;MRPS5;RPS5;SYMPK;MRPL23;RPL13A;CLP1;POLR2G;PRPF4;NXT1;BICD1;NR4A2;CPSF2;MRPL24;RPL36A;RPL12;NUP54;SMG5;NUP85;DDX17;RPL9;HNRNPUL1;YTHDC1;THOC3;MRPL13;MRPL35
prerank,neurotransmitter uptake (GO:0001504),0.7816740163281486,1.8272547742919432,0.013015184381778741,0.22836180743345452,0.976,3/12,2.16%,ATP1A2;SLC22A2;SLC1A3
prerank,negative regulation of growth (GO:0045926),-0.4503910237507279,-1.8252365225229545,0.0,0.054411690952192684,0.82,33/121,11.08%,APBB2;SLIT2;PTPRJ;ACVRL1;TGFB2;ADAM15;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;NOTCH1;NDRG3;RACK1;SH3BP4;FHL1;BMPR2;SOX17;CCDC85B;RERG;CCN3;TGFB1;OSGIN2;MT2A;APBB1;ING4;RTN4;SESN2;CDKN1B;NDUFA13
prerank,sodium ion transmembrane transport (GO:0035725),0.5342762277683607,1.822674342409288,0.0,0.23173090111617242,0.982,11/84,3.73%,SCN7A;ATP1A2;SLC6A13;SLC24A3;SLC8A3;SLC6A12;SLC6A9;NALCN;ATP1B3;SLC8A1;SLC6A1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.7488943159495839,1.8170363783653913,0.006024096385542169,0.23832972269821825,0.986,4/15,8.85%,IGF1;ROCK2;PRKCA;CAMK2D
prerank,modulation by symbiont of host process (GO:0044003),-0.794823957538347,-1.8147670071317534,0.0,0.06102181139184594,0.852,7/10,15.45%,B2M;UBB;RPS27A;UBC;HGS;MRC1;UBA52
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.5308887578681697,-1.8142100421132556,0.0021645021645021645,0.06016236515566171,0.856,18/42,14.64%,RAC1;VIT;ATXN3;PTK2;CORO2B;NOTCH1;MINK1;FZD4;LIMS1;CORO1C;FBLN2;ECM2;EMP2;NPNT;RHOA;GCNT2;SPOCK1;NF1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.6127515596238726,-1.8136202556312622,0.0021231422505307855,0.05921883652342269,0.857,15/27,22.51%,MAP3K5;UBB;IKBKB;RPS27A;UBC;MAPK8;CHUK;MAP2K7;CUL1;MAP3K8;UBA52;CCDC88C;SKP1;MAPK3;MAPK11
prerank,vasodilation (GO:0042311),-0.7349015115753752,-1.8095450442585523,0.00398406374501992,0.061192005303609,0.871,7/13,12.75%,NOS3;KLF2;KCNMA1;SOD1;NOS1;GPER1;ADRB2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.8421577575345877,1.8093700367256431,0.002197802197802198,0.2519556932540266,0.991,4/10,5.87%,APPL2;PID1;GRB10;PRKCB
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.49313566186364965,-1.8079876340191046,0.0,0.061197453309779194,0.875,24/67,14.52%,UTRN;FN1;LIMS2;RAC1;VIT;CARMIL1;DOCK1;PTK2B;LIMS1;FLNA;CALR;FERMT2;FBLN2;GSK3B;MYOC;ECM2;EMP2;NPNT;CDK6;CRK;S100A10;CDH13;JUP;NEDD9
prerank,cell projection organization (GO:0030030),-0.5832340051868161,-1.8028276310765678,0.004310344827586207,0.06434946348444315,0.894,7/30,4.32%,RHOJ;PARVB;RAC1;GSN;ITGB1;PACSIN2;NCKAP1
prerank,endocardial cushion development (GO:0003197),-0.6176975056682624,-1.7887631118206941,0.006097560975609756,0.07635877901906994,0.934,13/21,24.13%,NOS3;ACVRL1;TGFB2;ENG;NOTCH1;BMPR2;TBX2;BMP2;HEYL;ACVR1;BMP4;HEY1;FOXF1
prerank,regulation of fatty acid oxidation (GO:0046320),0.7252743036510396,1.7867167906700545,0.007874015748031496,0.3182181275620664,0.999,4/16,5.18%,PRKAG2;APPL2;PPARA;ACADL
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.6787181495265301,1.7842182326446674,0.0038240917782026767,0.3147044073227537,0.999,4/24,3.44%,IGF1;SORBS1;PPP1R3G;IGF2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.6032278462295182,1.7830190743847982,0.0018214936247723133,0.3069497443761691,0.999,9/40,3.12%,BMP6;ADGRV1;OSR1;WNT4;WNT6;BMP7;FBN2;SLC8A1;KL
prerank,regulation of small molecule metabolic process (GO:0062012),0.6416437834469249,1.7750344746043556,0.001949317738791423,0.32447353490967096,1.0,6/28,6.13%,RORA;PPARA;PRKN;PDK1;ACADL;EPHX2
prerank,alpha-amino acid catabolic process (GO:1901606),0.6334957941646732,1.7711108789057424,0.0073937153419593345,0.3277507765937396,1.0,11/29,15.19%,DDO;ALDH4A1;ACADSB;CBS;FAH;HSD17B10;HOGA1;THNSL2;PRODH;AADAT;GSTZ1
prerank,negative regulation of vascular permeability (GO:0043116),-0.732390285219627,-1.7708551480245869,0.0,0.09495169718553977,0.965,10/12,7.87%,SLIT2;PTPRJ;CLDN5;PDE3A;RAMP2;FERMT2;CEACAM1;DDAH1;PDE2A;VEGFA
prerank,chloride transport (GO:0006821),-0.47420917032514953,-1.767461765595222,0.0,0.09718679158034864,0.973,20/74,11.74%,SLC4A10;SLC12A7;SLC12A2;SLC26A7;ANO1;ANO4;CLIC4;GABRB3;SLC12A6;SLC1A1;CLIC5;GABRB1;TTYH3;SLC12A8;SLC4A8;ANO3;LRRC8A;SLC12A4;GABRG3;SLC26A6
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.5916010216023592,-1.7670138124457107,0.004210526315789474,0.09577471496116387,0.974,14/28,23.48%,OCLN;RAC1;RPS3;CLIP1;MET;PAK1;NAV3;GIT1;TOGARAM1;CKAP5;MAPRE1;NUMA1;DCTN1;HSPA1B
prerank,mesoderm development (GO:0007498),-0.6417672941767929,-1.7657391534626357,0.002066115702479339,0.09551158259682711,0.975,7/18,11.94%,TIE1;TBX1;BMX;TBX3;VEGFA;IKZF1;MESD
prerank,positive regulation of bone mineralization (GO:0030501),0.603644093774529,1.7637581730877208,0.003656307129798903,0.3439530928780888,1.0,9/35,3.12%,BMP6;ADGRV1;OSR1;WNT4;BMP7;FBN2;LTF;SLC8A1;KL
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.6483672534375174,-1.7617841814325228,0.003968253968253968,0.09820372410093493,0.977,7/18,11.02%,FN1;CD200;CD34;TGFB2;ITGB8;PTGS2;LTBP1
prerank,hemidesmosome assembly (GO:0031581),-0.7530506820577145,-1.7609346651351068,0.0019011406844106464,0.09738785076510316,0.977,4/11,6.24%,ITGA6;ITGB4;PLEC;LAMA3
prerank,carnitine shuttle (GO:0006853),0.7698780402987488,1.7565977352205184,0.007905138339920948,0.36076538515694195,1.0,3/11,5.76%,PRKAG2;PRKAA2;CPT2
prerank,endocardial cushion morphogenesis (GO:0003203),-0.6429406085703753,-1.7559355835255028,0.004048582995951417,0.10250092558125697,0.981,9/18,11.74%,NOS3;ACVRL1;TGFB2;ENG;NOTCH1;TGFBR2;TBX2;BMP2;HEYL
prerank,embryonic organ morphogenesis (GO:0048562),0.5844386319433632,1.7521652231047748,0.0017123287671232876,0.36704621816494926,1.0,10/42,4.40%,EFEMP1;FBN1;FGFR2;HOXC4;RBP4;FBN2;HOXB4;HOXB3;HOXA3;PDGFRA
prerank,response to cadmium ion (GO:0046686),-0.5976530521543428,-1.7512254162220335,0.002066115702479339,0.10610844228074567,0.986,12/26,10.31%,MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;MT2A;JUN;MAPK8;CHUK
prerank,establishment of endothelial barrier (GO:0061028),-0.5764157980266432,-1.750643299514939,0.0041841004184100415,0.10510538621841892,0.986,12/29,11.40%,PECAM1;RAP1A;TJP2;PDE4D;MSN;F11R;PPP1R16B;ROBO4;PDE2A;TJP1;SOX18;RAB1A
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.570758652313437,1.7494465574000067,0.001841620626151013,0.3673266918040216,1.0,9/46,6.34%,ALDH1A1;NPR3;LGR4;RBPJ;ADAMTS5;NOVA1;MAP2K6;TLE3;NRDC
prerank,macrophage differentiation (GO:0030225),0.7305285118353287,1.7491146421821424,0.010822510822510822,0.35779389779488346,1.0,3/13,7.99%,IL31RA;MMP9;CSF1
prerank,cellular response to cadmium ion (GO:0071276),-0.6100974673729723,-1.7448217355828661,0.002070393374741201,0.1104673390745105,0.989,12/24,10.31%,MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;MT2A;JUN;MAPK8;CHUK
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.5942011555795057,-1.7436705419245342,0.006211180124223602,0.11006680750672657,0.989,12/26,21.14%,OCLN;RAC1;RPS3;CLIP1;MET;STMN2;PAK1;NAV3;TOGARAM1;MAPRE1;NUMA1;DCTN1
prerank,cellular amino acid catabolic process (GO:0009063),0.511098539896897,1.743243423829626,0.0,0.3685854740591031,1.0,27/87,15.19%,DDO;ALDH4A1;ABAT;ACADSB;CBS;MCCC2;AASS;FAH;ALDH7A1;IVD;DBT;HSD17B10;BCKDHA;HOGA1;HMGCL;GCDH;ALDH6A1;BCKDHB;PRODH;AUH;PIPOX;SHMT1;AADAT;HIBCH;HMGCLL1;ASPA;GSTZ1
prerank,triglyceride homeostasis (GO:0070328),0.6326733442023311,1.743170224786175,0.001890359168241966,0.35857204958260014,1.0,5/26,7.52%,RORA;C1QTNF3;IL18;APOC4;LIPC
prerank,positive regulation of protein polymerization (GO:0032273),-0.4819061465879243,-1.7427762836323146,0.0,0.10940887295608619,0.989,28/65,21.14%,OCLN;RAC1;CARMIL1;HSP90AA1;PTK2B;RPS3;CDC42EP3;CLIP1;NCKAP1;NCK1;MET;BAIAP2L1;PAK1;NAV3;NCK2;BIN1;TOGARAM1;CDC42EP5;TPPP;TPPP3;PRKCE;CDC42EP2;EVL;PINK1;NCKAP1L;MAPRE1;NUMA1;DCTN1
prerank,regulation of dendritic spine development (GO:0060998),-0.6429712388930526,-1.7384854879726679,0.008130081300813009,0.11364908788322631,0.991,11/19,25.51%,MEF2C;SHANK3;PPFIA2;GRIN3A;LLPH;KIF1A;CAMK2B;PSEN1;FMR1;SHANK1;FOXO6
prerank,sterol metabolic process (GO:0016125),0.5426721506459383,1.7371873005338136,0.006872852233676976,0.37243323362402475,1.0,12/60,12.25%,PRKAG2;CYP26B1;CYP27A1;LIPA;INSIG2;ABCA1;FDXR;ABCA5;PMVK;SOAT2;RXRA;GBA2
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.7164667439565533,-1.7365794004839448,0.0019455252918287938,0.11402070204436134,0.991,6/12,10.62%,ACTB;ACTG1;LAMA5;LAMA3;ZDHHC7;VANGL2
prerank,thyroid hormone generation (GO:0006590),0.7826185257900717,1.735618267942281,0.014861995753715499,0.368175964726812,1.0,3/10,2.60%,CPQ;SLC5A5;DUOX2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.7046600689715312,-1.7331006116778738,0.0038022813688212928,0.11677026313602623,0.992,7/13,20.26%,NOS3;HSP90AA1;CALM1;GCH1;MTHFD1L;QDPR;AKT1
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.6568870499842915,-1.7328905430645396,0.0,0.11523802750569993,0.992,8/18,9.39%,SPTBN1;ACTB;STX7;VTI1B;VAMP8;ZDHHC2;ZDHHC7;APPL1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.6476692743254584,1.7293425964107063,0.015779092702169626,0.38140322897230056,1.0,2/22,0.39%,IGF1;ROCK2
prerank,neutrophil degranulation (GO:0043312),-0.3680865077795092,-1.7292931545060495,0.0,0.11907138630730446,0.994,147/425,24.59%,PTPRB;PECAM1;PTPRJ;FTH1;EEF1A1;B2M;RAP1A;ATP8A1;HSPA8;ADGRE5;ADAM10;RAC1;HSP90AA1;IQGAP1;CST3;GSN;HSP90AB1;FTL;PRG2;MAGT1;OSTF1;EEF2;RAB31;PSAP;PPIA;CTSD;PKM;PTPRN2;CD55;RAB27A;PLEKHO2;ATG7;CKAP4;NRAS;AP2A2;CD93;VAT1;ATP6V0A1;PGLYRP1;DOCK2;ACTR10;CD44;CTSB;PTPRC;VAMP8;STOM;CEACAM1;NDUFC2;TNFRSF1B;PPIE;GOLGA7;LAMP1;TMC6;ERP44;CD63;ATP11B;CPNE3;GRN;HEXB;PDAP1;PSMD13;RHOA;HMOX2;MAN2B1;APEH;TMEM30A;SCAMP1;ATP6V0C;ARL8A;TUBB4B;LAMTOR1;TMBIM1;HRNR;IMPDH1;TOLLIP;CAP1;DBNL;FUCA2;STK10;ATP11A;TCIRG1;LRG1;DGAT1;PSMC3;ACTR2;SNAP25;PSMD12;SVIP;JUP;IMPDH2;ALDOA;GDI2;LPCAT1;CD47;CSNK2B;CTSZ;LAMTOR2;CYBB;CDA;CYB5R3;GM2A;RHOG;RNASE3;QPCT;MIF;ALDOC;PRCP;RAB37;DSP;TIMP2;BRI3;S100A11;PADI2;BST2;PLAUR;PSEN1;ACLY;IRAG2;TYROBP;DDOST;PRKCD;NCKAP1L;CD300A;CTSC;SLC11A1;ADGRG3;ENPP4;VAPA;VCP;HPSE;CPPED1;PYGL;C3;MANBA;SLC2A3;GCA;GHDC;HSPA1B;NPC2;RAB7A;RAB3A;ARSB;CD68;FABP5;SRP14;LCN2;HUWE1
prerank,maintenance of blood-brain barrier (GO:0035633),-0.576299926183359,-1.7286811301343508,0.0,0.1182240645910173,0.994,17/30,8.15%,SLC12A2;PECAM1;ACTB;CLDN5;ESAM;ACTG1;OCLN;TJP2;JAM2;LSR;ITGB1;MBP;F11R;SLC1A1;WNK3;TJP1;MFSD2A
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7099809264329059,1.72591823462879,0.01037344398340249,0.38539430918105866,1.0,3/16,1.90%,RORA;PRKN;PDK1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.4857063798550356,-1.7254895396026066,0.0,0.12107717820225088,0.995,24/57,23.06%,RPL11;RPS24;RPS15;RPL38;RPS7;RPS19;RPL26;RPS6;RPS25;RPL14;RPL5;RPL35A;RPS28;RPL7;RPS17;DHX37;RBIS;RPS16;HEATR3;EBNA1BP2;NOC2L;WDR74;NOP16;NIP7
prerank,neutrophil activation involved in immune response (GO:0002283),-0.3667528032954323,-1.7220899403873065,0.0,0.12404031768827972,0.997,147/428,24.59%,PTPRB;PECAM1;PTPRJ;FTH1;EEF1A1;B2M;RAP1A;ATP8A1;HSPA8;ADGRE5;ADAM10;RAC1;HSP90AA1;IQGAP1;CST3;GSN;HSP90AB1;FTL;PRG2;MAGT1;OSTF1;EEF2;RAB31;PSAP;PPIA;CTSD;PKM;PTPRN2;CD55;RAB27A;PLEKHO2;ATG7;CKAP4;NRAS;AP2A2;CD93;VAT1;ATP6V0A1;PGLYRP1;DOCK2;ACTR10;CD44;CTSB;PTPRC;VAMP8;STOM;CEACAM1;NDUFC2;TNFRSF1B;PPIE;GOLGA7;LAMP1;TMC6;ERP44;CD63;ATP11B;CPNE3;GRN;HEXB;PDAP1;PSMD13;RHOA;HMOX2;MAN2B1;APEH;TMEM30A;SCAMP1;ATP6V0C;ARL8A;TUBB4B;LAMTOR1;TMBIM1;HRNR;IMPDH1;TOLLIP;CAP1;DBNL;FUCA2;STK10;ATP11A;TCIRG1;LRG1;DGAT1;PSMC3;ACTR2;SNAP25;PSMD12;SVIP;JUP;IMPDH2;ALDOA;GDI2;LPCAT1;CD47;CSNK2B;CTSZ;LAMTOR2;CYBB;CDA;CYB5R3;GM2A;RHOG;RNASE3;QPCT;MIF;ALDOC;PRCP;RAB37;DSP;TIMP2;BRI3;S100A11;PADI2;BST2;PLAUR;PSEN1;ACLY;IRAG2;TYROBP;DDOST;PRKCD;NCKAP1L;CD300A;CTSC;SLC11A1;ADGRG3;ENPP4;VAPA;VCP;HPSE;CPPED1;PYGL;C3;MANBA;SLC2A3;GCA;GHDC;HSPA1B;NPC2;RAB7A;RAB3A;ARSB;CD68;FABP5;SRP14;LCN2;HUWE1
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5852723748085846,-1.7220639467768721,0.004338394793926247,0.12235621949763789,0.997,6/24,5.90%,PECAM1;MSN;ITGB1;F11R;SEMA4D;ITGA4
prerank,bone development (GO:0060348),0.5906855518795875,1.720183786747914,0.005504587155963303,0.39764421005286954,1.0,10/39,5.41%,CYP26B1;RANBP3L;FGFR2;GNAS;LTF;SH3PXD2B;AKAP13;GJA1;SULF1;LRRC17
prerank,regulation of plasminogen activation (GO:0010755),-0.7270156678841706,-1.7200410998018372,0.003992015968063872,0.12355879884682691,0.998,5/12,6.76%,THBS1;RUNX1;SERPINE2;PLGRKT;CLEC3B
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5427979483521816,-1.7187038829397936,0.0044943820224719105,0.1238559899580089,0.998,12/34,14.52%,LIMS2;RAC1;CARMIL1;DOCK1;LIMS1;FLNA;CALR;FERMT2;MYOC;CRK;S100A10;NEDD9
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7718204647290635,1.7175817750769038,0.011013215859030838,0.39816490847417413,1.0,4/10,3.79%,ATP1A2;OSR1;NEDD4;PCSK9
prerank,substantia nigra development (GO:0021762),-0.5289295767181156,-1.7141165325982233,0.007159904534606206,0.12868999074174697,0.998,19/37,25.98%,ACTB;GNB4;CALM1;PLP1;MBP;NDRG2;RHOA;S100A1;HSPA5;INA;CKB;CALM2;YWHAQ;YWHAH;PADI2;CALM3;SEC16A;CNP;SYNGR3
prerank,regulation of urine volume (GO:0035809),0.7540519234628765,1.7083665985322336,0.010706638115631691,0.4238263389374006,1.0,4/10,11.08%,NPR3;ADM;NPR1;TFAP2B
prerank,bicarbonate transport (GO:0015701),-0.5876074185170048,-1.7076269343190602,0.0020876826722338203,0.13637464893972612,1.0,10/25,15.43%,SLC4A10;SLC26A7;CA4;SLC39A8;SLC4A8;CA2;SLC4A2;SLC26A6;CYB5R1;CFTR
prerank,positive regulation of tissue remodeling (GO:0034105),0.770340143150527,1.7067913802730972,0.008492569002123142,0.4201887264897433,1.0,2/10,1.22%,ROCK2;IL18
prerank,glycerolipid catabolic process (GO:0046503),-0.6354885047539076,-1.7067460998870942,0.004132231404958678,0.13613863609903032,1.0,9/19,15.14%,GPCPD1;ABHD2;MGLL;SMPD4;GDPD1;GDPD3;LYPLA2;PNPLA6;PLA2G4A
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.6959961981848765,1.7065225888839053,0.012096774193548387,0.411951497036329,1.0,4/16,1.00%,IGF1;TGFBR3;RBPJ;FGFR2
prerank,neutrophil mediated immunity (GO:0002446),-0.36125570442868205,-1.7027734069449108,0.0,0.14068282776147586,1.0,148/432,24.59%,PTPRB;PECAM1;PTPRJ;FTH1;EEF1A1;B2M;RAP1A;ATP8A1;HSPA8;ADGRE5;ADAM10;RAC1;HSP90AA1;IQGAP1;CST3;GSN;HSP90AB1;FTL;PRG2;MAGT1;OSTF1;EEF2;RAB31;PSAP;PPIA;CTSD;PKM;PTPRN2;CD55;RAB27A;PLEKHO2;ATG7;CKAP4;NRAS;AP2A2;CD93;VAT1;ATP6V0A1;PGLYRP1;DOCK2;ACTR10;CD44;CTSB;PTPRC;VAMP8;STOM;CEACAM1;NDUFC2;TNFRSF1B;PPIE;GOLGA7;LAMP1;TMC6;ERP44;CD63;ATP11B;CPNE3;GRN;HEXB;PDAP1;PSMD13;RHOA;HMOX2;MAN2B1;APEH;TMEM30A;SCAMP1;ATP6V0C;ARL8A;TUBB4B;LAMTOR1;KMT2E;TMBIM1;HRNR;IMPDH1;TOLLIP;CAP1;DBNL;FUCA2;STK10;ATP11A;TCIRG1;LRG1;DGAT1;PSMC3;ACTR2;SNAP25;PSMD12;SVIP;JUP;IMPDH2;ALDOA;GDI2;LPCAT1;CD47;CSNK2B;CTSZ;LAMTOR2;CYBB;CDA;CYB5R3;GM2A;RHOG;RNASE3;QPCT;MIF;ALDOC;PRCP;RAB37;DSP;TIMP2;BRI3;S100A11;PADI2;BST2;PLAUR;PSEN1;ACLY;IRAG2;TYROBP;DDOST;PRKCD;NCKAP1L;CD300A;CTSC;SLC11A1;ADGRG3;ENPP4;VAPA;VCP;HPSE;CPPED1;PYGL;C3;MANBA;SLC2A3;GCA;GHDC;HSPA1B;NPC2;RAB7A;RAB3A;ARSB;CD68;FABP5;SRP14;LCN2;HUWE1
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.6310458050002278,-1.700806072390117,0.005940594059405941,0.14195903965822904,1.0,13/17,31.08%,RAB27A;KCNB1;STX1A;CACNA1G;SLC4A8;CACNA1H;SYT10;SYT4;CACNA1I;RAB3A;DOC2B;UNC13D;RAB15
prerank,negative regulation of signaling receptor activity (GO:2000272),0.625366492893172,1.698862399530655,0.013333333333333334,0.4333694678460622,1.0,5/25,3.94%,ERRFI1;PPARA;SLC6A9;SNX6;CRHBP
prerank,cellular protein metabolic process (GO:0044267),-0.36290165198830554,-1.698128567017744,0.0,0.1440091219205851,1.0,136/396,15.97%,FN1;ST3GAL6;EEF1A1;ST8SIA4;IGFBP6;STK38;RPL37A;RPL41;ADAM10;RPL11;RPL13;RPL27A;RPS21;RPLP1;GAS6;CST3;RPL17;RPL23;RPS24;SPARCL1;RPL19;RPL21;RPS9;CDH2;RPL6;RPS15;RPL38;RPL37;RPL4;DAB2IP;RPSA;RPS7;RPS8;SFTPA2;SFTPA1;RPS3;RPL8;RPS23;RPS19;RPS11;RPL34;RPL28;RPL18A;RPL26;MSLN;DENND3;RPL24;RPS29;RPS14;LGMN;RPL18;CKAP4;RPS6;RPL23A;RPS12;RPS20;WARS1;SPP1;IGFBP5;LAMB2;MRRF;PDIA6;RPS25;RPS18;HSP90B1;RPL3;CHRM3;SARS1;FBXW2;NEDD8;ADPRH;RPL32;LGALS1;RPL36;RPS27A;FAM20C;RPL14;PCMT1;RPL5;RPS2;APP;RPL27;MRPL32;RPL31;PRSS23;RPS27;CHEK2;RPL29;MSRB3;ZDHHC2;NUCB1;RPLP2;MAN2B1;RPLP0;RPL35A;EIF4G1;FURIN;MRPS14;RPL7A;RPS28;RPL7;RPN1;PLOD2;LTBP1;RPS17;SCG2;MEN1;RPS10;CHGB;STOML2;RPL30;FUCA2;CALU;RPS4X;MMP15;GSPT2;CDKL3;RRBP1;VCAN;ERO1A;IDE;MRPS16;CCN1;RSL24D1;RPS26;RPS16;MRPS5;RPS5;MRPL23;UBE2G1;UBA52;RPL13A;VGF;WFS1;FBXL2;ST8SIA2
prerank,macrophage activation involved in immune response (GO:0002281),-0.6787858030949324,-1.6976974319994789,0.0078125,0.1427676761656667,1.0,8/13,19.89%,PLCG2;LBP;SBNO2;GRN;DYSF;IFI35;CX3CR1;TYROBP
prerank,regulation of catabolic process (GO:0009894),-0.6276314073659416,-1.6969382012464833,0.010460251046025104,0.14198450601807355,1.0,9/18,10.91%,FAP;ITGB1;NEDD4L;FAF1;CHEK2;ZDHHC2;ZDHHC7;FURIN;HGS
prerank,positive regulation of cell junction assembly (GO:1901890),-0.4780882602050527,-1.6962567319315571,0.005012531328320802,0.14119318547071008,1.0,19/56,12.24%,TEK;CAV1;PTPRJ;CLDN5;KDR;RAC1;LIMS1;FERMT2;CLSTN2;MYOC;VEGFA;IL1RAP;NRXN1;SYNDIG1;COL16A1;EPHB1;ACE2;CLSTN3;S100A10
prerank,positive regulation of stem cell differentiation (GO:2000738),0.6998662958426366,1.6957130681921375,0.0136986301369863,0.43673309793582327,1.0,4/16,5.91%,SOX5;HOXB4;SOX6;PTN
prerank,neuromuscular junction development (GO:0007528),0.626389917583434,1.6955376247357503,0.02411873840445269,0.4281408787853893,1.0,9/24,8.66%,UNC13C;PDZRN3;LRP4;NEDD4;PPFIBP2;CACNB4;LRRK2;DNAJA3;MUSK
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.527100752773691,-1.6953205580993918,0.004608294930875576,0.14081132758240542,1.0,16/38,18.10%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;NDUFA13;NDUFS1;NDUFB11;NDUFB10;NDUFA1;NDUFB4;NDUFS7
prerank,mesenchyme morphogenesis (GO:0072132),-0.6377379934306263,-1.6945667593825997,0.007920792079207921,0.14026564041767572,1.0,8/17,11.74%,NOS3;ACVRL1;TGFB2;ENG;NOTCH1;TBX2;BMP2;HEYL
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.5379888910771404,-1.694301037281501,0.011061946902654867,0.1390229556208032,1.0,16/32,12.33%,RHOJ;KDR;THBS1;KLF4;MEOX2;NOTCH1;GATA2;HDAC5;JCAD;CARD10;PDCD10;VEGFA;PTGS2;RHOA;PIK3C2A;MAP3K3
prerank,acylglycerol homeostasis (GO:0055090),0.6520857199559214,1.693342215034589,0.018108651911468814,0.4279831830429072,1.0,4/20,7.52%,RORA;IL18;APOC4;LIPC
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.5014070681269244,-1.6913860447032412,0.0,0.14151197178874944,1.0,13/44,11.43%,MEF2C;MICAL2;ENG;NOTCH1;HES1;SOX17;TGFBR2;TBX2;TBX3;RYR2;VANGL2;SOX18;NDRG4
prerank,positive regulation of nuclear division (GO:0051785),0.6222809978499244,1.6899409599776447,0.020599250936329586,0.43233301341067887,1.0,7/25,11.42%,IGF1;DMRT1;PDGFRB;IGF2;PHIP;NPM2;TGFA
prerank,regulation of lipid biosynthetic process (GO:0046890),0.6025433611329616,1.6893201101701403,0.008849557522123894,0.42609767872274557,1.0,6/32,5.20%,PRKAG2;PPARA;SORBS1;ZBTB20;AVIL;PRKAA2
prerank,zinc ion homeostasis (GO:0055069),-0.5605497968708328,-1.6884700123941492,0.006564551422319475,0.14440611534794293,1.0,17/28,16.19%,SLC39A10;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;SLC30A5;MT2A;SLC39A8;SLC30A1;SLC39A7;SLC39A14;MT3;ATP13A2
prerank,negative regulation of metabolic process (GO:0009892),0.5348917772659882,1.687875661716218,0.005405405405405406,0.4239108877602017,1.0,9/54,6.34%,ALDH1A1;NPR3;LGR4;RBPJ;ADAMTS5;NOVA1;MAP2K6;TLE3;NRDC
prerank,glycolipid metabolic process (GO:0006664),-0.49834250835957944,-1.6877245570944794,0.009828009828009828,0.14393326132708398,1.0,12/47,10.98%,ST3GAL4;ST6GALNAC3;ST3GAL6;ESYT2;PSAP;SUMF1;SMPD4;HEXB;HEXA;ST8SIA6;CERK;GLTP
prerank,arachidonic acid secretion (GO:0050482),0.7604859659857867,1.687642591502613,0.012195121951219513,0.409077385808301,1.0,3/10,5.24%,BDKRB2;ANXA1;ACE
prerank,arachidonate transport (GO:1903963),0.7604859659857867,1.687642591502613,0.012195121951219513,0.409077385808301,1.0,3/10,5.24%,BDKRB2;ANXA1;ACE
prerank,body fluid secretion (GO:0007589),0.6938156267571061,1.686435942337925,0.01910828025477707,0.40609172923837106,1.0,2/15,0.70%,SLC22A4;SLC22A2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.6001573639405675,1.6860283428335496,0.01651376146788991,0.4002226082595704,1.0,7/31,4.40%,OSR1;FGFR2;HOXC4;HOXB4;HOXB3;HOXA3;PDGFRA
prerank,negative regulation of axon extension (GO:0030517),-0.5469356072522608,-1.6858977832248838,0.002066115702479339,0.14511565218873076,1.0,13/30,13.96%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;RTN4;SEMA6C;SEMA3G;CDKL3;MT3
prerank,ethanol metabolic process (GO:0006067),0.7386035022820989,1.6852376692573248,0.025974025974025976,0.3960282399470138,1.0,1/12,0.14%,ALDH1A1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.7524759954809177,1.6847259892838302,0.02109704641350211,0.39126451867659534,1.0,3/11,5.40%,IGF1;PLCB1;IGF1R
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.6466939830676802,1.681576448093945,0.009784735812133072,0.39539006543729976,1.0,2/20,6.22%,IGF1;NIBAN2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6909622880523862,1.6809521609311493,0.011764705882352941,0.39106584421455703,1.0,6/17,7.40%,BMP6;SASH1;LTF;TRIM5;CACTIN;PRKCA
prerank,regulation of cell junction assembly (GO:1901888),-0.5586038177502319,-1.6793003314326003,0.022964509394572025,0.15404346406344419,1.0,8/27,3.00%,MEF2C;PRKCH;CLDN5;RAP1A;OCLN;RUNX1;CBFB;F11R
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.6732006413902698,-1.6788572037684262,0.007920792079207921,0.15305054888336386,1.0,7/13,15.78%,KCNB1;STX1A;CACNA1G;CACNA1H;SYT10;SYT4;CACNA1I
prerank,regulation of Rac protein signal transduction (GO:0035020),0.6943230826672859,1.6780904473724116,0.017278617710583154,0.3951184164763282,1.0,3/16,3.32%,ARHGAP24;AUTS2;ALS2
prerank,membrane lipid biosynthetic process (GO:0046467),-0.4675090199529839,-1.6756892137370216,0.002386634844868735,0.15694934872686453,1.0,18/58,9.43%,ST3GAL4;CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ELOVL5;ACER2;SPTLC2;PLPP1;DEGS2;KDSR;PRKD3;PPM1L;SPNS2;SGPL1;ELOVL6;ST8SIA6
prerank,ketone body metabolic process (GO:1902224),0.757537894204624,1.6728115552880642,0.02702702702702703,0.4080717372796706,1.0,7/10,16.54%,ACSS3;HMGCL;BDH1;BDH2;HMGCLL1;HMGCS2;OXCT1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.5985096939466044,-1.672133214579697,0.01593625498007968,0.16147315132375756,1.0,11/20,25.51%,SHANK3;LRP8;LLPH;RELN;DBNL;CAMK2B;PSEN1;DBN1;FMR1;SHANK1;FOXO6
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.6776662444294534,1.6708093282831487,0.028513238289205704,0.40883922611091716,1.0,2/16,0.39%,IGF1;ROCK2
prerank,secretion (GO:0046903),0.7163145596136429,1.6698172184432705,0.008097165991902834,0.40620681720577156,1.0,3/14,1.75%,SLC22A4;SLC22A2;FBLN5
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.6789300565866853,-1.668282098564162,0.016260162601626018,0.16475421291362566,1.0,7/12,15.08%,EFNA5;ACTN4;KANK1;CORO1C;AP1AR;SPRY4;RCC2
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.6789300565866853,-1.668282098564162,0.016260162601626018,0.16475421291362566,1.0,7/12,15.08%,EFNA5;ACTN4;KANK1;CORO1C;AP1AR;SPRY4;RCC2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.510391100521423,1.6682767577155968,0.01011804384485666,0.4051511949570916,1.0,18/61,16.40%,EYA4;EYA1;EYA2;FGFR4;SMOC2;PDGFRB;USP7;STPG4;CEBPG;RTEL1;NPAS2;PRKD2;MRE11;BABAM2;WRN;RAD51;PML;HGF
prerank,sphingolipid metabolic process (GO:0006665),-0.4228098389386616,-1.6674657480920598,0.0,0.16424847111213467,1.0,25/108,9.70%,ST6GALNAC3;CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ESYT2;ELOVL5;ACER2;SPTLC2;PLPP1;SERINC1;DEGS2;PSAP;KDSR;PRKD3;SUMF1;PPM1L;SMPD4;SPNS2;SGPL1;HEXB;HEXA;ELOVL6;CERK
prerank,aspartate family amino acid catabolic process (GO:0009068),0.6522608859923287,1.6656546585514813,0.01761252446183953,0.4085060190433956,1.0,7/19,14.79%,DDO;AASS;ALDH7A1;GCDH;PIPOX;AADAT;ASPA
prerank,negative regulation of protein polymerization (GO:0032272),-0.5645023600554041,-1.6653800104230043,0.004366812227074236,0.16616061405375848,1.0,13/27,20.87%,SLIT2;KANK3;KANK1;HIP1R;STMN2;CYRIB;SSH2;SSH1;KANK4;STMN1;TUBB4A;PRKCD;MAPRE1
prerank,cardiac muscle tissue development (GO:0048738),0.5292883237086254,1.6645084412915514,0.010362694300518135,0.4065876572226058,1.0,12/50,7.19%,ADAMTS9;GJB6;NOTCH2;BMP7;RBP4;CSRP3;CBY1;AKAP13;SIK1;GJA1;MAML1;NDUFV2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6731355421094954,1.6629343528314728,0.016494845360824743,0.40586426125574415,1.0,3/16,3.89%,IGF1;IGFBP2;IGFBP4
prerank,diterpenoid metabolic process (GO:0016101),0.5308023434737098,1.6624215865346106,0.0050335570469798654,0.40175656380611124,1.0,9/55,6.18%,ALDH1A1;RBP4;ABCA4;SDC2;GPC6;RBP1;GPC3;LRP2;NAPEPLD
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.6702232946847898,-1.6616332938322382,0.010141987829614604,0.17071306108302042,1.0,4/12,3.07%,CAV1;PDE4D;CALM1;GJD3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.4703959643654272,-1.6602603901613284,0.004761904761904762,0.17150551549646106,1.0,27/54,24.46%,CAV1;RPL11;RPS3;DNAJA1;IVNS1ABP;UBXN1;PINX1;SOX4;CTNNB1;ARRB1;RPL5;CHP1;OGT;ISG15;CAMLG;COPS9;NXN;PRMT3;SPOPL;N4BP1;PRKCG;ARRB2;AKT1;SIRT7;TNFAIP3;HSPA1B;SPRY2
prerank,positive regulation of glucose import (GO:0046326),0.6272321948153223,1.6589425142864775,0.028513238289205704,0.4081704736806634,1.0,3/21,2.08%,IGF1;OSBPL8;SORBS1
prerank,positive regulation of T cell proliferation (GO:0042102),0.5324487495597309,1.65787695787361,0.008333333333333333,0.40598452992976886,1.0,8/55,7.56%,IGF1;IGFBP2;IL18;IGF2;ANXA1;IL6;PDCD1LG2;CCL19
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.7332476013930661,1.6571266827380242,0.021413276231263382,0.4030590902554117,1.0,6/12,9.43%,DPYD;CTPS1;DPYSL3;CTPS2;DPYS;ALDH6A1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.4326150100814025,-1.6569738014443005,0.0,0.1758352510130383,1.0,33/91,10.01%,ABCG2;FTH1;SLC39A10;TFRC;SCARA5;FTL;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;ATOX1;IREB2;SLC40A1;SLC30A5;SOD1;NEDD8;SLC31A1;MT2A;SLC22A17;ARF1;APP;SLC39A8;ISCU;FBXL5;HMOX2;FRRS1;SLC30A1;SLC39A7;ATP6V1A
prerank,ganglion development (GO:0061548),-0.6914819062543064,-1.656755433745492,0.00927643784786642,0.1745589429297752,1.0,4/11,6.01%,NRP2;UNC5C;TUBB3;CTNNB1
prerank,negative regulation of response to stimulus (GO:0048585),-0.4697582247171249,-1.6556826604167165,0.0024390243902439024,0.1746221740695304,1.0,26/60,20.04%,SLIT2;KLF7;CD34;KLF4;MCTP1;HHIP;VPS13C;UBASH3B;SOCS5;DDAH1;KIF26A;YBX1;AQP11;CDK6;LPCAT3;TLE5;PTPN1;MAP3K3;CASK;CLU;NR1H2;COL3A1;WFS1;ACVR1;SH2B3;THY1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5826042708477078,1.655114205802424,0.016363636363636365,0.40441904737670553,1.0,7/31,5.73%,TGFBR3;RBPJ;FGFR2;TPM1;TNNC1;TNNT2;LRP2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.5674309655789367,-1.653094714992182,0.01276595744680851,0.17736361552627974,1.0,11/24,11.39%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;VEGFA;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6796661762511551,-1.6530663716857934,0.009560229445506692,0.17570117062845697,1.0,6/12,11.43%,PTPRJ;APOD;CBL;F3;HGS;NDRG4
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.6504220240569244,-1.6530493763428593,0.007858546168958742,0.17407039134773555,1.0,5/14,10.16%,GAB1;KDR;FLT4;VEGFA;PIK3CD
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5186134028003039,-1.6522431051308164,0.00936768149882904,0.17379853624033348,1.0,17/35,11.39%,SEMA6A;NRP2;SEMA7A;SEMA6D;RAC1;PLXND1;SEMA3C;SEMA4D;SEMA3E;PLXNA4;FLNA;ARHGDIA;MET;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,endothelial cell differentiation (GO:0045446),-0.6871245843558622,-1.6521367193504581,0.005952380952380952,0.17234132921575882,1.0,6/12,11.16%,TIE1;KDR;ACVRL1;JAG1;BMPR2;SOX18
prerank,cell junction assembly (GO:0034329),-0.4220026861549268,-1.6519197314452705,0.0,0.17110767597150386,1.0,23/100,5.99%,DNM3;FN1;SHANK3;SPOCK2;ADGRL3;ACTB;CLDN5;ACTG1;ITGA6;LIMS2;CDH11;CTNND2;PKP4;CDH1;PLXND1;CDH2;GJC1;KIRREL3;LIMS1;FLNA;NRCAM;FERMT2;VMP1
prerank,dicarboxylic acid transport (GO:0006835),0.5934574903628579,1.6518266695029962,0.013333333333333334,0.4101461435421823,1.0,12/28,10.58%,SLC13A3;SLC1A3;PDPN;SLC25A18;GJA1;SLC13A5;FOLR1;FOLR2;ABCC2;SLC25A22;SLC22A6;SLC19A1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.43983068355648586,-1.6489611290544195,0.0056022408963585435,0.1746325253614383,1.0,32/86,21.14%,OCLN;RAC1;CARMIL1;PTK2B;RPS3;CDC42EP3;CLIP1;NCKAP1;WDR1;NCK1;MET;BAIAP2L1;STMN2;APP;PAK1;NAV3;COLGALT1;EDN1;NCK2;BIN1;CLU;TOGARAM1;CDC42EP5;PRKCE;CDC42EP2;CFL2;EVL;PSEN1;NCKAP1L;MAPRE1;NUMA1;DCTN1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.46441104793519183,1.6473309819979511,0.0044444444444444444,0.4212060018211487,1.0,14/117,6.86%,IGF1;CYP26B1;ALDH1A2;PCCA;PPARA;ALDH4A1;ABAT;ACADSB;MCCC2;ACOT4;SCPEP1;ECHDC3;PTGR1;HOGA1
prerank,modified amino acid transport (GO:0072337),0.6811536943629471,1.6461568036854364,0.022448979591836733,0.4202716436685957,1.0,6/15,10.58%,SLC6A13;SLC16A12;PDPN;FOLR1;FOLR2;SLC19A1
prerank,mesonephros development (GO:0001823),0.7381725528750822,1.6456162002704753,0.016701461377870562,0.41685957868354123,1.0,3/11,5.51%,OSR1;BMP7;FGF1
prerank,cAMP biosynthetic process (GO:0006171),0.7113852384535806,1.645543168352185,0.0407725321888412,0.41180376474404423,1.0,2/10,0.71%,ADCY5;ADCY1
prerank,cardiac muscle contraction (GO:0060048),0.5756092622254791,1.6447218767327079,0.017953321364452424,0.40953109510521574,1.0,7/34,3.07%,ATP1A2;TPM1;DMD;CSRP3;TNNC1;TNNT2;SLC8A1
prerank,endoderm formation (GO:0001706),-0.5111642506524896,-1.6440210399027575,0.007058823529411765,0.18202427967405396,1.0,12/35,13.27%,COL8A1;FN1;COL12A1;COL6A1;SOX17;ITGA5;ITGA4;LAMA3;SOX7;MMP15;COL4A2;ITGA7
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.4496201629104836,-1.6439455407009893,0.0079155672823219,0.18053541272269016,1.0,26/73,20.29%,NTRK3;CAV1;FNIP2;TFRC;BCAR3;HSP90AA1;GAS6;HSP90AB1;NGF;TGFB1;MTCP1;CD44;APP;PDCD10;VEGFA;PAK1;EIF4G1;NOS1;TERF2IP;TNKS1BP1;RAF1;PRKD1;MIF;PINK1;AKT1;ATP2B4
prerank,negative regulation of complement activation (GO:0045916),-0.7122824114050909,-1.6436476616788491,0.020560747663551402,0.17952206254026137,1.0,4/10,15.98%,CD55;SUSD4;A2M;CR2
prerank,smooth muscle cell differentiation (GO:0051145),-0.6779330122377534,-1.6419952779880658,0.013618677042801557,0.18096896744893673,1.0,7/12,23.10%,MEF2C;MRTFB;TMEM204;HEY2;APLNR;BMP4;HEY1
prerank,regulation of centrosome cycle (GO:0046605),-0.5687258307942146,-1.640524756361285,0.018556701030927835,0.18215525931608917,1.0,15/21,35.78%,CHMP5;CHMP2B;CHMP1B;CHMP1A;GEN1;CHMP3;PDCD6IP;CHMP4C;VPS4B;CEP131;AURKA;ATF5;NPM1;PKHD1;XRCC3
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.4143236077541184,1.6400943963606365,0.0013908205841446453,0.42056007699788905,1.0,43/248,10.26%,BICC1;IGFBP2;RNF220;WLS;LRRK1;TCF7L2;PTK7;LGR4;FGFR2;MCC;PRKN;LRP4;ZEB2;DAB2;DKK3;RBMS3;DKK1;TBL1XR1;IGFBP4;PRICKLE1;INVS;LYPD6;TMEM64;TLE3;ZNRF3;GPC3;LRRK2;FRAT1;GLI3;PSME4;PSMA2;GNAQ;PSMA3;FOLR1;SIAH2;AMFR;TLE1;USP34;PSMD8;AXIN2;DVL3;LATS1;SMURF2
prerank,cellular glucan metabolic process (GO:0006073),0.7312932253666594,1.639918029429685,0.0326530612244898,0.41612373738823044,1.0,2/11,1.70%,PRKAG2;PHKB
prerank,membrane organization (GO:0061024),-0.3737019064312822,-1.6366493836873364,0.0,0.18777083423325136,1.0,88/227,24.76%,DNM3;SPTBN1;CERT1;HIP1;SGIP1;ACTB;ACTG1;SH3KBP1;HSPA8;TFRC;FNBP1L;CBL;STON2;REEP3;REEP1;UBB;REPS2;SH3GLB1;FNBP1;PACSIN2;FZD4;CHMP5;CHMP2B;SYNJ1;CORO1C;AP2A2;ARPC3;ATP2C1;CCDC88A;VTI1B;VAMP8;ARRB1;RPS27A;UBC;CHP1;HIP1R;DNM2;LEMD2;AMPH;DYSF;AP2M1;TOR1B;LPCAT3;PIK3C2A;HGS;GLTP;NECAP1;TMEM43;NSFL1C;BIN1;DNM1;EPN2;ADRB2;ACTR2;PICK1;PIP5K1C;AGFG1;CFTR;UBA52;M6PR;TLCD2;DVL2;SYT2;SGCZ;ARPC4;CHMP1B;SUN1;SH3GL2;ARRB2;ARPC1A;AP2B1;ANK3;CHMP1A;CTDNEP1;VAPA;ACTR3;MFN2;CHMP3;GCA;AP2A1;CHRNB1;TIMM50;CHMP7;PDCD6IP;SCARB2;HUWE1;OTOF;SYP
prerank,positive regulation of ossification (GO:0045778),0.552559698373577,1.6363180460401203,0.012987012987012988,0.4236744260118799,1.0,8/39,3.12%,BMP6;ADGRV1;OSR1;WNT4;BMP7;FBN2;SLC8A1;KL
prerank,regulation of Wnt signaling pathway (GO:0030111),0.46089976888996653,1.6362018810800767,0.00966183574879227,0.4190146135286108,1.0,22/108,7.29%,DCDC2;WLS;PTK7;TRABD2B;FGFR2;RNF43;PRKN;WWOX;DKK1;MACF1;GRB10;VGLL4;CBY1;SULF1;GPC3;LRRK2;ITGA3;APCDD1;TCF7L1;GNAQ;SALL1;FOLR1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.7238362849261787,1.6361120273534795,0.028397565922920892,0.40957909022493094,1.0,2/12,4.96%,IGF1;CAMTA1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7238362849261787,1.6361120273534795,0.028397565922920892,0.40957909022493094,1.0,2/12,4.96%,IGF1;CAMTA1
prerank,negative regulation of cell development (GO:0010721),0.6067847920310486,1.6360999122526734,0.020146520146520148,0.40484794651264494,1.0,4/25,2.73%,IGF1;FBN1;APPL2;LTF
prerank,heart looping (GO:0001947),-0.49418195444445534,-1.6360076789454838,0.004807692307692308,0.18733688216396355,1.0,11/40,11.43%,MEF2C;MICAL2;ENG;NOTCH1;SOX17;TGFBR2;TBX2;TBX3;VANGL2;SOX18;NDRG4
prerank,regulation of receptor binding (GO:1900120),-0.7042058419130546,-1.6358553553096158,0.013618677042801557,0.18606040831895568,1.0,4/10,7.36%,B2M;ADAM15;ATP2A2;ATP2A3
prerank,regulation of chondrocyte differentiation (GO:0032330),0.609118264479308,1.6354872429381115,0.015180265654648957,0.4020984854346191,1.0,5/24,5.90%,SOX5;ADAMTS12;EFEMP1;SOX6;ADAMTS7
prerank,regulation of bone mineralization (GO:0030500),0.5080054915722456,1.6343234228729129,0.013377926421404682,0.4012631496283219,1.0,14/55,8.63%,BMP6;ADGRV1;OSR1;WNT4;BMP7;FBN2;BMP2K;SLC8A1;KL;ECM1;PTN;BCOR;DDR2;ATRAID
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.7011002553039501,-1.6323728336030625,0.014732965009208104,0.1907141967410068,1.0,7/10,20.19%,PRKG1;CD9;SERPINE2;CEACAM1;ALOX12;SH2B3;PRKCD
prerank,regulation of sequestering of triglyceride (GO:0010889),0.674946986270138,1.6322121067035842,0.021526418786692758,0.40413859591295787,1.0,3/15,5.02%,OSBPL8;PPARA;APOC4
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.7011804068382228,-1.6303017336328818,0.011673151750972763,0.19310204406860806,1.0,4/11,4.38%,NOS3;HSP90AA1;CALM1;GCH1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.6905004749817898,-1.6291517909346422,0.0162748643761302,0.19379271140911894,1.0,4/11,9.22%,CD200;CD34;THBS1;PTGS2
prerank,cellular response to organonitrogen compound (GO:0071417),-0.41589172846801004,-1.628623364155181,0.0,0.19319764505583187,1.0,31/99,15.43%,MEF2C;SLIT2;ACTB;RAP1A;PDE3A;CDH1;SH3BP4;GABRB3;IGFBP5;CAPN2;CTNNB1;HSP90B1;GABRB1;AHR;PDE2A;KCNQ1;MTOR;SSH1;SESN2;CPEB1;ZFP36L1;XBP1;LAMTOR1;SLC26A6;SPAAR;HCN1;HRH1;JUP;NR1H4;LAMTOR2;CFTR
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5913419311735368,-1.6270822387770405,0.01263157894736842,0.19437992365807663,1.0,10/20,11.39%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.6254726204382404,-1.6263397188955184,0.02178217821782178,0.19400777598262597,1.0,7/15,15.23%,NTRK3;KDR;F3;VEGFA;SCG2;CDH13;CXCL12
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.7253748839919577,1.6263016064889804,0.046218487394957986,0.4197936195517836,1.0,5/10,9.30%,IVD;ACADL;ACAD11;ACADS;GCDH
prerank,embryonic skeletal system development (GO:0048706),0.5581289474112782,1.6240827448192734,0.02333931777378815,0.42230330980286096,1.0,9/35,6.09%,OSR1;HOXC4;RBP4;HOXB4;HOXB3;HOXA3;PDGFRA;SULF1;SLC2A10
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6548626985243121,1.6239306714240975,0.012121212121212121,0.4182610308348103,1.0,5/17,10.56%,IGF1;PDGFRB;CCN4;VTN;FGF9
prerank,myoblast differentiation (GO:0045445),0.6929791097757044,1.623733233658791,0.02636916835699797,0.41438312291175966,1.0,3/14,1.05%,IGF1;TCF7L2;EPAS1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5638944756426427,-1.622442307534605,0.01606425702811245,0.19952566907153815,1.0,11/24,22.51%,MEF2C;CDH2;CDON;CTNNB1;OLFM2;BNIP2;BOC;TCF3;CTNNA1;SPAG9;MAPK11
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.6408420105661385,1.6185877886918443,0.041176470588235294,0.423474615834548,1.0,5/20,8.42%,IGF1;ZBTB20;PRKAA2;PRKAA1;ARNT
prerank,positive regulation of glycolytic process (GO:0045821),0.6408420105661385,1.6185877886918443,0.041176470588235294,0.423474615834548,1.0,5/20,8.42%,IGF1;ZBTB20;PRKAA2;PRKAA1;ARNT
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6536670491160927,-1.6173647486521177,0.019455252918287938,0.20770839310109784,1.0,7/13,16.12%,SEMA7A;TGFB2;PLCG2;TGFB1;CD74;IRAK3;LAPTM5
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.6895369771346633,-1.6165015345902785,0.01972386587771203,0.20776252184894736,1.0,3/10,1.94%,IL33;KDR;NAMPT
prerank,stem cell differentiation (GO:0048863),0.5425890320752692,1.6156297347627604,0.015037593984962405,0.4292380507412744,1.0,11/39,9.37%,OSR1;FGFR2;KIT;HOXB4;JARID2;EPOP;ACE;UFL1;SETD6;MTF2;FBXL17
prerank,chloride transmembrane transport (GO:1902476),-0.4749242318651092,-1.614657113811155,0.00909090909090909,0.2096633625300381,1.0,17/48,16.89%,SLC12A7;SLC12A2;ANO1;ANO4;GABRB3;SLC12A6;SLC1A1;GABRB1;SLC12A8;SLC4A8;ANO3;LRRC8A;SLC12A4;GABRG3;ANO2;CFTR;GLRA3
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6916485771706212,-1.6144121902355761,0.012962962962962963,0.20847055628720237,1.0,5/10,11.43%,PTPRJ;APOD;PTPN12;HGS;NDRG4
prerank,regulation of osteoblast differentiation (GO:0045667),0.4777977489202385,1.6132515459830612,0.00778816199376947,0.43269236840412845,1.0,15/82,7.50%,IGF1;RANBP3L;BMP6;WNT4;FGFR2;BMP7;FBN2;SMAD6;LTF;SMOC1;CCN4;TMEM64;SUFU;IL6;DDR2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5912752831327974,-1.6125844141203594,0.024439918533604887,0.21041439164304632,1.0,10/18,27.92%,JAM2;ITGB1;ITGA4;ADD2;SLC39A8;CX3CR1;PODXL2;SELPLG;SELP;ITGB7
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6664908014647568,-1.6123194370846106,0.0196078431372549,0.20925994380780444,1.0,9/12,18.75%,CAV1;CTNNA3;RYR2;CACNA1C;BIN1;JUP;DSG2;DSP;TRPM4
prerank,positive regulation of dendrite extension (GO:1903861),-0.6072091646241599,-1.611786218538157,0.026871401151631478,0.20866046618306394,1.0,13/17,29.94%,NEDD4L;ITSN2;RNF157;SYT4;CPNE9;SYT2;RASAL1;PLAA;CPNE5;RIMS2;SYT17;SYT1;SMURF1
prerank,regulation of mitotic nuclear division (GO:0007088),0.5219009469511408,1.610613735502291,0.007042253521126761,0.4372520182369466,1.0,12/55,11.42%,IGF1;BMP7;DMRT1;PDGFRB;IGF2;OBSL1;TOM1L2;CCDC8;CUL9;CUL7;PHIP;TGFA
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.6599854261318977,1.6085552467094741,0.025691699604743084,0.4396735456223852,1.0,5/16,3.96%,ATP1A2;DMD;GSTM2;SLC8A1;ANK2
prerank,acylglycerol metabolic process (GO:0006639),-0.5045829254623999,-1.607623119811023,0.006369426751592357,0.21538354707525595,1.0,10/37,12.83%,ABHD2;CAV1;DGKH;MGLL;DGKB;DGKI;LYPLA2;DGKZ;DGKG;DGAT1
prerank,endothelial cell migration (GO:0043542),-0.5007063615088383,-1.606063187670179,0.012106537530266344,0.21678849148629917,1.0,22/37,24.36%,NOS3;ID1;FAP;PLXND1;PXN;CCN3;MYH9;VEGFA;EMP2;NR4A1;RHOA;DPP4;SOX18;SCG2;CDH13;CYP1B1;ADGRA2;PLEKHG5;PRKX;PTP4A3;EGR3;STAT1
prerank,lipid phosphorylation (GO:0046834),-0.6847196282222155,-1.605084973425813,0.020833333333333332,0.21718020502521368,1.0,7/10,24.15%,DGKH;DGKB;DGKI;DGKZ;DGKG;DGKE;DGKQ
prerank,regulation of dendrite extension (GO:1903859),-0.595044028600722,-1.6043427684710645,0.022727272727272728,0.21708607451751977,1.0,13/18,29.94%,NEDD4L;ITSN2;RNF157;SYT4;CPNE9;SYT2;RASAL1;PLAA;CPNE5;RIMS2;SYT17;SYT1;SMURF1
prerank,cellular response to fluid shear stress (GO:0071498),-0.6713304738117682,-1.6034020995890492,0.02095238095238095,0.21751913371172857,1.0,4/12,3.12%,MEF2C;KLF2;KLF4;SREBF2
prerank,limb development (GO:0060173),0.5896944585763441,1.6033344579366546,0.02029520295202952,0.45451501709725045,1.0,7/28,6.81%,LRP4;DKK1;INTU;SMOC1;ZNRF3;GLI3;SALL1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5687706807130342,-1.6031646990251327,0.02,0.2163636570899161,1.0,5/21,2.22%,PRKCH;FOXP1;SLC39A10;RUNX1;CBFB
prerank,cardiac myofibril assembly (GO:0055003),0.6831852201483418,1.6019034243134516,0.026871401151631478,0.4551132780299055,1.0,5/15,4.40%,CSRP3;PDGFRB;NEBL;OBSL1;PDGFRA
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.668622927562608,1.600780783531084,0.0371900826446281,0.4544465279720404,1.0,2/15,5.21%,MOXD1;AANAT
prerank,response to prostaglandin E (GO:0034695),0.7140511664933034,1.6002954004069627,0.046610169491525424,0.45167758893686377,1.0,5/10,18.80%,TGFBR3;CCL19;PTGER4;GNG2;SFRP1
prerank,myotube differentiation (GO:0014902),0.6357457672133615,1.5998794661213998,0.04642166344294004,0.448892649217278,1.0,4/17,2.21%,IGF1;ADAM12;ADAMTS5;ADAMTS15
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.44422557958212183,-1.5998239223304904,0.005025125628140704,0.2214836304482127,1.0,26/64,12.45%,UTRN;LIMCH1;EFNA5;ACTG1;ACER2;THBS1;JAG1;PTK2;ADAM15;SLK;PTK2B;MINK1;SEMA3E;CORO1C;NEXMIF;GSK3B;GPM6B;MYOC;EMP2;AJAP1;PEAK1;RHOA;CDK6;DUSP3;CDH13;CASK
prerank,cell projection assembly (GO:0030031),-0.5552736000145915,-1.5997759615210247,0.02610441767068273,0.22000276052797008,1.0,5/22,4.32%,RHOJ;PARVB;RAC1;GSN;NCKAP1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.5062233611307096,-1.5988387003047477,0.017582417582417582,0.22048242288356812,1.0,11/34,8.44%,GAB1;SEMA6A;KDR;RAMP2;MT1G;DAB2IP;NOTCH1;HSPB1;FLT4;VEGFA;NR4A1
prerank,primary alcohol metabolic process (GO:0034308),0.6007802105186129,1.598263100265217,0.03896103896103896,0.4500618118116887,1.0,3/25,6.18%,IGF1;RBP4;NAPEPLD
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6602931433319573,1.5981255388557456,0.03048780487804878,0.44619812457313496,1.0,2/15,1.37%,IGF1;PRKN
prerank,determination of heart left/right asymmetry (GO:0061371),-0.4778805606690979,-1.5978439550454138,0.0024937655860349127,0.22090773528214294,1.0,11/43,11.43%,MEF2C;MICAL2;ENG;NOTCH1;SOX17;TGFBR2;TBX2;TBX3;VANGL2;SOX18;NDRG4
prerank,positive regulation of protein secretion (GO:0050714),0.4866408049804142,1.5974872089579064,0.011345218800648298,0.44434175897367095,1.0,8/69,2.23%,IGF1;BMP6;WLS;TCF7L2;C1QTNF3;RBP4;FRMD4A;NLGN2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5703738185623479,1.5964086225235472,0.022304832713754646,0.44396182748259677,1.0,3/29,3.68%,IL31RA;FER;STAT5B
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.7143258077274748,1.5962631776663825,0.03991596638655462,0.44038433016043216,1.0,2/10,2.75%,SOX5;SOX6
prerank,regulation of acrosome reaction (GO:0060046),0.7115928300679442,1.5955608348692607,0.05708245243128964,0.4386150773236852,1.0,3/10,3.93%,PLA2G10;PLCB1;SPINK13
prerank,presynapse assembly (GO:0099054),0.657935435261347,1.595092934420779,0.03937007874015748,0.4362532095693973,1.0,6/16,7.48%,LRP4;CEL;NLGN2;IL1RAPL1;PTPRD;PTEN
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.5867409246001971,1.594283818305009,0.020637898686679174,0.4349945194768523,1.0,5/29,2.80%,TGFBR3;FGFR2;TPM1;TNNC1;TNNT2
prerank,monocarboxylic acid catabolic process (GO:0072329),0.6164599493509424,1.5937865116645717,0.034482758620689655,0.4327781958487627,1.0,4/21,6.86%,CYP26B1;CEL;FAH;HOGA1
prerank,skeletal system development (GO:0001501),0.4322044046882904,1.593681724391668,0.0,0.42932935834893915,1.0,25/148,7.92%,IGF1;SOX5;BMP6;NPR3;FBN1;FGFR2;BMP7;RBP4;WWOX;GNAS;COL9A2;SOX6;IGF2;COL1A2;SH3PXD2B;COL13A1;AKAP13;GJA1;SULF1;PRELP;ANKRD11;SUFU;EN1;EXTL1;DYM
prerank,negative regulation of platelet activation (GO:0010544),-0.6088731645066038,-1.5925624977856245,0.017509727626459144,0.23046246384992392,1.0,9/16,20.19%,PRKG1;NOS3;CD9;SERPINE2;CEACAM1;THBD;ALOX12;SH2B3;PRKCD
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4709660252866869,1.5925329936879042,0.009538950715421303,0.42945536499340625,1.0,8/85,1.29%,IGF1;TGFBR3;BMP6;TCF7L2;OSR1;FGFR2;MCC;ANGPT1
prerank,liver development (GO:0001889),0.5522438879795258,1.5899282954323204,0.03518518518518519,0.4344994963334367,1.0,10/32,12.46%,TGFBR3;WNT4;ARID5B;ANXA1;PRKCSH;PCSK9;IL6;CEBPG;COBL;PKD2
prerank,receptor internalization (GO:0031623),-0.4872524439866871,-1.5871589049544625,0.009302325581395349,0.2398913733925483,1.0,16/44,14.46%,DNM3;CAV1;TFRC;CD9;ITGB1;RAMP2;RAB31;ACKR3;ARRB1;CEACAM1;DNM2;RAMP1;AP2M1;DNM1;CD81;CALCRL
prerank,negative regulation of potassium ion transport (GO:0043267),-0.6353310490123459,-1.5871092170217176,0.019267822736030827,0.238272016766413,1.0,5/13,11.81%,CAV1;NEDD4L;PTK2B;NOS1;BIN1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5016654796157225,-1.5864274524624629,0.01263157894736842,0.2382007384010465,1.0,15/37,20.09%,RPL11;RPL23;HSP90AB1;RPS7;UCHL5;UBXN1;PDCL3;BAG6;RPL5;OGT;CAMLG;RYBP;N4BP1;TLK2;NOP53
prerank,proteoglycan metabolic process (GO:0006029),0.5702632360572392,1.5858978949495688,0.03076923076923077,0.44412789807158026,1.0,4/26,5.24%,IGF1;ADAMTS12;GAL3ST3;SULF1
prerank,retina homeostasis (GO:0001895),-0.5491255992363492,-1.5850368512328055,0.030425963488843813,0.23975287032899792,1.0,6/23,6.09%,ACTB;POTEF;B2M;ACTG1;HSPB1;SOD1
prerank,ear morphogenesis (GO:0042471),0.6233861099748605,1.5828471910617468,0.0345489443378119,0.45041173702943127,1.0,3/20,1.00%,OSR1;ZIC1;FGFR2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5740684956032296,1.5823979443462666,0.0444015444015444,0.4480716933427736,1.0,3/26,2.08%,IGF1;OSBPL8;SORBS1
prerank,T cell migration (GO:0072678),-0.6383380695599672,-1.5810162273379658,0.02819548872180451,0.24691617307962854,1.0,4/13,10.16%,SLC12A2;MSN;S1PR1;PIK3CD
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.618780740082363,-1.580759457518819,0.03300970873786408,0.24579893925670523,1.0,4/13,9.30%,IL33;KDR;NAMPT;EDN1
prerank,negative regulation of TOR signaling (GO:0032007),0.5383476121256934,1.5804387666779127,0.026501766784452298,0.4508195168889153,1.0,14/36,11.36%,NPRL3;FNIP1;DEPTOR;SZT2;SESN1;PRKAA2;NPRL2;PDCD6;UBR2;RNF152;PRKAA1;EPM2A;FLCN;AKT1S1
prerank,mesenchymal cell differentiation (GO:0048762),0.5136243145992617,1.5798203808649023,0.01282051282051282,0.44916206415759224,1.0,8/51,2.97%,RANBP3L;TGFBR3;ROCK2;WNT4;RBPJ;FGFR2;BMP7;LOXL3
prerank,negative regulation of cell adhesion (GO:0007162),-0.4216908502054188,-1.5796503329920288,0.005494505494505495,0.2466539155284816,1.0,20/72,6.03%,PODXL;SEMA6A;ACER2;ADAM10;ACVRL1;JAG1;CDH1;PLXND1;PTK2;CORO2B;NOTCH1;SEMA4D;TGFBI;ARHGDIB;FZD4;PLXNA4;TGFB1;ARHGDIA;NEXMIF;PTPRC
prerank,embryonic eye morphogenesis (GO:0048048),0.7085813116015358,1.579485196233726,0.052521008403361345,0.44646182106009347,1.0,4/11,4.95%,EFEMP1;FBN1;FBN2;KDM2B
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.574916208821069,1.5787593250898646,0.034926470588235295,0.4451814665279918,1.0,3/26,4.96%,IGF1;FHL2;CAMTA1
prerank,steroid metabolic process (GO:0008202),0.4804565920531071,1.5770176237592075,0.019769357495881382,0.4470435755538891,1.0,8/72,5.73%,CYP26B1;CYP27A1;LIPA;HSD17B1;NR1I2;FDXR;HSD17B10;LRP2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.6927978044064501,1.576595271985065,0.029723991507430998,0.4447635778142575,1.0,5/13,7.83%,SORBS1;IGF2;PRKCZ;ECHDC3;GKAP1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.43847646041143634,-1.5758550339711979,0.019444444444444445,0.25321080628185,1.0,22/67,10.85%,ELMO1;NRP2;KDR;RAC1;HSP90AA1;PTK2;DOCK1;CLEC14A;FYN;PTK2B;DAB2IP;NCKAP1;PXN;HSPB1;BCAR1;NCK1;FLT4;VEGFA;RHOA;PAK2;NCK2;CRK
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.41798678316982985,1.5753113115903792,0.0075075075075075074,0.44541341083815117,1.0,38/186,11.06%,BICC1;IGFBP2;TCF7L2;TRABD2B;MCC;RNF43;PRKN;WWOX;LRP4;DAB2;DKK3;RBMS3;DKK1;RNF213;IGFBP4;GRB10;VGLL4;PRICKLE1;CBY1;INVS;TMEM64;TLE3;ZNRF3;APCDD1;GLI3;PSME4;PSMA2;PSMA3;SIAH2;AMFR;TLE1;PSMD8;WIF1;AXIN2;DVL3;LATS1;HDAC1;PSMD3
prerank,lipid oxidation (GO:0034440),-0.6492462358773783,-1.5745296539688478,0.037037037037037035,0.2543235550805995,1.0,3/12,12.63%,ADIPOR2;PPARGC1A;ALOX12
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6705273709034174,-1.5742577417402561,0.026515151515151516,0.2532604983542058,1.0,3/11,1.99%,MECOM;CD34;RUNX1
prerank,activation of protein kinase B activity (GO:0032148),0.5594021344931588,1.5741294683438873,0.030592734225621414,0.4454504849894684,1.0,6/29,5.51%,IGF1;OSBPL8;IL18;PDPK1;RICTOR;FGF1
prerank,dopamine metabolic process (GO:0042417),0.6071967308662858,1.573313948317699,0.05952380952380952,0.44464300142956725,1.0,3/18,2.45%,MOXD1;PRKN;SNCAIP
prerank,heart contraction (GO:0060047),0.533369086157795,1.5730259646278975,0.02491103202846975,0.4420754642143766,1.0,8/41,5.24%,ATP1A2;TPM1;DMD;CSRP3;TNNC1;TNNT2;SLC8A1;ACE
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.6208020438666557,-1.5724312521501136,0.040983606557377046,0.255650981646992,1.0,4/14,14.24%,ENTPD1;ENTPD7;ENTPD2;NUDT1
prerank,thymus development (GO:0048538),-0.62806308073883,-1.5700342371879308,0.0273972602739726,0.2596428919170797,1.0,4/13,6.87%,TBX1;HES1;SOD1;SIX1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.4069124978684113,-1.5694943416444653,0.008086253369272238,0.2591139475148422,1.0,32/93,16.76%,NTRK3;CAV1;FNIP2;PDE4D;RASSF2;TFRC;BCAR3;HSP90AA1;GAS6;HSP90AB1;NGF;RACK1;TGFB1;NCK1;MTCP1;CD44;APP;PDCD10;VEGFA;PAK1;CNKSR3;DDIT4;EIF4G1;NCK2;NOS1;SPTBN4;NLRP2B;TERF2IP;TNKS1BP1;RAF1;PRKD1;MIF
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5618532531159113,1.5693452198281772,0.04182509505703422,0.45039190115226274,1.0,8/32,8.88%,IGF1;PPARA;PID1;ZBTB20;PRKAA2;PRKAA1;ARNT;NUPR1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6112850437058718,1.5692999881646401,0.03665987780040733,0.4470362601043319,1.0,5/23,8.42%,IGF1;ZBTB20;PRKAA2;PRKAA1;ARNT
prerank,regulation of striated muscle contraction (GO:0006942),0.5723938048854288,1.5684553260211869,0.041666666666666664,0.44622077221228235,1.0,4/27,3.96%,ATP1A2;SLC8A3;DMD;ANK2
prerank,neurotransmitter secretion (GO:0007269),-0.472875507803885,-1.5676681588403976,0.018018018018018018,0.2614997244158397,1.0,24/44,32.67%,HSPA8;LIN7A;PTPRN2;STX1A;NRXN1;SYT10;PCLO;GAD1;CPLX2;SNAP25;SYN2;PIP5K1C;CDK5;PPFIA3;RAB3A;OTOF;CPLX1;SNAPIN;RIMS2;SNPH;SYT1;SLC32A1;GRM4;SYN1
prerank,regulation of intracellular pH (GO:0051453),-0.5029403383959089,-1.5662737659084414,0.029473684210526315,0.2628231742350679,1.0,12/34,18.98%,SLC4A10;SLC9A2;SLC9A8;CHP1;SLC4A8;CA2;SLC4A2;SLC26A6;SLC9B1;CFTR;ATP5F1B;TMEM165
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.6787437269368486,-1.565624256378774,0.03260869565217391,0.2626518757244378,1.0,6/10,18.74%,KLF4;PTPRC;TLE5;IRAK3;SIGIRR;SH2B3
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.613398875774501,1.5654417162348533,0.04466019417475728,0.45261949654494,1.0,3/20,4.99%,WNT4;C1QTNF3;SIK1
prerank,glycoprotein catabolic process (GO:0006516),0.6235775875739423,1.5639931845660813,0.03837953091684435,0.45353469206516317,1.0,6/17,13.42%,ADAMTS12;ADAMTS9;FBXO44;FBXO6;EDEM1;NGLY1
prerank,atrioventricular valve development (GO:0003171),-0.6083656498220283,-1.5631571375363635,0.025096525096525095,0.2668747780526906,1.0,12/14,31.94%,TGFB2;NOTCH1;BMPR2;TGFBR2;BMP2;HEYL;APLNR;ACVR1;GJA5;SLIT3;ZFPM1;TBX20
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5974255649246958,-1.5631281745475962,0.032719836400818,0.2652766442234974,1.0,4/15,9.23%,ENTPD1;CMPK1;ENTPD7;ENTPD2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.5278699512584997,1.5619444906129867,0.0341726618705036,0.45672361486690904,1.0,10/43,8.63%,IGF1;BMP6;WNT4;BMP7;FBN2;LTF;CCN4;IL6;DDR2;ATRAID
prerank,male meiosis I (GO:0007141),0.6359894725139495,1.5617449441091182,0.04970178926441352,0.45411334956009747,1.0,3/16,6.30%,MYBL1;SLC25A31;HSF2BP
prerank,peptidyl-tyrosine modification (GO:0018212),0.4947922151024638,1.5615619259756608,0.03247863247863248,0.4513309144256805,1.0,11/56,4.40%,EFEMP1;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;TPST1;FER;EPHA4;ABI2;PDGFRA
prerank,receptor metabolic process (GO:0043112),-0.4558648402767081,-1.561241014021961,0.007263922518159807,0.26781377023776887,1.0,20/53,14.46%,DNM3;CAV1;TFRC;CD9;ITGB1;RAMP2;RAB31;ACKR3;SH3GLB1;LGMN;TGFB1;DNM2;RAMP1;AP2M1;DNM1;LMTK2;EHD3;MVB12A;CD81;CALCRL
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.498082420910228,-1.5594957777173297,0.006550218340611353,0.26994712819592837,1.0,16/30,28.21%,TPT1;ACKR3;RPS3;CD44;BCL2L1;DDX39B;CD74;CLU;CXCL12;MIF;CDKN2D;PTTG1IP;SNAI2;PSMD10;YJU2;TMEM161A
prerank,regulation of focal adhesion assembly (GO:0051893),-0.44595469445738517,-1.5593643924878697,0.013054830287206266,0.26864060693980035,1.0,24/54,12.24%,TEK;LIMCH1;EFNA5;PTPRJ;APOD;ACTG1;KDR;THBS1;RAC1;ACVRL1;PTK2;SLK;LIMS1;CORO1C;FAM107A;FERMT2;GPM6B;MYOC;VEGFA;PEAK1;RHOA;COL16A1;DUSP3;S100A10
prerank,monocyte differentiation (GO:0030224),0.6820123193838822,1.557824228375299,0.049886621315192746,0.4603963480436511,1.0,1/10,0.01%,IL31RA
prerank,neural crest cell migration (GO:0001755),-0.49150869553932486,-1.5561906106165289,0.018648018648018648,0.2740199729604304,1.0,13/36,11.39%,FN1;SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;TBX1;SEMA3E;CORO1C;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5645572197939296,-1.5555710493037667,0.035196687370600416,0.2737542235901527,1.0,8/19,7.89%,PRKCH;CLDN5;OCLN;RUNX1;CBFB;F11R;IKBKB;TJP1
prerank,leukocyte tethering or rolling (GO:0050901),-0.577836400272792,-1.555368293230243,0.038539553752535496,0.27256280588536924,1.0,9/17,27.92%,JAM2;ITGB1;ITGA4;ADD2;CX3CR1;PODXL2;SELPLG;SELP;ITGB7
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.5832536227550135,-1.5551741126749814,0.03292181069958848,0.27146594431153004,1.0,6/18,11.15%,PLCG2;LBP;DOCK2;SBNO2;DYSF;IFI35
prerank,cellular response to sterol (GO:0036315),0.6753387059709683,1.5541616580249105,0.03695652173913044,0.4687031161804801,1.0,3/13,3.75%,RORA;INSIG2;GRAMD1C
prerank,receptor signaling pathway via STAT (GO:0097696),0.5763194230171258,1.5520345925766514,0.04664179104477612,0.4721070642000224,1.0,2/25,3.68%,IL31RA;STAT5B
prerank,regulation of glycolytic process (GO:0006110),0.47720518160747155,1.551310733828217,0.022146507666098807,0.47103174276296883,1.0,10/68,10.15%,IGF1;PRKAG2;PPARA;ZBTB20;PRKAA2;NDC1;PRKAA1;ARNT;NUPR1;NUP107
prerank,positive regulation of embryonic development (GO:0040019),0.6129312072376147,1.5509499506968936,0.04339250493096647,0.46877969481552983,1.0,5/19,6.22%,OSR1;WNT4;SCX;PLCB1;NIBAN2
prerank,integrin-mediated signaling pathway (GO:0007229),-0.4137191276520728,-1.5499372023860911,0.007957559681697613,0.28166191899898374,1.0,26/73,16.17%,FN1;SEMA7A;ADAM10;PTK2;ITGB1;ITGB4;ITGB8;ADAM15;DOCK1;PTK2B;ITGA5;BCAR1;LAMA5;FERMT2;LAMA3;CEACAM1;MYH9;CUL3;COL16A1;ISG15;ERBIN;CD47;NEDD9;RCC2;COL3A1;PRKD1
prerank,hepaticobiliary system development (GO:0061008),0.6015543170549174,1.5491484229275574,0.07228915662650602,0.4714569731642385,1.0,5/20,3.79%,TGFBR3;WNT4;ARID5B;PRKCSH;PCSK9
prerank,manganese ion transport (GO:0006828),-0.6110862990776866,-1.548187147991291,0.04093567251461988,0.2839753786261082,1.0,11/14,29.83%,TRPC3;TRPC6;ATP2C1;SLC39A8;TRPC4;SLC39A14;TRPC1;TMEM165;SLC11A1;TRPC7;ATP2C2
prerank,regulation of phospholipase activity (GO:0010517),0.6988167253368529,1.547815990778263,0.048582995951417005,0.47267793299465144,1.0,2/10,1.89%,FGFR2;PDPK1
prerank,bone morphogenesis (GO:0060349),0.6562783740211984,1.5477749759250536,0.056485355648535567,0.4695174224119144,1.0,3/14,2.73%,CYP26B1;FGFR2;LTF
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5813269505011267,1.5467050535026108,0.04789272030651341,0.46984702980815984,1.0,7/22,12.63%,SH3D19;TIMP3;SNX9;SNX33;NRDC;PTPN3;PACSIN3
prerank,striated muscle contraction (GO:0006941),0.4994048559424745,1.5465805943248119,0.02631578947368421,0.46697536915486537,1.0,13/53,13.73%,ATP1A2;TPM1;DMD;CSRP3;TNNC1;TNNT2;SLC8A1;ARHGEF11;RCSD1;DTNA;SCN3B;SCN2B;CCDC78
prerank,lipoprotein catabolic process (GO:0042159),-0.6478413160323038,-1.5462197952760668,0.03288201160541586,0.2868662973253393,1.0,4/11,10.46%,CTSD;ABHD17B;LYPLA2;ABHD17A
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.5076790923015807,-1.5460105569690583,0.023109243697478993,0.2855480938883477,1.0,18/29,34.18%,RPS21;RPS8;RPS19;RPS14;DCAF13;BMS1;DHX37;RPS16;TBL3;KRI1;PWP2;TSR1;MRPS11;ABT1;UTP20;UTP4;HELB;RPP40
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4623411864468008,1.5450071473536853,0.019736842105263157,0.4685950711879205,1.0,6/74,2.18%,IGF1;EYA4;EYA1;TCF7L2;EYA2;BCL2
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.4016280316606595,-1.54426975523564,0.007853403141361256,0.288123415568601,1.0,29/88,16.17%,TEK;CAV1;PTPRM;NRP2;TIE1;KDR;THBS1;ACVRL1;F3;CAV2;BMPR2;PPP1R16B;ATP5F1A;NRAS;PDCL3;EMC10;FLT4;VEGFA;NR4A1;PIK3CD;BMP2;SCG2;XDH;SYNJ2BP;CDH13;SPARC;NF1;ATP5IF1;PRKD1
prerank,negative regulation of reproductive process (GO:2000242),0.6293510594520484,1.544063627231538,0.0547945205479452,0.46832608400081216,1.0,4/17,5.24%,IGF1;SPINK13;GJA1;SULF1
prerank,maturation of SSU-rRNA (GO:0030490),-0.4908394958567782,-1.5440446267181491,0.026748971193415638,0.28709090438462886,1.0,14/34,23.47%,RPS8;RPS19;RPS14;DCAF13;DDX52;BMS1;RPS28;DHX37;WDR3;RPS16;TSR3;PWP2;TSR1;MRPS11
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.43813420765497985,-1.5422542751929686,0.014084507042253521,0.2896791297341272,1.0,22/54,21.25%,MEF2C;TMSB4X;NOS3;KDR;THBS1;ACVRL1;ETS1;ATP5F1A;HSPB1;GATA2;TGFB1;VEGFA;JUP;CSNK2B;NF1;PRKD1;PRCP;CD40;ATP5F1B;AKT1;ATP2B4;GADD45A
prerank,purine ribonucleotide transport (GO:0015868),-0.5875512009446389,-1.5421063483483148,0.0335195530726257,0.288355828992705,1.0,7/16,16.21%,ABCC4;LRRC8C;LRRC8D;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.48870093062404835,-1.5414298935396042,0.01948051948051948,0.28818394780705936,1.0,17/33,12.45%,SEMA6A;RHOJ;BMPER;KLF2;THBS1;KLF4;PKM;PPP1R16B;CREB3L1;ITGA5;CEMIP2;CEACAM1;VEGFA;TJP1;S100A1;SYNJ2BP;EPN2
prerank,signal release from synapse (GO:0099643),-0.46884954077675695,-1.5413286513400843,0.02466367713004484,0.286801982706392,1.0,23/43,32.67%,HSPA8;LIN7A;PTPRN2;STX1A;NRXN1;SYT10;PCLO;GAD1;CPLX2;SNAP25;SYN2;PIP5K1C;CDK5;PPFIA3;RAB3A;OTOF;CPLX1;SNAPIN;SNPH;SYT1;SLC32A1;GRM4;SYN1
prerank,endothelial cell proliferation (GO:0001935),-0.5703916004997298,-1.5409424048625193,0.04201680672268908,0.2860569852882018,1.0,5/17,3.91%,TEK;BMPER;CD34;ACVRL1;BMPR2
prerank,regulation of cardiac conduction (GO:1903779),0.49409430297602325,1.5407897355669684,0.02910958904109589,0.47532264880215946,1.0,11/54,5.95%,ATP1A2;ITPR1;SLC8A3;STIM1;CORIN;ATP1B3;SLC8A1;DMPK;ANK2;NPR2;TMEM65
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.606830337576798,1.540402659545298,0.045098039215686274,0.47345662057210425,1.0,4/18,8.62%,FBN1;LTF;LRRC17;FSTL3
prerank,maturation of 5.8S rRNA (GO:0000460),0.6267122065492062,1.5402426534086244,0.05009633911368015,0.47080374152344995,1.0,5/17,10.51%,NSA2;MPHOSPH6;FTSJ3;NOL9;PRKDC
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.5414627575387996,1.5401549059835637,0.03345724907063197,0.4680207901592806,1.0,4/34,3.44%,IGF1;DMRT1;PDGFRB;IGF2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5790466079516111,1.5396076735039168,0.03461538461538462,0.4667412612653201,1.0,4/23,4.46%,PRKAG2;CEMIP;BMP7;SPHK1
prerank,positive regulation of behavior (GO:0048520),-0.6645665899978236,-1.5394937598668397,0.05304518664047151,0.2876361322862146,1.0,3/10,4.40%,MEF2C;SGIP1;STRA6
prerank,regulation of DNA repair (GO:0006282),0.5057944453899819,1.5390609526361083,0.02385008517887564,0.46547243439801655,1.0,3/44,0.99%,EYA4;EYA1;EYA2
prerank,kidney development (GO:0001822),0.4738801626774305,1.5383657778899629,0.013223140495867768,0.46469885033322456,1.0,13/65,7.04%,OSR1;GREB1L;WNT4;BMP7;LRP4;CTSH;PCSK9;PYGO1;ARL3;ACE;SULF1;SALL1;KANK2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5322523113966683,-1.5373366745493786,0.03696098562628337,0.29089236028937465,1.0,11/22,18.58%,RPL23;RPS15;RPL37;RPS7;UBB;RPS20;SPRED2;DDX5;EEF1E1;EIF5A;ATR
prerank,regulation of microtubule polymerization (GO:0031113),-0.4593421827259165,-1.5365940883872156,0.02666666666666667,0.29108777415047155,1.0,17/40,25.07%,OCLN;RAC1;RPS3;CLIP1;MET;PRUNE1;STMN2;PAK1;NAV3;STMN1;TOGARAM1;TUBB4A;MAPRE1;NUMA1;DCTN1;CAMSAP3;CAMSAP1
prerank,adenine nucleotide transport (GO:0051503),-0.5759606226704328,-1.535439073823808,0.029850746268656716,0.2921221126160089,1.0,7/17,16.21%,ABCC4;LRRC8C;LRRC8D;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.46916669927697285,-1.5353014654610513,0.0215311004784689,0.2908738397748074,1.0,18/42,14.37%,UTRN;TEK;PTPRJ;KDR;RAC1;PTK2B;LIMS1;FERMT2;GSK3B;MYOC;VEGFA;EMP2;COL16A1;CDK6;S100A10;CDH13;JUP;GFUS
prerank,nucleoside catabolic process (GO:0009164),0.6935900164245998,1.5352761850401597,0.06041666666666667,0.4714868462889903,1.0,6/11,12.28%,DPYD;UPB1;NT5M;DPYS;DERA;UPP2
prerank,macrophage activation (GO:0042116),-0.494386589173042,-1.535271724519496,0.019736842105263157,0.28934158353856076,1.0,11/34,14.27%,FOXP1;PLCG2;LBP;CD93;SBNO2;APP;DYSF;IFI35;CLU;C1QA;IFNGR1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6181812899128487,1.5339076667017226,0.054989816700611,0.4731635074561402,1.0,1/19,0.03%,IGF1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.6419471611548406,-1.5338749562877414,0.045871559633027525,0.2909665138554219,1.0,8/11,22.97%,UQCRH;UQCR11;UQCRQ;UQCC3;UQCRC2;UQCRC1;CYCS;UQCR10
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5548592209898495,-1.5337760541418353,0.02092050209205021,0.28964847237267927,1.0,5/19,9.37%,SLCO1C1;KLF2;KLF4;APP;MAPK8
prerank,platelet degranulation (GO:0002576),-0.38727908104108194,-1.5336017631611725,0.0,0.2884879290711225,1.0,31/118,9.01%,PCDH7;ABCC4;VWF;FN1;PECAM1;TMSB4X;ACTN4;THBS1;TGFB2;GAS6;CD9;CALM1;LHFPL2;PSAP;TAGLN2;FLNA;ACTN1;WDR1;ENDOD1;TGFB1;CD109;FAM3C;SOD1;VTI1B;CLEC3B;APP;VEGFA;CYRIB;CD63;SRGN;A2M
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5046156264583777,-1.532948841420483,0.020224719101123594,0.2884867849103711,1.0,13/30,22.91%,NOS3;BMP5;TNFSF10;BCL2L1;GSK3B;TMBIM1;ARHGEF2;RNF34;FAS;CASP8;TNFRSF10B;TNFAIP3;FAIM
prerank,protein localization to membrane (GO:0072657),-0.3543051939718252,-1.532200000866056,0.0,0.2887812445339075,1.0,53/187,13.95%,SPTBN1;BSG;SHANK3;CAV1;RAP1A;DLG2;EFR3B;LIN7A;GAS6;CDH1;SLMAP;AGRN;KCNB2;EHD4;RAMP2;F11R;RAB3C;ATP1B1;SH3GLB1;KCNB1;FLNA;RFTN1;MAP7;IKBKB;ZDHHC15;NKD2;FERMT2;ITGA4;EHD1;WNK3;PTCH1;RAMP1;TMED2;EMP2;ZDHHC2;NRXN1;TTC7A;TSPAN17;RAB38;C2CD5;ABHD17A;RAB3B;HGS;MYO5A;TM9SF3;S100A10;SPTBN4;SYNJ2BP;EHD3;PICK1;CACNB2;CD81;JUP
prerank,response to muramyl dipeptide (GO:0032495),-0.6418528378540768,-1.531707999867242,0.02663934426229508,0.2882257811008931,1.0,6/12,18.69%,VIM;NOD1;CHMP5;ARHGEF2;ERBIN;IRF5
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.5921866677727783,-1.5314805326732435,0.025145067698259187,0.287219839536403,1.0,13/17,28.23%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;ATP5F1E;STOML2;ATP5PD;ATP5F1B;VPS9D1;ATP5MC2;ATP5MF;ATP5MC1;ATP5PF
prerank,endoplasmic reticulum organization (GO:0007029),-0.4193101789836407,-1.5314093320945332,0.005063291139240506,0.2858984867062412,1.0,39/72,33.56%,REEP3;REEP1;CAV2;RTN3;REEP5;SHTN1;STX1A;APP;SMPD4;CCDC47;TOR1B;RTN4;LPCAT3;LMAN2;BNIP1;LMAN2L;SEC61G;ATL2;SEC16B;SPTSSB;GET4;VAPA;TLE6;OTOF;SEC16A;REEP2;ZBED3;RNF112;SEC31A;WDR83OS;ATL3;TMEM33;STX5;SEC61B;UBE2J2;RAB18;TRDN;SEC31B;DOP1B
prerank,metal ion homeostasis (GO:0055065),-0.469666889935522,-1.5303759916104471,0.022727272727272728,0.2868833928127567,1.0,16/40,21.60%,TMTC2;SLC12A7;SLC12A2;CAV1;SLC12A6;SLC12A8;GRIN1;SLC12A4;KCNA1;MT3;WFS1;COX11;LETM1;JPH2;ANK3;KCNH2
prerank,protein localization to cell periphery (GO:1990778),-0.3665090880834219,-1.5291507970064124,0.0030303030303030303,0.28820947271626096,1.0,38/133,13.95%,SPTBN1;BSG;CAV1;RAP1A;EFR3B;LIN7A;GAS6;CDH1;SLMAP;KCNB2;EHD4;RAMP2;F11R;RAB3C;ATP1B1;KCNB1;FLNA;MAP7;IKBKB;NKD2;EHD1;WNK3;PTCH1;RAMP1;TMED2;EMP2;ZDHHC2;TTC7A;TSPAN17;C2CD5;RAB3B;MYO5A;S100A10;SPTBN4;EHD3;CACNB2;CD81;JUP
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5426169370367617,-1.5288951687111645,0.02217741935483871,0.28726435900002645,1.0,5/21,6.03%,PRKCH;FOXP1;SLC39A10;RPS3;PTPRC
prerank,regulation of neuroinflammatory response (GO:0150077),0.6017466187356071,1.5277258566893641,0.05555555555555555,0.4900213063234371,1.0,6/19,8.88%,IGF1;IL18;SPHK1;IL6;MMP9;NUPR1
prerank,regulation of GTPase activity (GO:0043087),-0.35477525491837747,-1.5269074971442609,0.0,0.2905132006228479,1.0,32/177,4.41%,DOCK9;PRKG1;CHN2;FGD5;EFNA5;LRCH1;FGD6;RAP1A;SIPA1L1;RGS6;ITGA6;BCAR3;TBC1D30;PKP4;PLXND1;PTK2;ITGB1;AGRN;F11R;RASIP1;ARHGAP27;CAV2;DAB2IP;CHN1;RACK1;SH3BP4;SEMA4D;NET1;DOCK10;LIMS1;TGM2;PLXNA4
prerank,inner mitochondrial membrane organization (GO:0007007),-0.4598924934352975,-1.526270701936546,0.017057569296375266,0.29034869067206726,1.0,26/47,25.49%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;GHITM;CHCHD3;ATP5F1E;NDUFA13;TIMM9;ROMO1;ATP5PD;MTX3;TIMM10B;TIMM13;IMMT;UQCC3;APOO;ATP5F1B;LETM1;TIMM29;HSPA9;TIMM22;SPG7;ATP5MC2;ATP5MF;ATP5MC1
prerank,positive regulation of protein processing (GO:0010954),-0.5508060918651301,-1.5247877568561437,0.036290322580645164,0.29255595024621717,1.0,6/19,10.21%,GSN;PLGRKT;NKD2;CLEC3B;MYH9;LPCAT3
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6573524859067135,-1.5239814400027571,0.04950495049504951,0.29303975509566266,1.0,3/10,9.76%,FN1;HSP90AB1;FURIN
prerank,regulation of protein dephosphorylation (GO:0035304),-0.46519045004169923,-1.5239639719070688,0.011235955056179775,0.2916080764163297,1.0,19/37,24.06%,CALM1;PPIA;PPP1R16B;TIPRL;TGFB1;PPP1R2;HSP90B1;YWHAB;PPP6R1;PPP1R16A;SYMPK;CALM2;PPP2R5A;PTBP1;PRKCD;CDCA2;NSMF;CALM3;PPP1R15A
prerank,endodermal cell differentiation (GO:0035987),-0.4899038930926047,-1.523721290405927,0.018475750577367205,0.2906909432384627,1.0,10/31,13.27%,COL8A1;FN1;COL12A1;COL6A1;ITGA5;ITGA4;LAMA3;MMP15;COL4A2;ITGA7
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5710565755106939,1.5225738575092327,0.055445544554455446,0.5033543607458346,1.0,6/23,8.85%,ATP1A2;CACNG1;NOS1AP;ANK2;CACNA2D1;CAMK2D
prerank,blood vessel morphogenesis (GO:0048514),-0.4338485209231513,-1.52147084961622,0.019184652278177457,0.294407115071845,1.0,21/54,9.37%,CAV1;ID1;COL4A1;KDR;ITGB8;CDH2;LAMA1;RAMP2;RASIP1;ENG;TBX1;HES1;SOX17;SLC1A1;STRA6;TGFBR2;TGFB1;LRP5;FLT4;VEGFA;HEY2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6596753020593116,-1.521203714006914,0.04595588235294118,0.29369989003530395,1.0,8/10,25.49%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;ATP5PD;VPS9D1;ATP5MC2;ATP5MC1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.4161208124168318,1.5208411430988387,0.0058309037900874635,0.5059593010363178,1.0,30/138,11.42%,IL31RA;EPHA7;EPHA3;FGFR2;FGFR4;BDKRB2;KIT;PDGFRB;FER;EPHA8;EPHA4;PDGFRA;DDR1;NPR2;IGF1R;PTN;CLNK;FRS2;PTPRD;DDR2;RYK;MTSS1;CSF1;MUSK;FRK;AXL;NPR1;EPHA2;JAK2;ERBB2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.627365075169622,1.5200746406846926,0.0410958904109589,0.5055312693830922,1.0,5/16,8.36%,DPYD;UPB1;DPYSL3;NT5M;DPYS
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6453462690010195,1.5191120090436574,0.05725971370143149,0.5055227121931474,1.0,5/13,9.66%,IGF1;PLCB1;SLC2A10;CCL19;GOLGA2
prerank,steroid biosynthetic process (GO:0006694),0.4754277312046764,1.5190128348680607,0.021630615640599003,0.5028025498096728,1.0,6/56,5.65%,PRKAG2;CYP27A1;INSIG2;HSD17B1;FDXR;HSD17B10
prerank,regulation of microtubule depolymerization (GO:0031114),-0.5204950979996648,-1.5186674819878896,0.019736842105263157,0.2980057044397804,1.0,14/25,27.61%,MAP1B;STMN2;NAV3;APC;ARHGEF2;APC2;TTBK2;MAP1A;CLASP2;SPEF1;CAMSAP3;CAMSAP1;TRPV4;FGF13
prerank,regulation of amyloid-beta formation (GO:1902003),0.5283458282252234,1.517197542219939,0.056261343012704176,0.5059096546235115,1.0,3/34,3.71%,IGF1;ROCK2;EPHA4
prerank,anterior/posterior pattern specification (GO:0009952),0.4740013068231003,1.516919855743745,0.033391915641476276,0.5037297108304646,1.0,8/53,4.23%,WLS;HOXC6;HOXC4;HOXB4;HOXB3;HOXA3;HOXC5;HOXA7
prerank,prostanoid biosynthetic process (GO:0046457),-0.5821514581443457,-1.5166287769265245,0.04220183486238532,0.3014901005331916,1.0,7/15,16.76%,PTGIS;PTGS2;EDN1;PTGDS;CD74;PLA2G4A;MIF
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.533231271971607,-1.5154957216442342,0.041584158415841586,0.302825321665068,1.0,9/23,23.02%,SLC12A7;SLC12A2;SLC12A6;SLC12A8;SLC12A4;PDK2;ATP6V0A4;KCNH2;CLCN3
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.49142977514601505,1.5150871057941546,0.022887323943661973,0.5066377232091196,1.0,5/44,5.65%,PRKAG2;CYP27A1;INSIG2;HSD17B1;HSD17B10
prerank,negative regulation of cell growth (GO:0030308),-0.37184500424248285,-1.514886170106871,0.0053475935828877,0.3026416667756142,1.0,42/121,25.56%,APBB2;SLIT2;PTPRJ;ACVRL1;TGFB2;ADAM15;NDRG3;RACK1;SH3BP4;FHL1;BMPR2;SOX17;CCDC85B;RERG;CCN3;TGFB1;OSGIN2;DCC;APBB1;RTN4;SESN2;CDKN1B;NDUFA13;SEMA3G;CDKL3;MT3;JADE1;CDA;BST2;WFDC1;RTN4R;BTG1;ESR2;CDKN1A;CDKN2D;OSGIN1;HYAL2;SIPA1;HSPA1B;DACT3;SPHK2;ULK2
prerank,positive regulation of cartilage development (GO:0061036),0.5985990148344853,1.513733656369099,0.06560636182902585,0.5078285181307738,1.0,3/17,2.75%,SOX5;SCX;SOX6
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.6645278940089778,1.513501885544818,0.06289308176100629,0.50559068717426,1.0,8/12,22.98%,SORBS1;IGF2;PRKCZ;GKAP1;PTPN11;C1QTNF12;IRS1;SNX5
prerank,ganglioside biosynthetic process (GO:0001574),-0.5821318045189219,-1.5126413008287078,0.04085603112840467,0.3062630194765873,1.0,8/15,18.54%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;B4GALT5;ST8SIA6;ST8SIA2;B4GALT6;ST3GAL1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.5209871569404523,-1.5122233507303993,0.036885245901639344,0.3057171767258217,1.0,6/25,6.03%,SPTBN1;PDE4D;RUNX1;PLCG2;RPS3;PTPRC
prerank,negative regulation of cartilage development (GO:0061037),0.6578332585563242,1.512135244018627,0.06722689075630252,0.5069272027560247,1.0,3/13,5.90%,ADAMTS12;EFEMP1;ADAMTS7
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6434171658941149,1.5114169895776233,0.05165289256198347,0.5064739221782986,1.0,3/14,5.90%,ADAMTS12;EFEMP1;ADAMTS7
prerank,platelet aggregation (GO:0070527),-0.4835720694166679,-1.5107149654625827,0.022935779816513763,0.3076612761123445,1.0,9/33,7.18%,FN1;ACTB;ACTG1;PPIA;FLNA;ACTN1;HSPB1;UBASH3B;MYH9
prerank,regulation of cellular pH (GO:0030641),-0.50712470037658,-1.510666115876439,0.025052192066805846,0.3063196653432808,1.0,9/29,12.01%,SLC4A10;SLC9A2;SLC9A8;CHP1;SLC4A8;CA2;SLC4A2;SLC26A6;SLC9B1
prerank,protein localization to cilium (GO:0061512),0.520305909593213,1.5097887206955503,0.056140350877192984,0.5084387746623317,1.0,14/32,18.84%,TULP3;TULP1;ARL3;INVS;WDR19;WDR35;ARL6;TCTN1;IFT122;IFT140;ATP6V1D;TULP2;BBS1;RAB29
prerank,regulation of blood circulation (GO:1903522),0.5170116340354453,1.50787504284012,0.039285714285714285,0.5115777678165233,1.0,6/34,5.24%,CELF2;BDKRB2;TPM1;TNNT2;DMPK;ACE
prerank,positive regulation of DNA repair (GO:0045739),0.48739592164041884,1.5076621954781544,0.041025641025641026,0.509305087723545,1.0,6/46,8.99%,EYA4;EYA1;EYA2;SLF1;SPIRE2;CEBPG
prerank,carnitine metabolic process (GO:0009437),0.6560651681031342,1.5075833583876823,0.07484407484407485,0.5066571296591914,1.0,6/12,13.69%,ACADL;CPT2;BBOX1;TMLHE;SHMT1;CPT1C
prerank,ribosomal small subunit assembly (GO:0000028),-0.5716167840606741,-1.5070218384471386,0.03536345776031434,0.31343398078034423,1.0,12/16,25.59%,RPS15;RPSA;RPS19;RPS14;RPS27;RPS28;ERAL1;RPS27L;RPS5;PWP2;MRPS11;ABT1
prerank,toxin transport (GO:1901998),0.6968957120931161,1.5068575658186285,0.07142857142857142,0.5059369347343026,1.0,3/10,2.94%,SLC22A2;ANTXR1;ANTXR2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5808862857451795,1.5060037686060777,0.05588822355289421,0.5058657290213899,1.0,6/21,7.35%,SNTA1;KCNA5;NOS1AP;ANK2;CACNA1D;CACNA2D1
prerank,response to iron ion (GO:0010039),0.6665925186541174,1.5055179146208593,0.052525252525252523,0.5046422022850645,1.0,3/12,3.64%,BMP6;BCL2;TFR2
prerank,regulation of glucose metabolic process (GO:0010906),0.5173057644230393,1.5052271580612846,0.04054054054054054,0.5028891824683631,1.0,4/34,3.92%,RORA;PRKN;PDK1;SLC45A3
prerank,diacylglycerol metabolic process (GO:0046339),-0.514928878355975,-1.5050630670135117,0.026584867075664622,0.31652622870257113,1.0,11/23,24.15%,DGKH;DGKB;DGKI;LIPE;DGKZ;DGKG;DGAT1;ANG;GPAM;DGKE;DGKQ
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.639165125648081,-1.5049425543616575,0.040697674418604654,0.3153343001086329,1.0,4/11,13.76%,RAC1;BCAR1;PAK1;STMN1
prerank,lung development (GO:0030324),0.5198674542002376,1.5049048623176282,0.054945054945054944,0.5012456650152362,1.0,7/33,5.54%,ERRFI1;FGFR2;RBP4;LOXL3;PDPN;FGF1;ITGA3
prerank,regulation of actomyosin structure organization (GO:0110020),0.6283511565617332,1.5045224823999943,0.08048289738430583,0.4996551240289545,1.0,5/13,6.35%,ROCK2;FHOD1;ALMS1;AKAP13;ASAP3
prerank,embryonic heart tube development (GO:0035050),-0.5957037782060703,-1.5035994876323358,0.06134969325153374,0.3171884570750839,1.0,9/14,26.87%,HES1;SOX17;TBX2;RYR2;SOX18;NDRG4;ACVR1;MEGF8;CITED2
prerank,regulation of spindle assembly (GO:0090169),-0.4989932848074627,-1.502308234189903,0.03508771929824561,0.31854954332188096,1.0,16/25,33.16%,CHMP5;CHMP2B;HNRNPU;CHMP1B;CHMP1A;NUMA1;CHMP3;SPAG5;HSPA1B;PDCD6IP;CHMP4C;DRG1;VPS4B;PLK1;DYNC1H1;HSPA1A
prerank,vascular transport (GO:0010232),0.4422624535384757,1.501396466441562,0.022222222222222223,0.5074010672739115,1.0,16/81,7.75%,ATP1A2;SLC6A13;LEPR;SLC24A3;SLC13A3;SLC22A2;SLC16A12;SLC38A3;SLC5A5;SLC6A9;SLC1A3;SLC6A1;LRP2;SLC2A10;ABCC2;SLC1A5
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.6425976829507943,1.4997113556541661,0.0855397148676171,0.510098716882225,1.0,5/13,11.76%,BMP6;DAB2;RBPMS;JAK2;BMPR1A
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.6021994758046605,-1.4982981163644984,0.05523809523809524,0.32675657471319053,1.0,10/13,28.67%,CSPG4;BGN;HEXB;HEXA;IDS;VCAN;DCN;ARSB;IDUA;NCAN
prerank,detection of mechanical stimulus (GO:0050982),-0.5373082863010776,-1.4978838178144356,0.032454361054766734,0.32628789613273435,1.0,6/19,7.01%,PIEZO2;PTK2;CDH2;PKD1;CTNNB1;PIEZO1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5864835803628625,-1.4976280526693622,0.03435114503816794,0.32533370636276143,1.0,12/16,28.23%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;ATP5F1E;STOML2;ATP5PD;ATP5F1B;ATP5MC2;ATP5MF;ATP5MC1;ATP5PF
prerank,positive regulation of ERAD pathway (GO:1904294),-0.6054556128601859,-1.4970152528178595,0.056466302367941715,0.3251246173999509,1.0,5/13,15.39%,CAV1;ATXN3;BAG6;HERPUD1;BCAP31
prerank,nuclear migration (GO:0007097),0.6441490899646304,1.4943591003397727,0.06512605042016807,0.5243919296845753,1.0,7/13,18.50%,SYNE2;CLMN;SYNE3;PAFAH1B1;SUN2;CEP120;TMEM201
prerank,regulation of multicellular organism growth (GO:0040014),0.6121137088522566,1.4942314673850172,0.05991735537190083,0.5219369409034513,1.0,2/15,3.68%,IGF1;STAT5B
prerank,ribosomal large subunit assembly (GO:0000027),-0.5147705042708154,-1.4935289296017034,0.036170212765957444,0.33222308262534184,1.0,11/24,21.82%,RPL11;RPL6;RPL24;RPL23A;RPL3;RPL5;RPLP0;RSL24D1;NOP53;NLE1;PPAN
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.5342557455130638,-1.493134382687185,0.05725971370143149,0.3317281586995402,1.0,12/21,30.27%,CAV1;PLTP;NFKBIA;PTCH1;NR1H2;ABCA3;ZDHHC8;NR1H3;TREM2;GPS2;ABCA7;PPARG
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.4949651353004006,1.4922038242455424,0.04440497335701599,0.5257471351883981,1.0,5/38,7.68%,BMP6;SASH1;DDX60;PRKCA;POLR3G
prerank,actin filament bundle organization (GO:0061572),0.5158922451199976,1.4921529674719332,0.06642066420664207,0.5231137762583858,1.0,9/33,7.18%,PAWR;RHOD;DPYSL3;SHROOM2;CALD1;BAIAP2;ESPN;BAIAP2L2;LIMA1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5144848583322518,-1.4917858180562444,0.03696098562628337,0.3335024094961958,1.0,10/24,15.88%,PDE4D;PDE3A;GNAI1;PEX5L;PDE2A;RNF157;UBE2B;PRKAR1A;PDE11A;APLNR
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5954105692166529,1.4913747113045481,0.06333973128598848,0.522711155624496,1.0,1/17,0.03%,IGF1
prerank,negative regulation of cilium assembly (GO:1902018),-0.6178737376541299,-1.4912572047174444,0.05758157389635317,0.33332044415470646,1.0,4/12,13.86%,TBC1D30;MAP4;LIMK2;ODF2L
prerank,sensory perception of sound (GO:0007605),0.4359327058968869,1.4912414013942923,0.025196850393700787,0.5204075179473439,1.0,16/88,10.88%,DCDC2;EYA1;ADGRV1;CEMIP;KIT;CCDC50;ALDH7A1;RIPOR2;CACNA1D;LRP2;TMC2;BIRC5;WHRN;EML2;GSDME;TFAP2A
prerank,cristae formation (GO:0042407),-0.506829793807914,-1.4906206127584487,0.03917525773195876,0.33345791645377865,1.0,18/27,30.48%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;CHCHD3;ATP5F1E;ATP5PD;IMMT;UQCC3;APOO;ATP5F1B;LETM1;SPG7;ATP5MC2;ATP5MF;ATP5MC1;ATP5PF;MICOS13
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6335921260072973,-1.4904803181483273,0.05363984674329502,0.33232851663616214,1.0,6/10,15.45%,UBB;NEDD8;RPS27A;UBC;ISG15;UBA52
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.46250734487334816,1.489420482745622,0.029315960912052116,0.5236338297636398,1.0,8/62,4.86%,IGF1;ROBO1;AUTS2;NOTCH2;LPAR1;ALS2;AKAP13;MAPRE2
prerank,negative regulation of leukocyte activation (GO:0002695),0.6201471798941248,1.4883373999100797,0.07773109243697479,0.5243848597082184,1.0,1/15,0.01%,IL31RA
prerank,metanephric mesenchyme development (GO:0072075),0.6837764894290894,1.488166074487555,0.08583690987124463,0.5221694531585516,1.0,2/10,0.73%,OSR1;WNT4
prerank,lymphocyte mediated immunity (GO:0002449),-0.6041723476203326,-1.4880806395243258,0.06563706563706563,0.3367908279812278,1.0,4/12,16.98%,JAG1;CD55;MSH2;BTN3A3
prerank,inorganic anion transmembrane transport (GO:0098661),-0.40947349685330653,-1.4869020564092437,0.026442307692307692,0.3382834381310283,1.0,23/63,16.89%,SLC12A7;SLC12A2;SLC26A2;ANO1;ANO4;SLC5A6;GABRB3;SLC12A6;SLC1A1;GABRB1;SLC12A8;SLC4A8;ANO3;LRRC8A;SLC12A4;GABRG3;SLC37A3;SLC25A30;XPR1;ANO2;CFTR;SLC25A3;GLRA3
prerank,response to unfolded protein (GO:0006986),-0.4233760187593903,-1.4863273859670736,0.033860045146726865,0.3382455815398991,1.0,16/48,13.06%,HSPA8;HSP90AA1;HSP90AB1;DAB2IP;DNAJA1;STT3B;HSPB1;HSPA14;DERL1;ERP44;TOR1B;HSPA5;PTPN1;HSPB8;HSPD1;HERPUD1
prerank,ceramide biosynthetic process (GO:0046513),-0.45519006647522936,-1.486152007239973,0.025943396226415096,0.3371490134177242,1.0,14/40,19.44%,ST6GALNAC3;SGMS1;SGMS2;ST8SIA4;SPTLC2;DEGS2;ST6GALNAC5;SMPD4;ST8SIA6;CERS4;ST8SIA2;CLN8;B4GALT6;SPTSSB
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.47507191301720064,-1.4860894513170724,0.03289473684210526,0.3357765590639124,1.0,14/30,24.85%,ST6GAL1;FUT8;MAGT1;STT3B;MCFD2;RPN1;MGAT1;DDOST;MGAT5;ALG5;MGAT2;ALG8;DPM1;UBE2J1
prerank,myotube cell development (GO:0014904),0.6718322203019103,1.4860064778485647,0.08723404255319149,0.5264746177283758,1.0,1/10,0.03%,IGF1
prerank,eye development (GO:0001654),0.46869873681827673,1.4858429058069842,0.039383561643835614,0.5242480763168462,1.0,11/54,8.53%,EFEMP1;FBN1;RBP4;MEIS1;FBN2;SLC39A5;SHROOM2;SMOC1;SH3PXD2B;PBX4;CHRDL1
prerank,transport across blood-brain barrier (GO:0150104),0.4378449390253486,1.485273496543875,0.027156549520766772,0.5234893777113975,1.0,16/83,7.75%,ATP1A2;SLC6A13;LEPR;SLC24A3;SLC13A3;SLC22A2;SLC16A12;SLC38A3;SLC5A5;SLC6A9;SLC1A3;SLC6A1;LRP2;SLC2A10;ABCC2;SLC1A5
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.367002297102089,-1.4851748037570542,0.005763688760806916,0.3366361609722023,1.0,28/114,15.80%,TMSB4X;ACTN4;TNFRSF11B;PTK2B;NFKBIA;LIMS1;IKBKB;EDA;ST18;TNFRSF11A;TNFRSF1B;CARD14;BIRC3;PSMD13;AIM2;PSMF1;COMMD7;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;TRAF1;PSME1;PSMB3
prerank,adherens junction organization (GO:0034332),-0.44322641613909025,-1.4847902774253803,0.024875621890547265,0.3361744349179287,1.0,16/48,14.51%,ACTB;CADM1;CDH11;CDH1;CDH2;RAMP2;FERMT2;CTNNB1;CSK;TJP1;PVR;PAK2;CADM3;CDH13;JUP;PIP5K1C
prerank,ceramide catabolic process (GO:0046514),-0.5901648295920956,-1.484616965479629,0.05030181086519115,0.33519618651086514,1.0,5/14,15.91%,ACER3;ACER2;HEXB;HEXA;GM2A
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5040137750809142,-1.4845327637625412,0.04821802935010482,0.33397902319669054,1.0,7/25,9.12%,RPL11;RPL23;HSP90AB1;RPS7;PDCL3;RPL5;PSMF1
prerank,ceramide metabolic process (GO:0006672),-0.439290818490691,-1.484289896302782,0.018957345971563982,0.33308465029839757,1.0,11/49,9.70%,ST6GALNAC3;SGMS1;SGMS2;ACER3;ACER2;SPTLC2;PLPP1;DEGS2;SMPD4;SGPL1;CERK
prerank,urogenital system development (GO:0001655),0.658561594464628,1.4842031310411437,0.1,0.524143903371157,1.0,2/11,3.48%,OSR1;ANXA1
prerank,microtubule bundle formation (GO:0001578),-0.44931415790386686,-1.4840538672285204,0.0319634703196347,0.3323204018549114,1.0,22/42,35.91%,NAV1;CLIP1;RP1;CHP1;MTCL1;TOGARAM1;CCDC66;TPPP;TPPP3;LRGUK;GAS2L1;NUMA1;SPEF1;FOXJ1;CFAP46;NCKAP5L;PLK1;DCX;PSRC1;CFAP206;CLASP1;CCDC40
prerank,regulation of heart contraction (GO:0008016),0.4375139743422119,1.4830785399042334,0.01751592356687898,0.525079679279726,1.0,14/90,5.95%,CELF2;ATP1A2;ITPR1;SLC8A3;TPM1;STIM1;CORIN;ATP1B3;TNNT2;SLC8A1;DMPK;ANK2;NPR2;TMEM65
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5749599943090203,-1.4826949387665649,0.05534351145038168,0.3343136647906654,1.0,4/15,7.27%,RPL11;RPL23;RPS7;RPL5
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.5401468921200029,-1.4825188599035057,0.0525164113785558,0.3333636674805165,1.0,10/20,21.85%,FAR2;ACSL4;ACACA;FAR1;DGAT1;FASN;ACSL3;SCD5;ACLY;SCD
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5889996368644782,-1.4822276852711116,0.046,0.3326636763978906,1.0,7/13,30.77%,TMSB4X;HEY2;PSEN1;SOX11;HEY1;PER2;SIN3A
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.6321971476150552,1.4815642971101046,0.07768924302788845,0.5274336620377983,1.0,5/14,12.28%,DPYD;UPB1;NT5M;DPYS;UPP2
prerank,external encapsulating structure organization (GO:0045229),0.3877243960478507,1.4809629675254778,0.004201680672268907,0.5266063481251093,1.0,34/205,6.29%,COL22A1;ADAMTS12;NID2;ADAMTS9;LAMC3;COL4A5;ADAM12;ITGA9;FBN1;COL4A6;SMOC2;LAMA2;ADAMTS5;THSD4;FBLN5;ADAMTS10;FBN2;ADAMTS15;TNC;PXDN;LOXL1;COL9A2;NID1;NDNF;SMOC1;MMP2;ITGAX;COL1A2;COL13A1;DDR1;ITGA3;ADAMTS7;MMP19;COL18A1
prerank,ganglioside metabolic process (GO:0001573),-0.528272501599531,-1.4809269260620777,0.05102040816326531,0.3344174350012528,1.0,9/20,18.69%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;HEXB;HEXA;ST8SIA6;GM2A;ST8SIA2;ABCA2
prerank,positive regulation of neuron migration (GO:2001224),-0.6199337451851201,-1.4804109834406305,0.04419889502762431,0.33430986247867356,1.0,7/11,22.66%,SEMA6A;DAB2IP;SHTN1;ARHGEF2;NSMF;SEMA3A;PLAA
prerank,extracellular structure organization (GO:0043062),0.38873678449089016,1.4802929368511308,0.00847457627118644,0.5260393755752582,1.0,34/204,6.29%,COL22A1;ADAMTS12;NID2;ADAMTS9;LAMC3;COL4A5;ADAM12;ITGA9;FBN1;COL4A6;SMOC2;LAMA2;ADAMTS5;THSD4;FBLN5;ADAMTS10;FBN2;ADAMTS15;TNC;PXDN;LOXL1;COL9A2;NID1;NDNF;SMOC1;MMP2;ITGAX;COL1A2;COL13A1;DDR1;ITGA3;ADAMTS7;MMP19;COL18A1
prerank,sphingolipid biosynthetic process (GO:0030148),-0.40472873673488546,-1.480061047933723,0.013192612137203167,0.3337065813096826,1.0,19/71,9.02%,CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ELOVL5;ACER2;SPTLC2;PLPP1;DEGS2;ST6GALNAC5;KDSR;PRKD3;PPM1L;ST8SIA1;SMPD4;SPNS2;SGPL1;ELOVL6
prerank,peptidyl-lysine dimethylation (GO:0018027),0.594377155167584,1.4797187753672443,0.056862745098039215,0.5253257645218843,1.0,7/18,19.76%,KMT2A;SETD7;SETD1A;ASH1L;KMT2B;SETD2;SETD4
prerank,positive regulation of DNA binding (GO:0043388),0.5178109920748177,1.4788534870703007,0.05904059040590406,0.5258002316416596,1.0,5/31,8.99%,IGF1;PRKN;NIBAN2;MMP9;CEBPG
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5552676709236211,1.478437475891089,0.07904411764705882,0.5246070125285229,1.0,7/24,10.73%,ARHGAP28;ARHGAP6;CGNL1;PHLDB2;RHPN2;ARHGEF18;PIK3R1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5761734519057293,1.4775594140507469,0.07692307692307693,0.5248023348807435,1.0,5/20,3.96%,ATP1A2;DMD;GSTM2;SLC8A1;ANK2
prerank,positive regulation of kinase activity (GO:0033674),0.42121974345683016,1.4761836261800103,0.020537124802527645,0.5264668815260991,1.0,22/107,8.66%,PRKAG2;EPHA7;EPHA3;FGFR2;FGFR4;KIT;LMO4;PDGFRB;ALS2;EPHA8;EPHA4;PDGFRA;DDR1;MRNIP;IGF1R;SNX9;XRCC5;DDR2;CCL19;RYK;CSF1;MUSK
prerank,activation of protein kinase A activity (GO:0034199),0.5827743912850801,1.4759865000147017,0.072,0.5245274032444754,1.0,2/16,0.71%,ADCY5;ADCY1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.509716393878282,-1.4753718642854738,0.03490759753593429,0.34406638578904175,1.0,11/24,21.03%,UBE3A;PTK2B;UBB;PKD1;UCHL5;TMF1;PSME3;PSME1;ATP5IF1;PINK1;CTSC
prerank,negative regulation of anoikis (GO:2000811),-0.5928797410623874,-1.4751607939954976,0.05426356589147287,0.34325490564281347,1.0,5/14,4.87%,CAV1;PTK2;ITGB1;NOTCH1;ITGA5
prerank,regulation of amyloid fibril formation (GO:1905906),-0.5787721976885177,-1.4750769197877647,0.053061224489795916,0.34210482949410936,1.0,9/15,27.24%,APP;CRYAB;CLU;IAPP;PFDN6;PFDN5;PSEN1;PFDN4;TREM2
prerank,negative regulation of chemotaxis (GO:0050922),-0.4779145312434169,-1.4737991187309933,0.040268456375838924,0.344031086645737,1.0,14/31,11.39%,SLIT2;SEMA6A;SEMA7A;SEMA6D;THBS1;SEMA3C;NOTCH1;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;DUSP3;SEMA3G
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.464910361939045,-1.4736006528732362,0.029953917050691243,0.3430493495561816,1.0,11/35,8.30%,TEK;NTRK3;ESAM;F11R;PTK2B;ARHGDIB;SEMA3E;ARHGDIA;BAIAP2L1;TJP1;ABI3
prerank,positive regulation of cell aging (GO:0090343),-0.61624880847565,-1.473253082642484,0.06859205776173286,0.34252422743850125,1.0,5/11,16.93%,B2M;YPEL3;ABI3;LMNA;EEF1E1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5855230905912248,1.4732246882944586,0.07991803278688525,0.5309437029596044,1.0,5/19,4.17%,TGFBR3;RBPJ;FGFR2;RBP4;VGLL4
prerank,intraciliary retrograde transport (GO:0035721),0.6375855633929834,1.4725579079112379,0.07802874743326489,0.5306287138598432,1.0,6/12,16.39%,DYNC2H1;WDR19;WDR35;IFT122;IFT140;DYNC2I1
prerank,intestinal absorption (GO:0050892),-0.5823301266113544,-1.472277971599636,0.06015037593984962,0.34349606791276793,1.0,4/13,11.74%,TJP2;F11R;KCNQ1;SLC26A6
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.4200367626716646,-1.472005774020294,0.027586206896551724,0.3427685794409943,1.0,23/50,24.46%,CAV1;RPS3;DNAJA1;IVNS1ABP;UBXN1;PINX1;SOX4;ARRB1;CHP1;OGT;ISG15;CAMLG;NXN;PRMT3;SPOPL;N4BP1;PRKCG;ARRB2;AKT1;SIRT7;TNFAIP3;HSPA1B;SPRY2
prerank,regulation of cellular biosynthetic process (GO:0031326),0.5478457287030059,1.4713407200050772,0.08349146110056926,0.5319750825868871,1.0,9/28,11.11%,PRKAG2;FGFR4;AVIL;NOS1AP;PRKAA2;MITF;SIRPA;MED1;JAK2
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.3991443182453223,-1.4703952914825276,0.016260162601626018,0.3455806631829956,1.0,34/68,35.89%,IL33;PLCG2;MBP;LBP;APP;XBP1;STAT3;CD74;HSPD1;ARHGEF2;IFIH1;TIRAP;MYD88;TYROBP;HYAL2;AGER;RAB7B;SPHK2;TLR7;TLR4;LPL;C1QTNF4;IL16;TLR6;DHX9;MAVS;NOD2;TLR1;NOS2;IL1A;TSLP;SYK;F2R;TLR8
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.5922379752098768,1.4698853185726302,0.09016393442622951,0.5340116761813027,1.0,3/15,5.21%,DAB2;BMP2K;WASL
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6586475438532698,1.4695554490252976,0.07291666666666667,0.5324194578313648,1.0,4/10,8.85%,OSR1;NEDD4;PCSK9;CAMK2D
prerank,purine nucleotide catabolic process (GO:0006195),-0.5844217406098445,-1.469285187217475,0.0546875,0.34695286867899244,1.0,6/13,15.56%,NT5C2;GDA;NT5C;HINT1;XDH;NT5E
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.4383143206786419,-1.468178108271831,0.033185840707964605,0.34828347666806336,1.0,23/42,28.63%,UBB;TRIM25;RPS27A;UBC;WRNIP1;ISG15;RPA1;UBA52;USP43;POLK;POLA1;FAAP20;POLN;SPRTN;POLE;POLD3;VCP;CDKN2D;POLD1;POLI;DTL;RFC5;USP10
prerank,regulation of monooxygenase activity (GO:0032768),-0.5081814451895103,-1.4681204099875296,0.058823529411764705,0.34708416416525034,1.0,8/23,11.41%,CAV1;NOS3;NOSTRIN;HSP90AA1;CALM1;DDAH1;DNM2;CYGB
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6837675193829973,1.4680598018714484,0.08842105263157894,0.5348296603766531,1.0,5/10,12.28%,DPYD;UPB1;NT5M;DPYS;UPP2
prerank,negative regulation of nuclear division (GO:0051784),0.6560904942285377,1.467104764439376,0.08488612836438923,0.5351673813336582,1.0,3/11,4.75%,BMP7;DMRT1;TOM1L2
prerank,muscle cell development (GO:0055001),0.5253479074945631,1.4668729182156492,0.06216696269982238,0.533465880928646,1.0,6/30,3.96%,IGF1;DMD;SLC8A1;MEGF10;NEBL;ANK2
prerank,regulation of T cell migration (GO:2000404),-0.5382271467215758,-1.466296377821682,0.05148514851485148,0.3503766612316336,1.0,5/18,9.24%,LRCH1;APOD;CD200;APP;RHOA
prerank,clathrin coat assembly (GO:0048268),-0.5771787062388729,-1.4647813054738108,0.05847953216374269,0.3528653130277187,1.0,5/15,11.66%,HIP1;SGIP1;HIP1R;PIK3C2A;NSG2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.6193411312188776,-1.4646279035705998,0.06529850746268656,0.35191337114646815,1.0,7/11,20.51%,NDUFA13;TIMM9;ROMO1;TIMM10B;TIMM13;TIMM29;TIMM22
prerank,regulation of muscle contraction (GO:0006937),0.5340496225553242,1.4640717376737267,0.07543520309477757,0.5396186090122365,1.0,3/26,2.30%,ATP1A2;TPM1;TNNC1
prerank,response to amyloid-beta (GO:1904645),0.48141985213064314,1.46398814736062,0.048986486486486486,0.5373912813670279,1.0,8/44,7.35%,IGF1;SNX6;MMP2;EPHA4;GJA1;IGF1R;MMP9;CACNA2D1
prerank,regulated exocytosis (GO:0045055),-0.34798046968184854,-1.4633798800361968,0.00303951367781155,0.3538117329811313,1.0,50/173,14.62%,PCDH7;ABCC4;VWF;FN1;PECAM1;TMSB4X;ACTN4;THBS1;TGFB2;GAS6;CD9;CALM1;LHFPL2;RAB31;PSAP;TAGLN2;FLNA;ACTN1;WDR1;STX1A;ENDOD1;TGFB1;CD109;FAM3C;SOD1;VTI1B;RAB11FIP1;CLEC3B;MYH9;APP;VEGFA;CYRIB;CD63;SRGN;A2M;SYT10;PCLO;CYB5R1;CPLX2;SYT4;CLU;SDF4;CDC37L1;MAGED2;SNAP25;RAB11FIP5;TMED10;ALDOA;PIP5K1C;SPARC
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.6455113418307581,-1.4626548754246806,0.04291044776119403,0.3529242306796044,1.0,2/10,2.97%,KLF4;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.6455113418307581,-1.4626548754246806,0.04291044776119403,0.3529242306796044,1.0,2/10,2.97%,KLF4;MBP
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6297389533847488,-1.4616996196892025,0.045112781954887216,0.3540208322280634,1.0,6/10,24.46%,SEMA6A;DAB2IP;XDH;CADM4;DCN;SPRY2
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.4166271600858915,-1.4606610863433698,0.02544529262086514,0.35532576442424163,1.0,28/54,23.06%,RPL11;RPL6;RPL26;RPL24;RPL23A;RPL3;RPL14;RPL5;MAK16;RPLP0;RPL35A;RPL7A;RPL7;RSL1D1;RSL24D1;RPF1;HEATR3;EBNA1BP2;NOP53;NLE1;RRP15;NOC2L;NHP2;EIF6;WDR74;PPAN;NOP16;NIP7
prerank,cellular response to glucagon stimulus (GO:0071377),0.5722501823615828,1.4605198479939134,0.07862903225806452,0.5459915545488203,1.0,2/17,0.71%,ADCY5;ADCY1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5356136783931358,1.4603728582710522,0.0674955595026643,0.5439536461937365,1.0,4/27,1.37%,ARHGAP28;ARHGAP6;CGNL1;PRKN
prerank,granulocyte differentiation (GO:0030851),-0.5349595618609762,-1.4598231985161396,0.06882591093117409,0.35599019280003785,1.0,8/18,22.87%,LEF1;CBFA2T3;LBR;TAL1;CDK2;SPI1;CDKN1A;CEBPA
prerank,alcohol catabolic process (GO:0046164),0.6486922225964724,1.4594481791832485,0.09808102345415778,0.5443761056397486,1.0,2/10,2.05%,CYP27A1;CEL
prerank,filopodium assembly (GO:0046847),-0.555533858597832,-1.458703137999467,0.05533596837944664,0.3574127685594514,1.0,4/16,5.04%,DNM3;FGD5;FGD6;SPATA13
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4528983243571241,-1.4586533118934886,0.04849884526558892,0.35617412436732737,1.0,13/35,15.88%,MEF2C;CAV1;PTPRM;THBS1;CAV2;ATP5F1A;PDCD10;SCG2;XDH;SYNJ2BP;SPARC;NF1;ATP5IF1
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.4181791542200212,-1.4584970231762933,0.02926829268292683,0.3538704876397544,1.0,27/56,34.26%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFAF4;NDUFA12;NDUFV1;NDUFB7;NDUFA13;NDUFS1;NDUFB11;NDUFB10;NDUFA1;NDUFB4;NDUFS7;NDUFAF8;BCS1L;DMAC2;NDUFAF3;NDUFC1;ACAD9;NDUFS2;NDUFS5;NDUFAB1;TMEM126A;NDUFA3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4181791542200212,-1.4584970231762933,0.02926829268292683,0.3538704876397544,1.0,27/56,34.26%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFAF4;NDUFA12;NDUFV1;NDUFB7;NDUFA13;NDUFS1;NDUFB11;NDUFB10;NDUFA1;NDUFB4;NDUFS7;NDUFAF8;BCS1L;DMAC2;NDUFAF3;NDUFC1;ACAD9;NDUFS2;NDUFS5;NDUFAB1;TMEM126A;NDUFA3
prerank,regulation of water loss via skin (GO:0033561),-0.5585254710546604,-1.457880101064492,0.06019417475728155,0.3527679748035757,1.0,9/15,32.66%,LSR;MET;HRNR;ALOX12;STMN1;UGCG;SFN;ALOXE3;TMEM79
prerank,establishment of skin barrier (GO:0061436),-0.5585254710546604,-1.457880101064492,0.06019417475728155,0.3527679748035757,1.0,9/15,32.66%,LSR;MET;HRNR;ALOX12;STMN1;UGCG;SFN;ALOXE3;TMEM79
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5478300219171371,1.4573561591472144,0.07279693486590039,0.5488049008316543,1.0,9/23,10.26%,TGFBR3;DKK3;ITGA3;SMAD3;FOLR1;NREP;BCL9;LATS1;SMURF2
prerank,carbohydrate homeostasis (GO:0033500),0.4512062117527346,1.456733433792201,0.047619047619047616,0.5483176360835216,1.0,11/67,7.95%,LEPR;TCF7L2;APPL2;FGFR4;RBP4;PRKAA2;IGF1R;IL6;PRKAA1;MCU;SLC30A8
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5803154074244471,-1.4557764671240896,0.07630522088353414,0.35647570882233004,1.0,3/13,9.23%,ENTPD1;ENTPD7;ENTPD2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.5576222371654859,-1.4553576603094398,0.06412825651302605,0.3561715608187684,1.0,6/15,17.34%,REEP3;REEP1;RTN3;RTN4;ATL2;ARL6IP1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.36304352552023644,-1.454924536163208,0.0111731843575419,0.3558450841587161,1.0,41/110,22.98%,FNIP2;HSPA8;TFRC;HSP90AA1;GSN;DAB2IP;RPS3;RACK1;SH3GLB1;WARS1;TGFB1;HJURP;MPP7;FAF1;GSK3B;GFAP;VEGFA;CRYAB;NAPB;SPIDR;HSPA5;RALB;PIH1D1;TAL1;CLU;SVIP;IAPP;TPPP;RAF1;CDC42EP2;PREB;PINK1;TIRAP;NOP53;PEX5;MMP1;BIK;VCP;HDAC6;BMF;MTLN
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.39599976421074656,-1.4541641762197373,0.023076923076923078,0.3564221999375594,1.0,34/69,33.97%,PTPRJ;IL33;THBS1;PLCG2;LBP;HSPB1;PTPRC;APP;STAT3;OAS2;ARHGEF2;CLU;IFNGR1;IFIH1;MIF;PSEN1;TIRAP;TYROBP;FRMD8;DDT;AGER;CCR2;SPHK2;TLR4;RASGRP1;LPL;FADD;C1QTNF4;DHX9;MAVS;NOD2;TLR1;IL1A;SYK
prerank,peptide catabolic process (GO:0043171),0.5559103465277343,1.4539704173579995,0.08,0.5546028091351424,1.0,5/23,7.13%,CPQ;CTSH;ACE;TPP1;NPEPPS
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.569030083570665,1.4531053522458093,0.0674373795761079,0.5549658997722685,1.0,4/21,6.11%,DCDC2;TEDC2;TTC23;ARMC9
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.457361567481366,-1.4525021641510765,0.04424778761061947,0.3593029263423201,1.0,12/32,9.05%,APOD;ACER2;THBS1;ACVRL1;JAG1;ADAM15;SEMA3E;CORO1C;FAM107A;NEXMIF;MYOC;AJAP1
prerank,lamellipodium assembly (GO:0030032),-0.4836407422669607,-1.4520488874079343,0.06904231625835189,0.3590860541172814,1.0,11/26,12.41%,PARVB;ABLIM1;RAC1;CARMIL1;ITGB1;S1PR1;SPATA13;ARHGEF6;CCDC88A;WHAMM;CDH13
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4475675869936465,1.4515385408863288,0.05490848585690516,0.5577049639055704,1.0,12/67,5.40%,EFEMP1;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;FER;EPHA4;ABI2;PDGFRA;DDR1;IGF1R
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6577793185688305,1.4510954989156317,0.08993576017130621,0.5566026477002218,1.0,2/10,8.60%,ADGRV1;WHRN
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5659923985510855,1.4490071022206994,0.0673469387755102,0.5609951994014013,1.0,7/20,12.57%,IGF1;PDGFRB;CCN4;ACE;VTN;BMPR1A;SERPINE1
prerank,midbody abscission (GO:0061952),-0.5292596666238969,-1.448384052857769,0.07692307692307693,0.36662756422930404,1.0,10/17,30.92%,CHMP5;CHMP2B;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;CEP55;VPS4B
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.528151226022775,1.4478396831078975,0.07692307692307693,0.5624103693731514,1.0,8/28,13.05%,ARHGAP28;NAA80;ARHGAP40;COTL1;ARHGAP35;LATS1;GBA2;FCHSD2
prerank,negative regulation of locomotion (GO:0040013),-0.590653536610501,-1.4475516596635758,0.06464646464646465,0.3674831451750769,1.0,5/12,11.76%,FRMD5;CCDC125;CRK;DUSP3;SPINT2
prerank,renal system development (GO:0072001),0.4595570656614246,1.447155957877624,0.05140961857379768,0.5620916070027616,1.0,13/52,11.08%,GREB1L;WNT4;RBP4;LRP4;PCSK9;PYGO1;ARL3;ACE;SULF1;SALL1;IFT27;TFAP2A;TFAP2B
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.5983860842307398,1.4470272727179616,0.09591836734693877,0.5599790724659882,1.0,4/15,6.34%,SH3D19;SNX9;SNX33;NRDC
prerank,basement membrane organization (GO:0071711),0.629344551197309,1.4469544175242952,0.07692307692307693,0.5577635706063195,1.0,5/14,5.00%,NID2;FLRT2;PXDN;NID1;NTNG2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.3711120609892323,-1.4459204209214207,0.013262599469496022,0.37025489234462694,1.0,40/94,23.41%,RPS6KA5;UBB;NFKBIA;NOD1;IKBKB;ST18;IL1R1;RPS27A;UBC;IL1RAP;PSMD13;PSMF1;RBX1;PSMB10;CHUK;PSMB6;TOLLIP;PSME3;PSMB5;MAP3K3;PSMC3;IRAK3;PSMD12;PSMB8;CUL1;MAP3K8;TAB3;PSME1;UBA52;PSMB3;RPS6KA4;IRAK1;PSMD5;MYD88;SKP1;MAPK3;PSMD9;PELI1;PSMB4;RELA
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.562026244896451,1.4449450219804232,0.0762081784386617,0.5616390238113265,1.0,5/21,3.96%,ATP1A2;DMD;GSTM2;SLC8A1;ANK2
prerank,regulation of cell growth (GO:0001558),-0.3323283618124631,-1.4448423684432112,0.0,0.3717618091775677,1.0,62/204,22.84%,APBB2;SLIT2;PTPRJ;LTBP4;TFRC;ADAM10;ACVRL1;TGFB2;ADAM15;NDRG3;RACK1;SH3BP4;NET1;FHL1;BMPR2;CDK11B;SOX17;CCDC85B;SOCS2;RERG;BCAR1;CCN3;TGFB1;FAM107A;OSGIN2;CEACAM1;KIF26A;APBB1;MTOR;MFSD2A;H3-3A;RTN4;SESN2;EIF4G1;CDKN1B;LAMTOR1;NDUFA13;RPS6KA1;EGLN2;MT3;SPOCK1;NRG3;JADE1;LAMTOR2;CDA;CISH;SGK1;AGTR1;BST2;SUPV3L1;AKT1;WFDC1;PAPPA2;PAK5;BTG1;ESR2;CDKN1A;CDKN2D;PTCH2;OSGIN1;HYAL2;SIPA1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.43900306802762107,-1.4440185322407817,0.04772727272727273,0.3725223876004417,1.0,14/39,11.76%,PODXL;FXYD5;JAG1;CDH1;KLF4;PTK2;MBP;NOTCH1;TGFB1;NEXMIF;VEGFA;NOTCH4;BMP2;SPINT2
prerank,amino acid transmembrane transport (GO:0003333),0.47082526205252007,1.4436332937339358,0.06678082191780822,0.5633740321384102,1.0,8/45,6.64%,SLC7A11;SLC22A4;SLC6A13;SLC22A2;SLC38A3;SLC25A18;SLC38A9;LRRC8E
prerank,regulation of osteoblast proliferation (GO:0033688),0.5922804147183941,1.4434127053045693,0.0825147347740668,0.5617056769330329,1.0,3/17,2.73%,NPR3;FGFR2;LTF
prerank,cellular response to glucose starvation (GO:0042149),0.4894870511659959,1.4426910518618499,0.055062166962699825,0.5616635559256096,1.0,11/41,8.90%,PRKAG2;PRKAG3;SZT2;SIK1;CPEB4;SESN1;PRKAA2;MTMR3;PRKAA1;ATG14;PIK3R4
prerank,cellular response to BMP stimulus (GO:0071773),0.4390767245884536,1.44249279217552,0.04975124378109453,0.5599094150362001,1.0,10/66,7.68%,ADAMTS12;TGFBR3;BMP6;BMP7;SMAD6;SLC39A5;SCX;ADAMTS7;SMAD3;RGMB
prerank,odontogenesis (GO:0042476),0.5005233159946018,1.4419704432038225,0.06739526411657559,0.5591161585048174,1.0,8/35,10.71%,OSR1;FGFR2;WNT6;COL1A2;ANKRD11;BCOR;AXIN2;HDAC1
prerank,negative regulation of macrophage activation (GO:0043031),0.5943095354206616,1.4407648677141587,0.09533468559837728,0.5604111721701078,1.0,2/16,4.13%,IL31RA;SYT11
prerank,cell-substrate junction assembly (GO:0007044),-0.468453508448392,-1.4395848875502555,0.05869074492099323,0.3824777684516954,1.0,10/33,9.17%,FN1;THSD1;ITGA6;ITGB4;PLEC;ACTN1;FERMT2;LAMA3;BCR;PEAK1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.45979731652699873,1.4394685764175845,0.041025641025641026,0.5623345520141888,1.0,4/53,2.53%,EYA4;EYA1;EYA2;PLA2R1
prerank,response to amino acid (GO:0043200),-0.4716550797435128,-1.439359296599466,0.05176470588235294,0.38168689926430865,1.0,18/31,27.04%,SH3BP4;CAPN2;MTOR;SESN2;CPEB1;XBP1;GRIN1;LAMTOR1;SPAAR;LAMTOR2;GLRA3;RRAGB;TMBIM6;NSMF;LAMTOR4;GLRA1;MEAK7;RPTOR
prerank,positive regulation of blood coagulation (GO:0030194),-0.5441425119540761,-1.4392491711284368,0.06444906444906445,0.3806852139810592,1.0,3/17,2.38%,ST3GAL4;THBS1;F3
prerank,synaptic vesicle cycle (GO:0099504),-0.4788536515585674,-1.439034699036297,0.052083333333333336,0.37985913866871557,1.0,17/30,34.60%,STX1A;SLC17A6;SYNDIG1;SYT10;PCLO;CPLX2;SNAP25;PIP5K1C;SYT7;CDK5;RAB3A;OTOF;CPLX1;SNAPIN;SLC32A1;WNT7A;SLC17A8
prerank,heart morphogenesis (GO:0003007),-0.41627598849980335,-1.4386010708902084,0.05141388174807198,0.37964438962924685,1.0,16/50,11.74%,NOS3;ACVRL1;TGFB2;PTK2;ENG;NOTCH1;TBX1;HES1;SOX17;TBX2;TBX3;VEGFA;RYR2;HEY2;BMP2;HEYL
prerank,angiogenesis involved in wound healing (GO:0060055),-0.6188945222247412,-1.438520475473562,0.08007448789571694,0.3785629627154412,1.0,6/11,7.87%,ADIPOR2;CD34;KDR;GATA2;MCAM;VEGFA
prerank,sodium ion export across plasma membrane (GO:0036376),0.6200976334188586,1.4382461267779107,0.10080645161290322,0.5638312652549048,1.0,2/13,2.26%,ATP1A2;ATP1B3
prerank,peptidyl-asparagine modification (GO:0018196),-0.45859536682951313,-1.4380120335230961,0.05066079295154185,0.3785714654821189,1.0,14/31,24.85%,ST6GAL1;FUT8;MAGT1;STT3B;MCFD2;RPN1;MGAT1;DDOST;MGAT5;ALG5;MGAT2;ALG8;DPM1;UBE2J1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.6695737202638928,1.4376204990868202,0.1,0.5634625043597865,1.0,1/10,0.21%,ATP1A2
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.5136339564001369,-1.4362694076292113,0.07172131147540983,0.38198217983379,1.0,9/21,15.56%,PDE4D;NT5C2;NUDT3;HPRT1;PDE2A;NUDT4;HINT1;XDH;NT5E
prerank,membrane depolarization during action potential (GO:0086010),0.5305660637523975,1.435065630613508,0.08301158301158301,0.5693536839035727,1.0,4/26,4.74%,SCN7A;ATP1A2;SLC8A1;CACNA1D
prerank,actin filament bundle assembly (GO:0051017),0.5009616699159359,1.4349649076407727,0.08918406072106262,0.5673395041052358,1.0,9/33,7.18%,PAWR;RHOD;DPYSL3;SHROOM2;CALD1;BAIAP2;ESPN;BAIAP2L2;LIMA1
prerank,protein localization to cell-cell junction (GO:0150105),-0.5501020305413523,-1.4345755102024735,0.08048289738430583,0.385107375863739,1.0,8/15,9.55%,ACTB;ACTG1;TJP2;LSR;F11R;MPP7;TJP1;PAK2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.4710767587239736,1.4342851102599072,0.06968641114982578,0.5674535845685448,1.0,8/46,7.05%,IGF1;TCF7L2;IL18;OGN;PDGFRB;CCN4;IL6;XRCC5
prerank,glial cell development (GO:0021782),-0.48353300767472573,-1.4339452642181771,0.0851528384279476,0.3854388695822644,1.0,13/25,22.64%,SOX4;APP;CDK6;NRROS;PICK1;MT3;NF1;EIF2B5;TPPP;EIF2B2;SOX10;DLL1;SOX11
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.39389262620301385,1.4335084009619472,0.022488755622188907,0.567765964197851,1.0,19/129,10.26%,RNF220;WLS;LRRK1;PTK7;LGR4;FGFR2;ZEB2;TBL1XR1;LYPD6;GPC3;LRRK2;FRAT1;PSME4;PSMA2;PSMA3;USP34;PSMD8;AXIN2;SMURF2
prerank,negative regulation of histone methylation (GO:0031061),0.6507620646796687,1.4329586830075878,0.11715481171548117,0.5672490394113058,1.0,4/10,7.80%,AASS;JARID2;BCOR;MTF2
prerank,regulation of blood coagulation (GO:0030193),-0.478087693186856,-1.432934653303899,0.06198347107438017,0.3867706344842334,1.0,6/27,3.49%,ST3GAL4;CAV1;CD34;THBS1;FAP;SERPINE2
prerank,protein O-linked mannosylation (GO:0035269),0.5572329345327304,1.432338540370099,0.09505703422053231,0.5669595484158009,1.0,4/18,4.37%,TMTC4;LARGE1;TMTC1;CRPPA
prerank,positive regulation of chemotaxis (GO:0050921),-0.43425465422344767,-1.4310832236196593,0.051643192488262914,0.3900534145767124,1.0,11/43,7.87%,NTRK3;TMSB4X;KDR;THBS1;STX3;F3;LGMN;HSPB1;TGFB1;MET;VEGFA
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.5087818583908104,-1.4306721640581863,0.07462686567164178,0.38982503649833367,1.0,13/19,33.16%,CHMP5;CHMP2B;HNRNPU;CHMP1B;CHMP1A;CHMP3;HSPA1B;PDCD6IP;CHMP4C;DRG1;VPS4B;PLK1;HSPA1A
prerank,regulation of membrane repolarization (GO:0060306),-0.568328631009014,-1.4298720129127789,0.07984031936127745,0.39043526225417213,1.0,4/13,7.61%,CAV1;KCNJ2;NEDD4L;KCNQ1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.5126024961467224,-1.4270066126019743,0.05835010060362173,0.39696400347247435,1.0,12/22,34.90%,PTPRJ;CEACAM1;DUSP3;DGKZ;LAPTM5;THY1;CD300A;FCGR2B;EZR;GPS2;PTPN22;PHPT1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.43571554560094666,1.4260108269018672,0.05555555555555555,0.5850344562926745,1.0,11/65,9.50%,RORA;SLC8A3;EPAS1;BMP7;NDNF;CPEB2;CPEB4;BNIP3;NPEPPS;ACAA2;MDM2
prerank,regulation of interleukin-2 production (GO:0032663),-0.42574763372358443,-1.4259381614958608,0.0525164113785558,0.3985242227685162,1.0,8/43,8.53%,SPTBN1;PDE4D;CD34;RUNX1;PLCG2;RPS3;PTPRC;NAV3
prerank,positive regulation of macrophage activation (GO:0043032),-0.5427170134174121,-1.4254220973027427,0.06326530612244897,0.3986754253956573,1.0,9/17,31.10%,IL33;THBS1;LBP;HSPD1;CEBPA;TREM2;KARS1;TLR4;TLR6
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5682053350040999,-1.4253144946991743,0.05938697318007663,0.39764101568882976,1.0,4/14,5.70%,PRKG1;MEF2C;SLIT2;IGFBP5
prerank,circulatory system development (GO:0072359),-0.3494773475484541,-1.4250595400048818,0.0031746031746031746,0.3968704894504953,1.0,38/118,17.66%,MEF2C;TEK;NTRK3;FN1;HEG1;MICAL2;ACVRL1;TGFB2;RAMP2;NOTCH1;TBX1;CXADR;PKD1;SOX17;STRA6;TGFBR2;SOX4;TGFB1;CRIP1;PDLIM7;FLT4;NOTCH4;LDB3;HEY2;ECE1;CDKN1B;CACNA1C;BMP2;SOX18;SMYD4;NF1;NXN;COL3A1;CASP8;APLNR;DVL2;ACVR1;ID2
prerank,positive regulation of GTPase activity (GO:0043547),-0.33312076953230463,-1.4247004118400313,0.006666666666666667,0.3965245481998378,1.0,48/188,12.37%,DOCK9;NTRK3;RAP1A;SIPA1L1;RGS6;ITGA6;TIAM1;BCAR3;TBC1D30;PKP4;ARHGAP42;ITGB1;AGRN;TBC1D8;SIPA1L2;F11R;ARHGAP27;CAV2;RACK1;SEMA4D;SIPA1L3;NET1;DOCK10;ARHGEF15;CCDC125;RABGAP1L;LIMS1;TGM2;CORO1C;FERMT2;ADPRH;ABR;GRTP1;GSK3B;SGSM1;BCR;TBC1D8B;TBC1D1;ARHGEF19;TBC1D13;ARHGEF26;ARHGAP25;ARHGEF5;ARHGEF10;EVI5;RANGAP1;S100A10;TBC1D10A
prerank,retrograde axonal transport (GO:0008090),-0.5412585426856334,-1.4236869509791112,0.08651911468812877,0.3978384038087993,1.0,10/16,32.71%,DLG2;ACTR10;SOD1;KIF1A;TMEM108;NEFL;MAP1A;HAP1;KIF5B;DYNC1H1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5959541744368626,-1.4235719905632214,0.08,0.39682778728180856,1.0,3/12,2.97%,FOXP1;KLF4;MBP
prerank,cellular response to acid chemical (GO:0071229),-0.48479895467246636,-1.423307484197,0.04408352668213457,0.3961509345211065,1.0,16/27,27.04%,KLF2;SH3BP4;CAPN2;VEGFA;MTOR;SESN2;CPEB1;XBP1;LAMTOR1;SPAAR;LAMTOR2;RRAGB;NSMF;LAMTOR4;GLRA1;RPTOR
prerank,response to metal ion (GO:0010038),-0.38813122229249436,-1.422991403078577,0.028423772609819122,0.39574961162711453,1.0,21/67,15.65%,CAV1;THBS1;TRPC3;CALM1;NEDD4L;MT1A;MT1X;KCNMA1;HOMER1;SLC30A5;CRIP1;ATP5F1D;MT2A;GPHN;PPP1CA;PPP3CA;MT3;ITPR3;AHCYL1;CALM2;TRPC1
prerank,regulation of stress fiber assembly (GO:0051492),0.43178833551129797,1.422787837068363,0.044657097288676235,0.5934892603058262,1.0,17/74,10.73%,ARHGAP28;ROCK2;ARHGAP6;CGNL1;TPM1;LPAR1;FHOD1;CCN2;ALMS1;PPM1E;PHLDB2;ASAP3;RHPN2;ARHGEF10L;ARHGEF18;ABL1;PIK3R1
prerank,positive regulation of cell migration (GO:0030335),-0.3195898390061795,-1.422772443591052,0.0037313432835820895,0.3951135690298756,1.0,66/253,12.50%,LEF1;GAB1;NTRK3;FN1;PECAM1;PODXL;CAV1;ACTG1;SEMA6A;ACTN4;SEMA7A;ITGA6;TIAM1;SEMA6D;KDR;THBS1;ADAM10;TGFB2;CARMIL1;SEMA3C;F3;PTK2;ITGB1;DOCK1;PLCG2;ROR2;PTK2B;DAB2IP;NOTCH1;RACK1;SEMA4D;BMPR2;SEMA3E;SHTN1;BCAR1;TGFB1;FAM107A;FERMT2;PTPRC;PDGFC;MYOC;PDCD10;VEGFA;TJP1;MTOR;PAK1;CPNE3;GRN;SEMA4B;EDN1;SEMA5B;RTN4;SEMA6C;APC;XBP1;PIK3CD;HSPA5;STAT3;BMP2;GCNT2;SEMA3G;TWIST2;GPER1;RIPOR1;CDH13;ARHGEF2
prerank,positive regulation of programmed cell death (GO:0043068),-0.3169618377196631,-1.4227224177405449,0.0,0.3940012517165293,1.0,67/272,15.45%,UNC13B;SLIT2;MAP3K5;MCF2L;ITGA6;TIAM1;RASSF2;TRIO;ARHGEF3;ITGB1;KCNMA1;DAB2IP;NGF;RASGRF2;UBB;RACK1;DNAJA1;CTSD;ARHGEF12;NET1;TNFSF10;PREX1;ATG7;SFRP4;TGM2;RPS6;ARHGEF17;SOX4;ARHGEF6;RHOB;CTNNB1;SOD1;FAF1;ABR;RPS27A;UBC;APBB1;HIP1R;DNM2;JUN;FOXO1;ARHGEF19;DDX20;ARHGEF26;MAPK8;ING4;APC;ARHGEF5;ATF4;BMP2;BIN1;GPER1;RYBP;REST;HSPD1;ARHGEF2;CLU;RNPS1;GADD45G;NLRP2B;IAPP;PLEKHN1;NF1;FAS;CYP1B1;CASP8;UBA52
prerank,prostaglandin biosynthetic process (GO:0001516),-0.5292722552931752,-1.422031815824251,0.08118811881188119,0.39456127890204745,1.0,10/18,29.95%,PTGIS;PTGS2;EDN1;PTGDS;CD74;PLA2G4A;MIF;HPGDS;PRXL2B;CBR1
prerank,negative regulation of receptor binding (GO:1900121),-0.6168945504915024,-1.4218314838830175,0.07421875,0.39380508208196835,1.0,4/10,7.36%,B2M;ADAM15;ATP2A2;ATP2A3
prerank,carboxylic acid transmembrane transport (GO:1905039),0.48283869412634267,1.4217507536869465,0.0631768953068592,0.5946452815067366,1.0,10/40,12.29%,SLC7A11;SLC13A3;SLC38A3;SLC38A9;SLC25A11;SLC27A1;SLC19A1;SLC36A2;SLC38A7;SLC38A2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.48983237270203506,1.4215504692579561,0.06972477064220184,0.5929580875086027,1.0,5/37,4.46%,PRKAG2;CEMIP;BMP7;PARD3;SPHK1
prerank,T cell homeostasis (GO:0043029),-0.6184011156797858,-1.4211344402530286,0.0807899461400359,0.3943116686343544,1.0,8/10,30.53%,ZC3H8;FAS;JAK3;PPP2R3C;AKT1;NCKAP1L;FADD;PMAIP1
prerank,response to ketone (GO:1901654),-0.48205137577283713,-1.420883115470936,0.07246376811594203,0.39366891908132734,1.0,8/24,8.78%,ABHD2;SLIT2;CAV1;THBS1;TGFB2;UBE3A;TGFB1;WBP2
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.4960738815123414,-1.4208428205751826,0.05928853754940711,0.39252533955145086,1.0,10/23,17.98%,UBB;COPS7A;RPS27A;UBC;DDB1;RBX1;UBA52;COPS8;COPS6;CETN2
prerank,cell junction organization (GO:0034330),-0.3875954455544284,-1.4198399593651456,0.03826530612244898,0.39377724022317406,1.0,20/71,9.24%,APBB2;ACTB;ACTG1;OCLN;TJP2;LIMS2;TGFB2;CTNND2;AGRN;CXADR;SEMA3E;LIMS1;FLNA;TGFB1;FERMT2;VMP1;PPFIA2;APP;TJP1;RHOA
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3806530152664189,1.4192836873569514,0.029185867895545316,0.5981132772125859,1.0,32/161,12.56%,BICC1;IGFBP2;TCF7L2;MCC;PRKN;LRP4;DAB2;DKK3;RBMS3;DKK1;IGFBP4;PRICKLE1;INVS;TMEM64;TLE3;ZNRF3;GLI3;PSME4;PSMA2;PSMA3;SIAH2;AMFR;TLE1;PSMD8;AXIN2;DVL3;LATS1;HDAC1;PSMD3;CYLD;SOX13;TMEM170B
prerank,catecholamine metabolic process (GO:0006584),0.6009515526244759,1.4192086893854854,0.1054945054945055,0.5959720175317708,1.0,5/14,16.96%,PRKN;SNCAIP;RNF180;LRTOMT;DRD2
prerank,response to glucagon (GO:0033762),0.5492384927206664,1.4190047651342035,0.08484848484848485,0.5942889109447084,1.0,2/19,0.71%,ADCY5;ADCY1
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.5044089131452832,-1.4183080351685866,0.06832298136645963,0.3963128649777478,1.0,5/22,12.42%,B2M;STX7;CD55;CYRIB;HSPD1
prerank,protein localization to plasma membrane (GO:0072659),-0.3431762433830849,-1.4179195956884307,0.008928571428571428,0.39595923942935923,1.0,37/129,13.95%,SPTBN1;BSG;RAP1A;EFR3B;GAS6;CDH1;SLMAP;KCNB2;EHD4;RAMP2;F11R;RAB3C;ATP1B1;KCNB1;FLNA;MAP7;IKBKB;NKD2;EHD1;CCDC88A;WNK3;PTCH1;RAMP1;TMED2;EMP2;ZDHHC2;TTC7A;TSPAN17;C2CD5;RAB3B;MYO5A;S100A10;SPTBN4;EHD3;CACNB2;CD81;JUP
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5288011382685711,-1.4175094084629347,0.0856610800744879,0.3958270762748433,1.0,6/17,20.04%,PTPRJ;CEACAM1;DUSP3;DGKZ;LAPTM5;THY1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.6083772267642629,-1.4165743563362785,0.07400379506641366,0.3968589048676705,1.0,5/11,20.29%,NOTCH1;FOXO1;LMNA;GLRX3;ATP2B4
prerank,aminoglycan biosynthetic process (GO:0006023),0.46083513670577286,1.4160623872184657,0.06944444444444445,0.6016852905210541,1.0,14/49,12.62%,B3GALT1;HS3ST3A1;PXYLP1;SDC2;HS3ST3B1;GPC6;GPC3;HAS1;XYLT2;B3GALT6;NDST2;HS6ST1;UGDH;GPC4
prerank,response to ATP (GO:0033198),-0.5317785503577229,-1.4158501947753666,0.07074569789674952,0.3974239575369537,1.0,13/18,42.72%,ABCC9;TRPC3;HSP90B1;SSH1;DGKQ;P2RY12;P2RY1;P2RX7;P2RX3;P2RY2;PDXP;CIB2;KCNJ11
prerank,transcription by RNA polymerase II (GO:0006366),0.35665651857938896,1.414217615546523,0.007957559681697613,0.6052143929832966,1.0,52/305,14.27%,GLIS3;RORA;SOX5;MAF;RBPJ;PPARA;NOTCH2;POLR2D;PRRX1;PHAX;ESRRG;CCN2;NR1I2;TBL1XR1;PAX5;CDK7;MAML3;ELOA;SSU72;TEAD1;MAML1;HSF2BP;INTS8;NR6A1;NRBP1;POLR2A;CCNT2;TEAD3;RPRD1B;CCNT1;GTF2F1;SNAPC5;MED1;TAF8;HDAC1;TAF1A;DTX1;RPRD2;RXRA;TAF3;CDC73;ICE2;GMEB2;GTF2I;AR;MAML2;NR1I3;WDR33;TRIM24;CREBBP;MNAT1;NELFB
prerank,extracellular matrix organization (GO:0030198),0.3563463572937273,1.4138488775172613,0.013227513227513227,0.6040177777522244,1.0,40/276,6.29%,COL22A1;ADAMTS12;NID2;COL26A1;ADAMTS9;LAMC3;COL4A5;ADAM12;ITGA9;FBN1;COL4A6;SMOC2;LAMA2;ADAMTS5;THSD4;FBLN5;ADAMTS10;FBN2;KLK2;FLRT2;ADAMTS15;TNC;PXDN;LOXL1;COL9A2;SCX;NID1;LOXL3;NDNF;SMOC1;MMP2;ITGAX;COL1A2;SH3PXD2B;COL13A1;DDR1;ITGA3;ADAMTS7;MMP19;COL18A1
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.5706256541916594,-1.4138038010611962,0.09351145038167939,0.4012744299680249,1.0,5/12,12.32%,JAG1;NOTCH1;HES1;HNRNPU;REST
prerank,ureteric bud development (GO:0001657),0.5651991056831924,1.4136659988048317,0.10975609756097561,0.602220971214922,1.0,5/17,6.81%,OSR1;FGFR2;BMP7;GPC3;SALL1
prerank,protein-containing complex disassembly (GO:0032984),-0.4050786414965244,-1.4134007304713003,0.03614457831325301,0.4010644587022347,1.0,17/54,22.45%,CAV1;HSPA8;RPL23;CTNNB1;VTI1B;VAMP8;GSK3B;MAP1LC3B;PYM1;APC;PPP1CA;SNX14;DVL2;GABARAPL1;VCP;CHMP3;LIX1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.3704903574553124,-1.4133714670621582,0.02040816326530612,0.3998950950937483,1.0,25/88,13.88%,STXBP6;FTH1;HSPA8;EXOC6;FTL;MON2;CLINT1;EXOC4;VPS13A;VPS13C;CLVS2;CLVS1;VAMP8;ARRB1;GOPC;ARF1;DNM2;APP;GOLGA7;EXOC5;SCAMP1;HGS;MYO5A;SCAMP2;AP1S2
prerank,cellular copper ion homeostasis (GO:0006878),-0.5528523517096455,-1.4132758347624035,0.08761904761904762,0.39891343405421287,1.0,5/14,7.70%,ATOX1;SLC31A1;MT2A;ARF1;APP
prerank,amino acid import across plasma membrane (GO:0089718),0.5368988098777898,1.412455864158658,0.0975609756097561,0.6038471556275999,1.0,5/24,2.16%,SLC22A4;SLC6A13;SLC22A2;SLC6A9;SLC1A3
prerank,metal ion export (GO:0070839),0.4924445596631454,1.4121937524579384,0.0946969696969697,0.6024194189286085,1.0,5/31,4.07%,ATP1A2;KCNA5;ATP1B3;KCNT2;KCND3
prerank,cellular glucose homeostasis (GO:0001678),-0.4298991804971813,-1.411646808544,0.0525164113785558,0.4018156664554711,1.0,14/41,13.37%,UNC13B;LRRC8D;GAS6;PPARGC1A;RACK1;KCNB1;SOX4;HK1;FOXO1;LRRC8A;XBP1;GPER1;SLC39A14;FOXK1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5218900784274577,1.411246412432856,0.08190476190476191,0.6032290366306836,1.0,7/25,8.55%,WNK4;DMD;SLC6A9;ATP1B3;ANK2;TCAF1;COX17
prerank,negative regulation of viral transcription (GO:0032897),-0.565851125602829,-1.4109501723215518,0.07751937984496124,0.402437722209053,1.0,7/13,20.75%,TRIM14;LARP7;TRIM13;MID2;TRIM27;IFITM3;UBP1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6201294959287637,-1.4099597262811647,0.09038461538461538,0.4036885343057658,1.0,7/10,15.88%,PDE4D;PDE3A;PDE2A;RNF157;UBE2B;PDE11A;APLNR
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3195478789601487,1.4095147890050292,0.0,0.6066504003081761,1.0,288/1667,13.20%,IGF1;GLIS3;CREB5;PRDM6;RORA;SOX5;BMP6;MAF;VGLL3;TCF4;TCF7L2;OSR1;AUTS2;AEBP1;ARNT2;RBPJ;ZIC1;ZNF462;HOXC6;FGFR2;FHL2;EPAS1;HLF;PPARA;KDM7A;NR2F2;PID1;NPAS3;IKZF2;IL18;KIT;HOXC4;CDK8;PRKN;WWOX;ATXN1;BRD8;ZEB2;ZKSCAN2;KCNIP3;KMT2A;PRRX1;MEIS1;DAB2;HOXB4;ESRRG;ARID5B;FHOD1;CSRP3;MXI1;FNIP1;CUX1;SMAD6;AASS;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DKK1;DMRT1;SCX;NR1I2;ASCL2;SOX6;TBL1XR1;CITED4;ZBTB20;SP100;PPARGC1B;HOXB3;RNASEL;TSHZ3;HIF3A;PAX5;NFYB;EPOP;MIDEAS;ZIC5;HOXA3;CDK7;BBX;IGF2;SSBP2;HOXC5;PKNOX2;TFR2;VSX2;NCOA2;STAT5B;JAZF1;MAML3;NFAT5;ELOA;ZFP90;HDAC8;HOXA7;FOXD1;ZHX2;SSU72;NFIB;TEAD1;ELF4;MGA;BAZ1B;ARID4A;TEF;ZNF367;RNF2;ARID1B;FIZ1;TNRC6B;IKZF4;GMEB1;KDM2B;CAMTA1;SOX1;SIX5;SALL4;ZFHX2;WASL;DPF2;IRF8;SP110;TNRC6A;ZNF250;FGF1;GLI3;PRKCB;ZNF569;TET1;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;ZMIZ1;ZFP37;BAZ1A;MAML1;PHF8;CXXC5;BCOR;SUFU;DLG1;THAP1;WWC1;IL6;WWC2;SALL1;NCOA3;RFXAP;ZNF23;KANK2;SMAD3;SSBP3;PHF14;EN1;PBX4;CHD4;PTEN;NCOA7;NR6A1;GABPB1;GABPB2;MTF2;PHF21A;ZKSCAN5;KDM2A;TCF12;ABRA;CCNT2;TEAD3;PER3;WWP2;LYAR;PIAS1;CBX8;RPRD1B;DNAJA3;RSF1;CCNT1;NFIA;PCGF5;ARNT;CBX2;GTF2F1;FSTL3;KAT8;KDM5B;CDK1;CAMK2D;MITF;KDM6B;KAT6B;CEBPG;KDM3B;EBF4;MDM2;IER5;NFYC;HOXB6;CREB3L2;NSD1;BATF2;IRF3;BCL9;MED1;AKAP8L;BBS7;DVL3;AGO2;ZSCAN29;FRK;SMURF2;IRX1;PHIP;ASXL2;ABL1;MED13;PRKDC;PARP9;SMARCA5;ATOH8;NEUROD2;HDAC1;PIK3R1;TSHZ1;FLCN;TFAP2A;TADA2A;CBX7;SMARCE1;ZNF8;HOXC8;TFAP2B;ARID3A;ZIC4;ZNF568;RXRA;ERBB2;TGFA;ZBTB38;MYB;ZBTB39;NPAS2;TAF3;BMPR1A;BCLAF3;ZBTB37;CRY1;CNOT2;ZNF177;RNF14;CDC73;E2F6;ORC2;SOX13;GMEB2;HSF1;PRKD2;PKD2;AR;HIVEP1;SERPINE1;PHF6;KLF5;CRTC1;MAML2;EZH1;SEBOX;CRTC3;GDNF;ZMIZ2;INO80;SMARCB1;PPIL4;CGGBP1;IFI27;HOXD4;NFATC4;TBK1;HOXA6;BCL2L12;NR1I3;EPC2;FOXK2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.4592686487468143,-1.4094751622883561,0.06209850107066381,0.4036943767261731,1.0,13/30,23.86%,CAV1;SEMA4D;PTPRC;SRCIN1;CADM4;SAMSN1;SH2B3;INPP5F;THY1;PRKCD;CD300A;HYAL2;SOCS1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.34917943578246946,-1.4089400207095955,0.022222222222222223,0.4037514373827635,1.0,33/118,10.03%,FMNL2;MEF2C;EFNA5;SHANK3;SIPA1L1;BMPER;PLXND1;NEDD4L;ETS1;CDH2;PHLDB1;CHN1;SEMA4D;TBX1;WARS1;INF2;TGFB1;ZDHHC15;FERMT2;CTNNB1;PPFIA2;GSK3B;CEACAM1;ZRANB1;FLT4;EMP2;ABI3;PAK1;CYRIB;LFNG;SRCIN1;PAK2;KIF1A
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5536566959917577,1.4089147643901017,0.09351145038167939,0.6061938408335494,1.0,1/19,0.03%,IGF1
prerank,positive regulation of hydrolase activity (GO:0051345),-0.3410203949048975,-1.4081317310534325,0.020348837209302327,0.4046665915951696,1.0,35/137,15.65%,DOCK9;RAP1A;RGS6;ITGA6;CD200;BCAR3;TBC1D30;PKP4;CALM1;ITGB1;AGRN;F11R;ARHGAP27;CAV2;PSAP;RPS3;RACK1;SEMA4D;NET1;DOCK10;LIMS1;TGM2;FERMT2;GSK3B;RHOA;MAPK8;BMP2;NDUFA13;EVI5;S100A10;MTMR9;MTCL1;NF1;CALM2;RGS10
prerank,B cell receptor signaling pathway (GO:0050853),-0.4544435022734762,-1.4081053466318456,0.06423982869379015,0.40347735587134886,1.0,10/32,10.16%,MEF2C;PLCG2;BMX;RFTN1;BCAR1;NFATC2;CD38;PTPRC;PLEKHA1;PIK3CD
prerank,positive regulation of histone methylation (GO:0031062),0.5282243238937978,1.4079620812949778,0.10133843212237094,0.6071099451665029,1.0,9/24,17.39%,AUTS2;KMT2A;JARID2;TET1;MTF2;MYB;SMAD4;PHF1;CTR9
prerank,positive regulation of cell differentiation (GO:0045597),0.3636524272292167,1.40786255250077,0.01646090534979424,0.6051274175712446,1.0,35/237,8.63%,IGF1;RANBP3L;SOX5;BMP6;TCF4;RIN2;WNT4;IL18;BMP7;MEDAG;FBN2;DAB2;HOXB4;CCN2;ZEB1;PLA2G10;LTF;SOX6;PLCB1;CCN4;PDPN;RIPOR2;MAPK9;GLIPR2;GJA1;TMEM64;PTN;IL6;SMAD3;NBL1;LMO3;DDR2;CSF1;SYAP1;ATRAID
prerank,negative regulation of gluconeogenesis (GO:0045721),0.6333875384514164,1.4076455888596684,0.11498973305954825,0.6035267442025919,1.0,5/11,17.99%,C1QTNF3;SIK1;CRY1;GCK;C1QTNF12
prerank,negative regulation of mRNA processing (GO:0050686),-0.539278945464586,-1.4075403123615766,0.08167330677290836,0.4036801477704443,1.0,7/15,28.92%,SRSF9;RNPS1;SRSF6;PCBP4;PTBP1;BARD1;SRSF7
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5451282609121353,1.4072359408261368,0.11909650924024641,0.6025608309071034,1.0,6/21,11.76%,IGF1;MMP2;GJA1;MMP9;FGF9;BMPR1A
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5928007179974499,1.4067898373261734,0.11940298507462686,0.6016797019961901,1.0,2/13,1.91%,ERRFI1;SNX6
prerank,regulation of fibroblast migration (GO:0010762),-0.5118121978746348,-1.4057247182153267,0.07889125799573561,0.40731473929349327,1.0,9/20,9.39%,PRR5L;THBS1;RAC1;PTK2;ITGB1;CORO1C;TGFB1;GNA12;APPL1
prerank,negative regulation of ossification (GO:0030279),0.528201207911887,1.4056201783153357,0.11044176706827309,0.6031632495942754,1.0,7/23,6.35%,RBPJ;LRP4;SMAD6;DKK1;ECM1;CHSY1;BCOR
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.48135998731683616,-1.405250653842079,0.07128309572301425,0.40728263005180537,1.0,11/23,19.57%,ELOVL7;FAR2;ELOVL5;ACSL4;FAR1;ELOVL6;DGAT1;ELOVL1;ACSL3;TECR;ACSL5
prerank,aorta development (GO:0035904),0.5972110380828647,1.405199361540286,0.11244979919678715,0.6022061132164028,1.0,3/14,2.95%,ADAMTS9;ROBO1;PDGFRB
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4393129308293085,-1.405189768437191,0.05895196506550218,0.4062340380696236,1.0,15/35,18.96%,ESR1;PLPP1;UBE3A;RBFOX2;KDM3A;DDX5;WBP2;TMF1;DDX54;GPER1;EGLN2;NCOA4;NR3C2;DDX17;PADI2
prerank,regulation of proteolysis (GO:0030162),-0.4124273034477781,-1.4042230166437568,0.053811659192825115,0.4075301030459765,1.0,19/48,21.92%,CAV1;LTBP4;CST3;SERPINE2;PERP;NEDD8;BAG6;DNAJC1;OGT;TBC1D10A;CASP8;SPOPL;CLN8;CDK5;PLAUR;CAMK2N1;CYFIP2;AKT1;HDAC6
prerank,regulation of hydrolase activity (GO:0051336),-0.3850560609299566,-1.4040747017465791,0.04087193460490463,0.4066971585649153,1.0,14/71,4.41%,PRKG1;CHN2;FGD5;EFNA5;CAV1;FGD6;SIPA1L1;PLXND1;PTK2;RASIP1;ARHGAP27;DAB2IP;CHN1;PLXNA4
prerank,protein targeting to mitochondrion (GO:0006626),-0.40677119831604025,-1.4040414851607006,0.043478260869565216,0.4055765363267185,1.0,23/52,29.75%,HSP90AA1;FBXO7;TOMM20;NDUFA13;TOMM22;HSPD1;TIMM9;ROMO1;TIMM10B;TIMM13;BCAP31;TIMM29;TIMM22;TOMM7;MFN2;TIMM50;FIS1;TIMM44;TSPO;AIP;CHCHD4;DNLZ;TOMM34
prerank,regulation of macrophage migration (GO:1905521),-0.6096458594877102,-1.4023582363732265,0.07330827067669173,0.4085672015625291,1.0,5/10,15.75%,MTUS1;CD200;PTK2B;CD81;CX3CR1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.5088797487156924,-1.4016278746033815,0.0891304347826087,0.4093319433132084,1.0,9/18,13.76%,HEG1;RASIP1;CCDC125;KANK1;MET;CUL3;MYOC;KCTD13;STMN1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.49672703589543843,1.4014860163891065,0.10037878787878787,0.6121356780335137,1.0,12/30,13.00%,TGFBR3;DKK3;ITGA3;SMAD3;FOLR1;NREP;FSTL3;BCL9;LATS1;SMURF2;TFAP2B;FSTL1
prerank,regulation of histone methylation (GO:0031060),0.6085431149091889,1.401238027931277,0.11516314779270634,0.6105479051202327,1.0,7/13,17.83%,AASS;JARID2;MTHFR;TET1;NSD1;CTR9;NNMT
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5034567500335694,1.4007055620155973,0.08752327746741155,0.610017678314149,1.0,2/30,1.17%,IGF1;NOTCH2
prerank,microvillus organization (GO:0032528),-0.5663612615204638,-1.4004896135384721,0.08494208494208494,0.41086672814049663,1.0,3/13,4.05%,RAP1A;FXYD5;MINK1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.37725437041809823,-1.4003949772911253,0.046632124352331605,0.40988833646264944,1.0,34/73,33.97%,PTPRJ;IL33;THBS1;PLCG2;LBP;HSPB1;PTPRC;APP;STAT3;OAS2;ARHGEF2;CLU;IFNGR1;IFIH1;MIF;PSEN1;TIRAP;TYROBP;FRMD8;DDT;AGER;CCR2;SPHK2;TLR4;RASGRP1;LPL;FADD;C1QTNF4;DHX9;MAVS;NOD2;TLR1;IL1A;SYK
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5127005565961253,1.399394133759853,0.11487758945386065,0.6121393053889046,1.0,5/26,5.20%,PRKAG2;LPGAT1;SLC45A3;ACADL;PRKAA2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5292522515150568,-1.3992444045428676,0.0836734693877551,0.4116352999462194,1.0,9/16,28.21%,TPT1;ACKR3;RPS3;BCL2L1;CLU;CXCL12;CDKN2D;SNAI2;TMEM161A
prerank,intestinal lipid absorption (GO:0098856),0.6194293516145186,1.3991680975262033,0.12751677852348994,0.6106608993141477,1.0,3/11,10.19%,CEL;LIMA1;SOAT2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5420961995937634,1.3990744647791293,0.11614173228346457,0.6086858352228537,1.0,7/21,13.12%,BMP6;DAB2;RBPMS;SLC2A10;JAK2;BMPR1A;VEPH1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.579896895649967,-1.3990277567739628,0.09230769230769231,0.4109903562271614,1.0,4/11,9.37%,TGFB2;JAG1;SOX4;HEY2
prerank,nitric oxide biosynthetic process (GO:0006809),-0.5680349760020006,-1.3988471053476599,0.09532710280373832,0.41025796196690567,1.0,7/13,22.38%,NOS3;GCH1;NOS1;CYP1B1;CYB5R3;AKT1;DDAH2
prerank,embryonic limb morphogenesis (GO:0030326),0.4911006098491397,1.3985714730333285,0.08921933085501858,0.6080265223887004,1.0,9/34,10.88%,CYP26B1;OSR1;INTU;FBXW4;GLI3;SALL1;WDPCP;HDAC1;TFAP2A
prerank,response to ethanol (GO:0045471),-0.5434534819520047,-1.3982642564032128,0.07869481765834933,0.4105854489956856,1.0,5/14,12.88%,SOD1;GRIN3A;ADCY7;GRIN1;SDF4
prerank,organic cation transport (GO:0015695),0.558402166677431,1.3978339912846958,0.1191919191919192,0.6082657136379362,1.0,2/20,0.70%,SLC22A4;SLC22A2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.36349394020275777,1.3977995730146484,0.02676056338028169,0.6062040006485492,1.0,27/199,6.78%,ALDH1A1;ROBO1;ROCK2;NPR3;LGR4;RBPJ;MCC;LRP4;ADAMTS5;NOVA1;SMAD6;DKK1;SLAMF8;ADM;CRHBP;SYT11;HOXA7;DUSP10;MAP2K6;NFIB;GJA1;TLE3;CHSY1;SFMBT1;NRDC;WWC1;WWC2
prerank,nitric oxide metabolic process (GO:0046209),-0.5556804655268405,-1.397393734049541,0.09633911368015415,0.4116688832009178,1.0,7/14,22.38%,NOS3;GCH1;NOS1;CYP1B1;CYB5R3;AKT1;DDAH2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3909902738553804,1.3968034173787252,0.037914691943127965,0.6073063064202481,1.0,12/121,6.79%,IL31RA;IGF1;BMP6;IL34;IL18;KIT;ANGPT1;IGF2;EPHA4;ACE;IL6;ENPP2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6032285989319716,1.3959490623051292,0.10828025477707007,0.6079634773748951,1.0,3/13,1.00%,TGFBR3;RBPJ;FGFR2
prerank,regulation of steroid biosynthetic process (GO:0050810),0.6243896968997426,1.3954008399182691,0.12882096069868995,0.6075715601665479,1.0,2/11,1.01%,WNT4;FGFR4
prerank,transepithelial transport (GO:0070633),-0.5321815579602693,-1.3951133129633218,0.09788867562380038,0.41616265032228195,1.0,4/15,4.32%,ABCG2;SLC12A2;CXADR;SLC1A1
prerank,positive regulation of cellular senescence (GO:2000774),-0.5914927728035848,-1.3941944175950913,0.09498207885304659,0.41725596722389663,1.0,4/10,16.93%,B2M;YPEL3;ABI3;EEF1E1
prerank,regulation of protein localization to membrane (GO:1905475),-0.4661459011919424,-1.3940995564459322,0.07625272331154684,0.4162977611122283,1.0,11/28,12.06%,SPTBN1;ACTB;GSN;FYN;STX7;VTI1B;VAMP8;ZDHHC2;ZDHHC7;APPL1;GPC1
prerank,keratan sulfate catabolic process (GO:0042340),0.6168461959935988,1.3938757580460923,0.11178861788617886,0.6102311200007627,1.0,4/11,5.37%,FMOD;OGN;OMD;PRELP
prerank,cytoplasmic translational initiation (GO:0002183),-0.5248372108228041,-1.3936420103544425,0.08450704225352113,0.41628629813651313,1.0,9/17,23.59%,EIF3I;EIF4G1;EIF3D;EIF4H;DHX29;EIF2D;EIF3A;EIF4B;EIF5
prerank,long-chain fatty acid transport (GO:0015909),0.5053618002781045,1.3933909343001492,0.09108527131782945,0.6097003545882959,1.0,6/30,10.77%,PRKAG2;ACSL1;PRKAA2;CPT2;SLC27A1;RPS6KB1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6051772095531035,1.392764143575702,0.14132762312633834,0.6096107693003652,1.0,2/13,3.75%,B3GALT1;GAL3ST3
prerank,diol metabolic process (GO:0034311),-0.5058175618225639,-1.392352454234199,0.07474747474747474,0.41848084222889004,1.0,6/19,4.38%,NOS3;PLPP1;HSP90AA1;CALM1;DEGS2;GCH1
prerank,regulation of cell migration (GO:0030334),-0.2978673695547855,-1.3917420130137947,0.0,0.4189120695572143,1.0,100/382,12.41%,LEF1;FRMD5;NTRK3;SLIT2;PECAM1;LIMCH1;PODXL;CAV1;PTPRJ;TMSB4X;CLDN5;TMEFF2;ACTG1;SEMA6A;ACTN4;SEMA7A;PRR5L;ITGA6;TIAM1;CLIC4;SEMA6D;KDR;THBS1;ADAM10;RAC1;ACVRL1;CARMIL1;DACH1;JAG1;CDH1;PLXND1;SEMA3C;F3;PTK2;ITGB1;ADAM15;ADARB1;ROR2;SLK;ENG;PTK2B;NOTCH1;SERPINE2;RACK1;SEMA4D;DOCK10;MCTP1;TMSB10;MINK1;SEMA3E;PLXNA4;SRGAP1;FLNA;KANK1;CORO1C;BCAR1;SPATA13;RHOB;TGFB1;FAM107A;IGFBP5;FERMT2;ROBO4;GNA12;CEACAM1;PDGFC;MYOC;PDCD10;VEGFA;TJP1;ABI3;PAK1;CYRIB;NAV3;FGF7;SRCIN1;CPNE3;GRN;SEMA4B;RHOA;PODN;EDN1;APPL1;SEMA5B;SEMA6C;APC;XBP1;PIK3CD;HSPA5;STAT3;BMP2;GCNT2;YTHDF3;DUSP3;SEMA3G;TWIST2;GPER1;RIPOR1;CD74;CDH13
prerank,toll-like receptor signaling pathway (GO:0002224),-0.3623469283678624,-1.3913981362684413,0.023255813953488372,0.41853458684191963,1.0,29/84,21.03%,PLCG2;LBP;SFTPA2;SFTPA1;UBB;LGMN;RFTN1;IKBKB;CTSB;HSP90B1;RPS27A;UBC;BIRC3;MAP3K1;S100A1;CHUK;HSPD1;IRAK3;PIK3C3;PIK3AP1;TAB3;NR1H4;CASP8;UBA52;UBE2D1;IRAK1;TIRAP;MYD88;CTSL
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.3771367810354151,-1.3913840311546715,0.03773584905660377,0.41738691956604496,1.0,35/72,27.67%,SLIT2;SHANK3;KANK3;HSPA8;KANK1;HIP1R;STMN2;CRYAB;CYRIB;NAV3;SSH2;SSH1;KANK4;APC;ARHGEF2;CLU;STMN1;IAPP;APC2;TUBB4A;PFDN6;PFDN5;PRKCD;MAPRE1;TTBK2;CLASP2;SHANK1;SPEF1;CAMSAP3;PFDN4;CAMSAP1;EMILIN1;TREM2;FGF13;SSH3
prerank,glycoprotein biosynthetic process (GO:0009101),0.41808954659967146,1.3912278385402195,0.06525285481239804,0.6123520523859474,1.0,9/79,3.93%,IGF1;B3GALT1;ST3GAL3;GALNTL5;LARGE1;B3GNT5;GAL3ST3;GAL3ST2;ST3GAL5
prerank,regulation of establishment of protein localization (GO:0070201),-0.5473997942570752,-1.3911428203303275,0.11022044088176353,0.41680124823726344,1.0,7/14,27.24%,CORO2B;DNAJA1;CTSD;SPIDR;PTP4A3;CEP295;TREM2
prerank,cholesterol homeostasis (GO:0042632),0.422561278747605,1.3910504668722585,0.0686106346483705,0.6107586619795744,1.0,10/64,8.39%,RORA;FGFR4;IL18;PLA2G10;PCSK9;ABCA1;EPHX2;LIMA1;LIPC;ABCA5
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.582893416710832,-1.390364346048291,0.11610486891385768,0.41770446194701016,1.0,8/10,38.20%,NCK1;JUN;DNAJB1;VHL;CITED2;HIF1AN;HSPA1A;BAG3
prerank,epithelial cell morphogenesis (GO:0003382),0.5662795184963297,1.3901398179180247,0.12962962962962962,0.6113501344111721,1.0,1/17,0.01%,COL22A1
prerank,Rac protein signal transduction (GO:0016601),-0.5010943885704355,-1.3901181913042981,0.07847082494969819,0.417118050347831,1.0,8/18,15.95%,ELMO1;TIAM1;RAC1;NCKAP1;EPS8;DBNL;CDH13;RHOG
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3752688087904614,1.3900826537015973,0.03412462908011869,0.6094305708807416,1.0,23/152,10.26%,RNF220;WLS;LRRK1;PTK7;LGR4;FGFR2;ZEB2;TBL1XR1;MACF1;LYPD6;SULF1;GPC3;LRRK2;FRAT1;PSME4;PSMA2;SALL1;PSMA3;WNT5B;USP34;PSMD8;AXIN2;SMURF2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.5643061612609721,1.3897773313682726,0.10040983606557377,0.6083092790748814,1.0,3/17,1.28%,ATP1A2;TFPI;BMP7
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.517118205704755,-1.3894909654763061,0.08806262230919765,0.4176804286538941,1.0,9/17,19.98%,EMC10;BAG6;EMC7;EMC1;CAMLG;EMC3;EMC6;EMC9;GET4
prerank,neural crest cell development (GO:0014032),-0.415660360005787,-1.3892729934283958,0.054373522458628844,0.4171504181095766,1.0,13/44,11.39%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;CDH2;SEMA4D;TBX1;SEMA3E;CORO1C;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,fat cell differentiation (GO:0045444),0.437438334515459,1.3890438525392017,0.07470288624787776,0.6083970799535958,1.0,11/57,11.08%,TCF7L2;OSBPL8;C1QTNF3;PID1;SMAD6;CBY1;WNT5B;TMEM120B;MED1;BBS7;TFAP2B
prerank,cellular modified amino acid catabolic process (GO:0042219),0.5755235042981569,1.388951543656749,0.12915851272015655,0.606584794211659,1.0,6/15,18.17%,ALDH4A1;GGACT;HOGA1;PRODH;ABHD12;ABHD16A
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4221120848869483,1.388570847320243,0.06484641638225255,0.6057314104351671,1.0,15/63,13.14%,IGF1;TCF7L2;WWOX;DEPTOR;SP100;SH3RF1;NOL3;SIAH2;BIRC6;FEM1B;PHIP;CYLD;CFLAR;AR;BCL2L12
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4614731732273014,-1.3880768902377056,0.08583690987124463,0.41913503321260775,1.0,19/31,30.53%,PPP1R13B;NMT1;YWHAB;GSK3B;HIP1R;MAPK8;YWHAG;BBC3;CASP8;YWHAQ;YWHAH;PPP3R1;CHCHD10;BAX;YWHAZ;PPP3CC;BID;SFN;PMAIP1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.6022317628311489,-1.3867430091081752,0.11466165413533834,0.42152452016538816,1.0,2/10,6.20%,CAV1;KCNAB1
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.3496177037631398,-1.386467835227328,0.03856749311294766,0.42111516540552163,1.0,44/107,24.25%,MAP3K5;THBS1;NIBAN1;DAB2IP;RASGRF2;CREB3L1;NCK1;TMEM117;HSP90B1;BAG6;GSK3B;ATP2A2;ATP2A3;JUN;TMX1;DERL1;ERP44;CCDC47;UBXN6;HSPA5;ATF4;SELENOK;ERO1A;HERPUD1;ERLEC1;BBC3;EIF2B5;BCAP31;CFTR;DNAJC10;WFS1;RNF5;DNAJB9;TNFRSF10B;ATF3;VCP;MBTPS1;BRSK2;CEBPB;TRIB3;BAX;PPP1R15A;THBS4;PPP1R15B
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5171362808315989,1.3864607222207626,0.09864603481624758,0.61031603878003,1.0,4/23,6.25%,IGF1;EFNB2;NIBAN2;MAML1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.42434888953540273,-1.3862713410346124,0.05689277899343545,0.42052905150285236,1.0,12/40,12.65%,RPL11;RPL23;PTK2;UBE3A;PTK2B;RPS7;PDCL3;GNA12;RPL5;FOXF2;UBQLN4;CLU
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.5870571821197281,-1.3861103909533292,0.09848484848484848,0.41982920051851524,1.0,5/10,23.86%,CD55;TGFBR2;CD81;NCKAP1L;SOCS1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5871391336764298,1.3852175463925092,0.142,0.6120340178655447,1.0,8/12,19.43%,SZT2;EPHA4;NFIB;PAFAH1B1;MYCBP2;GLI2;CHRNB2;EPHB2
prerank,acidic amino acid transport (GO:0015800),0.5515063593870851,1.3850913856276699,0.10537190082644628,0.6103438371292884,1.0,7/17,9.27%,SLC6A13;SLC1A3;SLC6A1;SLC25A18;GJA1;LRRC8E;SLC25A22
prerank,cation transmembrane transport (GO:0098655),0.45783738883302755,1.3843658038504567,0.08421052631578947,0.6105263911194254,1.0,3/44,1.60%,TRPM3;ATP1A2;SLC6A9
prerank,positive regulation of signal transduction (GO:0009967),0.3572789735020671,1.3841151105189593,0.020242914979757085,0.6091891229557178,1.0,37/238,7.87%,IGF1;DCDC2;ROBO1;BMP6;SASH1;WLS;RBPJ;FGFR2;SMOC2;SORBS1;NLGN2;BMP2K;LOXL3;IGF2;MAML3;MACF1;GRB10;CCBE1;TEDC2;TTC23;SULF1;LRRK2;PRKCZ;FGF1;PRKCB;PDE6G;ARMC9;ZMIZ1;MAML1;IL6;SALL1;LMO3;PRKCA;PTEN;RWDD3;GKAP1;VTN
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5188608186357341,1.384054674031134,0.12293577981651377,0.6073593517363493,1.0,3/22,1.27%,FGFR2;NOTCH2;STXBP4
prerank,lysine catabolic process (GO:0006554),0.6001927682308763,1.3838645397816047,0.11728395061728394,0.603949462387279,1.0,5/12,13.41%,AASS;ALDH7A1;GCDH;PIPOX;AADAT
prerank,lysine metabolic process (GO:0006553),0.6001927682308763,1.3838645397816047,0.11728395061728394,0.603949462387279,1.0,5/12,13.41%,AASS;ALDH7A1;GCDH;PIPOX;AADAT
prerank,proteasome assembly (GO:0043248),-0.5800795909528219,-1.3816987038082922,0.09262759924385633,0.43026051616292305,1.0,7/11,33.26%,PSMD13;POMP;PSMD5;OTUD6B;PSMD9;PSMD10;PSMG1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5404494938084655,1.3816170204766454,0.13188976377952755,0.6088697774874965,1.0,2/19,1.05%,BMP6;AFDN
prerank,positive regulation of dephosphorylation (GO:0035306),-0.4509863556211807,-1.3815356496362245,0.07724425887265135,0.4294460025516361,1.0,14/27,23.45%,CALM1;PPIA;PPP1R16B;TGFB1;BMP2;MTMR9;SYMPK;CALM2;PPP2R5A;PTBP1;PRKCD;CDCA2;NSMF;CALM3
prerank,renal water homeostasis (GO:0003091),0.5111589425147208,1.3812126079362064,0.10331384015594541,0.6080967040673332,1.0,2/23,0.71%,ADCY5;ADCY1
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.5119483290600055,-1.3805045464964236,0.0874751491053678,0.4309927261936163,1.0,8/19,18.74%,LIFR;RUNX1;CBFB;KLF4;TLE5;IFIH1;IRAK1;SH2B3
prerank,membrane fusion (GO:0061025),-0.4389053742543062,-1.3800397014087706,0.08172043010752689,0.4310909658305774,1.0,8/33,11.96%,DNM3;NSF;VTI1B;CHP1;DNM2;DYSF;NSFL1C;DNM1
prerank,sterol homeostasis (GO:0055092),0.41982733653976134,1.379020802740248,0.07547169811320754,0.6132590513878883,1.0,10/65,8.39%,RORA;FGFR4;IL18;PLA2G10;PCSK9;ABCA1;EPHX2;LIMA1;LIPC;ABCA5
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6247406642394338,1.3786930451888224,0.14533622559652928,0.6122989459071109,1.0,3/10,7.52%,PLA2G10;ENPP2;LIPC
prerank,catecholamine biosynthetic process (GO:0042423),0.6145532530195009,1.3780355547252996,0.1297071129707113,0.612221766907732,1.0,1/11,0.10%,MOXD1
prerank,negative regulation of signal transduction (GO:0009968),0.34825787889379173,1.3773485888056125,0.02316076294277929,0.6124716513195524,1.0,48/249,11.42%,CYP26B1;ADAMTS12;LEPROT;TRABD2B;LGR4;RNF43;PID1;WWOX;TULP3;DKK3;BCL2;DKK1;LTF;MGRN1;NEDD4;CRHBP;GRB10;VGLL4;CBY1;CACTIN;SULF1;GPC3;LRRK2;PRKCZ;APCDD1;GLI3;PRKCB;SLC2A10;NIBAN2;SUFU;PDCD6;KANK2;NTN1;HERC4;PTEN;SIAH2;WWP2;TLE1;FSTL3;YTHDF2;RPGRIP1L;PTGIR;WIF1;TNS2;RPS6KB1;APLN;IFT122;ERBB2
prerank,T-helper cell differentiation (GO:0042093),-0.5433626117536833,-1.3762184642453035,0.10424710424710425,0.44031561077864845,1.0,2/14,0.81%,LEF1;FOXP1
prerank,histone H3-K36 demethylation (GO:0070544),0.6268952617361871,1.3753851118354978,0.13566739606126915,0.6167783352467925,1.0,4/10,7.94%,KDM7A;KDM2B;PHF8;KDM2A
prerank,bile acid and bile salt transport (GO:0015721),-0.4672133466278817,-1.3753208892396618,0.09766454352441614,0.4415144732566479,1.0,5/24,6.94%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;CEACAM1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.5732351328678698,-1.3747067100526418,0.10654205607476636,0.4419337793056487,1.0,3/11,11.81%,CAV1;NEDD4L;BIN1
prerank,regulation of kinase activity (GO:0043549),0.40487902847762514,1.3745197567963434,0.07424960505529225,0.6173128584878881,1.0,25/89,14.05%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;LMO4;PDGFRB;SLAMF8;EPHA8;EPHA4;PDGFRA;DDR1;NPRL2;IGF1R;DDR2;RBL2;RYK;MUSK;AXL;EPHA2;ERBB2;TSPYL2;ROS1;MRE11;CDKN1C
prerank,heart process (GO:0003015),-0.5429513997655715,-1.3742617813104583,0.1079429735234216,0.4419382235815272,1.0,3/14,6.09%,SGCD;FYN;SOD1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4311354949510722,-1.3740528222839583,0.07551487414187644,0.44135393976591486,1.0,11/36,11.41%,CAV1;NOS3;NOSTRIN;HSP90AA1;CALM1;SCARB1;GCH1;DDAH1;DNM2;S100A1;CYGB
prerank,carboxylic acid transport (GO:0046942),0.4403050044629129,1.3730187944485148,0.08231173380035026,0.6199590576120072,1.0,7/55,3.98%,SLC6A13;SLC13A3;SLC16A12;SLC38A3;SLC6A12;SLC6A9;LLGL2
prerank,regulation of steroid metabolic process (GO:0019218),0.5176115494728271,1.3714264055504914,0.09961685823754789,0.6229976501466534,1.0,3/23,6.13%,RORA;ACADL;EPHX2
prerank,regulation of intracellular protein transport (GO:0033157),-0.44655631291076686,-1.3710579323569616,0.08904109589041095,0.448324545978124,1.0,11/32,21.67%,PRR5L;PTPN14;TGFB1;PDCD10;OAZ1;PTPN1;RIPOR1;ATP13A2;BMP4;SIRT7;UHMK1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5843608927176696,1.3707833941683847,0.14919354838709678,0.6230178194890162,1.0,5/14,11.50%,IL18;ANXA1;PRKCZ;CCL19;MYB
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.41394949516772067,1.3705938216067757,0.06430868167202572,0.6216557546968859,1.0,16/72,14.50%,FGFR2;FGFR4;FGFBP1;POLR2D;FLRT2;KL;FGF1;HNRNPH1;FRS2;POLR2A;GTF2F1;FGF9;CEP57;MAPK1;FIBP;FGF20
prerank,sodium-independent organic anion transport (GO:0043252),-0.5965441073579212,-1.370529753617354,0.09883720930232558,0.44852696921456053,1.0,6/10,18.04%,SLCO1C1;SLCO2A1;SLCO2B1;SLCO3A1;SLC16A2;SLCO4A1
prerank,pore complex assembly (GO:0046931),0.5510064755691603,1.370404977290301,0.14198782961460446,0.6202448696378613,1.0,5/19,10.15%,PLEKHA7;AFDN;NDC1;GSDMD;NUP107
prerank,regulation of protein metabolic process (GO:0051246),-0.40547381857907977,-1.370147288889076,0.06338028169014084,0.44836480603998224,1.0,14/44,10.91%,LTBP4;KLF2;HSP90AB1;KLF4;NEDD4L;FAF1;NEDD8;APP;CHEK2;ZDHHC2;SSH1;MAPK8;FURIN;HGS
prerank,positive regulation of histone acetylation (GO:0035066),-0.4670798004941751,-1.3692523210574932,0.10759493670886076,0.44962692086576644,1.0,7/23,11.15%,RPS6KA5;PPARGC1A;ARRB1;WBP2;GLYR1;NOS1;PIH1D1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5392857270520924,-1.3690975538469252,0.11306042884990253,0.44890255018185754,1.0,9/15,21.78%,ARPC1B;ARPC3;WHAMM;ACTR2;ARPC4;ARPC5L;ARPC1A;TRIM27;ACTR3
prerank,cardiac conduction system development (GO:0003161),0.4931015127475822,1.3689395071110095,0.12299465240641712,0.6226876422634312,1.0,4/24,6.25%,GJB6;NOTCH2;GJA1;MAML1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.499540316251455,-1.3681134053767274,0.09670781893004116,0.4504166852234253,1.0,7/19,16.67%,BAG6;DDIT4;BCL3;MSH2;AEN;RPS27L;USP28
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.38177039069561675,-1.3678057031124753,0.06088992974238876,0.4500419311319046,1.0,22/57,22.24%,MAP3K5;FYN;CTSD;TNFSF10;NOD1;LGMN;PERP;AIM2;SOX7;GRIN1;NDUFA13;USP50;GPER1;REST;TBC1D10A;BCAP31;CASP8;FOXL2;CYFIP2;ACVR1C;CYCS;CASP1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.44387077100519234,-1.367686803553887,0.06726457399103139,0.44916634798815924,1.0,12/32,16.67%,PPP1R13B;BAG6;DDX5;DDIT4;BCL3;HINT1;MSH2;PDK2;MYBBP1A;AEN;RPS27L;USP28
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.5754566318800781,1.3675174670318988,0.14736842105263157,0.6252492272908619,1.0,5/13,13.00%,FBN1;FBN2;NBL1;CHRDL1;FSTL1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.38520345855294913,1.367485946524611,0.056162246489859596,0.6233674521548394,1.0,15/113,8.79%,IGF1;BMP6;TCF7L2;OSR1;FGFR2;NOTCH2;STXBP4;JAML;ECM1;FGF1;PTN;PDCD6;PRKCA;ARNT;VEGFB
prerank,neuron development (GO:0048666),-0.3330101692435299,-1.3674831523636615,0.025396825396825397,0.4485299724279879,1.0,23/141,7.71%,FRY;MEF2C;PTPRM;PBX3;TGFB2;RUNX1;STX3;PLP1;MAP4;TENM2;VSX1;B4GALT5;BLOC1S2;EHD1;GSK3B;RP1;ETV1;GPM6B;ATP8A2;TENM4;STMN2;APP;MYOC
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.36158118372035225,-1.3668074378633306,0.034782608695652174,0.44917221331222984,1.0,28/72,16.12%,ARHGEF28;HEG1;RAC1;ARHGEF3;PRAG1;F11R;RASIP1;NET1;ARHGDIB;CCDC125;GPR4;EPS8L2;KANK1;ARHGDIA;ARRB1;MET;BCR;CUL3;MYOC;PDCD10;EPS8;KCTD13;LPAR6;ARHGEF2;STMN1;COL3A1;ADGRG1;RAF1
prerank,positive regulation of developmental growth (GO:0048639),-0.4070609444284503,-1.366323746643187,0.07175925925925926,0.449399757241768,1.0,25/49,29.94%,SEMA7A;AGRN;NEDD4L;NGF;SEMA4D;SHTN1;ITSN2;RNF157;PPIB;DBNL;SYT4;CPNE9;SYT2;RASAL1;DBN1;INSR;L1CAM;DLL1;PLAA;CPNE5;RIMS2;SYT17;SYT1;ISLR2;SMURF1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5225071734119535,-1.3660309296267825,0.10638297872340426,0.44891614178803935,1.0,9/16,21.67%,ESR1;RBFOX2;DDX5;DDX54;EGLN2;NCOA4;DDX17;PADI2;ESR2
prerank,regulation of macrophage activation (GO:0043030),0.48243721816239626,1.3652653986566916,0.10925925925925926,0.6285830633666676,1.0,5/30,6.76%,IL31RA;PLA2G10;SPHK1;MYO18A;IL6
prerank,protein insertion into ER membrane (GO:0045048),-0.4262179893596005,-1.3638913673019954,0.08085106382978724,0.45338034111862857,1.0,20/37,32.46%,STX1A;EMC10;BAG6;APP;CCDC47;EMC7;EMC1;CAMLG;SEC61G;EMC3;EMC6;EMC9;GET4;VAPA;OTOF;WDR83OS;STX5;SEC61B;UBE2J2;EMC4
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.47843744106860525,-1.3638602312904613,0.0918580375782881,0.45228104165975297,1.0,11/21,27.61%,STMN2;NAV3;APC;ARHGEF2;APC2;TTBK2;CLASP2;SPEF1;CAMSAP3;CAMSAP1;FGF13
prerank,positive regulation of cell motility (GO:2000147),-0.3149883635502173,-1.3636902220842562,0.01694915254237288,0.4515974021164819,1.0,63/205,15.23%,LEF1;NTRK3;PECAM1;PODXL;CAV1;SPOCK2;ACTG1;SEMA6A;ACTN4;SEMA7A;ITGA6;TIAM1;SEMA6D;KDR;THBS1;ADAM10;CARMIL1;CAVIN1;SEMA3C;F3;PTK2;ITGB1;ROR2;PTK2B;NOTCH1;RACK1;SEMA4D;SEMA3E;BCAR1;TGFB1;FAM107A;FERMT2;PDGFC;MYOC;PDCD10;VEGFA;TJP1;PAK1;CPNE3;GRN;SEMA4B;EDN1;SEMA5B;SEMA6C;APC;XBP1;PIK3CD;HSPA5;STAT3;BMP2;GCNT2;SEMA3G;TWIST2;GPER1;RIPOR1;CDH13;PPP3CA;CCN1;RET;COL1A1;NEDD9;CSF1R;CXCL12
prerank,activation of protein kinase activity (GO:0032147),0.3898483005052155,1.363421920003555,0.054313099041533544,0.6322598039889528,1.0,8/106,1.89%,IGF1;ADCY5;OSBPL8;ADCY1;NRK;IL18;ANGPT1;PDPK1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.5252479643391846,1.3632616744941037,0.1303501945525292,0.6307349753629372,1.0,3/22,5.73%,ALDH1A2;RBP1;LRP2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.5907198470119803,1.3632579456344616,0.13016528925619836,0.628772368349204,1.0,4/12,15.86%,ROCK2;PICALM;RANBP9;FLOT2
prerank,cellular response to amyloid-beta (GO:1904646),0.47589787878312706,1.363226317699303,0.10810810810810811,0.6268921018508298,1.0,6/35,7.35%,IGF1;SNX6;EPHA4;GJA1;IGF1R;CACNA2D1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.387605799648709,-1.3622050077142525,0.04714640198511166,0.45422610010272846,1.0,11/56,6.64%,PLCG2;LBP;SFTPA2;SFTPA1;UBB;NOD1;LGMN;CTSB;HSP90B1;RPS27A;UBC
prerank,smooth muscle contraction (GO:0006939),0.5711359313481159,1.3620430063739453,0.15524193548387097,0.628708362283359,1.0,4/14,3.07%,ROCK2;BDKRB2;MYLK;SLC8A1
prerank,negative regulation of cell motility (GO:2000146),-0.3440491739170172,-1.3618696447792757,0.03313253012048193,0.4539000165695237,1.0,20/108,5.70%,FRMD5;SLIT2;LIMCH1;PTPRJ;CLDN5;TMEFF2;CLIC4;ACVRL1;DACH1;JAG1;CDH1;ADAM15;ADARB1;ENG;MCTP1;CCDC125;SRGAP1;KANK1;RHOB;IGFBP5
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.3455868454655287,-1.361240192638132,0.02601156069364162,0.45450671904138107,1.0,46/107,21.38%,CAV1;SLC39A10;TPT1;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;ATP1B1;SLC10A7;SLC30A5;CALR;ATP2C1;MT2A;ATP2A2;ATP2A3;SLC39A8;RYR2;HTR2A;SLC24A2;ATP13A4;EDN1;SLC30A1;SLC39A7;STIM2;RMDN3;STOML2;ATP2B1;SLC39A14;ATP13A5;MT3;SLC24A5;CXCL12;ATP13A2;CD40;CCL13;NPTN;TMEM165;ATP2B2;ATP2B4;SLC39A6;SLC11A1;TMEM203
prerank,regulation of adaptive immune response (GO:0002819),-0.49518540673428746,-1.3601102024203051,0.12992125984251968,0.4562247970757591,1.0,10/18,35.66%,AHR;ADCY7;SAMSN1;TRIM27;FCGR2B;SKAP1;FADD;IL4I1;SASH3;IL6ST
prerank,cognition (GO:0050890),-0.4087273281329896,-1.3598522914231503,0.06651884700665188,0.455722239116018,1.0,12/42,15.99%,ST3GAL4;SHROOM4;MAGT1;STRA6;CHMP2B;FAM107A;APP;MFSD2A;SLC1A4;DGCR2;NF1;PTCHD1
prerank,positive regulation of apoptotic process (GO:0043065),-0.3032231564487093,-1.3597330521686388,0.004464285714285714,0.4548782241455898,1.0,75/293,15.45%,UNC13B;SLIT2;MAP3K5;MCF2L;ITGA6;TIAM1;RASSF2;TRIO;TGFB2;FAP;ARHGEF3;ITGB1;KCNMA1;DAB2IP;NGF;RASGRF2;UBB;RPS3;RACK1;DNAJA1;CTSD;ARHGEF12;NET1;TNFSF10;PREX1;ATG7;SFRP4;TGM2;RPS6;ARHGEF17;TPD52L1;SOX4;ARHGEF6;RHOB;CTNNB1;SOD1;FAF1;ABR;RPS27A;UBC;APBB1;HIP1R;DNM2;JUN;FOXO1;ARHGEF19;GRN;PTGIS;DDX20;ARHGEF26;MAPK8;ING4;APC;ARHGEF5;TLE5;ATF4;BMP2;BIN1;GPER1;RYBP;REST;MYBBP1A;HSPD1;ARHGEF2;CLU;RNPS1;GADD45G;NLRP2B;IAPP;PLEKHN1;NF1;FAS;CYP1B1;CASP8;UBA52
prerank,regulation of mitotic spindle organization (GO:0060236),-0.42326555705689645,-1.3593666542036071,0.07142857142857142,0.4546198488205101,1.0,18/35,33.86%,CHMP5;CHMP2B;GNAI1;HNRNPU;CHMP1B;CHMP1A;NUMA1;DCTN1;CHMP3;HSPA1B;PDCD6IP;CHMP4C;DRG1;VPS4B;PLK1;DYNC1H1;HSPA1A;PSRC1
prerank,activation of adenylate cyclase activity (GO:0007190),0.4715179836840199,1.358911799957354,0.11070110701107011,0.636491774794813,1.0,3/35,0.84%,ADCY5;ADCY1;LGR4
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.505761471037759,1.3589015260196313,0.11829944547134935,0.6345550793064374,1.0,1/25,0.03%,IGF1
prerank,protein K11-linked ubiquitination (GO:0070979),0.49400734308224514,1.3587435703943878,0.1311787072243346,0.6330901187038808,1.0,10/27,19.94%,PRKN;UBE2E2;ANAPC13;UBE2L3;CDC26;UBE2A;UBE2H;ANAPC2;ANAPC5;CDC23
prerank,stress-activated MAPK cascade (GO:0051403),-0.3842826311941665,-1.3584140831617029,0.04929577464788732,0.45603737218214285,1.0,22/61,23.57%,MAP3K5;UBB;NOD1;MINK1;IKBKB;ARHGEF6;RPS27A;UBC;MAPK8;ZFP36L1;CHUK;MAP2K7;MAP3K12;CUL1;MAP3K8;TAB3;UBA52;IRAK1;SKP1;MAPK3;MAPK11;MAPK10
prerank,genitalia development (GO:0048806),-0.5491324582147902,-1.3583355453976045,0.12804878048780488,0.4551199518803413,1.0,4/12,11.20%,PKD1;STRA6;TBX3;FOXF2
prerank,ERK1 and ERK2 cascade (GO:0070371),0.527438922889758,1.3583271307438365,0.12079207920792079,0.6324018380326245,1.0,2/21,3.31%,IGF1;CTSH
prerank,epithelial to mesenchymal transition (GO:0001837),0.4433813767246731,1.357453848918653,0.10752688172043011,0.6332016548903782,1.0,6/47,2.97%,TGFBR3;ROCK2;WNT4;RBPJ;BMP7;LOXL3
prerank,positive regulation of protein binding (GO:0032092),-0.3862575126477752,-1.3573823794045456,0.07524271844660194,0.4564812287156967,1.0,16/56,13.04%,CAV1;CLDN5;B2M;EPB41;TIAM1;RPL11;PKD1;GSK3B;ADD2;HIP1R;APP;DERL1;RALB;BMP2;MEN1;IDE
prerank,myelination (GO:0042552),-0.3996587253932789,-1.3572934270520698,0.07175925925925926,0.45555326645756145,1.0,21/46,19.12%,ADGRG6;ACER3;PLP1;MAL;MBP;MARVELD1;B4GALT5;TNFRSF21;CMTM8;SCN8A;MYOC;PLLP;ARHGEF10;GPC1;ABCD2;NF1;EIF2B5;TPPP;EIF2B2;B4GALT6;SOX10
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5094488481222421,1.3571761803404419,0.1157495256166983,0.6321768949867994,1.0,5/24,8.42%,RORA;CCBE1;SULF1;IL6;ARNT
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.6103476476506796,1.3561347479899843,0.13786008230452676,0.6334541227649356,1.0,1/12,0.09%,CYP26B1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.3367949444668585,-1.3556718497290543,0.03333333333333333,0.45874365833250746,1.0,30/113,12.87%,UNC13B;FNIP2;ESR1;TFRC;HSP90AA1;RASIP1;DAB2IP;RPS3;RACK1;SH3GLB1;WARS1;TGFB1;FERMT2;MPP7;FAF1;GSK3B;PIEZO1;VEGFA;SPIDR;DDB1;RBX1;EIF4G1;ISG15;GBP5;PIH1D1;USP50;RPA1;TAL1;CLU;PSMC3
prerank,organic hydroxy compound transport (GO:0015850),-0.4220620717650225,-1.355464724311123,0.08296943231441048,0.45817502084518325,1.0,7/36,6.94%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;SLC16A1;STRA6;CEACAM1
prerank,proteoglycan biosynthetic process (GO:0030166),0.48229677244436453,1.355238477256252,0.10905730129390019,0.6344917288269333,1.0,4/31,3.75%,IGF1;PXYLP1;HS3ST3B1;GAL3ST3
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.5158773327069189,-1.3547211167644009,0.09980806142034548,0.4590915711715378,1.0,9/16,24.17%,TRIB2;TNFRSF21;CD274;JAK3;TYROBP;DLL1;FCGR2B;AGER;VSIR
prerank,cardiac cell development (GO:0055006),-0.5797628849139319,-1.354663771533631,0.132,0.45810520120876774,1.0,5/11,7.87%,JAG1;NOTCH1;CXADR;MYH11;VEGFA
prerank,protein mono-ADP-ribosylation (GO:0140289),0.6009520441688292,1.354409958540455,0.15800865800865802,0.6351368581176569,1.0,6/11,20.03%,PARP4;PARP10;PARP12;PARP9;TIPARP;PARP14
prerank,histone monoubiquitination (GO:0010390),0.505258263082557,1.3542869876979566,0.1245136186770428,0.6336440897700049,1.0,11/24,17.61%,DDB2;RNF2;KDM2B;BCOR;CUL4B;CDC73;RNF20;PCGF1;CTR9;UBE2E1;DTX3L
prerank,positive regulation of MAP kinase activity (GO:0043406),0.41196948870941286,1.353147221448055,0.07954545454545454,0.6351097339313986,1.0,9/66,5.51%,ROBO1;SASH1;IL34;KIT;DKK1;PDGFRB;PDGFD;LRRK2;FGF1
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5505707612771237,-1.3527884654145468,0.10586011342155009,0.46200063697944743,1.0,4/12,15.23%,JAM2;APP;RHOA;CXCL12
prerank,negative regulation of interleukin-1 production (GO:0032692),0.5142695770556609,1.3525425935169566,0.12692307692307692,0.6350572112193048,1.0,1/23,0.03%,IGF1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6040699630268144,1.352392735700866,0.1447084233261339,0.6336129835267893,1.0,2/10,3.19%,OXSR1;CXCL13
prerank,fatty acid beta-oxidation (GO:0006635),0.4354031988784734,1.3523013540245952,0.08963093145869948,0.6320299911149254,1.0,16/51,14.16%,IVD;EHHADH;ACADL;ECI2;HSD17B10;CPT2;ACAD11;ECHDC1;ACADS;ACAA2;GCDH;ACAT2;AUH;AMACR;ACOX1;BDH2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.4535621516619385,-1.3514579335502337,0.1111111111111111,0.46445246089690206,1.0,8/25,12.65%,KLF2;HSP90AA1;HSP90AB1;KLF4;DDAH1;PTGS2;EDN1;CLU
prerank,cation transport (GO:0006812),0.3683902115031108,1.3511900499996872,0.0391566265060241,0.6336165958247317,1.0,13/167,4.07%,TRPM3;SCN7A;ATP1A2;SLC22A4;SLC22A2;SLC8A3;SLC5A5;SLC6A9;KCNQ4;KCNA5;SLC41A1;SLC8A1;KCND3
prerank,response to acidic pH (GO:0010447),-0.5389910521793441,-1.3507025216716946,0.1342155009451796,0.46536101215627373,1.0,4/13,13.52%,GPR4;LGMN;CHP1;RAB11FIP5
prerank,positive regulation of hemostasis (GO:1900048),-0.5907877293693293,-1.3499084892868254,0.1303501945525292,0.4653006630362483,1.0,2/10,1.81%,ST3GAL4;THBS1
prerank,positive regulation of coagulation (GO:0050820),-0.5907877293693293,-1.3499084892868254,0.1303501945525292,0.4653006630362483,1.0,2/10,1.81%,ST3GAL4;THBS1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.455262631417267,1.3496875684993501,0.09461966604823747,0.6366453886503985,1.0,8/43,7.32%,IGF1;IL18;PDGFRB;CCN4;MMP2;GJA1;IL6;MMP9
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5957638660171538,1.3489752142209859,0.14435146443514643,0.6370538382057409,1.0,3/10,5.28%,HOXB4;ACE;UFL1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5161322540519682,1.348922268327063,0.11281070745697896,0.6353257780965654,1.0,10/23,18.57%,C1QTNF3;PPARA;SIK1;NUPR1;CRY1;PFKFB1;GCK;C1QTNF12;NCOR1;HDAC4
prerank,glucose homeostasis (GO:0042593),0.39556145679170907,1.3486053911973777,0.07666098807495741,0.6344341765931996,1.0,12/83,7.95%,LEPR;TCF7L2;APPL2;FGFR4;RBP4;HK2;PRKAA2;IGF1R;IL6;PRKAA1;MCU;SLC30A8
prerank,visual perception (GO:0007601),0.3959283788896269,1.3482692574140644,0.06472491909385113,0.6336083318357322,1.0,18/84,16.66%,EYA4;ADGRV1;EFEMP1;ZIC2;CRYGS;TULP1;COL18A1;GPR143;EML2;DHRS3;IMPG2;CRYZ;MYO9A;RGS16;TULP2;KIFC3;CHRNB2;DNAJC19
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5203750510206564,-1.3473998669916665,0.10379241516966067,0.4710121222408674,1.0,2/16,2.52%,CLDN5;CLDN11
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6079004008050379,1.346976515151366,0.16216216216216217,0.6359525906898817,1.0,3/10,8.46%,IGF2;PCGF5;PRMT7
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5426302143882221,1.3466266682940091,0.1497005988023952,0.6351114314367212,1.0,4/17,7.35%,SNTA1;NOS1AP;ANK2;CACNA2D1
prerank,melanocyte differentiation (GO:0030318),0.6045527106462769,1.346044516090923,0.15705765407554673,0.6350918912643406,1.0,2/11,1.24%,LRMDA;KIT
prerank,anion transmembrane transport (GO:0098656),0.4086875667354102,1.3457377879803303,0.090311986863711,0.6342294613109334,1.0,15/67,11.51%,SLC6A13;SLC13A3;SLC13A4;SLC16A12;SLC6A9;SLC1A3;SLC25A18;SLC13A5;LRRC8E;SLC25A11;SLC25A22;SLC27A1;SLC13A1;SLC19A1;SLC35A1
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.3313741714364289,-1.345401307210618,0.03426791277258567,0.47552367852791305,1.0,53/132,23.59%,RPL11;HSP90AA1;HSP90AB1;RPL6;RPS15;RPL38;RPSA;RPS19;RPL24;LUC7L2;RPS14;RPL23A;SRSF1;RPL3;RPL5;SF3B1;CPSF7;RPS27;KHDC4;DDX20;SRSF5;RPLP0;DDX39B;RPS28;SRSF9;CPSF6;CLNS1A;USP39;STRAP;XAB2;PRPF18;ERAL1;SNRPC;SRSF6;EIF4H;RPS27L;SRPK1;RSL24D1;RPS5;CLP1;DHX29;YTHDC1;NOP53;NLE1;EIF2D;EIF3A;EIF6;PWP2;PPAN;EIF4B;SNRPG;MRPS11;EIF5
prerank,regulation of cartilage development (GO:0061035),0.5377231223365642,1.3450324089740926,0.14619883040935672,0.6347522027839175,1.0,3/18,2.75%,SOX5;SCX;SOX6
prerank,cardiac ventricle morphogenesis (GO:0003208),0.45436016164650656,1.3449528372517268,0.11619718309859155,0.6331868929069842,1.0,6/41,2.80%,TGFBR3;RBPJ;FGFR2;TPM1;TNNC1;TNNT2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.38839097103629266,1.3446089258494005,0.0695364238410596,0.6324456736176864,1.0,15/90,6.84%,LEPR;APPL2;EPAS1;IL18;ACSL1;ESRRG;GNAS;ALMS1;PPARGC1B;GRB10;GJA1;ACADL;IGF1R;CPT2;PTH2R
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.4756680819636684,-1.3443147123030046,0.11764705882352941,0.4774242767080246,1.0,5/22,7.64%,NTRK3;RAP1A;NGF;EHD1;STMN2
prerank,positive regulation of leukocyte activation (GO:0002696),-0.493119998207573,-1.3439121430032903,0.1111111111111111,0.4773337811346281,1.0,10/18,33.76%,IL33;THBS1;LBP;HSPD1;CEBPA;CRLF2;KARS1;TLR4;TLR6;TSLP
prerank,membrane repolarization during action potential (GO:0086011),-0.5421472656280218,-1.3438315260543265,0.1138996138996139,0.4763921625470543,1.0,5/13,14.72%,KCNJ2;ATP1A1;ATP1B1;KCNQ1;KCNIP2
prerank,cellular response to ketone (GO:1901655),0.46210749245333294,1.343586838500802,0.1213768115942029,0.6336300670417987,1.0,3/35,0.71%,ROCK2;ADCY5;ADCY1
prerank,regulation of ERAD pathway (GO:1904292),-0.5740349914306117,-1.343547494287081,0.12761904761904763,0.47600971400185726,1.0,5/11,13.06%,ATXN3;UBXN1;BAG6;AQP11;HERPUD1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5891110995429004,1.3429739037119093,0.1518987341772152,0.6337664043085626,1.0,3/12,2.26%,WNK4;DMD;ATP1B3
prerank,histone modification (GO:0016570),0.37669925034585416,1.3428065173417694,0.058823529411764705,0.6324978937294787,1.0,14/109,10.71%,EYA4;EYA1;EYA2;BRD8;PRDM5;TBL1XR1;MIDEAS;BAZ1B;UFL1;PRMT7;KAT8;KAT6B;NSD1;HDAC1
prerank,iron ion transmembrane transport (GO:0034755),-0.5766348722451368,-1.3427947871937558,0.11070110701107011,0.47692187680660597,1.0,4/10,13.34%,SCARA5;SLC40A1;SLC39A8;SLC39A14
prerank,receptor-mediated endocytosis (GO:0006898),-0.33153355758428565,-1.3427887014656261,0.025714285714285714,0.47579959123690757,1.0,37/132,15.68%,DNM3;CAV1;SGIP1;TFRC;FNBP1L;HSP90AA1;CD9;SCARB1;ITGB1;RAMP2;ARHGAP27;CAV2;RAB31;ACKR3;SCARF1;AP2A2;STAB1;CALR;HSP90B1;PDLIM7;HIP1R;DNM2;RAMP1;AP2M1;LMBR1L;LRP3;DNM1;CANX;ADRB2;CD81;MRC1;CALCRL;PIP5K1C;SPARC;PI4KB;M6PR;TMEM108
prerank,amino sugar metabolic process (GO:0006040),-0.5885207355796026,-1.3427885362778087,0.12686567164179105,0.4746558422195112,1.0,2/10,0.56%,CSGALNACT1;ST6GAL1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.44552959411983883,-1.3422818985423048,0.10792951541850221,0.47483855462023566,1.0,8/26,12.65%,KLF2;HSP90AA1;HSP90AB1;KLF4;DDAH1;PTGS2;EDN1;CLU
prerank,sphingosine biosynthetic process (GO:0046512),-0.5770975940627603,-1.34174974767259,0.1203883495145631,0.47392402601788647,1.0,3/11,1.86%,ACER3;ACER2;SPTLC2
prerank,sphingoid biosynthetic process (GO:0046520),-0.5770975940627603,-1.34174974767259,0.1203883495145631,0.47392402601788647,1.0,3/11,1.86%,ACER3;ACER2;SPTLC2
prerank,striated muscle tissue development (GO:0014706),-0.4464597148133501,-1.3416368435939934,0.08902691511387163,0.4731122141655657,1.0,9/29,6.87%,MEF2C;PGM5;CAV1;SGCD;BMP5;MYL6;BMPR2;TBX2;SIX1
prerank,regulation of protein kinase A signaling (GO:0010738),0.5194904305452371,1.3412691569679285,0.13644859813084112,0.6355057143160826,1.0,3/20,5.48%,ADGRV1;AKAP7;LRRK2
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.4809648068285891,-1.340698500027758,0.11751662971175167,0.47453893197797253,1.0,6/20,18.10%,HSP90AA1;HSP90AB1;HSPD1;CLU;TMEM35A;PFDN6
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.6028827736774199,1.3401339965039034,0.15550755939524838,0.637288587507698,1.0,3/10,10.86%,PRKAA2;PRKAA1;FLCN
prerank,T cell mediated immunity (GO:0002456),-0.5519480651470454,-1.339154564395062,0.1320754716981132,0.4775660522620598,1.0,4/13,8.12%,CADM1;JAG1;CD55;EMP2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.31955509211896965,-1.3390304745900319,0.01834862385321101,0.4767619537796337,1.0,45/149,19.88%,PRKCH;CAV1;TFRC;RPS6KA5;UBB;NFKBIA;RPS3;PPIA;NOD1;ROR1;TRIM14;IKBKB;EDA;TRIM25;RPS27A;UBC;TNFRSF11A;APP;CARD14;IL1RAP;AIM2;SLCO3A1;ZBTB7A;CHUK;RTKN2;STAT3;ARHGEF2;CLU;IRAK3;TAB3;TERF2IP;TRIM13;TRAF1;UBA52;CX3CR1;CARD16;PRKD1;RPS6KA4;CD40;IRAK1;RNF25;TIRAP;MID2;TRIM27;MYD88
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.5569828278776475,-1.3388606658808242,0.13372093023255813,0.47605651641121544,1.0,2/11,2.22%,RUNX1;CBFB
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.41833259197168565,-1.3386572077185688,0.09255079006772009,0.4754989952412362,1.0,13/39,19.49%,EFR3B;SOCS2;SOCS5;PIK3C2B;TTC7A;PIK3CD;PIK3C2A;PIK3C3;ITPKB;PI4KB;CISH;PIK3R3;PIP4K2A
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.5248287991912908,-1.3383753563983758,0.10483870967741936,0.4751565428551358,1.0,9/14,31.43%,RCC1L;UQCC2;RPUSD4;FASTKD3;TRUB2;TRMT10C;MRPS27;COA3;MPV17L2
prerank,mononuclear cell differentiation (GO:1903131),0.4947832914287983,1.3382832048702902,0.12981744421906694,0.6411763549607593,1.0,1/24,0.01%,IL31RA
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.39186882846833854,1.337685394696317,0.06611570247933884,0.641360385621114,1.0,26/95,12.62%,HS3ST3A1;CEMIP;PXYLP1;ANGPT1;ST3GAL3;FMOD;UST;SDC2;HS3ST3B1;OGN;GPC6;OMD;B4GALT1;PRELP;GPC3;CHSY1;CHST3;HAS1;XYLT2;B3GALT6;NDST2;CHST15;HS6ST1;UGDH;B4GALT2;GPC4
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.41606318186520996,-1.3370216340669148,0.08466819221967964,0.4777804305217932,1.0,12/38,15.46%,NOS3;THBS1;BMP5;TNFSF10;BCL2L1;GSK3B;TMBIM1;ARHGEF2;RNF34;FAS;CASP8;MADD
prerank,negative regulation of calcium ion transport (GO:0051926),0.5303976160019732,1.3369561916303119,0.1440501043841336,0.641961985989014,1.0,1/15,0.21%,ATP1A2
prerank,postreplication repair (GO:0006301),-0.3911961383932797,-1.336417576002336,0.09050772626931568,0.47828530332479935,1.0,21/45,24.80%,UBB;TRIM25;RPS27A;UBC;UBE2B;ISG15;RPA1;MSH2;UBA52;USP43;POLK;FAAP20;UBE2V2;POLN;SPRTN;POLD3;VCP;POLD1;NSMCE1;POLI;DTL
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5355043424903164,1.3362166539349312,0.16535433070866143,0.6424068319888734,1.0,6/16,17.39%,AUTS2;KMT2A;BCOR;MYB;SMAD4;CTR9
prerank,sensory perception of light stimulus (GO:0050953),0.3896850820376285,1.3350115198794688,0.07580645161290323,0.644499228500491,1.0,19/87,16.66%,EYA4;ADGRV1;EFEMP1;ZIC2;CRYGS;TULP1;COL18A1;GPR143;WHRN;EML2;DHRS3;IMPG2;CRYZ;MYO9A;RGS16;TULP2;KIFC3;CHRNB2;DNAJC19
prerank,connective tissue development (GO:0061448),0.4683648657734666,1.3348259382569858,0.1299638989169675,0.6433066146263522,1.0,6/35,5.24%,SOX5;ARID5B;SCX;SOX6;SH3PXD2B;SULF1
prerank,monosaccharide transmembrane transport (GO:0015749),0.5510688762210414,1.3347469608989582,0.13840155945419103,0.6417839518164052,1.0,3/16,6.09%,SLC2A12;SLC45A3;SLC2A10
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.42031146949173304,-1.334395873374988,0.0880503144654088,0.48268157095057884,1.0,20/33,39.62%,PTPRJ;RPS3;CEACAM1;DUSP3;DGKZ;CD81;LAPTM5;THY1;CD300A;RELA;EZR;CARD11;PTPN22;KCNN4;PHPT1;RC3H1;TRAT1;CD226;TESPA1;LCK
prerank,negative regulation of cell migration (GO:0030336),-0.32248440621405733,-1.333624619807129,0.033950617283950615,0.4837391611472779,1.0,25/137,5.73%,SLIT2;LIMCH1;PTPRJ;PTPRG;CLDN5;TMEFF2;CLIC4;RAC1;ACVRL1;DACH1;JAG1;CDH1;ADAM15;ADARB1;ENG;DAB2IP;MCTP1;ARHGDIB;SRGAP1;KANK1;CORO1C;RHOB;CALR;IGFBP5;NEXMIF
prerank,embryonic digit morphogenesis (GO:0042733),0.5382378451318504,1.3335360746980665,0.1494949494949495,0.6436617798146216,1.0,6/18,10.71%,OSR1;INTU;GLI3;SALL1;WDPCP;HDAC1
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5783570860376214,-1.333348806185871,0.1290909090909091,0.48337378552778976,1.0,2/10,3.36%,RAP1A;NGF
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4924791780189056,1.3332055987975195,0.137291280148423,0.6429078910070375,1.0,5/26,6.35%,ROCK2;PRKN;FHOD1;ALMS1;ASAP3
prerank,negative regulation of cellular protein localization (GO:1903828),0.4612574111466469,1.333183033519163,0.12087912087912088,0.6412306956241061,1.0,9/34,11.93%,LEPROT;ROCK2;RIPOR2;SNX33;UBXN2B;PICALM;LATS1;FLCN;ACTN2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5210189807949713,1.3330974832612328,0.13306451612903225,0.6397452055050596,1.0,6/20,11.93%,OSR1;NEDD4;PCSK9;MMP9;CAMK2D;ACTN2
prerank,vitamin transport (GO:0051180),0.47925611055433975,1.3329412804292864,0.12704174228675136,0.6384301718383123,1.0,9/29,10.58%,SLC35F3;PDPN;TCN2;SLC2A10;FOLR1;FOLR2;SLC27A1;SLC19A2;SLC19A1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.3668782865886496,-1.3316365027398551,0.06733167082294264,0.48670610589046615,1.0,18/65,13.25%,HIP1;PTPRJ;SH3KBP1;BCAR3;CBL;DAB2IP;MVB12B;PTPN12;CCDC88A;CEACAM1;RHBDF2;HIP1R;SHKBP1;HGS;DUSP3;GPER1;CDH13;MVB12A
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.5184645845240856,-1.3311137146159184,0.16297786720321933,0.4869522943336115,1.0,4/14,6.19%,TMSB4X;NFKBIA;PKD1;FAF1
prerank,cyclooxygenase pathway (GO:0019371),-0.5865014554525063,-1.3310961943299744,0.12363636363636364,0.48587920009373076,1.0,5/10,29.95%,PTGIS;PTGS2;PTGDS;HPGDS;CBR1
prerank,chondrocyte differentiation (GO:0002062),0.47229699768173655,1.3308103116937418,0.12880143112701253,0.6432694724210126,1.0,7/32,7.27%,SOX5;OSR1;SCX;SOX6;NFIB;SULF1;WNT5B
prerank,intracellular lipid transport (GO:0032365),0.5141070843026257,1.330509979744839,0.13857677902621723,0.6424412717206776,1.0,4/21,6.61%,PRKAG2;PRKAA2;CPT2;SGPP1
prerank,cAMP metabolic process (GO:0046058),0.55745101392604,1.3303086113957647,0.17758985200845667,0.6412955215319793,1.0,2/13,0.71%,ADCY5;ADCY1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.45046220539570647,1.3295215102447957,0.11071428571428571,0.6420391769924898,1.0,7/40,6.43%,ARHGAP6;KIT;LPAR1;PDGFRB;PDGFRA;LPAR2;GNAQ
prerank,copper ion homeostasis (GO:0055070),-0.48973466132686994,-1.3292531269994283,0.13359528487229863,0.4898506126961134,1.0,5/17,7.70%,ATOX1;SLC31A1;MT2A;ARF1;APP
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.4201354134221369,-1.328666790542334,0.11181434599156118,0.4903390394617504,1.0,15/32,33.49%,CEPT1;MFSD2A;LPCAT3;GPAT4;LPCAT1;LPIN3;CSNK2B;LPIN1;LCAT;SLC44A5;SLC44A2;PEMT;CHPT1;STARD10;ACHE
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.4227271771462575,-1.3284308790855965,0.1074561403508772,0.4899456799055008,1.0,14/36,20.09%,RPL11;HSP90AB1;UCHL5;UBXN1;BAG6;AQP11;PSMF1;OGT;CAMLG;RYBP;N4BP1;PRKCG;TLK2;NOP53
prerank,mesonephric tubule development (GO:0072164),0.5457844751849336,1.3283632002483514,0.16056910569105692,0.6436814937175616,1.0,3/15,1.28%,OSR1;FGFR2;BMP7
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.5237099595212714,-1.3278527104816893,0.11847389558232932,0.4903270685003479,1.0,6/14,28.92%,SRSF9;RNPS1;SRSF6;PCBP4;PTBP1;SRSF7
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.45308874460109694,-1.3277431076821902,0.11410788381742738,0.48952066300867897,1.0,13/26,25.12%,NOS3;ACER3;ACER2;SPTLC2;GCH1;NOS1;CYP1B1;CYB5R3;ABCA2;AKT1;DDAH2;SPTLC1;SPHK2
prerank,oligodendrocyte development (GO:0014003),-0.5083440434486429,-1.3275073493312184,0.14859437751004015,0.48906582096408663,1.0,7/15,19.12%,PLP1;B4GALT5;EIF2B5;TPPP;EIF2B2;B4GALT6;SOX10
prerank,lipid translocation (GO:0034204),-0.4806488097337078,-1.3272979632380033,0.1326530612244898,0.48858263797988216,1.0,8/21,12.13%,ATP10A;ATP8B1;ATP8A1;ATP8A2;ATP11C;ATP11B;TMEM30A;ATP11A
prerank,positive regulation of phospholipase activity (GO:0010518),0.5188634295298934,1.3263079828033744,0.14367816091954022,0.6482262526062117,1.0,5/22,4.40%,FGFR2;KIT;PDPK1;PDGFRB;PDGFRA
prerank,positive regulation of angiogenesis (GO:0045766),-0.334894355565888,-1.3262546395285413,0.03867403314917127,0.4902604770987823,1.0,30/108,10.16%,GAB1;TEK;NOS3;BMPER;TIE1;CD34;KDR;THBS1;RUNX1;F3;KLF4;ITGB1;ETS1;ITGB8;RAMP2;PKM;PIK3R6;HSPB1;ITGA5;GATA2;RHOB;PDCL3;EMC10;VEGFA;TJP1;GRN;PTGIS;S100A1;XBP1;PIK3CD
prerank,positive regulation of phosphorylation (GO:0042327),0.34176260826643434,1.3261676606586956,0.034916201117318434,0.6469445362480314,1.0,44/240,11.69%,IGF1;EPHA7;LEPR;ROCK2;IL34;EPHA3;FGFR2;FGFR4;KIT;ANGPT1;PELI2;DAB2;LMO4;FNIP1;ZBTB20;PDGFRB;IGF2;EPHA8;EPHA4;FAM20A;PDGFRA;DDR1;PRKAA2;IGF1R;LRRK2;FGF1;MMP9;DDR2;PRKAA1;ATG14;RYK;ARNT;MUSK;VEGFB;AXIN2;DVL3;AXL;ABL1;FGF9;FLCN;EPHA2;FXR1;ERBB2;RAP2A
prerank,actin polymerization or depolymerization (GO:0008154),0.4321437505037319,1.3259394972872773,0.1092896174863388,0.6459344515339381,1.0,13/50,11.11%,MICAL3;ARHGAP6;GAS7;AVIL;ABI2;WASF1;WASL;WASF3;SPIRE2;CORO7;PSTPIP2;COBL;JAK2
prerank,neutrophil activation (GO:0042119),-0.5456743723084272,-1.3258711160634387,0.14285714285714285,0.49022068675690966,1.0,5/12,20.19%,PREX1;KMT2E;IL15;TYROBP;PRKCD
prerank,regulation of cellular senescence (GO:2000772),-0.43983159444911457,-1.325427057488715,0.11752136752136752,0.49038994712078593,1.0,8/28,16.93%,B2M;YPEL3;YBX1;ABI3;CDK6;RSL1D1;MAP3K3;EEF1E1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.30636490205568734,1.324983609762232,0.0011049723756906078,0.6471839640532215,1.0,173/1082,13.20%,IL31RA;IGF1;GLIS3;CREB5;RORA;BMP6;TCF4;TCF7L2;OSR1;AUTS2;WNT4;ARNT2;RBPJ;ZIC1;ZNF462;FGFR2;EPAS1;HLF;PPARA;NR2F2;PID1;NPAS3;IL18;HOXC4;CDK8;BMP7;PRKN;WWOX;BRD8;ZEB2;KMT2A;MEIS1;DAB2;HOXB4;ESRRG;FHOD1;CSRP3;ZIC2;MYBL1;DMRT1;SCX;NR1I2;ASCL2;TBL1XR1;CITED4;PLCB1;SP100;PPARGC1B;HOXB3;RNASEL;NFYB;CDK7;IGF2;TP53INP2;SSBP2;TFR2;NCOA2;STAT5B;MAML3;NFAT5;MYRFL;ZFP90;HDAC8;HOXA7;NFIB;TEAD1;ELF4;ARID1B;FIZ1;SOX1;NDP;WASL;DPF2;IRF8;FGF1;MSANTD1;GLI3;TET1;ZMIZ1;NIBAN2;MAML1;PHF8;ARHGEF11;IL6;SALL1;NCOA3;RFXAP;SMAD3;SSBP3;BLM;PBX4;NCOA7;NEK4;GABPB1;GABPB2;RGMB;MTF2;TRIM56;TCF12;ABRA;CCNT2;LYAR;RPRD1B;RSF1;CCNT1;NFIA;PCGF5;ARNT;GTF2F1;FSTL3;KAT8;BRCA2;MITF;KDM6B;KAT6B;CEBPG;RASL11A;MAP3K2;PICALM;IER5;CREB3L2;NSD1;IRF3;BCL9;MED1;AKAP8L;DVL3;AGO2;PHIP;ASXL2;ABL1;MED13;PRKDC;PARP9;SMARCA5;ATOH8;HDAC1;PIK3R1;FLCN;TFAP2A;TFAP2B;TRIM45;RXRA;ERBB2;ZBTB38;MYB;NPAS2;BMPR1A;KMT2B;BCLAF3;RNF14;ICE2;HSF1;RNF20;PRKD2;PKD2;AR;HIVEP1;SERPINE1;KLF5;CRTC1;MAML2;CRTC3;GDNF;ZMIZ2;INO80;SMARCB1;FZD2;HOXD4;TBK1;BCL2L12;NR1I3;FOXK2
prerank,positive regulation of B cell proliferation (GO:0030890),-0.44821162393172864,-1.3246636680330988,0.09292035398230089,0.4913820116729645,1.0,11/29,20.80%,MEF2C;TFRC;NFATC2;CD38;PTPRC;CD74;CD81;MIF;CD40;TIRAP;NCKAP1L
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3860715329983174,1.324377489884803,0.0919175911251981,0.6473422281649073,1.0,14/85,10.88%,DCDC2;EYA1;ADGRV1;CEMIP;CCDC50;ALDH7A1;RIPOR2;CACNA1D;LRP2;BIRC5;WHRN;EML2;GSDME;TFAP2A
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6065190591061044,1.3242807609940046,0.170995670995671,0.6458854226751225,1.0,2/10,5.49%,IL18;PRKCZ
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4546677555514637,1.3241981996093872,0.12477718360071301,0.6443696404356248,1.0,7/37,7.00%,ALCAM;ADGRL1;JAML;FAT4;IL1RAPL1;AMIGO3;PTPRD
prerank,positive regulation of metabolic process (GO:0009893),0.3774694887761554,1.3240659955234395,0.07317073170731707,0.6430471314669864,1.0,16/103,6.84%,LEPR;APPL2;EPAS1;IL18;ACSL1;ESRRG;CAMK1D;GNAS;ALMS1;PPARGC1B;GRB10;GJA1;ACADL;IGF1R;CPT2;PTH2R
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5047434598520267,1.3240209002648011,0.14931237721021612,0.6414899387220687,1.0,3/22,2.79%,PPARA;SORBS1;ZBTB20
prerank,cellular response to hexose stimulus (GO:0071331),-0.4605600367884282,-1.3239327933745826,0.12629399585921325,0.49236461702742856,1.0,9/23,13.34%,UNC13B;GAS6;RACK1;KCNB1;SOX4;XBP1;SLC26A6;GPER1;SLC39A14
prerank,regulation of MAPK cascade (GO:0043408),0.3596593152314135,1.3234502076015318,0.04748201438848921,0.6415476543016794,1.0,18/157,6.76%,IGF1;EPHA7;TGFBR3;ROCK2;KSR1;FGFR2;NRK;KIT;PELI2;LPAR1;TRIM5;IGF2;EPHA8;GFRAL;IGF1R;WWC1;ADRA1D;IL6
prerank,regulation of T cell chemotaxis (GO:0010819),0.5768733615524421,1.3231980898672902,0.16204690831556504,0.6406082010391587,1.0,2/11,3.19%,OXSR1;CXCL13
prerank,eye morphogenesis (GO:0048592),0.5192956088881145,1.3230788386255892,0.14960629921259844,0.6393046241539637,1.0,4/19,2.90%,EFEMP1;FBN1;FBN2;SHROOM2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5164172500589328,-1.3229643808045655,0.15369649805447472,0.4938852465834041,1.0,6/15,7.87%,TMSB4X;KDR;LGMN;HSPB1;MET;VEGFA
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5360980402812122,1.3223616210334297,0.16216216216216217,0.6397473700463847,1.0,7/17,12.39%,ATP1A2;SLC8A1;ANK2;CACNA1D;CACNA2D1;SCN3B;SCN2B
prerank,vasculogenesis (GO:0001570),-0.42438113996651566,-1.32165831765636,0.11013215859030837,0.496436614400027,1.0,13/32,11.16%,CAV1;KDR;ITGB8;RAMP2;RASIP1;ENG;NOTCH1;SOX17;TGFBR2;TGFB1;VEGFA;HEY2;SOX18
prerank,positive regulation of B cell activation (GO:0050871),-0.38872276634402575,-1.3213290567221492,0.07674418604651163,0.4961422159524678,1.0,25/50,34.70%,MEF2C;SH3KBP1;TFRC;NFATC2;CD38;PTPRC;XBP1;CD74;CD81;MIF;CD40;TIRAP;PPP2R3C;NCKAP1L;KMT5C;CLCF1;SHLD3;RIF1;SHLD2;NOD2;BST1;VAV3;IL7;SYK;SASH3
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5472623515152703,1.3213118003525852,0.164,0.6412400488049488,1.0,3/17,5.20%,PRKAG2;PPARA;PRKAA2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.4111652386716921,-1.3210672934695822,0.0958904109589041,0.49573987525872043,1.0,9/37,8.54%,CAV1;RPS7;UBB;RPS3;RACK1;NCK1;SOD1;BCL2L1;SFPQ
prerank,regulation of platelet aggregation (GO:0090330),-0.4936421613647874,-1.3205089913774999,0.13627254509018036,0.49617670181839113,1.0,5/17,6.94%,PRKG1;CD9;F11R;SERPINE2;CEACAM1
prerank,negative regulation of developmental process (GO:0051093),-0.34936902974110184,-1.3201041145093824,0.08478802992518704,0.4960825910499881,1.0,18/69,10.79%,KLF7;NOS3;TFRC;GAS6;CST3;NOTCH1;TBX1;ARHGEF15;KANK1;TBX2;VAT1;TGFB1;DCC;GRIN3A;NOTCH4;HEY2;CDK6;BMP2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.5080967606496374,-1.3200906914668833,0.14340344168260039,0.4950318834708207,1.0,13/16,34.29%,SRSF1;SFPQ;DDX5;SRSF9;SRSF6;DDX17;RBM17;HNRNPM;PUF60;SCNM1;CELF4;DHX9;PQBP1
prerank,peptide metabolic process (GO:0006518),0.39944424283442775,1.3200033596179404,0.10509031198686371,0.6433780199629789,1.0,10/75,8.19%,CPQ;AEBP1;DMD;GSTM2;GSTT4;GSTT1;ACE;TPP1;NPEPPS;CPXM1
prerank,respiratory tube development (GO:0030323),0.47465495092757415,1.3193362344338464,0.14471243042671614,0.6436323423213054,1.0,6/28,5.54%,FGFR2;RBP4;LOXL3;PDPN;FGF1;ITGA3
prerank,response to interleukin-4 (GO:0070670),-0.5802068328140361,-1.3190027757039715,0.14230019493177387,0.4969686501194724,1.0,4/10,19.40%,LEF1;XBP1;TCF7;JAK3
prerank,negative regulation of myotube differentiation (GO:0010832),-0.5466154014140111,-1.3189759425778553,0.130859375,0.49592798070668614,1.0,4/12,10.15%,NOTCH1;CCN3;HDAC5;XBP1
prerank,anterior/posterior axis specification (GO:0009948),0.5469953820392651,1.318913183734733,0.18181818181818182,0.643177687979038,1.0,1/15,0.46%,WLS
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.4396922570752945,1.3187067400433745,0.13494809688581316,0.6421491226812768,1.0,5/40,7.32%,IGF1;PRKN;BNIP3;NOL3;MMP9
prerank,serine family amino acid catabolic process (GO:0009071),0.5949756660787254,1.3183781351658206,0.20412371134020618,0.6414582297349913,1.0,4/10,18.82%,CBS;THNSL2;SHMT1;DLD
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.48973541851448743,-1.3181224774600127,0.14549180327868852,0.497202507991986,1.0,3/18,3.28%,MTUS1;SLIT2;PTK2B
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.5484295364867702,-1.3177165897746608,0.15873015873015872,0.49720986961367447,1.0,10/12,42.68%,CRYAB;CLU;IAPP;PFDN6;PFDN5;PFDN4;TREM2;VBP1;LDLR;PFDN1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5302744117307174,1.3175432773595928,0.18275154004106775,0.642318092601491,1.0,3/16,3.63%,RANBP3L;PLCB1;RIPOR2
prerank,diol biosynthetic process (GO:0034312),-0.5257881028855494,-1.3174323347745,0.12648221343873517,0.4967951483874413,1.0,4/15,4.38%,ACER3;ACER2;SPTLC2;GCH1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.4454051713201416,-1.3170502929428223,0.1148936170212766,0.49684718254518295,1.0,12/30,20.09%,RPL11;HSP90AB1;UCHL5;UBXN1;BAG6;OGT;CAMLG;RYBP;SVIP;N4BP1;TLK2;NOP53
prerank,positive regulation of response to stimulus (GO:0048584),-0.3930249476380409,-1.3159396446075056,0.0898876404494382,0.49883003948452426,1.0,26/40,40.11%,B2M;TGFB2;YPEL3;HOMER1;ABI3;RSAD2;IFIH1;EEF1E1;IL15;PRKCD;FMR1;NSMCE4A;NSMCE1;FCGR2B;CD80;CGAS;DHX9;ACOX2;MAVS;ILK;BCLAF1;ARG2;ANKLE1;GATA3;HMGA1;CDKN2AIP
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5532170056807544,-1.3158276322210032,0.11844660194174757,0.4980218594179941,1.0,4/11,17.60%,FAP;BCL2L1;PTGIS;ZC3H12A
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5600645633280248,-1.3154797405319447,0.14684014869888476,0.4979765798560545,1.0,5/11,23.02%,CREB3L1;HSPA5;ATF4;ATF3;CEBPB
prerank,cellular response to lipid (GO:0071396),0.3487733681296887,1.3153227686176825,0.055162659123055166,0.6472774852836465,1.0,19/191,7.27%,RORA;ATP1A2;ROCK2;ADCY5;PTK7;ADCY1;TFPI;EPHA3;WNT6;PID1;CXCL13;CRHBP;CACTIN;SSTR2;IL6;NCOA3;PDCD1LG2;UBE2L3;WNT5B
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5534127732204753,1.3152742688218857,0.1574642126789366,0.6457656198648855,1.0,2/14,4.13%,IGF1;SYT11
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5286926038589199,-1.3148884520266306,0.15495867768595042,0.4985010237976437,1.0,7/14,26.33%,THBS1;ITGA4;PDCD4;GPER1;CD40;RGCC;CCL2
prerank,lipoxygenase pathway (GO:0019372),-0.5127811488921732,-1.314849080879413,0.162,0.4975374385755716,1.0,4/14,12.63%,GPX4;PTGS2;PON2;ALOX12
prerank,endoderm development (GO:0007492),-0.5228979272683534,-1.314728152635751,0.1506276150627615,0.49678704786804917,1.0,8/13,40.59%,SOX17;SOX7;DUSP1;DUSP4;TBX20;DUSP5;DUSP2;GATA4
prerank,negative regulation of mitochondrion organization (GO:0010823),0.4563177951853862,1.3145564202395863,0.1393596986817326,0.6463589509109652,1.0,6/33,10.86%,IGF1;PRKN;BNIP3;NOL3;ACAA2;FLCN
prerank,fatty acid catabolic process (GO:0009062),0.39756480613816053,1.3137785870449765,0.10355987055016182,0.6472546768629355,1.0,17/67,14.65%,PCCA;CEL;EHHADH;ACADL;ECI2;HSD17B10;CPT2;ACAD11;ECHDC1;ACADS;PHYH;ACAA2;ACAT2;AUH;ACOX1;BDH2;HACL1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.29688268672864615,1.3137751672681446,0.0,0.6456315620685353,1.0,282/1645,14.18%,IL31RA;IGF1;GLIS3;CREB5;RORA;SOX5;MAF;VGLL3;TCF4;TCF7L2;OSR1;EFEMP1;WNT4;ARNT2;RBPJ;DENND4A;ZIC1;HOXC6;EPAS1;HLF;PPARA;KDM7A;NR2F2;NPAS3;IKZF2;KIT;HOXC4;BMP7;ATXN1;ZEB2;TULP3;ZKSCAN2;KMT2A;PRRX1;MEIS1;HOXB4;SNX6;DKK3;ESRRG;ARID5B;RUNX1T1;MXI1;CUX1;SMAD6;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DMRT1;SCX;NR1I2;ASCL2;SOX6;TBL1XR1;ZBTB20;PLCB1;SP100;LOXL3;PPARGC1B;HOXB3;TSHZ3;HIF3A;PAX5;NFYB;JARID2;EPOP;MIDEAS;ZIC5;HOXA3;BBX;IGF2;TP53INP2;SSBP2;HOXC5;PKNOX2;VSX2;NCOA2;STAT5B;NFAT5;ELOA;MYRFL;VGLL4;ZFP90;PRICKLE1;HOXA7;FOXD1;ZHX2;CBY1;NFIB;BEND5;TEAD1;ELF4;L3MBTL2;MGA;BAZ1B;ARID4A;TEF;ZNF367;ARID1B;IKZF4;GMEB1;KDM2B;CAMTA1;SOX1;SIX5;SALL4;ZFHX2;NDP;DPF2;PERM1;IRF8;SP110;ZNF250;MSANTD1;GLI3;PRKCB;ZNF569;METTL4;SFMBT1;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;ZMIZ1;NIBAN2;ZFP37;BAZ1A;PHF8;BCOR;ARHGEF11;SUFU;THAP1;WWC1;TYMS;IL6;WWC2;SALL1;GPBP1;UBE2L3;RFXAP;ZNF23;XRCC5;SMAD3;BLM;PHF14;EN1;GPBP1L1;PBX4;CHD4;NCOA7;NR6A1;NEK4;POLR3G;RGMB;MTF2;ZKSCAN5;TRIM56;KDM2A;TCF12;POLR2A;CCNT2;BIRC5;TEAD3;WWP2;PIAS1;RSF1;CCNT1;NFIA;PCGF5;ARNT;ZMYND15;TLE1;FSTL3;ZNF628;KAT8;KDM5B;CAMK2D;BRCA2;MITF;KAT6B;CEBPG;KDM3B;MAP3K2;PICALM;EBF4;MDM2;MBTD1;NFYC;HOXB6;CREB3L2;NSD1;BATF2;IRF3;MED1;BBS7;DVL3;NUP107;ZSCAN29;SMURF2;IRX1;PHIP;ABL1;MED13;SCMH1;PARP9;L3MBTL3;SMARCA5;ATOH8;NEUROD2;ASCC2;HDAC1;ZBTB11;TSHZ1;TFAP2A;TADA2A;SMARCE1;ZNF8;HOXC8;TFAP2B;ARID3A;ZIC4;ZNF568;TRIM45;RXRA;ERBB2;TGFA;ZBTB38;MYB;ZBTB39;NPAS2;KMT2B;ZBTB37;CRY1;CNOT2;ZNF177;RNF14;E2F6;SOX13;GMEB2;HSF1;RNF20;CCNE1;CBFA2T2;PSPC1;AR;HIVEP1;PHF6;KLF5;SEBOX;ZMIZ2;SMARCB1;FZD2;HOXD4;NFATC4;HOXA6;NONO;EPC2;FOXK2;SRCAP;SNAI1;HOXB9;SCML4;TFDP2;RRP8;MLXIP;CLOCK;ZNF148;ZFX;SRF;POLR3C;DMRTA2;KDM5C;UBE2V1;MTDH;CDKN1C;BATF;CREBBP;NLK;MNAT1
prerank,amino acid import (GO:0043090),0.5150914532781539,1.3137735580670942,0.15517241379310345,0.6440166241748629,1.0,5/21,3.73%,SLC22A4;SLC6A13;SLC22A2;SLC1A3;SLC6A1
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.3459154853133749,-1.3128261165569437,0.09090909090909091,0.5009168359160389,1.0,27/84,10.16%,TEK;TMSB4X;FOXP1;NOS3;NRP2;KDR;THBS1;RAC1;SCARB1;ETS1;PTK2B;BMPR2;LGMN;ATP5F1A;HSPB1;BCAR1;GATA2;RHOB;TGFB1;CALR;EMC10;MET;FLT4;VEGFA;GRN;EDN1;PIK3CD
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.48369854688197267,-1.312783121896974,0.12007874015748031,0.4999734083724534,1.0,9/18,30.67%,CD34;PTPRC;NAV3;LAPTM5;TRIM27;HDAC7;TNFAIP3;EZR;ZFP36
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.4543209771406372,-1.3127551361771914,0.12366737739872068,0.49895522601973813,1.0,17/24,36.53%,UBB;RPS27A;UBC;RPA1;UBA52;POLK;LIG4;POLE;POLD3;POLB;POLD1;LIG3;RFC5;RPA3;RPA2;XRCC1;RFC2
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.47473536969343516,-1.3122497920927843,0.14940239043824702,0.4992350183044131,1.0,8/19,11.74%,TGFB2;NOTCH1;BMPR2;TGFBR2;SOX4;HEY2;BMP2;HEYL
prerank,carbohydrate transport (GO:0008643),-0.5476069898198233,-1.3122132478310444,0.1509090909090909,0.49826315398557547,1.0,3/11,11.74%,AQP11;SLC50A1;SLC26A6
prerank,activation of GTPase activity (GO:0090630),-0.3459045084996117,-1.311946363923218,0.05307262569832402,0.49790271616867254,1.0,28/89,12.37%,NTRK3;SIPA1L1;TIAM1;TBC1D30;ARHGAP42;TBC1D8;SIPA1L2;SIPA1L3;ARHGEF15;CCDC125;RABGAP1L;CORO1C;ADPRH;ABR;GRTP1;SGSM1;BCR;TBC1D8B;TBC1D1;ARHGEF19;TBC1D13;ARHGEF26;ARHGAP25;ARHGEF5;ARHGEF10;EVI5;RANGAP1;TBC1D10A
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.31190166259413726,1.311794033974419,0.013173652694610778,0.6483156713613232,1.0,103/572,13.15%,GLIS3;PRDM6;BMP6;TCF7L2;OSR1;AEBP1;RBPJ;FGFR2;FHL2;PPARA;NR2F2;PRKN;WWOX;ATXN1;ZEB2;KCNIP3;DAB2;ARID5B;MXI1;FNIP1;CUX1;AASS;SATB1;PRDM5;ZEB1;DKK1;DMRT1;NR1I2;ASCL2;TBL1XR1;SP100;IGF2;NEDD4;VSX2;JAZF1;ZFP90;HDAC8;HOXA7;ZHX2;NFIB;RNF2;KDM2B;SOX1;DPF2;IRF8;GLI3;MXD1;ZBTB32;ZFP37;CXXC5;BCOR;SUFU;DLG1;THAP1;WWC1;WWC2;SALL1;KANK2;SMAD3;EN1;NR6A1;MTF2;PHF21A;PER3;WWP2;LYAR;CBX8;DNAJA3;CBX2;MITF;MDM2;NSD1;MED1;FRK;SMURF2;IRX1;PARP9;HDAC1;FLCN;TFAP2A;CBX7;ZNF8;TFAP2B;ZNF568;RXRA;MYB;TAF3;CRY1;CNOT2;ZNF177;CDC73;E2F6;ORC2;SOX13;HSF1;AR;HIVEP1;PHF6;EZH1;CGGBP1;IFI27;NFATC4;NR1I3
prerank,positive regulation of phosphatase activity (GO:0010922),-0.4693840470721813,-1.3117222178114505,0.11776859504132231,0.4974372799013793,1.0,11/21,24.25%,MEF2C;CALM1;HSP90AB1;MTOR;BMP2;MTMR9;CALM2;CD300A;CALM3;PPP1R15A;PPP1R15B
prerank,tight junction assembly (GO:0120192),-0.38458096756323457,-1.3116548981345533,0.09836065573770492,0.4965415228857733,1.0,9/49,3.00%,PECAM1;CLDN5;ESAM;ACTG1;OCLN;CLDN11;LSR;RAMP2;F11R
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3636504266966932,1.3113094722283332,0.07256894049346879,0.6482092761462886,1.0,28/138,14.18%,RORA;RBPJ;PPARA;NOTCH2;POLR2D;ESRRG;CCN2;NR1I2;TBL1XR1;CDK7;MAML3;TEAD1;MAML1;NR6A1;NRBP1;POLR2A;TEAD3;GTF2F1;MED1;TAF8;HDAC1;RXRA;TAF3;AR;MAML2;NR1I3;CREBBP;MNAT1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.34695848290295495,1.3107309053256464,0.05726256983240224,0.6484455054966517,1.0,18/170,9.06%,IGF1;PRDM6;ROCK2;AFF2;ZNF462;IGF2BP1;NOVA1;PRDM5;DKK1;SLC8A1;TRIM5;CACTIN;MTMR3;ZUP1;ATRAID;KDM6B;SIRPA;FUBP1
prerank,cardiac muscle cell action potential (GO:0086001),0.4730865872608982,1.3104097111230277,0.15221579961464354,0.6477780679930063,1.0,7/30,7.35%,ATP1A2;DMD;SLC8A1;ANK2;KCND3;CACNA1D;CACNA2D1
prerank,negative regulation by host of viral process (GO:0044793),0.5935959506984104,1.309832227565185,0.20204081632653062,0.6479179000106325,1.0,2/10,2.73%,PRKN;LTF
prerank,protein oxidation (GO:0018158),0.5791416554426416,1.3095544859769614,0.18200836820083682,0.6471701975480817,1.0,2/11,2.97%,LOXL1;LOXL3
prerank,calcium-mediated signaling (GO:0019722),0.37900107181969817,1.3084410022711455,0.10093167701863354,0.6488639850971903,1.0,16/93,8.22%,RCAN2;ADGRL1;ACKR2;CCR9;CXCR5;PDPK1;SLC8A1;DMPK;ANK2;CXCR6;SPHK1;LRRK2;PPP1R9A;PRKAA1;MCU;GPR143
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3515550239878253,-1.3080121591742035,0.08446866485013624,0.5051351197597423,1.0,22/76,21.08%,TEK;NTRK3;CARMIL1;PTK2B;CDC42EP3;NCKAP1;WDR1;NCK1;BAIAP2L1;EDN1;NCK2;BIN1;SORBS3;NES;CDC42EP5;PRKCE;CDC42EP2;CFL2;CDK5;EVL;NCKAP1L;NUMA1
prerank,regulation of organelle assembly (GO:1902115),0.3931838352301475,1.3079270603010906,0.10197368421052631,0.6488067143710171,1.0,9/73,6.56%,DCDC2;NPRL3;SPICE1;ODAD3;ALMS1;NPRL2;MTMR3;TBC1D9B;SDCCAG8
prerank,regulation of cholesterol efflux (GO:0010874),-0.4306184627589929,-1.3074780998648048,0.12719298245614036,0.5054148335356157,1.0,18/30,30.79%,CAV1;PLTP;SREBF2;NFKBIA;PTCH1;LAMTOR1;NR1H2;ABCA3;ABCA2;ZDHHC8;NR1H3;TTC39B;TREM2;GPS2;ABCA7;PPARG;NAXE;SHH
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4884871547892722,1.3074484352555755,0.14770459081836326,0.6487164655330476,1.0,5/24,10.80%,LEPR;PID1;COQ10A;GFPT2;ADRB3
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.55741082018902,1.3070871846559031,0.1950207468879668,0.6481909157059431,1.0,2/14,1.68%,AUTS2;KMT2A
prerank,regulation of neuron migration (GO:2001222),-0.4344319682986716,-1.3064662522580164,0.1288981288981289,0.5069186864824491,1.0,12/26,22.66%,SEMA6A;DAB2IP;SHTN1;NEXMIF;ARHGEF2;CAMK2B;COL3A1;ADGRG1;NTNG1;NSMF;SEMA3A;PLAA
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.49818932776721925,1.3059115663201082,0.19361702127659575,0.6501347862395891,1.0,3/21,5.30%,ADCY5;ADCY1;NPR2
prerank,lamellipodium organization (GO:0097581),-0.42833045929675834,-1.3055936243853228,0.1130820399113082,0.5082218127237008,1.0,9/29,6.15%,PARVB;ABLIM1;RAC1;CARMIL1;ITGB1;S1PR1;SPATA13;ARHGEF6;CCDC88A
prerank,homeostasis of number of cells (GO:0048872),-0.5363569676180554,-1.3048288162003843,0.14595660749506903,0.5091758705055496,1.0,5/12,15.75%,NOS3;NOTCH1;CCN3;LPCAT3;CX3CR1
prerank,protein deneddylation (GO:0000338),-0.5584350933609966,-1.3042792508885066,0.14962121212121213,0.5096804097188063,1.0,3/10,17.77%,COPS7A;COPS8;COPS6
prerank,myoblast fusion (GO:0007520),0.5546549064108132,1.3039417431993157,0.1750503018108652,0.6542570295192177,1.0,3/12,2.21%,ADAM12;ADAMTS5;ADAMTS15
prerank,cellular response to glucose stimulus (GO:0071333),-0.427133707679049,-1.303595410093369,0.12249443207126949,0.5105785700426123,1.0,10/30,13.52%,UNC13B;GAS6;RACK1;PTPRN2;KCNB1;SOX4;XBP1;GPER1;SLC39A14;RAB11FIP5
prerank,glycogen metabolic process (GO:0005977),0.4735701999211023,1.302851931502504,0.15612648221343872,0.655992182194342,1.0,4/27,9.46%,PRKAG2;PHKB;GYS1;NHLRC1
prerank,xenobiotic transport (GO:0042908),0.5385370020768943,1.3020372311833999,0.15120967741935484,0.6569588315750119,1.0,5/17,7.33%,SLC22A4;SLC22A2;NR1I2;GJA1;ABCC2
prerank,actin filament polymerization (GO:0030041),0.4721422741523404,1.3019807448331944,0.16116504854368932,0.6555521862421249,1.0,10/29,11.11%,ARHGAP6;GAS7;WASF1;WASL;WASF3;SPIRE2;CORO7;PSTPIP2;COBL;JAK2
prerank,inorganic cation transmembrane transport (GO:0098662),0.3320515267718769,1.3014165443365517,0.03825136612021858,0.6556978073568125,1.0,19/268,4.74%,TRPM3;SCN7A;ATP1A2;SLC6A13;SLC24A3;KCNK2;SLC8A3;SLC6A12;SLC6A9;KCNQ4;NALCN;KCNA5;SLC41A1;SLC1A3;ATP1B3;SLC8A1;SLC6A1;KCND3;CACNA1D
prerank,camera-type eye development (GO:0043010),0.49560848335281965,1.301094503943525,0.14395393474088292,0.6551142669569434,1.0,4/25,2.90%,EFEMP1;FBN1;FBN2;SHROOM2
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.40609545637931405,-1.3010302752729512,0.1320754716981132,0.5164231915768326,1.0,12/34,17.60%,PDE4D;CALM1;ATP1B1;ATP2A2;KCNQ1;ADRA1A;RYR2;NOS1;CHGA;CALM2;PLN;ZC3H12A
prerank,cellular response to interleukin-4 (GO:0071353),-0.5643036990162605,-1.3009477253039463,0.17958412098298676,0.5156067679826888,1.0,4/10,19.40%,LEF1;XBP1;TCF7;JAK3
prerank,potassium ion homeostasis (GO:0055075),-0.4553167050313947,-1.3005935626980143,0.12375249500998003,0.5155363027238317,1.0,10/23,11.54%,SLC12A7;SLC12A2;KCNJ2;ATP1A1;KCNMA1;ATP1B1;SLC12A6;SLC12A8;SLC12A4;ATP1A3
prerank,cellular defense response (GO:0006968),0.43445298251805936,1.3005285462980347,0.13970588235294118,0.6551691325137977,1.0,2/40,1.52%,DCDC2;CCR9
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.43227669390445667,-1.300446352674185,0.1279826464208243,0.5148520552570455,1.0,11/27,18.75%,CAV1;PDE4D;ATP2A2;CTNNA3;RYR2;CACNA1C;JUP;DSG2;PLN;DSP;TRPM4
prerank,protein mannosylation (GO:0035268),0.48625198993870866,1.300009890580132,0.17169811320754716,0.6551350083566754,1.0,4/22,4.37%,TMTC4;LARGE1;TMTC1;CRPPA
prerank,translesion synthesis (GO:0019985),-0.38925551841577893,-1.2999794778127425,0.09090909090909091,0.5151105743933729,1.0,20/42,28.63%,UBB;REV3L;TRIM25;RPS27A;UBC;ISG15;RPA1;UBA52;USP43;POLK;FAAP20;POLN;SPRTN;POLD3;VCP;POLD1;POLI;DTL;RFC5;USP10
prerank,nucleus organization (GO:0006997),-0.3864397719554988,-1.2999380805737408,0.1108433734939759,0.5141679274572694,1.0,21/47,26.80%,SYNE1;REEP3;RPS19;CHMP5;CHMP2B;LEMD2;BIN1;NUP54;CHMP1B;SUN1;PITPNB;IRAG2;CHMP1A;CTDNEP1;NUP133;NUMA1;CHMP3;CHMP7;PDCD6IP;CHMP4C;CEP55
prerank,T cell receptor signaling pathway (GO:0050852),-0.31417350710255076,-1.2999116153848769,0.03550295857988166,0.5131947368780438,1.0,45/138,23.41%,PTPRJ;PDE4D;PLCG2;FYN;INPP5D;DENND1B;RFTN1;BCAR1;IKBKB;NCK1;PTPRC;TNFRSF21;CSK;PAK1;PSMD13;PSMF1;PAK2;PSMB10;PIK3CD;CHUK;PSMB6;STOML2;PSME3;PSMB5;MOG;PSMC3;PSMD12;PSMB8;CUL1;NFKBIZ;PSME1;EIF2B5;PSMB3;EIF2B2;BTN3A3;ZC3H12A;PSMD5;THY1;SKP1;TXK;FYB2;RBCK1;PSMD9;PSMB4;RELA
prerank,"transcription, DNA-templated (GO:0006351)",0.34136716488989977,1.2994967584727128,0.05374823196605375,0.6550449175646739,1.0,28/207,12.36%,GLIS3;SOX5;MAF;POLR2D;SCX;PAX5;CDK7;ELOA;GTF3C5;HSF2BP;THAP1;POLR3GL;POLR3G;POLR2A;CCNT2;RSF1;CCNT1;GTF2F1;SMN1;SMARCA5;TAF1A;DTX1;GTF3C3;TAF3;CDC73;GMEB2;HIPK3;HSF1
prerank,protein hydroxylation (GO:0018126),-0.5049634326084642,-1.2993869073448483,0.15708812260536398,0.5136886045550766,1.0,8/15,29.23%,P3H2;EGLN3;PLOD2;PLOD3;JMJD7;PLOD1;VPS33B;HIF1AN
prerank,regulation of protein localization to nucleus (GO:1900180),-0.39053936319809973,-1.2991936904557388,0.11936936936936937,0.5131408038062912,1.0,24/43,36.09%,TFRC;LIMK2;TGFB1;FERMT2;GSK3B;CARD10;SESN2;WWTR1;ATP13A2;SUMO3;CTNNA1;AKT1;BMP4;OTUD7B;BYSL;SIN3A;SHH;MFHAS1;PLK1;NGFR;PARK7;CDK5RAP3;TESK1;LIF
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.5230550345081824,-1.2991026741110712,0.14864864864864866,0.5123193252623593,1.0,7/13,30.32%,LGMN;PERP;TBC1D10A;CASP8;CYFIP2;NLRC4;FADD
prerank,cellular response to organic cyclic compound (GO:0071407),0.3489963516214989,1.2989646530772911,0.07196401799100449,0.6550026390741518,1.0,16/141,7.29%,RORA;ATP1A2;ROCK2;ADCY5;ADCY1;TFPI;IL18;SLC5A5;CRHBP;AANAT;SSTR2;LRRK2;NCOA3;UBE2L3;BLM;FOLR1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.36243111151593455,1.2987321649472903,0.07704160246533127,0.6541655978252052,1.0,22/132,9.79%,IGF1;SH3D19;PPARA;DAPK1;ZBTB20;TRIM5;VGLL4;PRKAA2;UFL1;NPRL2;LRRK2;SNX9;SNX33;NRDC;BNIP3;OPTN;RNF152;PRKAA1;DAGLB;ARNT;PLEKHF1;ITCH
prerank,positive regulation of MAPK cascade (GO:0043410),0.3329817472026313,1.2985752456183763,0.056451612903225805,0.6530817603256226,1.0,32/245,7.93%,IGF1;ROBO1;ROCK2;IL34;KSR1;FGFR2;FGFR4;NOTCH2;KIT;ANGPT1;PELI2;MTURN;LPAR1;CCN2;PDGFRB;TRIM5;IGF2;EPHA8;GFRAL;PDGFRA;GLIPR2;PDGFD;IGF1R;LRRK2;PRKCZ;FGF1;WWC1;ADRA1D;IL6;PRKCA;CCL19;RYK
prerank,positive regulation of telomerase activity (GO:0051973),-0.4180649158708267,-1.2982743581030642,0.14382022471910114,0.5133945207649686,1.0,7/33,10.52%,NEK7;HSP90AA1;HSP90AB1;KLF4;CTNNB1;PARM1;MAP2K7
prerank,regulation of protein modification process (GO:0031399),-0.37606454995462435,-1.2977135399604856,0.07459207459207459,0.5138022108607625,1.0,17/50,15.53%,FN1;FNIP2;PTK2;ATG7;PPP1R16B;HSPB1;CORO1C;WARS1;CCDC88A;SPRED2;PPIB;SESN2;CADM4;MT3;RABL3;PPP1R16A;CCDC88C
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5164814351845696,1.2976532208683067,0.1790744466800805,0.6543873274615809,1.0,8/17,20.58%,PPARA;PID1;NUPR1;FLCN;PFKFB1;NCOR1;HDAC4;PDE12
prerank,regulation of angiogenesis (GO:0045765),-0.3030041704104873,-1.2973626699513277,0.032467532467532464,0.5137277696659169,1.0,41/192,8.87%,GAB1;TEK;CLDN5;PTPRM;NOS3;SEMA6A;RHOJ;BMPER;TIE1;CD34;KDR;THBS1;TGFB2;RUNX1;PLXND1;F3;KLF4;ITGB1;ETS1;ITGB8;RAMP2;DAB2IP;SEMA3E;PPP1R16B;PIK3R6;HSPB1;WARS1;STAB1;GATA2;RHOB;PDCL3;CTNNB1;SARS1;CEMIP2;EMC10;CEACAM1;SERPINF1;VEGFA;EMP2;GRN;PTGIS
prerank,regulation of cellular component size (GO:0032535),-0.4238938526752157,-1.2973546370696094,0.13071895424836602,0.5127217621323275,1.0,17/30,27.51%,MSN;RAC1;RIN3;MTOR;EPS8;AP2M1;PPP1CA;RAB3B;ATP13A2;PEX11B;RAP1GAP2;HP1BP3;LAMTOR4;PPP1R15A;EZR;RPTOR;NEB
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4314725121046938,1.2969161063644754,0.1497326203208556,0.6549144601478141,1.0,16/42,17.78%,RBBP4;HNRNPC;ARID1B;CECR2;NASP;CHD4;SMARCA5;HDAC1;SMARCE1;INO80;SMARCB1;SRCAP;SMARCA2;SMARCC1;ACTR6;SMARCA1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.38246485887103626,1.296894680153989,0.0978441127694859,0.6534321743161158,1.0,14/77,12.50%,IGF1;TCF7L2;PRKN;BCL2;SH3RF1;NOL3;MMP9;SIAH2;BIRC6;ACAA2;BCL2L2;PHIP;CFLAR;AR
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.44613920080106906,-1.2968400811050473,0.1368421052631579,0.513098996295493,1.0,13/24,28.97%,ABCG2;ABCB10;SUCLA2;RSAD1;ATP5IF1;UROD;UROS;FECH;FLVCR1;HMBS;COX15;TSPO;ABCB6
prerank,negative regulation of cell differentiation (GO:0045596),0.34690210223616125,1.2966073673168377,0.06552706552706553,0.6526851435450529,1.0,24/181,8.93%,RANBP3L;RORA;ADAMTS12;ADGRV1;OSR1;EFEMP1;PPARA;BMP7;MEIS1;RUNX1T1;SMAD6;IGF2;ANKRD26;ABCA1;TMEM64;ADAMTS7;SUFU;IL6;SMAD3;PTEN;IQCB1;ABCA5;YTHDF2;USF3
prerank,regulation of cell differentiation (GO:0045595),-0.314141578294719,-1.2960581416819397,0.04152249134948097,0.5141460123539221,1.0,42/148,18.71%,SLC6A6;SPOCK2;LTBP4;TRPS1;ZFHX3;TIAM1;RUNX1;CBFB;HSP90AB1;KLF4;PTK2;PHLDB1;NGF;TBX1;TGFB1;SIX1;NOTCH4;EMP2;PTHLH;RUNX2;DDX5;HEY2;ZFP36L1;APC;CDK6;YWHAG;UQCC2;ATF4;MCRIP1;RPS6KA1;BIN1;REST;NF1;NR1D2;RAF1;BCL6B;APC2;YWHAH;ID2;CASZ1;GREM1;DDX17
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.4051868242847874,-1.2956909340581826,0.10251046025104603,0.5141231862569926,1.0,8/35,7.60%,HIP1;SGIP1;B2M;RAC1;CBL;HNRNPK;ARF1;HIP1R
prerank,protein polymerization (GO:0051258),0.41281769124430495,1.2955898014984957,0.13518197573656845,0.6542038875652101,1.0,13/56,11.11%,ARHGAP6;PRKN;GAS7;WASF1;WASL;ARL6;WASF3;SPIRE2;RNF135;CORO7;PSTPIP2;COBL;JAK2
prerank,protein K48-linked deubiquitination (GO:0071108),-0.45147115523455883,-1.2952911198952866,0.13663366336633664,0.5141498120798097,1.0,14/23,25.91%,ATXN3;OTUD7A;MINDY2;MINDY1;USP50;USP37;OTUD3;OTUB1;USP8;OTUD7B;TNFAIP3;USP5;USP33;YOD1
prerank,apoptotic process (GO:0006915),-0.29921861628422747,-1.295260577228744,0.027131782945736434,0.513209017790125,1.0,68/203,22.36%,HIP1;EFNA5;ELMO1;SEMA6A;FAP;ADAM15;MAL;PPARD;PTK2B;NFKBIA;PPIA;TBX1;CDK11B;NCKAP1;MAGI3;CIT;TGFBR2;ARHGEF6;RHOB;TNFRSF21;DCC;BCL2L1;BAG6;EGLN3;PLAGL1;AHR;GAPDH;PDCD4;APP;ADRA1A;MTOR;FOXO1;DDIT4;ING4;PAEP;RTN4;BNIP2;OGT;NDUFS1;YARS1;HSPD1;BNIP1;BBC3;DAP;IAPP;PRUNE2;FAS;JADE1;RFK;CASP8;AHCYL1;AKAP1;RAF1;PRKCE;CDK5;LIG4;TNFRSF10B;CYFIP2;MYD88;PDE1B;PRKCD;AKT1;GADD45A;PAK5;BIK;BMF;CASP1;TRAIP
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5036626463829083,-1.2948610440802046,0.17169811320754716,0.5131904373119811,1.0,4/15,13.20%,GRM3;GRM7;HOMER1;GRM8
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.5431587367720294,-1.2948371384104562,0.14849624060150377,0.512224090630705,1.0,5/11,14.72%,KCNJ2;ATP1A1;ATP1B1;KCNQ1;KCNIP2
prerank,histone lysine demethylation (GO:0070076),0.47668024169997425,1.2946049158667243,0.14625228519195613,0.6556415376510852,1.0,12/25,18.39%,KDM7A;KDM2B;PHF8;KDM2A;KDM5B;KDM6B;KDM3B;KDM5C;KDM6A;PHF2;RIOX2;KDM4D
prerank,regulation of cell killing (GO:0031341),-0.49320655863840585,-1.2940392083750052,0.16966067864271456,0.5132336261529906,1.0,5/16,16.37%,RAC1;TGFB2;CD55;MAPK8;DVL2
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.40429331104522104,-1.2935658609915193,0.10105263157894737,0.5134550128303035,1.0,17/32,24.25%,CALM1;HSP90AB1;PPIA;PPP1R16B;TGFB1;MTOR;SYMPK;CALM2;PPP2R5A;PTBP1;PRKCD;CDCA2;CD300A;NSMF;CALM3;PPP1R15A;PPP1R15B
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.35170148549761787,-1.2934162601623471,0.07356948228882834,0.5128064814593619,1.0,19/70,10.97%,MEF2C;TEK;FN1;TMEFF2;PARVB;RAC1;SIPA1L3;ACTN1;PXN;LAMA5;LAMB2;FERMT2;ITGA4;SRCIN1;PEAK1;RHOA;RELN;ATF4;ITGA8
prerank,epithelial cell-cell adhesion (GO:0090136),0.595129158310947,1.2932529658399288,0.18633540372670807,0.6580907624108004,1.0,2/11,1.24%,PLEKHA7;KIT
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.4552020336150465,-1.2921963195660628,0.13043478260869565,0.5150257676719491,1.0,11/23,23.79%,HSP90AA1;NDUFA13;TOMM22;TIMM9;ROMO1;TIMM10B;TIMM13;TIMM29;TIMM22;BMF;BAX
prerank,negative regulation of angiogenesis (GO:0016525),-0.34540323123632605,-1.2914719612104764,0.07712082262210797,0.5160019121903336,1.0,23/84,14.62%,TEK;SLC12A2;CLDN5;PTPRM;SEMA6A;KLF2;THBS1;TGFB2;KLF4;DAB2IP;SEMA3E;CREB3L1;STAB1;CTNNB1;SARS1;SERPINF1;HGS;HHEX;SYNJ2BP;EPN2;COL4A2;ISM1;SPARC
prerank,JNK cascade (GO:0007254),-0.403309318693166,-1.2912143188526024,0.11312217194570136,0.515667341016063,1.0,12/40,15.45%,MAP3K5;UBB;NOD1;MINK1;ARHGEF6;RPS27A;UBC;MAPK8;MAP2K7;MAP3K12;TAB3;UBA52
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.4651430716501232,-1.2909089857490534,0.15151515151515152,0.5154880507473455,1.0,9/19,28.94%,LBP;PIK3AP1;NR1H4;PRKCE;IRAK1;TIRAP;TRIL;ITGB2;TLR4
prerank,vacuolar acidification (GO:0007035),-0.44772026595959447,-1.2908138946245398,0.14143426294820718,0.5147387233089054,1.0,13/21,26.57%,DMXL1;ATP6V0A1;GRN;TCIRG1;DMXL2;ATP6V0A4;ATP6V0A2;SLC11A1;ATP6V0D2;CLN5;ATP6V0E2;TMEM9;ATP6V1H
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.486039842689746,1.2904201550903254,0.17025440313111545,0.6650655178170385,1.0,6/24,11.08%,EPHA7;PCSK9;SRPK2;NUPR1;TFAP2A;TFAP2B
prerank,insulin receptor signaling pathway (GO:0008286),-0.3525679997785272,-1.2899642155638502,0.09069767441860466,0.5158545619730692,1.0,21/69,13.34%,GAB1;GRB14;BCAR3;NAMPT;AP3S1;CAV2;BCAR1;ATP6V0A1;GSK3B;FOXO1;APPL1;C2CD5;ATP6V1A;APC;ATP6V0C;PIK3C2A;PDK2;TCIRG1;ATP6V1E1;IDE;SLC39A14
prerank,positive regulation of vasoconstriction (GO:0045907),-0.5301525900843769,-1.289769521683204,0.16149068322981366,0.5153785845823498,1.0,3/13,7.85%,CAV1;ADRA1B;ADRA1A
prerank,response to sterol (GO:0036314),0.5652752934264313,1.289713507353284,0.21271929824561403,0.6655906354349326,1.0,1/11,0.14%,RORA
prerank,regulation of interleukin-4 production (GO:0032673),-0.460022348800475,-1.289150649318458,0.13675213675213677,0.5160327145061211,1.0,2/21,1.62%,LEF1;SLC7A5
prerank,regulation of wound healing (GO:0061041),-0.37953162244082345,-1.2889890895276523,0.11963882618510158,0.5154123165582679,1.0,12/42,13.41%,CAV1;ACTG1;OCLN;PTK2;ITGB1;KANK1;CD109;AJAP1;CRK;CASK;SRSF6;CADM4
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5461347832648827,-1.288947145506442,0.1436893203883495,0.5145486924763324,1.0,6/11,18.32%,CAV1;ATG7;FOXO1;ATP6V1A;FAS;ATP6V0A2
prerank,central nervous system myelination (GO:0022010),-0.5513903533568687,-1.2886806911656123,0.16173570019723865,0.5142915670463916,1.0,7/11,19.12%,PLP1;B4GALT5;TENM4;CLU;B4GALT6;ABCA2;SOX10
prerank,negative regulation of secretion by cell (GO:1903531),-0.39614296125962045,-1.2883207433130177,0.11778290993071594,0.5142563070772143,1.0,11/38,13.88%,STXBP6;GRM7;NOTCH1;VAMP8;RHBDF2;TNFRSF1B;SLC30A1;RSAD2;SYT4;CHGA;CYP51A1
prerank,wound healing (GO:0042060),0.4008975541634819,1.288159747067825,0.12520593080724876,0.6687114557086355,1.0,10/62,8.87%,IGF1;TPM1;JAML;MACF1;SYT11;PDGFRA;FGF1;SMAD3;MIA3;DCBLD2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.3057890641618032,-1.2879192152286731,0.03215434083601286,0.5143681446023008,1.0,51/163,23.41%,MEF2C;PTPRJ;PDE4D;PLCG2;FYN;INPP5D;BMX;DENND1B;RFTN1;BCAR1;IKBKB;NCK1;NFATC2;CD38;PTPRC;TNFRSF21;CSK;PAK1;PSMD13;PSMF1;PAK2;PSMB10;PLEKHA1;PIK3CD;CHUK;PSMB6;STOML2;PSME3;PSMB5;MOG;PSMC3;PSMD12;PSMB8;CUL1;NFKBIZ;PSME1;EIF2B5;PSMB3;EIF2B2;BTN3A3;ZC3H12A;PSMD5;THY1;SKP1;TXK;NCKAP1L;FYB2;RBCK1;PSMD9;PSMB4;RELA
prerank,phospholipid catabolic process (GO:0009395),-0.44639340653846277,-1.287827779656572,0.13934426229508196,0.5136016430422746,1.0,6/24,15.14%,GPCPD1;SMPD4;GDPD1;GDPD3;PNPLA6;PLA2G4A
prerank,phosphate ion homeostasis (GO:0055062),0.5830079605970504,1.2873622117199515,0.22176591375770022,0.6696183590207792,1.0,3/10,11.08%,FGFR4;SLC34A3;TFAP2B
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.42211015291370346,1.2871987439062786,0.15384615384615385,0.6685392773246224,1.0,6/48,3.96%,JPH1;CEMIP;DMD;PDPK1;GSTM2;ANK2
prerank,cardiac ventricle development (GO:0003231),-0.4656731351637234,-1.2869467959479401,0.17515274949083504,0.5150404753583099,1.0,7/20,11.74%,ENG;NOTCH1;HES1;STRA6;PDE2A;HEY2;HEYL
prerank,mesenchyme development (GO:0060485),0.5323793309732163,1.2860048758645277,0.19421487603305784,0.670540146045972,1.0,2/15,1.28%,FGFR2;BMP7
prerank,negative regulation of lipid storage (GO:0010888),0.5088687065115683,1.285924409206518,0.189453125,0.6692149978466673,1.0,4/19,6.76%,OSBPL8;PPARA;ABCA1;IL6
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5601249000397848,1.2851685920107252,0.1885245901639344,0.6698495744928047,1.0,1/12,0.06%,UNC13C
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.3484769458196692,-1.2848719055642062,0.06313131313131314,0.5194755412881957,1.0,28/72,24.60%,LIFR;RUNX1;GAS6;CBFB;HSP90AB1;RACK1;IKBKB;PTPRC;CDC37;BIRC3;CHUK;PTPN1;CD74;IRAK3;IFNGR1;TRAF1;CASP8;MADD;SIGIRR;IRAK1;SHARPIN;JAK1;RBCK1;TNFAIP3;OTULIN;SOCS1;STAT1;TRIM44
prerank,histone H3-K4 trimethylation (GO:0080182),0.5798659703429215,1.2845666280004642,0.1941544885177453,0.6701384869182845,1.0,6/11,21.64%,KMT2A;SETD1A;CTR9;WDR82;BEND3;TET3
prerank,regulation of B cell proliferation (GO:0030888),-0.3886438612098465,-1.2844020922542319,0.12442396313364056,0.5196622864470938,1.0,15/44,20.83%,MEF2C;TFRC;NFATC2;CD38;PTPRC;TNFRSF21;AHR;CD74;CD81;MIF;CD40;TIRAP;TYROBP;NCKAP1L;CD300A
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.39440314725968045,-1.2843615503687225,0.1334841628959276,0.5187780703810749,1.0,19/38,22.38%,CAV1;KLF2;CD34;RAC1;HSP90AA1;HSP90AB1;KLF4;DDAH1;PTGIS;PTGS2;EDN1;CLU;CD47;CX3CR1;ZC3H12A;AKT1;ATP2B4;INSR;DDAH2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.4189672249712125,-1.2841851953802879,0.1456953642384106,0.5181963314612834,1.0,14/31,20.58%,SHANK3;SIPA1L1;ZDHHC15;PPFIA2;LRP8;ABI3;SRCIN1;KIF1A;RELN;DBNL;CAMK2B;CDK5;CFL1;DBN1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.42658032877141683,1.2830245847297779,0.1651705565529623,0.6732256906568161,1.0,6/43,9.05%,IGF1;LTF;SYT11;CACTIN;NLRC3;SIRPA
prerank,cell-cell junction assembly (GO:0007043),-0.3514403796901529,-1.2817846449539338,0.09359605911330049,0.5236406215456749,1.0,17/63,9.55%,ACTB;CLDN5;ACTG1;CDH11;CTNND2;CD9;PKP4;CLDN11;CDH2;RAMP2;GJC1;GJD3;WDR1;CTNNB1;TJP1;RHOA;PAK2
prerank,membrane repolarization (GO:0086009),0.5293829644107275,1.281357277644367,0.20502092050209206,0.6765207754624322,1.0,3/15,4.07%,ATP1A2;ATP1B3;KCND3
prerank,regulation of ossification (GO:0030278),0.43788927000853534,1.281226840275249,0.15384615384615385,0.6753898596441172,1.0,9/36,7.50%,RBPJ;LRP4;BMP2K;SMAD6;DKK1;ECM1;CHSY1;PTN;DDR2
prerank,protein prenylation (GO:0018342),-0.5611074076726699,-1.2806291769719194,0.16936936936936936,0.5257866509653756,1.0,5/10,21.05%,PGGT1B;RABGGTB;PTAR1;RCE1;RABGGTA
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4996950615047734,-1.280622047574976,0.16767676767676767,0.5248040502835125,1.0,6/15,6.69%,TMSB4X;THBS1;NOTCH1;LGMN;HSPB1;MET
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5606688611384559,1.2805086267408115,0.18354430379746836,0.6760318355315215,1.0,1/12,0.68%,B3GALT1
prerank,heart development (GO:0007507),-0.303783021467897,-1.2800813087751695,0.045774647887323945,0.5252902252169144,1.0,34/150,11.43%,MEF2C;TEK;NTRK3;FN1;HEG1;SGCD;MEF2D;MICAL2;BMP5;ACVRL1;TGFB2;PTK2;RAMP2;NOTCH1;TBX1;BMPR2;CXADR;PKD1;SOX17;STRA6;TGFBR2;TBX2;SOX4;TGFB1;CRIP1;PDLIM7;VEGFA;LDB3;ECE1;CDKN1B;CACNA1C;BMP2;SOX18;NDRG4
prerank,detection of visible light (GO:0009584),0.5303109275496597,1.279327745996172,0.1975560081466395,0.6780161620257334,1.0,3/16,6.43%,ABCA4;TULP1;GNAQ
prerank,aorta morphogenesis (GO:0035909),0.5197535834758003,1.2790776943241255,0.20647773279352227,0.677229676188102,1.0,4/17,2.95%,ADAMTS9;RBPJ;MYLK;PDGFRB
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.4952625630210951,-1.2790030948637887,0.15587044534412955,0.5271881585928085,1.0,4/16,8.51%,STX7;PTPRC;CEACAM1;CYRIB
prerank,protein autoubiquitination (GO:0051865),0.395280347594412,1.278948555742035,0.14967105263157895,0.6760768892810872,1.0,18/61,18.36%,RNF220;PRKN;RNF213;DDB2;SH3RF1;RNF181;WWP2;AMFR;MDM2;ITCH;SH3RF2;UBE2A;RNF122;RAD18;TRIM17;OBI1;DTX3L;TRAF6
prerank,import into cell (GO:0098657),0.4242168049615783,1.2786923264466272,0.13675213675213677,0.6754057754213698,1.0,5/41,2.16%,ATP1A2;SLC22A4;SLC6A13;SLC22A2;SLC1A3
prerank,lipid modification (GO:0030258),-0.39485562036480604,-1.2786699047719732,0.13305613305613306,0.5270448992408823,1.0,10/37,12.63%,DGKH;PLPP1;MBOAT1;DGKB;DGKI;LPCAT3;PORCN;DGKZ;DGKG;ALOX12
prerank,heart trabecula morphogenesis (GO:0061384),0.4988670801799856,1.278541602422812,0.17355371900826447,0.6743310508938797,1.0,4/18,1.34%,TGFBR3;RBPJ;BMP7;RBP4
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.49336501327523485,-1.2778484611094718,0.18127490039840638,0.5283315279862927,1.0,7/15,10.14%,BMPER;KLF4;PKM;ITGA5;VEGFA;TJP1;S100A1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.563111067903727,-1.2764053601875798,0.18198874296435272,0.5312040948962446,1.0,5/10,22.88%,PTPRC;CEACAM1;CX3CR1;ARRB2;FCGR2B
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.42691544267052584,-1.2762827418059364,0.1301518438177874,0.5305395317659327,1.0,10/29,9.59%,SLIT2;SHANK3;KANK3;KANK1;HIP1R;TJP1;CYRIB;SSH2;SSH1;KANK4
prerank,sulfur amino acid metabolic process (GO:0000096),0.4784666856259342,1.2760667009718591,0.1860036832412523,0.6802471172696511,1.0,5/24,10.60%,CBS;MSRA;MTHFR;AHCY;CDO1
prerank,dicarboxylic acid catabolic process (GO:0043649),0.5587213010014992,1.2759976492351501,0.2012987012987013,0.6789327503329841,1.0,5/13,17.35%,DDO;ACOT4;ASPA;MTHFS;QPRT
prerank,negative regulation of interferon-beta production (GO:0032688),0.5813320109527326,1.2758552742551146,0.20594965675057209,0.67785734990967,1.0,3/10,9.05%,CACTIN;NLRC3;SIRPA
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.4922114789493812,-1.2758077915380361,0.15678776290630975,0.5309486798875334,1.0,7/15,30.25%,TGFB2;TGFB1;IRAK3;JAK3;TGFB3;SMAD7;CUEDC2
prerank,brain development (GO:0007420),0.35298625675921336,1.2753246604579005,0.10090361445783133,0.6779175580005945,1.0,21/136,8.84%,EPHA7;AFF2;ARNT2;ZIC1;ATXN1;MEIS1;ZIC2;B3GNT5;SOX6;SHROOM2;PAFAH1B3;NFIB;ZFHX2;SYNJ2;PHF8;SETD1A;AMIGO3;PBX4;PTEN;CDK5RAP1;PAFAH1B1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.4697512332066229,1.2750808978609856,0.16666666666666666,0.67716127758513,1.0,7/27,8.39%,PPARA;IL18;PLA2G10;ABCA1;MAPK9;CSF1;ABCA5
prerank,histone H2A monoubiquitination (GO:0035518),0.5134147076119188,1.274241773196107,0.1799163179916318,0.677973297806521,1.0,7/17,14.80%,DDB2;RNF2;KDM2B;BCOR;PCGF5;CUL4B;PCGF1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.32335325920671865,-1.2741986247393084,0.05507246376811594,0.5343881694839963,1.0,36/101,22.08%,MSN;THBS1;NIBAN1;HSP90AA1;KLF4;EEF2;VIM;NFKBIA;ATG7;RPL26;SOX4;TGFB1;PERP;FAF1;RPL5;MTOR;PYM1;EIF4G1;EIF3D;BCL3;OGT;YTHDF3;RPS4X;TBC1D10A;RPS27L;NR1H2;CASP8;EIF3C;VPS11;AGTR1;CYFIP2;AKT1;METTL3;FMR1;EIF6;NR1H3
prerank,gland development (GO:0048732),0.3963908666831926,1.2734646749875898,0.14967105263157895,0.6788992346988584,1.0,10/59,7.10%,TGFBR3;WNT4;FGFR2;DKK3;ARID5B;ANXA1;PRKCSH;PCSK9;SALL1;ARHGAP35
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.49876373766360077,-1.2730520971798738,0.18220338983050846,0.5354522671753001,1.0,4/14,15.56%,ABCG2;SLCO2B1;HMOX2;BLVRB
prerank,heme catabolic process (GO:0042167),-0.49876373766360077,-1.2730520971798738,0.18220338983050846,0.5354522671753001,1.0,4/14,15.56%,ABCG2;SLCO2B1;HMOX2;BLVRB
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.41713886440969494,-1.2728380888648274,0.15711252653927812,0.5349732439552459,1.0,10/29,18.41%,UBB;IKBKB;RPS27A;UBC;BIRC3;CHUK;CASP8;UBA52;CD40;UBE2D1
prerank,sterol biosynthetic process (GO:0016126),0.4374713084244722,1.2722029201414442,0.1551094890510949,0.6811148112078481,1.0,6/33,11.27%,PRKAG2;INSIG2;PMVK;ACAA2;ACAT2;FDPS
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.32821636155682543,-1.272056247967785,0.08959537572254335,0.5359954754322263,1.0,31/95,24.30%,MEF2C;LBP;DAB2IP;VIM;CHMP5;SBNO2;TNFRSF1B;DEFA6;PDCD4;CYRIB;RHOA;MAPK8;XBP1;CD180;GIT1;CX3CR1;CARD16;CD274;ZC3H12A;ADAM9;IRAK1;TIRAP;MYD88;NR1H3;CASP1;TNFAIP3;PLAA;FCGR2B;RELA;CD80;CD68
prerank,homocysteine metabolic process (GO:0050667),0.5685284355203494,1.2712159045695137,0.21535181236673773,0.6824917687713042,1.0,2/11,5.55%,CBS;MTHFR
prerank,intracellular pH reduction (GO:0051452),-0.41164703848591966,-1.270661181879363,0.15137614678899083,0.5387966771501693,1.0,19/33,26.57%,DMXL1;ATP6V0A1;RAB38;ATP6V1A;ATP6V0C;TCIRG1;ATP6V1E1;DMXL2;ATP6V0A4;ATP6V0A2;RAB39A;SLC11A1;ATP6V0D2;CLCN3;RAB7A;ATP6V0E2;ATP6V1B2;TMEM9;ATP6V1H
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.425186152269484,-1.270612232529646,0.164,0.5379271923135339,1.0,11/25,25.99%,HSPA8;BAG1;HSPA14;HSPA5;ST13;ERO1A;DNAJC7;DNAJB1;HSPA9;HSPA1B;HSPE1
prerank,histone H3-K4 methylation (GO:0051568),0.4761232711047836,1.2705610765327802,0.17281553398058253,0.6829644086754166,1.0,12/26,22.90%,KMT2A;ASH2L;SETD1A;KMT2B;KDM6A;CTR9;WDR82;DYDC2;SETD4;BEND3;TET3;DPY30
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.2967093381160087,1.270389880384584,0.019165727170236752,0.6819503632523284,1.0,137/834,13.20%,IGF1;GLIS3;RORA;BMP6;TCF4;TCF7L2;OSR1;AUTS2;ARNT2;RBPJ;ZNF462;FGFR2;EPAS1;HLF;PPARA;NR2F2;PID1;IL18;HOXC4;CDK8;PRKN;WWOX;BRD8;ZEB2;KMT2A;MEIS1;DAB2;HOXB4;FHOD1;CSRP3;MYBL1;DMRT1;SCX;NR1I2;ASCL2;TBL1XR1;CITED4;PPARGC1B;HOXB3;RNASEL;NFYB;CDK7;IGF2;SSBP2;TFR2;NCOA2;STAT5B;MAML3;NFAT5;HDAC8;HOXA7;NFIB;TEAD1;ELF4;FIZ1;SOX1;WASL;DPF2;IRF8;FGF1;GLI3;TET1;ZMIZ1;MAML1;WWC1;IL6;SALL1;NCOA3;RFXAP;SMAD3;SSBP3;NCOA7;GABPB1;GABPB2;MTF2;TCF12;ABRA;CCNT2;RPRD1B;RSF1;CCNT1;NFIA;PCGF5;ARNT;GTF2F1;FSTL3;KAT8;MITF;KDM6B;KAT6B;CEBPG;IER5;IRF3;BCL9;MED1;AKAP8L;DVL3;AGO2;PHIP;ASXL2;ABL1;MED13;PRKDC;SMARCA5;ATOH8;HDAC1;PIK3R1;FLCN;TFAP2A;APLN;TFAP2B;RXRA;ZBTB38;MYB;NPAS2;BMPR1A;BCLAF3;CDC73;HSF1;PRKD2;PKD2;AR;HIVEP1;SERPINE1;KLF5;CRTC1;MAML2;CRTC3;GDNF;ZMIZ2;INO80;SMARCB1;HOXD4;TBK1;BCL2L12;NR1I3;FOXK2
prerank,regulation of metal ion transport (GO:0010959),0.5112519719430707,1.2698282285518663,0.18951612903225806,0.6821443637039226,1.0,5/16,7.35%,STIM1;BCL2;ANK2;DLG1;CACNA2D1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.385894176784755,1.2691519433694147,0.13804173354735153,0.6826579093848683,1.0,16/66,12.12%,TGFBR3;ROBO1;FGFR2;MCC;NR2F2;DUSP10;NFIB;SULF1;NLRC3;MTSS1;NUPR1;BRCA2;MED1;ATOH8;CDC73;APOH
prerank,regulation of histone modification (GO:0031056),0.5465337853575635,1.2690175817625955,0.2045929018789144,0.6816119331609903,1.0,6/13,19.37%,IGF2;MTHFR;AKAP8L;FLCN;NNMT;CDK9
prerank,Rho protein signal transduction (GO:0007266),0.4111892792584416,1.2687491591776225,0.14285714285714285,0.6809717002022222,1.0,10/53,7.96%,ROCK2;ARHGAP6;ARHGAP29;RHOD;PDPN;COL1A2;ARHGEF11;NTN1;EPS8L1;MYO9B
prerank,lipid transport (GO:0006869),-0.3240726788803239,-1.2687144130996073,0.07506702412868632,0.5420156175041845,1.0,31/97,19.43%,ABCC4;PITPNC1;CERT1;ATP8B1;SLCO1C1;ATP8A1;PLTP;SCARB1;SLCO2A1;SLCO2B1;PPARD;LBP;TNFAIP8L3;CEACAM1;SPNS2;MFSD2A;SLCO3A1;GLTP;ABCD3;ABCD2;STARD5;NR1H4;GM2A;ABCA3;PRELID3B;MTTP;CLN8;ABCA2;PITPNA;PITPNB;ABCG1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5315224601393105,-1.2686698611578509,0.17523809523809525,0.5411166025094732,1.0,5/11,24.02%,P3H2;EGLN3;EGLN2;P4HA2;P4HA1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.38967965201852883,-1.2686476951455647,0.14072494669509594,0.540183860023606,1.0,10/39,7.89%,RAP1A;MSN;HSPA8;TIE1;HSP90AA1;DAB2IP;NOTCH1;HJURP;GFAP;TJP1
prerank,regulation of transmembrane transport (GO:0034762),-0.4006606931980199,-1.2685279879132743,0.14254859611231102,0.5395153955254599,1.0,5/31,2.60%,ACTB;SLC2A1;OCLN;KCNJ2;NEDD4L
prerank,negative regulation of protein secretion (GO:0050709),-0.38598024619436905,-1.2684535576574785,0.1359447004608295,0.5387571269626866,1.0,11/38,14.03%,CD200;KCNB1;CCN3;RAB11FIP1;RHBDF2;REST;RSAD2;CHGA;RAB11FIP5;CYP51A1;SIRT4
prerank,negative regulation of secretion (GO:0051048),-0.541268177298755,-1.2684284976455948,0.19074074074074074,0.537829738011486,1.0,7/10,30.72%,VAMP8;CD74;PTGER3;NR1H3;SPX;VAMP3;EGF
prerank,organonitrogen compound catabolic process (GO:1901565),0.4053490166027152,1.2682839247598134,0.14735099337748345,0.6810274910261805,1.0,9/57,7.52%,CPQ;CLPX;PLA2G10;GGACT;ACE;TPP1;ENPP2;NPEPPS;LIPC
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.33724351857553336,-1.2678030344071813,0.12280701754385964,0.5385419127622649,1.0,34/79,28.46%,CTSD;LGMN;AP2A2;CAPZA2;ACTR10;DYNLL2;ARF1;KIF26A;DNM2;MFSD6;AP2M1;DCTN3;CD74;CANX;SEC23A;AP1S2;DCTN4;KIF3B;SH3GL2;KIF11;AP2B1;KIF15;CTSL;DCTN1;AP2A1;FCGR2B;CAPZA1;RAB7A;KIF4A;KLC2;CTSE;SEC31A;KLC1;KIF23
prerank,negative regulation of cellular process (GO:0048523),-0.2662818880217132,-1.267010633451555,0.011834319526627219,0.5397347159985304,1.0,105/521,12.79%,ZBTB7C;APBB2;SLIT2;PODXL;PTPRJ;FTH1;NOS3;IGFBP6;CD200;CD34;JAM2;ADAM10;BMP5;PLPP1;ACVRL1;TGFB2;PTPN14;CD9;CBFA2T3;PLXND1;TES;KLF4;PPP2R5C;ETS1;ADAM15;PPP1R13B;ADARB1;WNT9A;ROR2;PDE8A;PTK2B;DAB2IP;NGF;NOTCH1;NDRG3;RACK1;SH3BP4;SEMA4D;TGFBI;TBX1;FHL1;ARHGDIB;P3H2;BMPR2;SFRP4;SOX17;PLXNA4;CCDC85B;ACTN1;RERG;VPS13C;CCN3;WARS1;PINX1;SOX4;RHOB;TGFB1;NCK1;ARHGDIA;OSGIN2;FERMT2;CTNNB1;VAMP8;TNFRSF21;ST18;TOB1;TNFRSF1B;ATP8A2;DDAH1;MYH9;APBB1;PDCD4;APP;ADRA1A;CRYAB;NOTCH4;PTHLH;WNT16;AQP11;NR4A1;PODN;DYSF;ING4;RTN4;SESN2;APC;CDK6;SOX7;LPCAT3;CDKN1B;NCK2;BTG3;BMP2;NOS1;HGS;NDUFA13;IFI35;MEN1;PBRM1;GPER1;REST;CDH13;CASK;CLU;LMNA
prerank,regulation of T cell cytokine production (GO:0002724),-0.5036088423002198,-1.2668261339265607,0.20717131474103587,0.5392380105643335,1.0,3/15,7.06%,B2M;CD55;TNFRSF1B
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3847949342175053,-1.2666805366393141,0.1278538812785388,0.5386699765764895,1.0,12/41,13.92%,SLC12A7;SLC12A2;KCNJ2;ATP1A1;ABCC9;ATP1B1;SLC12A6;SLC12A8;SLC12A4;ATP1A3;KCNJ8;KCNJ15
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.44879046955353596,1.2663659845777393,0.1841620626151013,0.685299766028009,1.0,5/33,3.11%,TCF7L2;PPARA;ANGPT1;PDPK1;NDNF
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.4669669278771361,1.2661883035673314,0.17810760667903525,0.6843212845965805,1.0,5/26,8.42%,RORA;CCBE1;SULF1;IL6;ARNT
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.37049712972932597,-1.265888633484166,0.11264367816091954,0.5398013014823486,1.0,15/48,12.33%,TMSB4X;NOS3;RHOJ;KDR;THBS1;ETS1;ATP5F1A;HSPB1;GATA2;TGFB1;JCAD;VEGFA;PTGS2;PIK3C2A;MAP3K3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.34301085010158944,-1.2658557475702756,0.10669975186104218,0.5388942461876999,1.0,18/70,15.80%,B2M;IKBKB;CALR;VAMP8;MFSD6;PSMD13;PSMF1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;CYBB;PSMB3
prerank,protein K63-linked ubiquitination (GO:0070534),0.42150132385432054,1.2656233246115653,0.1607773851590106,0.6845596334408678,1.0,9/41,9.79%,PRKN;UBE2E2;TRIM5;NEDD4;RNF152;TRIM56;RNF135;WWP2;ITCH
prerank,SNARE complex assembly (GO:0035493),-0.5492520877443114,-1.2651201454916956,0.17350746268656717,0.539944294949122,1.0,2/10,6.22%,STXBP6;VAMP8
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.37710157949374257,-1.2645468932065014,0.13488372093023257,0.5405791149175638,1.0,17/44,20.80%,CARMIL1;GSN;PTK2B;CDC42EP3;NCKAP1;NCK1;BAIAP2L1;NCK2;BIN1;WHAMM;CDC42EP5;SPIRE1;PRKCE;ARPC4;CDC42EP2;EVL;NCKAP1L
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5137573507239747,1.264067705890197,0.19795918367346937,0.6875906164745731,1.0,2/17,2.68%,LPGAT1;PLA2G10
prerank,translational elongation (GO:0006414),-0.31882647180958096,-1.2634202707227578,0.06371191135734072,0.542594728691035,1.0,38/101,29.09%,EEF1A1;EEF2;RACK1;EEF1D;GFM1;MRPL32;MRPL33;MRPS14;MRPL38;EEF1G;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;EEFSEC;EEF1B2;MRPS35;MRPS28;MRPL13;MRPL35;GTPBP2;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;TUFM;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14;EEF1A2;AURKAIP1;GTPBP1;CHCHD1
prerank,serine family amino acid metabolic process (GO:0009069),0.5263926407700767,1.263409285903884,0.20930232558139536,0.6881957061766264,1.0,5/16,13.02%,CBS;SRR;THNSL2;CDO1;SHMT1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.4988366201641776,-1.2633395628384108,0.16227180527383367,0.5418358754849776,1.0,4/14,19.40%,THBS1;IRAK3;CMKLR1;JAK3
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5209897116707527,-1.2628548600541738,0.19056603773584907,0.5421569638003092,1.0,3/12,9.30%,TMEFF2;TGFB1;EDN1
prerank,regulation of protein catabolic process (GO:0042176),-0.3278068892530878,-1.262579950933718,0.08707865168539326,0.5419102234114562,1.0,26/99,13.88%,EEF1A1;WWP1;NSF;NEDD4L;DAB2IP;ATG7;FLNA;PLK2;FAF1;GSK3B;GFAP;FOXO1;CHEK2;ZDHHC2;DDB1;FURIN;OAZ1;APC;CDKN1B;HGS;NDUFA13;AZIN1;EGLN2;IRAK3;IDE;CYP51A1
prerank,regulation of fibrinolysis (GO:0051917),-0.5131813652463704,-1.261669966720905,0.18110236220472442,0.5433633569729233,1.0,3/13,12.47%,THBS1;FAP;THBD
prerank,regulation of nervous system process (GO:0031644),0.5050566549485526,1.2613489824584874,0.18495934959349594,0.6929697832286151,1.0,2/18,0.88%,ROCK2;SLC8A3
prerank,regulation of cellular respiration (GO:0043457),-0.4664751929302627,-1.2612662739821872,0.19959677419354838,0.5434585254629481,1.0,9/17,35.50%,CBFA2T3;PRDM16;IDE;NOP53;VCP;IFNAR1;NOS2;PRELID1;IFNLR1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5127078945324252,-1.2611702018230628,0.17196261682242991,0.5427447296544345,1.0,3/12,5.70%,PRKG1;MEF2C;IGFBP5
prerank,respiratory system development (GO:0060541),0.4390384600711758,1.2611619113282952,0.1721014492753623,0.6920469218547765,1.0,6/32,5.54%,FGFR2;RBP4;LOXL3;PDPN;FGF1;ITGA3
prerank,muscle tissue morphogenesis (GO:0060415),0.5202313998495048,1.261088709084156,0.216,0.6907575331826825,1.0,2/16,2.34%,TGFBR3;MYLK
prerank,response to peptide hormone (GO:0043434),0.4158024205015277,1.260625045289297,0.17198581560283688,0.6907320569774164,1.0,4/43,3.68%,TGFBR3;ROCK2;ANXA1;STAT5B
prerank,fatty acid transmembrane transport (GO:1902001),0.5090532932232864,1.2603898513388816,0.2037735849056604,0.6899421508145412,1.0,3/19,5.76%,PRKAG2;PRKAA2;CPT2
prerank,embryonic appendage morphogenesis (GO:0035113),0.5558207534659311,1.2601902942861405,0.22244488977955912,0.6891060020187572,1.0,2/12,4.65%,CYP26B1;FBXW4
prerank,B cell activation (GO:0042113),-0.3463497517146929,-1.2598121645819431,0.11192214111922141,0.5452980053535809,1.0,24/68,21.42%,MEF2C;PTPRJ;TPD52;KLF6;ITGB1;PLCG2;HDAC5;ITGA4;PTPRC;ZBTB7A;PIK3CD;HHEX;MSH2;HSPD1;RABL3;CASP8;FLT3;TCF3;CR2;CD40;DNAJB9;JAK3;ADGRG3;HDAC9
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.5107128681050156,-1.2594066111716786,0.20037105751391465,0.545462661051531,1.0,10/13,29.24%,RACK1;NCK1;HSPA5;PTPN1;WFS1;DNAJB9;PPP1R15A;PPP1R15B;BFAR;ABCA7
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5525944384099571,1.2590172207136636,0.21115537848605578,0.6910616698271883,1.0,1/11,0.45%,COLEC12
prerank,negative regulation of protein binding (GO:0032091),-0.3403135859426516,-1.2580061414306334,0.09900990099009901,0.5484101687437078,1.0,26/71,21.71%,CAV1;ACTB;B2M;ADAM15;RACK1;ITGA4;GSK3B;ATP2A2;ATP2A3;MAPK8;CTNNBIP1;PPP1CA;RALB;TLE5;NES;ADRB2;DISC1;CTSZ;SYMPK;CARD16;TMBIM6;ARRB2;PRKCD;AKT1;TTBK2;CDKN1A
prerank,organic acid transport (GO:0015849),0.3647822314886803,1.2573564904050252,0.1334355828220859,0.694536081441308,1.0,21/94,11.41%,SLC7A11;SLC6A13;SLC13A3;SLC38A3;SLC6A12;ACSL1;PDPN;NCOA2;SLCO1B1;SLC43A1;SLC13A5;FOLR1;FOLR2;ABCC2;SLC1A5;SLC25A11;SLC27A1;SLC22A6;SLC19A1;SLC36A2;RXRA
prerank,cellular component assembly (GO:0022607),-0.282043831398754,-1.257284309837778,0.04961832061068702,0.5492984628625458,1.0,49/253,11.66%,SPTBN1;ACTB;SLC2A1;ACTG1;OCLN;RHOJ;PARVB;LIMS2;RAC1;LIN7A;GAS6;GSN;PPARGC1A;PTK2B;STX7;REPS2;RTN3;HES1;NCKAP1;LIMS1;WIPF1;FLNA;PLS3;CAPZA2;TGFB1;FAM107A;SKAP2;FERMT2;VMP1;BAG6;RP1;GPM6B;BAIAP2L1;LRRTM3;ADD2;CARD10;PDCD10;IL1RAP;SHROOM1;STK25;MICAL1;EPS8;RHOA;RTN4;APC;CD2AP;ST13;YTHDF3;PCLO
prerank,positive regulation of vacuole organization (GO:0044090),-0.5506305368679363,-1.257119335937215,0.20488721804511278,0.5487642453927132,1.0,4/10,19.49%,SH3GLB1;GRN;RALB;PIP4K2A
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.2967238340802517,-1.257074211183977,0.05357142857142857,0.5479126732769457,1.0,36/151,14.86%,TEK;NTRK3;RAP1A;SEMA7A;BMPER;KDR;GAS6;ROR2;PDE8A;PTK2B;NOTCH1;ACKR3;ROR1;TNFAIP8L3;TGFB1;CD44;FERMT2;PTPRC;ARRB1;TNFRSF11A;PDGFC;APP;FLT4;ADRA1A;NPNT;HTR2A;MAP2K7;BMP2;GCNT2;NDRG4;GPER1;CD74;MAP3K12;MT3;DSTYK;CSF1R
prerank,ERBB signaling pathway (GO:0038127),-0.34751384291681475,-1.2568180298519778,0.11684782608695653,0.5476640779012761,1.0,15/64,10.64%,GAB1;RPS6KA5;HSP90AA1;IQGAP1;CBL;PTK2;PTK2B;REPS2;PTPN12;BCAR1;TGFB1;CDC37;CPNE3;NCK2;PIK3C2A
prerank,regulation of lipid metabolic process (GO:0019216),0.3734528794744966,1.2566137203688656,0.1266025641025641,0.6952932377357596,1.0,14/88,11.41%,PRKAG2;RORA;FGFR4;PPARA;TBL1XR1;NFYB;NCOA2;CHD9;PMVK;APOC1;NFYC;MED1;FDPS;RXRA
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.4652605520601,-1.2563706998445412,0.17276422764227642,0.5479779701190517,1.0,4/17,8.27%,TGFB2;MID1;PDCD10;STK25
prerank,nucleocytoplasmic transport (GO:0006913),0.4260424814075966,1.2561060527014534,0.1836007130124777,0.6953417696681979,1.0,10/40,19.86%,ATXN1;PHAX;NUTF2;SMN1;NEMF;NXT2;LSG1;RSRC1;GEMIN5;SNRPF
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5042512209187453,1.256102353446228,0.23125,0.6938896920189321,1.0,3/15,3.92%,PPARA;ADM;SLC45A3
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.42890601476556445,-1.2558310648709394,0.14435146443514643,0.5485632342567768,1.0,11/25,20.76%,CD200;ITGB1;CXADR;ITGA5;ITGA4;CTNNA3;ITGA7;JUP;DSG2;DSP;JAM3
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.46846816920311335,1.2555528607246866,0.19274809160305342,0.694195210092431,1.0,5/26,12.46%,ATP1A2;GSTM2;THADA;GNB5;PKD2
prerank,carbohydrate derivative catabolic process (GO:1901136),0.49252742586035064,1.2552923722187443,0.19919517102615694,0.6935409467447117,1.0,5/18,13.42%,ADAMTS9;FBXO44;FBXO6;DERA;NGLY1
prerank,vasoconstriction (GO:0042310),-0.5205109024058703,-1.254918478980573,0.19569471624266144,0.550073974735694,1.0,4/11,10.64%,EDNRA;ACTA2;EDN1;PIK3C2A
prerank,B cell differentiation (GO:0030183),-0.3730231200179889,-1.2545460513479143,0.14123006833712984,0.5501827622325222,1.0,20/46,21.42%,PTPRJ;TPD52;KLF6;ITGB1;PLCG2;HDAC5;ITGA4;PTPRC;ZBTB7A;HHEX;MSH2;RABL3;FLT3;TCF3;CR2;IRF2BP2;DNAJB9;JAK3;ADGRG3;HDAC9
prerank,neuron projection morphogenesis (GO:0048812),0.34496377128436767,1.2537577367619444,0.1261127596439169,0.6966404247280698,1.0,22/137,9.11%,DCDC2;ALCAM;FGFR2;NRK;BMP7;LRP4;GAS7;SDC2;PARD3;ALS2;DTNBP1;BAIAP2;NTNG2;WASL;LRRK2;LRP2;ARC;NBL1;PTEN;RYK;FARP1;MYO16
prerank,regulation of mitochondrial fusion (GO:0010635),0.5694902197555423,1.253756470233171,0.23417721518987342,0.6951958510536086,1.0,3/11,6.51%,PID1;PRKN;BNIP3
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3629396284531767,-1.2536938099120474,0.1380952380952381,0.551500155451299,1.0,15/46,22.24%,PIEZO2;F11R;PIEZO1;PDE2A;MAPK8;MAP3K1;CASP8AP2;FAS;CASP8;CD40;TNFRSF10B;MYD88;GADD45A;MAPK3;CASP1
prerank,axonogenesis (GO:0007409),-0.2804552481046204,-1.2536401057824562,0.03968253968253968,0.5507242788235561,1.0,55/237,12.43%,SPTBN1;GAB1;SLIT2;BSG;EFNA5;SHANK3;KLF7;ACTB;SEMA6A;NRP2;SEMA7A;SH3KBP1;SEMA6D;RPS6KA5;HSP90AA1;MAP1B;SEMA3C;HSP90AB1;S100A6;PTK2;UNC5C;LAMA1;TNR;UNC5D;FYN;NOTCH3;NOTCH1;SEMA4D;SEMA3E;SHTN1;B4GALT5;NRCAM;LAMA5;TUBB3;ROBO4;LAMA3;DCC;PDLIM7;APBB1;APP;NRXN1;GFRA2;SEMA4B;SEMA5B;SEMA6C;PIK3CD;LYPLA2;RELN;SEMA3G;EPHB1;SLITRK5;EFNB3;GPC1;SPTBN4;LMTK2
prerank,sphingolipid catabolic process (GO:0030149),-0.4810305243078389,-1.2535654334488142,0.17670682730923695,0.5499666464489628,1.0,4/15,7.97%,ACER3;ACER2;SMPD4;SGPL1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.38613906091079464,-1.2530247172359645,0.14446952595936793,0.5504667085274078,1.0,9/39,8.75%,UTRN;FXYD5;NEDD4L;FHL1;HOMER1;TRPC6;CHRM3;WNK3;FXYD6
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.541556785813962,-1.2530051901992056,0.19540229885057472,0.5486122402452933,1.0,4/10,18.41%,CDC42EP3;APC;CDC42EP5;CDC42EP2
prerank,regulation of pseudopodium assembly (GO:0031272),-0.541556785813962,-1.2530051901992056,0.19540229885057472,0.5486122402452933,1.0,4/10,18.41%,CDC42EP3;APC;CDC42EP5;CDC42EP2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.42919400656234197,1.252899093671562,0.1853211009174312,0.6962749653372103,1.0,11/32,14.09%,SDC2;CUX1;IL1RAPL1;NEDD4;OBSL1;PTPRD;CUL7;ADGRB3;RAP2A;LZTS1;CDKL5
prerank,regulation of protein kinase C signaling (GO:0090036),0.5439079680774589,1.252046242508146,0.1875,0.697487536767779,1.0,2/14,2.01%,ADGRV1;GPD1L
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.3280782873197344,-1.2513850600129959,0.1012987012987013,0.552085825338074,1.0,28/84,23.00%,UBB;BUB3;RPS27A;UBC;CUL3;ECRG4;PSMD13;PSMF1;PSMB10;FBXO31;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PTTG1;PSME1;ANAPC16;UBA52;PSMB3;CDK2;BUB1B;UBE2D1;PSMD5;ANAPC7;PSMD9;PSMB4
prerank,Golgi localization (GO:0051645),-0.5390627664903281,-1.2505751740144258,0.21485943775100402,0.5533493618787056,1.0,4/11,12.04%,COPG1;PDCD10;STK25;RIPOR1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.48883652228160734,1.2499512914172104,0.21739130434782608,0.70233141234057,1.0,3/18,9.40%,ROCK2;EPHA4;PICALM
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.4072437779458204,-1.2499451033572482,0.16561844863731656,0.554148921645317,1.0,10/30,18.41%,UBB;IKBKB;RPS27A;UBC;BIRC3;CHUK;CASP8;UBA52;CD40;UBE2D1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.44121944821720727,-1.2491804296912055,0.2028688524590164,0.5552279476517549,1.0,5/20,12.75%,CAV1;KCNB2;CHRM3;ATP2B1;ADRB2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.386500021069742,1.2485819725798564,0.17341977309562398,0.7050225709813671,1.0,7/59,8.27%,ALDH1A2;CYP27A1;HSD17B10;HOGA1;LIPH;LIPC;SRR
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.45734528707768585,1.2478714285393586,0.18382352941176472,0.7057447175608665,1.0,3/25,3.96%,CEMIP;PDPK1;ANK2
prerank,regulation of vacuole organization (GO:0044088),0.48169137461119704,1.2477501734610748,0.1902834008097166,0.7046430770881519,1.0,3/20,5.39%,NPRL3;NPRL2;MTMR3
prerank,zinc ion transport (GO:0006829),-0.44014942461929174,-1.2475411094366158,0.16498993963782696,0.5586414376797434,1.0,6/21,13.96%,SLC30A5;SLC39A8;SLC30A1;SLC39A7;SLC39A14;MT3
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.5085385458254162,-1.2474999858997886,0.20300751879699247,0.5577920017353224,1.0,7/12,36.47%,PLCG2;RAB27A;GRIN1;TLR4;CD36;TLR6;ADGRB1
prerank,regulation of anoikis (GO:2000209),-0.4573249976081908,-1.2473716876221024,0.19166666666666668,0.5572014067618497,1.0,8/19,16.05%,CAV1;PTK2;ITGB1;NOTCH1;ITGA5;TLE5;MYBBP1A;BRMS1
prerank,cell chemotaxis (GO:0060326),0.39494178150270376,1.2468298714160955,0.17420435510887772,0.7058592825697578,1.0,9/60,4.40%,KIT;ACKR2;CCR9;LPAR1;CXCR5;PDGFRB;RAB13;CXCR6;PDGFRA
prerank,activation of phospholipase C activity (GO:0007202),0.45216917014292785,1.2459989227494226,0.19844357976653695,0.7067980474131887,1.0,4/29,6.43%,ARHGAP6;LPAR1;LPAR2;GNAQ
prerank,BMP signaling pathway (GO:0030509),0.3846658635629897,1.2455409568410072,0.17258883248730963,0.7066912700470241,1.0,6/62,2.67%,TGFBR3;BMP6;BMP7;SMAD6;SLC39A5;SCX
prerank,mitochondrion morphogenesis (GO:0070584),0.5538553119228133,1.2453331144791822,0.22075055187637968,0.7059138702299347,1.0,2/11,4.45%,PID1;WASF1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.43885723203052973,-1.2452072209875162,0.17755102040816326,0.5623215400908534,1.0,6/20,10.82%,RPS6KA5;PPARGC1A;SOX4;ARRB1;GLYR1;NOS1
prerank,muscle tissue development (GO:0060537),-0.49558256844281634,-1.2448159289913643,0.19477911646586346,0.5624561731961741,1.0,5/13,7.93%,PGM5;ENG;STRA6;PTCH1;CSRP2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.4441875402061275,-1.2447963839454972,0.17764471057884232,0.5605956271920999,1.0,15/23,30.53%,PPP1R13B;NMT1;YWHAB;MAPK8;YWHAG;BBC3;CASP8;YWHAQ;YWHAH;PPP3R1;YWHAZ;PPP3CC;BID;SFN;PMAIP1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.4441875402061275,-1.2447963839454972,0.17764471057884232,0.5605956271920999,1.0,15/23,30.53%,PPP1R13B;NMT1;YWHAB;MAPK8;YWHAG;BBC3;CASP8;YWHAQ;YWHAH;PPP3R1;YWHAZ;PPP3CC;BID;SFN;PMAIP1
prerank,dendrite morphogenesis (GO:0048813),0.4227441651103148,1.2447411521449594,0.17032967032967034,0.7060782992649163,1.0,8/35,9.00%,DCDC2;LRP4;SDC2;WASL;PTN;ARC;PTEN;FARP1
prerank,protein heterooligomerization (GO:0051291),-0.4599733598296841,-1.2443430540360503,0.20315581854043394,0.5608631725596528,1.0,8/17,21.70%,PKD1;MAT2A;CPSF7;GRIN1;CPSF6;TMEM120A;FARSA;KCNC2
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.34043681669261244,-1.2441266323930231,0.1076923076923077,0.5604832319935477,1.0,27/72,23.41%,CARD10;CARD14;BIRC3;PSMD13;PSMF1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;COPS8;PSMB3;IRAK1;TNFRSF10B;TIRAP;PSMD5;AKT1;SKP1;PSMD9;PSMB4;NFKB2;RELA
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4595029592315219,1.2437763407060554,0.22324723247232472,0.7074527337480347,1.0,5/24,6.88%,ERRFI1;ROCK2;HOXA7;SGPP1;NCOA3
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5393874010875991,-1.2430800492263483,0.20411985018726592,0.5624071942276267,1.0,4/10,24.03%,TNFRSF1B;TRPM4;AGER;CCR2
prerank,cellular response to ATP (GO:0071318),-0.4996859939371138,-1.2429094091616741,0.19109461966604824,0.5619392576728337,1.0,9/14,42.36%,HSP90B1;SSH1;P2RY12;P2RY1;P2RX7;P2RX3;P2RY2;PDXP;CIB2
prerank,ERBB2 signaling pathway (GO:0038128),-0.4001410338094652,-1.2427003796066376,0.1721698113207547,0.5614747776999393,1.0,7/31,12.98%,GAB1;HSP90AA1;PTPN12;CDC37;MYOC;CPNE3;ERBIN
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4425384542168319,1.2426743125735078,0.1785063752276867,0.7094120469267275,1.0,5/35,3.00%,ADCY1;KSR1;IRAG1;PDE7B;PDE7A
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.29974958284287173,1.2415457336531506,0.05263157894736842,0.7115398550716536,1.0,67/476,11.89%,IL31RA;IGF1;CREB5;RORA;TCF4;WNT4;ARNT2;ZIC1;PPARA;NR2F2;NPAS3;BMP7;KMT2A;ESRRG;ZIC2;MYBL1;SCX;NR1I2;TBL1XR1;PLCB1;SP100;TP53INP2;MYRFL;ZFP90;NFIB;TEAD1;ELF4;ARID1B;NDP;MSANTD1;GLI3;ZMIZ1;NIBAN2;PHF8;ARHGEF11;IL6;SALL1;SMAD3;BLM;PBX4;NEK4;RGMB;TRIM56;RSF1;KAT8;BRCA2;MITF;KAT6B;MAP3K2;PICALM;CREB3L2;NSD1;MED1;DVL3;PHIP;MED13;PARP9;ATOH8;HDAC1;TFAP2A;TFAP2B;TRIM45;RXRA;MYB;NPAS2;KMT2B;RNF14
prerank,regulation of axon extension (GO:0030516),-0.38159319679282866,-1.2414329631013685,0.16774193548387098,0.5640427517313553,1.0,14/37,22.40%,SEMA7A;SHTN1;NRCAM;GSK3B;DNM2;RTN4;SEMA3G;DBNL;CDKL3;MT3;DBN1;L1CAM;RTN4R;SEMA3A
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.4305227660387711,-1.2409939336449474,0.17291666666666666,0.5643899320327165,1.0,9/24,20.48%,B2M;CALR;MFSD6;CANX;IDE;SEC23A;BCAP31;TAPBP;TAPBPL
prerank,regulation of postsynapse organization (GO:0099175),-0.4150699315954222,-1.2407310946195416,0.19868995633187772,0.5641651156762102,1.0,10/28,10.46%,SHANK3;SIPA1L1;HOMER1;ZDHHC15;PPFIA2;ABHD17B;ABI3;SRCIN1;KIF1A;ABHD17A
prerank,electron transport chain (GO:0022900),-0.4858376972936752,-1.2407309402667257,0.20428015564202334,0.5632216957503302,1.0,8/15,32.56%,PDIA5;PPARGC1A;NDUFA5;ENOX2;CYB561;ETFB;POR;ETFA
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.4828331559098173,-1.2406908129729541,0.19723865877712032,0.5623952113314297,1.0,11/16,32.68%,NOS3;GUCY1B1;GUCY1A1;DDAH1;NOS1;KCNC2;DDAH2;MAFA;CD36;AGT;NOS2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.44751213158185954,1.2399534559654901,0.19140625,0.7148097980183628,1.0,5/29,3.92%,PPARA;LPGAT1;SORBS1;ZBTB20;SLC45A3
prerank,microvillus assembly (GO:0030033),-0.49314457941854517,-1.239703377229401,0.2046783625730994,0.5640165866516377,1.0,3/14,4.05%,RAP1A;FXYD5;MINK1
prerank,lymphocyte differentiation (GO:0030098),-0.3372794102700679,-1.2395937835326352,0.12441314553990611,0.5633793020135897,1.0,27/68,21.42%,PTPRJ;TPD52;KLF6;ITGB1;PLCG2;SOX4;HDAC5;ITGA4;PTPRC;JAG2;LFNG;ZBTB7A;LMBR1L;PIK3CD;HHEX;IKZF1;MSH2;RABL3;FLT3;TCF3;CR2;TOX;DNAJB9;JAK3;DLL4;ADGRG3;HDAC9
prerank,cellular sodium ion homeostasis (GO:0006883),0.5152393456129557,1.2391156892247877,0.22857142857142856,0.7158150674229405,1.0,3/15,3.07%,ATP1A2;ATP1B3;SLC8A1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.3911140730389023,-1.2390517354979609,0.17342342342342343,0.5639190084020245,1.0,13/34,25.74%,MEF2C;GSK3B;GRIN1;GABRG3;INSYN2A;ARRB2;AKT1;GABRA5;GRID2;GABRE;MAPK8IP2;GABRG2;GLRA1
prerank,glycosphingolipid metabolic process (GO:0006687),-0.37790602847335486,-1.2390504943785803,0.1517412935323383,0.5629893782216141,1.0,11/42,10.98%,ST6GALNAC3;ESYT2;PSAP;ST6GALNAC5;SUMF1;ST8SIA1;SMPD4;HEXB;HEXA;CERK;GLTP
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3360239153998231,1.2388232851116079,0.1074964639321075,0.7151893532345285,1.0,34/166,14.18%,RORA;RBPJ;PPARA;NOTCH2;POLR2D;ESRRG;CCN2;NR1I2;TBL1XR1;CDK7;MAML3;TEAD1;MAML1;NR6A1;NRBP1;POLR2A;TEAD3;RSF1;GTF2F1;MED1;TAF8;SMARCA5;HDAC1;TAF1A;POLR1F;RXRA;POLR1A;TAF3;AR;MAML2;NR1I3;TAF1D;CREBBP;MNAT1
prerank,negative regulation of transposition (GO:0010529),0.5044807985466686,1.238641981591302,0.232,0.7142973366886342,1.0,7/16,21.92%,MYBL1;UBR2;MOV10;TUT4;DDX4;PIWIL4;TUT7
prerank,chordate embryonic development (GO:0043009),0.3895028486257472,1.2372967202822247,0.16449511400651465,0.7168928311580723,1.0,7/55,5.24%,ALDH1A2;ARNT2;FGFR2;BMP7;RBP4;IGF2;SULF1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5407276525662246,1.2369642927110225,0.2366255144032922,0.7164214484858272,1.0,4/11,8.85%,CACNG1;NOS1AP;CACNA2D1;CAMK2D
prerank,regulation of cellular localization (GO:0060341),0.40659594149188655,1.2367775932916694,0.17454545454545456,0.715605834219389,1.0,10/46,11.21%,ADCY5;STXBP4;PARD6G;PRKN;FER;LRRK2;WWC1;CAMK2D;DVL3;MAD1L1
prerank,response to lipopolysaccharide (GO:0032496),-0.3000025972005911,-1.2366237585517303,0.06109324758842444,0.5686096044467864,1.0,43/138,24.30%,MEF2C;FOXP1;NOS3;SCARB1;LBP;DAB2IP;VIM;CHMP5;GCH1;SBNO2;TNFRSF11A;TNFRSF1B;DEFA6;PDCD4;RHOA;MAPK8;XBP1;NOS1;CD180;GIT1;IRAK3;ERBIN;HNRNPA0;CX3CR1;CARD16;CD274;ZC3H12A;ADAM9;IRAK1;TIRAP;MYD88;SLC11A1;LIAS;NR1H3;CASP1;TNFAIP3;GGT1;PLAA;PELI1;IFNAR1;RELA;CD80;CD68
prerank,nucleotide catabolic process (GO:0009166),-0.46752330954885124,-1.236267437217457,0.2051792828685259,0.5687150637462275,1.0,8/16,26.75%,NT5C2;NUDT3;GDA;NT5C;XDH;NT5E;VCP;NT5C1A
prerank,regulation of actin nucleation (GO:0051125),-0.515311602617207,-1.2360166288965662,0.222007722007722,0.5684975118034574,1.0,8/12,34.40%,GSN;ARF1;WHAMM;PICK1;ARFIP2;ARFIP1;CORO1A;SCIN
prerank,exit from mitosis (GO:0010458),-0.5089882568080899,-1.2348451662485112,0.2125984251968504,0.5707859403093618,1.0,8/12,40.22%,EPS8;PPP2R2D;SIRT7;CHMP7;CLASP2;CLASP1;UBE2C;UBE2S
prerank,gonad development (GO:0008406),0.41078025006951585,1.2348380737438829,0.2078853046594982,0.7198656111059348,1.0,8/41,12.50%,WNT4;NR2F2;KIT;LRP2;SALL1;NUP107;FGF9;AR
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.462097547225507,-1.2345884774156457,0.19723865877712032,0.5705473207053098,1.0,9/18,33.00%,ATXN3;NCK1;BAG6;XBP1;FCGR2B;BAX;ERN1;PMAIP1;RNF185
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.4051374086059221,-1.2336608453133209,0.17757009345794392,0.5720506216495974,1.0,14/29,24.27%,ELOVL7;ELOVL5;ACSL4;ACACA;ELOVL6;ELOVL1;FASN;ACSL3;TECR;SCD5;ACLY;ACSL5;SCD;ACSF3
prerank,regulation of mitochondrial translation (GO:0070129),-0.4276846817352206,-1.2328926353019678,0.17819706498951782,0.5731551784011034,1.0,9/21,26.00%,RCC1L;UQCC2;RPUSD4;FASTKD3;TRUB2;MTG1;TRMT10C;MRPS27;COA3
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5054178565378459,1.2325087234794425,0.2361904761904762,0.7253766845045156,1.0,4/15,8.60%,ADGRV1;KIT;TMC2;WHRN
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.4290495484911131,-1.232326265751078,0.2012072434607646,0.5737422544967485,1.0,5/21,10.32%,CAV1;CTNNB1;GSK3B;APC;PPP1CA
prerank,phospholipid transport (GO:0015914),-0.3543961605303999,-1.232205144471402,0.1689497716894977,0.5731224412665952,1.0,19/52,19.43%,ATP10A;PITPNC1;ATP8B1;ATP8A1;PLTP;SCARB1;TNFAIP8L3;ATP8A2;MFSD2A;ATP11C;ATP11B;TMEM30A;ATP11A;ABCA3;PRELID3B;MTTP;PITPNA;PITPNB;ABCG1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4725537382554885,1.232094880933599,0.21705426356589147,0.7251186337563668,1.0,3/22,4.78%,ROCK2;PPP4R4;PTPA
prerank,positive regulation of translation (GO:0045727),-0.3131407239325854,-1.2316598224061714,0.12112676056338029,0.5736894279977401,1.0,32/94,22.06%,THBS1;NIBAN1;RPS9;EEF2;VIM;PKM;RPL26;SOX4;YBX3;RPL5;MTOR;RCC1L;PYM1;EIF3D;UQCC2;BCL3;YTHDF3;RPUSD4;RPS4X;RPS27L;EIF2B5;EIF3C;POLR2G;EIF5A;EIF5AL1;FASTKD3;TRUB2;METTL3;FMR1;EIF6;UHMK1;TRMT10C
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.33077512416647925,-1.231351444808452,0.11597938144329897,0.5736667833358988,1.0,26/75,20.48%,TEK;NRP2;KDR;F3;BMPR2;PPP1R16B;NRAS;GATA2;PDCL3;ITGA4;EMC10;JCAD;FLT4;VEGFA;NR4A1;PIK3CD;BMP2;SCG2;CDH13;APLNR;PRKD1;AGTR1;PLXNB3;ANG;AKT1;BMP4
prerank,microglial cell activation (GO:0001774),-0.4345744759051767,-1.2311921266921946,0.20675944333996024,0.573162758359759,1.0,10/21,27.83%,APP;GRN;CLU;C1QA;IFNGR1;CX3CR1;TYROBP;AGER;TREM2;ITGB2
prerank,potassium ion export across plasma membrane (GO:0097623),0.5145710565675258,1.2311718119589312,0.24481327800829875,0.7264485937646351,1.0,3/13,4.07%,KCNA5;KCNT2;KCND3
prerank,synapse assembly (GO:0007416),-0.34333358560035887,-1.230194644513971,0.1240506329113924,0.5748587657443721,1.0,12/67,8.78%,DNM3;SHANK3;SPOCK2;ADGRL3;CDH1;PLXND1;CDH2;GABRB3;KIRREL3;NRCAM;LRRTM3;NRXN1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.533025445362769,1.230145248908477,0.241869918699187,0.7280183441171376,1.0,4/13,13.41%,ADHFE1;IDH2;PHYH;AADAT
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.515878106733426,-1.2301161022910343,0.21305182341650672,0.574124456047317,1.0,5/11,17.34%,RTN4;LPCAT3;BNIP1;ATL2;ARL6IP1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.43036266167521336,-1.2298611106677935,0.1645021645021645,0.5739005673642136,1.0,9/23,14.98%,SLIT2;MSN;THBS1;BMP5;PTK2;STK10;CMKLR1;CSF1R;AKIRIN1
prerank,regulation of signal transduction (GO:0009966),0.32455431963492776,1.2295257268549402,0.12357954545454546,0.7283928129854761,1.0,32/190,11.34%,DCDC2;IGFBP2;RORA;SLC8A3;ZIC1;FGFR2;TULP3;NCAM1;PLCB1;INTU;SP100;TRIM5;DTNBP1;IRAK2;IGFBP4;LLGL2;SULF1;LRRK2;ITGA3;TCF7L1;GRK3;ZDHHC3;AMFR;GRK5;GRK4;FBXL17;IGFBP7;WDR11;DHRS3;GNG7;DTX1;LLGL1
prerank,autophagosome maturation (GO:0097352),-0.39678545850960395,-1.2295234453603217,0.1572052401746725,0.5739824584102187,1.0,11/32,22.45%,CALM1;VMP1;VTI1B;VAMP8;ATP2A2;MAP1LC3B;SNX14;GABARAPL1;VCP;CHMP3;LIX1
prerank,mitochondrial fusion (GO:0008053),-0.4521343609523223,-1.2290116092125252,0.21001926782273603,0.5744064948758394,1.0,8/18,27.16%,CHCHD3;MIEF1;STOML2;MIEF2;MFN2;BAX;SPG7;FIS1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4790662847519228,1.228747192721271,0.23653846153846153,0.7293211670606556,1.0,5/20,10.46%,SLC8A3;MAIP1;MCU;YME1L1;MICU1
prerank,cellular response to inorganic substance (GO:0071241),-0.4376116206256616,-1.2280598536142742,0.22641509433962265,0.5758997216269427,1.0,8/21,21.98%,GUCY1B1;FOXO1;SPIDR;MT3;CDK2;FMR1;KCNC2;RTF2
prerank,regulation of developmental growth (GO:0048638),0.4422717151217205,1.2278843866735012,0.1946564885496183,0.7305424313830438,1.0,6/29,10.44%,IGF1;PLCB1;STAT5B;MUSK;LATS1;ABL1
prerank,microtubule anchoring at centrosome (GO:0034454),0.5601783802764135,1.2278524782222446,0.24583333333333332,0.7292273108473571,1.0,2/10,7.13%,NINL;CEP19
prerank,metal ion transport (GO:0030001),-0.3205841068062635,-1.2278493837819278,0.10972568578553615,0.5755109497672775,1.0,32/86,19.26%,CAV1;TPT1;TRPC3;RAMP2;MAGT1;FYN;SLC30A5;ATP2C1;SLC3A2;GRIN3A;CACNA1E;ATP2A3;NIPAL3;RAMP1;SLC39A8;TRPC4;RYR2;CACNG3;SLC30A1;CACNA1C;NDFIP2;NIPAL4;SELENOK;PANX1;MT3;CALCRL;TRPC1;CACNA1B;NIPAL2;NIPA2;CACNB3;PSEN1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.39606860351791306,-1.227427753550312,0.1806981519507187,0.5757834257242556,1.0,15/30,33.16%,HSPA8;SELENOF;BAG1;HSPA14;HSPA5;ST13;ERO1A;DNAJC7;DNAJB1;HSPA9;HSPA1B;HSPE1;CHCHD4;UGGT1;HSPA1A
prerank,meiosis I (GO:0007127),0.4579313822003847,1.2272435989662542,0.22727272727272727,0.7297002319295763,1.0,3/23,6.30%,MYBL1;SLC25A31;HSF2BP
prerank,regulation of programmed cell death (GO:0043067),-0.29304260574968716,-1.2269757816763325,0.08823529411764706,0.5760371223265929,1.0,48/161,22.41%,MECOM;HIP1;ACTN4;ACER3;ACER2;TPT1;HSP90AA1;TARDBP;PPP1R13B;SLK;RPS3;TGM2;ACTN1;BCAR1;PERP;CALR;CTSB;LGALS1;LRP8;BIRC3;MAGED1;ZBTB7A;RTN4;BCL3;RSL1D1;CLU;FAS;MADD;FLT3;WFS1;BRMS1;RAF1;SGK1;RTKN;DCPS;RABGGTB;CDK5;TIGAR;PINK1;TNFRSF10B;JAK3;NOP53;AKT1;RABGGTA;PAX8;VCP;CASP1;OSGIN1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.502689750078144,1.2263867155257853,0.21218074656188604,0.7308820279407633,1.0,3/16,11.64%,LEPROT;VTA1;CHMP6
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.39212228961173845,-1.226193708644982,0.1746031746031746,0.577180300853423,1.0,15/32,27.61%,STMN2;NAV3;APC;ARHGEF2;STMN1;APC2;TUBB4A;FKBP4;MAPRE1;TTBK2;CLASP2;SPEF1;CAMSAP3;CAMSAP1;FGF13
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.30377047604811286,1.2259012123778739,0.06940874035989718,0.7310083574428279,1.0,34/348,6.13%,IGF1;ROBO1;BMP6;SLC24A3;ROCK2;OSR1;SLC22A2;RBPJ;FGFR4;AFDN;WNT6;PID1;BMP7;ANGPT1;PRKN;RBMS3;DKK1;SCX;NOS1AP;CTSH;DTNBP1;PCSK9;SRPK2;ITGAX;ANK2;MBIP;FOXD1;MAPK9;TNRC6B;GJA1;TNRC6A;FGF1;SLC2A10;EPHX2
prerank,cellular response to growth factor stimulus (GO:0071363),-0.2927838036291548,-1.22561103781392,0.07038123167155426,0.577775437844793,1.0,42/151,11.34%,MEF2C;NTRK3;EEF1A1;RAP1A;SEMA6A;PDE3A;KDR;ACVRL1;IQGAP1;KLF4;RAMP2;MT1G;PDE8A;DAB2IP;NOTCH1;RACK1;TBX1;BMPR2;PTPN12;LIMS1;LGMN;HSPB1;BCAR1;TGFBR2;TGFB1;CD44;EHD1;CTNNB1;CLEC3B;PDE2A;SMAD9;STMN2;FLT4;VEGFA;RUNX2;NR4A1;CPNE3;APPL1;ZFP36L1;BMP2;NOS1;DUSP3
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.518298524927524,-1.2244496389742958,0.22846441947565543,0.5799725088240058,1.0,3/11,7.28%,PTPRC;CEACAM1;AHR
prerank,ameboidal-type cell migration (GO:0001667),-0.3541735567132176,-1.2243461192763356,0.1568627450980392,0.5793656830198204,1.0,15/51,11.39%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;TBX1;SEMA3E;CORO1C;CCN3;ITGA4;SGPL1;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,positive regulation of cell projection organization (GO:0031346),0.3418893890756254,1.22392076153125,0.1441578148710167,0.7356493989929126,1.0,17/115,7.10%,PLXNA2;ROBO1;PTK7;EPHA3;CAMK1D;CUX1;DPYSL3;AVIL;IL1RAPL1;NDNF;GRIP1;OBSL1;PLXNC1;PLK5;PTN;PTPRD;ARHGAP35
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.46481333062501623,-1.2238031133825005,0.225,0.5799189797506117,1.0,10/17,28.35%,COX4I1;COX6C;NDUFA4;COX6A1;COX7C;COX8A;COX5A;CYCS;COX15;COX4I2
prerank,muscle cell differentiation (GO:0042692),0.42247469704236146,1.2236352273094047,0.2339622641509434,0.7350594131640059,1.0,5/32,3.73%,RORA;DMD;SPEG;MEGF10;NEBL
prerank,postsynaptic membrane organization (GO:0001941),0.4957632068267368,1.2231265776840983,0.24901960784313726,0.7351560341600691,1.0,6/17,11.34%,LRP4;CEL;NLGN2;DNAJA3;MUSK;DLG4
prerank,regulation of protein binding (GO:0043393),-0.30855124515154825,-1.2227601657240708,0.10451977401129943,0.5818698509816582,1.0,31/114,16.03%,CAV1;ACTB;CLDN5;B2M;EPB41;TIAM1;RPL11;RACK1;PKD1;HDAC5;GSK3B;ADD2;HIP1R;APP;PRMT8;DERL1;MAPK8;CTNNBIP1;PPP1CA;RALB;TLE5;BMP2;CRK;MEN1;MARK2;NES;IDE;DISC1;CTSZ;SYMPK;CARD16
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.32827657872051386,-1.222082111711313,0.14720812182741116,0.5819290235711799,1.0,33/78,28.46%,CTSD;LGMN;AP2A2;CAPZA2;ACTR10;DYNLL2;ARF1;KIF26A;DNM2;AP2M1;DCTN3;CD74;CANX;SEC23A;AP1S2;DCTN4;KIF3B;SH3GL2;KIF11;AP2B1;KIF15;CTSL;DCTN1;AP2A1;FCGR2B;CAPZA1;RAB7A;KIF4A;KLC2;CTSE;SEC31A;KLC1;KIF23
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.32827657872051386,-1.222082111711313,0.14720812182741116,0.5819290235711799,1.0,33/78,28.46%,CTSD;LGMN;AP2A2;CAPZA2;ACTR10;DYNLL2;ARF1;KIF26A;DNM2;AP2M1;DCTN3;CD74;CANX;SEC23A;AP1S2;DCTN4;KIF3B;SH3GL2;KIF11;AP2B1;KIF15;CTSL;DCTN1;AP2A1;FCGR2B;CAPZA1;RAB7A;KIF4A;KLC2;CTSE;SEC31A;KLC1;KIF23
prerank,positive regulation of biosynthetic process (GO:0009891),0.40768685338878513,1.2219424262586533,0.19782214156079855,0.737360381628855,1.0,5/40,2.79%,WNT4;PPARA;SORBS1;SCX;ZBTB20
prerank,regulation of extracellular matrix organization (GO:1903053),0.5013825326418707,1.2216669624190015,0.2515090543259557,0.7368017317549787,1.0,6/15,9.87%,AEBP1;FGFR4;DDR1;SLC2A10;DDR2;RIC1
prerank,ncRNA transcription (GO:0098781),-0.4895146151101526,-1.2213219442503365,0.22586520947176686,0.5831331733845396,1.0,7/13,25.43%,CAVIN1;BRF1;GTF3C1;SPIN1;ANG;SIRT7;SNAPC2
prerank,axon guidance (GO:0007411),-0.2789372346009138,-1.2211925159291435,0.05693950177935943,0.5825235804150362,1.0,50/201,12.31%,SPTBN1;GAB1;SLIT2;BSG;EFNA5;SHANK3;KLF7;PTPRM;SEMA6A;NRP2;SEMA7A;SH3KBP1;SEMA6D;RPS6KA5;RAC1;PLXND1;SEMA3C;PTK2;UNC5C;LAMA1;TNR;UNC5D;FYN;NOTCH3;CHN1;NOTCH1;SEMA4D;SEMA3E;PLXNA4;LAMA5;TUBB3;ROBO4;LAMA3;DCC;PDLIM7;TMEFF1;VEGFA;NRXN1;GFRA2;SEMA4B;SEMA5B;SEMA6C;PIK3CD;LYPLA2;RELN;SEMA3G;EPHB1;EFNB3;GPC1;SPTBN4
prerank,regulation of telomerase activity (GO:0051972),-0.36796921013108125,-1.2207192352264895,0.17164179104477612,0.5829135921748017,1.0,9/45,11.31%,NEK7;HSP90AA1;HSP90AB1;KLF4;PINX1;CTNNB1;PARM1;MAP2K7;MEN1
prerank,telomere maintenance (GO:0000723),0.39925566892599534,1.220641317809618,0.20100502512562815,0.7385166145283433,1.0,19/50,21.85%,SP100;HUS1B;ACD;XRCC5;BLM;TEP1;PRKDC;DCLRE1B;RTEL1;MRE11;APEX1;WRN;STN1;RAD51;TPRKB;POLD2;RAD50;NBN;TERF2
prerank,regulation of interleukin-12 production (GO:0032655),-0.3587156758674239,-1.2202537300983034,0.16666666666666666,0.5833094047563173,1.0,14/47,23.69%,FOXP1;THBS1;PLCG2;HSPD1;IRAK3;CD47;CMKLR1;LAPTM5;CD40;IRF5;JAK3;TIRAP;MAPK11;AGER
prerank,synapse organization (GO:0050808),0.3392957553477093,1.2201640121871626,0.14349112426035504,0.738548836818072,1.0,21/125,9.00%,UNC13C;PDZRN3;SDK1;SLC8A3;LRP4;NLGN2;GPC6;DKK1;NEDD4;SLC6A1;OBSL1;PPFIBP2;IGFN1;CACNB4;LRRK2;PTPRD;PTEN;RYK;MUSK;PCDHB10;FARP1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4197083215207287,1.219800651017328,0.1833648393194707,0.738322244944973,1.0,6/38,9.38%,LEPROT;PRKN;LRRK2;UBE2L3;NPEPPS;HSPA1L
prerank,calcium ion import across plasma membrane (GO:0098703),0.5244368391197602,1.219672348108462,0.24696356275303644,0.7373305378840668,1.0,3/14,7.35%,SLC8A3;SLC8A1;CACNA2D1
prerank,protein dephosphorylation (GO:0006470),0.33648570240350173,1.219455670234151,0.1476407914764079,0.7366140634792434,1.0,15/135,5.50%,EYA4;EYA1;PTPN13;PPP2R2B;EYA2;LHPP;PPM1M;PTPN4;DUSP10;SSU72;PPM1E;CDC14B;PTPRA;MTMR3;PTPN9
prerank,positive regulation of cell population proliferation (GO:0008284),0.29460091150188256,1.2194516533794462,0.06427688504326329,0.7352229923213645,1.0,48/423,8.55%,IL31RA;IGF1;TGFBR3;BMP6;TCF7L2;OSR1;IL34;RBPJ;FGFR2;FGFR4;PID1;EFNB2;IL18;MEIS1;BCL2;SCX;LTF;PDGFRB;FER;MEGF10;CTSH;IGF2;CCN4;SRPK2;ITGAX;IL13RA1;ASH2L;PDGFRA;SPHK1;GJA1;PDGFD;UFL1;IGF1R;FGF1;PTN;TET1;TTK;ADRA1D;CDC123;IL6;FOLR2;PTEN;DDR2;CSF1;BIRC5;GRK5;RPRD1B;COX17
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.5067549426281266,1.2192219934398612,0.24949698189134809,0.7344978454858705,1.0,7/14,16.86%,FTSJ3;DDX18;NOL9;NIFK;ZNHIT3;BOP1;ZNHIT6
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3602393000420239,-1.2184277142530127,0.15654205607476634,0.587368206981617,1.0,18/44,25.68%,PTPRJ;STK38;DAB2IP;DNAJA1;UCHL1;PDCD4;PTPN1;SPRY4;IRAK3;NF1;DUSP1;SH2B3;PRKCD;BMP4;CD300A;HYAL2;SPRY2;SORL1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.4404486427049218,-1.2179983413468956,0.20689655172413793,0.5876454640116044,1.0,12/20,35.63%,HSP90AB1;PKD1;CCNY;CCNYL1;AKT1;RGCC;PSMD10;PSRC1;PROX1;CCND1;ADAM17;CCND3
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.3135662404051774,-1.2177607997056237,0.12806539509536785,0.5873745506965065,1.0,40/98,22.08%,SLCO1C1;NSF;THBS1;KLF4;PPARD;NFKBIA;SFRP4;CHCHD2;TGFBR2;TGFB1;ARRB1;GHITM;ACACA;VEGFA;CD63;ECE1;EIF4G1;RAB1A;XDH;ACE2;PICK1;ROMO1;MT3;NR1H2;FASN;ZC3H12A;AGTR1;GREM1;RAB1B;INPP5F;ARRB2;ACLY;AKT1;INSR;FMR1;ATAD1;PAX8;GADD45A;CDKN1A;NR1H3
prerank,superoxide anion generation (GO:0042554),0.5081143158354041,1.2177425103042134,0.23658051689860835,0.7375626236584766,1.0,4/13,13.64%,DUOX2;TAFA4;NCF2;DUOX1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.37647828107391135,1.2176276752727038,0.19725557461406518,0.7365050211279985,1.0,7/61,7.12%,PRKAG2;FGFR4;PPARA;OAZ3;PSME4;PSMA2;PSMA3
prerank,histone lysine methylation (GO:0034968),0.43148720585239764,1.217314901104445,0.22429906542056074,0.7360725681996783,1.0,10/33,18.51%,KMT2A;PRDM5;ASH2L;SETD6;SMYD3;KMT2B;KDM6A;N6AMT1;WDR82;DYDC2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3327061480081141,1.2167665323695123,0.14098837209302326,0.7363347649271124,1.0,19/140,7.96%,ARHGAP28;ARHGAP24;ARHGAP6;GMIP;ARHGAP29;CGNL1;FGD4;RHOD;ARHGAP20;SYDE2;ARHGAP26;SOS2;AKAP13;ARHGAP12;ARHGAP40;ARHGEF11;ARHGAP35;ARHGAP9;MYO9B
prerank,regulation of endothelial cell migration (GO:0010594),-0.32227906474347395,-1.2159205584481094,0.1361111111111111,0.5914638423227522,1.0,28/85,10.16%,TEK;SLIT2;FOXP1;PTPRM;NRP2;RHOJ;BMPER;KDR;THBS1;RAC1;ACVRL1;SCARB1;PTK2;ETS1;PTK2B;DAB2IP;BMPR2;BCAR1;RHOB;CALR;EMC10;CEACAM1;FLT4;VEGFA;EMP2;GRN;EDN1;PIK3CD
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5238504696076325,-1.2154978705068444,0.21482889733840305,0.591712494914535,1.0,3/10,1.54%,LRCH1;APOD;CD200
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.40470887562285524,1.215116056317701,0.1894353369763206,0.7398714368902363,1.0,3/41,5.83%,PRKAG2;LACC1;NDC1
prerank,amide transport (GO:0042886),-0.4113554556283998,-1.2150529744452048,0.21978021978021978,0.5918663913096741,1.0,7/26,10.98%,ABCG2;CERT1;PLTP;SLC5A6;SLC38A5;AQP11;GLTP
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.5035066090470566,-1.21489435712116,0.23449612403100775,0.5914220426629417,1.0,6/12,29.09%,MAOA;DDC;AMD1;SRM;SMS;ODC1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.282602908100794,1.2143351726658658,0.03299203640500569,0.7408446867975608,1.0,149/807,14.11%,GLIS3;PRDM6;BMP6;TCF7L2;OSR1;AEBP1;WNT4;RBPJ;FGFR2;FHL2;PPARA;NR2F2;BMP7;PRKN;WWOX;ATXN1;ZEB2;KCNIP3;DAB2;SNX6;DKK3;ARID5B;RUNX1T1;MXI1;FNIP1;CUX1;AASS;SATB1;PRDM5;ZEB1;ZIC2;DKK1;DMRT1;NR1I2;ASCL2;TBL1XR1;PLCB1;SP100;LOXL3;TSHZ3;JARID2;MIDEAS;IGF2;VSX2;JAZF1;VGLL4;ZFP90;PRICKLE1;HDAC8;HOXA7;FOXD1;ZHX2;CBY1;BEND5;L3MBTL2;ARID4A;RNF2;IKZF4;KDM2B;SOX1;DPF2;IRF8;GLI3;SFMBT1;MXD1;ZBTB32;NIBAN2;ZFP37;CXXC5;BCOR;SUFU;DLG1;THAP1;WWC1;WWC2;SALL1;KANK2;XRCC5;SMAD3;EN1;NR6A1;MTF2;PHF21A;KDM2A;BIRC5;PER3;WWP2;LYAR;CBX8;DNAJA3;RSF1;CBX2;ZMYND15;TLE1;KAT8;MITF;KAT6B;MDM2;MBTD1;NSD1;MED1;FRK;SMURF2;IRX1;SCMH1;PARP9;L3MBTL3;ATOH8;HDAC1;FLCN;TFAP2A;CBX7;SMARCE1;ZNF8;TFAP2B;ZNF568;RXRA;ZBTB38;MYB;TAF3;CRY1;CNOT2;ZNF177;CDC73;E2F6;ORC2;SOX13;HSF1;CBFA2T2;PSPC1;AR;HIVEP1;PHF6;EZH1;CGGBP1;IFI27;NONO;NR1I3;FOXK2;SNAI1;SCML4;TFDP2;CLOCK;DICER1;ZNF148;KDM5C;MTDH;CDKN1C;CREBBP
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.4579707668551103,-1.2141090035850053,0.21456692913385828,0.5926863086914583,1.0,11/17,35.63%,PKD1;CCNY;CCNYL1;AKT1;RGCC;PSMD10;PSRC1;PROX1;CCND1;ADAM17;CCND3
prerank,response to X-ray (GO:0010165),0.5207746955941093,1.2132104263129253,0.24260355029585798,0.742771954815955,1.0,4/14,7.25%,ANXA1;XRCC5;BLM;XRCC4
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.49320868352388847,-1.2131956762050482,0.2034548944337812,0.5943572107315891,1.0,5/13,6.37%,NFKBIA;PKD1;FLNA;YWHAB;GOPC
prerank,histone H2B ubiquitination (GO:0033523),0.5543466158976552,1.2131421960347497,0.2587991718426501,0.7415765546460917,1.0,7/10,22.88%,CDC73;RNF20;CTR9;UBE2E1;DTX3L;PAF1;WAC
prerank,protein phosphorylation (GO:0006468),0.2932770201490427,1.2129907143886371,0.066429418742586,0.740668316596913,1.0,93/479,14.23%,PRKAG2;TGFBR3;ROCK2;OXSR1;EFEMP1;EPHA3;FGFR2;FGFR4;NRK;WNK4;KIT;CDK8;DAPK1;PRKAG3;PDPK1;PDK1;CAMK1D;BMP2K;PDGFRB;RNASEL;DMPK;FER;MAP4K5;CDK7;EPHA8;EPHA4;FAM20A;SRPK2;ABI2;MAP2K6;PDGFRA;MAPK9;BAZ1B;DDR1;SIK1;RICTOR;PRKAA2;IGF1R;LRRK2;PRKCZ;PRKCB;MAML1;STK17B;TTK;PRKCA;GRK3;DDR2;PRKAA1;NEK4;NRBP1;RYK;BIRC5;GRK5;BIRC6;CCNT1;PKN2;MUSK;CDK1;CAMK2D;PIK3R4;NEK10;GRK4;CLSPN;VRK2;LATS1;FRK;ABL1;PRKDC;RPS6KB1;JAK2;COQ8B;ERBB2;IKBKE;BMPR1A;MAPKAPK2;CRY1;PRKAG1;HIPK3;CCNE1;PRKD2;STK24;TBK1;ROS1;MAPK1;DCLK1;MAP3K7;PRKACB;MORC3;STK26;NIM1K;CDKL5;NLK;CDK15
prerank,ATP transport (GO:0015867),-0.5309066237039811,-1.2124667767279351,0.23616236162361623,0.5954314085919411,1.0,5/10,27.58%,SLC25A42;CD47;SLC17A9;SLC25A4;ABCC6
prerank,limb morphogenesis (GO:0035108),0.4764570638974215,1.2118573462237516,0.25333333333333335,0.7427010162914586,1.0,3/20,5.68%,CYP26B1;FBXW4;GLI3
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.35202379232591025,-1.2114569653346645,0.16009852216748768,0.5974141154112377,1.0,25/49,35.95%,F3;LBP;NOD1;STAT3;RAB1A;CD74;TIRAP;MYD88;HYAL2;AFAP1L2;RELA;HSPA1B;TLR7;TLR4;FADD;MAVS;NOD2;TLR1;NOS2;HSPA1A;SYK;PARK7;F2R;TLR8;RIPK1
prerank,calcium ion transmembrane transport (GO:0070588),0.36202059506211953,1.210895634380302,0.17246835443037975,0.7441393944235686,1.0,13/86,10.46%,TRPM3;SLC24A3;SLC8A3;NALCN;SLC8A1;CACNA1D;MAIP1;TRPC4AP;CACNA2D1;MCU;YME1L1;MCOLN3;MICU1
prerank,potassium ion transport (GO:0006813),0.3406890510694757,1.210834204141652,0.15944272445820434,0.7429436470166184,1.0,9/120,4.07%,ATP1A2;SLC24A3;KCNK2;KCNQ4;NALCN;KCNA5;SLC1A3;ATP1B3;KCND3
prerank,metanephros development (GO:0001656),0.45577391989693733,1.2101215917326291,0.24767225325884543,0.743669738593025,1.0,4/26,4.24%,OSR1;BMP7;CTSH;FOXD1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.4978878223099628,-1.2097185639477441,0.2375249500998004,0.6012063746395816,1.0,5/12,17.60%,ESR1;TGFB1;STAT3;LIN28B;ZC3H12A
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5259713189053046,-1.2095567527777786,0.23929961089494164,0.6007379696234271,1.0,2/10,2.22%,RUNX1;CBFB
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.40516146545606496,-1.209124737859802,0.20750551876379691,0.6009792253207519,1.0,11/25,18.75%,CAV1;CALM1;CXADR;ATP2A2;CTNNA3;RYR2;CACNA1C;JUP;DSG2;DSP;TRPM4
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3154121153187862,1.2089158277013512,0.15223463687150837,0.7460435876442405,1.0,30/190,9.50%,RORA;NPRL3;C1QTNF3;ITPR1;CGNL1;PPARA;BMP7;GPD1L;BCL2;FNIP1;DEPTOR;MGRN1;VGLL4;ARHGAP12;CACTIN;UACA;PRKAA2;NPRL2;WWC1;PDCD6;WWC2;UBR2;MMP9;NLRC3;PTEN;PRKAA1;TLE1;BCL2L2;EPM2A;MDM2
prerank,histone H2A ubiquitination (GO:0033522),0.48340627766274263,1.208675970106138,0.23625254582484725,0.7453801147874631,1.0,9/17,17.61%,DDB2;RNF2;KDM2B;BCOR;UBR2;CUL4B;UBE2A;PCGF1;DTX3L
prerank,tyrosine metabolic process (GO:0006570),0.5436820997611806,1.208301993924007,0.26348547717842324,0.745124365911875,1.0,3/11,15.19%,FAH;DCT;GSTZ1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.49520387518921594,-1.2082332445821915,0.22328244274809161,0.6025430370235151,1.0,7/12,29.16%,HNRNPU;LARP7;NELFCD;NELFE;RNF168;EAPP;RNF8
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5227595109689841,-1.2079043780305074,0.2361904761904762,0.6025203007996777,1.0,3/10,19.24%,SEC14L1;RNF125;GPATCH3
prerank,sensory organ development (GO:0007423),0.3864542321727058,1.2078693482640699,0.20770519262981574,0.7450685078953745,1.0,9/51,8.53%,RBP4;MEIS1;SLC39A5;ASCL2;SHROOM2;SMOC1;SH3PXD2B;PBX4;CHRDL1
prerank,protein heterotetramerization (GO:0051290),-0.4854856716125251,-1.207156373212523,0.22690763052208834,0.6037347464893934,1.0,8/13,33.59%,PKD1;CPSF7;GRIN1;CPSF6;FARSA;HSD17B8;GRIN2B;KRT10
prerank,protein homotetramerization (GO:0051289),0.39062953658817456,1.2071136927449773,0.20847457627118643,0.7460868591598461,1.0,10/49,13.99%,ALDH1A2;APPL2;UPB1;CBY1;HSD17B10;SSBP1;GOLGA2;PKD2;SHMT1;CRYZ
prerank,relaxation of muscle (GO:0090075),0.5133432034478865,1.2070067100040558,0.23046092184368738,0.7450565162063468,1.0,3/13,3.07%,ATP1A2;GSTM2;SLC8A1
prerank,calcium ion import into cytosol (GO:1902656),0.5068749212719799,1.2069934570091954,0.26877470355731226,0.7437447053653014,1.0,3/15,7.35%,SLC8A3;SLC8A1;CACNA2D1
prerank,muscle organ development (GO:0007517),0.3794233542912585,1.206589182036649,0.18135593220338983,0.7436308840532548,1.0,8/54,4.90%,IGF1;VAMP5;DMD;LAMA2;LARGE1;SOX6;SPEG;SGCE
prerank,sprouting angiogenesis (GO:0002040),-0.34919856892382667,-1.2064322330782595,0.1756440281030445,0.6048412618729804,1.0,15/51,9.71%,TEK;SLIT2;BMPER;RSPO3;KDR;THBS1;ACVRL1;RAMP2;ENG;PTK2B;SEMA3E;FLT4;VEGFA;NR4A1;ESM1
prerank,regulation of TOR signaling (GO:0032006),0.36849699170564765,1.206429264759883,0.18959731543624161,0.7427716558484162,1.0,15/67,11.36%,NPRL3;FNIP1;DEPTOR;ARAF;RICTOR;PRKAA2;NPRL2;SLC38A9;PDCD6;UBR2;PRKAA1;EPM2A;MLST8;FLCN;AKT1S1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.36609085026031485,-1.2062487267851119,0.17715617715617715,0.6044347148641175,1.0,10/39,11.93%,TEK;KDR;THBS1;GAS6;RAMP2;GATA2;ITGA4;PDCD4;SCG2;GPER1
prerank,organelle fission (GO:0048285),-0.4089313399179172,-1.2062170501825173,0.20512820512820512,0.603574637730749,1.0,8/24,18.65%,DNM3;CORO1C;DNM2;MIEF1;DNM1;PEX11B;SEC16B;MTFR1L
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4657399136112359,1.2060271362018873,0.24497991967871485,0.7425698332450308,1.0,5/20,6.48%,ROCK2;FHOD1;RAB13;LLGL2;DLG1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.38306934143129795,-1.2057952768239921,0.18322295805739514,0.6038039033708392,1.0,8/33,10.61%,TGFB2;KLF4;ETS1;GATA2;TGFB1;GNL3;JUN;STAT3
prerank,"phototransduction, visible light (GO:0007603)",0.5065712671748175,1.2056722269481406,0.2564102564102564,0.7423523764755465,1.0,3/14,6.43%,ABCA4;PDE6G;GNAQ
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.40004699982915937,-1.20505488234364,0.21141649048625794,0.6049783026286876,1.0,11/27,19.88%,UBB;RPS27A;UBC;MAP3K1;HSPD1;IRAK3;TAB3;UBA52;IRAK1;TIRAP;MYD88
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.4437968233066904,1.2050192612075517,0.24770642201834864,0.7429640638933348,1.0,11/26,21.20%,LTF;CACTIN;NLRC3;LYAR;ITCH;PCBP2;MAPKBP1;TRAFD1;TRAF3IP1;ILRUN;NFKBIL1
prerank,lipid catabolic process (GO:0016042),0.49392725515483704,1.204932838997872,0.24746450304259635,0.7419377662351906,1.0,4/18,7.52%,CEL;ACADL;LIPH;LIPC
prerank,cellular response to lectin (GO:1990858),-0.3074902080926184,-1.2047859585234515,0.11294765840220386,0.6038696108606311,1.0,31/104,23.41%,KRAS;RPS6KA5;PLCG2;FYN;NRAS;IKBKB;PAK1;PSMD13;PSMF1;PAK2;PSMB10;CHUK;PSMB6;PSME3;PSMB5;ICAM2;PSMC3;PSMD12;PSMB8;CUL1;TAB3;PSME1;PSMB3;RAF1;PSMD5;TYROBP;PRKCD;SKP1;PSMD9;PSMB4;RELA
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.3074902080926184,-1.2047859585234515,0.11294765840220386,0.6038696108606311,1.0,31/104,23.41%,KRAS;RPS6KA5;PLCG2;FYN;NRAS;IKBKB;PAK1;PSMD13;PSMF1;PAK2;PSMB10;CHUK;PSMB6;PSME3;PSMB5;ICAM2;PSMC3;PSMD12;PSMB8;CUL1;TAB3;PSME1;PSMB3;RAF1;PSMD5;TYROBP;PRKCD;SKP1;PSMD9;PSMB4;RELA
prerank,actin-myosin filament sliding (GO:0033275),0.41147362530049536,1.2046852959103793,0.213768115942029,0.7400279101284579,1.0,4/38,2.80%,TPM1;DMD;TNNC1;TNNT2
prerank,muscle filament sliding (GO:0030049),0.41147362530049536,1.2046852959103793,0.213768115942029,0.7400279101284579,1.0,4/38,2.80%,TPM1;DMD;TNNC1;TNNT2
prerank,heterochromatin organization (GO:0070828),-0.482663009658146,-1.2046567236553765,0.23985239852398524,0.6033431365132514,1.0,4/14,11.47%,MECOM;PRDM16;SMCHD1;BAHD1
prerank,signal transduction by p53 class mediator (GO:0072331),-0.39048797933409385,-1.2044653999660793,0.20430107526881722,0.6029769077599557,1.0,8/30,12.41%,ACER2;PPP1R13B;DDX5;SESN2;BCL3;HINT1;PDK2;MYBBP1A
prerank,epithelium development (GO:0060429),0.3383423331545307,1.2038904782154691,0.15118110236220472,0.741138971893558,1.0,10/107,7.04%,ALDH1A2;ERRFI1;OSR1;WNT4;FGFR2;LOXL3;TPP1;PTER;SALL1;KANK2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.40553767237425636,1.2037370912832575,0.21350364963503649,0.7402091548044898,1.0,5/41,9.05%,IGF1;SYT11;CACTIN;NLRC3;SIRPA
prerank,negative regulation of cell population proliferation (GO:0008285),-0.2583239991408063,-1.2033787943818808,0.03333333333333333,0.6051177859294004,1.0,69/351,12.41%,ZBTB7C;PTPRJ;APOD;FTH1;B2M;NOS3;IGFBP6;CD200;BMP5;PLPP1;ACVRL1;TGFB2;FAP;PTPN14;CBFA2T3;TES;KLF4;PPP2R5C;ETS1;ADARB1;WNT9A;ROR2;PTK2B;DAB2IP;NGF;NOTCH1;SH3BP4;P3H2;BMPR2;HES1;SFRP4;RERG;CCN3;WARS1;PINX1;GATA2;SOX4;TGFB1;IGFBP5;CTNNB1;ST18;TOB1;TBX3;ATP8A2;DDAH1;APP;ADRA1A;PTHLH;PAK1;AQP11;MAGED1;PODN;ING4;CTNNBIP1;APC;CDK6;SOX7;CDKN1B;NCK2;BTG3;BMP2;HGS;IFI35;MEN1;NDRG4;PBRM1;GPER1;REST;CDH13
prerank,cell-cell junction organization (GO:0045216),-0.31414569344439913,-1.2033479630448651,0.12430939226519337,0.6042855525429018,1.0,19/79,10.39%,CLDN5;CADM1;OCLN;TJP2;LIMS2;TGFB2;CDH11;CTNND2;PKP4;CDH1;CDH2;GJC1;CXADR;LIMS1;TGFB1;CSK;TJP1;PVR;CADM3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.33085836168179134,-1.2032734085192218,0.145,0.6035700760757553,1.0,17/67,15.80%,B2M;IKBKB;CALR;VAMP8;PSMD13;PSMF1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;CYBB;PSMB3
prerank,autonomic nervous system development (GO:0048483),-0.45023202893300956,-1.2027523199852694,0.22933884297520662,0.6041015885939874,1.0,7/17,22.64%,FN1;SOX4;KIF26A;NF1;SOX10;SEMA3A;SOX11
prerank,regulation of gene expression (GO:0010468),0.27689127435675365,1.2023921814006608,0.04189636163175303,0.7429192082009288,1.0,134/903,12.54%,IGF1;PRDM6;RORA;ROBO1;BMP6;SLC24A3;ROCK2;OSR1;EFEMP1;SLC22A2;WNT4;AFF2;ARNT2;RBPJ;DENND4A;ZNF462;FGFR4;AFDN;WNT6;PID1;NOTCH2;BMP7;ANGPT1;IGF2BP1;PRKN;ATXN1;TULP3;NOVA1;ESRRG;RBMS3;PRDM5;MYBL1;DKK1;SCX;NR1I2;LTF;SOX6;PPARGC1B;SLC8A1;NOS1AP;NFYB;ZC3H7B;TRIM5;CTSH;IGF2;DTNBP1;PTBP2;SSBP2;CCN4;NCOA2;SRPK2;ITGAX;ANK2;MBIP;FOXD1;MAPK9;TNRC6B;SOX1;GJA1;CACTIN;PRKAA2;PERM1;TNRC6A;FGF1;HNRNPH1;SON;METTL4;SLC2A10;EPHX2;TCF7L1;ZUP1;ZFP37;SUFU;THAP1;WWC1;IL6;WWC2;GPBP1;UBE2L3;SMAD3;ABCC2;GPBP1L1;PRKAA1;MTF2;RBL2;ZKSCAN5;ATG14;CSF1;POLR2A;WWP2;NFIA;TLE1;ATRAID;ZNF628;MUSK;YTHDF2;BRCA2;MITF;KDM6B;KAT6B;SIRPA;FUBP1;PICALM;NFYC;PARP10;NSD1;MED1;NUP107;AGO2;ABL1;PARP9;FGF9;ATOH8;ASCC2;HDAC1;ZBTB11;FLCN;TFAP2A;APLN;PCBP2;ZBTB38;MYB;BMPR1A;RNF14;SOX13;TRIM26;TRIM43;PRKAG1;SLC38A2;RNF20;PSPC1;AR;SNX12;ADNP2
prerank,negative regulation of cell communication (GO:0010648),-0.42173477154982014,-1.2016382296722865,0.20416666666666666,0.6061827122206396,1.0,6/21,17.24%,HHIP;UBASH3B;SOCS5;KIF26A;PTPN1;ACVR1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.48352029812093145,-1.2015790876086274,0.211864406779661,0.6054492096573908,1.0,6/13,23.86%,RUNX1;CBFB;TGFBR2;NKAP;NCKAP1L;SOCS1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.3492442980158824,-1.2013845055779286,0.18823529411764706,0.6050870051211433,1.0,9/45,5.38%,GAB1;RPS6KA5;IQGAP1;CBL;PTK2;PTK2B;REPS2;BCAR1;TGFB1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.4805789690410242,-1.2013443484184274,0.23446893787575152,0.6043072975072687,1.0,7/13,22.88%,AQP11;LPCAT3;CLU;NR1H2;WFS1;NR1H3;FCGR2B
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5227814410726263,-1.2012424491104314,0.2476007677543186,0.6036797802118199,1.0,4/10,19.58%,ACTN4;TBX1;RARB;RXRB
prerank,regulation of secretion (GO:0051046),-0.482937482260297,-1.201007269481393,0.22574257425742575,0.6034448657750955,1.0,5/13,17.75%,KCNQ1;OAS2;POFUT2;SGK1;ACSL3
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.44329010946349984,1.2008882883271244,0.21626617375231053,0.7459454428012058,1.0,4/27,7.50%,IGF1;PDGFRA;SPHK1;DDR2
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.3057050685184102,-1.2006980531176696,0.12362637362637363,0.6034264796873108,1.0,31/105,23.41%,KRAS;RPS6KA5;PLCG2;FYN;NRAS;IKBKB;PAK1;PSMD13;PSMF1;PAK2;PSMB10;CHUK;PSMB6;PSME3;PSMB5;ICAM2;PSMC3;PSMD12;PSMB8;CUL1;TAB3;PSME1;PSMB3;RAF1;PSMD5;TYROBP;PRKCD;SKP1;PSMD9;PSMB4;RELA
prerank,stabilization of membrane potential (GO:0030322),0.49656631032957554,1.200690134395243,0.24893617021276596,0.7451762837323215,1.0,1/16,0.38%,KCNK2
prerank,motor neuron axon guidance (GO:0008045),-0.4607736277164671,-1.2005570331973543,0.24470134874759153,0.6028809775061064,1.0,4/15,7.57%,SLIT2;RAC1;CHN1;TMEFF1
prerank,positive regulation of proteolysis (GO:0045862),0.39013701476515794,1.2000993591938067,0.22202486678507993,0.745523923184549,1.0,8/55,7.78%,SH3D19;FGFR4;CTSH;CCBE1;SNX9;SNX33;NRDC;WDR48
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.36298921755765773,-1.200074183154918,0.1941747572815534,0.6032872415134596,1.0,13/40,10.85%,LEF1;TIAM1;TGFB2;JAG1;NOTCH1;TGFBR2;TGFB1;FERMT2;CTNNB1;MTOR;WWTR1;BMP2;GCNT2
prerank,supramolecular fiber organization (GO:0097435),-0.2631502127786088,-1.2000459768881049,0.041474654377880185,0.602477448000731,1.0,106/334,19.34%,COL8A1;PGM5;HIP1;COL25A1;MYO1D;ELMO1;COL6A3;COL12A1;B2M;TLL1;SHROOM4;ITGA6;COL8A2;COL4A1;ADAM10;RAC1;TGFB2;CARMIL1;ITM2B;CST3;GSN;HSP90AB1;ITGB4;COL5A2;COL6A2;PLEC;SLK;VIM;UBB;TGFBI;P3H2;COL15A1;CLIP1;COL6A1;ACTN1;TNXB;MYH11;CORO1C;BCAR1;COLGALT2;CLIP2;RHOB;LUM;CCDC88A;LAMA3;COL27A1;RPS27A;UBC;COL14A1;ADAMTS14;GFAP;MARCKS;CHP1;HIP1R;STMN2;APP;EMP2;SHROOM1;COLGALT1;H3-3A;RHOA;PPIB;FURIN;ARHGAP25;COL16A1;CD2AP;MFAP4;PLOD2;MTM1;ERMN;MYO5A;WHAMM;ARHGEF2;COL4A2;STMN1;IAPP;ALDOA;INPPL1;COL1A1;NF1;HOOK1;MARCKSL1;TPM3;CYP1B1;TPM4;COL3A1;UBA52;CCDC88C;TPPP;RHOG;STMN4;P4HA2;COL5A3;TPPP3;TMOD1;USP9X;COL28A1;DSP;GREM1;PLOD3;CDC42EP2;STMN3;EVL;ADAMTS3;CKAP5;FLII
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.3581248844252524,-1.1989185289481048,0.20518358531317496,0.6048091518035704,1.0,23/46,29.75%,FBXO7;TOMM20;HK1;TOMM22;HSPD1;TIMM9;ROMO1;TIMM10B;TIMM13;BCAP31;PINK1;AKT1;TIMM22;TOMM7;MFN2;TIMM50;FIS1;TIMM44;TSPO;AIP;CHCHD4;DNLZ;TOMM34
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.35046550492000517,1.1988049149822153,0.1743827160493827,0.7478697949301983,1.0,12/87,8.49%,FGFR2;FGFR4;FGFBP1;POLR2D;FLRT2;NDNF;KL;FGF1;HNRNPH1;FRS2;POLR2A;GTF2F1
prerank,regulation of cell-cell adhesion (GO:0022407),-0.36223659674372793,-1.1987444185834333,0.16666666666666666,0.6044082036274251,1.0,13/39,12.09%,EFNA5;PODXL;PTPRG;JAG1;CDH1;PTK2;MINK1;TGFB1;CEACAM1;ZDHHC2;DPP4;SPINT2;TENM3
prerank,negative regulation of leukocyte migration (GO:0002686),-0.51815768987131,-1.1986975202778345,0.25523809523809526,0.6036464128267629,1.0,3/10,1.84%,SLIT2;CD200;BMP5
prerank,regulation of coagulation (GO:0050818),-0.5118009883075683,-1.1983309505781363,0.2574626865671642,0.6037790886758536,1.0,3/11,17.68%,CAV1;HS3ST5;PROCR
prerank,regulation of MAP kinase activity (GO:0043405),0.3488098824387846,1.1978852861453153,0.18035426731078905,0.7492670282957263,1.0,9/92,5.51%,ROBO1;IL34;KSR1;KIT;BMP7;PDGFRB;PDGFD;LRRK2;FGF1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.45968123849656917,1.1975325821242888,0.2631578947368421,0.7490251080497506,1.0,3/19,4.05%,ROBO1;SMOC2;CCBE1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.31729966252553793,-1.1974371578796406,0.14666666666666667,0.6052961502613963,1.0,37/87,33.04%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFAF4;NDUFA12;NDUFV1;NDUFB7;UQCC2;NDUFA13;NDUFS1;NDUFB11;SDHAF2;SMIM20;NDUFB10;NDUFA1;UQCC3;NDUFB4;NDUFS7;FASTKD3;NDUFAF8;BCS1L;DMAC2;COA3;COA8;NDUFAF3;COX16;COA5;CHCHD4;SDHAF1;NDUFC1;ACAD9;NDUFS2;NDUFS5;NDUFAB1;TMEM126A
prerank,protein deacylation (GO:0035601),-0.4067371233553785,-1.197409314235591,0.20161290322580644,0.6044774288308129,1.0,11/23,30.77%,HDAC5;ABHD17B;LYPLA2;ABHD17A;SIRT7;HDAC7;HDAC6;LYPLA1;SIRT6;HDAC3;SIN3A
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.49439124055951755,-1.1972901881173603,0.2475442043222004,0.6038868624297018,1.0,8/12,38.91%,HSPA5;SEC62;SEC61G;SEC63;SEC61B;SEC61A2;SGTB;SEC61A1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.4798887740304167,-1.1968016218590607,0.22745901639344263,0.6043304156556824,1.0,3/13,2.30%,CAV1;PDE4D;CALM1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.3040943206949503,-1.1964101773383613,0.1452991452991453,0.6045850917891922,1.0,20/100,8.27%,GAB1;TEK;NTRK3;FN1;PIP5K1B;KDR;TGFB2;CBL;PPP2R5C;PTK2;ROR2;DAB2IP;PIK3IP1;SEMA4D;ROR1;PPP1R16B;CEACAM1;PDGFC;MYOC;WNT16
prerank,positive regulation of immune response (GO:0050778),-0.33334679798983213,-1.1959930573297284,0.16957605985037408,0.6048911460815282,1.0,26/64,35.89%,TGFB2;PTPRC;GRN;XBP1;GBP5;IFI35;CD74;RSAD2;CD81;IL15;POLR3D;FCGR2B;POLR3F;SPHK2;SKAP1;SLC15A4;ITGB2;KARS1;FADD;DHX9;NOD2;NLRP3;SASH3;CCL5;IL6ST;TLR8
prerank,sodium ion homeostasis (GO:0055078),0.4643313863640889,1.1958783175236147,0.2560483870967742,0.7525813500349448,1.0,3/21,3.07%,ATP1A2;ATP1B3;SLC8A1
prerank,leukotriene biosynthetic process (GO:0019370),-0.4630887965662606,-1.195658175166587,0.2551440329218107,0.6048824142596675,1.0,8/14,37.39%,PLA2G4A;GGT1;LTA4H;GGTA1;PLA2G5;ALOX5AP;MGST2;GGT5
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.4403190588662022,-1.1953170326759084,0.2333965844402277,0.6049354211763163,1.0,8/18,33.25%,HHEX;ENY2;NUP133;DDX25;THOC2;ZC3H11A;NUP93;IWS1
prerank,regulation of protein phosphorylation (GO:0001932),-0.26841226257642226,-1.1948652663357364,0.06181818181818182,0.6053353134417847,1.0,73/256,17.60%,TEK;NTRK3;FN1;SLIT2;PECAM1;LIMCH1;EFNA5;OCLN;FNIP2;PRR5L;BMPER;TFRC;KRAS;KDR;NIBAN1;RAC1;HSP90AA1;GAS6;PPP2R5C;PTK2;TARDBP;PDE8A;FYN;ENG;DAB2IP;RACK1;PPIA;SEMA4D;TBX1;HSPB1;LIMK2;CORO1C;WARS1;TGFB1;PDCL3;CAMKK2;SOD1;CCDC88A;ARRB1;CHP1;APP;FLT4;CARD14;VEGFA;PAK1;FGF7;SLCO3A1;SESN2;WWTR1;RALB;ATF4;BMP2;MEN1;XDH;GPER1;SPTBN4;CD74;IBTK;CADM4;CCN1;MT3;TERF2IP;CSF1R;FAS;CCDC88C;DNAJC10;AKAP8;DVL2;PPP2R5A;ANKRD54;KNDC1;CD40;ZC3H12A
prerank,regulation of protein polymerization (GO:0032271),0.4164311799398677,1.1947287702850593,0.24293785310734464,0.7546017594197629,1.0,7/35,13.05%,ARHGAP28;ARHGAP40;COTL1;LATS1;ABL1;GBA2;FCHSD2
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.29971196670641176,-1.19467752178211,0.13186813186813187,0.6050004908719989,1.0,32/107,16.39%,MEF2C;SLC12A2;GRM3;ITGB1;GRM7;CDH2;NGF;MCTP1;HOMER1;GRIK4;CLSTN2;ABR;DLGAP1;LRP8;DGKI;BCR;BTBD9;APP;SLC4A8;KCNMB4;PXK;RELN;KCTD13;DGKZ;CLSTN3;CPLX2;GRM8;NRG3;CNTNAP4;TMEM108;CX3CR1;CACNA1B
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.44388133770080485,1.1946242321768408,0.23540489642184556,0.7535564278691204,1.0,3/26,5.06%,LGR4;APPL2;CACTIN
prerank,monocarboxylic acid transport (GO:0015718),-0.350348610987821,-1.1945250628286155,0.18457943925233644,0.6045615333820364,1.0,17/51,14.60%,ABCC4;ABCG2;ATP8B1;SLCO1C1;SLC16A9;SLCO2A1;SLCO2B1;SLC16A1;SLC5A6;CEACAM1;SLC6A8;SLCO3A1;SLC16A4;SLC26A6;STARD5;SLC16A2;NR1H4
prerank,cellular response to drug (GO:0035690),-0.4051075762471598,-1.19441501543843,0.23958333333333334,0.6040043605902747,1.0,7/25,12.32%,MEF2C;ACER2;TFRC;GAS6;KCNQ1;AIM2;REST
prerank,regulation of epidermal cell differentiation (GO:0045604),0.44686066024318777,1.1943432530139506,0.2543352601156069,0.7530736649781822,1.0,2/21,0.39%,ERRFI1;ROCK2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.47528647606368146,-1.1933316459144405,0.2622309197651663,0.6061397549381987,1.0,9/13,32.29%,TMEM30A;CD81;SEC16B;BRSK2;INSIG1;SEC16A;SORL1;TM9SF4;TMEM30B
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.4775318997207618,-1.1932497864395064,0.24521072796934865,0.6055094639617241,1.0,8/13,31.20%,SOD1;ZC3H8;CAMK4;TOX;BMP4;FOXJ1;SHH;VNN1
prerank,negative regulation of ATPase activity (GO:0032780),0.4934822443029898,1.1929538946560103,0.24853228962818003,0.7558195316816515,1.0,4/16,11.46%,LTF;TNNT2;THADA;OXA1L
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4710804741978426,-1.1928385345772736,0.2662835249042146,0.6057748560027744,1.0,5/13,13.69%,CD9;ITGB1;SREBF2;CDH13;CD81
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4833225854099701,1.1927597137380608,0.2535496957403651,0.7550417904877058,1.0,2/16,3.14%,NPR3;NOS1AP
prerank,skeletal muscle tissue development (GO:0007519),-0.38063352513975085,-1.1926868174959369,0.1979381443298969,0.6053250964007626,1.0,6/32,7.79%,MEF2C;CAV1;MYL6;CAV2;SIX1;LEMD2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3231758635911941,1.1920379451963052,0.1485884101040119,0.7559803999065113,1.0,20/150,6.43%,PRKAG2;ERRFI1;PTPN13;PID1;PRKN;DMD;PLPP3;PDPK1;GPD1L;SMAD6;PARD3;DEPTOR;DKK1;DTNBP1;PPM1E;CACTIN;LRRK2;PRKCZ;FBLN1;GNAQ
prerank,inner ear morphogenesis (GO:0042472),0.46906791353653854,1.1919342752463782,0.26522593320235754,0.7549575735289468,1.0,2/22,1.00%,ZIC1;FGFR2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2943645006363556,-1.191805162187598,0.1359773371104816,0.6069942766640836,1.0,38/119,19.49%,PIP5K1B;EFR3B;PITPNM2;PLCG2;INPP5D;BMX;PIK3R6;INPP4A;SOCS2;SYNJ1;SOCS5;PIK3C2B;ARF1;CDS1;CDIPT;PGAP4;TTC7A;PLEKHA1;PIK3CD;PIK3C2A;MTM1;MTMR6;PITPNM3;PIK3R5;PIK3C3;MTMR9;INPPL1;SACM1L;PIP5K1C;SBF1;ITPKB;PI4KB;CISH;PIGZ;MTMR12;PIK3R3;INPP5F;PIP4K2A
prerank,pancreas development (GO:0031016),0.5239180787013076,1.191420452422308,0.27235772357723576,0.7551108436138959,1.0,1/12,0.51%,TCF7L2
prerank,Ras protein signal transduction (GO:0007265),0.3254485604712762,1.19023681098863,0.1691616766467066,0.7571740434469442,1.0,17/137,7.96%,IGF1;ROCK2;ARHGAP6;KSR1;ARHGAP29;RHOD;RRAS2;PDPN;PLD1;COL1A2;ABI2;WASF1;HACD3;ARHGEF11;NTN1;EPS8L1;MYO9B
prerank,hydrogen peroxide metabolic process (GO:0042743),0.46269800849851134,1.1900573612940764,0.25096525096525096,0.7563756233256581,1.0,5/19,14.15%,PXDN;DUOX2;DUOX1;ACOX1;MAOB
prerank,oligosaccharide metabolic process (GO:0009311),-0.3510395409509212,-1.1899664703903319,0.19910514541387025,0.6110758348817338,1.0,9/46,9.51%,ST3GAL4;ST6GALNAC3;ST3GAL6;ST8SIA4;FUT8;ST6GALNAC5;ST8SIA1;ST8SIA6;MAN2B1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.37013772223539454,-1.1897249373497003,0.22573839662447256,0.6108825724073159,1.0,14/37,21.18%,GRM3;GRM7;PTK2B;KCNB1;HOMER1;GRIK4;GRIN3A;APP;GRIN1;GRM8;GRIA2;GRIK2;FMR1;GRID2
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4085021099231871,-1.1892474199302778,0.25256673511293637,0.611309185792558,1.0,5/22,17.18%,APOD;CEACAM1;GPER1;PPP2R5A;BSCL2
prerank,carbohydrate derivative transport (GO:1901264),-0.43450936462425677,-1.1890978953068432,0.23858921161825727,0.6108212669907153,1.0,5/18,8.15%,PLTP;SCARB1;LBP;SLC10A7;MFSD2A
prerank,axonemal dynein complex assembly (GO:0070286),0.43581539160034705,1.1889884913178634,0.23948811700182815,0.7581241471720639,1.0,8/28,14.99%,ODAD3;DNAI4;SPAG1;TTC12;CCDC65;ODAD1;DNAAF3;ODAD2
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5353773621290541,1.1887923769824882,0.28421052631578947,0.7574190623150626,1.0,4/11,11.93%,LEPROT;SNX33;PICALM;ACTN2
prerank,regulation of interleukin-10 production (GO:0032653),-0.3586640787895137,-1.1885400396939634,0.21395348837209302,0.6114297917442431,1.0,15/44,24.17%,CD34;PLCG2;TRIB2;TNFRSF21;ISG15;STAT3;HSPD1;CD47;CD274;JAK3;TYROBP;DLL1;FCGR2B;AGER;VSIR
prerank,protein kinase B signaling (GO:0043491),0.4443925483222899,1.1883210429939164,0.2391713747645951,0.7576119844395547,1.0,1/23,0.03%,IGF1
prerank,regulation of cellular component organization (GO:0051128),-0.28740367186066024,-1.1874519118285718,0.12578616352201258,0.6134702091121794,1.0,32/135,15.26%,HIP1;LTBP4;RAP1A;HSPA8;TFRC;HSP90AA1;STON2;DAB2IP;SEMA4D;NET1;PACSIN2;CDK11B;STK38L;SOCS2;BCAR1;FAM107A;HJURP;GFAP;CEACAM1;HIP1R;HNRNPU;TJP1;MTOR;PTPN1;LAMTOR1;ERMN;EGLN2;CDH13;IRAK3;SPOCK1;NRG3;LAMTOR2
prerank,axonal fasciculation (GO:0007413),0.5277908484650684,1.1871192826120078,0.27139874739039666,0.7598072032725409,1.0,3/12,7.10%,EPHA3;EPHA4;ARHGAP35
prerank,regulation of neuron projection development (GO:0010975),-0.283831130503198,-1.186803070622558,0.11242603550295859,0.6143462280318123,1.0,62/163,22.40%,NTRK3;SHANK3;RAP1A;SIPA1L1;ITGA6;FBXO7;CDH2;PRAG1;ROR2;PTK2B;DAB2IP;CHN1;ROR1;SERPINI1;MBOAT1;SCARF1;KANK1;RTN4RL1;ZDHHC15;CCDC88A;DCC;PPFIA2;GSK3B;EFHC2;STMN2;RTN4IP1;MFSD2A;ABI3;PAK1;MARK1;SRCIN1;PAK2;KIF1A;RELN;NDRG4;TENM3;MARK2;RET;MT3;SPOCK1;DISC1;CAMK2B;PRKD1;KNDC1;SCN1B;TOX;NTNG1;ITM2C;NPTN;CDK5;PSEN1;PLXNB3;FKBP4;RIT2;CFL1;AKT1;DBN1;CRMP1;RTN4R;FUT9;BRSK2;SEMA3A
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.5252056370696331,1.1866669596541835,0.2662337662337662,0.7598631742813577,1.0,3/11,7.27%,DAB2;DKK1;WNT5B
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.36480833901705284,-1.1858262744112802,0.21040723981900453,0.6161183856454985,1.0,19/39,32.12%,UBB;RPS27A;UBC;DDB1;RBX1;RPA1;OGG1;UBA52;POLK;POLD3;NTHL1;POLD1;GTF2H2;XPA;ERCC5;RFC5;ERCC3;GTF2H5;RPA3
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.2848647898060103,-1.1854263607919446,0.12416107382550336,0.6163155543624428,1.0,32/151,15.14%,ST3GAL4;CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ELOVL5;ACER2;CEPT1;SPTLC2;PLPP1;DEGS2;GCH1;B4GALT5;KDSR;PRKD3;PPM1L;GPHN;SPNS2;SGPL1;MFSD2A;ELOVL6;FURIN;LPCAT3;GPAT4;ELOVL1;TYW1;LPCAT1;LPIN3;CSNK2B;CERS4;PLA2G4A
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.4463898081054596,-1.1852719392559563,0.22736418511066397,0.6158910715985699,1.0,3/17,7.10%,TEK;NTRK3;BAIAP2L1
prerank,positive regulation of cellular component movement (GO:0051272),-0.4131677351222649,-1.1849377310884395,0.23440860215053763,0.6159901585517374,1.0,6/24,7.87%,SPOCK2;ACTN4;CAVIN1;ETS1;RPS19;VEGFA
prerank,muscle contraction (GO:0006936),0.32688844578223314,1.1849006095581816,0.16566265060240964,0.7638101778830234,1.0,13/126,4.61%,ROCK2;BDKRB2;TPM1;DMD;SNTA1;SORBS1;TNNC1;MYLK;TNNT2;SLC8A1;CALD1;TLN1;CHRNE
prerank,negative regulation of cell activation (GO:0050866),-0.4692090121036615,-1.1845405335626122,0.2649402390438247,0.6162118887715784,1.0,4/14,12.47%,NOS3;CD200;GPER1;THBD
prerank,defense response to tumor cell (GO:0002357),0.5374915353454306,1.1837548381113807,0.2709677419354839,0.7659617009137241,1.0,3/10,4.73%,DAPK1;RBMS3;PLK5
prerank,cartilage development (GO:0051216),0.38596277053590794,1.183564235425166,0.21404109589041095,0.7652612460584292,1.0,7/49,7.27%,SOX5;OSR1;SCX;SOX6;NFIB;SULF1;WNT5B
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.2899642562917409,1.1828622058587712,0.10526315789473684,0.766030143489611,1.0,48/390,8.79%,IL31RA;IGF1;EPHA7;ROCK2;EPHA3;FGFR2;FGFR4;FGFBP1;COL4A6;EFNB2;BDKRB2;KIT;ANGPT1;POLR2D;SDC2;SORBS1;FLRT2;PLCB1;PDGFRB;KL;FER;IGF2;EPHA8;MMP2;EPHA4;GRB10;GFRAL;BAIAP2;PDGFRA;DDR1;WASL;SULF1;PDGFD;IGF1R;FGF1;HNRNPH1;CLNK;FRS2;MMP9;DDR2;RYK;MTSS1;CSF1;POLR2A;ANGPT2;GTF2F1;MUSK;VEGFB
prerank,vascular process in circulatory system (GO:0003018),0.504347364751328,1.1825090855959173,0.2975708502024291,0.7644822961352075,1.0,4/13,10.63%,ROCK2;ACE;SCPEP1;NPR1
prerank,regulation of tube diameter (GO:0035296),0.504347364751328,1.1825090855959173,0.2975708502024291,0.7644822961352075,1.0,4/13,10.63%,ROCK2;ACE;SCPEP1;NPR1
prerank,chromatin remodeling (GO:0006338),0.33772827081535334,1.1813467359445058,0.18681318681318682,0.766641967036905,1.0,37/100,20.71%,SATB1;JARID2;RBBP4;BAZ1B;HNRNPC;ARID1B;CECR2;BAZ1A;CHD4;RSF1;KDM5B;KDM6B;SMARCA5;HDAC1;NPM2;TADA2A;SMARCE1;MYB;EZH1;INO80;SMARCB1;SRCAP;KDM5C;SMARCA2;SMARCC1;INO80C;KDM6A;SMARCD3;BAZ2B;MPND;SMARCA1;KDM4D;HDAC4;BRDT;KAT2B;RUVBL2;CBX3
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.30532961078481796,-1.1810035234768164,0.1827956989247312,0.6249735372058578,1.0,26/92,10.16%,TEK;FOXP1;NRP2;KDR;THBS1;RAC1;TGFB2;SCARB1;ETS1;DOCK1;PLCG2;PTK2B;BMPR2;IQSEC1;BCAR1;RHOB;CALR;EMC10;FLT4;VEGFA;MTOR;FGF7;GRN;EDN1;RTN4;PIK3CD
prerank,positive regulation of cholesterol transport (GO:0032376),-0.400140769617825,-1.180441387460222,0.24248927038626608,0.6256958893791309,1.0,13/27,30.27%,CAV1;PLTP;NFKBIA;PTCH1;LPCAT3;NR1H2;ABCA3;ZDHHC8;NR1H3;TREM2;GPS2;ABCA7;PPARG
prerank,neural tube closure (GO:0001843),0.40782519915674914,1.1802914021061586,0.25618374558303886,0.7685028889838079,1.0,9/34,11.24%,LMO4;PRICKLE1;KDM2B;MTHFR;LRP2;FOLR1;DVL3;COBL;IFT122
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.48808614457999616,-1.1795339537093263,0.25849056603773585,0.6272087053830689,1.0,4/12,16.27%,STX3;STX1A;SNAP25;STX2
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.42764391949550157,1.1791963510646306,0.25523809523809526,0.7690740286619048,1.0,9/29,11.52%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ
prerank,CENP-A containing chromatin organization (GO:0061641),0.42764391949550157,1.1791963510646306,0.25523809523809526,0.7690740286619048,1.0,9/29,11.52%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.36473407457610535,1.1783253520816221,0.215,0.7703034022898406,1.0,7/56,6.30%,BMP6;BMP7;DAB2;SMAD6;DKK1;RBPMS;TTK
prerank,heme biosynthetic process (GO:0006783),-0.41242322314266827,-1.1775885161073345,0.23975409836065573,0.6316555752117972,1.0,11/22,28.97%,ABCG2;ABCB10;ATP5IF1;UROD;UROS;FECH;FLVCR1;HMBS;COX15;TSPO;ABCB6
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4314990697852109,1.1774387851847354,0.2598870056497175,0.7717403480344323,1.0,7/28,10.77%,APPL2;PID1;GRB10;PRKCZ;PRKCB;TNS2;RPS6KB1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.44573707645439997,-1.1773391774595956,0.2682926829268293,0.631435984810556,1.0,9/16,19.74%,THBS1;PPP1R16B;GATA2;JCAD;PDCD10;VEGFA;APLNR;AGTR1;DLL4
prerank,positive regulation of gene expression (GO:0010628),0.28469242820848195,1.177085113641015,0.1130952380952381,0.7714540687403506,1.0,63/442,11.61%,IGF1;ROBO1;BMP6;SLC24A3;ROCK2;OSR1;SLC22A2;C1QTNF3;RBPJ;FGFR4;AFDN;WNT6;PID1;BMP7;ANGPT1;PRKN;RBMS3;PLA2R1;DKK1;SCX;NOS1AP;CTSH;DTNBP1;TFR2;PLD1;SRPK2;ITGAX;ANK2;MBIP;FOXD1;MAPK9;BAZ1B;TNRC6B;GJA1;TNRC6A;FGF1;SLC2A10;EPHX2;IL6;SMAD3;PRKAA1;CSF1;POLR2A;TLE1;MUSK;MITF;FUBP1;SAMD4A;MED1;AGO2;PRKDC;FGF9;SMARCA5;PIK3R1;TAF1A;RPS6KB1;METTL14;TFAP2A;POLR1F;FXR1;ERBB2;LARP6;POLR1A
prerank,collagen fibril organization (GO:0030199),0.3454524152650586,1.1769185628422718,0.2155887230514096,0.7706586675072048,1.0,11/88,4.43%,COL22A1;COL26A1;COL4A5;COL4A6;PXDN;LOXL1;COL9A2;SCX;LOXL3;COL1A2;COL13A1
prerank,long-term synaptic potentiation (GO:0060291),0.4546020137058064,1.176804553972509,0.2551984877126654,0.7697340905238649,1.0,4/21,6.89%,SLC8A3;TSHZ3;PRKCZ;ARC
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5276994515358726,1.1765519598175602,0.3096774193548387,0.7692120572030123,1.0,2/11,1.78%,IGF2BP1;NOVA1
prerank,mRNA transport (GO:0051028),-0.3012041365229939,-1.1764756607446476,0.15267175572519084,0.6329391133545935,1.0,46/101,35.96%,SRSF2;SRSF1;SRSF5;DDX39B;ZFP36L1;CPSF3;HHEX;SRSF9;RBM8A;RNPS1;SRSF6;NUP37;AGFG1;SYMPK;NXT1;CPSF2;NUP54;SMG5;NUP85;YTHDC1;THOC3;NUP133;MAGOH;FMR1;POM121;THOC6;EIF4E;DDX25;THOC2;NUP153;EIF4A3;SMG6;KIF5C;SRSF7;ALYREF;ZFP36;NUP42;CPSF1;ZC3H11A;NUP93;DHX38;U2AF1L4;CHTOP;NUP35;SRSF3;NCBP2
prerank,amyloid fibril formation (GO:1990000),-0.3479243631645795,-1.1763169217479574,0.20147420147420148,0.632492067429084,1.0,12/51,9.76%,B2M;ADAM10;ITM2B;CST3;GSN;UBB;TGFBI;RPS27A;UBC;APP;H3-3A;FURIN
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.43234393766575485,-1.1762275664903523,0.22355289421157684,0.6318608249119537,1.0,6/18,20.48%,ESR1;TGFB1;DDX5;ZC3H12A;MAP2K2;BMP4
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.40937949943278984,-1.1761566866469757,0.2515212981744422,0.6311784306437597,1.0,8/23,15.53%,MYO10;MAP6;CCDC88A;KIF1A;TUBA1B;TUBA1A;HOOK1;CCDC88C
prerank,negative regulation of cell junction assembly (GO:1901889),0.4362910169328483,1.1761200985109679,0.25089605734767023,0.7691705965426108,1.0,5/25,7.48%,ROCK2;ARHGAP6;ACE;PHLDB2;PTEN
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.38186031381229857,1.1761198165895035,0.2275132275132275,0.767882203583578,1.0,8/47,9.87%,ROCK2;WNT4;C1QTNF3;SIK1;ACADL;SIRPA;APOC1;SLC27A1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.38639181002502776,-1.175537982984383,0.24066390041493776,0.6321560681902694,1.0,17/28,25.95%,MAP3K5;DAB2IP;TMEM117;BAG6;ATP2A3;ATF4;SELENOK;ERO1A;BBC3;DNAJC10;TNFRSF10B;BRSK2;CEBPB;TRIB3;BAX;PPP1R15A;ERN1
prerank,nitrogen compound transport (GO:0071705),0.32039497195088423,1.1753771949132563,0.1913946587537092,0.7687267894132722,1.0,16/141,8.41%,SLC7A11;SLC22A4;SLC6A13;SLC22A2;SLC38A3;SLC6A12;SLC35F3;PDPN;TCN2;LRP2;NDC1;SLC43A1;ZG16;ABCC2;SLC1A5;MIA3
prerank,regulation of cellular response to heat (GO:1900034),-0.31629759001645874,-1.1753456206278232,0.15873015873015872,0.6318057047941446,1.0,22/77,21.48%,HSPA8;CD34;HSP90AA1;HSP90AB1;GSK3B;CHORDC1;BAG1;CRYAB;MTOR;RPA1;HSPB8;DNAJC7;NUP37;CAMK2B;DNAJB1;NUP54;NUP85;ATR;FKBP4;NUP133;POM121;MAPK3
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.39414738715605324,-1.1752001722129195,0.23044397463002114,0.6312997931822588,1.0,15/27,27.55%,FBXO7;MBOAT1;HOMER1;CCDC88A;GSK3B;EFHC2;MARK1;DISC1;NTNG1;PSEN1;AKT1;BRSK2;FCGR2B;TREM2;FRMD7
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.40508655596277665,-1.1749870718563877,0.23421588594704684,0.6310026556968823,1.0,8/25,20.80%,ITGA6;THBS1;APP;KCTD20;MIF;PSEN1;ANG;NCKAP1L
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.31961110228611694,-1.1748033196678143,0.17761557177615572,0.6306290693153255,1.0,19/75,14.62%,TEK;CLDN5;PTPRM;SEMA6A;THBS1;TGFB2;KLF4;DAB2IP;SEMA3E;STAB1;CTNNB1;SARS1;SERPINF1;HGS;HHEX;SYNJ2BP;COL4A2;ISM1;SPARC
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.36424951592547306,1.1747556799192016,0.23178807947019867,0.7692649672459818,1.0,13/59,14.14%,ROCK2;OXSR1;PDPK1;LRRK2;PRKCA;CDK1;CAMK2D;PRKDC;HIPK3;PRKD2;TBK1;MAPK1;NLK
prerank,visual system development (GO:0150063),0.39994042107094807,1.1746973659653908,0.24448529411764705,0.7681599068862738,1.0,7/37,8.53%,RBP4;MEIS1;SLC39A5;SMOC1;SH3PXD2B;PBX4;CHRDL1
prerank,fatty acid biosynthetic process (GO:0006633),-0.32088470734561997,-1.1744589419378169,0.18717948717948718,0.6306901773260217,1.0,17/63,21.85%,ABHD2;ELOVL7;ELOVL5;GPX4;ACACA;ELOVL6;PTGS2;XBP1;ABCD3;ALOX12;ELOVL1;TECRL;TECR;SCD5;ACLY;LIAS;SCD
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.45960551860036275,-1.1735914105199305,0.2625482625482625,0.6321782252240714,1.0,6/14,19.43%,CARD10;CARD14;COPS8;IRAK1;TNFRSF10B;TIRAP
prerank,positive regulation of neuron death (GO:1901216),0.3853432876947621,1.173571690495587,0.23636363636363636,0.7701966444970675,1.0,10/46,11.33%,EPHA7;EFNB2;DKK1;PCSK9;SRPK2;NUPR1;PICALM;TFAP2A;TFAP2B;EIF2S1
prerank,telomere capping (GO:0016233),0.48997332724235515,1.1731918699653114,0.27892561983471076,0.7700582545720102,1.0,9/16,21.85%,ACD;PRKDC;DCLRE1A;DCLRE1B;MRE11;STN1;RAD50;NBN;TERF2
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.3610269848844663,-1.1730064016672521,0.23148148148148148,0.6329265169774309,1.0,10/37,26.41%,ENTPD1;ENTPD7;ENTPD2;NUDT1;RNASE3;MTREX;SUPV3L1;NUDT16;RNASEH2C;HNRNPD
prerank,inositol lipid-mediated signaling (GO:0048017),0.37931536777683367,1.1729943865956083,0.24210526315789474,0.7694052588733075,1.0,14/50,16.07%,IGF1;ADAP2;PLCB1;PDGFRB;PDGFRA;IGF1R;GPR143;PIK3R1;RPS6KB1;PLCD1;GAB2;PLCL1;PLCE1;EXOC1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.3952188713025993,1.1729736696319149,0.24579124579124578,0.7681850660136167,1.0,5/41,3.29%,AFDN;BMP7;PLPP3;CXCL13;MEGF10
prerank,regulation of phosphatase activity (GO:0010921),-0.40644487530643164,-1.1724978537845772,0.23975409836065573,0.6334606560130801,1.0,8/24,13.76%,TIPRL;PPP1R2;HSP90B1;CHP1;BMP2;MTMR9;ZCCHC9;PPP6R1
prerank,mammary gland epithelium development (GO:0061180),0.49426411714393537,1.1722929631912498,0.28448275862068967,0.7688839706268745,1.0,4/14,11.11%,WNT4;LATS1;EPHA2;JAK2
prerank,COPII vesicle coating (GO:0048208),-0.32635580229574657,-1.1713925601056645,0.19900497512437812,0.6339109360481835,1.0,29/61,30.98%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;SEC23A;PPP6R1;TMED10;CNIH1;CTSZ;ANKRD28;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;CTSC;TRAPPC4;TRAPPC9;SEC16A;COL7A1;SEC31A;TRAPPC1;STX5;TRAPPC5;GRIA1;GORASP1;PEF1
prerank,vesicle coating (GO:0006901),-0.32635580229574657,-1.1713925601056645,0.19900497512437812,0.6339109360481835,1.0,29/61,30.98%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;SEC23A;PPP6R1;TMED10;CNIH1;CTSZ;ANKRD28;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;CTSC;TRAPPC4;TRAPPC9;SEC16A;COL7A1;SEC31A;TRAPPC1;STX5;TRAPPC5;GRIA1;GORASP1;PEF1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.32635580229574657,-1.1713925601056645,0.19900497512437812,0.6339109360481835,1.0,29/61,30.98%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;SEC23A;PPP6R1;TMED10;CNIH1;CTSZ;ANKRD28;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;CTSC;TRAPPC4;TRAPPC9;SEC16A;COL7A1;SEC31A;TRAPPC1;STX5;TRAPPC5;GRIA1;GORASP1;PEF1
prerank,lung epithelium development (GO:0060428),0.5312150822695965,1.1713416192320905,0.3006396588486141,0.7704511012686052,1.0,1/10,0.35%,ERRFI1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.44083380810220835,-1.1707171983437392,0.2698706099815157,0.6349268699455664,1.0,4/16,12.57%,MEF2C;MCTP1;KCNMB4;CPLX2
prerank,icosanoid secretion (GO:0032309),0.5004003146694286,1.170500693275237,0.2900763358778626,0.7716541574028196,1.0,3/12,5.24%,BDKRB2;ANXA1;ACE
prerank,apical junction assembly (GO:0043297),-0.3386562778186243,-1.1704307811710202,0.22556390977443608,0.6348669575941326,1.0,12/53,10.02%,PECAM1;CLDN5;ESAM;OCLN;CLDN11;RAMP2;F11R;WDR1;MPP7;RHOA;PAK2;APC
prerank,cellular calcium ion homeostasis (GO:0006874),-0.28554760482385944,-1.1701598143493037,0.1299093655589124,0.6347614787059424,1.0,45/133,20.29%,CAV1;TPT1;TRPC3;SLC35G1;CAV2;ATP1B1;SLC10A7;TRPC6;CALR;ATP2C1;ATP2A2;ATP2A3;TRPC4;RYR2;HTR2A;SLC24A2;ATP13A4;CCDC47;EDN1;SMDT1;SLC30A1;KCTD17;STIM2;RMDN3;STOML2;ATP2B1;GPER1;SELENOK;HERPUD1;MCUB;ATP13A5;SLC24A5;CXCL12;TRPC1;WFS1;ATP13A2;PLN;CD40;CCL13;NPTN;LETM1;TMEM165;PSEN1;ATP2B2;ATP2B4
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5011600894809125,-1.1699402910427437,0.265625,0.6345497292456868,1.0,5/10,24.76%,SHANK3;APP;CAMK2B;NPTN;SYP
prerank,RNA destabilization (GO:0050779),0.4655397728473124,1.1698205243356414,0.27485380116959063,0.7724253442461056,1.0,3/18,10.80%,ROCK2;YTHDF2;METTL14
prerank,cellular response to starvation (GO:0009267),0.31811975996743885,1.1694679507914338,0.18695652173913044,0.7722287125653738,1.0,32/147,13.96%,PRKAG2;NPRL3;PPARA;PRKAG3;FNIP1;SZT2;PCSK9;SIK1;CPEB4;SESN1;PRKAA2;NPRL2;MTMR3;LRRK2;SLC38A9;WIPI1;RNF152;PRKAA1;LAMP2;ATG14;PIK3R4;ATP6V0D1;ATP6V0E1;MLST8;FLCN;EIF2S1;PRKAG1;STK24;MAPK1;RRP8;STK26;NIM1K
prerank,regulation of interleukin-6 production (GO:0032675),-0.29873737079355345,-1.1694095155350157,0.16314199395770393,0.6350910479287215,1.0,45/96,33.97%,IL33;CD200;GAS6;PLCG2;MBP;LBP;ARRB1;APP;XBP1;STAT3;CD74;HSPD1;ARHGEF2;IRAK3;CD47;IFIH1;ZC3H12A;TIRAP;MYD88;TYROBP;NCKAP1L;TNFAIP3;HYAL2;AFAP1L2;AGER;RAB7B;SPHK2;TLR7;TREM2;FOXJ1;TLR4;LPL;C1QTNF4;IL16;TLR6;DHX9;MAVS;NOD2;PTPN22;TLR1;C5AR2;NOS2;IL1A;TSLP;SYK
prerank,pharyngeal system development (GO:0060037),-0.4626701304978127,-1.169329862705869,0.2661122661122661,0.6344528342870389,1.0,6/15,7.46%,BMP5;TGFB2;TBX1;BMPR2;HES1;PTCH1
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.30236751747704327,-1.168919811529324,0.16310160427807488,0.6346714106518904,1.0,23/87,10.85%,EFNA5;ESAM;RAC1;IQGAP1;CORO2B;F11R;PTK2B;ARHGDIB;SEMA3E;RHOB;ARHGDIA;FAM107A;CCDC88A;GPM6B;HIP1R;MTOR;ABI3;PAK1;ARHGEF19;EPS8;RHOA;ARHGEF5;CRK
prerank,pulmonary valve development (GO:0003177),-0.42720412355323845,-1.1687338575114319,0.262,0.6342853062153019,1.0,11/18,11.74%,SLIT2;NOS3;TGFB2;JAG1;NOTCH1;BMPR2;STRA6;NFATC1;TNFRSF1B;HEY2;HEYL
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5408341245217444,1.1686680887290188,0.2907949790794979,0.7720908038666522,1.0,3/10,19.26%,TULP1;CACNA2D4;GNAT1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5408341245217444,1.1686680887290188,0.2907949790794979,0.7720908038666522,1.0,3/10,19.26%,TULP1;CACNA2D4;GNAT1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3862341812582927,-1.1682139828489932,0.24416135881104034,0.6348255646613089,1.0,13/29,24.76%,SLC4A10;MCTP1;APP;ZDHHC2;CAMK2B;NCDN;GRIK2;DBN1;PPFIA3;NSMF;SHISA6;RAB3A;SYP
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3389793880961988,1.1681478658897457,0.20128824476650564,0.7723722822839619,1.0,24/95,14.11%,TGFBR3;PPARA;ZEB2;DAB2;PDPK1;SNX6;DKK3;SMAD6;ITGA3;SLC2A10;SMAD3;FOLR1;NREP;LEMD3;BCL9;LATS1;SMURF2;FLCN;HTRA4;LDLRAD4;VEPH1;ADAMTSL2;CDKN1C;CREBBP
prerank,protein modification by small protein conjugation (GO:0032446),0.28679206574465615,1.1681091318517158,0.13895781637717122,0.7712165645307808,1.0,57/361,12.61%,ASB2;PDZRN3;RNF220;EYA1;TRIM63;EPAS1;RNF43;PRKN;SPSB1;HIF3A;TRIM5;MGRN1;NEDD4;RNF213;ATG10;RNF138;UFL1;ZNRF3;NDC1;TRPC4AP;CAND1;UBE2L3;RNF181;UBR2;RNF152;KLHL7;CUL9;RNF135;WWP2;AMFR;PIAS1;BIRC6;CRBN;USP7;TRAF7;CUL7;FBXL17;MDM2;ITCH;UBA7;NUP107;SMURF2;TRIM35;PRKDC;NEUROD2;UBA3;DTX1;FBXO4;MYCBP2;CUL4B;RNF14;CDC73;TRIM26;TRIM43;RNF20;FBXO11;RCHY1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.32698150972343715,-1.1677605411934346,0.21158690176322417,0.6352239409249612,1.0,17/59,13.34%,HMCN1;PECAM1;BSG;PTPRM;CADM1;CDH1;ITGB1;CDH2;PKD1;KIRREL3;ROBO4;CEACAM1;PVR;CADM3;TENM3;CDH13;CNTN6
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3920838186477514,-1.1677215090258717,0.24752475247524752,0.6344737478794628,1.0,12/26,22.72%,SGIP1;FNBP1L;AP2A2;ITSN2;AP2M1;CANX;PIP5K1C;SNAP91;INPP5F;AP2B1;DLL1;AP2A1
prerank,myofibril assembly (GO:0030239),0.3954150342922858,1.1676559499506842,0.25220458553791886,0.7713709909683181,1.0,6/42,4.40%,TPM1;CSRP3;TNNT2;PDGFRB;OBSL1;PDGFRA
prerank,positive regulation of cell development (GO:0010720),-0.37637324856498705,-1.1676096904262994,0.25054945054945055,0.633930371754831,1.0,11/31,22.91%,PDE3A;TGM2;SERPINF1;GPER1;CX3CR1;SPEN;LIG4;TYROBP;BMP4;SOX11;FAIM
prerank,cellular response to purine-containing compound (GO:0071415),0.5416432047288723,1.167342615174847,0.30515463917525776,0.7710330747695492,1.0,2/10,3.07%,GSTM2;SLC8A1
prerank,dendritic spine organization (GO:0097061),-0.39137345274133956,-1.1669992982631805,0.24416135881104034,0.6346471536849828,1.0,8/26,13.07%,SHANK3;CTNND2;FYN;DOCK10;LGMN;ARF1;EPHB1;PICK1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.34880551471747046,1.166502043873587,0.22056384742951907,0.7722789892720229,1.0,10/86,6.30%,BMP6;RBPJ;BMP7;ZEB2;DAB2;RBPMS;FOXD1;SULF1;SLC2A10;TTK
prerank,relaxation of cardiac muscle (GO:0055119),0.5019928091402885,1.166147880729455,0.31,0.7721070303032223,1.0,3/13,3.07%,ATP1A2;GSTM2;SLC8A1
prerank,cellular response to cytokine stimulus (GO:0071345),0.2839387832252375,1.1660438689868504,0.12311557788944724,0.7711854247891798,1.0,35/416,5.50%,IL31RA;RORA;ADAMTS12;LEPR;OXSR1;PTPN13;IL34;PID1;IL18;KIT;DAPK1;BCL2;ZEB1;DUOX2;PTPN4;DPYSL3;IL1RAPL1;FER;CNTFR;ANXA1;RIPOR2;MMP2;STAT5B;IRAK2;ITGAX;CRHBP;GRB10;NFAT5;IL13RA1;COL1A2;ZFAND6;CACTIN;NPR2;IRF8;PTPN9
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.5048640165716248,-1.166013037449978,0.28383458646616544,0.6365108830450348,1.0,4/10,22.56%,APC;RCC2;KNSTRN;SPAG5
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.31434824249119997,-1.1656515459030898,0.2109375,0.6366328631837043,1.0,18/74,12.39%,LEF1;TIAM1;BMP5;TGFB2;PHLDB1;DAB2IP;IL17RD;TGFBR2;TGFB1;FERMT2;CTNNB1;SPRED2;MTOR;WWTR1;BMP2;GCNT2;MCRIP1;SDHAF2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.44649977339285585,-1.1640523931477915,0.29236499068901306,0.6401514590171589,1.0,7/15,14.72%,KCNJ2;ATP1A1;ATP1B1;KCNQ1;KCNN2;KCNJ8;KCNIP2
prerank,regulation of apoptotic process (GO:0042981),-0.23814914573976223,-1.163921792663156,0.006944444444444444,0.6396833948148952,1.0,147/676,15.54%,LEF1;MEF2C;UNC13B;TEK;SLIT2;HIP1;MAP3K5;ACTN4;MCF2L;PTMA;ITGA6;TIAM1;ACER2;RASSF2;TFRC;KDR;TRIO;THBS1;ADAM10;TPT1;HSP90AA1;ARHGEF3;GAS6;RNF144B;CBL;HNRNPK;PTK2;ITGB1;TARDBP;PPP1R13B;KCNMA1;SLK;PTK2B;DAB2IP;NGF;RASGRF2;UBB;NFKBIA;RPS3;RACK1;DNAJA1;PPIA;CTSD;SEMA4D;ARHGEF12;NET1;TNFSF10;PREX1;ATG7;SFRP4;TGM2;FLNA;ACTN1;SOCS2;RPS6;HSPB1;BCAR1;ARHGEF17;IKBKB;SOX4;ARHGEF6;RHOB;PERP;ARHGDIA;CD38;CALR;CD44;CTSB;PLK2;CTNNB1;HSP90B1;SOD1;FAF1;ABR;BCL2L1;LGALS1;RPS27A;UBC;GSK3B;TBX3;LRP8;WNK3;EGLN3;SIGMAR1;SERPINB9;APBB1;HIP1R;DNM2;RNF157;FLT4;PDCD10;BAG1;CARD14;VEGFA;TJP1;CRYAB;BIRC3;JUN;FOXO1;ARHGEF19;MAGED1;DDX20;ARHGEF26;ZBTB7A;MAPK8;ING4;RTN4;PAK2;BNIP2;HYPK;APC;XBP1;HSPA5;ARHGEF5;BCL3;ATF4;BMP2;RSL1D1;RPS6KA1;BIN1;GPER1;RYBP;EGLN2;REST;CD74;HSPD1;ARHGEF2;CLU;BNIP1;HIGD2A;RNPS1;GADD45G;NLRP2B;MT3;IAPP;DSTYK;NR1H4;PLEKHN1;NF1;CIAPIN1;FAS;CYP1B1;CASP8;UBA52;MADD;SIX4;FLT3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5159147492823376,1.1634806692487971,0.29354207436399216,0.7774483853250623,1.0,2/12,7.99%,RBP4;MUC13
prerank,response to retinoic acid (GO:0032526),0.36978369967961866,1.1634395196413603,0.24917491749174916,0.7763193088236113,1.0,5/59,3.31%,PTK7;EPHA3;WNT6;RBP4;CTSH
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.5004433587037818,-1.1627595328282114,0.275390625,0.6419202975411161,1.0,5/10,30.15%,HSPA5;ATF4;HERPUD1;CCL2;NFE2L2
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.34471270861984304,-1.1623962873966294,0.21038961038961038,0.6420373876103938,1.0,14/46,10.97%,TEK;FN1;TMEFF2;PARVB;RAC1;PXN;LAMA5;LAMB2;FERMT2;ITGA4;SRCIN1;PEAK1;RHOA;ITGA8
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.2930857226646699,-1.1622490067553892,0.17174515235457063,0.6415537832729724,1.0,36/109,23.57%,RAC1;CALM1;PLCG2;IKBKB;NFATC2;NFATC1;JUN;PAK1;PSMD13;PSMF1;MAPK8;PAK2;MAP3K1;PSMB10;CHUK;MAP2K7;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PPP3CA;CUL1;TAB3;PSME1;PSMB3;PPP3R1;NFATC3;PSMD5;SKP1;MAPK3;PSMD9;PSMB4;RELA;MAPK10
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.33634422591701063,-1.1622230554916655,0.19248826291079812,0.639933700763223,1.0,19/51,26.70%,REEP3;CHMP2B;LEMD2;LBR;RANGAP1;LMNA;NUP37;VRK1;PPP2R2A;CC2D1B;NUP85;NUP133;POM121;CHMP3;CCNB2;CHMP7;BANF1;CHMP4C;UBE2I
prerank,mitotic nuclear membrane organization (GO:0101024),-0.33634422591701063,-1.1622230554916655,0.19248826291079812,0.639933700763223,1.0,19/51,26.70%,REEP3;CHMP2B;LEMD2;LBR;RANGAP1;LMNA;NUP37;VRK1;PPP2R2A;CC2D1B;NUP85;NUP133;POM121;CHMP3;CCNB2;CHMP7;BANF1;CHMP4C;UBE2I
prerank,cellular metal ion homeostasis (GO:0006875),0.33979745251168186,1.162033981966339,0.2222222222222222,0.7792804819511128,1.0,10/102,3.96%,ATP1A2;SLC24A3;SLC8A3;STIM1;CSRP3;SLC41A1;ATP1B3;SLC8A1;DMPK;ANK2
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.3937541671291701,1.1619815859421352,0.26523297491039427,0.7781738004837754,1.0,6/39,7.95%,TCF7L2;RBP4;NLGN2;TFR2;MCU;SLC30A8
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.2990599353144226,-1.161975983799139,0.181360201511335,0.639825778543204,1.0,42/96,35.96%,SRSF2;SRSF1;SRSF5;DDX39B;CPSF3;HHEX;SRSF9;RBM8A;RNPS1;SRSF6;NUP37;AGFG1;SYMPK;NXT1;CPSF2;NUP54;SMG5;NUP85;YTHDC1;THOC3;NUP133;MAGOH;POM121;THOC6;EIF4E;DDX25;THOC2;NUP153;EIF4A3;SMG6;SRSF7;ALYREF;NUP42;CPSF1;ZC3H11A;NUP93;DHX38;U2AF1L4;CHTOP;NUP35;SRSF3;NCBP2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5316082099701148,1.1618102420804048,0.2839248434237996,0.7774203651283375,1.0,5/10,12.45%,GRB10;PRKCB;VTN;ARNT;PRKD2
prerank,bicellular tight junction assembly (GO:0070830),-0.34298820057126056,-1.1618002537324368,0.23113207547169812,0.6394573319381991,1.0,10/46,10.02%,PECAM1;CLDN5;ESAM;OCLN;CLDN11;RAMP2;F11R;MPP7;PAK2;APC
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5149816403963323,1.1616225198107073,0.29831932773109243,0.7767400368399836,1.0,4/11,12.36%,IL34;PRKCA;CSF1;HSF1
prerank,negative regulation of heart contraction (GO:0045822),0.5207562477881653,1.1616213269144806,0.30165289256198347,0.7755001335607391,1.0,1/11,0.21%,ATP1A2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.2753127864324163,-1.161546207995909,0.13157894736842105,0.6393399671453296,1.0,68/173,31.37%,SPTBN1;NSF;GAS6;CD55;MIA2;CAPZA2;ACTR10;DYNLL2;TMED5;VTI1B;COPG1;GOPC;CUL3;TMED2;BET1L;MCFD2;LMAN2;DCTN3;RAB1A;TRAPPC6B;WHAMM;SPTBN4;ARFGAP2;LMAN2L;SEC23A;TMED10;TMED3;CNIH1;DCTN4;CTSZ;ATL2;BCAP31;TRIP11;GBF1;TEX261;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;ANK3;CTSC;DCTN1;VAPA;TRAPPC4;TMEM115;TMED7;CAPZA1;RAB2A;SEC16A;COL7A1;USE1;KDELR3;SEC31A;COPA;TRAPPC1;ATL3;STX5;TRAPPC5;MPPE1;RANGRF;GRIA1;GORASP1;TMED1;SPTBN5;BCAP29;PEF1;DYNC1I1
prerank,microtubule nucleation (GO:0007020),0.4379954278607324,1.1614451677607827,0.2731006160164271,0.7747919702628863,1.0,9/20,20.29%,CCDC57;TUBGCP6;GOLGA2;TUBGCP2;RANBP9;TUBG1;AKAP9;TPX2;CENPJ
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.33762543304877124,1.161347919349506,0.21207177814029363,0.7738678249727957,1.0,9/86,7.87%,IGF1;EPHA7;BMP6;ANGPT1;IGF2;PRKCZ;IL6;ENPP2;VTN
prerank,negative regulation of translation (GO:0017148),0.33783268011405204,1.1613253298034818,0.23567921440261866,0.7726957587444261,1.0,25/87,19.32%,ROCK2;IGF2BP1;DAPK1;CPEB2;EIF4EBP1;CPEB4;TYMS;YTHDF2;SAMD4A;AGO2;METTL14;UNK;FXR1;SHMT1;CNOT8;CNOT7;LARP1;TSC1;ENC1;CNOT10;GIGYF2;DDX3X;RBM4;DHFR;LSM14A
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.49017221817098444,1.1612101487547977,0.3091286307053942,0.7718065091224132,1.0,3/13,11.22%,LARGE1;CHST3;RENBP
prerank,intracellular protein transmembrane transport (GO:0065002),-0.35419562407726896,-1.1610876410484563,0.21957040572792363,0.6397313305253686,1.0,19/42,29.88%,TOMM20;C2CD5;HSPA5;HSPD1;SEC62;ROMO1;SEC61G;ZFAND2B;PEX1;PEX5;PEX10;TIMM50;PEX16;SEC63;TIMM44;RTN2;CHCHD4;DNLZ;SEC61B
prerank,negative regulation of cytokine production (GO:0001818),-0.27258482625832614,-1.161086591725887,0.15771812080536912,0.6388891949144716,1.0,56/163,24.17%,LEF1;FN1;TMSB4X;APOD;CD200;CD34;THBS1;RPS6KA5;RAC1;GAS6;KLF4;TRIB2;TRIM25;PTPRC;SARS1;TNFRSF21;ARRB1;CEACAM1;RNF125;PDCD4;ADCY7;NAV3;SRGN;NLRC5;BCL3;ISG15;ATP2B1;IRAK3;ABCD2;ASB1;NR1H4;CMKLR1;IFIH1;LAPTM5;RPS6KA4;SIGIRR;CD274;N4BP1;ZC3H12A;NPTN;GPATCH3;INHA;JAK3;TRIM27;TYROBP;NCKAP1L;SLC11A1;HDAC7;HDAC9;OTUD7B;TNFAIP3;DLL1;FCGR2B;AGER;RGCC;VSIR
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.47941326901209574,1.1610419678903305,0.30528375733855184,0.7710358281280018,1.0,5/15,7.50%,FGFR4;PDPN;DDR1;IL6;DDR2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.393837531440487,-1.1609809577958958,0.25862068965517243,0.6383308265199514,1.0,11/24,15.90%,RACK1;CREB3L1;UBXN1;BCL2L1;AQP11;XBP1;LPCAT3;CLU;HERPUD1;NR1H2;WFS1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3144547027892483,1.160951713180197,0.20575539568345325,0.7700849730828877,1.0,12/142,4.52%,ATP1A2;ADCY5;BDKRB2;ACKR2;CCR9;LPAR1;CXCR5;SLC8A1;CXCL13;CXCR6;PDGFRA;LPAR2
prerank,sphingosine metabolic process (GO:0006670),-0.4421092286511776,-1.160361305876932,0.25697211155378485,0.6392534066862454,1.0,4/17,1.89%,ACER3;ACER2;SPTLC2;PLPP1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.4770162069912923,-1.1598589620647872,0.2841121495327103,0.6397457367302468,1.0,3/12,18.75%,ANO1;CFTR;TRPM4
prerank,cellular response to amino acid stimulus (GO:0071230),-0.3711179283074999,-1.1594439030122679,0.22477064220183487,0.6399930437447796,1.0,17/33,27.04%,SESN3;FYN;SH3BP4;CAPN2;MTOR;SESN2;CPEB1;XBP1;LAMTOR1;SPAAR;LAMTOR2;RRAGB;NSMF;LAMTOR4;CASTOR1;GLRA1;RPTOR
prerank,regulation of gastrulation (GO:0010470),0.49857317529183554,1.1592578068486814,0.30620985010706636,0.7738961682990975,1.0,3/14,6.08%,OSR1;SCX;PHLDB2
prerank,regulation of necroptotic process (GO:0060544),-0.40172965618122064,-1.1591183001738794,0.25510204081632654,0.6400417483358438,1.0,10/23,23.77%,HSP90AA1;YBX3;CDC37;BIRC3;OGT;ARHGEF2;CASP8;SLC25A4;PELI1;PDCD6IP
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.38382558702121117,1.1589688110893805,0.26287744227353466,0.773482807275445,1.0,6/39,3.79%,OSR1;WNK4;DMD;GPD1L;NEDD4;PCSK9
prerank,TOR signaling (GO:0031929),0.4228765386688438,1.1588291808634947,0.28489483747609945,0.7726646466246626,1.0,8/26,10.86%,NPRL3;FNIP1;EIF4EBP1;RICTOR;SYAP1;MLST8;RPS6KB1;FLCN
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.4490275660900751,1.1588189966450744,0.283203125,0.7714691175037445,1.0,2/21,2.68%,OSBPL8;PLA2G10
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.37361266506640817,-1.1586636593880533,0.25164113785557984,0.6404403166535692,1.0,19/33,35.68%,HIP1;BCAR3;CBL;CCDC88A;HIP1R;SHKBP1;GPER1;PDE6H;PLAUR;AKT1;AFAP1L2;ARAP1;HAP1;BTC;EGF;AGT;NCF1;ADAM17;CNOT9
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.44577319345795197,1.1585006167865406,0.2845849802371542,0.7712115630231958,1.0,7/21,17.82%,PPARA;PRKN;TFAP2A;SLC30A10;PLIN5;ABCB7;TRAP1
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.36092028111530905,-1.158196127606405,0.22270742358078602,0.6409387528829421,1.0,8/36,5.38%,MEF2C;SLIT2;PTPRM;THBS1;ACVRL1;DAB2IP;NOTCH1;TGFB1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.31777686732551796,1.1581218411971093,0.19939577039274925,0.7710975559809962,1.0,21/140,11.34%,ADCY5;JPH1;BDKRB2;ACKR2;CCR9;LPAR1;CXCR5;SLC8A1;CXCL13;CXCR6;PDGFRA;LPAR2;ADRA1D;CACNA2D1;F2RL2;PTGIR;GLP1R;ABL1;PTGER1;F2RL3;DLG4
prerank,regulation of neuron projection arborization (GO:0150011),0.4693811633163556,1.1578778176749174,0.314,0.7706113917113219,1.0,7/15,15.33%,GRIP1;MACF1;NTNG2;DVL3;DLG4;MYO9A;MOV10
prerank,ceramide transport (GO:0035627),-0.47524445559212264,-1.1577877225020325,0.27184466019417475,0.6412153398447026,1.0,3/12,3.46%,CERT1;PLTP;PSAP
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.45717824625502523,-1.1577549442602173,0.24319066147859922,0.6404424253118501,1.0,6/13,18.61%,ELOVL7;ELOVL5;ELOVL6;ELOVL1;TECRL;TECR
prerank,negative regulation of neuron death (GO:1901215),-0.2952929221332975,-1.1573822638642617,0.19948186528497408,0.6406737785330161,1.0,30/93,19.13%,MEF2C;CD200;CD34;FBXO7;PPARGC1A;PTK2B;NGF;LGMN;SOD1;GSK3B;FOXQ1;SIX1;TNFRSF1B;GRN;SET;EIF4G1;ATF4;MSH2;REST;CHGA;MT3;NENF;SIX4;WFS1;ATP13A2;PRKCG;CDK5;TYRO3;LIG4;PINK1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.2866297306291618,-1.157284019687487,0.17579250720461095,0.6401276312101335,1.0,28/112,9.82%,MEF2C;CLDN5;ID1;PDE3A;ACVRL1;TGFB2;CBL;PTK2;ITGB1;F11R;ENG;UBB;LIMS1;PXN;TGFBR2;TGFB1;FERMT2;RPS27A;UBC;CLEC3B;PDE2A;SMAD9;SMAD5;JUN;RHOA;APPL1;FURIN;ZFP36L1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.426477402268891,-1.157092334949977,0.2606060606060606,0.6398284567996018,1.0,8/18,19.57%,ELOVL7;ELOVL5;ACSL4;ELOVL6;ELOVL1;ACSL3;TECR;ACSL5
prerank,positive regulation of viral life cycle (GO:1903902),-0.4120661053793673,-1.1569705222028623,0.2729124236252546,0.6393559290958748,1.0,7/22,22.28%,CHMP2B;LGALS1;DDB1;CD74;TYRO3;FMR1;CHMP3
prerank,epiboly involved in wound healing (GO:0090505),-0.44366421946230833,-1.1569046354996597,0.266260162601626,0.6387034766037373,1.0,7/16,13.58%,TMEFF2;FLNA;CD44;CEACAM1;PDCD10;RHOA;CCN1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.4236329297496007,1.1567811177840284,0.27703984819734345,0.7724640013916119,1.0,5/27,6.24%,FGFR4;SMOC2;PDGFRB;NIBAN2;PARP4
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.5047987101618526,-1.156337763849978,0.3045186640471513,0.639458069038484,1.0,6/10,28.81%,RPUSD4;TSR3;RPUSD1;NHP2;RPUSD2;NOP10
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.46378092104266955,-1.1561760704600046,0.2965779467680608,0.6390687998302428,1.0,7/13,29.16%,HNRNPU;LARP7;NELFCD;NELFE;RNF168;EAPP;RNF8
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.44663222595625107,1.1561547701107149,0.28160919540229884,0.7730968993616141,1.0,4/20,3.68%,ATP1A2;ATP1B3;SLC8A1;LACC1
prerank,regulation of insulin secretion (GO:0050796),0.33052610736383736,1.1559511646681166,0.2220447284345048,0.7725242207181575,1.0,14/101,7.95%,ADCY5;TCF7L2;ITPR1;STXBP4;RBP4;PRKN;KCNA5;NLGN2;CACNA1D;IL6;PRKCA;RAPGEF4;MCU;SLC30A8
prerank,regulation of autophagosome assembly (GO:2000785),0.4002507212721038,1.1557235222740003,0.26788990825688075,0.7719491193742627,1.0,8/33,13.27%,NPRL3;NPRL2;MTMR3;LRRK2;NUPR1;TMEM39A;FEZ1;RAB3GAP1
prerank,response to UV-B (GO:0010224),-0.47568580664844934,-1.1556440848956846,0.2732673267326733,0.6397285808353521,1.0,6/12,23.41%,CRIP1;MFAP4;MSH2;CDKN1A;HYAL2;RELA
prerank,cell-matrix adhesion (GO:0007160),0.333422741296317,1.1553788766910127,0.24100156494522693,0.7717454247611628,1.0,11/95,5.54%,ADAMTS12;NID2;ADAMTS9;FBLN5;RHOD;SORBS1;FERMT1;COL13A1;DDR1;SGCE;ITGA3
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4694353423329434,1.1549194115695318,0.2968127490039841,0.7719211919804108,1.0,4/18,8.85%,ATP1A2;SLC43A1;MMP9;CAMK2D
prerank,negative regulation of cell aging (GO:0090344),-0.4400710360085916,-1.1542941088117757,0.25889328063241107,0.6424786015241851,1.0,4/16,16.76%,YBX1;CDK6;MAP3K3;MIF
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.4112623290971935,-1.1540620932675214,0.22661122661122662,0.6422986051848241,1.0,7/21,14.55%,CSGALNACT1;CSPG4;BGN;CHST9;CHST11;VCAN;CHSY3
prerank,positive regulation of histone modification (GO:0031058),-0.36144430998887644,-1.1539125402361825,0.2613390928725702,0.6418717338237283,1.0,11/33,21.48%,RPS6KA5;PPARGC1A;ARRB1;GLYR1;NOS1;APLNR;AKAP8;RPS6KA4;CTBP1;FMR1;MAPK3
prerank,regulation of cell cycle (GO:0051726),-0.2594218783408771,-1.153762698732487,0.1037344398340249,0.6414344704965873,1.0,89/271,26.22%,MECOM;APBB2;NEK7;THBS1;ADAM10;TGFB2;FAP;IQGAP1;RPL23;HSP90AB1;TARDBP;TTC28;PPP1R13B;ADARB1;DAB2IP;NOTCH1;RACK1;FBXL3;PKD1;CDK11B;RHOB;TGFB1;CALR;PTPRC;TBX3;PLAGL1;LIN54;APBB1;HNRNPU;PDCD4;BIRC3;JUN;NR4A1;ING4;APC;CDK6;CDKN1B;STAT3;BMP2;MEN1;JUNB;BIN1;GPER1;WHAMM;MYBBP1A;TMEM8B;GADD45G;MASTL;NLRP2B;MADD;GBF1;DUSP1;MIF;CTBP1;ZBTB17;SOX2;ID2;GAS2L1;CDK5;CAMK2N1;INHA;NOP53;TFAP4;CHMP1A;L3MBTL1;BMP4;MYBL2;METTL3;GADD45A;UHMK1;CDKN1A;CDKN2D;MFN2;CCNB2;GMNC;UHRF2;SIPA1;AFAP1L2;GADD45B;RGCC;PPP1R15A;CHEK1;DTL;HRAS;NUPR2;CDKN3;HBP1;ERN1;CDC14A
prerank,response to cytokine (GO:0034097),0.31292604118797307,1.153421653760735,0.20913107511045656,0.775041397308117,1.0,17/141,7.89%,ALDH1A2;PTPN13;PID1;TIMP3;BCL2;PTPN4;DPYSL3;SP100;IL1RAPL1;ANXA1;IRAK2;NFAT5;SPHK1;PTPN9;SMAD3;PRKCA;TRIM56
prerank,protein O-linked glycosylation (GO:0006493),0.33804433268303463,1.1532599556530228,0.2269170579029734,0.7742806161229262,1.0,11/96,6.04%,TMTC4;ST3GAL3;GALNT15;GALNT14;GALNT18;LARGE1;GXYLT2;TMTC1;B3GNT5;CRPPA;TET1
prerank,response to histamine (GO:0034776),-0.501643707464313,-1.1530087087436969,0.294921875,0.6426635771918835,1.0,6/10,36.68%,GABRB3;GABRB1;HRH1;GABRG2;DRD3;GABRB2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.29746156078287866,-1.152830553625056,0.1827956989247312,0.6423123688334307,1.0,23/87,10.85%,CLDN5;ID1;ACVRL1;TGFB2;CBL;PTK2;ITGB1;F11R;ENG;UBB;PXN;TGFBR2;TGFB1;FERMT2;RPS27A;UBC;SMAD9;SMAD5;JUN;RHOA;APPL1;FURIN;GCNT2
prerank,phagolysosome assembly (GO:0001845),-0.48247229128620395,-1.1526897270781467,0.3047034764826176,0.6418676370501343,1.0,8/12,31.45%,SYT7;RAB39A;RAB7A;RAB7B;RAB14;RAB20;PLA2G5;CORO1A
prerank,RNA metabolic process (GO:0016070),0.32133362004380195,1.1524722324897028,0.21565731166912852,0.7753310224420856,1.0,21/127,11.94%,CELF2;POLR2D;ATXN1;RBMS1;NOVA1;RNASEL;ADAD1;RBPMS;HNRNPC;HNRNPH1;RBMS2;RBM5;POLR2A;GTF2F1;NOL9;TENT2;SND1;AGO2;METTL14;PCBP2;RBM39
prerank,carboxylic acid metabolic process (GO:0019752),-0.36275794522762905,-1.152397634752304,0.24565217391304348,0.6418226832178842,1.0,12/33,22.48%,CSGALNACT1;ST6GAL1;SLC2A1;PTGIS;SIRT4;PLA2G4A;CYB5R3;MIF;ST3GAL1;GSTO2;LIAS;SLC2A3
prerank,triglyceride biosynthetic process (GO:0019432),0.460022323527607,1.1516300285930605,0.30210325047801145,0.7766727109255309,1.0,2/18,1.78%,AGMO;LPGAT1
prerank,regulation of dopamine secretion (GO:0014059),0.42939498897924117,1.1516129742444543,0.28413284132841327,0.775516215324763,1.0,9/25,18.24%,PRKN;DTNBP1;SYT11;SYT12;GDNF;FGF20;CHRNB2;DRD2;SNCA
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.4635102334704459,-1.1514142339856275,0.2803921568627451,0.6437157024718536,1.0,7/13,37.59%,GLRX5;GLRX3;ISCA2;ISCA1;CIAO2B;BOLA2;YAE1
prerank,regulation of cell population proliferation (GO:0042127),-0.23444353264621584,-1.1512384100566266,0.01935483870967742,0.643392022305211,1.0,131/691,12.79%,LEF1;KITLG;ZBTB7C;NTRK3;FN1;PTPRJ;FTH1;CLDN5;NOS3;ACER3;TIAM1;IGFBP6;ACER2;LIFR;CD200;TFRC;KRAS;KDR;THBS1;ADAM10;BMP5;PLPP1;ACVRL1;TGFB2;NAMPT;RUNX1;STX3;PTPN14;JAG1;CBFA2T3;TES;RPL23;KLF4;RPS9;PPP2R5C;PTK2;ETS1;ADARB1;TBC1D8;WNT9A;ROR2;ENG;PTK2B;DAB2IP;NGF;NOTCH1;SH3BP4;TBX1;P3H2;BMPR2;HES1;SFRP4;LIMS1;LGMN;RPS6;RERG;RBFOX2;TGFBR2;WARS1;PINX1;TBX2;SOX4;TGFB1;CALR;TSPAN31;KDM4C;CTNNB1;JAG2;LRP5;CCDC88A;ST18;TOB1;GNL3;TNFRSF11A;TBX3;EGLN3;SIX1;ATP8A2;DDAH1;CUL3;PDGFC;APP;FLT4;PDCD10;ADRA1A;VEGFA;TJP1;JUN;ECRG4;EMP2;PTHLH;PAK1;AQP11;ELN;CNOT6L;FGF7;RHOA;PODN;EDN1;ING4;ESM1;ZFP36L1;DPP4;APC;CDK6;WWTR1;XBP1;SOX7;CDKN1B;RTKN2;NCK2;BTG3;STAT3;BMP2;GCNT2;HGS;HHEX;IFI35;MEN1;ACE2;JUNB;PBRM1;GPER1;RPS4X;TCIRG1;GLI1;REST;CDH13;ARHGEF2;CLU;LMNA
prerank,cellular response to metal ion (GO:0071248),-0.2863247467321134,-1.1511934447528287,0.17378048780487804,0.6426962468358051,1.0,29/123,10.93%,MEF2C;SLC12A2;B2M;DLG2;CLIC4;IQGAP1;CDH1;PLCG2;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;LGMN;CPNE8;MT2A;JUN;ADCY7;CPNE2;CPNE3;MAPK8;CDKN1B;CHUK;CACNA1H;KCNA1;SYT10
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4228519352270484,1.15083471909513,0.27756653992395436,0.7765377128490654,1.0,10/29,11.95%,TCF7L2;PYGO1;ASH2L;TLE3;TCF7L1;TLE1;AXIN2;BCL9;HDAC1;CDC73
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4041486347348278,1.1504366842817593,0.26862745098039215,0.7765120107490784,1.0,10/37,11.76%,IGF1;TPM1;MMP2;GJA1;TAFA5;MMP9;PTEN;FGF9;APLN;BMPR1A
prerank,actin nucleation (GO:0045010),-0.41131620605171865,-1.1502149996236724,0.2778904665314402,0.6444600978618801,1.0,10/21,21.78%,ARPC1B;ARPC3;WHAMM;ACTR2;SPIRE1;ARPC4;ARPC5L;ARPC1A;TRIM27;ACTR3
prerank,regulation of macrophage differentiation (GO:0045649),0.47042637773291257,1.150191398968577,0.2766393442622951,0.7760127930511681,1.0,4/15,12.36%,IL34;PRKCA;CSF1;HSF1
prerank,nucleosome assembly (GO:0006334),0.4044666961297414,1.1498728101457694,0.28051001821493626,0.7757715290369215,1.0,8/31,16.50%,RBBP4;NASP;RSF1;KAT6B;SMARCA5;NAP1L3;NAA60;NAP1L1
prerank,transition metal ion transport (GO:0000041),-0.35728873981245135,-1.1493404526054052,0.24503311258278146,0.6460391592533927,1.0,12/35,9.66%,FTH1;TFRC;TRPC3;ATOX1;IREB2;SLC30A5;TRPC6;ATP2C1;SLC31A1;SLC39A8;TRPC4;SLC30A1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.4953962773831489,-1.149133093417356,0.2770137524557957,0.645833280524684,1.0,6/10,19.75%,EMC10;EMC7;EMC1;EMC3;EMC6;EMC9
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4945598254193737,1.1489960858149502,0.3002028397565923,0.7772254981552452,1.0,3/13,11.05%,PDPK1;IGF2;APLN
prerank,cellular response to fatty acid (GO:0071398),0.49818205052713005,1.1489858827716162,0.3054989816700611,0.7760691315327707,1.0,1/12,1.17%,PID1
prerank,negative regulation of translational initiation (GO:0045947),0.49123550294646134,1.1489204717068637,0.30062630480167013,0.775060384296175,1.0,6/13,22.86%,EIF4EBP1;AGO2;LARP1;RBM4;TPR;PAIP2B
prerank,cardiocyte differentiation (GO:0035051),0.513899326979634,1.148671642032411,0.3142857142857143,0.7745959502081899,1.0,4/10,8.94%,CBY1;AKAP13;SIK1;KDM6B
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3846192728558243,1.1483887440821834,0.27106227106227104,0.7742656384649139,1.0,9/43,10.77%,PID1;SORBS1;IGF2;GRB10;PRKCZ;PRKCB;GKAP1;TNS2;RPS6KB1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.48010202905188787,-1.1481677628389284,0.30223880597014924,0.6475822005033808,1.0,4/11,11.93%,MEF2C;TGFB2;TGFB1;GPER1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.4500080338675062,-1.1481506401669948,0.2897959183673469,0.6468063210504442,1.0,8/15,29.88%,HSP90B1;DERL1;HERPUD1;AUP1;TMEM129;VCP;SYVN1;SEC61B
prerank,macroautophagy (GO:0016236),0.32233499847237357,1.1477469270979426,0.2225609756097561,0.7749240016637544,1.0,24/118,15.63%,PRKAG2;PRKN;PRKAG3;ATG10;PRKAA2;MTMR3;WIPI1;PRKAA1;LAMP2;ATG14;VTA1;PIK3R4;UVRAG;STAM2;FUNDC1;CHMP6;VPS37A;VPS37C;PRKAG1;STX17;TMEM74;VPS39;AMBRA1;ATG3
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.3887675057007628,-1.1476707986776473,0.27956989247311825,0.6473107719716628,1.0,8/24,16.76%,TPT1;ACKR3;CD44;BCL2L1;CD74;CLU;CXCL12;MIF
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4084021830280871,-1.1473684579218222,0.27385892116182575,0.6473328735729812,1.0,6/20,11.93%,THBS1;GSN;SFRP4;ITGA4;PDCD4;GPER1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3952123446346396,1.1471361294929412,0.29174311926605506,0.7754807974182103,1.0,4/33,3.48%,STXBP4;PLCB1;UBE2E2;ANXA1
prerank,cellular response to nitrogen compound (GO:1901699),0.44533294893115494,1.1469892916330426,0.3026315789473684,0.7747366158058906,1.0,3/20,12.36%,ROCK2;BLM;HSF1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.32760308004728983,-1.1463098140187176,0.21889400921658986,0.6494162855805435,1.0,19/55,23.00%,FHL1;PINX1;PSMD13;PSMF1;RBX1;PSMB10;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;PSMB3;PSMD5;SKP1;PSMD9;PSMB4
prerank,calcium ion transport (GO:0006816),0.32798000876944167,1.1462383626835213,0.22706065318818042,0.7756904586684878,1.0,10/113,4.91%,TRPM3;SLC24A3;ITPR1;SLC8A3;STIM1;NALCN;SLC8A1;ANK2;CACNA1D;CACNG7
prerank,glucose transmembrane transport (GO:1904659),-0.4210071932075182,-1.1460873197623254,0.2837022132796781,0.6492048948530549,1.0,2/18,3.07%,SLC2A1;PPARD
prerank,aortic valve development (GO:0003176),-0.35719574556844846,-1.1459191981983625,0.26157407407407407,0.6488338140829282,1.0,13/34,11.74%,SLIT2;NOS3;TIE1;JAG1;NOTCH1;BMPR2;TGFB1;NFATC1;TNFRSF1B;ELN;HEY2;BMP2;HEYL
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.3730548736824415,-1.1456623816803027,0.2696629213483146,0.648738788743735,1.0,10/29,21.04%,HSP90AA1;HSP90AB1;PPIA;PINX1;RPA1;TERF2IP;TNKS1BP1;ANKRD28;CDK2;NHP2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.4867661973626084,-1.1454927124148335,0.3106796116504854,0.6483622143537323,1.0,7/11,18.96%,SLIT2;RIN3;CCN3;DUSP1;MIF;GREM1;PADI2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.4359014244519329,1.145469101687473,0.3055028462998102,0.7767296833590215,1.0,6/23,7.38%,TULP3;MGRN1;GPC3;GLI3;SUFU;HERC4
prerank,endothelial cell development (GO:0001885),-0.3934186075734945,-1.1450777481478183,0.2601279317697228,0.648646064347516,1.0,9/25,7.28%,PECAM1;RAP1A;PDE4D;MSN;COL15A1;PPP1R16B;ROBO4;MET;PDE2A
prerank,regulation of cellular metabolic process (GO:0031323),0.3749640591540255,1.1447680180417288,0.2722419928825623,0.7775881695430318,1.0,4/45,2.62%,PPARA;PID1;PRKN;DKK1
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.34298013401833954,-1.1447376295206038,0.2318181818181818,0.6487557999098585,1.0,18/47,24.20%,KLF4;NFKBIA;TGFB1;APP;EDN1;SSH1;EIF4G1;NR1H2;EIF2A;AGTR1;NOLC1;AKT1;PUM3;NR1H3;EIF4E;PCIF1;RBM4B;DDX25
prerank,error-prone translesion synthesis (GO:0042276),-0.4027905867575196,-1.144725646798489,0.2809224318658281,0.6479644085493893,1.0,7/21,16.16%,UBB;REV3L;RPS27A;UBC;RPA1;UBA52;POLK
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3323333565630797,-1.1445353012352129,0.24434389140271492,0.6477036705355997,1.0,23/47,31.75%,THBS1;PLCG2;RAB27A;TGFBR2;TGFB1;SOD1;GRIN1;XDH;ACE2;ROMO1;ZC3H12A;AGTR1;TYROBP;PRKCD;GADD45A;CDKN1A;ITGB2;DCXR;TLR4;CBR1;CD36;TLR6;AGT
prerank,regulation of sodium ion transport (GO:0002028),0.3989986896757399,1.144330779335463,0.2846299810246679,0.7776588988955949,1.0,7/34,6.48%,WNK4;SNTA1;GPD1L;NKAIN4;NEDD4;SIK1;DLG1
prerank,positive regulation of locomotion (GO:0040017),-0.38314610094834994,-1.144266721580155,0.2796610169491525,0.6476260903304494,1.0,5/27,5.38%,SPOCK2;THBS1;STX3;CAVIN1;TGFB1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.44338640249897165,-1.1439767634717672,0.30753968253968256,0.647562617878465,1.0,2/15,7.99%,LEF1;JUN
prerank,positive regulation of hormone secretion (GO:0046887),0.46082684250990585,1.1437574457320425,0.2946768060836502,0.7780997863608746,1.0,2/17,3.64%,C1QTNF3;TFR2
prerank,cardiac atrium morphogenesis (GO:0003209),-0.43518963666291494,-1.1437351499495816,0.30134357005758156,0.6474048022179083,1.0,6/16,10.79%,TGFB2;ENG;NOTCH1;BMPR2;HEY2;BMP2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3678360891106128,1.1430632260248432,0.272572402044293,0.7789995963326062,1.0,13/54,12.62%,HS3ST3A1;PXYLP1;SDC2;HS3ST3B1;GPC6;GPC3;HAS1;XYLT2;B3GALT6;NDST2;HS6ST1;UGDH;GPC4
prerank,neuron maturation (GO:0042551),-0.41802557040914345,-1.1429754428361094,0.28857715430861725,0.648642314324047,1.0,11/18,27.78%,SCARF1;B4GALT5;ANKS1A;APP;PICK1;C1QA;B4GALT6;CLN5;C3;RND1;ACTL6B
prerank,acylglycerol catabolic process (GO:0046464),-0.3707982771119429,-1.1428904714480586,0.27069351230425054,0.6480648960584603,1.0,4/30,10.23%,ABHD2;MGLL;LIPE;LYPLA2
prerank,cellular response to alkaloid (GO:0071312),0.47176679978422886,1.1423315189307774,0.3114754098360656,0.7799196226549518,1.0,4/17,7.25%,GSTM2;SLC8A1;CRHBP;BLM
prerank,epidermis development (GO:0008544),0.36332415509278115,1.1422801811760297,0.26895306859205775,0.7789058826108347,1.0,3/56,2.43%,SVEP1;FGFR2;CCN2
prerank,regulation of aerobic respiration (GO:1903715),-0.43868767802755537,-1.1422122915596191,0.2961460446247465,0.6490783788862555,1.0,6/15,21.92%,CBFA2T3;UQCC2;IDE;PINK1;NOP53;VCP
prerank,nucleoside salvage (GO:0043174),-0.5028644459265168,-1.1416993290183073,0.30528375733855184,0.6496606719956218,1.0,7/10,31.87%,HPRT1;UCKL1;CDA;DCK;UCK1;UCK2;UPP1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5025910824918711,1.1414401539539958,0.3044397463002114,0.7801605579164057,1.0,3/12,6.76%,DOCK11;NOTCH2;IL6
prerank,protein localization to cell surface (GO:0034394),0.42670260803547366,1.1413752016416314,0.28277153558052437,0.7791588718967589,1.0,5/26,7.91%,ANGPT1;FBLN5;PIGU;ANK2;GGA2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3463865523946511,1.1412414867500513,0.2581699346405229,0.7783852279995314,1.0,13/69,12.11%,POLR2D;PHAX;CDK7;INTS8;POLR2A;CCNT2;RPRD1B;CCNT1;GTF2F1;SNAPC5;TAF8;RPRD2;ICE2
prerank,Golgi to plasma membrane transport (GO:0006893),-0.34026119774635344,-1.1412059914701316,0.23648648648648649,0.6501517519267429,1.0,9/47,9.22%,SPTBN1;STXBP6;NSF;EXOC6;RAB31;EXOC4;GOPC;GOLGA7;EXOC5
prerank,histone exchange (GO:0043486),0.3935497761447344,1.1411841150830528,0.3010948905109489,0.7773985202971935,1.0,12/37,16.00%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ;SRCAP;CENPX;ACTR6
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3970092019509686,1.1406631939459773,0.3082706766917293,0.7777130147449214,1.0,5/33,4.27%,ADAMTS9;MCC;NR2F2;SP100;DUSP10
prerank,cellular respiration (GO:0045333),-0.3461340813574712,-1.1406491616185943,0.2516703786191537,0.6508485334885608,1.0,17/41,29.96%,PPARGC1A;ATP5F1D;NDUFA5;UQCRH;NDUFS1;COQ10B;NDUFS7;UQCRC2;UQCRC1;MTFR1L;CYCS;UQCR10;MTLN;ETFB;COX15;COX4I2;NR4A3
prerank,second-messenger-mediated signaling (GO:0019932),0.33928524348996575,1.14061106685562,0.25121555915721233,0.7767128884664795,1.0,11/82,7.85%,RCAN2;ACKR2;CCR9;CXCR5;PDPK1;NDNF;CXCR6;SPHK1;LRRK2;PPP1R9A;MCU
prerank,polyol metabolic process (GO:0019751),-0.33797728209103656,-1.1405598158982495,0.24509803921568626,0.6502953761271818,1.0,11/46,15.42%,CALM1;PLCG2;PLCB4;INPP5D;INPP4A;SYNJ1;NUDT3;PLCB3;NUDT4;INPPL1;ITPKB
prerank,chromatin assembly or disassembly (GO:0006333),0.5157022879615036,1.1404160492950393,0.35051546391752575,0.776145867148808,1.0,2/11,4.38%,HDAC8;RBBP4
prerank,chromatin remodeling at centromere (GO:0031055),0.40988313048027264,1.1399766734882355,0.2713472485768501,0.7761828996256023,1.0,9/31,11.52%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ
prerank,negative regulation of wound healing (GO:0061045),-0.3719316065744739,-1.1399329795378157,0.2653927813163482,0.6511774047110047,1.0,9/28,12.47%,SLC12A2;CD34;SERPINE2;CD109;AJAP1;EDN1;CRK;CASK;THBD
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.45599417354232596,1.139926479378562,0.3178294573643411,0.77518679990563,1.0,5/17,8.68%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,regulation of oxidoreductase activity (GO:0051341),0.48968295601987333,1.13948220071637,0.32150313152400833,0.7753139668850003,1.0,4/13,11.46%,SZT2;SLAMF8;ABL1;OXA1L
prerank,androgen receptor signaling pathway (GO:0030521),-0.4785935384639232,-1.1394205498727135,0.2841121495327103,0.6517232994252768,1.0,4/11,8.98%,PLPP1;KDM3A;DDX5;TMF1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4860490390412906,-1.1389478520531349,0.30842911877394635,0.6521429417877028,1.0,5/10,36.05%,ESR1;PSMC3;THRA;PSMC5;PSMC4
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.47481675953068414,1.138863063847983,0.3054393305439331,0.7759319221915154,1.0,2/14,3.19%,OXSR1;CXCL13
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.41731619947676535,-1.1385000467039557,0.32563025210084034,0.6525217963656723,1.0,8/19,17.56%,CSGALNACT1;NDST3;HS6ST2;EXT1;EXTL3;XYLT1;HS6ST3;HS3ST5
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.2689317120413298,-1.1383862813893286,0.14743589743589744,0.6520261185655618,1.0,24/159,7.15%,HMCN1;PECAM1;BSG;ADGRL3;CLDN5;PTPRM;CADM1;TGFB2;CDH11;CDH1;CLDN11;ITGB1;CDH2;UNC5D;TENM2;LRFN5;CXADR;PKD1;KIRREL3;TGFBR2;ROBO4;ATP2C1;CEACAM1;TENM4
prerank,negative regulation of MAPK cascade (GO:0043409),-0.2952555238183537,-1.138289228875515,0.1913265306122449,0.6514865230785974,1.0,40/87,30.54%,CAV1;PTPRJ;SEMA6A;STK38;DAB2IP;PPIA;PTPRC;SPRED2;UCHL1;FOXO1;CNKSR3;PTPN1;DUSP3;GPER1;SYNJ2BP;SPRY4;IRAK3;NF1;DUSP1;WNK2;SH2B3;CAMK2N1;PRKCD;BMP4;CD300A;HYAL2;DUSP6;SPRY2;DUSP4;SORL1;EMILIN1;PSMD10;EZR;PTPRR;DUSP26;SPRED3;TLR4;ABCA7;PEBP1;DUSP7
prerank,positive regulation of cation channel activity (GO:2001259),-0.34375318885552475,-1.1382216472423328,0.2552204176334107,0.6508580950481784,1.0,15/40,26.69%,SHANK3;TMSB4X;CALM1;RELN;ADRB2;KCNIP2;CALM2;STAC3;JPH2;ANK3;CALM3;CCR2;HAP1;CCL2;CASQ1
prerank,ion transport (GO:0006811),0.32401701909513264,1.1373729699034394,0.24413145539906103,0.7790372826284911,1.0,8/111,3.07%,TRPM3;SLC24A3;SLC8A3;WNK4;SLC5A5;SLC1A3;SLC20A2;SLC8A1
prerank,"phagocytosis, engulfment (GO:0006911)",-0.35520047101416574,-1.1373686386451913,0.2739420935412027,0.652277605556621,1.0,7/36,9.80%,ELMO1;THBS1;RAC1;GSN;DOCK1;MYH9;ARHGAP25
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.26434006440604263,-1.137162683616073,0.1414141414141414,0.652046263753266,1.0,38/175,14.90%,TMSB4X;ACTN4;TNFRSF11B;PTK2B;DAB2IP;NFKBIA;RPS3;LIMS1;IKBKB;EDA;YBX3;TNFRSF21;ST18;TNFRSF11A;TNFRSF1B;SMPD4;CARD14;BIRC3;NPNT;PSMD13;AIM2;PSMF1;COMMD7;ZFP36L1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;GPER1;ARHGEF2;PSMC3;ERBIN;GBP3;PSMD12;PSMB8;TRAF1;PSME1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4956257955529771,1.1368510789081219,0.3057199211045365,0.7794341254736478,1.0,3/12,8.88%,IL18;IL6;NUPR1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5032456417947585,1.1366815356175461,0.33771929824561403,0.778801709552396,1.0,4/11,6.00%,EFNB2;DKK1;SOX6;FRS2
prerank,regulation of viral entry into host cell (GO:0046596),-0.3681357100517435,-1.13612896743897,0.25158562367864695,0.6540732946666512,1.0,11/30,22.40%,LY6E;GSN;TRIM14;TRIM25;LGALS1;CD74;HS3ST5;MID2;TRIM27;IFITM3;CIITA
prerank,keratan sulfate biosynthetic process (GO:0018146),0.41430809765394466,1.13602840416646,0.3063583815028902,0.7795899478608666,1.0,6/26,5.37%,ST3GAL3;FMOD;OGN;OMD;B4GALT1;PRELP
prerank,triglyceride catabolic process (GO:0019433),0.4503243538402785,1.1357592673588641,0.3023255813953488,0.7792325095891425,1.0,4/19,16.17%,LIPH;LIPC;FABP7;FABP4
prerank,cAMP-mediated signaling (GO:0019933),0.43557440514269835,1.1354991130993732,0.314453125,0.7788131226017482,1.0,4/24,3.00%,ADCY1;KSR1;PDE7B;PDE7A
prerank,female gonad development (GO:0008585),0.44579356961102656,1.1350955253978512,0.2980392156862745,0.778840491971053,1.0,2/19,1.24%,NR2F2;KIT
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.2722865889265544,-1.1349749475068611,0.19940476190476192,0.6564379347598346,1.0,41/136,19.45%,TMSB4X;ID1;ESR1;CD200;GAS6;KLF4;BHLHE40;DAB2IP;NFKBIA;HES1;PKD1;SFRP4;FLNA;FZD6;ARRB1;CHP1;PTCH1;LRRC14;PTGIS;AIM2;COMMD7;NLRC5;CTNNBIP1;CHUK;MEN1;HEYL;IRAK3;ERBIN;NLRP2B;DAP;CMKLR1;CYP1B1;WFS1;BRMS1;SIGIRR;ZC3H12A;ID2;IRAK1;SPI1;HES6;ARRB2
prerank,cellular response to retinoic acid (GO:0071300),0.383500729706395,1.1347383812037906,0.28596491228070176,0.7787199219916963,1.0,3/42,1.12%,PTK7;EPHA3;WNT6
prerank,regulation of calcium-mediated signaling (GO:0050848),0.41891931583604136,1.1347143378350042,0.2981132075471698,0.777658953910103,1.0,6/25,12.06%,ITPR1;LRRK2;GPR143;CCL4;NEUROD2;TMBIM4
prerank,regulation of neuron death (GO:1901214),-0.30248928896409055,-1.13464588397555,0.20843672456575682,0.656501061649804,1.0,33/82,23.76%,MEF2C;MAP3K5;CD200;CD34;PPARGC1A;FYN;UBB;DCC;GSK3B;EGLN3;SIGMAR1;TNFRSF1B;CHP1;DDIT4;EIF4G1;EPHB1;EGLN2;REST;CLU;CHGA;C1QA;CTSZ;NENF;ATP13A2;CDK5;TRIM2;TYROBP;AKT1;GRID2;NSMF;FCGR2B;SARM1;SNCG
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.36531830370752066,-1.1344711472995794,0.2678185745140389,0.6561884258275706,1.0,8/33,11.93%,PRKG1;MEF2C;APOD;IGFBP5;PDCD4;CDKN1B;NDRG4;GPER1
prerank,regulation of establishment of planar polarity (GO:0090175),-0.29715978439835794,-1.134431576489475,0.21621621621621623,0.6554932676190829,1.0,30/88,23.95%,TIAM1;RAC1;ROR2;FZD4;AP2A2;FZD6;ARHGEF19;PSMD13;PSMF1;RHOA;AP2M1;PSMB10;VANGL2;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;DVL2;PRICKLE2;ARRB2;PSMD5;AP2B1;AP2A1;PSMD9;PSMB4;SPEF1
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.4569677005781037,-1.1343029429414961,0.3026315789473684,0.6550743922600709,1.0,7/13,37.54%,TGFB1;SOD1;TYROBP;PRKCD;ITGB2;SYK;CRP
prerank,potassium ion transmembrane transport (GO:0071805),0.31248917360953116,1.1342454415218426,0.2183206106870229,0.777914894955853,1.0,10/135,4.07%,ATP1A2;SLC24A3;KCNK2;KCNQ4;NALCN;KCNA5;SLC1A3;ATP1B3;KCNT2;KCND3
prerank,regulation of interleukin-8 production (GO:0032677),-0.3117417427344122,-1.1331678337820539,0.23759791122715404,0.6573384078067434,1.0,36/69,35.95%,TMSB4X;F3;KLF4;LBP;NOD1;PTPRC;ARRB1;BCL3;STAT3;RAB1A;CD74;TIRAP;MYD88;OTUD7B;HYAL2;AFAP1L2;RELA;HSPA1B;TLR7;TLR4;FADD;TLR6;MAVS;NOD2;PTPN22;TLR1;C5AR2;NOS2;HSPA1A;SYK;PARK7;F2R;CD33;ANXA4;TLR8;RIPK1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.4591056826836011,1.132277362012618,0.30648330058939094,0.7821853643171487,1.0,3/15,3.92%,PPARA;LPGAT1;SLC45A3
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5050830184761567,1.1322655336922167,0.31453362255965295,0.7810901637599201,1.0,1/11,0.24%,TGFBR3
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3534871675824283,-1.1321446219119076,0.2618510158013544,0.6592501485691102,1.0,19/37,34.04%,UBB;RPS27A;UBC;DDB1;RBX1;RPA1;UBA52;POLK;POLD3;NTHL1;POLD1;GTF2H2;XPA;ERCC5;RFC5;ERCC3;GTF2H5;RPA3;RPA2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.32261909771754355,-1.1319472842324156,0.22325581395348837,0.65897516878041,1.0,14/54,14.72%,CAV1;KCNJ2;NEDD4L;KCNMA1;FHL1;FLNA;KCNAB1;KCNQ1;CD63;KCNMB4;BIN1;KCNN2;KCNJ15;KCNIP2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.39912231515473623,-1.1316295617176824,0.3007662835249042,0.659001051651458,1.0,7/21,12.73%,SLIT2;TGFB2;DAB2IP;CYRIB;ARHGAP25;CD2AP;SPRY4
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.42618310217043287,-1.1315963991384406,0.3101391650099404,0.6583196291256063,1.0,10/17,23.02%,CAV1;KLF7;CEACAM1;APOLD1;AJAP1;MAFF;DSPP;PRKX;DLL1;CEBPB
prerank,snRNA transcription (GO:0009301),0.34180950790613035,1.131510796316914,0.2601626016260163,0.7820506275284773,1.0,13/70,12.11%,POLR2D;PHAX;CDK7;INTS8;POLR2A;CCNT2;RPRD1B;CCNT1;GTF2F1;SNAPC5;TAF8;RPRD2;ICE2
prerank,positive regulation of neutrophil migration (GO:1902624),0.4459678331061061,1.1314589908342518,0.32688588007736946,0.7810612546178423,1.0,5/18,8.68%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.3985866415548204,-1.13141759735945,0.2857142857142857,0.6580212431645315,1.0,11/23,29.88%,HSP90B1;DERL1;HERPUD1;AUP1;PREB;TMEM129;VCP;SEC16A;SYVN1;RANGRF;SEC61B
prerank,protein transport (GO:0015031),-0.2453551009807942,-1.1312298222742425,0.11483253588516747,0.657767837848933,1.0,128/332,28.77%,SPTBN1;TFRC;NSF;STX3;TBC1D30;TBC1D8;RAMP2;RAB31;RAB3C;STX7;MIA2;RABGAP1L;CHMP2B;STX1A;SLC10A7;TANGO6;ATP6V0A1;EHD1;VMP1;TMED5;HSP90B1;COPG1;ADPRH;ARF5;GRTP1;SCG5;STX6;SGSM1;ARF1;MYH9;TBC1D8B;TBC1D1;DNM2;RAMP1;RAB28;OLFM2;TMED2;GOLGA7;SIL1;TBC1D13;NAPB;SYNDIG1;RAB38;SCAMP1;STX12;ATP6V1A;ATP6V0C;RAB3B;SCG2;RAB1A;EVI5;TCIRG1;CD74;TBC1D10A;LMTK2;ARHGEF2;ATP6V1E1;CLU;CANX;SCAMP2;PICK1;LMAN2L;TMED10;TMED3;CALCRL;KIF13A;RABL3;TMEM167A;LAPTM5;STX2;HERC2;ATP6V0A4;RABGAP1;MTTP;YWHAH;SNX1;CHMP1B;KIF3B;ATP6V0A2;PREB;RAB1B;TBC1D10B;ABCG1;SYS1;SCAMP3;ANK3;CHMP1A;EIF2D;ARFIP2;ATP6V0D2;TVP23A;RAB8A;HDAC6;TBC1D22A;CHMP3;NECAB3;AP2A1;RAB8B;TMED7;SCFD2;RAB7A;ARL4A;RAB3A;ATP6V0E2;SNX27;ARRDC3;ZDHHC17;RAB14;ATP6V1B2;RAB5B;MCOLN1;RAB6B;VLDLR;ARFIP1;NEURL1B;ATP6V1H;CTTN;TBC1D5;SEC31A;COPA;TOM1;IL10RA;ARL6IP5;VPS33B;ARF3;STX5;VPS26B;RAB20
prerank,megakaryocyte differentiation (GO:0030219),0.5118938708259622,1.1311779040759329,0.33814432989690724,0.7807210908154384,1.0,4/11,17.55%,KIT;MED1;CDKN2B;IL11
prerank,regulation of epithelial cell migration (GO:0010632),-0.3259699422031707,-1.1310364484900628,0.2693208430913349,0.6574614509375363,1.0,13/51,9.54%,PTPRG;RHOJ;BMPER;TGFB2;PTK2;DOCK1;PLCG2;DAB2IP;BMPR2;CORO1C;CEACAM1;EMP2;RTN4
prerank,mitotic cytokinetic process (GO:1902410),-0.39887610003637575,-1.1309691563839508,0.2743362831858407,0.6568480285411596,1.0,12/20,30.92%,CHMP5;CHMP2B;RHOA;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;CEP55;CNTROB;VPS4B
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.4437637067124749,1.13062704824647,0.3320388349514563,0.7811967802184289,1.0,5/19,8.68%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,apoptotic cell clearance (GO:0043277),-0.36571039311859477,-1.1305523693027115,0.28354978354978355,0.6572144113968632,1.0,5/30,4.39%,THBS1;RAC1;GAS6;SCARB1;TGM2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3733602106216779,-1.1303943266281935,0.2754237288135593,0.6568684010141435,1.0,14/28,27.75%,MAP1B;PRUNE1;STMN2;STMN1;STMN4;STMN3;GAS2L1;FKBP4;MAPRE1;MAP1A;CLASP2;CAMSAP3;CAMSAP1;SKA3
prerank,negative regulation of histone acetylation (GO:0035067),-0.4853145790849318,-1.1285032268221709,0.31176470588235294,0.6612872300964293,1.0,7/11,36.85%,SET;CTBP1;SPI1;NOC2L;SIN3A;THAP7;TAF7
prerank,sarcomere organization (GO:0045214),0.422057093371284,1.1284147364526984,0.29545454545454547,0.7862149456664583,1.0,3/27,2.80%,TPM1;CSRP3;TNNT2
prerank,peripheral nervous system development (GO:0007422),-0.39303691168407884,-1.1283209205588545,0.27176220806794055,0.661027749018432,1.0,6/23,14.64%,ADGRG6;NGF;SERPINI1;SCN8A;GPC1;NF1
prerank,sensory perception of smell (GO:0007608),-0.47628002886053583,-1.1281867721808305,0.32688588007736946,0.6606079360845255,1.0,2/11,10.93%,ADCY3;SYT10
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.47176660137991444,1.1280958040712072,0.3299595141700405,0.7860146018260875,1.0,6/16,17.38%,PIGG;PIGV;PIGX;PIGC;PIGQ;PIGN
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.4137408351940922,-1.1273007814644505,0.31160896130346233,0.662200593001593,1.0,10/20,13.96%,NOTCH1;SMAD9;SMAD5;VEGFA;RUNX2;SESN2;XBP1;ATF4;BMP2;MT3
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.43062761270421723,-1.1271916783350915,0.3150684931506849,0.661704745149882,1.0,10/16,38.81%,TARDBP;ZFP36L1;PLEKHN1;ZC3H12A;RBM24;CPEB3;ZFP36;ZC3H12D;RC3H1;TRIM71
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3664479743746611,-1.1267185073407888,0.2741228070175439,0.6622107724844434,1.0,10/30,14.55%,CSGALNACT1;CSPG4;BGN;CHST9;CHST11;HEXB;HEXA;IDS;VCAN;CHSY3
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3427027522063808,-1.1266979415881415,0.26741573033707866,0.6614817646196555,1.0,18/40,22.19%,HIP1;SGIP1;B2M;CBL;HNRNPK;SFRP4;ARRB1;VEGFA;CD63;CLU;PICK1;BICD1;GREM1;ARRB2;INSR;FMR1;ATAD1;C3
prerank,acute inflammatory response (GO:0002526),-0.38196782217192216,-1.1266064096098416,0.291220556745182,0.6609409253555927,1.0,11/23,37.54%,F3;LBP;CTNNBIP1;SIGIRR;CEBPB;AHSG;VNN1;MYLK3;HPR;HP;CRP
prerank,regulation of protein autophosphorylation (GO:0031952),0.38776659903692445,1.1265863036840051,0.29608938547486036,0.7892380753328173,1.0,2/36,0.35%,EPHA7;ERRFI1
prerank,inner dynein arm assembly (GO:0036159),-0.47101508782122636,-1.1264711172688189,0.34901960784313724,0.6605123058879069,1.0,8/11,47.14%,CFAP100;CCDC40;DNAAF4;CCDC39;DNAH1;DNAAF1;DNAI3;CFAP73
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.45890966015401824,1.126470780833769,0.31673306772908366,0.7884488267702807,1.0,3/17,3.96%,SNTA1;GPD1L;ANK2
prerank,regulation of protein transport (GO:0051223),-0.37699630088605957,-1.12642773383209,0.2785862785862786,0.6598327371405793,1.0,15/27,30.93%,HSPA8;DNAJA1;RHBDF2;CHP1;DNAJC1;PTPN1;NDFIP2;ATP13A2;NDFIP1;DISP1;ARFIP1;SNX3;PPM1F;LCP1;STXBP5L
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3934042106700693,1.1264059476334964,0.28990825688073396,0.7875077226562344,1.0,6/33,11.42%,IGF1;IGF1R;PTEN;MYO16;PIK3R1;ERBB2
prerank,synaptic vesicle localization (GO:0097479),-0.44618763439886355,-1.1262901976906912,0.33072407045009783,0.6594130234628008,1.0,8/13,31.89%,RAB27A;SYNJ1;DNM2;SYNDIG1;CDK5;KIF5C;SNAPIN;KIF5B
prerank,negative regulation of fat cell differentiation (GO:0045599),0.38775301319349703,1.1262323527396918,0.282793867120954,0.786901440928457,1.0,5/34,7.08%,RORA;RUNX1T1;ANKRD26;IL6;SMAD3
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.3564380772241555,-1.1261297134905297,0.27350427350427353,0.6590640497895911,1.0,5/29,9.42%,CADM1;STX7;LAMP1;CYRIB;PVR
prerank,regulation of translation (GO:0006417),-0.26661741193924576,-1.126097861307463,0.1625,0.6583688656472844,1.0,51/173,24.20%,THBS1;NIBAN1;EEF2;VIM;RPS3;RACK1;RPL26;HSPB1;SOX4;CALR;IGFBP5;EIF1B;TOB1;RPL5;EIF4G3;GAPDH;APP;YBX1;MTOR;PYM1;EIF4G1;EIF3D;BCL3;YTHDF3;RPS6KA1;RPS4X;SHFL;EIF4H;RPS27L;EIF3B;RPL13A;RIDA;EIF3C;EIF1;EIF2B2;EIF2A;EIF5B;NOLC1;MRPL13;MTG1;METTL3;FMR1;EIF6;EIF4B;PUM3;EIF4E;EIF5;PCIF1;PUS7;RBM4B;DDX25
prerank,excitatory postsynaptic potential (GO:0060079),-0.41476521507060293,-1.1259315990430527,0.28512396694214875,0.6580429466036549,1.0,7/19,22.77%,MEF2C;GSK3B;GRIN1;ARRB2;AKT1;GRID2;MAPK8IP2
prerank,inositol phosphate metabolic process (GO:0043647),-0.3333496691265828,-1.1255752284024256,0.2736077481840194,0.6582331837778556,1.0,11/46,15.42%,CALM1;PLCG2;PLCB4;INPP5D;INPP4A;SYNJ1;NUDT3;PLCB3;NUDT4;INPPL1;ITPKB
prerank,organophosphate ester transport (GO:0015748),-0.38406535825179816,-1.1254304357871208,0.29880478087649404,0.6578413835578012,1.0,11/24,23.65%,PITPNC1;PLTP;SCARB1;TNFAIP8L3;ABCA3;PRELID3B;MTTP;PITPNA;PITPNB;OSBPL5;NPC2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3880600680552989,-1.1250964111214463,0.2894736842105263,0.657976460256702,1.0,14/25,25.13%,HIP1;BCAR3;CBL;CCDC88A;HIP1R;RTN4;SHKBP1;GPER1;PDE6H;PLAUR;AKT1;AFAP1L2;ARAP1;HAP1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.42673135384671523,1.124903263951083,0.32037037037037036,0.7895521036349462,1.0,2/21,2.73%,EPHA7;LTF
prerank,positive regulation of cell cycle process (GO:0090068),0.32993165551017645,1.1247815330057156,0.2708333333333333,0.7888039772769198,1.0,11/91,11.42%,IGF1;CXCR5;DMRT1;PDGFRB;IGF2;CDC14B;UBXN2B;PKN2;PHIP;NPM2;TGFA
prerank,RNA export from nucleus (GO:0006405),-0.2891270666990831,-1.1240207822726178,0.2222222222222222,0.6601433359772034,1.0,43/100,35.96%,SRSF2;SRSF1;SRSF5;DDX39B;CPSF3;HHEX;SRSF9;RBM8A;RNPS1;SRSF6;NUP37;AGFG1;SYMPK;NXT1;CPSF2;NUP54;SMG5;NUP85;YTHDC1;THOC3;NUP133;MAGOH;POM121;THOC6;EIF4E;DDX25;THOC2;NUP153;EIF4A3;SMG6;SRSF7;ALYREF;NUP42;CPSF1;ZC3H11A;NUP93;DHX38;U2AF1L4;CHTOP;HNRNPA1;NUP35;SRSF3;NCBP2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.42958370425192016,-1.1237137261788002,0.323943661971831,0.6602166693933528,1.0,11/17,30.12%,CALM1;SPRED2;DDIT4;EIF4G1;CADM4;CALM2;CALM3;DGKQ;SPRY2;SPRED3;SMAD7
prerank,regulation of monocyte differentiation (GO:0045655),0.4699397657939434,1.1228400190584589,0.33402922755741127,0.7932500168174224,1.0,4/14,7.99%,IL34;HOXA7;ACIN1;CSF1
prerank,neural crest cell differentiation (GO:0014033),-0.41493449889130996,-1.122757833763465,0.3136094674556213,0.6619717034715991,1.0,2/18,2.75%,MEF2C;CDH2
prerank,reticulophagy (GO:0061709),0.48733618879997165,1.1216681052695212,0.3543788187372709,0.7955348628173755,1.0,3/12,10.75%,UFL1;RETREG1;TEX264
prerank,regulation of DNA recombination at telomere (GO:0072695),0.43513971419575087,1.1209320108384067,0.3052434456928839,0.7953830716021719,1.0,3/19,8.04%,POLR2D;ACD;POLR2A
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.43513971419575087,1.1209320108384067,0.3052434456928839,0.7953830716021719,1.0,3/19,8.04%,POLR2D;ACD;POLR2A
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.45259877815028826,1.1209111965426142,0.3557312252964427,0.7943323389831877,1.0,3/17,5.06%,ATP1A2;SLC8A1;GJA1
prerank,negative regulation of type I interferon production (GO:0032480),0.3773546789601806,1.1208722533350657,0.2974910394265233,0.793334016178043,1.0,13/40,14.27%,CACTIN;NLRC3;RNF135;RNF216;SIRPA;ITCH;IRF3;UBA7;PCBP2;IKBKE;CYLD;TBK1;NLRX1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5097423425591686,1.12047521797378,0.35095137420718814,0.7932995211937119,1.0,1/10,0.31%,BMP6
prerank,nuclear body organization (GO:0030575),0.4828587046229147,1.120428827283609,0.3235908141962422,0.7923029244785779,1.0,2/12,3.90%,AFF2;SRPK2
prerank,sympathetic nervous system development (GO:0048485),-0.43368205038744545,-1.1201355918361067,0.31274900398406374,0.6682063175414414,1.0,6/15,22.64%,NRP2;SOX4;CTNNB1;NF1;SEMA3A;SOX11
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.30231488496395054,-1.1200602919074514,0.2493150684931507,0.6676235400829843,1.0,19/78,11.93%,SPTBN1;PRKCH;ACTB;STX3;ITGB1;STX7;TGFB1;NKD2;VTI1B;VAMP8;BCL2L1;WNK3;ABI3;ZDHHC2;ZDHHC7;AP2M1;APPL1;TMBIM1;GPER1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.4149162168520215,-1.119755800427043,0.301556420233463,0.6676085815612276,1.0,8/17,11.81%,NOTCH1;SERPINE2;HES1;TGFB1;TNFRSF1B;TENM4;BMP2;BIN1
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.25488413424809053,-1.1196855815270834,0.17328519855595667,0.667029149779234,1.0,73/224,25.79%,UNC13B;SLC12A7;GRM3;DLG2;KCNQ3;CALM1;ATXN3;PLP1;GRM7;MBP;EXOC4;MINK1;GABRB3;SLC12A6;SLC1A1;HOMER1;SYPL1;CAMKK2;GRIK4;GABRB1;CHRM3;DLGAP1;CACNA1E;HTR2A;NRXN1;AMPH;KCNMB4;GRIN1;SLC12A4;KCNA1;SYT10;RPS6KA1;GABRG3;SYNJ2BP;GAD1;CACNB2;SNAP25;PCDHB14;BSN;PRKAR1A;HRH1;APBA3;SYN2;KCNIP2;KCNQ2;CAMK4;PTCHD1;CACNA1B;GLRA3;GRIA2;SLC6A5;CDK5;CACNB3;KCND2;GRIK2;RIT2;CAMKK1;GABRA5;HRH2;GABRE;NPTX1;SST;CHRNB1;NPY;SNCG;PNOC;CPLX1;GABRG2;HAP1;KCNC4;HTR2C;GLRA1;CNP
prerank,regulation of feeding behavior (GO:0060259),0.5014292402275203,1.1196192342553175,0.3674321503131524,0.79343915278629,1.0,1/11,0.35%,LEPR
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.45103009496263513,-1.1196037455926262,0.32771535580524347,0.6664808753103985,1.0,8/13,32.01%,SLC4A10;GRIK2;PPFIA3;SHISA6;RAB3A;SYP;SLC8A2;SHISA8
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2969701467029156,-1.1189149647151877,0.2421875,0.6675160096464191,1.0,25/76,19.45%,TMSB4X;CD200;KLF4;DAB2IP;NFKBIA;FAF1;ARRB1;CHP1;LRRC14;PTGIS;AIM2;COMMD7;NLRC5;CHUK;IRAK3;ERBIN;NLRP2B;DAP;CMKLR1;CYP1B1;BRMS1;ZC3H12A;IRAK1;SPI1;ARRB2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.4192152866098508,-1.1188602597253123,0.316,0.6669154190792099,1.0,10/17,31.00%,SFRP4;TMEM100;BMP4;BTG1;RFX3;FGF2;FOXJ1;SFN;SULT2B1;AHI1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.4311102581591703,1.1187900288286583,0.3288973384030418,0.7946024586726174,1.0,5/20,10.06%,EPAS1;PRKN;ZMIZ1;ITCH;WASHC1
prerank,artery morphogenesis (GO:0048844),-0.3627269644326061,-1.1187609533357183,0.2972972972972973,0.6664169712069281,1.0,11/30,9.37%,TGFB2;JAG1;ENG;NOTCH1;TBX1;BMPR2;HES1;STRA6;TBX2;VEGFA;HEY2
prerank,positive regulation of protein modification process (GO:0031401),-0.2553684559595775,-1.1184785275967926,0.16666666666666666,0.6664551186684666,1.0,63/203,20.96%,TEK;NTRK3;PECAM1;LIMCH1;EFNA5;TFRC;KRAS;KDR;NIBAN1;RAC1;HSP90AA1;GAS6;CALM1;PTK2;PDE8A;ENG;RACK1;PPIA;SEMA4D;TBX1;ATG7;PPP1R16B;LIMK2;TGFB1;CAMKK2;ARRB1;CHP1;APP;FLT4;CARD14;RAMP1;VEGFA;PAK1;FGF7;SLCO3A1;RALB;BMP2;GPER1;CD74;SVIP;CCN1;MT3;TERF2IP;CSF1R;FAS;SYMPK;CALM2;BRMS1;DVL2;PPP2R5A;KNDC1;CD40;NPTN;PIK3R3;PLAUR;PINK1;PTBP1;PRKCD;AKT1;BMP4;CDCA2;INSR;FMR1
prerank,regulation of transposition (GO:0010528),0.48768354154502414,1.118231671679534,0.3670103092783505,0.7950108385806639,1.0,2/13,7.14%,MYBL1;UBR2
prerank,nuclear membrane reassembly (GO:0031468),-0.3203729402260691,-1.1181617847338714,0.25707547169811323,0.6666040096679062,1.0,20/54,26.70%,REEP3;CHMP2B;LEMD2;LBR;NSFL1C;RANGAP1;LMNA;NUP37;VRK1;PPP2R2A;CC2D1B;NUP85;NUP133;POM121;CHMP3;CCNB2;CHMP7;BANF1;CHMP4C;UBE2I
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.29649016766804004,-1.1176133256150194,0.248,0.6672532994361848,1.0,29/85,23.00%,TIAM1;RAC1;ROR2;FZD4;AP2A2;FZD6;ARHGEF19;PSMD13;PSMF1;RHOA;AP2M1;PSMB10;VANGL2;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;DVL2;PRICKLE2;ARRB2;PSMD5;AP2B1;AP2A1;PSMD9;PSMB4
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.42166553757536596,1.1175921379551357,0.3465909090909091,0.7956921742948779,1.0,2/22,3.71%,ROCK2;EPHA4
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4880753355535222,1.1172808931951996,0.32346723044397463,0.7954864326743827,1.0,2/12,8.41%,PPARA;MIA3
prerank,gliogenesis (GO:0042063),-0.4319968698900078,-1.1172629881322866,0.32170542635658916,0.6674510743967549,1.0,5/15,10.65%,TGFB2;CD9;CDH2;CDK6;RELN
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.3757430826865392,-1.1167642630238208,0.305668016194332,0.6680709277149562,1.0,9/25,17.38%,PKM;HK1;GAPDH;PFKM;FOXK1;TPI1;ALDOA;PFKP;ALDOC
prerank,erythrocyte differentiation (GO:0030218),0.36244139171441075,1.116266734743621,0.2928082191780822,0.7973425462821426,1.0,9/44,12.76%,TGFBR3;KIT;ACIN1;UFL1;LYAR;CEBPG;MED1;JAK2;SLC25A38
prerank,glial cell differentiation (GO:0010001),-0.3674577761842216,-1.116142936150982,0.32894736842105265,0.6690010830677626,1.0,12/28,19.12%,ADGRG6;CDH2;SOX4;STAT3;RELN;GPC1;PICK1;EIF2B5;TPPP;SOX2;CDK5;SOX10
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.29273778018160107,1.1160848354681623,0.23582089552238805,0.7967669708318245,1.0,29/182,11.76%,IGF1;ROBO1;SLC24A3;ROCK2;WNT4;NOTCH2;PRKN;RBMS3;PCSK9;TNRC6B;PRKAA2;TNRC6A;TET1;SLC2A10;OPTN;ABCC2;PRKAA1;RBL2;WWP2;PICALM;PARP10;AGO2;PARP9;ATOH8;HDAC1;FLCN;APLN;DLG4;BMPR1A
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3292369533483699,-1.1154213411280423,0.2822384428223844,0.6701764054402508,1.0,12/48,12.31%,LIMS2;RAC1;CARMIL1;DOCK1;LIMS1;FLNA;CALR;FERMT2;MYOC;CRK;S100A10;CDKL3
prerank,regulation of Notch signaling pathway (GO:0008593),-0.30157190845150783,-1.1154033019631842,0.2630208333333333,0.6694740088285748,1.0,19/76,12.45%,NOS3;TGFB2;JAG1;PRAG1;SREBF2;NOTCH3;NOTCH1;CCN3;GATA2;JAG2;ARRB1;PDCD10;NOTCH4;LFNG;ZBTB7A;MFNG;STAT3;SYNJ2BP;EPN2
prerank,neurotrophin signaling pathway (GO:0038179),-0.4009846377609352,-1.1153373418228685,0.31049250535331907,0.6688806065675054,1.0,4/21,9.32%,RAP1A;NGF;BCAR1;DDIT4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.4241981956224799,1.1150005817050646,0.32342007434944237,0.7977057788194082,1.0,9/23,17.06%,ZEB2;DAB2;SLC2A10;FLCN;CDKN1C;CREBBP;SMAD4;CDKN2B;SDCBP
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.4241981956224799,1.1150005817050646,0.32342007434944237,0.7977057788194082,1.0,9/23,17.06%,ZEB2;DAB2;SLC2A10;FLCN;CDKN1C;CREBBP;SMAD4;CDKN2B;SDCBP
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.32830777728340416,-1.1148979612258543,0.27790432801822323,0.6692552163794907,1.0,14/46,14.23%,MEF2C;SHANK3;GRM3;GRM7;CDH2;PTK2B;HOMER1;DGKI;CACNG3;NRXN1;RELN;DGKZ;GRM8;CACNG2
prerank,amino acid transport (GO:0006865),0.35895161421406613,1.1146566750030102,0.2977624784853701,0.7975834605676019,1.0,10/49,12.29%,SLC7A11;SLC38A3;SLC6A12;PDPN;SLC38A9;SLC43A1;SLC1A5;SLC36A2;SLC38A7;SLC38A2
prerank,regulation of nervous system development (GO:0051960),-0.3383127273167182,-1.1142939126760376,0.2972972972972973,0.6699695289723772,1.0,15/37,25.82%,BHLHE40;HES1;CTNNB1;TNFRSF1B;PRUNE1;TENM4;HEY2;HEYL;CX3CR1;HES6;DLL1;HEY1;GBX1;ZPR1;KIF14
prerank,regulation of ATP biosynthetic process (GO:2001169),0.4516325686955914,1.114204197919313,0.3312883435582822,0.7977902003541318,1.0,2/16,1.17%,PPARA;PID1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5109425904285649,1.1139578763711067,0.358974358974359,0.7974417990492272,1.0,4/10,19.76%,SETD6;SETD7;SETD2;SETD4
prerank,Notch signaling involved in heart development (GO:0061314),0.488887958055222,1.1138832971364223,0.3458333333333333,0.7965529709423163,1.0,2/11,1.17%,RBPJ;NOTCH2
prerank,centromere complex assembly (GO:0034508),0.38389877895490454,1.1138759321741558,0.32304900181488205,0.7954793506372526,1.0,11/36,15.70%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ;CENPX;MIS12
prerank,organelle fusion (GO:0048284),-0.38697665808874065,-1.1137222837065563,0.30019120458891013,0.6707471888152765,1.0,9/22,27.16%,CHCHD3;MIEF1;VPS18;MIEF2;VPS11;MFN2;BAX;SPG7;FIS1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4849924105076434,-1.1137180653015692,0.3567251461988304,0.6699908754102809,1.0,4/10,13.07%,DGKH;PLPP1;PRKD3;PICK1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.3754740930436007,-1.1136100489907124,0.3141592920353982,0.6694650889719314,1.0,9/25,25.74%,MEF2C;GSK3B;GRIN1;INSYN2A;ARRB2;AKT1;GRID2;MAPK8IP2;GLRA1
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.3871616822869761,-1.1135986025873486,0.3311827956989247,0.6687411545067441,1.0,8/21,9.37%,NOS3;GAS6;PTK2B;NOTCH1;ASPN;TGFB1;SRGN;HEY2
prerank,protein localization to phagophore assembly site (GO:0034497),0.49923692037276995,1.1135840784296451,0.354978354978355,0.7952024338042346,1.0,4/11,13.38%,WIPI1;TRAPPC8;ATG9A;STX17
prerank,regulation of vasculogenesis (GO:2001212),-0.4571997480016698,-1.113581861671588,0.32945736434108525,0.6680150587013932,1.0,7/14,11.52%,RAP1A;CD34;KDR;CEACAM1;EMP2;HEY2;XDH
prerank,neuron cell-cell adhesion (GO:0007158),0.4739446077947493,1.1135625870133186,0.3404669260700389,0.7941806088792265,1.0,2/14,2.23%,CEL;NLGN2
prerank,proteolysis (GO:0006508),0.28296048327551643,1.1134669338752492,0.24043715846994534,0.7933665810691215,1.0,23/252,9.50%,ADAMTS12;ADAMTS9;CPQ;ADGRV1;AEBP1;TRABD2B;CLPX;CAPN9;CTSH;MMP2;ACE;TPP1;ADAMTS7;MMP19;SUFU;NPEPPS;MMP9;CPXM1;USP25;CUL7;YME1L1;FBXO6;MDM2
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.48875602126247775,-1.1126345079701485,0.34355828220858897,0.6699103961755916,1.0,8/10,43.98%,DNAJB1;HSPA1B;SORL1;DNAJB6;HSPA1A;DNAJB2;DNAJA4;DNAJB8
prerank,glycerolipid metabolic process (GO:0046486),-0.4681495145149281,-1.1125325020027041,0.3699421965317919,0.6694351673968557,1.0,6/11,29.76%,DGKB;DGKZ;DGKG;PGP;DGKQ;PLA2G15
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.43392453353912025,-1.1121698453973021,0.3469387755102041,0.6696776764854323,1.0,8/15,34.32%,SIX1;VEGFA;SIX4;BMP4;PAX8;AGT;NOG;PAX2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.43596126281519887,-1.1121607745301971,0.352,0.668942441507651,1.0,5/13,15.33%,BMP5;SOD1;BMP2;REST;ERLIN2
prerank,negative regulation of inflammatory response (GO:0050728),0.2941203755282529,1.1115317973823944,0.2460202604920405,0.7977219354161738,1.0,8/182,3.61%,IGF1;RORA;ADCY5;ADCY1;C1QTNF3;PPARA;SLAMF8;ADM
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3009384573431883,1.1115231482743593,0.2656023222060958,0.7966663747193351,1.0,18/150,6.00%,TCF7L2;OSBPL8;FGFR2;FGFR4;IL18;KIT;ANGPT1;PDPK1;PDGFRB;KL;IGF2;GFRAL;PDGFRA;RICTOR;IGF1R;FGF1;LRP2;FRS2
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.258339656099586,-1.1114070557974909,0.20382165605095542,0.6701850133304117,1.0,44/172,16.56%,PIP5K1B;DGKH;PITPNM2;CEPT1;PLCG2;INPP5D;BMX;CRLS1;PIK3R6;INPP4A;SYNJ1;DGKB;PIK3C2B;ARF1;CDS1;FAR1;MFSD2A;CDIPT;CPNE3;PLEKHA1;PIK3CD;LPCAT3;PIK3C2A;GPAT4;MTM1;GPAT3;DGKZ;MTMR6;DGKG;PITPNM3;PIK3R5;PIK3C3;MTMR9;INPPL1;LPCAT1;SACM1L;LPIN3;CSNK2B;PIP5K1C;SBF1;PLA2G4A;PI4KB;ETNK1;LPIN1
prerank,neuronal action potential (GO:0019228),0.4290869207791244,1.111044505339841,0.32504780114722753,0.796960374029102,1.0,1/22,0.09%,SCN7A
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.487723158925469,-1.1109796144457917,0.34269662921348315,0.670642521868106,1.0,6/10,30.28%,GALNT13;GALNT2;GALNT1;POGLUT3;MGAT5B;POGLUT1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.47158359119612736,1.1109371905221228,0.338,0.7961899817906948,1.0,4/15,7.99%,IL18;PLA2G10;MAPK9;CSF1
prerank,cellular senescence (GO:0090398),-0.37311865645700937,-1.110881189894129,0.31875,0.6701590783662797,1.0,9/27,25.17%,TBX2;CALR;TBX3;ECRG4;ID2;SPI1;PRKCD;CDKN1A;HRAS
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4297119590705739,-1.1108257463273965,0.34710743801652894,0.669566119984413,1.0,5/14,8.57%,LIMS2;LIMS1;FLNA;EMP2;CD63
prerank,positive regulation of response to wounding (GO:1903036),-0.38314656870750946,-1.1107477089502575,0.3147410358565737,0.6690184342942317,1.0,7/24,8.82%,ACTG1;OCLN;PTK2;ITGB1;SCARF1;KANK1;GRN
prerank,regulation of actin filament depolymerization (GO:0030834),0.47913899967624474,1.1104232620422272,0.3333333333333333,0.7965586449387884,1.0,2/12,7.18%,PLEKHH2;LIMA1
prerank,negative regulation of hippo signaling (GO:0035331),0.4796341924471209,1.1102471080233791,0.3333333333333333,0.796005239303628,1.0,3/12,6.78%,VGLL4;WWC1;WWC2
prerank,endocrine system development (GO:0035270),0.42633920761233735,1.1102180165681603,0.34345351043643263,0.7950105546029219,1.0,3/21,6.81%,WNT4;DKK3;SALL1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.27918472133754635,-1.1101339491062605,0.23138297872340424,0.6699141070667718,1.0,29/108,16.12%,HIP1;MAP3K5;ACER2;GSN;F3;NGF;RPS3;RACK1;CTSD;TNFSF10;NOD1;ST18;EGLN3;ATP2A3;HIP1R;SOX7;NDUFA13;XDH;GPER1;REST;HSPD1;CASP8AP2;RPS27L;BBC3;DAP;FAS;BCAP31;CASP8;LAPTM5
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.46830792168532176,1.1100669968552481,0.3373737373737374,0.7943373800292798,1.0,3/15,9.50%,PRKN;BCL2;MDM2
prerank,protein deubiquitination (GO:0016579),-0.2492389334319272,-1.1099886551486964,0.14814814814814814,0.6695601626447265,1.0,69/242,23.12%,ACTB;ESR1;IL33;ATXN3;USP38;OTUD7A;MINDY2;UBB;NFKBIA;UCHL5;TOMM20;MINDY1;EIF3F;NEDD8;RHOT1;USP29;RPS27A;UBC;USP31;UCHL1;ZRANB1;BIRC3;PSMD13;PSMF1;RHOA;PSMB10;APC;OGT;HGS;USP50;PSMB6;ENY2;PSME3;USP37;PSMB5;ADRB2;OTUD3;PSMC3;UCHL3;OTUB1;PSMD12;FOXK1;PSMB8;OTUD1;PSME1;CFTR;UBA52;IFIH1;PSMB3;RUVBL1;MYSM1;USP28;USP9X;ZC3H12A;WDR20;USP8;UBE2D1;ARRB2;RCE1;PSMD5;OTUD6B;POLB;OTUD7B;VCP;TNFAIP3;USP5;PSMD9;PSMB4;OTULIN
prerank,positive regulation of endocytosis (GO:0045807),-0.32666371161492697,-1.1099613437493576,0.2971698113207547,0.668874187281683,1.0,7/45,3.38%,HIP1;SGIP1;B2M;CBL;HNRNPK;NEDD4L;RAB31
prerank,sodium ion import across plasma membrane (GO:0098719),-0.4218700452689294,-1.109935468336483,0.32748538011695905,0.668188496721982,1.0,2/17,0.54%,SLC12A2;SLC9A2
prerank,canonical glycolysis (GO:0061621),-0.38237701795327883,-1.109456179530032,0.32991803278688525,0.6679415378733855,1.0,9/24,17.38%,PKM;HK1;GAPDH;PFKM;FOXK1;TPI1;ALDOA;PFKP;ALDOC
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.38237701795327883,-1.109456179530032,0.32991803278688525,0.6679415378733855,1.0,9/24,17.38%,PKM;HK1;GAPDH;PFKM;FOXK1;TPI1;ALDOA;PFKP;ALDOC
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.41942289769408136,-1.1090822837135281,0.3227176220806794,0.6682457249717938,1.0,9/17,30.73%,HSP90B1;DERL1;HERPUD1;AUP1;TMEM129;VCP;SYVN1;SEC61B;HM13
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.3561909828157628,-1.109034124267236,0.32229580573951433,0.6676272453118652,1.0,16/32,33.37%,APP;TMED10;NR1H4;EIF2A;TIGAR;NOLC1;PRKCD;PUM3;EIF4E;PCIF1;RBM4B;DDX25;RPL10;ATXN2;METTL18;PGAM1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.3782954129759109,-1.1088089878645921,0.319755600814664,0.6675035593838349,1.0,4/25,3.90%,B2M;SLC7A5;PLCG2;CD55
prerank,cellular response to hormone stimulus (GO:0032870),0.3373275380053202,1.108691932156207,0.3018867924528302,0.7970510923050349,1.0,10/69,6.98%,ATP1A2;TFPI;SLC5A5;BRD8;CTSH;NCOA2;STAT5B;CRHBP;NCOA3;UBE2L3
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.4240806077743402,1.1086568377953154,0.31679389312977096,0.7960687758727314,1.0,3/24,2.58%,JPH1;DMD;GSTM2
prerank,B cell activation involved in immune response (GO:0002312),-0.44468853047375784,-1.108627545089947,0.3371868978805395,0.66726096574935,1.0,6/13,29.16%,CD180;MSH2;LIG4;RNF168;FCGR2B;RNF8
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.37980947180608,1.1085088269946537,0.32926829268292684,0.7953579709010564,1.0,6/39,6.25%,ROBO1;RBPJ;BMP2K;MAML3;ZMIZ1;MAML1
prerank,peptidyl-threonine modification (GO:0018210),0.33879581319210633,1.108479060502099,0.2993421052631579,0.7943720863832952,1.0,15/66,14.32%,ROCK2;OXSR1;PDPK1;LRRK2;PRKCA;CDK1;CAMK2D;GALNT16;PRKDC;HIPK3;PRKD2;TBK1;MAPK1;NLK;GALNTL6
prerank,glycolipid biosynthetic process (GO:0009247),0.37767742195999193,1.1083409811979754,0.3093145869947276,0.7936715503034172,1.0,10/38,12.89%,LARGE1;B3GNT5;PIGU;A4GALT;ST3GAL5;PIGG;PIGV;GBGT1;PIGC;PIGQ
prerank,cilium organization (GO:0044782),0.28790421277297074,1.1082099075952216,0.24266666666666667,0.792972899919582,1.0,62/210,19.75%,DCDC2;ASAP1;INTU;AVIL;RAB3IP;ARL3;DYNC2H1;CDC14B;CCDC57;IFT80;CC2D2A;ARMC9;WDR19;UBXN10;TTC8;WDPCP;KIF27;WDR35;ARL6;CEP19;IQCB1;TEKT2;TCTN1;SCLT1;ATP6V0D1;PARVA;CEP89;BBS7;FBF1;OFD1;WDR11;IFT122;CFAP126;TTC39C;PKD2;EXOC3;ARMC2;IFT140;CFAP298;CCDC65;WDR90;CEP164;CFAP70;CFAP410;ATP6V1D;EXOC7;EXOC1;DYNC2I1;CFAP20;PDE6D;RAB11FIP3;ARF4;RP2;TMEM237;BBS1;RTTN;TRAF3IP1;IFT81;IFT46;BBS2;CEP78;TTC17
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.46541650794663325,-1.1080521096878626,0.3283018867924528,0.6681064845801825,1.0,5/11,19.10%,GSN;ST18;PIH1D1;FAS;PLAUR
prerank,iron-sulfur cluster assembly (GO:0016226),-0.37983329604617566,-1.107948151681699,0.3083511777301927,0.6676296400103949,1.0,13/24,37.71%,ISCU;CIAPIN1;GLRX5;GLRX3;HSCB;ISCA2;HSPA9;ISCA1;CIAO2B;BOLA2;NFS1;NUBP1;NUBP2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.2775066728096986,-1.107111918376155,0.24258760107816713,0.669139815189129,1.0,31/104,18.41%,CAV1;BMPER;HTRA3;NOTCH1;UBB;ASPN;BMPR2;PRDM16;IL17RD;TGFBR2;CCN3;TGFB1;CD109;RPS27A;UBC;SPRED2;CRIM1;SMAD9;SMAD5;LEMD2;ZBTB7A;BMP2;STRAP;SKIL;UBA52;ACVR1;TGFB1I1;PPM1A;GREM1;TRIM33;UBE2D1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.46183932558690827,1.106846477479461,0.337890625,0.7956629313828192,1.0,4/14,8.91%,TPP1;ACD;XRCC5;BRCA2
prerank,regulation of mRNA processing (GO:0050684),-0.3561433969498323,-1.106843327875465,0.2882882882882883,0.669090535664408,1.0,11/32,21.22%,HNRNPK;CDK11B;QKI;LARP7;ZFP36L1;KHDRBS3;SRPK1;AHCYL1;SAFB2;YTHDC1;SLTM
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.39014846810015014,-1.1068103463581658,0.33402922755741127,0.6684376329262954,1.0,8/21,10.48%,CAV1;PDE4D;RASSF2;RACK1;NCK1;CNKSR3;DDIT4;NCK2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.35913162929147474,1.1065099943696264,0.3134851138353765,0.795566465568229,1.0,5/45,6.30%,BMP6;BMP7;DAB2;RBPMS;TTK
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3074405481970423,-1.1064839513454805,0.2747524752475248,0.668572993451796,1.0,24/65,27.48%,FHL1;PINX1;PSMD13;PSMF1;RBX1;PSMB10;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;PSMB3;PSMD5;SKP1;PSMD9;PSMB4;INTS3;CHEK1;PSMD10;CHMP4C;AVEN
prerank,regulation of AMPA receptor activity (GO:2000311),-0.37784922001812066,-1.1062372149548008,0.3432203389830508,0.6684961680835618,1.0,11/25,23.72%,MEF2C;SHANK3;MINK1;CACNG3;RELN;ADRB2;CACNG2;CNIH3;SHISA6;MAPK8IP2;SHANK1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3408507553191298,-1.1062336243819237,0.3008658008658009,0.6677648610109507,1.0,8/34,11.34%,PTPRB;PTPRJ;DUSP16;PTPN12;UBASH3B;PTPN1;DUSP8;DUSP3
prerank,positive regulation of secretion by cell (GO:1903532),0.33803028531623935,1.10611355560547,0.29526916802610115,0.7955945547512374,1.0,5/70,3.51%,IGF1;BMP6;FRMD4A;PLA2G10;DTNBP1
prerank,regulation of endocytosis (GO:0030100),0.3453499947565147,1.1059289036084679,0.31155778894472363,0.7950561503643154,1.0,14/61,12.63%,EPHA3;DAB2;TFR2;SYT11;SPHK1;RUFY2;GPC3;SNX33;CCL19;PICALM;ABL1;RUBCN;SNX12;PACSIN3
prerank,positive regulation of cell killing (GO:0031343),-0.4414276893350061,-1.1057094094700395,0.33530571992110453,0.6683540871832351,1.0,3/13,16.37%,RAC1;MAPK8;DVL2
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.45994402489506164,1.105357952305299,0.35714285714285715,0.7955554285932828,1.0,5/16,14.11%,NAA80;AANAT;NAA35;NAA60;CREBBP
prerank,spliceosomal complex assembly (GO:0000245),0.3596013892985302,1.1053069625723888,0.3063063063063063,0.7946230799768164,1.0,10/46,13.75%,CELF2;SRPK2;NOL3;RBM5;SF3A3;DDX23;SMN1;SNRNP200;SCAF11;CRNKL1
prerank,Rap protein signal transduction (GO:0032486),-0.4811603387479302,-1.1046203898865778,0.3532710280373832,0.6704866440287977,1.0,2/10,5.89%,RAP1A;PLK2
prerank,central nervous system neuron development (GO:0021954),-0.4264410283101999,-1.1044278786494721,0.332657200811359,0.6702584230439204,1.0,4/15,9.45%,HSP90AA1;HSP90AB1;B4GALT5;LHX6
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.49183681377857813,1.1043418723506064,0.36024844720496896,0.7962559112310561,1.0,2/11,1.82%,PRKN;DAB2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4311364616740762,1.1042454961407793,0.32673267326732675,0.7954617676630474,1.0,5/19,8.85%,CUX1;IL1RAPL1;OBSL1;PTPRD;CUL7
prerank,protein ubiquitination (GO:0016567),0.2658924376381302,1.1041396035376103,0.22373300370828184,0.7947188186123748,1.0,73/471,12.61%,ASB2;PDZRN3;RNF220;SASH1;TRIM63;EPAS1;RNF43;PRKN;PELI2;BCL2;SPSB1;UBE2E2;HIF3A;TRIM5;MGRN1;NEDD4;RNF213;FBXW4;RNF138;DDB2;RNF217;ZNRF3;PSME4;PSMA2;FBXO44;SH3RF1;TRPC4AP;CAND1;UBE2L3;RNF181;PSMA3;NPEPPS;UBR2;RNF152;SPOP;KLHL7;CUL9;RNF135;SIAH2;WWP2;AMFR;BIRC6;CRBN;USP7;TRAF7;CUL7;RC3H2;UBE4A;FBXL17;NHLRC1;FBXO6;MDM2;PSMD8;ITCH;SMURF2;TRIM35;PRKDC;NEUROD2;DTX1;PSMD3;SH3RF2;RBBP6;FBXO4;MYCBP2;KLHL22;CUL4B;RNF14;CDC73;TRIM26;TRIM43;RNF20;FBXO11;RCHY1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.38006425951608525,-1.1038429584211198,0.30353430353430355,0.6711063839915977,1.0,10/23,24.36%,HSP90AB1;CDC37;NLRC5;IFNGR1;NR1H2;JAK1;TXK;NR1H3;SOCS1;STAT1
prerank,regulation of interleukin-1 production (GO:0032652),-0.4274798741162793,-1.103790941353388,0.3300970873786408,0.6705206322650545,1.0,4/15,13.99%,FOXP1;GAS6;CEACAM1;TMED10
prerank,COPII-coated vesicle budding (GO:0090114),-0.30191229606191966,-1.1036345583573484,0.2641025641025641,0.6701892133250058,1.0,31/68,30.98%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;SEC23A;PPP6R1;TMED10;CNIH1;CTSZ;ANKRD28;SEC16B;PREB;CNIH3;RAB1B;TRAPPC2;CTSC;VAPA;TRAPPC4;TRAPPC9;SEC16A;COL7A1;SEC31A;TRAPPC1;SEC23B;STX5;TRAPPC5;GRIA1;GORASP1;PEF1
prerank,axon development (GO:0061564),-0.2979699292460777,-1.1031911108516348,0.259946949602122,0.670552122244591,1.0,29/78,25.05%,KLF7;ACTB;MAP1B;S100A6;PLP1;GRM7;SHTN1;RTN4RL1;NRCAM;DCC;APBB1;APP;RTN4;SLITRK5;MARK2;SPTBN4;LMTK2;NTNG1;CDK5;DSCAML1;ANK3;L1CAM;RAB8A;BRSK2;MAP1A;RAB3A;ZPR1;EPHB3;ZDHHC17
prerank,iron ion homeostasis (GO:0055072),-0.31484630349094234,-1.1026362713374882,0.28746928746928746,0.6712789589011587,1.0,16/58,10.01%,ABCG2;FTH1;B2M;TFRC;SCARA5;FTL;IREB2;SLC40A1;SOD1;NEDD8;SLC22A17;ISCU;FBXL5;HMOX2;FRRS1;ATP6V1A
prerank,peptidyl-arginine modification (GO:0018195),-0.42622392053431923,-1.10259262313832,0.33396946564885494,0.6706748600763032,1.0,3/15,8.10%,ART3;KRTCAP2;PRMT8
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.4575279104048756,1.1025410670595703,0.34980237154150196,0.7980881186823003,1.0,4/16,9.05%,APPL2;PPARA;NLRC3;SIRPA
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.2902429619700148,-1.1019504714472035,0.2603092783505155,0.6716068936831382,1.0,30/87,23.78%,KLF4;FHL1;PINX1;FAM107A;PSMD13;PSMF1;RBX1;ZFP36L1;PSMB10;APC;CDK6;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;JADE1;CDK2AP2;PSMB3;PSMD5;SKP1;CDKN1A;CDKN2D;PSMD9;PSMB4;E2F7;RGCC
prerank,Golgi to endosome transport (GO:0006895),-0.42198296238775307,-1.1018274948046742,0.33537832310838445,0.671211657546962,1.0,8/16,25.06%,MON2;VPS13A;VPS13C;AP1AR;GBF1;SYS1;AP2A1;RAB14
prerank,cilium assembly (GO:0060271),0.27739551806260665,1.1015063216719752,0.2442159383033419,0.7997829114572464,1.0,82/297,19.70%,DCDC2;ASAP1;NINL;INTU;ALMS1;AVIL;RAB3IP;ARL3;DYNC2H1;CDC14B;CCDC57;IFT80;HAUS4;CEP152;CC2D2A;ARMC9;WDR19;SDCCAG8;UBXN10;TTC8;WDPCP;TBC1D32;KIF27;WDR35;ARL6;CEP19;IQCB1;ARL13A;CDK1;RPGRIP1L;PAFAH1B1;TEKT2;TCTN1;SCLT1;ATP6V0D1;PARVA;CEP89;BBS7;FBF1;OFD1;WDR11;HAUS1;IFT27;IFT122;SFI1;TTC39C;CEP57;CFAP74;EXOC3;KIF3C;TNPO1;IFT140;CFAP298;CCDC65;WDR90;CEP63;CEP164;CFAP70;DNAAF3;CFAP410;ATP6V1D;EXOC7;EXOC1;DYNC2I1;CFAP20;TUBG1;IFT22;PDE6D;RAB11FIP3;CEP97;ARF4;RP2;TMEM237;BBS1;AKAP9;TRAF3IP1;IFT81;IFT46;BBS2;CNTRL;GAS8;CEP78
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.47592261170712824,-1.101396674431065,0.36007462686567165,0.6715569088282015,1.0,6/10,28.69%,ST6GAL1;ST3GAL1;GNPDA1;AMDHD2;GNPDA2;NANP
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2983211016365458,-1.101300439305209,0.268733850129199,0.6710606783249462,1.0,18/75,13.92%,SLC12A7;SLC12A2;SLC9A2;SLC39A10;KCNJ2;ATP1A1;ABCC9;ATP1B1;SLC12A6;SLC12A8;SLC39A8;SLC24A2;SLC12A4;ATP1A3;KCNJ8;TRPV2;SLC39A14;KCNJ15
prerank,positive regulation of heart rate (GO:0010460),-0.41071763831902514,-1.1011830525418271,0.34475374732334046,0.6706285410548707,1.0,7/17,9.30%,PDE4D;ADRA1B;ATP2A2;KCNQ1;ADRA1A;RYR2;EDN1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.3232112820529736,-1.1009395854479058,0.30963302752293576,0.670606505653099,1.0,17/45,25.95%,TGFB1;DDX5;BUD23;GRSF1;LIN28B;MAP2K2;UTP15;SUPV3L1;HNRNPLL;BMP4;RBM22;SIRT7;RBM20;RELA;ZPR1;HRAS;ERN1
prerank,zinc ion transmembrane transport (GO:0071577),-0.3864806820568918,-1.1006298652500013,0.3434959349593496,0.6707006048600593,1.0,6/22,13.34%,SLC39A10;SLC30A5;SLC39A8;SLC30A1;SLC39A7;SLC39A14
prerank,membrane assembly (GO:0071709),0.38464170119434504,1.1005785890394142,0.3356164383561644,0.8011882369217813,1.0,8/34,9.40%,LRP4;CEL;NLGN2;IL1RAPL1;PTPRD;UBXN2B;PTEN;PICALM
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.37633192873451865,-1.100341881418208,0.34591194968553457,0.6707389357652143,1.0,4/23,9.42%,CADM1;PIK3R6;LAMP1;PVR
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.4498887646491126,-1.1003186257803883,0.35,0.6700749270083499,1.0,2/12,5.38%,ESR1;TGFB1
prerank,positive regulation of wound healing (GO:0090303),-0.34305917429408633,-1.1000652725271076,0.284796573875803,0.6700210401169588,1.0,10/36,10.15%,ST3GAL4;ACTG1;OCLN;THBS1;PTK2;ITGB1;KANK1;FERMT2;MTOR;XBP1
prerank,protein targeting to lysosome (GO:0006622),-0.3970412835323454,-1.1000387335109263,0.32748538011695905,0.6693556239285724,1.0,11/20,25.68%,HSPA8;SNX16;HGS;CLU;NCOA4;M6PR;LAPTM5;GNPTAB;RAB7A;SCARB2;SORL1
prerank,retinol metabolic process (GO:0042572),0.4631988041618766,1.0995762623926408,0.33861386138613864,0.802828004291466,1.0,3/14,15.97%,RBP4;DHRS3;RDH11
prerank,actin filament organization (GO:0007015),0.3008919039264343,1.0993456263097487,0.3037037037037037,0.8024322423356859,1.0,23/151,8.13%,SHROOM3;CGNL1;TPM1;MYO5C;RHOD;FHOD1;DPYSL3;SHROOM2;AVIL;MYO1H;NEBL;ABI2;BAIAP2;ARHGAP12;WASL;FAT1;BAIAP2L2;DLG1;PPP1R9A;RHOBTB2;SPIRE2;MCU;CORO7
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.28090652125909105,-1.099322033729847,0.2712765957446808,0.6705630887797784,1.0,38/100,23.48%,RPL11;RNF144B;CBFA2T3;HSP90AB1;RNF144A;RACK1;TRIB2;UCHL5;UBXN1;NKD2;SOCS5;BAG6;GSK3B;GNA12;ZYG11B;RBX1;OGT;FOXF2;CAMLG;UBQLN4;RYBP;CLU;HERPUD1;ELOB;ARIH2;COP1;RNF19B;N4BP1;TLK2;NOP53;ARIH1;VCP;RNF19A;USP5;CEBPA;TRIB3;MAP1A;HSPA1B
prerank,regulation of actin filament polymerization (GO:0030833),-0.30201058022336863,-1.0992491211435271,0.272264631043257,0.6700607147595296,1.0,18/69,11.81%,SLIT2;ESAM;KANK3;CARMIL1;PTK2B;CDC42EP3;NCKAP1;KANK1;NCK1;BAIAP2L1;HIP1R;CYRIB;SSH2;SSH1;KANK4;NCK2;DBNL;BIN1
prerank,positive regulation of T cell migration (GO:2000406),0.4250452575480665,1.0992473942880863,0.34279918864097364,0.8016099682528764,1.0,2/20,3.19%,OXSR1;CXCL13
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4466294239605541,1.0991501454502823,0.3475609756097561,0.8008064661850223,1.0,2/17,1.19%,ROBO1;EFNB2
prerank,regulation of tissue remodeling (GO:0034103),0.44249069371567945,1.0988386504851564,0.3629032258064516,0.8006435408734569,1.0,2/18,1.22%,LEPR;IL18
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4215085541986515,1.098767180062975,0.35135135135135137,0.7998244928568741,1.0,2/20,0.85%,TGFBR3;RBPJ
prerank,response to interferon-alpha (GO:0035455),-0.41691828298400324,-1.0984239746126285,0.32854209445585214,0.6716416744039198,1.0,6/16,22.88%,GAS6;ADAR;BST2;IFITM3;RO60;IFNAR1
prerank,protein modification process (GO:0036211),-0.29414585488168127,-1.0983595480650314,0.28609625668449196,0.6711236359924906,1.0,22/76,19.38%,ST3GAL6;ST8SIA4;STK38;CHRM3;FBXW2;NEDD8;ADPRH;MAN2B1;RPN1;PLOD2;MMP15;CDKL3;ERO1A;UBA52;FBXL2;ST8SIA2;QPCT;DUSP12;YES1;RABGGTB;ST3GAL1;PPP4R2
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.39517614480463076,-1.0982002120206589,0.34408602150537637,0.6707911344553407,1.0,10/21,11.34%,LIMCH1;EFNA5;ACTG1;PTK2;SLK;CORO1C;GPM6B;PEAK1;RHOA;DUSP3
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.37962006733903175,-1.098063606162348,0.33669354838709675,0.6704114932410461,1.0,4/22,13.11%,ESR1;MED17;PSMC3;MED14
prerank,anion transport (GO:0006820),-0.35103616739133936,-1.097816629321462,0.3292433537832311,0.6704007278943317,1.0,6/33,2.70%,ABCG2;SLC26A7;LRRC8C;LRRC8D;LRRC8B;SLCO2B1
prerank,regulation of histone acetylation (GO:0035065),-0.3419967796721033,-1.097708959902312,0.3172866520787746,0.6699435284294708,1.0,12/33,21.48%,RPS6KA5;PPARGC1A;HDAC5;ARRB1;SET;GLYR1;NOS1;RPS6KA4;CTBP1;SPI1;NOC2L;MAPK3
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.47477382572192145,1.097659819989942,0.36438923395445133,0.8018961716581706,1.0,1/12,1.22%,IL18
prerank,negative regulation of insulin secretion (GO:0046676),-0.41042986743046295,-1.0974008855948496,0.3545816733067729,0.6700227201114314,1.0,6/17,14.03%,KLF7;KCNB1;CCN3;REST;CHGA;SIRT4
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.44907885466483466,-1.096944413885731,0.3597560975609756,0.6704745855173638,1.0,6/12,18.13%,HSP90AA1;HSP90AB1;B4GALT5;EPHB1;SPTBN4;B4GALT6
prerank,glutathione biosynthetic process (GO:0006750),-0.46598625906388264,-1.0967617018000884,0.36645962732919257,0.6702317640941486,1.0,5/11,32.53%,GCLM;GGT1;CHAC2;MGST2;OPLAH
prerank,glycosaminoglycan catabolic process (GO:0006027),0.3484485768558982,1.096308390999004,0.3197389885807504,0.8045334789941396,1.0,8/55,5.38%,CEMIP;FMOD;SDC2;OGN;GPC6;OMD;PRELP;GPC3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.31193942789551216,1.0962185795886792,0.30637636080870917,0.8037160905808256,1.0,9/101,5.51%,ROBO1;IL34;CEMIP;KIT;LTF;PDGFRB;PDGFD;LRRK2;FGF1
prerank,myelin assembly (GO:0032288),-0.47224840169372917,-1.0958497087847703,0.3726937269372694,0.6717890843322608,1.0,7/10,24.20%,CD9;TENM4;GPC1;TPPP;ABCA2;NCMAP;EPB41L3
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.28765896037609934,-1.0957778291056148,0.2857142857142857,0.6712497213001459,1.0,34/86,26.33%,KLF2;UBB;RPS27A;UBC;EGLN3;VEGFA;PSMD13;PSMF1;RBX1;PSMB10;LIMD1;ATF4;PSMB6;PSME3;PSMB5;EGLN2;PSMC3;PSMD12;PSMB8;ELOB;PSME1;UBA52;PSMB3;DNAJB1;PSMD5;ATF3;HIGD1A;PSMD9;PSMB4;VHL;CUL2;CHEK1;PSMD10;EPO
prerank,negative regulation of cellular senescence (GO:2000773),-0.45251848205966877,-1.0957709805892937,0.36257309941520466,0.670552561696851,1.0,3/13,12.33%,YBX1;CDK6;MAP3K3
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5002339276024643,1.095718051193315,0.3528138528138528,0.8039976065653178,1.0,3/10,16.12%,KIT;BTLA;LYN
prerank,sterol transport (GO:0015918),-0.40244227213222816,-1.0956243005155821,0.3542074363992172,0.6702277463731491,1.0,4/19,23.65%,CAV1;LCAT;OSBPL5;NPC2
prerank,regulation of DNA binding (GO:0051101),0.35693940207197195,1.0953690742869278,0.3404634581105169,0.8039305126879595,1.0,6/44,8.99%,IGF1;PRKN;SP100;MMP9;RSF1;CEBPG
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.46463791544219146,1.0953048269475534,0.3770833333333333,0.8030842433218097,1.0,3/14,11.93%,ATP1B3;ANK2;ACTN2
prerank,response to estrogen (GO:0043627),-0.3506795647956752,-1.0944417900678083,0.31880733944954126,0.6727028786590212,1.0,8/31,14.67%,CAV1;ESR1;TRIM25;SERPINB9;ARID5A;WBP2;SFR1;NCOA4
prerank,regulation of axonogenesis (GO:0050770),0.3500806449064653,1.0942406810942935,0.31666666666666665,0.8049866242486285,1.0,8/51,7.48%,PLXNA2;ROBO1;LRP4;KIF13B;EPHA4;PLXNC1;ARHGAP35;PTEN
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.45134962268631085,-1.0942319505306606,0.35375494071146246,0.6725301829793916,1.0,9/12,41.36%,UCKL1;CDA;DCK;UCK1;UCK2;UMPS;UPP1;TK2;CAD
prerank,phospholipid translocation (GO:0045332),-0.37070980738987025,-1.0942019018663292,0.33192389006342493,0.6718889490182638,1.0,9/28,12.13%,ATP10A;ATP8B1;ATP8A1;ATP8A2;MFSD2A;ATP11C;ATP11B;TMEM30A;ATP11A
prerank,renal filtration (GO:0097205),-0.46343077061087123,-1.094143782927627,0.34296724470134876,0.6713446387398336,1.0,3/10,7.33%,CD34;MCAM;TBC1D8B
prerank,regulation of glucose transmembrane transport (GO:0010827),0.4374787069772877,1.0940764019174065,0.3785310734463277,0.8043694627369823,1.0,2/18,5.87%,PRKAG2;PRKCB
prerank,negative regulation of cell cycle process (GO:0010948),0.3405014100128947,1.094061130139397,0.32053422370617696,0.8033680855324877,1.0,8/61,6.57%,BMP7;DMRT1;RBBP4;L3MBTL2;MGA;TOM1L2;RNF2;RBBP7
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.3625710425258905,1.0939093976628456,0.3290909090909091,0.8027791444858452,1.0,1/41,0.08%,PRKAG2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4016557172747589,1.0938975302741234,0.3422562141491396,0.8017882521141751,1.0,2/26,1.91%,ERRFI1;SNX6
prerank,cellular response to insulin stimulus (GO:0032869),-0.27301192884362857,-1.0937720597199088,0.2570621468926554,0.671559332696219,1.0,45/124,23.23%,GAB1;GRB14;BCAR3;NAMPT;AP3S1;CAV2;RAB31;PKM;BCAR1;HDAC5;ATP6V0A1;GSK3B;CEACAM1;FOXO1;ZDHHC7;APPL1;C2CD5;CPEB1;ZFP36L1;ATP6V1A;APC;XBP1;ATP6V0C;PIK3C2A;MYO5A;PDK2;TCIRG1;ATP6V1E1;IDE;SLC39A14;LPIN3;LPIN1;ATP6V0A4;ATP6V0A2;PIK3R3;AKT1;INSR;ATP6V0D2;HDAC9;RAB8A;DENND4C;CAPN10;RAB8B;TRIB3;INSIG1
prerank,negative regulation of viral life cycle (GO:1903901),-0.42117045634126055,-1.0933406236201055,0.3697813121272366,0.6718971994119257,1.0,7/15,22.40%,LY6E;GSN;PPIA;BST2;MID2;IFITM3;CIITA
prerank,positive regulation of cellular component organization (GO:0051130),0.3128849590428682,1.0932492597481316,0.30236220472440944,0.8025421803043231,1.0,15/107,7.56%,FRMPD4;TRABD2B;ASAP1;BMP7;ADGRL1;LRP4;DAB2;FNIP1;TFR2;CRB3;GPC3;IGF1R;BNIP3;SLF1;CCL19
prerank,positive regulation of phospholipid transport (GO:2001140),-0.47128412038509593,-1.0932241308751744,0.3800738007380074,0.6714992650015351,1.0,7/10,42.61%,TMEM30A;ABCA3;DBI;ABCA7;PRELID1;ABCB4;TRIAP1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.31398229109518355,1.092899851143932,0.30963665086887837,0.802478823404918,1.0,19/95,12.45%,NINL;ALMS1;RAB3IP;HAUS4;CEP152;CC2D2A;SDCCAG8;IQCB1;CDK1;RPGRIP1L;PAFAH1B1;TCTN1;SCLT1;CEP89;FBF1;OFD1;HAUS1;SFI1;CEP57
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.45587681542092484,-1.0928454228371305,0.37570093457943926,0.6717436666780696,1.0,6/12,28.49%,DAB2IP;XBP1;PTPN1;BAX;ERN1;TMEM33
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.2837767112068587,-1.0919713850366293,0.2543640897755611,0.6732598162579986,1.0,32/88,23.79%,FNIP2;TFRC;DAB2IP;RPS3;RACK1;SH3GLB1;WARS1;TGFB1;MPP7;FAF1;GSK3B;VEGFA;SPIDR;HGS;PIH1D1;TAL1;CLU;CHGA;TPPP;ATP13A2;CDC42EP2;TIRAP;MMP1;SDC4;BIK;VCP;BMF;MTLN;RAB7A;PDCD6IP;RGCC;BAX
prerank,cellular response to UV-A (GO:0071492),0.4789543763684428,1.091798250404347,0.36382536382536385,0.8044751551714269,1.0,3/11,9.42%,MMP2;MMP9;CERS1
prerank,regulation of vasoconstriction (GO:0019229),-0.36512986769673056,-1.0913121019682672,0.33472803347280333,0.6743225665411595,1.0,9/27,11.79%,CAV1;BMPR2;ADRA1B;CHRM3;ADRA1A;KCNMB4;ECE1;ACE2;ATP2B1
prerank,cellular response to interleukin-1 (GO:0071347),-0.2606497131607729,-1.0904666444679143,0.2433234421364985,0.6757344525275562,1.0,49/143,23.41%,RPS6KA5;DAB2IP;UBB;NFKBIA;NOD1;IKBKB;ST18;IL1R1;RPS27A;UBC;IL1RAP;PTGIS;PSMD13;PSMF1;RBX1;PSMB10;CHUK;PSMB6;TOLLIP;PSME3;PSMB5;MAP3K3;PSMC3;IRAK3;GBP3;PSMD12;PSMB8;CUL1;MAP3K8;TAB3;CD47;PSME1;UBA52;PSMB3;RPS6KA4;CD40;ZC3H12A;CCL13;IRAK1;PSMD5;MYD88;SKP1;MAPK3;MAPK11;PSMD9;HYAL2;PELI1;PSMB4;RELA
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3110525280368427,1.090328371606547,0.2820919175911252,0.807438512092946,1.0,10/102,4.51%,ADCY5;ADCY1;PDPK1;SORBS1;INSIG2;FER;RAB13;PCSK9;CRHBP;CPEB2
prerank,Wnt signaling pathway (GO:0016055),0.3142203555193303,1.0900539418651074,0.3080495356037152,0.8072184783127369,1.0,15/92,10.14%,WLS;TCF7L2;WNT4;WNT6;PLPP3;LRRK2;FRAT1;TCF7L1;ARL6;WNT5B;PTEN;RYK;USP34;BCL9;DVL3
prerank,positive regulation of multicellular organismal process (GO:0051240),0.2743841939074097,1.0899832304261585,0.2803738317757009,0.806359119758403,1.0,33/308,7.08%,SOX5;LEPR;C1QTNF3;APPL2;EPAS1;IL18;DAB2;ACSL1;ESRRG;GNAS;PLA2R1;SCX;SOX6;PLCB1;ALMS1;PPARGC1B;PDPN;ITGAX;GRB10;ABCA1;FOXD1;GLIPR2;GJA1;ACADL;IGF1R;CPT2;PTN;NIBAN2;ADRA1D;IL6;PTH2R;NCOA3;SMAD3
prerank,regulation of adenylate cyclase activity (GO:0045761),0.41900425761090987,1.0899455681241337,0.34911242603550297,0.8054326291087444,1.0,3/22,4.74%,ADGRV1;STIM1;CACNA1D
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.4338092978918191,-1.089825868461618,0.3507751937984496,0.6767643062518143,1.0,7/13,27.87%,CD44;CD74;MIF;PTTG1IP;SNAI2;PSMD10;YJU2
prerank,aggrephagy (GO:0035973),-0.35815511945624595,-1.089629568379459,0.34232365145228216,0.6766337622597723,1.0,8/27,15.45%,VIM;UBB;DYNLL2;RPS27A;UBC;WDFY3;CFTR;UBA52
prerank,L-glutamate transmembrane transport (GO:0015813),0.4911958746351654,1.0894288040952567,0.39439655172413796,0.8058357963896332,1.0,3/10,9.27%,SLC1A3;SLC25A18;SLC25A22
prerank,protein autophosphorylation (GO:0046777),0.294108565225865,1.0892375077570013,0.29428571428571426,0.8053722679979213,1.0,27/157,12.60%,OXSR1;FGFR2;FGFR4;KIT;DAPK1;PDPK1;PDGFRB;FER;EPHA8;EPHA4;PDGFRA;DDR1;SIK1;IGF1R;LRRK2;STK17B;DDR2;GRK5;MUSK;CAMK2D;VRK2;ABL1;JAK2;ERBB2;MAPKAPK2;PRKD2;STK24
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3911414655207004,1.0889045778963193,0.3567567567567568,0.8052840672852624,1.0,4/27,4.86%,JPH1;DMD;ANK2;CACNB4
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2925126962860333,-1.0888659002737011,0.2890625,0.6779185505271408,1.0,18/75,17.57%,GPCPD1;DGKH;SERINC1;SERINC5;CRLS1;SYNJ1;SMPD4;FAR1;GDPD1;CPNE3;PLCB3;GDPD3;PNPLA6;CSF1R;PLA2G4A;ABCA3;PGP;PIGZ
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.33917727674354786,-1.0883804462290367,0.3246753246753247,0.6784635410192867,1.0,16/35,24.25%,CALM1;HSP90AB1;TIPRL;PPP1R2;HSP90B1;GSK3B;MTOR;MASTL;PPP6R1;CSNK2B;CALM2;BOD1;CD300A;CALM3;PPP1R15A;PPP1R15B
prerank,maturation of LSU-rRNA (GO:0000470),0.4008353198411686,1.0880697016176513,0.33815551537070526,0.8065286364306594,1.0,7/26,16.86%,NSA2;FTSJ3;DDX18;NIFK;ZNHIT3;BOP1;ZNHIT6
prerank,chemical synaptic transmission (GO:0007268),-0.24488928794220663,-1.0877983325673497,0.23109243697478993,0.6792171139888964,1.0,89/284,26.59%,UNC13B;SLC12A7;GRM3;DLG2;HSPA8;KCNQ3;LIN7A;CALM1;ATXN3;PLP1;GRM7;MBP;EXOC4;PTPRN2;MINK1;GABRB3;SLC12A6;SLC1A1;HOMER1;STX1A;SYPL1;CAMKK2;GRIK4;GABRB1;CHRM3;DLGAP1;CACNA1E;SLC17A6;HTR2A;NRXN1;NAPB;AMPH;KCNMB4;GRIN1;SLC12A4;KCNA1;SYT10;RPS6KA1;GABRG3;SLC1A4;SYNJ2BP;GAD1;CACNB2;SNAP25;PCDHB14;BSN;PRKAR1A;HRH1;APBA3;SYN2;KCNIP2;KCNQ2;CAMK4;PTCHD1;CACNA1B;GLRA3;GRIA2;STAC3;SLC6A5;CDK5;CACNB3;KCND2;GRIK2;RIT2;CAMKK1;GABRA5;GRID2;PPFIA3;TSPOAP1;HRH2;GABRE;NPTX1;SHISA6;SST;CHRNB1;NPY;SNCG;RAB3A;PNOC;CPLX1;GABRG2;HAP1;KCNC4;HTR2C;GLRA1;CNP;APBA2;CHRM1;KIF1B
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.4733159631795149,-1.0877964604349488,0.3857404021937843,0.6785119239462791,1.0,6/10,26.47%,SVIP;ERLEC1;INSIG1;UBE2J1;YOD1;UBAC2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3841990155693836,1.0877673963278158,0.3537037037037037,0.80630024509377,1.0,4/31,6.47%,RANBP3L;SMAD6;TMEM64;SUFU
prerank,DNA biosynthetic process (GO:0071897),-0.41809931959200836,-1.0877118033665267,0.3607843137254902,0.678008182670209,1.0,8/16,26.39%,PPIA;WRNIP1;POLA1;POLE;POLD3;CDKN2D;POLD1;POLL
prerank,positive regulation of transferase activity (GO:0051347),0.299900086224199,1.0875335058179627,0.3398496240601504,0.8058832124567729,1.0,19/142,8.66%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;LMO4;PDGFRB;IGF2;EPHA8;EPHA4;PDGFRA;DDR1;IGF1R;ACD;UBE2L3;XRCC5;DDR2;RYK;MUSK
prerank,polarized epithelial cell differentiation (GO:0030859),-0.4314972122627251,-1.0874208162350238,0.34592445328031807,0.6780246668776292,1.0,3/13,9.24%,MSN;ZDHHC7;RHOA
prerank,secondary alcohol metabolic process (GO:1902652),0.3715401502484296,1.0873772572752354,0.33697632058287796,0.8052942933989121,1.0,8/42,12.25%,CYP27A1;ABCA1;ABCA5;IDH2;SOAT2;RXRA;IDH3G;GBA2
prerank,regulation of microtubule nucleation (GO:0010968),-0.47690356049189236,-1.0873729042791118,0.3433962264150943,0.6774517015213847,1.0,7/10,33.16%,PAK1;GIT1;CKAP5;DCTN1;HSPA1B;RANGRF;HSPA1A
prerank,regulation of cytoskeleton organization (GO:0051493),-0.27384749643307005,-1.0872520449561551,0.28700906344410876,0.6770572614981832,1.0,26/108,12.26%,EFNA5;CLIC4;RAC1;IQGAP1;PTK2;CORO2B;PHLDB1;F11R;MAP6;RHOB;FAM107A;CAPN2;CCDC88A;GSK3B;GPM6B;HIP1R;TJP1;MTOR;PAK1;ARHGEF19;RHOA;PAK2;ARHGEF5;CRK;SORBS3;MARK2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.40718013874103887,-1.0868023890154976,0.3714859437751004,0.677406986177113,1.0,9/17,24.25%,CALM1;HSP90AB1;PTPRC;MTOR;CALM2;CD300A;CALM3;PPP1R15A;PPP1R15B
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.38173616269972416,1.0867319602143524,0.35472370766488415,0.8059628652845398,1.0,3/32,2.58%,CEMIP;PDPK1;GSTM2
prerank,signal peptide processing (GO:0006465),-0.45581717826682056,-1.0865721346622177,0.34970530451866405,0.6773546246985838,1.0,6/11,31.38%,FURIN;PCSK5;CLN5;SEC11A;HM13;SPCS3
prerank,vasculature development (GO:0001944),0.4406156535380936,1.0865560570614485,0.35876288659793815,0.8053684852157035,1.0,3/16,4.40%,ERRFI1;PDGFRB;PDGFRA
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3896119503168811,-1.0861370136177866,0.35319148936170214,0.6777564700271493,1.0,11/18,28.70%,MSN;HSP90AA1;FAF1;CD81;ATP5IF1;VPS11;ABCA2;CTSC;PTTG1IP;EZR;RNF128
prerank,protein localization to chromatin (GO:0071168),-0.39963622868369575,-1.0861338247143277,0.3613963039014374,0.6770666968441086,1.0,10/18,32.07%,ESR1;LEMD2;PIH1D1;TASOR;MSH2;MCM8;CHMP7;SGF29;PPHLN1;PLK1
prerank,protein palmitoylation (GO:0018345),-0.3584977589582399,-1.0857356320071425,0.3528138528138528,0.6774253458726586,1.0,13/30,27.61%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;PORCN;HHAT;SELENOK;ZDHHC4;ZDHHC8;ZDHHC20;ZDHHC17;ZDHHC5
prerank,cellular protein catabolic process (GO:0044257),0.3422473270343934,1.0857002506684619,0.3409893992932862,0.8066708015637719,1.0,10/59,9.50%,ADAMTS12;PRKN;CLPX;CTSH;PCSK9;ADAMTS7;BNIP3;SIAH2;YME1L1;MDM2
prerank,pyruvate metabolic process (GO:0006090),-0.3091144822898487,-1.0851063431353005,0.3213429256594724,0.6784110372880638,1.0,12/52,17.38%,BSG;PKM;SLC16A1;ME1;HK1;GAPDH;PDHA1;PFKM;TPI1;ALDOA;LDHA;ALDOC
prerank,small GTPase mediated signal transduction (GO:0007264),-0.27779328961780164,-1.08504889312389,0.30939226519337015,0.6778527510062613,1.0,33/103,18.23%,ARHGAP31;RAPGEF5;TIAM1;RASGRP3;KRAS;RAC1;SHTN1;RERG;NRAS;G3BP1;PLK2;CCDC88A;ABR;BCR;MRAS;CHP1;JUN;NUCB1;RAB38;RALB;USP50;KSR2;RHEB;GRAP;RUNDC3A;NF1;CCDC88C;PRKD1;USP28;RRAS;USP8;CDK2;RGS19
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.4722729347682989,1.0849407297573237,0.3739495798319328,0.8076553054032547,1.0,3/12,8.39%,PPARA;ABCA1;ABCA5
prerank,cellular response to osmotic stress (GO:0071470),0.4231756885553214,1.08462365765543,0.3556910569105691,0.8075538408883803,1.0,4/21,7.82%,OXSR1;MYLK;LRRC8E;RCSD1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.40674514590977967,-1.084510997249163,0.3486973947895792,0.6785198556562723,1.0,5/17,11.93%,PRKG1;MEF2C;PDCD4;CDKN1B;GPER1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.31413382184177946,-1.0844442781517765,0.3333333333333333,0.6779982036878088,1.0,11/48,13.61%,FNIP2;CRIP1;BCL2L1;BAG6;TNFRSF1B;CHEK2;DDIT4;BCL3;MSH2;AEN;RPS27L
prerank,cellular response to heat (GO:0034605),-0.34664767719940304,-1.0836253958221331,0.3418013856812933,0.6794473013497232,1.0,5/35,2.39%,ANO1;THBS1;HSP90AA1;HSP90AB1;ATXN3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.3343837597631607,-1.083505185479281,0.3254310344827586,0.6790678704981596,1.0,12/35,13.76%,HEG1;TGFB2;RASIP1;DAB2IP;CCDC125;KANK1;MET;CUL3;MYOC;KCTD13;SPRY4;STMN1
prerank,regulation of neurogenesis (GO:0050767),-0.30730491765443485,-1.0834021203625455,0.32323232323232326,0.6786193836351968,1.0,20/55,23.10%,B2M;BHLHE40;NOTCH1;HES1;TGM2;CTNNB1;PRUNE1;SERPINF1;HEY2;HEYL;GPER1;REST;CX3CR1;SPEN;LIG4;HES6;DLL1;SOX11;FAIM;HEY1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.39321493730490753,1.0832422104972799,0.3527272727272727,0.8101851903612839,1.0,2/26,3.14%,NPR3;NOS1AP
prerank,neural tube development (GO:0021915),0.4507692159384785,1.0831150677704529,0.35823754789272033,0.8094836563394201,1.0,1/15,0.23%,ALDH1A2
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4991556236767454,1.083053056355891,0.3879668049792531,0.8086296914999399,1.0,5/10,13.92%,ACD;DCLRE1A;DCLRE1B;RTEL1;APEX1
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.3587219189604822,-1.0829580642049588,0.3333333333333333,0.6791198926410931,1.0,4/29,5.63%,JAM2;GAS6;LGMN;CALR
prerank,telomere maintenance via recombination (GO:0000722),0.475145291585941,1.082653057245089,0.38228941684665224,0.8086271614677077,1.0,7/11,28.24%,TEP1;RAD51;TPRKB;RAD50;ERCC4;SMC5;SMC6
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.24313761203349485,-1.082277273552672,0.21176470588235294,0.6801506270787282,1.0,55/234,16.37%,PRKCH;CAV1;ESR1;CD200;TFRC;RPS6KA5;PPARGC1A;PLCG2;UBB;NFKBIA;RPS3;PPIA;NOD1;ROR1;FZD4;TRIM14;IKBKB;HDAC5;EDA;TRIM25;CTNNB1;RPS27A;UBC;TNFRSF11A;LRP8;APP;CARD14;VEGFA;IL1RAP;AIM2;SLCO3A1;ZBTB7A;EDN1;ARHGEF5;CHUK;RTKN2;STAT3;RELN;ARHGEF2;CLU;IRAK3;STK36;PPRC1;TAB3;JUP;TERF2IP;TRIM13;TRAF1;UBA52;CX3CR1;TCF3;CARD16;PRKD1;RPS6KA4;DVL2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4404457955351784,1.0819536003026244,0.35080645161290325,0.8095214885703503,1.0,4/16,10.08%,LHPP;AMPD3;ADSL;GMPS
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.3927506332902649,-1.0817352129533693,0.34773218142548595,0.6807957777107425,1.0,4/18,6.19%,MSN;HSP90AA1;DAB2IP;FAF1
prerank,ESCRT complex disassembly (GO:1904896),-0.45937283639576293,-1.0809894191592482,0.3850806451612903,0.6813178794631408,1.0,7/10,35.03%,CHMP5;CHMP2B;CHMP1B;CHMP1A;CHMP7;VPS4B;IST1
prerank,ESCRT III complex disassembly (GO:1904903),-0.45937283639576293,-1.0809894191592482,0.3850806451612903,0.6813178794631408,1.0,7/10,35.03%,CHMP5;CHMP2B;CHMP1B;CHMP1A;CHMP7;VPS4B;IST1
prerank,positive regulation of cell adhesion (GO:0045785),-0.2899433265496309,-1.0809539990078116,0.2717948717948718,0.6807139606312191,1.0,13/74,8.32%,FRMD5;PTPRJ;ZFHX3;RAC1;TGFB2;VIT;STX3;LIMS1;TGM2;FBLN2;VEGFA;ECM2;NPNT
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.36545063247371307,-1.0809252382203656,0.34394904458598724,0.6801078605460414,1.0,4/27,2.60%,UTRN;FXYD5;SLMAP;NEDD4L
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.38354353696188986,1.080599568802083,0.34307992202729043,0.8123168469231078,1.0,7/30,7.35%,SNTA1;KCNA5;GPD1L;ANK2;CACNA1D;GJA1;CACNA2D1
prerank,fatty acid oxidation (GO:0019395),0.3389911094533918,1.0801564349927821,0.336734693877551,0.8124947183874617,1.0,15/57,14.65%,EHHADH;ACADL;ECI2;HSD17B10;CPT2;ACAD11;ECHDC1;ACADS;PHYH;ACAA2;ACAT2;AUH;ACOX1;BDH2;HACL1
prerank,actin cytoskeleton reorganization (GO:0031532),0.33893951744120343,1.0801018151372634,0.3445378151260504,0.8116107810070282,1.0,9/63,5.14%,AUTS2;PTK7;NRK;KIT;ANTXR1;FER;ANXA1;DTNBP1;RICTOR
prerank,O-glycan processing (GO:0016266),0.3474574273065764,1.0797488651135672,0.34455128205128205,0.8115550270245275,1.0,5/54,2.72%,ST3GAL3;GALNT15;GALNT14;GXYLT2;B3GNT5
prerank,negative regulation of cell death (GO:0060548),-0.28628262985098457,-1.079567021559321,0.3277310924369748,0.6829833140072918,1.0,29/88,20.48%,MECOM;CD200;CD34;PPARGC1A;PDE8A;FYN;CCN3;SOX4;NCK1;FERMT2;GSK3B;TNFRSF1B;WNT16;EIF4G1;CLU;CHGA;SRSF6;CCN1;MT3;NENF;WFS1;PRKD1;ATP13A2;DCPS;CDK5;TIGAR;PINK1;AKT1;BMP4
prerank,negative regulation of protein modification process (GO:0031400),0.32368366661493,1.0789680340698724,0.343801652892562,0.8126098251521422,1.0,15/79,9.05%,PTPN13;PID1;PRKN;DMD;SNTA1;PLPP3;PTPA;CACTIN;PRKAA2;LRRK2;FBLN1;PTEN;PRKAA1;ATG14;SIRPA
prerank,intermediate filament organization (GO:0045109),-0.4057796315887364,-1.078700994498873,0.34012219959266804,0.684601738931961,1.0,6/17,25.93%,VIM;GFAP;MTM1;DSP;NEFL;DNAJB6
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.4355425738107954,1.0786114252505097,0.35177865612648224,0.8125776594791855,1.0,5/17,15.33%,LPGAT1;PLA2G10;PLA2G4B;SERAC1;PLA2G12A
prerank,positive regulation of isotype switching (GO:0045830),-0.4208737859203709,-1.0784821671584492,0.3938223938223938,0.6845046137967556,1.0,8/15,31.50%,TFRC;TGFB1;CD40;KMT5C;CLCF1;SHLD3;RIF1;SHLD2
prerank,negative regulation of defense response (GO:0031348),0.32194663383317706,1.0783939070830562,0.34846029173419774,0.8121520676643248,1.0,15/77,16.15%,RORA;C1QTNF3;PPARA;CACTIN;NLRC3;LYAR;SIRPA;ITCH;ENPP3;PCBP2;MAPKBP1;NLRP12;PTGER4;CDH5;TRAFD1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.47065839565845424,1.0783545660630052,0.4,0.8112348638779976,1.0,1/12,0.19%,ADAMTS12
prerank,response to molecule of bacterial origin (GO:0002237),-0.29456385746669966,-1.0783385908596386,0.31139240506329113,0.6841722183984599,1.0,20/69,22.88%,FOXP1;NOS3;LBP;GCH1;TNFRSF11A;CYRIB;NOS1;IRAK3;ERBIN;HNRNPA0;IRAK1;IRF5;TIRAP;SLC11A1;LIAS;TNFAIP3;GGT1;PELI1;IFNAR1;FCGR2B
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3987077896292022,1.0775511869925911,0.36257309941520466,0.8123675738083307,1.0,4/26,8.62%,FBN1;HOXA7;LRRC17;FSTL3
prerank,negative regulation of catalytic activity (GO:0043086),-0.376672924999114,-1.0772051750655254,0.3501006036217304,0.6863737285025069,1.0,8/24,16.80%,NOTCH1;NOS1;TMBIM1;NES;APBA3;MT3;ATP5IF1;PLN
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.31469556918861263,-1.0771795983149937,0.33649289099526064,0.6857350791211806,1.0,17/50,22.01%,THBS1;GAS6;KLF4;NGF;CD44;VEGFA;PAK2;PIH1D1;RPS6KA1;RNF34;MT3;CARD16;RAF1;ARL6IP1;PLAUR;AKT1;CDKN2D
prerank,positive regulation of protein export from nucleus (GO:0046827),0.4573238588194987,1.0769907817379345,0.3770491803278688,0.8128853967121012,1.0,1/15,0.51%,TCF7L2
prerank,negative regulation of kinase activity (GO:0033673),0.3351113668418263,1.0767991143672873,0.3339317773788151,0.8123566719683087,1.0,7/62,6.43%,PRKAG2;PDPK1;DEPTOR;DTNBP1;PPM1E;NPRL2;GNAQ
prerank,blood circulation (GO:0008015),-0.3176348551990689,-1.0765710178828078,0.3333333333333333,0.6866281324110983,1.0,17/49,19.74%,SGCD;NOS3;ACVRL1;MEOX2;TBC1D8;GUCY1B1;GCLM;GUCY1A1;SOD1;ELN;ACE2;CXCL12;CYB5R3;PLN;SGCZ;AGTR1;DLL4
prerank,negative regulation of programmed cell death (GO:0043069),0.26714097062224496,1.076449231801379,0.28350515463917525,0.8123172593171699,1.0,53/355,11.31%,IL31RA;IGF1;OSR1;FHL2;NOTCH2;ANGPT1;DAB2;BCL2;SMAD6;DKK1;SCX;LTF;IFIT3;CTSH;ANXA1;PDPN;ARAF;SPHK1;ZFAND6;PRKAA2;IGF1R;LRP2;SON;NIBAN2;KRT18;MYO18A;BNIP3;SH3RF1;IL6;NOL3;KANK2;MMP9;PRKAA1;BIRC5;SIAH2;GRK5;BIRC6;CDK1;NUPR1;BCL2L2;YME1L1;ITCH;MED1;NAA35;AXL;PHIP;PRKDC;HDAC1;PIK3R1;RPS6KB1;TFAP2A;TFAP2B;SH3RF2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3652278069398038,1.0764209209108233,0.3563636363636364,0.8113932794456282,1.0,9/38,11.52%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;SMARCA5;CENPQ
prerank,aortic valve morphogenesis (GO:0003180),0.38386557804394944,1.0763605902018747,0.36823104693140796,0.8105571597237948,1.0,3/30,2.28%,ROBO1;ROCK2;SMAD6
prerank,homotypic cell-cell adhesion (GO:0034109),0.36365538968225963,1.0760599631596321,0.3391915641476274,0.8103447251892187,1.0,6/39,4.40%,MEGF11;PLPP3;GNAS;MEGF10;TLN1;PDGFRA
prerank,ventricular septum morphogenesis (GO:0060412),0.3939782635676721,1.076006405564353,0.35150375939849626,0.8094742612671295,1.0,2/27,0.29%,TGFBR3;ROBO1
prerank,vesicle transport along actin filament (GO:0030050),-0.3857141860417564,-1.0758538163747862,0.354639175257732,0.6878869431226773,1.0,3/19,2.00%,MYO1D;ACTN4;FNBP1L
prerank,T cell differentiation (GO:0030217),0.36267103061978656,1.075682982681307,0.3456140350877193,0.8093301199513633,1.0,7/40,12.17%,LEPR;KIT;ANXA1;GLI3;NHEJ1;MR1;SOX13
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.29730415491855333,-1.0756173586386466,0.3117206982543641,0.6877634404464628,1.0,28/62,28.21%,TPT1;ACKR3;DNAJA1;PPIA;CREB3L1;HSPB1;YBX3;BCL2L1;XBP1;RTKN2;NDUFA13;ARHGEF2;CLU;HERPUD1;CXCL12;PLAUR;PINK1;TMBIM6;AKT1;NOC2L;CDKN2D;PTTG1IP;CREB3;URI1;SNAI2;EPO;SYVN1;TMEM161A
prerank,hippo signaling (GO:0035329),0.39728527972896943,1.0752821620105653,0.3530534351145038,0.8094008871760359,1.0,6/26,10.14%,AMOTL2;FAT4;TEAD1;WWC1;TEAD3;LATS1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.28598798589777463,1.0747843762848086,0.3208092485549133,0.8097851852766422,1.0,27/166,12.46%,IGF1;FGFR4;SMOC2;ZEB2;SLC6A9;LPGAT1;SORBS1;PDGFRB;NOS1AP;IGF2;PLD1;SLC45A3;IL6;SMAD3;CCL19;ARNT;SLC27A1;SAMD4A;PRKDC;RPS6KB1;METTL14;NPM2;FXR1;ERBB2;LARP6;PRKD2;PKD2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.23511976087097733,-1.0745603466297202,0.2289156626506024,0.6898028459593019,1.0,102/314,26.17%,WWP1;ATXN3;PPP2R5C;NEDD4L;UBB;FBXL3;STT3B;UBXN1;ZNRF1;BUB3;TRIM25;CTNNB1;HSP90B1;FAF1;ARRB1;BAG6;RPS27A;UBC;RMND5B;UCHL1;CUL3;ECRG4;DERL1;FBXL5;PSMD13;PSMF1;DDB1;UBE2B;RBX1;PSMB10;FBXO31;HSPA5;KCTD17;KCTD13;FBXL20;FEM1A;PSMB6;NSFL1C;PSME3;PSMB5;ERCC8;PSMC3;AGAP3;HERPUD1;PSMD12;PSMB8;RNF34;CUL1;KLHL42;PTTG1;TRIM13;PSME1;ANAPC16;ERLIN2;UBE2G1;UBA52;ZFAND2B;DNAJC10;PSMB3;WFS1;FBXL2;COP1;SPSB3;SPOPL;AUP1;CCNF;FBXL14;CDK2;DCAF12;BUB1B;UBE2D1;RNF5;DNAJB9;ARRB2;TRIM2;SHARPIN;PSMD5;FBXO17;ZSWIM8;SKP1;KCTD5;TMEM129;VCP;RBCK1;RNF103-CHMP3;FBXO9;ANAPC7;PLAA;PSMD9;PELI1;PSMB4;PCNP;HUWE1;CUL2;SPSB4;UBE2J1;BFAR;DMAC2;KIF14;DCAF11;YOD1;PSMD10
prerank,anterograde axonal transport (GO:0008089),-0.3338108494309229,-1.0745461571088737,0.3413566739606127,0.6891527184734161,1.0,18/37,32.76%,DLG2;AP3S1;HSPB1;BLOC1S2;SOD1;AP3M2;KIF1A;KIF3B;NEFL;MAP1A;KIF4A;HAP1;KIF1B;KIF5C;SNAPIN;MAPK8IP3;KIF5B;AP3B2
prerank,N-glycan processing (GO:0006491),-0.39815813924373356,-1.0744644481777577,0.3737166324435318,0.6886970453991268,1.0,7/18,15.97%,ST8SIA4;FUT8;ST8SIA1;ST8SIA6;MAN1A2;MAN2A2;ST8SIA2
prerank,transition metal ion homeostasis (GO:0055076),0.39955899573927084,1.0742020353214985,0.3694029850746269,0.8103682278693501,1.0,6/28,9.40%,CP;HEPH;PRKN;TFR2;NEO1;PICALM
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.345485964751448,1.0737511959939576,0.3618181818181818,0.8105829140083611,1.0,5/48,5.98%,ADCY5;ADCY1;AMPD3;NPR2;ADSL
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.39553363699190924,-1.0735033259243374,0.3516260162601626,0.6904208692156907,1.0,8/18,12.33%,RHOJ;KDR;GATA2;JCAD;VEGFA;PTGS2;PIK3C2A;MAP3K3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3721558112782971,1.0734458603957437,0.38461538461538464,0.810464711447588,1.0,14/37,19.11%,DYNC2H1;IFT80;WDR19;WDR35;IFT27;IFT122;KIF3C;TNPO1;IFT140;DYNC2I1;IFT22;TRAF3IP1;IFT81;IFT46
prerank,positive regulation of heart contraction (GO:0045823),0.4215226156494533,1.073338068371897,0.3586337760910816,0.8097543294905729,1.0,4/19,11.05%,ATP1A2;ADM;SCN3B;APLN
prerank,cortical cytoskeleton organization (GO:0030865),0.3578763233762334,1.072987218492712,0.33558178752107926,0.8097164714820916,1.0,7/41,7.67%,ROCK2;RHOD;FHOD1;RAB13;LLGL2;DLG1;RHOBTB2
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.3027887996678827,-1.0728382567372692,0.34032634032634035,0.6914307120765496,1.0,19/57,23.79%,KDR;FBXO7;PPARGC1A;TNFSF10;CAMKK2;GSK3B;HIP1R;MIEF1;GPER1;BBC3;MIEF2;SPIRE1;PLAUR;PINK1;DCN;BIK;BMF;CHCHD10;BAX
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.32729674689588606,-1.0724014728142952,0.3488888888888889,0.6918451560887554,1.0,10/39,15.46%,MYO1D;ACTN4;FNBP1L;PPFIA2;KIF1A;RAB1A;MYO5A;SYT4;NDE1;BICDL1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.4800907233945485,1.0723210751692513,0.3583690987124464,0.8105328954762013,1.0,1/10,1.49%,ZEB2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4652907057877278,1.072105712690145,0.3971486761710794,0.8101415322277731,1.0,3/12,13.95%,NINL;CEP19;BICD2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3277516030531196,-1.0720088025913002,0.35926773455377575,0.6921536356138608,1.0,6/39,4.63%,PTPRJ;SH3KBP1;CBL;DAB2IP;PTPN12;LGMN
prerank,positive regulation of exocytosis (GO:0045921),-0.33580658238277844,-1.0719505435093117,0.35176991150442477,0.6915977970359046,1.0,14/35,31.08%,RAB27A;HGS;CFTR;ATP13A2;SDC4;CLASP2;RAB7A;PDCD6IP;RAB3A;SYTL4;UNC13D;ATP6AP1;VPS4B;RAB15
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.42417860510430294,-1.0716808373393798,0.3798449612403101,0.6916435955555466,1.0,5/14,28.55%,GAS6;NLRP2B;CARD16;TRAIP;GPS2
prerank,hemopoiesis (GO:0030097),-0.28466114393867553,-1.0715006840623276,0.30833333333333335,0.6913949145910382,1.0,33/87,22.87%,MECOM;KITLG;TEK;MFAP5;CD34;KDR;TGFB2;RUNX1;JAG1;KIRREL3;TGFBR2;TGFB1;PTPRC;FLT4;NOTCH4;RUNX2;RTKN2;ATF4;TAL1;ARIH2;GLRX5;CSF1R;FLT3;RRAS;TOX;SH2B3;TIRAP;L3MBTL1;BMP4;MKNK2;PRKX;DLL1;CEBPA
prerank,sulfur compound transport (GO:0072348),0.38647153696898817,1.0707834792081588,0.3653483992467043,0.8127340659133804,1.0,7/27,10.43%,SLC6A13;SLC13A4;SLC35F3;SLC25A11;SLC27A1;SLC19A2;SLC13A1
prerank,artery development (GO:0060840),-0.3761834704583517,-1.0704830580757256,0.36929460580912865,0.6933747186098648,1.0,8/23,7.87%,ACVRL1;ENG;TBX1;BMPR2;HES1;STRA6;PDE2A;VEGFA
prerank,regulation of phagocytosis (GO:0050764),-0.30230579945466474,-1.0703525219763348,0.30434782608695654,0.6930224233797813,1.0,11/53,10.49%,GAS6;SCARB1;RACK1;RAB27A;TGM2;GATA2;CALR;DOCK2;PTPRC;DYSF;LMAN2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4342088591654445,-1.070327747059486,0.376984126984127,0.692389549489301,1.0,5/13,10.65%,SHANK3;LGMN;APP;ZDHHC2;RELN
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.4437298940454173,-1.069892689536572,0.4044526901669759,0.6928586102480405,1.0,3/12,6.03%,RUNX1;CBFB;PTPRC
prerank,cell part morphogenesis (GO:0032990),0.4611004839725801,1.0697719954385412,0.37687366167023556,0.8144648570624511,1.0,2/13,4.45%,PID1;WASF1
prerank,regulation of cell motility (GO:2000145),-0.26233155481336884,-1.0696124988286928,0.3046153846153846,0.6928551723471543,1.0,27/121,10.85%,FRMD5;TMSB4X;SPOCK2;RAC1;CAVIN1;PLXND1;PRAG1;SLK;SERPINE2;DOCK10;TMSB10;CCDC125;MINK1;PLXNA4;FLNA;SPATA13;RHOB;TGFB1;ROBO4;CEACAM1;ABI3;CYRIB;FGF7;SRCIN1;RHOA;CDK6;CRK
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.42203750717501964,-1.0692847500579303,0.3821782178217822,0.6929792151781058,1.0,5/13,12.48%,NOS3;GLS;DDAH1;NOS1;GAD1
prerank,canonical Wnt signaling pathway (GO:0060070),0.3271379753839242,1.0688808603475342,0.351027397260274,0.8158597262069693,1.0,12/68,10.14%,TCF7L2;WNT4;WNT6;PLPP3;LRRK2;FRAT1;TCF7L1;WNT5B;PTEN;RYK;BCL9;DVL3
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.42321455209277237,1.0687161598348216,0.3872255489021956,0.8152534617438119,1.0,1/18,0.06%,UNC13C
prerank,cellular response to hypoxia (GO:0071456),0.29616736046188336,1.0685934617870934,0.3348982785602504,0.8146279807141006,1.0,16/126,9.55%,RORA;SLC8A3;EPAS1;BMP7;HIF3A;NDNF;CPEB2;PSME4;PSMA2;BNIP3;PSMA3;NPEPPS;ARNT;ACAA2;MDM2;PSMD8
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.2731957109243636,-1.0685271219786112,0.3082901554404145,0.6942292076360789,1.0,17/93,8.27%,MAP3K5;RASSF2;TGFB2;ANKRD6;PTK2B;DAB2IP;MID1;MINK1;SH3RF3;TPD52L1;EMC10;APP;FLT4;PDCD10;VEGFA;STK25;WNT16
prerank,negative regulation of histone modification (GO:0031057),0.44598310523843077,1.0682645704420952,0.4,0.8145324143932413,1.0,2/14,3.15%,AASS;JARID2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.28570851518392026,-1.0680934374568427,0.3425692695214106,0.6945751117143183,1.0,17/76,18.48%,ANO1;ESR1;GPR4;TGM2;HOMER1;ADRA1B;GNA14;ADRA1A;HTR2A;GNA11;LPAR6;HRH1;PTGER3;CMKLR1;CX3CR1;AGTR1;CCKBR
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4099889682209726,-1.0676854988944402,0.3988439306358382,0.6949269625888711,1.0,6/16,19.83%,CAV1;TRIM14;TRIM25;FUCA2;HS3ST5;TRIM27
prerank,myelin maintenance (GO:0043217),-0.4648773957998972,-1.067091325870324,0.40425531914893614,0.6958290577626348,1.0,6/10,26.51%,SOD1;CLU;ABCD2;EPB41L3;PRX;MYRF
prerank,protein stabilization (GO:0050821),-0.2500624432727829,-1.0667520059803743,0.29721362229102166,0.6959815395472259,1.0,39/168,13.96%,HIP1;RASSF2;RPL11;HSP90AA1;RPL23;HSP90AB1;PPARGC1A;RPS7;ATP1B1;SOX17;FLNA;SOX4;PDCL3;CALR;BAG6;CDC37;RPL5;CHP1;GAPDH;HIP1R;PDCD10;BAG1;CRYAB;GOLGA7;LAMP1;CHEK2;GRN;UBE2B;PPIB;RTN4;HYPK;STX12;CAMLG;HSPD1;CLU;OTUD3;CDC37L1;MTMR9;MT3
prerank,phagosome maturation (GO:0090382),-0.33952790582934045,-1.0666151155410617,0.3611111111111111,0.6956554917251715,1.0,18/35,26.57%,RAB31;ATP6V0A1;RAB38;ATP6V1A;ATP6V0C;TCIRG1;ATP6V1E1;ATP6V0A4;ATP6V0A2;RAB39A;MREG;ATP6V0D2;RAB7A;ATP6V0E2;RAB14;ATP6V1B2;MCOLN1;ATP6V1H
prerank,establishment of epithelial cell polarity (GO:0090162),-0.3876701192936921,-1.0660995175609373,0.34811529933481156,0.696318626471519,1.0,4/19,3.66%,CYTH3;MSN;CYTH1;SIPA1L3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.39799623221483976,1.065701183946974,0.3603082851637765,0.8204368931057404,1.0,4/23,7.43%,C1QTNF3;BMP7;UACA;NLRC3
prerank,Fc receptor signaling pathway (GO:0038093),-0.2669671317615038,-1.065550589017476,0.32590529247910865,0.6970057498703126,1.0,36/110,23.57%,RAC1;CALM1;PLCG2;IKBKB;NFATC2;NFATC1;JUN;PAK1;PSMD13;PSMF1;MAPK8;PAK2;MAP3K1;PSMB10;CHUK;MAP2K7;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PPP3CA;CUL1;TAB3;PSME1;PSMB3;PPP3R1;NFATC3;PSMD5;SKP1;MAPK3;PSMD9;PSMB4;RELA;MAPK10
prerank,ephrin receptor signaling pathway (GO:0048013),0.31545772181040316,1.06548072244946,0.35993485342019543,0.8200482158150459,1.0,9/82,5.21%,EPHA7;ROCK2;EPHA3;EFNB2;SDC2;EPHA8;MMP2;EPHA4;WASL
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.44154839180121236,-1.0653462705787653,0.39097744360902253,0.6968312717389284,1.0,3/13,1.89%,ABHD2;ESR1;PLPP1
prerank,mitotic cytokinesis (GO:0000281),0.3522796657083118,1.0651674094536023,0.37828371278458844,0.8199139721827285,1.0,7/47,5.85%,ROCK2;KLHDC8B;ARL3;SNX18;SNX9;SNX33;SON
prerank,outflow tract septum morphogenesis (GO:0003148),0.3903724466639994,1.064864305476654,0.3840304182509506,0.8197378523300701,1.0,4/24,5.73%,ROBO1;FGFR2;SMAD6;LRP2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.36359455901744026,-1.0647838643869614,0.3547008547008547,0.6976427633202618,1.0,5/24,5.27%,TEK;KDR;GAS6;RAMP2;GATA2
prerank,cardiac muscle cell contraction (GO:0086003),-0.3922540884408121,-1.064729044589357,0.3627254509018036,0.6971050600158414,1.0,7/19,17.92%,KCNJ2;ATP1A1;GSN;CACNA1G;CACNA1C;SCN1A;SCN1B
prerank,RNA processing (GO:0006396),0.28398998091804073,1.0641938160689317,0.3098995695839311,0.8205618256606144,1.0,53/176,19.90%,CELF2;ATXN1;RBMS1;NOVA1;RNASEL;ADAD1;SRPK2;RBPMS;HNRNPC;HNRNPH1;SON;RBMS2;TSEN34;NOL3;RBM5;SLU7;SF3A3;DDX23;RP9;NOL9;PRPF3;TENT2;AKAP8L;PDCD7;TUT1;RBM39;SCAF11;NONO;DICER1;TSEN2;SRRM4;LSM5;SNRNP40;DHX8;CSTF3;HNRNPH3;SNRPA1;DHX15;RNGTT;HNRNPR;U2AF1;TUT4;NUDT21;PRPF6;HNRNPA2B1;RSRC1;LSM3;RBM4;LSM1;SRSF11;LSM4;SNRPF;PPIG
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.2685606329367296,-1.064016915761078,0.3128491620111732,0.6982104575715556,1.0,30/101,24.30%,MEF2C;LBP;DAB2IP;VIM;CHMP5;TGFB1;SBNO2;TNFRSF1B;DEFA6;PDCD4;RHOA;MAPK8;XBP1;CD180;GIT1;CX3CR1;CARD16;CD274;PRKCE;ZC3H12A;ADAM9;IRAK1;MYD88;NR1H3;CASP1;TNFAIP3;PLAA;RELA;CD80;CD68
prerank,dendritic spine morphogenesis (GO:0060997),-0.40820902713397467,-1.0639421750621885,0.3860369609856263,0.697712648319762,1.0,3/15,3.75%,SHANK3;CTNND2;DOCK10
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.3052798824152786,-1.0636398123952955,0.33004926108374383,0.6977318434363866,1.0,23/51,33.86%,HSPB1;APP;AIM2;STAT3;GBP5;USP50;PANX1;TMED10;CASP8;MYD88;TYROBP;S100A13;CASP1;AGER;NLRC4;TLR4;LPL;CD36;IL16;TLR6;NOD2;P2RX7;NLRP3
prerank,regulation of cell adhesion (GO:0030155),0.29554375202727795,1.0636150852105097,0.33431516936671574,0.8211312366863733,1.0,11/129,4.57%,EPHA7;PLXNA2;ROCK2;IL18;ANGPT1;TPM1;RHOD;EPHA8;RIPOR2;EPHA4;PLXNC1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.4945922072149249,1.063586918208393,0.39361702127659576,0.8202190029673516,1.0,6/10,20.01%,MTHFR;TYMS;SHMT1;MTHFS;DHFR;MTHFD2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.45167356257030133,-1.063176972325477,0.4019607843137255,0.6981573052216026,1.0,6/11,22.85%,YBX3;BIRC3;ARHGEF2;CASP8;SLC25A4;PELI1
prerank,positive regulation of protein transport (GO:0051222),0.3274989494232771,1.0631160330967684,0.3391167192429022,0.8204859448267596,1.0,3/67,1.88%,IGF1;BMP6;FRMD4A
prerank,regulation of astrocyte differentiation (GO:0048710),-0.43815221950404715,-1.0630010872154596,0.396078431372549,0.6979021502227802,1.0,6/12,17.66%,NOTCH1;SERPINE2;HES1;BMP2;BIN1;ID2
prerank,regulation of isotype switching (GO:0045191),-0.4216912395335974,-1.0629695520838534,0.4045368620037807,0.6973073867459931,1.0,10/14,46.31%,TFRC;KMT5C;SHLD3;SLC15A4;RIF1;SHLD2;KMT5B;IL4;MAD2L2;PARP3
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.4704675613734528,-1.0625879387069896,0.40980392156862744,0.6976808341589287,1.0,5/10,26.08%,ACER2;NEXMIF;CYP1B1;JAM3;SNAI2
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.45941363550485526,-1.0621012070980076,0.3930635838150289,0.6982798503207592,1.0,6/10,36.68%,GABRG3;GABRA5;GABRE;GABRG2;GABRG1;GABRB2
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3550815679032441,1.0612251558573533,0.37037037037037035,0.8244424949303704,1.0,6/44,4.50%,ROCK2;TPM1;LPAR1;FHOD1;CCN2;PPM1E
prerank,cellular protein modification process (GO:0006464),0.24625799148049743,1.061216042342779,0.2787418655097614,0.8234866045247958,1.0,152/983,12.60%,PRKAG2;ASB2;ROCK2;OXSR1;PTPN13;B3GALT1;CP;FBN1;APLP2;NRK;EPAS1;WNK4;CDK8;ST3GAL3;DAPK1;PRKAG3;GALNTL5;LARGE1;UST;PDPK1;PDK1;ITIH2;SDC2;LHPP;CEL;BMP2K;TNC;LOXL1;SERPIND1;PPM1M;SPSB1;B3GNT5;PTPN4;UBE2E2;RNASEL;HIF3A;DMPK;FER;MAP4K5;CDK7;PIGU;ANXA1;RAB13;PRKCSH;NAA80;FAM20A;PCSK9;IGFBP4;SRPK2;ST3GAL5;OBSL1;NEURL2;DUSP10;ARAF;PPM1E;MAPK9;FBXW4;ATG10;DDB2;CDC14B;PTPRA;DCAF4;SIK1;PRKAA2;UFL1;GPC3;MTMR3;MSRA;LRRK2;PRKCZ;PTPN9;WIPI1;PSME4;PRKCB;PARP4;MAML1;STK17B;PSMA2;RBBP7;FBXO44;IL6;CAND1;F5;CCDC8;UBE2L3;PTPRD;PSMA3;PRKCA;GRK3;PTEN;PRKAA1;NEK4;NRBP1;CUL9;RYK;CSF1;BIRC5;WWP2;GRK5;USP25;BIRC6;CCNT1;DCAF10;MIA3;CHRDL1;PKN2;FSTL3;CDK1;TGM5;CAMK2D;CUL7;PIK3R4;KLHL11;NEK10;GRK4;FEM1B;FBXO6;ASB3;PSMD8;GOLGA2;VRK2;PARP10;IGFBP7;KBTBD7;UBA7;LATS1;FRK;PMM2;ABL1;PRKDC;PARP9;UBA3;PSMD3;JAK2;COQ8B;ERBB2;SLC35A1;IKBKE;FBXO4;KLHL22;BMPR1A;MAPKAPK2;CUL4B;PTPN3;PRKAG1;HIPK3;CCNE1;PRKD2;FBXO11;SENP8;STK24;SERP1
prerank,positive regulation of filopodium assembly (GO:0051491),0.3948644602114305,1.061172330057574,0.36801541425818884,0.8226306353987412,1.0,4/24,5.21%,DOCK11;DPYSL3;RIPOR2;WASL
prerank,response to steroid hormone (GO:0048545),-0.3441868878967135,-1.0610147335631848,0.3438155136268344,0.7003971918211588,1.0,7/31,5.38%,ABHD2;CAV1;ATP1A1;THBS1;TGFB2;UBE3A;TGFB1
prerank,telomere organization (GO:0032200),0.36021426612848023,1.06040504505167,0.3836805555555556,0.8236822200331833,1.0,12/43,15.55%,SP100;HUS1B;ACD;XRCC5;BLM;PRKDC;DCLRE1B;RTEL1;MRE11;APEX1;WRN;STN1
prerank,receptor catabolic process (GO:0032801),0.39226416292052935,1.0599922739290148,0.36742424242424243,0.8238085808854179,1.0,6/24,9.09%,RNF43;NEDD4;PCSK9;ZNRF3;PIK3R4;UVRAG
prerank,glutamate metabolic process (GO:0006536),-0.3786263051569858,-1.0598209517435093,0.3793103448275862,0.702785137268262,1.0,4/19,12.48%,GLS;GCLM;ALDH18A1;GAD1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.31214601266644176,-1.0597486858295544,0.3926940639269406,0.7023045930535367,1.0,17/46,26.17%,MSN;PPIA;SOD1;ARF1;PDCD4;PAK2;RPLP0;TALDO1;HNRNPDL;MIF;PITPNA;JAK1;HSPA9;CFL1;CAPZA1;HNRNPF;IL12RB2
prerank,oligodendrocyte differentiation (GO:0048709),0.4372725106799508,1.0594357882180678,0.3865877712031558,0.8244510521464377,1.0,2/19,2.75%,SLC8A3;SOX6
prerank,protein neddylation (GO:0045116),-0.4272724131404051,-1.0592910768248107,0.39655172413793105,0.7027905938862854,1.0,4/13,14.54%,NEDD8;RBX1;DCUN1D1;DCUN1D2
prerank,RNA 3'-end processing (GO:0031123),-0.2889386412052213,-1.0592029979453947,0.35036496350364965,0.7023077276000453,1.0,35/69,35.96%,SRSF2;SRSF1;CPSF7;SRSF5;DDX39B;CPSF3;SRSF9;RBM8A;RNPS1;SRSF6;SYMPK;CLP1;LIN28B;CPSF2;CSTF2T;PCF11;CSTF2;THOC3;SUPV3L1;MAGOH;THOC6;THOC2;EIF4A3;SRSF7;ALYREF;CSTF1;TENT4B;CPSF1;ZC3H11A;MTPAP;DHX38;U2AF1L4;CHTOP;SRSF3;NCBP2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3275978403730705,1.0588581682580158,0.35494880546075086,0.8250610299216339,1.0,3/57,1.83%,ADCY5;ADCY1;LPAR1
prerank,positive regulation of cellular protein localization (GO:1903829),-0.2874931729593489,-1.058766177107082,0.36,0.7027332941193265,1.0,16/69,11.56%,TFRC;STX3;HSP90AB1;FYN;LIMK2;TGFB1;FERMT2;CCDC88A;GNL3;GSK3B;CARD10;RTN4;SESN2;APC;WWTR1;GPR137B
prerank,organelle organization (GO:0006996),-0.2247589746147561,-1.0584917584077929,0.23076923076923078,0.7027366049491226,1.0,119/388,25.58%,FMNL2;FGD5;CAV1;ATP8B1;SYNE1;FGD6;NOS3;SEMA6A;MICAL2;SH3KBP1;FNBP1L;PPARGC1A;ARAP3;CAV2;RAB31;STX7;PPIA;SIPA1L3;CXADR;PACSIN2;REEP5;CHMP5;LYSMD3;CHMP2B;CHCHD2;VPS13C;VMP1;TMED5;TFB2M;RHOT1;ZRANB1;SMPD4;TMED2;MICAL1;MARK1;TOR1B;RAB38;LIMD1;LMAN2;SPRYD3;YTHDF3;RAB1A;NSFL1C;PCLO;STOML2;ABCD3;BIN1;CHGA;VPS18;BNIP1;MAST3;LMAN2L;PPRC1;ABCD2;TMED10;MIEF2;SIRT4;TMED3;NEDD9;MTX3;FMNL3;MSTO1;BRWD3;ODF2;ATL2;DIAPH3;PRKD1;TRIP11;GBF1;VPS11;PEX1;ABCA3;PEX11B;BSCL2;AUP1;SEC16B;CCL13;CHMP1B;ABCD4;VPS51;ATP5F1B;PITPNB;LIG4;VPS13D;PINK1;SPTSSB;IRAG2;THY1;MREG;CFL1;CHMP1A;NUMA1;PAK5;ARHGAP10;CYCS;VAPA;MAST1;CHMP3;TNFAIP3;BCS1L;PEX10;SIPA1;CHMP7;CLASP2;TMED7;RAB7A;CHCHD10;PDCD6IP;GEM;HUWE1;RAB2A;KIF4A;PEX16;CDC42BPB;RAB14;CAMSAP1;TMEM135;SEC16A;MCOLN1
prerank,negative regulation of RNA splicing (GO:0033119),-0.3873147102374751,-1.0580973560790317,0.398406374501992,0.7030540590745226,1.0,7/19,20.16%,SRSF9;RNPS1;SRSF6;RPS26;TMBIM6;PCBP4;PTBP1
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.4587022199875582,-1.0579809749475069,0.40980392156862744,0.7026774183135334,1.0,6/10,49.81%,NCKAP1L;VSIR;TLR4;IL12A;FOXP3;IL12B
prerank,cellular response to interleukin-12 (GO:0071349),-0.3084586104939346,-1.0578693059015052,0.3916083916083916,0.70227995455424,1.0,15/48,20.20%,MSN;PPIA;SOD1;ARF1;PDCD4;PAK2;RPLP0;TALDO1;HNRNPDL;CD47;MIF;PITPNA;JAK1;HSPA9;CFL1
prerank,T cell proliferation (GO:0042098),-0.41580052427133796,-1.05786330307913,0.39883268482490275,0.7016087664310576,1.0,3/13,9.62%,CADM1;MSN;LMBR1L
prerank,neutrophil migration (GO:1990266),-0.29616433664474234,-1.0578052304648842,0.3612565445026178,0.701076520996165,1.0,8/58,10.16%,PECAM1;BSG;TGFB2;PPIA;CXADR;EDN1;PPIB;PIK3CD
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.28449280844903096,-1.0577331611014607,0.3460559796437659,0.7005818274200877,1.0,22/79,14.11%,SLIT2;BMPER;THBS1;HTRA3;DAB2IP;NOTCH1;BMPR2;CREB3L1;CRIM1;SMAD9;SMAD5;LEMD2;PTPN1;BMP2;HGS;HHEX;GPC1;EPN2;CASK;SPRY4;CADM4;SKIL
prerank,fatty acid elongation (GO:0030497),-0.41765497534393314,-1.0572941129355156,0.40540540540540543,0.7010530079410072,1.0,5/13,18.61%,ELOVL7;ELOVL5;ELOVL6;ELOVL1;TECR
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.41358201257888194,1.0566779391184646,0.3867735470941884,0.8299883851945107,1.0,4/18,5.91%,IL34;SLC45A3;SOX1;PTN
prerank,mitochondrial fission (GO:0000266),-0.39755205845192887,-1.056563353241395,0.40357852882703776,0.7021698809489514,1.0,4/16,11.96%,DNM3;DNM2;MIEF1;DNM1
prerank,keratan sulfate metabolic process (GO:0042339),0.37094559945466815,1.0558824215951264,0.38181818181818183,0.8311656698166908,1.0,6/31,5.37%,ST3GAL3;FMOD;OGN;OMD;B4GALT1;PRELP
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.4712210278211458,1.0556904648823737,0.4058252427184466,0.8307471869182536,1.0,2/12,9.75%,IL18;IL17D
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.37605192285767974,-1.0555446110636688,0.40081799591002043,0.7040077207999004,1.0,5/21,11.40%,RPL11;RPL23;RPS7;RPL5;RAB1A
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.4021535802936041,1.0553684007385358,0.366412213740458,0.830653864918176,1.0,4/22,9.48%,DMD;NOS1AP;CACNB4;GNB5
prerank,pre-replicative complex assembly (GO:0036388),-0.2922658648288141,-1.05506842825765,0.36470588235294116,0.704535269853132,1.0,17/64,17.26%,UBB;RPS27A;UBC;PSMD13;PSMF1;PSMB10;PSMB6;PSME3;PSMB5;PSMC3;MCM4;PSMD12;PSMB8;PSME1;UBA52;PSMB3;MCM8
prerank,regulation of cilium assembly (GO:1902017),0.3323173063114207,1.0549623261562053,0.37833333333333335,0.830756098904802,1.0,17/62,18.85%,DCDC2;ODAD3;TBC1D9B;SDCCAG8;ARHGAP35;CROCC;CYLD;TBC1D19;IFT140;CDKL5;TBC1D17;ATG3;CEP120;USP6NL;TBC1D15;CEP97;TBC1D7
prerank,negative regulation of gene expression (GO:0010629),0.2598527397018853,1.054796190722455,0.32526881720430106,0.8302346017515381,1.0,37/302,11.29%,IGF1;ROBO1;SLC24A3;ROCK2;WNT4;LGR4;NOTCH2;IGF2BP1;DAPK1;PRKN;RBMS3;JARID2;PTBP2;SYT11;RBBP4;TNRC6B;PRKAA2;TNRC6A;SLC2A10;RBBP7;TYMS;ABCC2;PRKAA1;MTF2;RBL2;WWP2;YTHDF2;PICALM;PARP10;SAMD4A;AGO2;PARP9;ATOH8;HDAC1;FLCN;APLN;FXR1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3865524910625589,1.054032907006333,0.3843137254901961,0.8312309774334005,1.0,6/26,8.16%,ATP1B3;NEDD4;ANK2;CACNA1D;DLG1;WWP2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.4194081659521675,-1.0538836579615756,0.4043824701195219,0.7068837627943525,1.0,8/13,34.18%,RPS21;BMS1;TBL3;KRI1;TSR1;ABT1;UTP20;RPP40
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.457161392287702,1.0535125725472874,0.4166666666666667,0.8306882108121904,1.0,1/12,1.02%,FHL2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.457161392287702,1.0535125725472874,0.4166666666666667,0.8306882108121904,1.0,1/12,1.02%,FHL2
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.39230781817923754,1.0530439877376636,0.41316270566727603,0.8309396699844442,1.0,9/26,12.36%,SMOC2;SPHK1;CCDC57;EIF4EBP1;PRKCA;PKN2;MDM2;RPS6KB1;HSF1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.33696911848493133,-1.0526274610183712,0.39503386004514673,0.709528997530873,1.0,13/33,18.94%,DNM3;STON2;SYNJ1;STX1A;ITSN2;DNM2;AMPH;DNM1;CANX;PIP5K1C;SYT2;CDK5;SNAP91
prerank,regulation of calcium ion import (GO:0090279),-0.3759915047898391,-1.0525233272160472,0.37250996015936255,0.7091255844389731,1.0,9/21,26.33%,FYN;CTNNB1;WNK3;SLC30A1;CXCL12;PLN;TRIM27;SPHK2;CCL2
prerank,peptidyl-proline modification (GO:0018208),-0.3539663445794559,-1.0523813384256864,0.3760504201680672,0.7088082340848958,1.0,6/25,11.71%,PPIA;P3H2;PPWD1;PPIE;PPIB;NKTR
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.4551344105379874,1.0521112407288564,0.3987603305785124,0.8324597362335281,1.0,2/13,4.57%,PLXNA2;PLXNC1
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.42215217019933393,-1.0520986813914666,0.390715667311412,0.7088387258777716,1.0,6/13,24.10%,NOTCH1;TGFB1;TBX3;BMP4;DLL1;EID2B
prerank,regulation of organelle organization (GO:0033043),-0.28007875496044515,-1.0519137507552618,0.34102564102564104,0.7086403716332249,1.0,28/80,24.31%,MSN;CLIC4;PTK2;F11R;PDE4DIP;CAPN2;RHOT1;PDE2A;PDCD10;TJP1;PAK2;ARHGEF5;MTM1;MYO5A;MARK2;EHD3;MIEF2;ATP13A2;VPS11;ARL6IP1;PREB;STMN3;PINK1;SIRT7;MAPK3;SPEF1;CAMSAP3;SCARB2
prerank,nervous system development (GO:0007399),0.25440254570062454,1.0514787329955386,0.33492252681764006,0.8332181468511525,1.0,38/429,5.47%,ALDH1A2;ROBO1;ADGRV1;SDK1;ARNT2;ZIC1;NOTCH2;IGF2BP1;PRKN;ATXN1;ZEB2;LPAR1;NLGN2;IGSF8;ZIC2;SZT2;PCDHA3;B3GNT5;SOX6;FAT4;INTU;AVIL;JARID2;ZIC5;CNTFR;PCSK9;ARTN;OBSL1;GFRAL;PAFAH1B3;ARHGAP26;TEAD1;IGFN1;NRSN2;NDP;DPF2;PMP22;TPP1
prerank,icosanoid biosynthetic process (GO:0046456),-0.4505340368719095,-1.0514709446282897,0.42441860465116277,0.7091727565991608,1.0,7/10,44.78%,PLA2G4A;LTA4H;PLA2G5;ALOX5AP;MGST2;FADS1;LTC4S
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.3886791904885126,-1.0513087569774118,0.4110169491525424,0.7082226505707468,1.0,5/16,5.59%,APOD;THBS1;ACVRL1;CORO1C;FAM107A
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.3886791904885126,-1.0513087569774118,0.4110169491525424,0.7082226505707468,1.0,5/16,5.59%,APOD;THBS1;ACVRL1;CORO1C;FAM107A
prerank,cGMP metabolic process (GO:0046068),-0.4318754539033198,-1.0512621909585842,0.4037735849056604,0.7076885244790888,1.0,3/12,7.28%,GUCY1B1;GUCY1A1;PDE2A
prerank,synaptic vesicle membrane organization (GO:0048499),-0.39408108683122667,-1.051104979518191,0.38551859099804303,0.7074053554255287,1.0,6/17,26.09%,STX3;STX1A;SNAP25;STX2;SYP;SYNGR2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.37295812055291716,-1.0508400012491041,0.38266384778012685,0.7073798370508362,1.0,8/20,32.53%,GATM;GCLM;PLOD2;GGT1;GAMT;CHAC2;MGST2;OPLAH
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.35397544631857214,-1.05035817226672,0.3978021978021978,0.7079315341790712,1.0,7/26,11.34%,EEF1A1;IQGAP1;PDE8A;DAB2IP;PTPN12;ZFP36L1;DUSP3
prerank,mesenchymal cell development (GO:0014031),-0.3892546843298792,-1.050087205872709,0.4,0.7079530904756584,1.0,10/18,33.49%,CDH2;NOTCH1;HEY2;HEYL;NOLC1;SOX11;SNAI2;PEF1;TBX20;KBTBD8
prerank,hydrogen peroxide catabolic process (GO:0042744),0.4714238858289826,1.0500556092708415,0.4351297405189621,0.8361139158511299,1.0,1/11,2.38%,PXDN
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.42347921355361695,1.0499308944433483,0.40540540540540543,0.8354912413500823,1.0,3/18,6.51%,BCL2;SLC25A31;BNIP3
prerank,regulation of autophagy (GO:0010506),0.27647874365615377,1.0498207577461731,0.3547008547008547,0.8348165073181959,1.0,31/216,11.14%,PRKAG2;LEPR;ITPR1;DAPK1;PRKN;PRKAG3;SNX6;BCL2;TRIM5;NEDD4;PRKAA2;UFL1;NPRL2;MTMR3;LRRK2;SLC38A9;BNIP3;OPTN;RNF152;PRKAA1;KAT8;NUPR1;ATP6V0D1;ATP6V0E1;PLEKHF1;GOLGA2;WASHC1;ABL1;MLST8;FLCN;RUBCN
prerank,regulation of superoxide anion generation (GO:0032928),-0.4159903818805966,-1.0494688280604612,0.3861003861003861,0.7089452855848333,1.0,7/14,37.54%,TGFB1;SOD1;TYROBP;PRKCD;ITGB2;SYK;CRP
prerank,regulation of ion transmembrane transport (GO:0034765),-0.32722514498394584,-1.0493082870640122,0.37168141592920356,0.7087107548000638,1.0,8/33,15.48%,KCNJ2;NEDD4L;CHRM3;WNK3;KCNQ1;KCNJ8;KCNJ15;AHCYL1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.3731359490475475,-1.048611715031906,0.36561264822134387,0.7098583301412688,1.0,9/21,17.56%,NDST3;HS3ST4;HS6ST2;EXT1;EXTL3;XYLT1;GPC1;HS6ST3;HS3ST5
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3570840622451721,-1.0483698210134724,0.39880952380952384,0.7098201251094677,1.0,8/24,13.96%,KLF2;NOTCH1;CREB3L1;VEGFA;SESN2;HSPA5;ATF4;MT3
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.4569174193808309,-1.0482786971618714,0.40425531914893614,0.7094014878888079,1.0,6/10,27.38%,CORO2B;DNAJA1;NDFIP2;NDFIP1;SNX3;PPM1F
prerank,sulfur compound biosynthetic process (GO:0044272),0.2992895235173994,1.0482561616340302,0.36336779911373707,0.8379287692745938,1.0,13/104,5.86%,ANGPT1;ST3GAL3;FMOD;UST;CBS;OGN;GSTM2;OMD;B4GALT1;GSTT1;PRELP;CHSY1;CHST3
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.429233483869421,-1.0481206848043152,0.416,0.7091495578556232,1.0,8/13,33.89%,GAS6;CD74;IFIH1;TRIM44;DHX9;MAVS;TSLP;IL7
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.2810991342991134,-1.0478155052444948,0.3657289002557545,0.7092516618819992,1.0,18/73,15.86%,KITLG;LMO2;RUNX1;CBFB;GATA2;PSMD13;PSMF1;PSMB10;PSMB6;TAL1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;TCF3
prerank,extracellular matrix assembly (GO:0085029),-0.3699126095429296,-1.0477032842354985,0.3824175824175824,0.70884521766347,1.0,9/23,12.90%,GAS6;RAMP2;TNXB;MYH11;TGFB1;LAMB2;GPM6B;MFAP4;NTN4
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3376345695672324,1.0475131381293261,0.3547297297297297,0.8389506714640459,1.0,12/52,15.14%,ADHFE1;ACOT4;MTHFR;HOGA1;FOLR2;IDH2;PHYH;SLC19A1;SHMT1;AADAT;ME3;MTHFS
prerank,DNA replication initiation (GO:0006270),-0.32825803164110934,-1.0475012579544094,0.36525612472160357,0.7087076122848758,1.0,20/37,36.86%,RPA1;MCM4;TOPBP1;PRIM1;MCM8;POLA1;CDK2;POLE4;POLE;MCM5;MCM10;POLE3;ORC1;RPA3;MCM6;GMNN;CDC6;RPA2;CDC7;CDC34
prerank,positive regulation of protein depolymerization (GO:1901881),-0.44865598236986615,-1.0473347017398387,0.42134831460674155,0.7084855227781587,1.0,4/11,18.61%,WDR1;STMN2;NES;CFL2
prerank,positive regulation of vasculature development (GO:1904018),0.3023872755372652,1.0469920076114299,0.358974358974359,0.8394003592551714,1.0,15/94,7.40%,SASH1;ADAM12;STIM1;SMOC2;PDPK1;HK2;ECM1;CTSH;ANXA3;ITGAX;SPHK1;FGF1;PRKCB;PDCD6;PRKCA
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.25279123747831383,1.0468496726030145,0.3404761904761905,0.8387534635534399,1.0,47/509,6.76%,IGF1;ROCK2;SASH1;WLS;ADGRV1;TCF7L2;OSBPL8;KSR1;FGFR2;FGFR4;IL18;KIT;ANGPT1;PRKN;PELI2;LPAR1;PDPK1;BCL2;FNIP1;LTF;PDGFRB;KL;ECM1;NOS1AP;TRIM5;IGF2;NEDD4;EPHA8;NFAT5;GFRAL;PDGFRA;SPHK1;AKAP13;GJA1;RICTOR;PDGFD;IGF1R;FGF1;SLC38A9;DDX60;LRP2;PRKCB;FRS2;CXXC5;WWC1;ADRA1D;IL6
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.34178132883669343,1.0465729126267262,0.38078902229845624,0.8385242862876201,1.0,6/51,4.50%,ROCK2;TPM1;LPAR1;FHOD1;CCN2;PPM1E
prerank,regulation of intracellular signal transduction (GO:1902531),0.2560458022801493,1.0465592711950644,0.3598014888337469,0.8375808627329571,1.0,47/420,8.73%,ARHGAP28;PRKAG2;ARHGAP24;ARHGAP6;GMIP;PTPN13;ARHGAP29;NRK;FGD4;PRKAG3;PDPK1;RHOD;ARHGAP20;AKAP7;SYDE2;ATRIP;ARAF;MAP2K6;RBBP4;ARHGAP26;SOS2;AKAP13;ARHGAP12;ZFAND6;RICTOR;PRKAA2;UFL1;ARHGAP40;LRRK2;FGF1;ARHGEF11;DLG1;WWC1;RBBP7;WWC2;BANP;OPTN;ARHGAP35;BLM;CHD4;PTEN;PRKAA1;ARHGAP9;MYO9B;GPR143;USP7;CDK1
prerank,regulation of response to external stimulus (GO:0032101),0.2913857763462098,1.0465126304082957,0.4,0.8367260022656544,1.0,15/121,7.98%,ADAMTS12;APPL2;EFNB2;NMT2;TRIM5;ANXA1;LACC1;PDGFRA;UFL1;CASP12;PDE6G;SETD6;CAMKMT;DAGLB;RNF135
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.44516261662510737,1.0465080475912587,0.40408163265306124,0.8357681222968129,1.0,4/14,13.58%,MRNIP;WDR48;ARID2;FANCB
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.32891737653781716,-1.0463952384786994,0.3804573804573805,0.7101807760123504,1.0,13/36,22.77%,SGMS1;DAB2IP;RPS3;PPIA;TPD52L1;TRAF1;FAS;MADD;CX3CR1;NR4A2;TMBIM6;MAZ;MAPK8IP2
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.21871585517544279,-1.045932807739795,0.2573099415204678,0.710706444742231,1.0,139/532,20.46%,FN1;PTPRJ;TMSB4X;ADIPOR2;B2M;ACTN4;MSN;IL33;HSPA8;LIFR;RPS6KA5;MAOA;TNFRSF11B;STX3;HSP90AA1;CBL;F3;ITGB1;LBP;FYN;PTK2B;MID1;VIM;INPP5D;ACKR3;UBB;NFKBIA;S1PR1;PPIA;NOD1;LIMS1;SOCS2;STX1A;LAMA5;IKBKB;TGFB1;EDA;TRIM25;CD44;HSP90B1;SOD1;ST18;BCL2L1;SOCS5;IL1R1;RPS27A;UBC;TNFRSF11A;LRP8;MT2A;CEACAM1;CSK;TNFRSF1B;ARF1;PDCD4;CARD14;VEGFA;BIRC3;IL1RAP;FOXO1;PSMD13;AIM2;PSMF1;PTGS2;APPL1;COMMD7;PAK2;RBX1;RPLP0;TALDO1;ADAR;PSMB10;PIK3CD;CDKN1B;CHUK;ISG15;STAT3;CRK;IFI35;PSMB6;TOLLIP;IL1RL2;PSME3;JUNB;PSMB5;MAP3K3;OAS2;RSAD2;CANX;PSMC3;IRAK3;PSMD12;PSMB8;CUL1;MAP3K8;IL17RE;HNRNPDL;TAB3;MT3;INPPL1;IFNGR1;CSNK2B;TRAF1;CSF1R;PSME1;CAMK2B;CXCL12;UBA52;IL20RB;FLT3;PSMB3;CISH;RPS6KA4;MIF;IL18BP;SOX2;CD40;CCL13;IL15;EIF5A;IRAK1;IL4R;IRF5;SH2B3;PITPNA;BST2;SPI1;JAK3;PSMD5;MYD88;SLA;JAK1;HSPA9;IFITM3;PRKCD;CFL1;AKT1;SKP1;CSF3R
prerank,striated muscle cell development (GO:0055002),-0.41520313445457174,-1.0458796361376916,0.3971774193548387,0.7101743046479903,1.0,1/14,0.29%,PGM5
prerank,embryonic organ development (GO:0048568),0.33221714088166127,1.0458438182642011,0.39965986394557823,0.8365101432941523,1.0,11/61,8.09%,RBPJ;FGFR2;KIT;RBP4;KMT2A;COL13A1;TEAD1;GLI3;SALL1;PBX4;TEAD3
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4133028082757668,-1.045749664569893,0.4161735700197239,0.7098359812885922,1.0,4/15,7.18%,KDR;PTK2B;BMX;AATK
prerank,positive regulation of catabolic process (GO:0009896),-0.29601785459083013,-1.0455794694658427,0.398989898989899,0.7096440733644817,1.0,15/65,13.04%,WWP1;NSF;NEDD4L;DAB2IP;ATG7;PLK2;GSK3B;FOXO1;DDB1;OAZ1;APC;CDKN1B;NDUFA13;EGLN2;IDE
prerank,multivesicular body organization (GO:0036257),-0.33492753653449525,-1.0453575736775533,0.4026548672566372,0.7095836069856774,1.0,14/31,30.92%,RAB27A;CHMP5;CHMP2B;HGS;MVB12A;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;VPS36;VPS28;VPS4B
prerank,axon extension (GO:0048675),0.4013559242858813,1.0448114311192322,0.41947565543071164,0.8382751558701127,1.0,2/23,0.61%,ALCAM;AUTS2
prerank,positive regulation of developmental process (GO:0051094),0.2791239710823476,1.0446826664906035,0.3633720930232558,0.8376565209164543,1.0,29/164,12.83%,SOX5;BMP7;PRKN;ADGRL1;CCN2;SCX;SOX6;PLCB1;GRIP1;FOXD1;GJA1;PTN;PHLDB2;NIBAN2;BNIP3;ENPP2;NCOA3;MCU;DVL3;AGO2;SMURF2;COBL;NEUROD2;DLG4;BMPR1A;RBM19;AR;RAPGEF3;GDNF
prerank,regulation of macroautophagy (GO:0016241),0.3018379977052293,1.044679116294294,0.3984251968503937,0.8367061144830715,1.0,28/105,17.31%,PRKAG2;PRKAG3;SNX6;NEDD4;SESN1;PRKAA2;LRRK2;SLC38A9;BNIP3;PRKAA1;ATP6V0D1;EPM2A;ATP6V0E1;MLST8;GPSM1;PRKAG1;LZTS1;TBK1;MAP3K7;ATP6V1D;RUFY4;EXOC7;EXOC1;LARP1;VPS26A;ATP6V1G2;VPS35;TSC1
prerank,nuclear membrane organization (GO:0071763),-0.38376430533000466,-1.0444461812376187,0.4029535864978903,0.7111644385850501,1.0,5/19,11.93%,TARDBP;TOR1B;TMEM43;NSFL1C;GPER1
prerank,mitochondrion organization (GO:0007005),-0.24725461152215425,-1.0443318941743827,0.328125,0.7107911465613421,1.0,55/165,25.13%,DNM3;NOS3;FBXO7;PPARGC1A;CAV2;CXADR;TOMM20;CHCHD2;VPS13C;ATP5F1D;TFB2M;RHOT1;BCL2L1;DNM2;CHCHD3;RAB38;MIEF1;MTM1;STOML2;TOMM22;NDUFS1;DNM1;HSPD1;HIGD2A;PPRC1;TIMM9;MIEF2;SIRT4;MTX3;TIMM10B;TIMM13;MSTO1;BCAP31;ATP5F1B;MTFR1L;VPS13D;PINK1;SUPV3L1;TIMM22;MYH14;SLC25A4;HIGD1A;CYCS;BIK;TOMM7;MFN2;BCS1L;HIGD1B;TIMM50;CHCHD10;BAX;ATCAY;SPG7;RAB5IF;HAP1
prerank,cellular iron ion homeostasis (GO:0006879),-0.30286773190654753,-1.0439775708588486,0.4019607843137255,0.7110171579420687,1.0,15/55,10.01%,ABCG2;FTH1;TFRC;SCARA5;FTL;IREB2;SLC40A1;SOD1;NEDD8;SLC22A17;ISCU;FBXL5;HMOX2;FRRS1;ATP6V1A
prerank,lymphocyte proliferation (GO:0046651),-0.3696105261314351,-1.0436407824209155,0.4041237113402062,0.7112572608708222,1.0,8/22,17.60%,MEF2C;MSN;PTPRC;LMBR1L;HSPD1;FLT3;CR2;CD40
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2975024202004422,-1.0434042243973043,0.36666666666666664,0.7112297520917839,1.0,13/53,14.90%,HSP90AB1;DAB2IP;UBB;PKD1;UCHL5;GNA12;TMF1;PSMF1;FOXF2;PSME3;UBQLN4;PSMC3;PSME1
prerank,neuron projection development (GO:0031175),-0.24442635674452692,-1.0431362573330907,0.35714285714285715,0.7112860944952922,1.0,25/168,8.40%,FRY;SHANK3;PTPRM;TRIO;STX3;CTNND2;PLP1;GRM7;MAP4;DAB2IP;NGF;UBB;DOCK10;MINK1;SHTN1;NCKAP1;BLOC1S2;EHD1;GSK3B;GPM6B;STMN2;DNM2;APP;MYOC;PAK1
prerank,phagosome acidification (GO:0090383),-0.36122776702698756,-1.042799967388475,0.4157303370786517,0.7114932402750882,1.0,15/26,28.77%,ATP6V0A1;RAB38;ATP6V1A;ATP6V0C;TCIRG1;ATP6V1E1;ATP6V0A4;ATP6V0A2;RAB39A;ATP6V0D2;RAB7A;ATP6V0E2;ATP6V1B2;ATP6V1H;RAB20
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.3025222433556577,-1.0425765495590185,0.38154613466334164,0.7114118914285338,1.0,8/52,6.77%,SPTBN1;PRKCH;EPB41;STX3;ITGB1;NKD2;GNAI1;WNK3
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.41261174262921635,-1.041770492586856,0.4198473282442748,0.7127874603009083,1.0,6/13,27.20%,STAT3;OAS2;CANX;JAK1;STAT1;OASL
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4275536938670805,1.041251259850841,0.4260700389105058,0.8449298332129429,1.0,3/16,9.15%,APPL2;ACADL;APOC1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.38447592468857433,-1.041017912747272,0.41346153846153844,0.7139862939217176,1.0,8/17,26.32%,PODXL;TGFB2;PIEZO1;RET;ADAM9;NCKAP1L;P2RY12;SKAP1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.44435616447915943,-1.0408550069454596,0.4157303370786517,0.7137226566868794,1.0,6/10,31.25%,OGT;PDK2;ZNF692;SIRT7;DGKQ;GNMT
prerank,cardiac muscle cell development (GO:0055013),0.4101428550282773,1.0408201746645092,0.4311594202898551,0.8450696633201105,1.0,5/20,4.40%,CSRP3;PDGFRB;SLC8A1;OBSL1;PDGFRA
prerank,cellular biogenic amine catabolic process (GO:0042402),0.46053751139043575,1.0406745207604635,0.43312101910828027,0.8444904218482132,1.0,4/10,23.36%,ALDH7A1;LRTOMT;SMOX;COMT
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.4081458185980417,-1.0405910295598702,0.4098360655737705,0.7137630171990319,1.0,8/15,30.44%,PRKCH;SFRP4;BMP4;NUMA1;ETV4;NME2;SFN;SULT2B1
prerank,cellular potassium ion homeostasis (GO:0030007),0.4410194463880662,1.0403256917163721,0.4262626262626263,0.8444810808123765,1.0,2/13,2.26%,ATP1A2;ATP1B3
prerank,T cell activation (GO:0042110),0.3191944427265288,1.04026618022577,0.39473684210526316,0.8436548543126766,1.0,5/69,2.65%,LEPR;KIT;JAML;KIF13B;CTPS1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4261394401665093,-1.0397666716187484,0.4147727272727273,0.7152105101856473,1.0,3/13,6.69%,PDE8A;RACK1;MET
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4483000802168601,1.0395669224639899,0.422360248447205,0.8446967727130872,1.0,3/14,7.32%,OSR1;ZEB1;MMP9
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.39202091470308575,-1.039322240702865,0.42768595041322316,0.7156519987754125,1.0,3/16,9.42%,CADM1;LAMP1;PVR
prerank,regulation of lymphocyte migration (GO:2000401),-0.4469047561382292,-1.0390962738688567,0.425891181988743,0.7155755621196119,1.0,2/10,1.66%,MSN;JAM2
prerank,central nervous system development (GO:0007417),0.2653607051233587,1.038976849034048,0.3795918367346939,0.8453092895197201,1.0,26/250,7.48%,EPHA7;AFF2;ARNT2;SLC8A3;ZIC1;PRKN;ATXN1;MEIS1;ZIC2;SZT2;B3GNT5;SOX6;SHROOM2;LOXL3;JARID2;ZIC5;PAFAH1B3;NFIB;ZFHX2;TPP1;SYNJ2;PHF8;SETD1A;AMIGO3;PBX4;PTEN
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.4498254671040354,-1.038959900457967,0.4376163873370577,0.7152634974542065,1.0,5/11,22.08%,SCARB1;MFSD2A;NR1H2;CTDNEP1;NR1H3
prerank,positive regulation of catalytic activity (GO:0043085),0.3558409738616183,1.0388194572851535,0.40699815837937386,0.8447986951721406,1.0,11/37,15.09%,FGFR4;IGF2;AZIN2;XRCC5;XRCC4;SSBP1;NHEJ1;ABL1;PSENEN;CIB1;WRN
prerank,lysosome localization (GO:0032418),-0.32457894093370676,-1.0387571335231947,0.39775280898876403,0.7151271327680488,1.0,20/37,31.89%,MAP6;BLOC1S2;MYH9;PIK3CD;LAMTOR1;CHGA;PLEKHM1;SPAG9;HDAC6;S100A13;RAB3A;SYTL4;MILR1;BORCS6;KLC2;SNAPIN;VPS33B;HPS6;NR4A3;KIF5B
prerank,regulation of secretion by cell (GO:1903530),-0.29693506203041425,-1.0386359767583628,0.3914027149321267,0.7147874006444139,1.0,25/54,31.08%,MEF2C;NSF;RAB3C;MCTP1;VAMP8;SCG5;RHBDF2;DNAJC1;KCNMB4;RAB3B;CPLX2;FMR1;RAB8A;RAB8B;RAB3A;LGI3;DISP1;CPLX1;HAP1;ARFIP1;VAMP3;RIMS2;SYT1;STXBP5L;RAB15
prerank,mRNA splice site selection (GO:0006376),0.3706200794974639,1.038415120430256,0.39615384615384613,0.8449191258953269,1.0,4/30,8.29%,CELF2;NOL3;SLU7;SF3A3
prerank,purine-containing compound catabolic process (GO:0072523),0.44396754700480207,1.0382087024767515,0.4294478527607362,0.8445461949097729,1.0,1/13,0.43%,DPYD
prerank,synaptic vesicle transport (GO:0048489),-0.4349075279293554,-1.0381804573138076,0.43263757115749524,0.7152773477492416,1.0,7/11,31.89%,RAB27A;SYNJ1;DNM2;CDK5;KIF5C;SNAPIN;KIF5B
prerank,response to muscle stretch (GO:0035994),0.4413045400159952,1.0381733820328005,0.43584521384928715,0.8436877132791134,1.0,3/15,3.07%,DMD;CSRP3;SLC8A1
prerank,positive regulation of type 2 immune response (GO:0002830),0.4420056967145327,1.037681128576785,0.42016806722689076,0.844077433992414,1.0,3/14,6.76%,IL18;PRKCZ;IL6
prerank,negative regulation of signaling (GO:0023057),-0.3484597947355148,-1.037667348394888,0.3978494623655914,0.7159298121775598,1.0,6/25,10.70%,HHIP;AP1AR;UBASH3B;SOCS5;KIF26A;PTPN1
prerank,negative regulation of protein metabolic process (GO:0051248),-0.3026599183641444,-1.0376520211430107,0.3894230769230769,0.715309668153434,1.0,12/48,18.96%,HSP90AB1;FLNA;CRYAB;EDN1;AZIN1;CLU;IRAK3;CYP51A1;IAPP;PFDN6;PRKCG;PFDN5
prerank,cellular response to amino acid starvation (GO:0034198),-0.2819610657461713,-1.0373744847244963,0.3720316622691293,0.7153176283802459,1.0,33/71,27.04%,MAP3K5;SESN3;SH3GLB1;DAPL1;MTOR;MAPK8;SESN2;ATP6V1A;ATP6V0C;WDR59;ATF4;LAMTOR1;RHEB;TCIRG1;ATP6V1E1;DAP;FAS;LAMTOR2;PRKD1;ITFG2;RRAGB;ATP6V0D2;MAPK3;CDKN1A;LAMTOR4;DEPDC5;CEBPB;ATP6V0E2;CASTOR1;ATP6V1B2;WDR24;ATP6V1H;RPTOR
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.44219030054124175,-1.0367601128821244,0.39768339768339767,0.7161302193679572,1.0,9/11,50.09%,CAMK4;SPI1;TYROBP;ITGB2;MAVS;TICAM1;STAP1;F2RL1;CD177
prerank,negative regulation of response to wounding (GO:1903035),-0.3756827416953269,-1.0366345031595763,0.3895582329317269,0.7157741307643523,1.0,8/19,21.35%,RTN4RL1;CD109;AJAP1;CRK;GIT1;CASK;INPP5F;RTN4R
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.4415868542212076,-1.0366269182433376,0.43100189035916825,0.7151543521491741,1.0,8/10,34.19%,MYD88;AKT1;CD68;TREM2;TLR4;CD36;TLR6;TICAM1
prerank,regulation of myoblast differentiation (GO:0045661),0.36119208486753374,1.0366246372823302,0.3912248628884826,0.8459160414979717,1.0,3/32,3.63%,RANBP3L;PLCB1;RIPOR2
prerank,phosphorylation (GO:0016310),0.25413864951008613,1.0366067645115846,0.36752136752136755,0.8450069865322921,1.0,71/385,14.23%,PRKAG2;EPHA7;ROCK2;OXSR1;NRK;WNK4;CDK8;DAPK1;PRKAG3;PDPK1;PDK1;BMP2K;RNASEL;DMPK;FER;MAP4K5;CDK7;FAM20A;SRPK2;SPHK1;MAPK9;SIK1;PRKAA2;LRRK2;PRKCZ;PRKCB;MAML1;STK17B;PRKCA;GRK3;PRKAA1;NEK4;NRBP1;RYK;BIRC5;GRK5;BIRC6;CCNT1;PKN2;CDK1;CAMK2D;PIK3R4;NEK10;GRK4;VRK2;LATS1;FRK;ABL1;PRKDC;JAK2;COQ8B;ERBB2;IKBKE;BMPR1A;MAPKAPK2;PRKAG1;HIPK3;CCNE1;PRKD2;STK24;TBK1;ROS1;MAPK1;DCLK1;PRKACB;MORC3;STK26;NIM1K;CDKL5;NLK;CDK15
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.46997733274623066,1.0365446400078804,0.43935926773455375,0.844234259558181,1.0,1/10,0.35%,ERRFI1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.4232466569077232,-1.0359362335541296,0.43685300207039335,0.7162563986729991,1.0,3/13,9.42%,STX7;CYRIB;PVR
prerank,base conversion or substitution editing (GO:0016553),-0.43325240259394265,-1.0358572368187486,0.4230769230769231,0.7158189638631394,1.0,5/11,25.11%,ADARB1;ADARB2;ADAR;METTL3;NUDT16
prerank,negative regulation of centrosome duplication (GO:0010826),-0.440762797909397,-1.0354523416833301,0.41566265060240964,0.7162492219840978,1.0,7/11,41.68%,MDM1;RBM14;CCNF;NPM1;TMEM67;KAT2A;CENATAC
prerank,C-terminal protein amino acid modification (GO:0018410),-0.44053164654803584,-1.0351804844058747,0.4231536926147705,0.7162876828067983,1.0,4/11,28.41%,ATG7;TTL;ICMT;AGTPBP1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.26856330085608904,-1.0349594418215786,0.4090909090909091,0.716186406886823,1.0,27/80,23.62%,THBS1;NIBAN1;EEF2;VIM;RACK1;RPL26;SOX4;LRRTM3;RPL5;MTOR;PYM1;EIF3D;BCL3;YTHDF3;RPS4X;CLU;RPS27L;IFNGR1;EIF3C;ABCA2;ABCG1;PRKCD;METTL3;FMR1;EIF6;RELA;PCIF1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4091008615371327,1.0347634088094628,0.40451745379876797,0.8482124178014628,1.0,7/19,20.01%,MTHFR;FOLR2;SLC19A1;SHMT1;MTHFS;DHFR;MTHFD2
prerank,central nervous system neuron differentiation (GO:0021953),-0.3328370197697166,-1.03474155459255,0.4004237288135593,0.7160964370788477,1.0,13/33,30.77%,SOX4;CTNNB1;MDGA2;SPOCK1;NR4A2;KNDC1;TOX;GRID2;NPY;AGTPBP1;LMX1A;FAIM2;SIN3A
prerank,positive regulation of viral transcription (GO:0050434),0.3821965180594016,1.0342262593498623,0.4090056285178236,0.8487014082732783,1.0,5/25,8.49%,POLR2D;POLR2A;RSF1;CCNT1;GTF2F1
prerank,regulation of hormone secretion (GO:0046883),0.4379523994386072,1.034168729217817,0.44779116465863456,0.8479068557204049,1.0,2/15,3.48%,SNX6;ANXA1
prerank,response to reactive oxygen species (GO:0000302),-0.29960244268907144,-1.0341472208057978,0.41404358353510895,0.7169693982478158,1.0,14/54,13.74%,APOD;FYN;RPS3;PXN;CAMKK2;SOD1;PDCD10;JUN;STK25;MAPK8;CHUK;PDK2;AGAP3;ROMO1
prerank,negative chemotaxis (GO:0050919),0.35958165195619074,1.033925276033834,0.3996383363471971,0.8475626935440926,1.0,3/33,2.39%,EPHA7;ROBO1;SEMA3B
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.4042448458621459,-1.0334080508719738,0.43103448275862066,0.718234423849983,1.0,4/14,12.73%,THBS1;CREB3L1;GPC1;SPRY4
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.40912501316137106,-1.0331714027941887,0.402321083172147,0.7181932705757349,1.0,5/14,10.70%,PTK2;SOCS2;PXN;STAT3;PTPN1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3901593148602884,1.0329028583617212,0.4106090373280943,0.8492797500777246,1.0,2/23,1.91%,ERRFI1;SNX6
prerank,positive regulation of binding (GO:0051099),-0.2727556341777806,-1.0328796505203592,0.37777777777777777,0.7183264919882796,1.0,18/84,11.31%,CAV1;CLDN5;B2M;EPB41;TIAM1;RPL11;NGF;HES1;PKD1;GSK3B;MET;ADD2;HIP1R;APP;DERL1;RALB;BMP2;MEN1
prerank,protein acetylation (GO:0006473),0.37056297117775405,1.0328102172402618,0.41187384044526903,0.8485549187827789,1.0,12/30,21.83%,NAA80;SPHK1;AANAT;NAA35;NAA60;ESCO1;CLOCK;CREBBP;DSCC1;KAT2B;KAT5;NAA50
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.3794848864418492,-1.032427487213806,0.4180327868852459,0.7188007139806596,1.0,7/18,20.16%,ESR1;TGFB1;RPS26;ZC3H12A;NRDE2;TMBIM6;PTBP1
prerank,myeloid leukocyte differentiation (GO:0002573),0.31482696627989853,1.0322071402522437,0.38778877887788776,0.8492143738908171,1.0,9/65,11.41%,IL31RA;KIT;MMP9;CCL19;OSTM1;CSF1;BATF2;EPHA2;RXRA
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3320115531490373,-1.0318523897837093,0.423728813559322,0.7196160214626847,1.0,7/33,9.17%,ESR1;RUNX1;CBFB;CALR;KDM4C;DDX5;H3-3A
prerank,protein modification by small protein removal (GO:0070646),-0.23151586523093035,-1.0315469765750847,0.30943396226415093,0.7197687047926548,1.0,56/252,17.81%,ACTB;ESR1;IL33;ATXN3;USP38;OTUD7A;UBB;NFKBIA;UCHL5;TOMM20;EIF3F;COPS7A;NEDD8;RHOT1;USP29;RPS27A;UBC;USP31;UCHL1;ZRANB1;BIRC3;PSMD13;PSMF1;RHOA;PSMB10;APC;OGT;HGS;USP50;PSMB6;PSME3;USP37;PSMB5;ADRB2;OTUD3;PSMC3;UCHL3;OTUB1;PSMD12;FOXK1;PSMB8;OTUD1;PSME1;CFTR;UBA52;COPS8;IFIH1;PSMB3;RUVBL1;MYSM1;USP28;USP9X;ZC3H12A;COPS6;WDR20;USP8
prerank,telomere maintenance via telomerase (GO:0007004),-0.336710309679438,-1.0313135730356606,0.4216335540838852,0.7197143111293414,1.0,9/28,21.04%,HSP90AA1;HSP90AB1;PINX1;RPA1;TERF2IP;TNKS1BP1;ANKRD28;CDK2;NHP2
prerank,cholesterol metabolic process (GO:0008203),0.31323012660357685,1.0312043880575388,0.40609137055837563,0.8509036502194437,1.0,12/68,12.25%,CYP27A1;CEL;INSIG2;ABCA1;ABCA5;PMVK;ACAA2;SOAT2;ACAT2;FDPS;RXRA;GBA2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.4108569734603506,1.0311061622326008,0.42276422764227645,0.8501935325765434,1.0,2/19,7.58%,PPARA;DAGLB
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3786673508831211,1.0310172550886734,0.4048507462686567,0.8494920428005466,1.0,8/26,21.64%,KMT2A;SETD1A;SETD2;CTR9;WDR82;SETD4;BEND3;TET3
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.3810033652379283,-1.0309047119584969,0.4297520661157025,0.7200170813752901,1.0,3/17,9.42%,CADM1;LAMP1;PVR
prerank,negative regulation of transport (GO:0051051),0.3281584615182751,1.0307534175366984,0.41089108910891087,0.8492884585442716,1.0,10/51,12.63%,EPHA3;PRKN;SYT11;SNX33;PTEN;WWP2;SIRPA;RUBCN;SNX12;PACSIN3
prerank,positive regulation of autophagy (GO:0010508),0.3054646755323246,1.030749793086486,0.4019138755980861,0.8483546956780343,1.0,22/81,16.62%,DAPK1;PRKN;TRIM5;SESN1;PRKAA2;UFL1;NPRL2;LRRK2;BNIP3;OPTN;RNF152;PRKAA1;EPM2A;PLEKHF1;FLCN;GPSM1;TBK1;MAP3K7;MTDH;RUFY4;LARP1;IRGM
prerank,epithelial structure maintenance (GO:0010669),0.4625885247816038,1.0304539661324896,0.4296724470134875,0.8482621037092326,1.0,2/11,7.99%,RBP4;MUC13
prerank,nucleosome organization (GO:0034728),0.32570098627382515,1.0303660594853412,0.3899159663865546,0.8475578724857636,1.0,20/55,22.10%,NASP;RSF1;ARID2;KAT6B;SMARCA5;SMARCE1;NAP1L3;INO80;SMARCB1;NAA60;SRCAP;SMARCC1;ACTR6;SMARCD3;NAP1L1;SETD2;BRDT;PAF1;ANP32B;SOX9
prerank,regulation of immune response (GO:0050776),-0.2489227783605875,-1.030185572225542,0.3684210526315789,0.7211941379506893,1.0,31/135,19.89%,FOXP1;B2M;CLEC2D;CD200;CD34;TGFB2;ITGB1;CXADR;DENND1B;ITGA4;LRP8;CSK;AHR;BIRC3;ADCY7;APPL1;PVR;NPDC1;RSAD2;ICAM2;CD81;COL1A1;COL3A1;CASP8;ULBP1;N4BP1;CD40;IL15;PIANP;TIRAP;TYROBP
prerank,organelle transport along microtubule (GO:0072384),-0.3319076169542368,-1.0295924886441634,0.41025641025641024,0.7219756144430646,1.0,7/31,16.43%,UBB;COPG1;RHOT1;RAB1A;NDE1;BICDL1;BICD1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.28639640702680746,1.0294933272832476,0.4171686746987952,0.8489567750222233,1.0,21/122,12.50%,IGF1;FGFR4;SMOC2;SLC6A9;SORBS1;PDGFRB;IGF2;PLD1;IL6;CCL19;SAMD4A;PRKDC;RPS6KB1;METTL14;NPM2;JAK2;FXR1;ERBB2;LARP6;PRKD2;AR
prerank,positive regulation of immune system process (GO:0002684),-0.3920288637558198,-1.0294248255704959,0.4251968503937008,0.7217343840791604,1.0,6/16,20.80%,TGFB2;VEGFA;PIK3CD;RSAD2;IL15;NCKAP1L
prerank,phagosome-lysosome fusion (GO:0090385),-0.4487128479282592,-1.0292832901001905,0.44881889763779526,0.7214326214539851,1.0,7/10,38.02%,SYT7;RAB39A;RAB7A;RAB7B;RAB20;PLA2G5;CLN3
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.3828612862572614,-1.029150813403995,0.42362525458248473,0.7210754814196162,1.0,6/18,20.09%,SEC14L1;RNF125;PUM2;BIRC3;GPATCH3;NOP53
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.38364477843719536,1.0290922430977028,0.4243614931237721,0.8490536636208171,1.0,12/25,24.83%,SLU7;SF3A3;DDX23;PRPF3;SCAF11;DBR1;SNRNP40;PRPF6;LSM1;SF3B3;KHSRP;SRRM1
prerank,MAPK cascade (GO:0000165),0.25723824669323897,1.0290903776738038,0.3945666235446313,0.8481173527058057,1.0,23/295,6.48%,IL31RA;IGF1;KSR1;FGFR2;FGFR4;NRK;IL18;KIT;ANGPT1;NCAM1;PDGFRB;KL;CTSH;ARTN;ARAF;PDGFRA;PTPRA;LRRK2;FGF1;PSME4;FRS2;PSMA2;DLG1
prerank,protein homooligomerization (GO:0051260),0.2897196061480278,1.02905313393584,0.41244573082489144,0.8472708469553212,1.0,17/114,10.46%,ALDH1A2;APPL2;UPB1;ALS2;RNF213;CBY1;IKZF4;HSD17B10;ARC;BLM;SLC1A5;RNF135;SSBP1;GOLGA2;GSDMD;CLYBL;MICU1
prerank,regulation of cellular component movement (GO:0051270),0.33438625064357447,1.028691477890039,0.4160839160839161,0.8472457942363414,1.0,4/49,3.58%,TGFBR3;ROCK2;SP100;PDPN
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.4323683560698758,-1.0285826180737274,0.44150943396226416,0.7219091420728497,1.0,6/11,31.96%,PUM2;LIMD1;STAT3;FMR1;ZFP36;DHX9
prerank,regulation of inflammatory response (GO:0050727),0.2737826655716592,1.0285692459175246,0.4124137931034483,0.8466458346358211,1.0,19/190,7.58%,RORA;ADAMTS12;C1QTNF3;PPARA;IL18;SNX6;ANXA1;CCN4;LACC1;SPHK1;UFL1;GPSM3;CASP12;SETD6;NAPEPLD;IL6;MMP9;NLRC3;DAGLB
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.3354043210125589,-1.0281310677191533,0.4230769230769231,0.7223486029782257,1.0,10/31,17.99%,KCNB1;STX1A;CACNA1G;CACNA1H;SYT10;REST;SYT4;CACNA1I;SYT2;SYT7
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.4325588079999807,-1.0279602756629287,0.444,0.7221648782702577,1.0,7/12,34.32%,SIX1;VEGFA;SIX4;PAX8;AGT;NOG;PAX2
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.47036317712461295,1.0279338767326083,0.4559139784946237,0.8474045204585331,1.0,2/11,7.52%,PLA2G10;LIPC
prerank,receptor recycling (GO:0001881),0.4680933048841914,1.0278734175238924,0.451271186440678,0.8466260570997137,1.0,5/10,14.65%,PLEKHJ1;REP15;ARFGEF2;PHETA1;RAB11B
prerank,spinal cord development (GO:0021510),-0.4234969081623795,-1.0277661226044368,0.43545279383429675,0.7220013799026098,1.0,8/12,24.55%,VIT;PKD1;SOX4;RELN;NF1;DLL1;SOX11;ZPR1
prerank,response to laminar fluid shear stress (GO:0034616),-0.4461530906386899,-1.0276963382512416,0.42429906542056073,0.721537962818063,1.0,3/10,3.12%,KLF2;KLF4;SREBF2
prerank,cellular response to leucine starvation (GO:1990253),-0.44493985418973125,-1.0273943951847793,0.44801512287334594,0.7216732687825403,1.0,4/10,18.47%,SESN3;MTOR;SESN2;RRAGB
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.2510446174318988,-1.0273106864360884,0.3987138263665595,0.7212585969014764,1.0,36/124,25.95%,FRY;PTPRM;RAC1;CARMIL1;STX3;PLP1;MAP4;BLOC1S2;EHD1;GSK3B;GPM6B;STMN2;APP;MYOC;PLEKHA1;STMN1;CSF1R;ODF2;BICDL1;TMEM108;STMN4;NCDN;STMN3;CDK5;SH3GL2;GPM6A;ARFIP2;L1CAM;UHMK1;VAPA;NPY;AGER;ATCAY;CAMSAP1;ADCYAP1;MICALL2
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.367755783368885,1.027028308902427,0.3950850661625709,0.8478946857995667,1.0,13/27,22.26%,BRD8;KAT8;KAT6B;CREBBP;NAT8;TRRAP;KAT2B;RUVBL2;KAT5;PHF20;MSL3;NAA50;TAF6L
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3750863700355682,1.0264689370377038,0.43503937007874016,0.8484177479433328,1.0,3/26,3.48%,PLCB1;UBE2E2;ANXA1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.4344528824108793,-1.0262257694157433,0.4448742746615087,0.7233380960384065,1.0,5/12,20.13%,TARDBP;JUN;REST;PSMC3;TFAP4
prerank,plasma membrane invagination (GO:0099024),0.3651305463490047,1.0262195121363038,0.42363636363636364,0.8481700016379321,1.0,6/29,7.84%,GULP1;ARHGAP12;SNX18;SNX9;SNX33;SPIRE2
prerank,mitochondrion transport along microtubule (GO:0047497),-0.4104847104529276,-1.0261416721612093,0.43538767395626243,0.7229355605859795,1.0,2/13,6.40%,UBB;RHOT1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.37828499668510973,-1.0261109966519923,0.4451345755693582,0.7223763808123255,1.0,7/17,22.06%,SREBF2;SOD1;LPCAT3;ERLIN2;ABCA2;ABCG1;MBTPS1
prerank,calcium ion import (GO:0070509),-0.3419343998633375,-1.0260248930869225,0.4074844074844075,0.7219487114657395,1.0,11/28,16.39%,CACNA1G;CACNA1E;ATP2A2;TRPC4;SMDT1;CACNA1H;CACNA1C;CACNB2;MCUB;CACNA1I;CACNA1B
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.3140173495996499,-1.0256965919387733,0.3952941176470588,0.7221451753590148,1.0,14/42,29.62%,WARS2;LARS2;WARS1;SARS1;YARS1;IARS1;NARS1;EEF1E1;FARSA;AARS2;CARS1;KARS1;MARS2;GARS1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.30353202005866564,1.0256715804395953,0.40491803278688526,0.8486560383022845,1.0,3/84,1.37%,IGF1;IGF2BP1;DAPK1
prerank,regulation of dendrite development (GO:0050773),-0.31746549489816395,-1.0253928516393833,0.40869565217391307,0.7222781211725818,1.0,11/37,8.58%,BMP5;NEDD4L;DAB2IP;SEMA4D;ZDHHC15;DCC;GSK3B;LRP8;RTN4IP1;MFSD2A;MARK1
prerank,negative regulation of apoptotic process (GO:0043066),0.24899723051922293,1.0251991506846572,0.4117647058823529,0.8490067622357599,1.0,75/444,13.68%,IL31RA;IGF1;OSR1;FHL2;NOTCH2;ANGPT1;PRKN;DAB2;SNX6;BCL2;FNIP1;SMAD6;DKK1;SCX;LTF;IFIT3;NDNF;CTSH;ANXA1;PDPN;RNF213;ARAF;SPHK1;KDM2B;ZFAND6;CPEB4;PRKAA2;IGF1R;LRP2;SON;NIBAN2;KRT18;MYO18A;BNIP3;SH3RF1;IL6;NOL3;MMP9;PRKCA;PRKAA1;BIRC5;SIAH2;GRK5;BIRC6;TLE1;CDK1;NUPR1;BCL2L2;RETREG1;YME1L1;ITCH;MED1;NAA35;AXL;PHIP;PRKDC;HDAC1;PIK3R1;RPS6KB1;TFAP2A;TFAP2B;SH3RF2;TMBIM4;APOH;CFLAR;HIPK3;GDNF;FSTL1;NFATC4;MAPK1;MRE11;ANXA5;NTSR1;CIB1;SLC30A10
prerank,plasma membrane repair (GO:0001778),-0.4119045918171296,-1.0247950561518333,0.4349514563106796,0.7231415881539888,1.0,6/13,24.52%,AHNAK2;MYH9;DYSF;SYT7;RAB3A;SYTL4
prerank,organic substance transport (GO:0071702),0.28755885678333803,1.0246668620477657,0.424886191198786,0.8495302588259809,1.0,19/121,11.17%,SLC22A4;SLC22A2;ABCA4;SLC35F3;ABCA9;TCN2;ABCA1;ABCA13;SLCO1B1;LRP2;NDC1;ZG16;ABCA5;MIA3;SLC22A6;SLC19A2;SLC19A1;MFSD2B;PLEKHA8
prerank,regulation of protein ubiquitination (GO:0031396),-0.2575899553207668,-1.0246525905143198,0.40054495912806537,0.7228270773924088,1.0,43/108,25.32%,CAV1;HSP90AA1;HSP90AB1;UBE3A;UBB;RPS3;DNAJA1;IVNS1ABP;UBXN1;PINX1;SOX4;FAM107A;ARRB1;CHP1;CUL3;BIRC3;DERL1;OGT;ISG15;NDFIP2;FOXF2;CAMLG;DCUN1D1;NXN;WFS1;LAPTM5;PRMT3;SPOPL;N4BP1;SPRTN;PRKCG;UBE2D1;PINK1;ARRB2;AKT1;SIRT7;TNFAIP3;NDFIP1;HSPA1B;SPRY2;HUWE1;PTTG1IP;TSPYL5
prerank,inorganic ion transmembrane transport (GO:0098660),-0.43046971552416746,-1.0244811796257098,0.45904761904761904,0.722637159957114,1.0,4/12,18.75%,ABCC9;CACNA1H;KCNJ8;TRPM4
prerank,positive regulation of lipid transport (GO:0032370),-0.418529241889583,-1.0244150943046,0.44145873320537427,0.7221692263198527,1.0,11/12,56.69%,SPP1;ABCA3;DBI;PRELID1;LRP1;ABCB4;TRIAP1;ABCA12;CYP19A1;PRAP1;ADIPOQ
prerank,negative regulation of blood pressure (GO:0045776),-0.41561614592896,-1.023563947548448,0.42973523421588594,0.7237088011067195,1.0,4/13,17.59%,NOS3;BMPR2;NOS1;PRCP
prerank,inorganic anion transport (GO:0015698),-0.2922623474094218,-1.0232408593021665,0.40189125295508277,0.72385341775588,1.0,7/53,6.11%,SLC4A10;SLC26A7;ANO1;ANO4;CLIC4;CLIC5;TTYH3
prerank,regulation of nuclear division (GO:0051783),0.40405393868715533,1.0231445948754903,0.4180790960451977,0.8525435466778252,1.0,4/20,8.85%,OBSL1;CCDC8;CUL9;CUL7
prerank,response to UV (GO:0009411),-0.2654271571467365,-1.02301814156079,0.3983516483516483,0.7238006034327209,1.0,33/95,28.21%,RPL26;UVSSA;MAPK8;UBE2B;BCL3;MAP2K7;ATF4;MFAP4;MEN1;MSH2;ERCC8;SDF4;COPS9;POLK;USP28;N4BP1;SPRTN;ATR;PRKCD;AKT1;NOC2L;METTL3;FMR1;CDKN2D;BMF;POLD1;RELA;GTF2H2;DTL;XPA;ERCC5;CAT;TMEM161A
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.4335165466671444,-1.022697303722136,0.44954128440366975,0.7239821303913783,1.0,5/11,22.43%,ITM2B;ITM2A;ITM2C;ABCA2;NECAB3
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3900503342476293,-1.0224467224482598,0.4403292181069959,0.7239929477868803,1.0,3/15,9.32%,NGF;BCAR1;DDIT4
prerank,negative regulation of endocytosis (GO:0045806),0.37497325649088753,1.0222038493065375,0.4245810055865922,0.8539829386609392,1.0,7/24,12.63%,EPHA3;SYT11;SNX33;APOC1;PICALM;RUBCN;PACSIN3
prerank,protein import into peroxisome matrix (GO:0016558),-0.4259349284379659,-1.022167174924147,0.43503937007874016,0.7241064785814345,1.0,6/12,29.55%,PEX5L;PEX1;PEX5;PEX10;PEX16;PEX13
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.42262576820078346,1.0220486926705228,0.4462474645030426,0.8534653839493868,1.0,3/16,5.24%,KLK2;ADM;ACE
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.3044302113402026,-1.0220213578975839,0.410958904109589,0.7238502978510366,1.0,11/43,12.32%,TGFB2;KLF4;ETS1;PPARD;GATA2;TGFB1;GNL3;JUN;DDX5;STAT3;REST
prerank,regulation of chromatin organization (GO:1902275),0.4265471403052947,1.0203300452344264,0.44308943089430897,0.8569799290867045,1.0,3/14,6.29%,IGF2;METTL4;SETD1A
prerank,proteasomal protein catabolic process (GO:0010498),-0.2310782659529006,-1.020249915910314,0.39158576051779936,0.7277035115066305,1.0,66/201,26.17%,WWP1;ATXN3;PPP2R5C;NEDD4L;UBXN1;ZNRF1;CTNNB1;FAF1;ARRB1;BAG6;RMND5B;UCHL1;CUL3;DERL1;PSMD13;CCDC47;PSMF1;DDB1;UBE2B;RBX1;PSMB10;UBXN6;KCTD17;KCTD13;PSMB6;NSFL1C;PSME3;PSMB5;ERCC8;PSMC3;AGAP3;PSMD12;ERLEC1;PSMB8;RNF34;KLHL42;TRIM13;PSME1;UBE2G1;ZFAND2B;PSMB3;COP1;SPSB3;SPOPL;RNF5;ARRB2;TRIM2;SHARPIN;PSMD5;ZSWIM8;KCTD5;VCP;RBCK1;BRSK2;PLAA;PSMD9;PELI1;PSMB4;PCNP;HUWE1;ATE1;SPSB4;BFAR;KIF14;DCAF11;PSMD10
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4485494820671465,1.0200423157159084,0.4331896551724138,0.8567701250443551,1.0,1/11,0.34%,LEPROT
prerank,cilium movement (GO:0003341),0.33153078557485705,1.01990885691521,0.43333333333333335,0.8561650230379313,1.0,9/48,14.99%,ODAD3;DNAI4;DNAH11;TEKT2;SPA17;DNHD1;ODAD1;CFAP70;ODAD2
prerank,establishment of protein localization to membrane (GO:0090150),0.31474952132399525,1.0197884730098175,0.41402337228714525,0.8555338377506836,1.0,19/66,17.77%,AFDN;PARD3;RAB3IP;SYNE3;ZDHHC1;ARL6;ZDHHC3;MICALL1;OXA1L;VPS37A;VPS37C;RAB3GAP1;PRKCI;RAB11B;ATG3;GRIN3B;VPS37D;SDCBP;TAOK2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.45276761381184993,1.0195053503112226,0.4306418219461698,0.8553448590426763,1.0,2/11,6.22%,RBBP4;NASP
prerank,regulation of RNA metabolic process (GO:0051252),0.320266189044288,1.0194563275015993,0.39700996677740863,0.8545509203461952,1.0,12/59,11.47%,AFF2;IGF2BP1;NOVA1;PTBP2;HNRNPH1;SON;METTL4;YTHDF2;MITF;RC3H2;MED1;PCBP2
prerank,regulation of cell development (GO:0060284),-0.31847733386132765,-1.019279298351394,0.4367816091954023,0.729542692248388,1.0,17/36,23.10%,BHLHE40;RPS19;HES1;CTNNB1;PRUNE1;FOXO1;GRN;HEY2;RHEB;HEYL;CX3CR1;HES6;ADGRA2;AKT1;HDAC9;DLL1;HEY1
prerank,regulation of G0 to G1 transition (GO:0070316),0.34577710026691966,1.0190536685778901,0.4231464737793852,0.8547408746498188,1.0,11/38,16.35%,RBBP4;L3MBTL2;MGA;RNF2;RBBP7;E2F6;TFDP2;APAF1;UXT;RAD51;CDKN2B
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.4022306165634073,1.0190037003390724,0.42748091603053434,0.8539454109394431,1.0,2/20,1.82%,PID1;DAB2
prerank,response to amino acid starvation (GO:1990928),-0.27666142301978014,-1.0187841325323277,0.40633245382585753,0.7301979524759945,1.0,33/72,27.04%,MAP3K5;SESN3;SH3GLB1;DAPL1;MTOR;MAPK8;SESN2;ATP6V1A;ATP6V0C;WDR59;ATF4;LAMTOR1;RHEB;TCIRG1;ATP6V1E1;DAP;FAS;LAMTOR2;PRKD1;ITFG2;RRAGB;ATP6V0D2;MAPK3;CDKN1A;LAMTOR4;DEPDC5;CEBPB;ATP6V0E2;CASTOR1;ATP6V1B2;WDR24;ATP6V1H;RPTOR
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.31092789014468525,1.018097151219564,0.4265402843601896,0.8553180913435796,1.0,8/72,5.40%,IGF1;IL18;KIT;PDGFRB;NEDD4;PDGFRA;PDGFD;IGF1R
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.39368285779756634,-1.017963160032036,0.42549019607843136,0.7316274841630034,1.0,3/15,4.46%,CSGALNACT1;CSPG4;BGN
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4121231149894714,1.0179512352960407,0.43670886075949367,0.8547949620724933,1.0,4/16,12.17%,BMP7;NAPEPLD;FLCN;SOX13
prerank,regulation of protein kinase B signaling (GO:0051896),0.26629750889214965,1.0176939413365678,0.42398884239888424,0.8545497353909796,1.0,22/193,7.56%,TCF7L2;OSBPL8;FGFR2;FGFR4;PPARA;IL18;KIT;ANGPT1;PDPK1;PDGFRB;KL;IGF2;GFRAL;PDGFRA;RICTOR;IGF1R;FGF1;LRP2;FRS2;PDCD6;PTEN;CCL19
prerank,negative regulation of peptidase activity (GO:0010466),-0.29707649548173676,-1.0168751380257337,0.4098360655737705,0.7338156378965984,1.0,8/47,7.50%,SPOCK2;CST3;SERPINE2;SERPINI1;UBXN1;SERPINF1;SERPINB9;GAPDH
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3870378766266355,1.0164391581825978,0.4326530612244898,0.8568709256531902,1.0,5/20,9.87%,WNT4;SIK1;ACADL;APOC1;SLC27A1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.3967886812087516,-1.015807370646447,0.44889779559118237,0.7359260771964523,1.0,6/15,30.92%,HGS;ATP13A2;SDC4;RAB7A;PDCD6IP;VPS4B
prerank,I-kappaB phosphorylation (GO:0007252),-0.4425681577055628,-1.0157433895897532,0.47701149425287354,0.73546297212928,1.0,4/10,28.94%,DAB2IP;CHUK;TLR7;TLR4
prerank,positive regulation of response to external stimulus (GO:0032103),0.28117792388193524,1.0149329309349409,0.4275147928994083,0.8599672006975804,1.0,13/128,7.68%,BMP6;SASH1;IL18;PDGFRB;CCN4;GPSM3;DDX60;PTN;NAPEPLD;OPTN;PRKCA;CCL19;POLR3G
prerank,regulation of Ras protein signal transduction (GO:0046578),0.29800180293203654,1.0147541814168535,0.41533546325878595,0.8595042426580829,1.0,13/86,11.11%,IGF1;DENND4A;NOTCH2;AKAP13;KANK2;EPS8L1;RALGPS1;MYO9B;ARHGEF18;KBTBD7;DENND4B;FLCN;JAK2
prerank,positive regulation of innate immune response (GO:0045089),-0.3307720978139284,-1.014359574231339,0.41683778234086244,0.7383002607227512,1.0,15/30,35.89%,LBP;RPS19;NLRC5;GBP5;IFI35;SPI1;POLR3D;POLR3F;SLC15A4;FADD;PLA2G5;DHX9;MAVS;CCL5;TLR8
prerank,positive regulation of protein acetylation (GO:1901985),0.43639372999045867,1.0143402099707524,0.45417515274949083,0.8596195567762408,1.0,5/12,20.51%,PRKAA2;PRKAA1;RAPGEF3;DDX3X;KAT5
prerank,regulation of protein localization (GO:0032880),-0.2895685232846028,-1.014005922199506,0.4244604316546763,0.7386011578736608,1.0,12/58,10.92%,HSP90AA1;HSP90AB1;RACK1;CTSD;RABGAP1L;TRIM14;TRIM25;STX6;MMD2;ZDHHC7;MAPK8;RSL1D1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.32408170264953334,1.0134992167935701,0.42782608695652175,0.8609671458696788,1.0,1/48,0.08%,PRKAG2
prerank,retinal metabolic process (GO:0042574),0.44041966390293075,1.0134486790212542,0.425,0.8601784714027225,1.0,4/12,19.49%,ABCA4;RDH11;RDH13;BCO2
prerank,oxoacid metabolic process (GO:0043436),0.37423243186434463,1.0127984421670717,0.45112781954887216,0.8610011291141806,1.0,2/27,2.99%,DDO;TPST1
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.2772425835362033,-1.0122015080860856,0.44642857142857145,0.7425316654996026,1.0,18/66,20.49%,TFRC;CDH1;FLNA;LIMK2;PINX1;TGFB1;FERMT2;CARD10;LARP7;SESN2;WWTR1;MEPCE;JUP;ZC3H12A;PSEN1;PRKCD;AKT1;RBM22
prerank,positive regulation of macroautophagy (GO:0016239),-0.2969520128533702,-1.0121989328597807,0.4380952380952381,0.741894033223805,1.0,17/48,23.70%,KDR;SPTLC2;SESN3;SH3GLB1;SESN2;RALB;HSPB8;ADRB2;TRIM13;SMCR8;VPS13D;PINK1;DCN;PIP4K2A;SLC25A4;SPTLC1;SCOC
prerank,aerobic respiration (GO:0009060),-0.3580604265341213,-1.0113916470443798,0.4581673306772908,0.7433190151708717,1.0,7/20,22.97%,ATP5F1D;UQCRH;NDUFS7;UQCRC2;UQCRC1;MTFR1L;UQCR10
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.43194109159156413,1.0113796478983776,0.45124282982791586,0.8638112286204003,1.0,2/14,9.75%,IL18;IL17D
prerank,skeletal muscle organ development (GO:0060538),-0.34704558120326895,-1.0113474035119343,0.4306122448979592,0.7428055238914124,1.0,5/26,6.87%,MEF2C;CAV1;MYL6;STRA6;SIX1
prerank,negative regulation of defense response to virus (GO:0050687),0.45803190467174315,1.011292403581284,0.44849785407725323,0.8631114906926196,1.0,4/10,19.04%,ITCH;PCBP2;TRAF3IP1;ILRUN
prerank,positive regulation of cell division (GO:0051781),0.34231774210267235,1.0111172591999067,0.44776119402985076,0.862660164819776,1.0,5/38,8.59%,FGFR2;CXCR5;CDC14B;FGF1;PKN2
prerank,response to nutrient levels (GO:0031667),-0.3850152262844202,-1.0109708989700341,0.4583333333333333,0.7431475812885703,1.0,5/17,10.68%,KCNB1;FAM107A;MTOR;EIF4G1;ATF4
prerank,regulation of microglial cell activation (GO:1903978),0.4191294921101697,1.0107947606772965,0.45617529880478086,0.8625553105545504,1.0,5/15,15.38%,SYT11;SPHK1;IL6;CST7;CX3CL1
prerank,protein secretion (GO:0009306),0.3206532008504561,1.0106765746328454,0.4359430604982206,0.8619320088884458,1.0,9/56,10.02%,WLS;TANGO2;ANXA1;RAB13;ARFGAP3;ABCA1;SLC30A8;MIA3;STEAP3
prerank,B cell proliferation (GO:0042100),-0.37713094639771194,-1.010570981385018,0.44047619047619047,0.7435614142691213,1.0,6/17,17.60%,MEF2C;PTPRC;CD180;HSPD1;CR2;CD40
prerank,positive regulation of JNK cascade (GO:0046330),-0.2737728620439528,-1.01049294930924,0.41686746987951806,0.7431386998428031,1.0,11/70,8.27%,MAP3K5;RASSF2;ANKRD6;PTK2B;DAB2IP;MINK1;SH3RF3;TPD52L1;APP;FLT4;WNT16
prerank,contractile actin filament bundle assembly (GO:0030038),-0.3870516486056864,-1.0104438598584728,0.44970414201183434,0.7419807535384645,1.0,6/15,10.75%,ITGB1;ARRB1;CUL3;PDCD10;RHOA;KCTD13
prerank,stress fiber assembly (GO:0043149),-0.3870516486056864,-1.0104438598584728,0.44970414201183434,0.7419807535384645,1.0,6/15,10.75%,ITGB1;ARRB1;CUL3;PDCD10;RHOA;KCTD13
prerank,carbohydrate catabolic process (GO:0016052),-0.3144613275212278,-1.0104159913517115,0.3986784140969163,0.741413371567971,1.0,13/38,23.11%,PKM;HK1;GAPDH;MAN2B1;MAN2C1;PFKM;TPI1;ALDOA;LDHA;ALDOC;MAN2B2;MANBA;PFKFB2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.32438375179602713,1.010371841195108,0.4152542372881356,0.8617860132866166,1.0,9/51,9.11%,NRK;BMP7;GAS7;ALS2;DTNBP1;WASF1;LRRK2;NBL1;MYO16
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4218157937525475,-1.0101483241244464,0.46476190476190476,0.7414503078347233,1.0,7/11,38.07%,TIRAP;TNFAIP3;TREM2;TLR6;MFHAS1;TLR1;PJA2
prerank,positive regulation of neurogenesis (GO:0050769),0.31150329197381943,1.0097700699320271,0.42992125984251967,0.8624209856067752,1.0,8/68,7.00%,PLXNA2;ROBO1;CUX1;IL1RAPL1;OBSL1;PLXNC1;LRP2;PTPRD
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.34878934550079477,-1.0095479789122914,0.42061855670103093,0.7422800672183153,1.0,11/22,37.71%,ISCU;CIAPIN1;GLRX5;HSCB;ISCA2;HSPA9;ISCA1;CIAO2B;NFS1;NUBP1;NUBP2
prerank,actin filament-based transport (GO:0099515),0.3943469283962802,1.0089824755996037,0.4567404426559356,0.8635744957234133,1.0,4/21,5.21%,MYO5C;SYNE2;MYO1H;WASL
prerank,folic acid metabolic process (GO:0046655),0.4071730751292898,1.0089694410210877,0.45473684210526316,0.8626930898654034,1.0,7/18,20.01%,MTHFR;FOLR2;SLC19A1;SHMT1;MTHFS;DHFR;MTHFD2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.3200005103405278,-1.0089371671150094,0.416289592760181,0.7431640291773982,1.0,13/33,26.08%,ACER2;TGFB2;PTK2;NEXMIF;DPP4;RET;CYP1B1;ADAM9;JAM3;NCKAP1L;ADA;P2RY12;SNAI2
prerank,neuron projection extension (GO:1990138),0.35448350567024683,1.0082087007878677,0.45567375886524825,0.863714171738691,1.0,2/32,0.61%,ALCAM;AUTS2
prerank,tube closure (GO:0060606),0.36046092178586103,1.0081639102731836,0.4542124542124542,0.8629030734774437,1.0,7/31,11.24%,LMO4;PRICKLE1;MTHFR;LRP2;FOLR1;COBL;IFT122
prerank,oligosaccharide biosynthetic process (GO:0009312),0.3943057161265441,1.0078496397898107,0.43584521384928715,0.8628102687358307,1.0,3/20,4.55%,B3GALT1;ST3GAL3;B4GALT1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.4128809156955785,-1.007830456553833,0.4387947269303202,0.7452126829401211,1.0,4/12,20.78%,SMCHD1;HNRNPU;YTHDC1;METTL3
prerank,tRNA 5'-leader removal (GO:0001682),-0.40083767880869003,-1.0071199699841382,0.4547325102880658,0.7463224034506374,1.0,7/13,28.40%,SSB;POP5;POP4;RPP21;RPP30;PRORP;POP7
prerank,positive regulation of vascular permeability (GO:0043117),0.4430890144941035,1.0069475511378256,0.44421906693711966,0.8642766880760602,1.0,2/12,1.29%,BMP6;ANGPT1
prerank,response to calcium ion (GO:0051592),-0.25745358486407033,-1.0066567612029007,0.43902439024390244,0.7468275507932829,1.0,29/102,17.99%,MEF2C;CAV1;CLIC4;THBS1;TRPC3;IQGAP1;CALM1;PLCG2;KCNMA1;LGMN;HOMER1;CPNE8;RYR2;CPNE2;CPNE3;KCNMB4;SYT10;SYT4;PPP3CA;ITPR3;KCNIP2;ITPKB;AHCYL1;CALM2;TRPC1;CPNE9;SYT2;ADAM9;SYT7
prerank,regulation of transport (GO:0051049),-0.3147488828869356,-1.005929438656499,0.43568464730290457,0.747938770340426,1.0,6/36,4.23%,ACTB;EPB41;ACTG1;ICA1;DNAJA1;REEP5
prerank,positive regulation of protein kinase activity (GO:0045860),-0.24242766930382353,-1.0057557025038828,0.4520123839009288,0.7477435760839407,1.0,32/148,12.75%,RAP1A;RASSF2;TGFB2;HSP90AA1;IQGAP1;GAS6;CALM1;HSP90AB1;PTK2;PTK2B;DAB2IP;MINK1;TGFBR2;MTCP1;PTPRC;CCDC88A;LRP8;PDCD10;VEGFA;EMP2;MMD2;PAK1;SRCIN1;RHOA;PAK2;RALB;RELN;PTPN1;PIH1D1;MARK2;CLU;ADRB2
prerank,regulation of protein secretion (GO:0050708),0.28105064806314,1.0057437915885374,0.44108761329305135,0.8664218438154534,1.0,11/119,7.58%,IGF1;BMP6;ITPR1;FRMD4A;KCNA5;LLGL2;CACNA1D;MYO18A;IL6;PRKCA;RAPGEF4
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.2928619335722249,-1.0051069272888267,0.457286432160804,0.7487204396049066,1.0,17/52,20.29%,SPTBN1;PRKCH;STX3;ITGB1;RACK1;NKD2;ATP2C1;WNK3;ZDHHC2;GPER1;RHOG;PRKCE;STAC3;ACSL3;ZDHHC8;AKT1;ATP2B4
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3757548340710402,1.0050602324097153,0.4589178356713427,0.8673017581107476,1.0,4/23,9.26%,NMT2;PDE6G;CAMKMT;GRK4
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.270506928527957,-1.0050410675452965,0.45260663507109006,0.7482465307154015,1.0,27/70,31.44%,CEPT1;MBOAT1;MFSD2A;LPCAT3;GPAT4;TMEM86B;LPCAT1;LPIN3;CSNK2B;NR1H2;PLA2G4A;LPIN1;ABCA3;LCAT;NR1H3;SLC44A5;PLA2G4F;SLC44A2;DBI;PLAAT1;PEMT;PLA2G15;CHPT1;PLA2G5;MBOAT2;LPCAT4;STARD10
prerank,myelination in peripheral nervous system (GO:0022011),-0.40913498861963177,-1.005031296311544,0.4701195219123506,0.7476343581287138,1.0,6/13,19.91%,ADGRG6;SOD1;MYOC;ARHGEF10;NF1;NCMAP
prerank,pulmonary valve morphogenesis (GO:0003184),0.40564757033831617,1.0050239259315006,0.4444444444444444,0.8664750427576899,1.0,3/17,2.28%,ROBO1;NOTCH2;SMAD6
prerank,embryonic digestive tract development (GO:0048566),0.4060422883504474,1.0045744223581223,0.4500978473581213,0.8667642477137266,1.0,4/18,6.81%,FGFR2;PDGFRA;GLI3;SALL1
prerank,cellular response to unfolded protein (GO:0034620),-0.33108464240946,-1.0045494307660805,0.4267515923566879,0.7481814895557705,1.0,13/26,25.95%,HSPA8;DAB2IP;ABCB10;HSPA14;HSPA5;PTPN1;HSPB8;HSPD1;TMBIM6;HSPA9;HSPA1B;BAX;ERN1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3811583439753969,1.004487411757918,0.46387832699619774,0.8660826245173664,1.0,3/24,4.29%,AUTS2;AVIL;ABI2
prerank,tRNA aminoacylation (GO:0043039),-0.31313255940137746,-1.0043592496012181,0.4584269662921348,0.7480401711275447,1.0,13/37,29.62%,WARS2;LARS2;WARS1;SARS1;YARS1;IARS1;NARS1;EEF1E1;FARSA;CARS1;KARS1;MARS2;GARS1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.3048807225710819,1.0042362295891436,0.43305785123966944,0.8658209081269347,1.0,7/75,5.00%,DCDC2;FGFR2;LRP4;SDC2;PARD3;BAIAP2;NTNG2
prerank,negative regulation of phosphorylation (GO:0042326),0.2950384740093813,1.0041792650683072,0.4437400950871632,0.8650709288632488,1.0,14/85,9.05%,PTPN13;PPARA;PID1;BMP7;PRKN;PLPP3;CACTIN;NPRL2;LRRK2;FBLN1;PTEN;ATG14;NUPR1;SIRPA
prerank,protein localization to Golgi apparatus (GO:0034067),-0.340866189122799,-1.0041320533516465,0.45397489539748953,0.7480121568531451,1.0,10/27,19.62%,VPS13A;VPS13C;ZDHHC15;GBP5;RIPOR1;TMED10;GBF1;VPS13D;SYS1;IFT20
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.25971335506696513,-1.0040635935258944,0.43768115942028984,0.7475209274537823,1.0,32/98,20.29%,SPTBN1;PRKCH;STX3;ITGB1;PPP1R13B;FYN;KCNB1;NKD2;NMT1;YWHAB;WNK3;CHP1;MAPK8;C2CD5;YWHAG;MIEF1;GPER1;BBC3;CD81;MIEF2;MTCL1;CASP8;RHOG;YWHAQ;PRKCE;STAC3;YWHAH;PPP3R1;ANK3;ZDHHC8;AKT1;ATP2B4
prerank,regulation of neuron differentiation (GO:0045664),-0.2722277385308322,-1.0040591738905995,0.4490358126721763,0.7468977416396944,1.0,23/76,18.05%,MEF2C;ZFHX3;TIAM1;NGF;HES1;NRCAM;CALR;SIX1;MMD2;RHOA;YWHAG;BMP2;HEYL;BIN1;REST;ARHGEF2;BRINP2;TCF3;DISP3;YWHAH;SOX2;ID2;CASZ1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.38146212416637715,-1.0039947603158799,0.4659090909090909,0.7464158723474711,1.0,4/17,8.54%,PPIA;HSPB1;SOD1;SFPQ
prerank,DNA repair (GO:0006281),0.25527888980712427,1.0038571463282213,0.44680851063829785,0.8649295955399426,1.0,72/284,17.87%,EYA1;FANCA;APEX2;RAD51B;ATRIP;BAZ1B;RAD51AP2;DDB2;HUS1B;RAD51C;TDP2;INIP;PDS5B;PSME4;PARP4;XRCC5;BLM;XRCC4;WDR48;FANCI;CDK1;BRCA2;MGME1;UVRAG;FBXO6;MBD4;MDC1;PDS5A;ABL1;PRKDC;DCLRE1A;PARP9;SMARCA5;ASCC2;TEX264;DCLRE1B;CUL4B;MPG;LIG1;INO80;PRIMPOL;MRE11;USP45;WDR33;FANCB;CIB1;FANCF;APEX1;UBE2V1;MNAT1;RAD23B;FANCE;FAAP100;UBE2A;CENPX;MLH1;BABAM2;WRN;FANCC;RAD18;RAD51;REXO4;BACH1;BRIP1;RNASEH2A;RPAIN;SETD2;TRRAP;XPC;ERCC6L2;DTX3L;FAAP24
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.3710347505386594,-1.003843069290912,0.4731610337972167,0.746168702939582,1.0,7/19,19.74%,NFATC2;NFATC1;EDN1;PPP3CA;HRH1;PPP3R1;NFATC3
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3667269824323599,1.0036672855161537,0.45131086142322097,0.864528654912829,1.0,7/27,8.90%,KIT;PDGFRB;EPHA8;PDGFRA;CCL19;ATG14;PIK3R4
prerank,mRNA destabilization (GO:0061157),0.3366191296385153,1.0036563048848703,0.4488330341113106,0.8636647903137107,1.0,5/38,10.80%,ROCK2;POLR2D;YTHDF2;RC3H2;METTL14
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3687539742053396,1.0033493651862644,0.44294003868471954,0.8635131511146112,1.0,2/26,1.27%,ADCY5;STXBP4
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.37665777950473134,1.0031893356713857,0.44550669216061184,0.8630511079824833,1.0,7/24,16.67%,LPGAT1;PLA2G10;SLC27A1;PLA2G4B;SERAC1;PLA2G12A;CDS2
prerank,regulation of potassium ion transport (GO:0043266),0.3491644317596292,1.0030085705733105,0.44045368620037806,0.8626322263615939,1.0,5/31,6.48%,KCNIP3;KCNA5;ANK2;CACNA1D;DLG1
prerank,bile acid metabolic process (GO:0008206),0.3679043071360633,1.0029624279980278,0.45255474452554745,0.8618685454213881,1.0,4/27,12.28%,CYP27A1;HSD17B10;GBA2;AMACR
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.21644605646010306,-1.002944157866582,0.47085201793721976,0.747846306484673,1.0,98/341,23.00%,WWP1;RNF144B;CBL;ATXN3;PPP2R5C;FBXO7;NEDD4L;OTUD7A;RNF144A;MVB12B;UBXN1;ZNRF1;BUB3;TRIM25;CTNNB1;UBAP1;FAF1;NEDD8;ARRB1;UBE3C;BAG6;RMND5B;UCHL1;RNF125;CUL3;ZRANB1;PSMD13;PSMF1;DDB1;UBE2B;RBX1;PSMB10;XBP1;RNF215;KCTD17;KCTD13;NDFIP2;FEM1A;PSMB6;TOLLIP;NSFL1C;PSME3;RNF150;PSMB5;UBQLN4;PTPN23;ERCC8;PSMC3;AGAP3;HERPUD1;MVB12A;PSMD12;PSMB8;RNF34;KLHL42;PTTG1;ARIH2;TRIM13;PSME1;KCTD21;ANAPC16;UBE2G1;ZFAND2B;PSMB3;COP1;SPSB3;SPOPL;USP9X;UBAP1L;RNF19B;TGFB1I1;FBXL14;BUB1B;UBE2D1;RNF5;PINK1;ARRB2;TRIM2;SHARPIN;PSMD5;ZSWIM8;RNF11;RNF168;KCTD5;UBA1;ARIH1;OTUD7B;VCP;RBCK1;TNFAIP3;RNF19A;ANAPC7;PLAA;UBL7;NDFIP1;PSMD9;PELI1;PSMB4
prerank,positive regulation of calcium ion transport (GO:0051928),-0.31264434000345354,-1.0028874407511006,0.451685393258427,0.7473610765299108,1.0,11/36,17.03%,CAV1;TRPC3;TRPC6;WNK3;STIM2;GRIN1;ATP2B1;CACNB2;CXCL12;WFS1;ORAI1
prerank,protein localization to mitochondrion (GO:0070585),0.43132906224234785,1.0028363339685673,0.4410480349344978,0.8612889339976293,1.0,3/11,6.59%,HK2;LRRK2;MAIP1
prerank,protein trimerization (GO:0070206),-0.39593951480874323,-1.00199961485598,0.45972495088408644,0.7482795246605434,1.0,9/14,34.36%,SCARA5;SIGMAR1;MIF;DISP1;SLC1A2;STEAP4;ASIC1;ALOX5AP;P2RX3
prerank,protein homotrimerization (GO:0070207),-0.39593951480874323,-1.00199961485598,0.45972495088408644,0.7482795246605434,1.0,9/14,34.36%,SCARA5;SIGMAR1;MIF;DISP1;SLC1A2;STEAP4;ASIC1;ALOX5AP;P2RX3
prerank,ion homeostasis (GO:0050801),-0.333876410886327,-1.001883766075081,0.4427966101694915,0.7479054768548572,1.0,6/30,11.07%,SLC4A10;NEDD4L;FHL1;WNK3;SLC4A8;SLC4A2
prerank,Golgi ribbon formation (GO:0090161),0.42607784658811576,1.0018786474899866,0.453781512605042,0.862855966824776,1.0,5/13,11.12%,MYO18A;OPTN;STX16;GOLGA2;VTI1A
prerank,estrogen metabolic process (GO:0008210),0.42559082716581775,1.001842273187893,0.4600389863547758,0.8620524065669691,1.0,2/15,5.65%,HSD17B1;HSD17B10
prerank,negative regulation of organelle assembly (GO:1902116),-0.31823379731462464,-1.0010692126807983,0.4535637149028078,0.7493145224942334,1.0,9/35,19.13%,TBC1D30;LIMK2;MDM1;RBM14;MTM1;ODF2L;FEZ2;SMCR8;PINK1
prerank,tRNA metabolic process (GO:0006399),-0.37166341171399736,-1.0009174381235826,0.45454545454545453,0.7490635447679735,1.0,8/17,28.40%,SARS1;SSB;POP5;RPP21;RPP30;ADAT1;KARS1;POP7
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.404632571172418,-1.0008434554380594,0.4621212121212121,0.7486079564273449,1.0,7/13,26.47%,SVIP;ERLEC1;BCAP31;BRSK2;UBE2J1;YOD1;UBAC2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.3998288105177925,-1.000361928016735,0.45472061657032753,0.7492046900067348,1.0,7/14,28.49%,DAB2IP;HSPA5;PTPN1;DNAJB9;BAX;BFAR;TMEM33
prerank,regulation of protein localization to centrosome (GO:1904779),-0.4372080071546526,-1.0000790094801586,0.4972067039106145,0.7493112338352429,1.0,4/10,16.43%,GSK3B;APC;NSFL1C;BICD1
prerank,skin development (GO:0043588),-0.2738691380109598,-0.9999078041359809,0.44522144522144524,0.7490986277807642,1.0,18/65,18.17%,ITGA6;CLIC4;JAG1;LSR;ITGB4;COL5A2;PKD1;MET;BCR;WNT16;HRNR;ALOX12;STMN1;COL1A1;COL3A1;COL5A3;ADAM9;DSP
prerank,epithelial cell differentiation (GO:0030855),0.2916332552613016,0.9998746795236745,0.444636678200692,0.8662918761932437,1.0,17/88,16.62%,MAF;FGFR2;DAB2;ANXA1;TPP1;PTER;CDK1;KDM6B;LATS1;HDAC1;UPK1A;CNN3;FSTL1;BDH2;FZD7;HNRNPH3;ASCL1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.35591603877791816,0.9998639495923903,0.46771037181996084,0.8654230515902314,1.0,4/30,9.38%,LEPROT;UBE2L3;NPEPPS;HSPA1L
prerank,membrane raft organization (GO:0031579),-0.3850329912739294,-0.9997390861984093,0.46975806451612906,0.7488966894393967,1.0,3/15,12.24%,RFTN1;EMP2;S100A10
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.22930417204070971,-0.9994988266683585,0.41914191419141916,0.7488365127861665,1.0,55/198,20.26%,PTPRB;PLPP1;DUSP16;CALM1;PLCG2;PLCB4;INPP5D;TNFAIP8L3;INPP4A;LIMK2;SYNJ1;TGFB1;GPX4;NUDT3;PTPRC;NADK;PGM2L1;HK1;ALPL;MTOR;PAK1;PLCB3;PAK2;CERK;NT5C;PIK3CD;LIMD1;PPP1CA;NUDT4;STAT3;DUSP8;GPD2;DUSP3;TOLLIP;PFKM;PPP3CA;ALDOA;PFKP;INPPL1;PLA2G4A;ITPKB;DUSP12;PGP;ALDOC;CLN8;PPM1A;PRKCG;CDK5;TIGAR;PIP4K2A;PANK2;ACP2;PFKFB3;LCAT;AKT1
prerank,stress granule assembly (GO:0034063),-0.36168994861819614,-0.9993190751024313,0.47657841140529533,0.7486426185687378,1.0,5/20,16.43%,RPS23;G3BP1;ATXN2L;YTHDF3;BICD1
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.3390284005794983,-0.998888827338299,0.4525862068965517,0.7490951405323264,1.0,10/28,23.10%,NOTCH3;GATA2;ARRB1;LFNG;ZBTB7A;DLL4;AKT1;METTL3;DLL1;HEY1
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.43435324176853746,-0.9983466473256022,0.4851301115241636,0.7498140949423965,1.0,2/10,5.02%,CARMIL1;WDR1
prerank,prostaglandin metabolic process (GO:0006693),-0.33798929099464115,-0.997594561239428,0.48261758691206547,0.751022841424531,1.0,10/26,27.00%,PTGIS;PTGS2;EDN1;PTGDS;CD74;PLA2G4A;MIF;PLAA;HPGDS;PRXL2B
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.4384834284923315,0.9971708765458268,0.46586345381526106,0.8715243008395415,1.0,4/12,16.12%,IL34;CSF1;MAPK1;LYN
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.38275143144749285,0.9970967020538002,0.4532803180914513,0.8708164765998467,1.0,3/22,5.48%,APPL2;KDM2B;LRRK2
prerank,regulation of membrane depolarization (GO:0003254),0.41307369251817366,0.9969319520211962,0.47551020408163264,0.8703674584914441,1.0,6/18,12.39%,GPD1L;LRRK2;CAMK2D;SCN3B;PTPN3;SCN2B
prerank,regulation of cell morphogenesis (GO:0022604),0.3514439117973133,0.9969010513557433,0.47435897435897434,0.8695499878686955,1.0,8/30,10.48%,SH3D19;PDPN;MACF1;NTNG2;CAPZB;ARC;PHIP;ZMYM4
prerank,innate immune response (GO:0045087),-0.22861986151295025,-0.9968112504909129,0.46360153256704983,0.7523909215695542,1.0,56/217,23.69%,B2M;SERINC5;PTK2;ADAM15;PLCG2;LBP;FYN;PTK2B;GCH1;TRIM14;IKBKB;CAPZA2;PGLYRP1;TRIM25;DEFA6;APP;ANKHD1;NLRC5;ADAR;PIK3CD;CHUK;ISG15;MFAP4;NRROS;CD74;CHGA;SHFL;SRPK1;TRIM13;CYBB;IFIH1;CX3CR1;AKAP1;CR2;RNASE3;STYK1;CD40;YES1;IRAK1;IRF5;BST2;MID2;SERINC3;TRIM27;MYD88;TYROBP;SLA;IFITM3;ANG;SLC11A1;C3;CIITA;OTULIN;RELA;CAPZA1;AGER
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.31427572648846536,-0.9967358209922773,0.4551422319474836,0.7519665583032932,1.0,11/38,14.86%,CAV1;GAS6;PTPRC;LRP8;APP;SRCIN1;NCK2;RELN;PTPN1;NEDD9;CSF1R
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3096874625807895,0.9964999331334932,0.45408163265306123,0.8696659671075713,1.0,17/62,20.95%,POLR2D;CDK7;ELOA;POLR2A;CCNT2;CCNT1;GTF2F1;CDC73;MNAT1;NELFB;TCEA1;SETD2;CTR9;ELL;CDK9;ELP2;PAF1
prerank,ventricular septum development (GO:0003281),0.3416907712232453,0.9964998668159978,0.455026455026455,0.8687712490344154,1.0,2/37,0.29%,TGFBR3;ROBO1
prerank,mRNA export from nucleus (GO:0006406),-0.25246654235688687,-0.9955581033089816,0.456359102244389,0.7542636167796057,1.0,44/102,35.96%,SRSF2;SRSF1;SRSF5;DDX39B;CPSF3;HHEX;SRSF9;ENY2;RBM8A;RNPS1;SRSF6;NUP37;AGFG1;SYMPK;NXT1;CPSF2;NUP54;SMG5;NUP85;YTHDC1;THOC3;NUP133;MAGOH;POM121;THOC6;EIF4E;DDX25;THOC2;NUP153;EIF4A3;SMG6;SRSF7;ALYREF;NUP42;CPSF1;ZC3H11A;NUP93;IWS1;DHX38;U2AF1L4;CHTOP;NUP35;SRSF3;NCBP2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3528448387920984,-0.994979061231319,0.4564755838641189,0.7544986943479417,1.0,8/22,22.71%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;ZDHHC4;ZDHHC8;ZDHHC20
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3528448387920984,-0.994979061231319,0.4564755838641189,0.7544986943479417,1.0,8/22,22.71%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;ZDHHC4;ZDHHC8;ZDHHC20
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.42954126844517704,-0.9948639680843699,0.47217235188509876,0.7541705843487275,1.0,2/11,10.16%,MEF2C;PIK3CD
prerank,cochlea morphogenesis (GO:0090103),-0.4244695006445336,-0.994533322017821,0.4878048780487805,0.7543673508977433,1.0,8/10,49.88%,TBX1;MYO3B;MYO3A;PAX2;TIFAB;HOXA1;HPN;POU3F4
prerank,gas transport (GO:0015669),-0.4329659468076111,-0.9945128010405254,0.4735812133072407,0.7537765554102355,1.0,2/10,11.41%,CA2;CYGB
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.3614859953185267,-0.9943274386025432,0.4709418837675351,0.7536184800037937,1.0,10/20,35.47%,ADAM10;TGFB1;ADAM9;PSEN1;MBTPS1;RELA;HM13;NGFR;SPPL2B;ADAM17
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.40656413244063816,0.9942713345203171,0.47835051546391755,0.8735740534516652,1.0,3/15,11.22%,LARGE1;CHST3;RENBP
prerank,purine nucleotide metabolic process (GO:0006163),-0.33721803151752694,-0.9940985851208368,0.47010309278350515,0.7535578664758289,1.0,8/24,15.56%,PRPS2;NT5C2;HPRT1;GDA;NT5C;XDH;GUK1;NT5E
prerank,positive regulation of protein phosphorylation (GO:0001934),0.24400701908253583,0.9940655161146142,0.4745098039215686,0.8732113910079079,1.0,48/348,11.76%,IGF1;PRKAG2;BMP6;LEPR;ROCK2;IL34;CEMIP;BMP7;ANGPT1;PELI2;DAB2;FNIP1;ALS2;IGF2;FAM20A;RBPMS;ARAF;SPHK1;MRNIP;PDGFD;LRRK2;FGF1;SNX9;TTK;IL6;ENPP2;XRCC5;MMP9;DDR2;CCL19;VTN;ATG14;CSF1;MUSK;VEGFB;NEK10;GDF1;AXIN2;DVL3;LATS1;ABL1;FGF9;FLCN;JAK2;FXR1;ERBB2;RAP2A;BMPR1A
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.4203159228375648,0.9940550395737012,0.48380566801619435,0.8714450829232634,1.0,2/13,3.68%,PLCB1;STAT5B
prerank,cellular response to interleukin-15 (GO:0071350),0.4203159228375648,0.9940550395737012,0.48380566801619435,0.8714450829232634,1.0,2/13,3.68%,PLCB1;STAT5B
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.4168236395720183,-0.993965719410404,0.47509578544061304,0.7532633415926463,1.0,3/10,12.65%,HSP90AA1;HSP90AB1;CLU
prerank,negative regulation of cyclase activity (GO:0031280),0.4260774763774373,0.9938070190360495,0.43912175648702595,0.8711824640227521,1.0,1/14,0.48%,ADGRV1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.43867945640623435,0.9933471725257245,0.4567901234567901,0.8715159421399347,1.0,3/11,12.86%,ARID1B;ZMIZ1;ZMIZ2
prerank,DNA metabolic process (GO:0006259),0.25246811737961794,0.9932731792341651,0.45490716180371354,0.8708215968453604,1.0,59/270,17.59%,TCF7L2;CBS;FANCA;SP100;RAD51B;SRPK2;TOP2B;ATRIP;DDB2;HUS1B;RAD51C;INIP;ACD;DMC1;PDS5B;PSME4;PARP4;TYMS;XRCC5;BLM;DDX23;USP7;CDK1;UVRAG;FBXO6;AXIN2;MBD4;PDS5A;PRKDC;RFC1;DCLRE1B;RTEL1;ORC2;MPG;LIG1;INO80;SMARCB1;PRIMPOL;MRE11;USP45;APEX1;TOP1MT;MNAT1;UBE2A;WRN;ORC3;FANCC;STN1;MCM2;RAD18;RAD51;REXO4;BACH1;RNASEH2A;RPAIN;ORC6;TRRAP;XPC;PURA
prerank,positive regulation of axonogenesis (GO:0050772),0.3316276901891525,0.9931715819947174,0.47587354409317806,0.8701920530843174,1.0,4/43,4.57%,PLXNA2;ROBO1;MACF1;PLXNC1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.3446705655193064,-0.992773951955017,0.4847870182555781,0.7555514695940254,1.0,10/24,18.67%,UBB;NOD1;RPS27A;UBC;RNF34;TAB3;AAMP;CASP8;UBA52;IRAK1
prerank,T cell activation involved in immune response (GO:0002286),-0.41528030635947016,-0.9927600670116347,0.464354527938343,0.7549565962879327,1.0,12/12,58.51%,CD74;SLC11A1;LCP1;MDK;ICAM1;ITGAL;F2RL1;IFNK;TNFSF18;EIF2AK4;LILRB1;FCER1G
prerank,cellular response to reactive oxygen species (GO:0034614),0.31665828884286334,0.9927170451208411,0.4674657534246575,0.8705714049623486,1.0,10/59,10.44%,OSER1;TPM1;FER;ANXA1;PDGFRA;MAPK9;IL6;MMP9;SIRPA;ABL1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3371388309460118,-0.9925131324320833,0.488272921108742,0.7549449014312225,1.0,8/24,14.44%,ITPR2;PLCG2;PTPRC;RYR2;HTR2A;IBTK;ERO1A;ITPR3
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.3507822879809841,0.9922893872892156,0.44385026737967914,0.8707400496092136,1.0,14/32,21.09%,CDC14B;MRNIP;BLM;CDK1;CLSPN;RINT1;MRE11;BABAM2;BRSK1;TAOK3;TRIM39;TAOK2;UIMC1;NBN
prerank,regulation of exocytosis (GO:0017157),-0.2931727755970662,-0.9919490806214734,0.45701357466063347,0.7557149926917467,1.0,22/46,31.08%,STXBP6;NSF;RAB3C;RAB27A;RAB3B;CPLX2;CFTR;RAB8A;CHMP3;RAB8B;CLASP2;RAB3A;LGI3;SYTL4;CPLX1;HAP1;RIMS2;SYT1;UNC13D;ATP6AP1;STXBP5L;RAB15
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.32636223380817303,0.9919141512256582,0.4608843537414966,0.8708057801372806,1.0,6/46,9.87%,AGPAT4;GPD1L;PLA2G10;PLD1;LIPH;SLC27A1
prerank,actin filament capping (GO:0051693),-0.37046988139406745,-0.9911406471366605,0.5,0.7563779322784512,1.0,5/18,8.65%,GSN;CAPZA2;VILL;ADD2;EPS8
prerank,barbed-end actin filament capping (GO:0051016),-0.37046988139406745,-0.9911406471366605,0.5,0.7563779322784512,1.0,5/18,8.65%,GSN;CAPZA2;VILL;ADD2;EPS8
prerank,regulation of cell cycle phase transition (GO:1901987),-0.2558410963092832,-0.9910219277108986,0.4744897959183674,0.7560763458747848,1.0,27/91,23.55%,BUB3;PSMD13;PSMF1;DDB1;PSMB10;CDKN1B;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;ANAPC16;PSMB3;BUB1B;UBE2D1;PSMD5;TFAP4;ATP2B4;SKP1;CDKN1A;ANAPC7;PSMD9;PSMB4;NEK11
prerank,response to nitric oxide (GO:0071731),-0.3992295320858772,-0.9908987481173014,0.43609022556390975,0.7557789309505266,1.0,5/13,21.70%,GUCY1B1;FOXO1;MT3;CDK2;KCNC2
prerank,negative regulation of glycolytic process (GO:0045820),0.4423240937104884,0.9908949595034532,0.47379454926624737,0.871687196176662,1.0,5/10,18.57%,PPARA;NUPR1;PFKFB1;NCOR1;HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4423240937104884,0.9908949595034532,0.47379454926624737,0.871687196176662,1.0,5/10,18.57%,PPARA;NUPR1;PFKFB1;NCOR1;HDAC4
prerank,positive regulation of protein catabolic process (GO:0045732),-0.25884440361887806,-0.9908228686673706,0.5,0.7553736681366575,1.0,20/84,13.04%,WWP1;MSN;NSF;HSP90AA1;NEDD4L;DAB2IP;ATG7;PLK2;FAF1;GSK3B;TNFRSF1B;FOXO1;DDB1;FURIN;OAZ1;APC;CDKN1B;NDUFA13;EGLN2;IDE
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.23827647549129,-0.9901558108639663,0.47560975609756095,0.7563570265936346,1.0,60/144,28.73%,PRR5L;GAS6;CDH1;PPP1R13B;SREBF2;FYN;SH3GLB1;KCNB1;FLNA;TGFB1;NMT1;YWHAB;GSK3B;CHP1;PDCD10;ZDHHC2;MAPK8;C2CD5;TMEM30A;OAZ1;YWHAG;MIEF1;RIPOR1;BBC3;CD81;JUP;MIEF2;MTCL1;ARIH2;CASP8;VPS11;YWHAQ;YWHAH;ZC3H12A;SEC16B;PINK1;PSEN1;PPP3R1;ANK3;PRKCD;RBM22;TOMM7;HYAL2;ZPR1;HUWE1;HRAS;SEC16A;SORL1;MICALL2;YWHAZ;PCM1;RNF31;PPP3CC;FIS1;ITGB2;ABLIM3;HDAC3;BID;TM9SF4;SFN
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2642448783913806,-0.9899184624361388,0.47668393782383417,0.7562938466007048,1.0,27/84,22.30%,MBNL1;NOVA2;HNRNPK;RBFOX1;QKI;RBFOX3;RBFOX2;HNRNPU;LARP7;DDX5;ZBTB7A;SRSF9;RBM8A;REST;KHDRBS3;RNPS1;SRSF6;SRPK1;RBMXL1;DDX17;YTHDC1;PCBP4;PTBP1;MAGOH;FMR1;TRA2B;RBM24
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.3497767625720214,-0.9897452018025094,0.4692144373673036,0.7561126255803657,1.0,11/22,31.82%,UBB;RPS27A;UBC;DDB1;RBX1;UBA52;CETN2;GTF2H2;XPA;ERCC3;GTF2H5
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.365889453233084,-0.9895303937649048,0.48118811881188117,0.7560186358566423,1.0,10/18,46.36%,BCAR1;BAG6;CMKLR1;LAX1;C5AR2;FPR3;BLK;C5AR1;SLA2;GPLD1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3051453890410689,0.9893522950234401,0.46063651591289784,0.8748450982754715,1.0,10/59,10.45%,TCF7L2;CDK8;TNRC6B;TNRC6A;IL6;PTEN;CDK1;MITF;MED1;MED13
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.2969311073770794,0.9891905640612988,0.48292682926829267,0.8743773847393819,1.0,12/69,12.01%,IGF1;PLCB1;PDGFRB;PDGFRA;IGF1R;PTEN;GPR143;MYO16;PIK3R1;RPS6KB1;ERBB2;PLCD1
prerank,UV protection (GO:0009650),-0.42606725298058706,-0.9889198794197119,0.48007590132827327,0.7568994977934304,1.0,6/10,33.40%,MFAP4;SDF4;XPA;ERCC5;CAT;FEN1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.43113750575974025,0.9888412788904011,0.45714285714285713,0.874376229842305,1.0,1/13,0.48%,ADGRV1
prerank,cytoskeleton organization (GO:0007010),0.27828781609196224,0.9884363958844732,0.48348348348348347,0.8745425644725474,1.0,15/114,7.74%,MICAL3;SH3D19;FGD4;TPM1;RHOD;OBSL1;ABI2;SYNE3;CNN2;CECR2;CAPZB;ARC;WDPCP;RHOBTB2;WASF3
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.4351556981053629,-0.9883871027105515,0.5,0.7576537556177049,1.0,8/10,45.29%,SH2B3;INPP5F;SOCS1;PPP2CA;NF2;PPP2R1A;PIBF1;PTPN2
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.3864672311046073,-0.9882863717353313,0.4959349593495935,0.7572784901765903,1.0,2/15,2.50%,PLTP;SCARB1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.35280977283143866,-0.9879375311461315,0.4682080924855491,0.7575094794230123,1.0,11/20,23.79%,TGM2;ATP2A2;CCDC47;KCTD17;SELENOK;HERPUD1;BCAP31;WFS1;PSEN1;RAP1GDS1;BAX
prerank,negative regulation of neuron projection development (GO:0010977),0.3147870224064932,0.9879241704482259,0.47863247863247865,0.8749804548441195,1.0,7/56,7.48%,EFNB2;LRP4;LPAR1;DPYSL3;EPHA4;PTPN9;PTEN
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.37460503461783873,0.9878383078719136,0.4664179104477612,0.8743228160669968,1.0,9/22,18.66%,FTSJ3;ERI3;ERI2;EXOSC8;NOL9;ERI1;NOP9;EXOSC3;NOP14
prerank,negative regulation of cellular component movement (GO:0051271),0.4142536740254861,0.9877581108027739,0.48927875243664715,0.8736347405455096,1.0,3/15,6.36%,TGFBR3;SP100;FBLN1
prerank,positive regulation of nervous system development (GO:0051962),-0.2948946269537097,-0.9875363179238446,0.4628712871287129,0.7578494559500937,1.0,17/42,24.82%,TGM2;CLSTN2;SERPINF1;IL1RAP;NRXN1;SYNDIG1;EPHB1;GPER1;CLSTN3;CX3CR1;SPEN;LIG4;GRID2;SOX11;LRRC4B;FAIM;EPHB3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.27667385005552214,-0.9870720602286551,0.4847715736040609,0.758437478868266,1.0,17/63,20.80%,MEF2C;TFRC;SLC7A1;NCK1;NFATC2;CD38;PTPRC;NCK2;CD74;CD81;MIF;CD274;CD40;IL15;JAK3;TIRAP;NCKAP1L
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.4057214567542303,-0.9864833293362307,0.49427480916030536,0.7592538346543408,1.0,8/12,34.93%,PTK2B;UBASH3B;RYR2;MTLN;CASQ1;TRDN;CASQ2;FKBP1B
prerank,positive regulation of insulin secretion (GO:0032024),0.33459286386054526,0.9863057551717348,0.47549909255898365,0.8764221029306283,1.0,5/36,7.95%,TCF7L2;RBP4;NLGN2;MCU;SLC30A8
prerank,B cell mediated immunity (GO:0019724),-0.4298520408060356,-0.986288476121305,0.49168207024029575,0.7591215351236106,1.0,8/10,54.02%,MSH2;CD74;FCGR2B;TLR8;CARD9;SLA2;CD27;CD19
prerank,regulation of cell death (GO:0010941),-0.2538066590212036,-0.9862762733643572,0.4820936639118457,0.7585334320619018,1.0,25/94,16.17%,ACER3;ACER2;PDE8A;UBB;CCN3;SOX4;NCK1;FERMT2;FAF1;DCC;TNFRSF1B;CHP1;CRYAB;WNT16;EIF4G1;APC;CDKN1B;EPHB1;CLU;SRSF6;CCN1;MT3;TRIM13;CTSZ;PRKD1
prerank,neuron projection regeneration (GO:0031102),0.44737733911963984,0.9858619695278071,0.47884187082405344,0.8767159602371689,1.0,3/10,8.35%,PTN;FOLR1;NREP
prerank,negative regulation of axonogenesis (GO:0050771),-0.32401249539060867,-0.9858078546794061,0.494824016563147,0.7590418370486932,1.0,11/27,21.35%,ARHGDIA;DCC;RHOA;RTN4;SEMA3G;EFNB3;CDKL3;MT3;GDI1;THY1;RTN4R
prerank,secondary palate development (GO:0062009),0.41618700782642726,0.9857927620931489,0.4563894523326572,0.876015792167807,1.0,1/14,0.24%,TGFBR3
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.29422355306637316,0.9857766779054319,0.4828150572831424,0.8751805473354592,1.0,12/75,10.51%,ROCK2;TULP3;NMT2;PLCB1;MGRN1;PDE6G;CAMKMT;ZDHHC3;GRK5;RPGRIP1L;GRK4;GNG7
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.42000846212391374,0.9855408548550517,0.46875,0.8749329942006848,1.0,2/14,1.48%,WNK4;DMD
prerank,macrophage chemotaxis (GO:0048246),0.44287982822610356,0.9853993848347715,0.4735812133072407,0.8744099105523829,1.0,3/10,17.65%,TAFA4;CKLF;EDNRB
prerank,neuron migration (GO:0001764),0.3219141867241767,0.9851953583537263,0.4635036496350365,0.8740455744587519,1.0,8/48,9.86%,DCDC2;AUTS2;NDNF;SOX1;SDCCAG8;SH3RF1;PAFAH1B1;TUBGCP2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.41288540347106417,-0.9850870712495999,0.4912621359223301,0.7590092456696704,1.0,6/12,36.33%,CUL3;ANAPC7;NSMCE2;DLGAP5;ESPL1;ANAPC4
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.41288540347106417,-0.9850870712495999,0.4912621359223301,0.7590092456696704,1.0,6/12,36.33%,CUL3;ANAPC7;NSMCE2;DLGAP5;ESPL1;ANAPC4
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.41288540347106417,-0.9850870712495999,0.4912621359223301,0.7590092456696704,1.0,6/12,36.33%,CUL3;ANAPC7;NSMCE2;DLGAP5;ESPL1;ANAPC4
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.30763606024962264,-0.9850376741917095,0.49311926605504586,0.7585240390941965,1.0,18/37,24.19%,EFNA5;PHLDB1;MAP6;FAM107A;GSK3B;STMN2;MARK2;STMN1;CDK2AP2;TPPP;STMN4;BICD1;STMN3;GAS2L1;MAPRE1;TRIM36;CLASP2;CAMSAP3
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.42521815629935555,0.9848833755530396,0.4798387096774194,0.8739745462255439,1.0,7/12,23.68%,IGF1R;BNIP3;UVRAG;IRGM;SETX;JMJD4;FYCO1
prerank,triglyceride metabolic process (GO:0006641),0.32637494579311765,0.9847079012122202,0.4743362831858407,0.873549318248039,1.0,10/48,16.79%,AGMO;LPGAT1;LIPH;LIPC;APOC1;APOH;FABP7;LMF1;FABP4;GK
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3668450749215956,-0.9843089595611728,0.46530612244897956,0.7596975425706394,1.0,6/17,16.98%,JAG1;CD55;STAT3;MSH2;IL18BP;BTN3A3
prerank,regulation of B cell activation (GO:0050864),-0.32827348908502263,-0.9839677320818853,0.47096774193548385,0.7599577561732145,1.0,12/25,34.83%,SH3KBP1;AHR;ZFP36L1;SAMSN1;LAPTM5;TNFAIP3;FCGR2B;FOXJ1;IL4I1;NOD2;IKZF3;THEMIS2
prerank,regulation of peptidase activity (GO:0052547),0.39150037477206345,0.9835431404825131,0.4787018255578093,0.8756864107491044,1.0,7/19,10.71%,ECM1;CTSH;A2ML1;NRDC;PSMA3;CST7;HDAC1
prerank,negative regulation of B cell activation (GO:0050869),-0.35600063679109045,-0.9834928903319643,0.4690831556503198,0.7605487792122243,1.0,9/21,22.88%,TNFRSF21;SAMSN1;LAPTM5;ID2;INHA;TYROBP;CD300A;TNFAIP3;FCGR2B
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3923160004553061,0.9834421792434527,0.4839319470699433,0.8741885961912679,1.0,2/20,5.01%,GSTM2;GSTT1
prerank,glutathione derivative metabolic process (GO:1901685),0.3923160004553061,0.9834421792434527,0.4839319470699433,0.8741885961912679,1.0,2/20,5.01%,GSTM2;GSTT1
prerank,cellular amide metabolic process (GO:0043603),0.2806182420543831,0.9828791780250693,0.5031055900621118,0.8748227459449185,1.0,10/102,8.19%,AEBP1;PCCA;PLPP3;MCCC2;PM20D1;ACOT4;MTHFR;NAPEPLD;FOLR2;CPXM1
prerank,regulation of store-operated calcium entry (GO:2001256),0.4478041165506168,0.9826978441305655,0.47835497835497837,0.8744417422573355,1.0,1/10,1.35%,STIM1
prerank,error-free translesion synthesis (GO:0070987),-0.34485859872708113,-0.9826162778181661,0.494,0.7620532786060639,1.0,8/22,22.50%,UBB;RPS27A;UBC;RPA1;UBA52;SPRTN;VCP;POLD1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.30029615936324905,0.9823547245167888,0.4824120603015075,0.8745031242435303,1.0,16/60,17.75%,TCF7L2;CDK8;TNRC6B;TNRC6A;IL6;PTEN;CDK1;MED1;MED13;SRF;CDK4;ATF7IP;MOV10;MED10;MED15;MED26
prerank,sensory perception (GO:0007600),0.33187723579154654,0.9822322284126669,0.489945155393053,0.8739472531242237,1.0,5/45,9.33%,ADGRV1;GNAS;TTC8;WHRN;RETREG1
prerank,regulation of cell size (GO:0008361),-0.3342670221459977,-0.9822295825981207,0.48535564853556484,0.762385752334305,1.0,5/23,9.30%,MSN;RAC1;MTOR;RHOA;EDN1
prerank,negative regulation of lyase activity (GO:0051350),0.4088167236608637,0.9822000292370627,0.47695390781563124,0.8731560471916064,1.0,1/16,0.48%,ADGRV1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3585744677680818,-0.9821498580020385,0.49506903353057197,0.7619631954691136,1.0,9/19,27.36%,PTPRJ;KDR;PTPRC;RYR2;BCAP31;PTGFR;TRPM2;FIS1;SELP
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.35890170763552703,-0.9821131339328304,0.4773662551440329,0.7614405608434186,1.0,5/18,10.65%,SHANK3;PTK2B;NRXN1;GRIN1;RELN
prerank,transferrin transport (GO:0033572),-0.3116888695806128,-0.981360314653319,0.4898419864559819,0.7626923029345991,1.0,15/33,26.57%,TFRC;ATP6V0A1;DNM2;ATP6V1A;ATP6V0C;TCIRG1;LMTK2;ATP6V1E1;ATP6V0A4;ATP6V0A2;ATP6V0D2;ATP6V0E2;ATP6V1B2;MCOLN1;ATP6V1H
prerank,negative regulation of proteolysis (GO:0045861),0.34672027999821536,0.9813598606756121,0.4700374531835206,0.8744155764840031,1.0,8/34,12.57%,TIMP3;ECM1;EPHA4;LRRK2;CST7;PTPN3;SNX12;GAS1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.3732174672045786,-0.9811485201041685,0.49707602339181284,0.7625893727503148,1.0,8/15,31.10%,GBP5;USP50;NLRP2B;MYD88;TREM2;TLR4;CD36;TLR6
prerank,regulation of response to interferon-gamma (GO:0060330),-0.38190989935518194,-0.980847486313653,0.4728682170542636,0.7627208447321615,1.0,6/14,24.36%,HSP90AB1;CDC37;IFNGR1;JAK1;SOCS1;STAT1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4234651763074345,-0.9805836420404976,0.5070422535211268,0.762751670938535,1.0,3/10,9.97%,PODXL;PIEZO1;DPP4
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3743938224754422,0.9804996819362832,0.4839924670433145,0.8757189174594193,1.0,4/21,10.46%,SLC8A3;MAIP1;MCU;MICU1
prerank,negative regulation of viral release from host cell (GO:1902187),0.42164800169609484,0.9804533771754638,0.4722222222222222,0.8749701160774936,1.0,4/13,16.20%,TRIM5;TRIM35;TRIM26;PML
prerank,acylglycerol biosynthetic process (GO:0046463),0.37632365929763467,0.9803386407758891,0.4763705103969754,0.8744076407402221,1.0,2/23,1.78%,AGMO;LPGAT1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.438362953703768,-0.9801084846270975,0.5133689839572193,0.7632600261925715,1.0,4/10,6.94%,RAP1A;CD34;KDR;CEACAM1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.3965093832405272,-0.9798462803084198,0.4727626459143969,0.7632796273409872,1.0,8/13,32.29%,TMEM30A;CD81;BCAP31;SEC16B;SEC16A;SORL1;TM9SF4;TMEM30B
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.2779398032220673,0.9797744280874137,0.4841930116472546,0.8748859053161465,1.0,11/110,6.53%,ADCY5;ADCY1;LGR4;ADGRL1;LPAR1;GNAS;ADM;ABCA1;LPAR2;GNAQ;ADRA1D
prerank,regulation of Golgi organization (GO:1903358),-0.36457853042503396,-0.9795155367885741,0.4888888888888889,0.7634629061388742,1.0,8/17,28.52%,PDE4DIP;PDCD10;MYO5A;EHD3;MAP2K2;MAPK3;CAMSAP3;STX5
prerank,positive regulation of synapse assembly (GO:0051965),-0.32088794978402657,-0.9794958209673156,0.474835886214442,0.7628923599293376,1.0,8/27,12.02%,AGRN;SEMA4D;CLSTN2;IL1RAP;NRXN1;SYNDIG1;EPHB1;CLSTN3
prerank,linoleic acid metabolic process (GO:0043651),0.39323397696709894,0.9793330412724818,0.44861660079051385,0.8750935978717658,1.0,2/17,2.58%,ACSL1;GSTM2
prerank,DNA geometric change (GO:0032392),0.3730074527538661,0.97893935003246,0.4608208955223881,0.8752007560590269,1.0,9/24,21.09%,ANXA1;BLM;RTEL1;MRE11;WRN;HNRNPA2B1;RECQL5;RAD50;NBN
prerank,cellular protein-containing complex assembly (GO:0034622),-0.23313569617129087,-0.9784660386632797,0.5047021943573667,0.7647833670811909,1.0,27/160,13.36%,STXBP6;HIP1;SGIP1;TIAM1;HSP90AA1;HSP90AB1;RPL38;PDE4DIP;PXN;TGFB1;NCK1;GPX4;VAMP8;HIP1R;PSMD13;AP2M1;POMP;RTN4;NCK2;PIK3C2A;NSG2;BIN1;HSPD1;CLU;ADRB2;HIGD2A;EIF4H
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3663202616058501,0.9780382268433352,0.4658040665434381,0.876565566084006,1.0,2/24,1.82%,PID1;DAB2
prerank,positive regulation of cell cycle (GO:0045787),0.3061823591710103,0.9780234338919347,0.504885993485342,0.8757442943732406,1.0,13/62,12.46%,FGFR2;SMOC2;SRPK2;SPHK1;CCDC57;EIF4EBP1;PRKCA;PKN2;NUPR1;MDM2;RPS6KB1;HSF1;PKD2
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.33700520117489774,0.9776560440519328,0.46296296296296297,0.8758416639367292,1.0,10/36,16.10%,RBBP4;L3MBTL2;MGA;RNF2;RBBP7;E2F6;TFDP2;APAF1;UXT;RAD51
prerank,negative regulation of response to external stimulus (GO:0032102),0.2762280865943006,0.9776335614922099,0.4826021180030257,0.8750350685561155,1.0,21/105,17.24%,RORA;C1QTNF3;PPARA;LTF;EPHA4;CACTIN;NLRC3;PTEN;LYAR;SIRPA;ITCH;ENPP3;PCBP2;SERPINE1;MAPKBP1;NLRP12;PTGER4;CDH5;TRAFD1;DRD2;VPS35
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.3615278405113284,0.9773920011368672,0.47454545454545455,0.8748225739861456,1.0,5/26,7.48%,SLC8A3;NLGN2;LRRK2;PRKCZ;PTEN
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.3983520773096617,-0.9768228939139352,0.4981132075471698,0.7682295560072891,1.0,6/13,13.41%,DAB2IP;PTPN1;HGS;HHEX;EPN2;CADM4
prerank,regulation of ion transport (GO:0043269),0.29361515497213936,0.9765484853044144,0.4868421052631579,0.8759969761909886,1.0,9/76,4.99%,PRKN;SNX6;KCNA5;NKAIN4;DTNBP1;NEDD4;SYT11;SYT12;SIK1
prerank,phosphatidic acid metabolic process (GO:0046473),0.32048427474941343,0.9763327787047693,0.4797297297297297,0.8757073964630748,1.0,6/48,9.87%,AGPAT4;GPD1L;PLA2G10;PLD1;LIPH;SLC27A1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.26008802385237023,-0.976072800742538,0.5162907268170426,0.769455189196208,1.0,26/75,22.87%,PTPRJ;HEG1;STK38;RASIP1;DAB2IP;LRP5;UCHL1;APC;CDKN1B;PTPN1;HHEX;MEN1;SPRY4;IRAK3;PRKAR1A;NF1;DUSP1;SH2B3;TFAP4;PRKCD;AKT1;BMP4;CD300A;GADD45A;HYAL2;CEBPA
prerank,cellular response to chemical stress (GO:0062197),-0.24910019831867997,-0.976047972249647,0.505586592178771,0.7688968316811927,1.0,35/96,28.21%,CAV1;PRR5L;LRRC8D;PPARGC1A;PPIA;ATG7;CHCHD2;SOD1;FOXO1;SESN2;ATF4;VKORC1L1;GSR;ERO1A;MT3;FAS;CYBB;PRKD1;ATP13A2;STX2;ZC3H12A;GPX7;PINK1;PYROXD1;CYCS;HSPA1B;PYCR2;PRDX6;KEAP1;PRDX1;GPX8;GPX3;TRPV4;CAT;TMEM161A
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.42147127625251257,-0.9759993059707106,0.49809160305343514,0.7684141498508283,1.0,4/10,15.75%,CTNNB1;VEGFA;DISC1;CX3CR1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.34822232010673543,0.9759339697267053,0.5121042830540037,0.8758816913115541,1.0,5/30,8.62%,KIT;HOXB4;ACE;UFL1;FSTL3
prerank,post-translational protein modification (GO:0043687),0.24252359650093452,0.9758505003087109,0.5298602287166455,0.8752116127520144,1.0,55/332,13.27%,ASB2;CP;FBN1;APLP2;EPAS1;ITIH2;SDC2;TNC;SERPIND1;SPSB1;HIF3A;RAB13;PRKCSH;PCSK9;IGFBP4;OBSL1;NEURL2;FBXW4;DDB2;DCAF4;GPC3;PSME4;PSMA2;RBBP7;FBXO44;IL6;CAND1;F5;CCDC8;PSMA3;CUL9;CSF1;DCAF10;MIA3;CHRDL1;FSTL3;CUL7;KLHL11;FEM1B;FBXO6;ASB3;PSMD8;IGFBP7;KBTBD7;UBA3;PSMD3;FBXO4;KLHL22;CUL4B;FBXO11;SENP8;ASB5;FSTL1;ESCO1;P4HB
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.254881920159272,0.9757885261449976,0.5064377682403434,0.8744980914348307,1.0,37/208,15.54%,RORA;WLS;PRKN;PELI2;LPAR1;PDPK1;LTF;ECM1;TRIM5;AKAP13;ZFAND6;GJA1;CACTIN;UFL1;PRKCB;CXXC5;OPTN;NLRC3;CCL19;TLE1;SLC20A1;GOLT1B;IKBKE;CFLAR;GPRC5B;TBK1;MAP3K7;UNC5CL;MAPKBP1;UBE2V1;MTDH;NLRP12;NLRX1;BIRC2;TRIM62;CX3CL1;TMEM9B
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.3220098264364393,-0.97570095780675,0.5091743119266054,0.7685104760725947,1.0,15/27,32.23%,ETS1;CD44;CYRIB;RHOA;HSPD1;CD47;IRAK1;THY1;RELA;CCR2;SKAP1;CCL2;ITGB2;NR4A3;MDK
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3203408694962963,-0.97562927298206,0.5147679324894515,0.7680759808419065,1.0,6/29,12.72%,ESR1;RUNX1;CBFB;PAK1;WBP2;VPS18
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.3433666766962981,-0.9756001232246816,0.4610526315789474,0.7675338178312529,1.0,4/21,3.28%,MTUS1;THBS1;PTK2;PTK2B
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.33858074917357484,0.9753955138108165,0.483695652173913,0.8746160772110955,1.0,6/33,12.90%,APPL2;STXBP4;PLK5;PTEN;CDC73;INO80
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.3973531656997095,0.9744958433945994,0.4940944881889764,0.8760614301187915,1.0,4/17,6.52%,RBPJ;MAML3;MAML1;WWC1
prerank,positive chemotaxis (GO:0050918),-0.36886166161099154,-0.9743541462065625,0.5153374233128835,0.7699495973712187,1.0,5/17,11.30%,PTPRJ;MET;VEGFA;FGF7;SCG2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.43363496539456164,0.9741705875262853,0.4868995633187773,0.8759939440991186,1.0,1/12,0.45%,COLEC12
prerank,response to interleukin-1 (GO:0070555),0.29811561948121174,0.9741449510298408,0.5016501650165016,0.8752028981035035,1.0,9/73,10.07%,ADAMTS12;ANXA1;IRAK2;CACTIN;ADAMTS7;PRKCA;CCL19;SIRPA;CCL4
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.37869942719478905,-0.9739577535818452,0.5102459016393442,0.7703370349463114,1.0,5/14,27.85%,MSN;RHOA;CAMSAP3;EZR;FOXJ1
prerank,phosphate ion transport (GO:0006817),0.39975894987953053,0.9737239265127312,0.48303393213572854,0.8754323821163,1.0,4/16,9.59%,SLC20A2;SLC34A3;SLC25A11;SLC20A1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.42335132569298095,0.9737189897310474,0.5020661157024794,0.8745945628738166,1.0,4/11,13.29%,CTPS2;SLC19A2;ENPP3;THTPA
prerank,cellular response to nutrient levels (GO:0031669),-0.2665008082675808,-0.9736594138422631,0.4916864608076009,0.7704429732686267,1.0,15/62,12.16%,HSPA8;SREBF2;BMPR2;ATG7;KCNB1;FAM107A;MAP1LC3B;MTOR;MFSD2A;FOXO1;EIF4G1;XBP1;RALB;RIPOR1;PDK2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3235533974727654,-0.973557730354792,0.4978540772532189,0.770090122206298,1.0,8/26,14.44%,ITPR2;PLCG2;PTPRC;RYR2;HTR2A;IBTK;ERO1A;ITPR3
prerank,regulation of catecholamine secretion (GO:0050433),0.3462029391264583,0.9735237489929113,0.4937833037300178,0.8742359393351411,1.0,4/29,4.13%,PRKN;DTNBP1;SYT11;SYT12
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3729598752763769,-0.9734994318857639,0.49079754601226994,0.7696033602558626,1.0,5/16,9.43%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;ST8SIA1;ST8SIA6
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.27278405111882814,-0.9730485527535264,0.4897025171624714,0.7700853143127105,1.0,18/54,23.48%,GAS6;RACK1;IKBKB;BIRC3;CHUK;NLRP2B;TRAF1;CASP8;MADD;CARD16;LAPTM5;SHARPIN;CASP1;RBCK1;TNFAIP3;TRAIP;OTULIN;HSPA1B
prerank,carbohydrate biosynthetic process (GO:0016051),0.3756155597956817,0.9725209930699431,0.4708249496981891,0.8758169288228064,1.0,3/21,4.55%,B3GALT1;ST3GAL3;B4GALT1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.257650680152072,-0.9723760380896525,0.49874686716791977,0.7711609470905699,1.0,27/78,23.56%,CAV1;RNF144B;CBFA2T3;RNF144A;RACK1;TRIB2;NKD2;SOCS5;GSK3B;ZYG11B;RBX1;CLU;HERPUD1;ELOB;ARIH2;BCAP31;COP1;RNF19B;NOP53;ARIH1;VCP;RNF19A;USP5;CEBPA;TRIB3;HSPA1B;SIRT6
prerank,regulation of actin filament-based process (GO:0032970),0.29618062730960065,0.9723108995716704,0.4992,0.8755395785061626,1.0,9/70,7.67%,ROCK2;EPHA3;RHOD;PDGFRB;BAIAP2;CNN2;RICTOR;ARHGAP35;RHOBTB2
prerank,cellular response to organic substance (GO:0071310),0.27266136156932597,0.9717401558437955,0.4984567901234568,0.8760691594766851,1.0,16/116,7.08%,PTPN13;PID1;IL18;PTPN4;DPYSL3;IL1RAPL1;NCOA2;STAT5B;NFAT5;SPHK1;PLK5;LRRK2;PTPN9;LRP2;NCOA3;SMAD3
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.29778147856061643,-0.9712532393470382,0.48775055679287305,0.7733239748309538,1.0,10/40,20.17%,LBP;PGLYRP1;GBP4;DEFA6;CHGA;ROMO1;RNASE3;TIRAP;MYD88;ANG
prerank,"wound healing, spreading of cells (GO:0044319)",0.36575035387416704,0.9711652950001709,0.497196261682243,0.8767027619712656,1.0,4/24,7.10%,ARHGAP24;PDPN;DDR1;ARHGAP35
prerank,protein export from nucleus (GO:0006611),0.3535885304474061,0.9710311750454428,0.45454545454545453,0.8761981307104025,1.0,1/27,0.13%,RANBP3L
prerank,mitochondrion localization (GO:0051646),-0.34495703013028456,-0.9710188674385791,0.5095785440613027,0.7733221107713735,1.0,10/19,28.06%,MARK1;MTM1;MARK2;MSTO1;MFN2;TLE6;ATCAY;HAP1;ZBED3;MEF2A
prerank,cellular macromolecule catabolic process (GO:0044265),0.31403445856468054,0.9708072629775191,0.48672566371681414,0.8758980870546481,1.0,9/49,14.74%,ADAMTS9;PRKN;FBXO44;SIAH2;FBXO6;SND1;NGLY1;RAB12;HTRA2
prerank,regulation of cell communication (GO:0010646),0.3322368034482475,0.9700365286955394,0.5109090909090909,0.8769879387405951,1.0,10/35,13.12%,SLC8A1;ANXA1;ANK2;GRK3;GRK5;CAMK2D;GRK4;IGFBP7;TSPYL2;VEPH1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.3889922681774479,0.9700091088714853,0.493801652892562,0.8762172685049722,1.0,3/18,3.98%,ROCK2;RIPOR2;LLGL2
prerank,regulation of vasculature development (GO:1901342),-0.3286798594615455,-0.9696981607250881,0.4978448275862069,0.7759937504854135,1.0,6/26,8.12%,BMPER;PLXND1;ETS1;WARS1;CTNNB1;EMP2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.35683720628600935,0.9696669036280877,0.4962686567164179,0.8762524218627376,1.0,5/26,6.69%,LARGE1;B3GNT5;GAL3ST2;ALG6;ALG2
prerank,response to hexose (GO:0009746),0.35801363873782854,0.9696168726854691,0.499001996007984,0.8755547112025223,1.0,1/25,0.51%,TCF7L2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.4078473496436297,-0.9695077076039806,0.4952741020793951,0.7758568321588513,1.0,2/10,9.24%,MSN;RHOA
prerank,calcium ion homeostasis (GO:0055074),0.28387879780410186,0.9693974911053865,0.5060606060606061,0.8752903506314182,1.0,8/95,3.96%,SLC24A3;SLC8A3;STIM1;CSRP3;SLC8A1;DMPK;FAM20A;ANK2
prerank,cellular response to dsRNA (GO:0071359),0.40176943424138656,0.9692706950395159,0.48504273504273504,0.8747870053567194,1.0,1/15,0.45%,COLEC12
prerank,regulation of JUN kinase activity (GO:0043506),-0.30895031925185545,-0.9692504326582151,0.49673202614379086,0.7758652952224089,1.0,9/33,10.23%,MAP3K5;DAB2IP;RPS3;DNAJA1;TNFRSF11A;PDCD4;PAK1;EDN1;ARHGEF5
prerank,regulation of fat cell differentiation (GO:0045598),0.29052845429070956,0.9688434158182596,0.49198717948717946,0.8750178993607544,1.0,11/74,10.39%,RORA;MEDAG;RUNX1T1;ANKRD26;TMEM64;IL6;SMAD3;LMO3;SYAP1;TAF8;ASXL2
prerank,digestive tract development (GO:0048565),0.34306516707976487,0.9687109893583613,0.5079928952042628,0.8745269536174303,1.0,6/33,10.55%,FGFR2;KIT;GLI3;SALL1;BBS7;COBL
prerank,bile acid biosynthetic process (GO:0006699),0.3593607068886368,0.9681775450150704,0.47155963302752296,0.8749818570279313,1.0,2/24,5.65%,CYP27A1;HSD17B10
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.25191766807402416,-0.9680102392651804,0.5133689839572193,0.7782692934082384,1.0,30/88,26.17%,FBXL3;FBXL5;PSMD13;PSMF1;RBX1;PSMB10;FBXO31;FBXL20;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;PSME1;PSMB3;FBXL2;CCNF;FBXL14;PSMD5;FBXO17;SKP1;FBXO9;PSMD9;PSMB4;CUL2;DMAC2;KIF14;PSMD10
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.412079306646125,-0.9678699929626604,0.5236220472440944,0.7779780658477247,1.0,4/11,20.48%,TGFB1;DDX5;MAP2K2;BMP4
prerank,phospholipid biosynthetic process (GO:0008654),-0.3011128669037581,-0.9676919977905573,0.5134474327628362,0.7777873558209686,1.0,6/36,8.81%,SGMS1;SGMS2;MBOAT1;CRLS1;FAR1;CPNE3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.36226970085480026,0.9674344363292209,0.500990099009901,0.8760323367341194,1.0,7/24,8.42%,NEDD4;GRB10;PRKCB;NIBAN2;PDCD6;VTN;ARNT
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.41105217833801405,-0.9671970106003962,0.5153256704980843,0.7783055856238051,1.0,3/11,5.79%,KANK1;CORO1C;CD44
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3724771252539153,-0.9667601532956136,0.5284552845528455,0.7787143360616695,1.0,3/16,9.24%,ST3GAL4;ETS1;RHOA
prerank,positive regulation of cilium assembly (GO:0045724),-0.3520112300347489,-0.9666337647451095,0.5086580086580087,0.7784333048722442,1.0,5/18,17.71%,CCDC88A;SEPTIN9;KCTD17;WRAP73;ENTR1
prerank,negative regulation of protein kinase activity (GO:0006469),0.2812628453381848,0.9665577401170601,0.529505582137161,0.8774434851137579,1.0,8/88,4.50%,PRKAG2;SLC8A3;PDPK1;DEPTOR;SLC8A1;DTNBP1;DUSP10;PPM1E
prerank,vesicle organization (GO:0016050),-0.2822964639145839,-0.9665476124939104,0.5084745762711864,0.7780389677410926,1.0,14/46,17.81%,CAV1;CD34;FNBP1L;CAV2;CHMP2B;ALS2CL;SRGN;LAMTOR1;USP50;DNM1;VPS18;HOOK1;VPS11;USP8
prerank,regulation of cilium movement (GO:0003352),0.4365500512237413,0.9664268943446461,0.503006012024048,0.8769195507294139,1.0,4/10,14.99%,DNAH11;CFAP298;CCDC65;ODAD2
prerank,cellular response to peptide (GO:1901653),0.30899321465305946,0.9663312080209254,0.5088852988691438,0.8762999132420549,1.0,6/56,7.35%,IGF1;SNX6;EPHA4;GJA1;IGF1R;CACNA2D1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3090945522061203,-0.9655287638421477,0.4835164835164835,0.779862435097485,1.0,9/31,14.11%,DLG2;MSN;LIN7A;WDR1;RHOA;MARK2;SYNJ2BP;ERBIN;MTCL1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.4450360245831009,0.9655259357942919,0.48478260869565215,0.8774656962535355,1.0,2/10,11.50%,JARID2;MYB
prerank,response to fatty acid (GO:0070542),0.39297233291844097,0.9652609520016371,0.5058139534883721,0.8772968382123063,1.0,1/17,1.17%,PID1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.40756821191561415,0.9652059212819983,0.4876543209876543,0.8766052203178892,1.0,3/12,10.06%,BRD8;CTSH;MED1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.3294479117620862,-0.9650996854952281,0.513978494623656,0.7802879091886836,1.0,5/26,12.46%,CAV1;LBP;RTN4;IFI35;RSAD2
prerank,positive regulation of synaptic transmission (GO:0050806),0.29562600800924427,0.9649782150113969,0.5016778523489933,0.8763283764850274,1.0,9/72,8.02%,ADCY1;SLC8A3;NLGN2;TSHZ3;DTNBP1;CACNG7;PRKCZ;ARC;ZDHHC3
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3712922601662818,0.9649263378613896,0.5135135135135135,0.875614284259001,1.0,8/21,19.39%,HK2;RPE;H6PD;RBKS;DERA;GPI;GCK;SHPK
prerank,adipose tissue development (GO:0060612),-0.404545955097433,-0.9647806531811127,0.5300970873786408,0.7804621906746954,1.0,4/11,10.15%,SPTLC2;NAMPT;LRP5;XBP1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.25207412903877724,0.9645296648181256,0.5418439716312057,0.8757609427674963,1.0,21/214,7.56%,EPHA7;TGFBR3;FGFR2;FGFR4;NOTCH2;TIMP3;ANGPT1;MTURN;CCN2;PDGFRB;DUSP10;PDGFRA;GLIPR2;PDGFD;PRKCZ;FBLN1;DLG1;LMO3;PRKCA;PTEN;CCL19
prerank,calcium ion transport into cytosol (GO:0060402),0.3764738873223082,0.9644742174025879,0.5018382352941176,0.8750750877194763,1.0,3/21,7.35%,JPH1;SLC8A1;CACNA2D1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.310543437152754,-0.9644472554098358,0.48535564853556484,0.7807024901263039,1.0,13/31,22.51%,MEF2C;CDH2;CDON;CTNNB1;BNIP2;BOC;TCF3;ID2;CTNNA1;PTBP1;HDAC9;SPAG9;MAPK11
prerank,chromatin organization (GO:0006325),0.2618722598989185,0.964206719462588,0.5167394468704513,0.874922180066571,1.0,42/132,20.83%,SATB1;JARID2;HDAC8;RBBP4;BAZ1B;SOX1;SETD7;TCF7L1;BAZ1A;MTF2;RSF1;KDM5B;KDM6B;SMARCA5;HDAC1;NPM2;TADA2A;SMARCE1;MYB;EZH1;INO80;SMARCB1;SNAI1;KDM5C;SMARCA2;SMARCC1;INO80C;KDM6A;PHF1;SMARCD3;BAZ2B;SETD2;MPND;SMARCA1;HMGN3;KDM4D;HDAC4;BRDT;KAT2B;RUVBL2;CBX3;BRWD1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.330128225631082,-0.9640148391014366,0.4924078091106291,0.7811481022332218,1.0,10/26,18.67%,UBB;NOD1;RPS27A;UBC;TAB3;AAMP;CASP8;UBA52;IFIH1;IRAK1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3990261699321372,0.963683659632752,0.5139186295503212,0.8753363493011186,1.0,1/16,0.34%,LEPROT
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.2501366171558712,-0.9631865932909256,0.5212765957446809,0.7824787026761593,1.0,28/85,23.48%,RNF144B;CBFA2T3;ATXN3;RNF144A;DAB2IP;RACK1;TRIB2;NKD2;SOCS5;BAG6;GSK3B;ZYG11B;RBX1;CLU;PSMC3;ELOB;ARIH2;COP1;RNF19B;NOP53;FMR1;ARIH1;VCP;RNF19A;USP5;CEBPA;TRIB3;HSPA1B
prerank,response to thyroid hormone (GO:0097066),0.39760330223347146,0.9623452067340508,0.484251968503937,0.8778935391268486,1.0,3/13,10.06%,BRD8;CTSH;MED1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.29601476449470265,0.9617396351561254,0.5159663865546219,0.8785014591368852,1.0,14/65,13.84%,FBN1;PPARA;FBN2;PDPK1;SNX6;SMAD6;SLC2A10;SMAD3;LEMD3;SMURF2;HTRA4;LDLRAD4;VEPH1;ADAMTSL2
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.2911044232420351,-0.9615804017398895,0.526431718061674,0.7858374066570116,1.0,16/41,29.67%,KCNJ2;KCNMA1;FLNA;KCNQ1;KCNMB4;NOS1;ACE2;KCNN2;KCNJ15;ANK3;KCNH2;KCNJ6;GABBR1;GNB1;KCNJ16;KCNJ10
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.3390246364343513,0.9615176777019586,0.5046210720887245,0.8781969935664222,1.0,4/29,8.73%,TERB2;HORMAD1;TEX11;MAJIN
prerank,regulation of lamellipodium assembly (GO:0010591),0.335527065029683,0.9614617533692662,0.4937388193202147,0.8774991903315399,1.0,7/34,11.05%,AUTS2;AVIL;FER;ABI2;CAPZB;PIK3R1;EPHA2
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.31244575739102476,-0.9613148908937856,0.5236051502145923,0.7858988705277452,1.0,8/32,12.72%,MEF2C;MCTP1;GSK3B;KCNMB4;SLC30A1;GPER1;CPLX2;VPS18
prerank,positive regulation of cytokine production (GO:0001819),-0.21183854039998218,-0.9612359853214829,0.575107296137339,0.7854936682641531,1.0,78/292,24.18%,SPTBN1;FOXP1;CADM1;PDE4D;LRRFIP1;IL33;CD200;SLC7A5;CD34;RUNX1;F3;PLCG2;MBP;LBP;RPS3;NOD1;RFTN1;G3BP1;TGFB1;CTNNB1;PTPRC;SOD1;IL1R1;GAPDH;APP;FLT4;CYRIB;PTGS2;APPL1;PAEP;XBP1;PIK3CD;ISG15;STAT3;ATF4;GBP5;CRCP;RAB1A;STOML2;CD74;HSPD1;ARHGEF2;TMED10;NR1H4;CSF1R;CYP1B1;IFIH1;LAPTM5;MIF;CD274;CD40;IL15;IRAK1;IRF5;TIRAP;TRIM27;MYD88;TYROBP;TXK;SLC11A1;POLR3D;HPSE;C3;S100A13;MAPK11;HYAL2;CEBPB;NFKB2;AFAP1L2;RELA;HSPA1B;AGER;RGCC;CD80;CRLF2;CCR2;POLR2L;POLR3F
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.30613507394100425,-0.9612198807061788,0.5238095238095238,0.7849276158128575,1.0,13/35,24.36%,ETS1;ABCB10;ZFP36L1;CDK6;STAT3;TAL1;ANKRD54;SPI1;HSPA9;NCKAP1L;MAPK11;HSPA1B;STAT1
prerank,C4-dicarboxylate transport (GO:0015740),0.4039679630593051,0.9611941512460113,0.5020325203252033,0.8772857538675439,1.0,5/14,9.27%,SLC25A18;SLC13A5;LRRC8E;SLC25A11;SLC25A22
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.26364271814714807,0.9611533619825349,0.509090909090909,0.8765513017460519,1.0,21/148,12.40%,PRKAG2;PRKAG3;PDPK1;ATRIP;MAP2K6;RBBP4;RICTOR;PRKAA2;RBBP7;BANP;BLM;CHD4;PRKAA1;USP7;CDK1;MDM2;MLST8;HDAC1;TAF3;PRKAG1;TTC5
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.44397025837300463,0.9609207612777314,0.5163265306122449,0.8763180793926467,1.0,2/10,3.92%,LPGAT1;SLC45A3
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.2983775495022704,0.9607360109651095,0.5137457044673539,0.8759429723496475,1.0,17/64,20.95%,POLR2D;CDK7;ELOA;POLR2A;CCNT2;CCNT1;GTF2F1;CDC73;MNAT1;NELFB;TCEA1;SETD2;CTR9;ELL;CDK9;ELP2;PAF1
prerank,negative regulation of binding (GO:0051100),0.286146387457359,0.9603618060303748,0.5056360708534622,0.8760506595393938,1.0,10/81,9.66%,ARHGAP28;DAB2;DKK1;SP100;IFIT2;LRRK2;PSME3IP1;RSF1;GTF2F1;GOLGA2
prerank,regulation of biomineral tissue development (GO:0070167),0.3523537379224677,0.9603447397768254,0.5123339658444023,0.8752831188856375,1.0,3/26,3.12%,ROCK2;BMP2K;ECM1
prerank,peroxisome organization (GO:0007031),-0.3210432893310271,-0.9601773630089915,0.5137420718816068,0.7868617020815878,1.0,10/25,27.16%,ABCD3;ABCD2;PEX1;PEX11B;SEC16B;ABCD4;PEX10;PEX16;TMEM135;FIS1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.40415911042365915,-0.9601284310468403,0.5183752417794971,0.7863708803129197,1.0,6/11,12.45%,SEMA6A;KLF2;THBS1;CREB3L1;SYNJ2BP;EPN2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.38420648536822205,0.959716281549512,0.494824016563147,0.8759614310022343,1.0,2/16,2.67%,WNT4;SCX
prerank,regulation of cholesterol esterification (GO:0010872),-0.4198688035933158,-0.9593609907225175,0.517175572519084,0.787659896445767,1.0,6/10,31.98%,LAMTOR1;AGTR1;ABCA2;ABCG1;AGT;STARD4
prerank,negative regulation of hemostasis (GO:1900047),0.421512006711113,0.9592369215052611,0.4955947136563877,0.8763163039872562,1.0,4/12,12.57%,TFPI;VTN;APOH;SERPINE1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.38725991496672707,-0.9591460560350632,0.5205479452054794,0.7875733966077745,1.0,8/12,44.96%,PLK2;BUB1B;ZWINT;BUB1;WEE2;NABP1;ZW10;PRCC
prerank,regulation of fibroblast proliferation (GO:0048145),0.3170147085357361,0.9591291619850447,0.5285714285714286,0.8757803310609561,1.0,5/45,7.50%,IGF1;PDGFRA;SPHK1;NLRC3;DDR2
prerank,cellular response to estrogen stimulus (GO:0071391),-0.371070293993132,-0.9583959769409636,0.5396825396825397,0.7887340889429464,1.0,5/14,14.67%,SERPINB9;ARID5A;WBP2;SFR1;NCOA4
prerank,glycine transport (GO:0015816),0.43573550276121853,0.9583609748989632,0.5173913043478261,0.8767920995101811,1.0,3/10,12.76%,SLC6A9;SLC36A2;SLC25A38
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.3944356290350178,-0.9582101475513313,0.5439252336448598,0.7885552929983275,1.0,2/12,1.98%,CSGALNACT1;FUT8
prerank,myeloid dendritic cell activation (GO:0001773),-0.3901180130792552,-0.9579968368166365,0.5377176015473888,0.7884475783427503,1.0,3/12,15.70%,TGFBR2;DOCK2;CAMK4
prerank,regulation of cellular catabolic process (GO:0031329),0.29999082545550654,0.9578520129544161,0.5426229508196722,0.8772062870857542,1.0,8/62,10.44%,ITPR1;DAPK1;PRKN;MTMR3;LRRK2;KAT8;NUPR1;ABL1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4076125626712933,0.9577571677212167,0.5340425531914894,0.8766199920356452,1.0,5/15,17.11%,WNT6;ANKRD11;HDAC1;GLI2;MSX1
prerank,lipid biosynthetic process (GO:0008610),0.28886101036681044,0.957576981894082,0.526984126984127,0.8762627685144957,1.0,8/77,7.55%,AGPAT4;ACSL1;HSD17B1;FDXR;PRKAA2;LIPH;LIPC;PRKAA1
prerank,actin filament depolymerization (GO:0030042),0.4319880496364679,0.9572839026376359,0.5161290322580645,0.876153169246591,1.0,1/11,0.33%,MICAL3
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.36943996743604335,0.9568885709577215,0.48653846153846153,0.8763055104477185,1.0,3/19,6.48%,PARD3B;PARD3;DLG1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.3921151127424121,-0.9567892923397782,0.5346153846153846,0.7907550300189651,1.0,3/13,9.22%,NAMPT;PTGIS;PTGS2
prerank,protein auto-ADP-ribosylation (GO:0070213),0.41316307737781555,0.956721275119128,0.5155555555555555,0.8758971035794982,1.0,6/12,28.03%,PARP10;PARP12;TIPARP;TNKS2;PARP2;TNKS
prerank,atrial septum development (GO:0003283),0.40450466885226577,0.9565923913414486,0.48541666666666666,0.8754062498056635,1.0,2/13,3.96%,NOTCH2;ANK2
prerank,regulation of phospholipase C activity (GO:1900274),0.400181684354623,0.9564959007807027,0.534,0.8748315150111682,1.0,3/15,4.40%,KIT;PDGFRB;PDGFRA
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.37287167153761397,0.9563816633673753,0.49521988527724664,0.8743018562160849,1.0,2/20,1.82%,PID1;DAB2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.25850818134519166,-0.9563601365244909,0.5219512195121951,0.7912251439482225,1.0,22/74,15.80%,NOTCH1;UBB;RPS27A;UBC;EGLN3;VEGFA;PSMD13;PSMF1;RBX1;PSMB10;LIMD1;PSMB6;PSME3;PSMB5;EGLN2;PSMC3;PSMD12;PSMB8;ELOB;PSME1;UBA52;PSMB3
prerank,immunoglobulin mediated immune response (GO:0016064),-0.4165630846912896,-0.9562030675397992,0.515426497277677,0.7910062122939315,1.0,3/10,22.88%,CD74;CD81;FCGR2B
prerank,positive regulation of interleukin-17 production (GO:0032740),0.36227908602736775,0.9561599665161903,0.5304659498207885,0.8740337050943742,1.0,4/22,8.61%,IL18;SPHK1;IL6;SLAMF6
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.3144568653797962,-0.9557457612405321,0.5098901098901099,0.7915020935749226,1.0,5/29,12.39%,BMP5;DAB2IP;IL17RD;SPRED2;SDHAF2
prerank,peptide cross-linking (GO:0018149),-0.32616562588630815,-0.9555710647108752,0.5230125523012552,0.7913022091242664,1.0,3/25,4.39%,FN1;THBS1;TGM2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.3268263368710109,-0.9551264762355509,0.5338809034907598,0.7917481089113587,1.0,7/26,12.32%,FBXO7;PDE8A;FYN;PPIA;HSPB1;ATF4;REST
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.3653915291588456,-0.954996208581359,0.5215686274509804,0.7914667538860968,1.0,10/16,48.33%,RBMXL1;TRA2B;PRDX6;DAZAP1;CELF4;CELF3;SF3B4;RBM3;TRA2A;NCBP1
prerank,rRNA modification (GO:0000154),-0.3438915808315956,-0.9549045312139898,0.5372807017543859,0.7910768435380253,1.0,8/21,21.04%,TFB2M;BUD23;FBL;TSR3;NSUN4;MRM2;THUMPD1;NHP2
prerank,sulfation (GO:0051923),0.43358760345501884,0.9547213691531636,0.5074626865671642,0.8767204385883379,1.0,2/11,11.32%,UST;SULT4A1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3423646654865702,-0.9545254570424815,0.5113871635610766,0.7913555325636583,1.0,6/20,13.69%,B2M;CD55;DENND1B;IL1R1;RSAD2;CD81
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.31145472266842983,-0.9544316583281172,0.5303030303030303,0.7909868700061812,1.0,6/30,16.96%,CD34;PLCG2;ISG15;STAT3;HSPD1;CD274
prerank,L-amino acid transport (GO:0015807),-0.31482407652050054,-0.9540927679272772,0.524731182795699,0.7911761564230094,1.0,8/28,12.14%,SLC7A5;SLC7A1;SFXN1;SLC1A1;SLC38A5;SLC3A2;SLC36A1;SLC1A4
prerank,blood vessel diameter maintenance (GO:0097746),0.32962442892341254,0.9538521443028519,0.5339130434782609,0.8780696693135156,1.0,4/34,6.14%,ROCK2;BDKRB2;ACE;SCPEP1
prerank,negative regulation of DNA binding (GO:0043392),-0.32062944458202225,-0.9538243621426176,0.54292343387471,0.7911872004410824,1.0,8/28,23.10%,LEF1;NFKBIA;JUN;HEY2;SUMO3;TFAP4;SOX11;HEY1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.37796350612649154,-0.9537090823407638,0.5237154150197628,0.7908434496991094,1.0,3/15,4.22%,TIAM1;RSPO3;SFRP4
prerank,response to UV-A (GO:0070141),0.39604983687351125,0.9536161159007566,0.4887525562372188,0.8778443031562844,1.0,3/14,9.42%,MMP2;MMP9;CERS1
prerank,apoptotic mitochondrial changes (GO:0008637),0.3358348118736155,0.9535344509472209,0.5,0.8772258559632456,1.0,4/32,6.51%,HK2;BCL2;IFIT2;BNIP3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.31123497766621827,-0.9534301353087942,0.5433403805496829,0.7909094020941939,1.0,14/27,30.81%,CD44;SPRED2;DDX5;CD74;MIF;EEF1E1;ATR;PTTG1IP;SNAI2;PSMD10;YJU2;SPRED3;PMAIP1;KMT5A
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.41208971423424556,0.9531678600918766,0.5116772823779193,0.8773295643721986,1.0,4/13,13.88%,PPARA;NFIB;NFATC4;SRF
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3289471720054497,0.9531536346172123,0.5154826958105647,0.876554293028103,1.0,4/36,6.76%,LEPROT;KIT;PIGU;IL6
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3088654032170865,-0.9529909390965348,0.534521158129176,0.7913218073003633,1.0,6/30,11.31%,ACVRL1;DACH1;BMPR2;PINX1;HNRNPU;MEN1
prerank,protein depolymerization (GO:0051261),0.34874005694807053,0.9527457686317048,0.5375939849624061,0.8767697203378729,1.0,2/27,1.96%,MICAL3;KIF2A
prerank,protein tetramerization (GO:0051262),0.29334452694287677,0.9526659382717535,0.5347682119205298,0.8761462831494358,1.0,11/67,13.99%,ALDH1A2;APPL2;UPB1;CBY1;HSD17B10;SSBP1;GOLGA2;OXA1L;PKD2;SHMT1;CRYZ
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.44460357407037726,0.9526590008348682,0.5251046025104602,0.8753618760104712,1.0,1/10,0.98%,APPL2
prerank,protein localization to cell junction (GO:1902414),-0.32536694337827404,-0.9526359739044287,0.49209932279909707,0.7915792027936907,1.0,10/22,20.76%,HEG1;TJP2;FERMT2;TJP1;PAK2;PCLO;BSN;DSP;JAK1;JAM3
prerank,regulation of establishment of cell polarity (GO:2000114),0.3923524654820847,0.9516933034044812,0.5205761316872428,0.8769211793651485,1.0,2/16,3.63%,ROCK2;RIPOR2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4080796626182294,0.9514401635911106,0.5138592750533049,0.8767403970087091,1.0,2/13,1.17%,PPARA;PID1
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.34188567115531765,-0.951414540847221,0.5206611570247934,0.7939677530475034,1.0,12/21,33.29%,DUSP3;SAMSN1;LAPTM5;JAK3;TNFAIP3;SOX11;FCGR2B;FOXJ1;LAX1;IL4I1;PTPN22;GPNMB
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.36221624454851303,-0.951379436261484,0.5492957746478874,0.7934511640588777,1.0,2/15,1.93%,STOX2;TGFB2
prerank,regulation of protein export from nucleus (GO:0046825),0.36227726949442907,0.9508728929776549,0.5313092979127134,0.8773576077228737,1.0,2/23,2.89%,TCF7L2;SP100
prerank,cellular component disassembly (GO:0022411),-0.2726936550501926,-0.9504317959568416,0.5443645083932853,0.7951572703323687,1.0,11/53,12.11%,BSG;TLL1;ADAM10;GSN;ADAM15;CD44;CAPN2;A2M;FURIN;ADAMTS4;MMP15
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3326474328377391,0.9504025256731663,0.5319926873857403,0.8776686936087129,1.0,10/34,11.14%,KIT;PDGFRB;EPHA8;PDGFRA;CCL19;ATG14;PIK3R4;WASHC1;PIK3R1;RUBCN
prerank,male gonad development (GO:0008584),0.32914254803083837,0.9503906882892557,0.5072202166064982,0.8769077677802981,1.0,3/34,5.73%,WNT4;KIT;LRP2
prerank,oogenesis (GO:0048477),0.38605828459590497,0.9503392291752955,0.5220883534136547,0.8762267921724686,1.0,2/15,5.91%,HORMAD1;PTN
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.40023035861217593,-0.9503136512989109,0.5248618784530387,0.794800424821574,1.0,4/11,11.40%,TJP2;F11R;TJP1;RAB1A
prerank,7-methylguanosine RNA capping (GO:0009452),0.34119870990398427,0.9502550458027724,0.5133214920071048,0.8748375057433019,1.0,4/31,8.49%,POLR2D;CDK7;POLR2A;GTF2F1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.34119870990398427,0.9502550458027724,0.5133214920071048,0.8748375057433019,1.0,4/31,8.49%,POLR2D;CDK7;POLR2A;GTF2F1
prerank,extracellular matrix disassembly (GO:0022617),-0.27217492054419556,-0.9497729247339546,0.5574162679425837,0.7954569472533871,1.0,11/53,12.11%,BSG;TLL1;ADAM10;GSN;ADAM15;CD44;CAPN2;A2M;FURIN;ADAMTS4;MMP15
prerank,positive regulation of intracellular transport (GO:0032388),-0.2991067472049641,-0.9496433049873682,0.532258064516129,0.7951683395367828,1.0,21/38,39.03%,PRR5L;EHD1;PDCD10;OAZ1;RIPOR1;NUMA1;MLC1;SPAG5;CAPN10;SORL1;PCM1;CEP131;PGAP1;DYNC1H1;ATP2A1;STK11;PCNT;PLK3;OAZ2;EIPR1;EHD2
prerank,protein monoubiquitination (GO:0006513),0.32846911028870257,0.9492555610701601,0.5395948434622467,0.8763916881995409,1.0,12/36,20.95%,PRKN;MGRN1;KLHL22;CDC73;RNF20;RAD18;OBI1;CTR9;UBE2E1;DTX3L;KLHL12;PAF1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.30335923486495686,0.9491342261029245,0.5228070175438596,0.8758579799007181,1.0,24/52,24.97%,POLR2D;EXOSC8;RC3H2;SAMD4A;CNOT2;DCP2;LSM5;PARN;CNOT8;CNOT7;CNOT10;EXOSC3;TUT4;LSM3;LSM1;LSM4;DDX6;PDE12;TUT7;EXOSC4;DCP1B;LSM6;DIS3;NT5C3B
prerank,cellular response to ionizing radiation (GO:0071479),-0.28157972029587636,-0.9487464511508078,0.5411471321695761,0.7966550129540443,1.0,16/47,25.32%,NET1;RPL26;RHOB;EEF1D;CRYAB;SPIDR;TNKS1BP1;RAD9A;ATR;LIG4;TLK2;GADD45A;CDKN1A;TMEM109;HRAS;TSPYL5
prerank,histone H3-K9 demethylation (GO:0033169),0.4227966825471066,0.9484587780236198,0.5384615384615384,0.8766450518186352,1.0,3/11,9.01%,KDM7A;PHF8;KDM3B
prerank,isotype switching (GO:0045190),-0.4120095698630676,-0.9484444084815651,0.5475285171102662,0.796787266701178,1.0,5/10,29.16%,MSH2;HSPD1;LIG4;RNF168;RNF8
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.3714473847328262,0.9481897981871671,0.511070110701107,0.8764645257585781,1.0,2/19,2.20%,IL34;CAMK1D
prerank,regulation of translational initiation (GO:0006446),-0.26420755714948385,-0.9476587193914883,0.5618556701030928,0.7980205613824566,1.0,22/63,24.25%,HSPB1;NCK1;EIF1B;EIF4G3;EIF4G1;NCK2;ATF4;YTHDF3;EIF4H;EIF3B;EIF2B5;EIF1;POLR2G;EIF2B2;EIF5B;ATF3;FMR1;UHMK1;EIF4B;CEBPB;EIF5;PPP1R15B
prerank,stem cell development (GO:0048864),-0.3614161196476042,-0.9474348104078636,0.5430861723446894,0.7979721292189721,1.0,9/16,33.49%,CDH2;PTPRC;NOLC1;SOX11;SNAI2;SHH;PEF1;WNT7A;KBTBD8
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.31449864361256724,0.9472581214912014,0.5313028764805414,0.8779449379080044,1.0,14/43,17.77%,HUS1B;CDC14B;MRNIP;BLM;CDK1;CLSPN;RINT1;MRE11;CHFR;BABAM2;BRSK1;TAOK3;TRIM39;TAOK2
prerank,cellular protein localization (GO:0034613),-0.20990367594177467,-0.9471758853930199,0.6383928571428571,0.7979888990068627,1.0,64/285,17.28%,ESAM;OCLN;ID1;NSF;STX3;TBC1D30;TBC1D8;REEP1;RAB31;STX7;RABGAP1L;FLNA;STX1A;ZDHHC15;FERMT2;EHD1;CTNNB1;TMED5;ADPRH;ARF5;GRTP1;SCG5;STX6;SGSM1;ARF1;TBC1D8B;TBC1D1;RAB28;TMED2;EMP2;CD63;SIL1;FGF7;TBC1D13;SEPTIN9;NAPB;SYNDIG1;HEY2;RAB38;STX12;ABHD17A;LAMTOR1;HGS;HHEX;RAB1A;CEP68;EVI5;MESD;TM9SF3;CD74;TBC1D10A;ARHGEF2;PICK1;TMED10;TMED3;KIF13A;RABL3;LAMTOR2;LAPTM5;STX2;BICD1;HERC2;RABGAP1;YWHAH
prerank,cellular response to oxidative stress (GO:0034599),0.2667718216513175,0.9469454631502521,0.5691176470588235,0.877917125942745,1.0,23/118,12.54%,TPM1;DAPK1;SOD3;PLA2R1;FER;PDGFRA;CPEB2;MAPK9;PRKAA2;MSRA;LRRK2;MMP9;PRKAA1;ARNT;TXNRD1;TXNRD2;VRK2;CCS;ABL1;EIF2S1;NCF2;PKD2;ADNP2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.41419606749562965,-0.9466269286403012,0.5272373540856031,0.7986961607857634,1.0,1/10,0.19%,PRKCH
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.2539674577450459,-0.946528461257983,0.5776081424936387,0.7983348451589088,1.0,19/73,16.12%,HIP1;ACER2;F3;NGF;RACK1;TNFSF10;NOD1;EGLN3;ATP2A3;HIP1R;XDH;HSPD1;CASP8AP2;RPS27L;BBC3;DAP;FAS;CASP8;LAPTM5
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2780380052795079,-0.9463775789699757,0.5645933014354066,0.7980812518671013,1.0,20/52,22.30%,MBNL1;NOVA2;RBFOX1;RBFOX3;RBFOX2;HNRNPU;DDX5;ZBTB7A;RBM8A;REST;KHDRBS3;RNPS1;SRSF6;DDX17;YTHDC1;PTBP1;MAGOH;FMR1;TRA2B;RBM24
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.24058007010394689,-0.9460232275714635,0.6005361930294906,0.7983820716259852,1.0,29/109,15.50%,PIP5K1B;PITPNM2;PLCG2;INPP5D;BMX;PIK3R6;INPP4A;SYNJ1;PIK3C2B;ARF1;CDS1;CDIPT;PLCB3;PLEKHA1;PIK3CD;PIK3C2A;MTM1;MTMR6;PITPNM3;PIK3R5;PIK3C3;MTMR9;INPPL1;SACM1L;PIP5K1C;CSF1R;SBF1;PLA2G4A;PI4KB
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.30182143626776037,-0.9459912781594748,0.5263157894736842,0.7978566534912552,1.0,12/33,16.39%,NGF;GRIK4;ABR;LRP8;BCR;BTBD9;SLC4A8;PXK;RELN;NRG3;CX3CR1;CACNA1B
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.31808128706213035,-0.9457398320657829,0.5536480686695279,0.7978717504712515,1.0,9/25,19.90%,TMTC2;CAV1;GRIN1;KCNA1;MT3;WFS1;ATP13A2;JPH2;ANK3
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.41091968804921053,-0.9457199055945329,0.5478424015009381,0.7973222668706171,1.0,5/10,36.85%,SET;CTBP1;NOC2L;THAP7;TAF7
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.30052809940716785,0.9456657191441675,0.540765391014975,0.8802183082726274,1.0,9/56,8.85%,ROCK2;ARL3;SNX18;CECR2;SNX9;SNX33;SON;SPIRE2;CUL7
prerank,peptidyl-serine modification (GO:0018209),-0.22420027562681447,-0.9455935405281275,0.6366559485530546,0.7970569378076556,1.0,50/166,22.18%,PRKCH;STK38;RPS6KA5;GAS6;GALNT13;PKD1;STK38L;TGFBR2;IKBKB;PLK2;GSK3B;GALNT2;MTOR;MARK1;MAPK8;PAK2;CHUK;RPS6KA1;MARK2;LMTK2;STK32B;STK32A;MAST3;MAP3K12;MASTL;PKN3;GALNT1;VRK3;VRK1;CAMK4;PRKD1;RPS6KA4;POGLUT3;SGK1;PRKCE;CDK2;PRKCG;ATR;CDK5;PINK1;TLK2;PRKCD;AKT1;MKNK2;TTBK2;SBK1;UHMK1;DCLK3;PRKX;MAST1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.36253844515754696,-0.9448989189288993,0.5242718446601942,0.7981067683991108,1.0,7/15,13.25%,MVB12B;PTPN12;LGMN;CEACAM1;RHBDF2;CDH13;MVB12A
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.3846734512176069,-0.9448513055587469,0.5282651072124757,0.7976003203054508,1.0,4/12,14.61%,PROM1;VEGFA;STAT3;RORB
prerank,negative regulation of blood coagulation (GO:0030195),-0.29431946691620375,-0.9447929573948852,0.5704845814977973,0.7971382523890976,1.0,7/38,12.47%,NOS3;CD34;F3;SERPINE2;A2M;EDN1;THBD
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.2448495604451818,-0.9446548496465667,0.5863874345549738,0.796869666497961,1.0,23/94,15.67%,MAP3K5;FNIP2;PPP1R13B;DAB2IP;TMEM117;CRIP1;BCL2L1;BAG6;TNFRSF1B;ATP2A3;CUL3;CHEK2;DDX5;ATF4;HINT1;PDK2;MYBBP1A;SELENOK;ERO1A;BBC3;CUL1;CYP1B1;DNAJC10
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.2566297452946195,-0.9445748257854274,0.5425531914893617,0.7964440175652986,1.0,26/72,27.55%,UBB;UVSSA;COPS7A;RPS27A;UBC;PPIE;DDB1;RBX1;RPA1;ERCC8;POLR2C;XAB2;UBA52;COPS8;POLR2G;POLK;COPS6;POLD3;POLD1;GTF2H2;POLR2L;HMGN1;XPA;ERCC5;LIG3;RFC5
prerank,positive regulation of phagocytosis (GO:0050766),-0.27591735640905013,-0.9444435288660349,0.5550239234449761,0.7961545932146963,1.0,8/47,6.03%,PTPRJ;GAS6;RAB31;RAB27A;GATA2;CALR;DOCK2;PTPRC
prerank,negative regulation of chemokine production (GO:0032682),0.4057462628903633,0.944330086722488,0.5392561983471075,0.8826556525735434,1.0,3/14,9.05%,C1QTNF3;IL6;SIRPA
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.2619951870134228,0.9438216924464836,0.5602409638554217,0.8830571863123788,1.0,29/128,16.31%,TGFBR3;BMP6;APPL2;BMP7;SMAD6;PARD3;SLC39A5;SCX;COL1A2;PRKCZ;ZMIZ1;SMAD3;RGMB;GDF1;ARHGEF18;SMURF2;ZFYVE9;BMPR1A;HIVEP1;ZMIZ2;ITGB5;MAP3K7;NLK;FAM83G;CDH5;SKI;SMAD4;CGN;SLC33A1
prerank,translational termination (GO:0006415),-0.24068291061261693,-0.9436547124598057,0.5642458100558659,0.7973425604622401,1.0,31/95,29.09%,MRRF;MRPL32;MRPL33;APEH;MRPS14;GSPT2;MRPL38;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;MRPS35;MRPS28;MRPL13;MRPL35;MTRF1L;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14;ETF1;AURKAIP1;CHCHD1
prerank,steroid hormone biosynthetic process (GO:0120178),0.33813441988875315,0.9433671591695569,0.5342706502636204,0.8833738024183786,1.0,5/29,15.04%,HSD17B1;FDXR;MED1;AKR1B1;HSD17B14
prerank,mitochondrial translation (GO:0032543),-0.23816908865407482,-0.9432081010356004,0.5864022662889519,0.797763245583033,1.0,30/104,26.84%,LARS2;MRRF;GFM1;NDUFA7;MRPL32;MRPL33;MRPS14;MRPL38;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;MRPS35;MRPS28;MRPL13;MRPL35;MTRF1L;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;TUFM;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14
prerank,regulation of protein kinase activity (GO:0045859),0.2644031373165093,0.9430310179366327,0.5597381342062193,0.8833315315775058,1.0,14/106,9.09%,PRKAG2;PDPK1;DEPTOR;ALS2;DTNBP1;PPM1E;MRNIP;SNX9;GNAQ;XRCC5;DDR2;CCL19;CSF1;UVRAG
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.40761414402118534,0.9429769526030205,0.5265392781316348,0.8826808236348648,1.0,3/12,10.08%,LHPP;ADSL;GMPS
prerank,skeletal muscle contraction (GO:0003009),0.3681348147608311,0.9426553031037429,0.5288270377733598,0.8826642793175836,1.0,3/19,13.73%,TNNC1;RCSD1;CCDC78
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.32018489980193976,-0.9421521718362097,0.5680345572354212,0.7996597226539431,1.0,9/27,20.96%,TGFB1;PUM2;DDX5;EIF4G1;LIMD1;STAT3;MAP2K2;BMP4;FMR1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.37877252855331,0.9421516197377656,0.5277777777777778,0.8830430329215652,1.0,4/18,14.82%,RAD51B;RAD51C;CDK1;CDK4
prerank,glycolytic process (GO:0006096),-0.31274244614931723,-0.9419832521657112,0.5419354838709678,0.7994513724703262,1.0,8/28,17.38%,PKM;HK1;GAPDH;PFKM;TPI1;ALDOA;LDHA;ALDOC
prerank,regulation of protein import into nucleus (GO:0042306),-0.29213480566033717,-0.9416390922754068,0.5558139534883721,0.7996410717113944,1.0,14/36,24.55%,APOD;CDH1;FLNA;TGFB1;CHP1;JUP;MDFIC;ZC3H12A;PSEN1;PRKCD;BMP4;RBM22;HYAL2;ZPR1
prerank,integrated stress response signaling (GO:0140467),-0.36579069237370504,-0.9415007714583662,0.5293005671077504,0.7993672224709495,1.0,5/14,30.15%,HSPA5;ATF4;HERPUD1;CCL2;NFE2L2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3716842779125199,0.9414970408786681,0.5304518664047151,0.8837596064255988,1.0,5/18,12.80%,ADCY1;CAMK1D;PRKD2;CRTC1;CRTC3
prerank,positive regulation of histone deacetylation (GO:0031065),-0.3903533254005367,-0.9411127528755767,0.5459882583170255,0.7996990746923048,1.0,5/12,17.35%,VEGFA;APLNR;AKAP8;PRKD1;CTBP1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.28131018062898566,0.940710917340431,0.5425361155698234,0.8848509389997541,1.0,10/80,7.56%,AUTS2;DOCK11;DPYSL3;AVIL;RIPOR2;ABI2;WASL;ARHGAP35;EPS8L1;CCL19
prerank,sulfur amino acid catabolic process (GO:0000098),0.4263579527531702,0.9405740058775759,0.5292887029288703,0.8844206067557308,1.0,1/10,2.11%,CBS
prerank,response to insulin (GO:0032868),0.2761863055292858,0.9405433283693692,0.551948051948052,0.8837008751408431,1.0,13/80,10.77%,PDPK1;SORBS1;INSIG2;FER;RAB13;PCSK9;CPEB2;SYAP1;TBC1D4;SLC27A1;PRKDC;PIK3R1;RPS6KB1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.385179714676868,0.9402517391731325,0.52734375,0.8835967776563345,1.0,2/15,4.40%,FGFR2;PDGFRA
prerank,positive regulation of collagen metabolic process (GO:0010714),0.37091154528107884,0.9402174894537098,0.5132382892057027,0.8829015292096287,1.0,2/17,2.67%,WNT4;SCX
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.41932575981221987,0.9401493744924162,0.5364806866952789,0.882274856866224,1.0,2/10,8.48%,HK2;GFPT2
prerank,regulation of synapse assembly (GO:0051963),-0.2817052603722363,-0.940054077857675,0.5922330097087378,0.8016244884197706,1.0,10/46,12.02%,MEF2C;LRFN5;CLSTN2;APP;IL1RAP;NRXN1;SYNDIG1;EIF4G1;EPHB1;CLSTN3
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.399880993135616,0.9399108713447798,0.49490835030549896,0.882064981499873,1.0,5/12,8.41%,PLCB1;SLAMF8;WASL;NBL1;MIA3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.2762362693139469,-0.939625638525421,0.5617433414043583,0.802024832185288,1.0,20/45,33.86%,HSPB1;APP;AIM2;STAT3;GBP5;USP50;PANX1;CASP8;MYD88;TYROBP;CASP1;AGER;NLRC4;TLR4;LPL;CD36;TLR6;NOD2;P2RX7;NLRP3
prerank,melanosome organization (GO:0032438),0.35404803007405716,0.9384472702464859,0.5245283018867924,0.8847642665252514,1.0,7/26,15.11%,SHROOM2;DTNBP1;GPR143;RAB32;BLOC1S4;AP1M1;AP3B1
prerank,spermatid development (GO:0007286),0.3340431919091301,0.9382627534696059,0.538878842676311,0.8844078425259675,1.0,6/32,14.08%,GALNTL5;ZMYND15;NME5;CEP57;CIB1;NECTIN2
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.29776483262224107,-0.9381214855084272,0.550321199143469,0.8049732709780162,1.0,13/31,25.95%,HSPA8;ATXN3;DAB2IP;HSPA14;HSPA5;PTPN1;HSPB8;TMBIM6;HSPA9;HDAC6;HSPA1B;BAX;ERN1
prerank,pyroptosis (GO:0070269),0.3911637805023267,0.9377600659632865,0.5475728155339806,0.8848188956853923,1.0,4/15,13.36%,GSDMA;GSDMD;GSDME;ZBP1
prerank,positive regulation of protein metabolic process (GO:0051247),-0.23916938502401924,-0.9376762337520569,0.6033519553072626,0.8054145280915529,1.0,26/110,13.04%,WWP1;KLF2;NSF;KLF4;NEDD4L;DAB2IP;NFKBIA;ATG7;TGFB1;PLK2;GSK3B;APP;ABCB10;FOXO1;DDB1;MAPK8;PAEP;EIF4G1;OAZ1;APC;CDKN1B;NDUFA13;RAB1A;EGLN2;CLU;IDE
prerank,response to estradiol (GO:0032355),0.33391718006601867,0.9376531215040839,0.5341506129597198,0.8842627350381959,1.0,6/31,7.77%,ANXA1;STAT5B;CRHBP;SSTR2;NCOA3;STRN3
prerank,multivesicular body assembly (GO:0036258),-0.301760771180236,-0.9375300773495203,0.5776805251641138,0.8051351240103123,1.0,13/30,30.92%,CHMP5;CHMP2B;HGS;MVB12A;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;VPS36;VPS28;VPS4B
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4013167139260975,0.9374092758788027,0.5255319148936171,0.8840807341362201,1.0,3/13,12.17%,BMP7;NAPEPLD;SOX13
prerank,hexose biosynthetic process (GO:0019319),0.30997853352600413,0.9371476400025993,0.522140221402214,0.883896665332329,1.0,9/42,14.13%,RBP4;SORD;SLC25A11;CHST15;CRY1;AKR1B1;ENO2;PFKFB1;GPI
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.2930967440168857,-0.9368219472504169,0.5659955257270693,0.8062295963770856,1.0,13/38,18.75%,CAV1;KCNJ2;CACNA1G;KCNQ1;CTNNA3;CACNA1C;BIN1;CACNB2;JUP;DSG2;SCN1B;DSP;TRPM4
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.329529964463654,-0.936550345376648,0.560081466395112,0.8062970475585385,1.0,7/22,25.12%,SLC7A5;TNFRSF1B;LAPTM5;TRPM4;TRIL;CCR2;SPHK2
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.23414622910923857,-0.936435147897154,0.6225352112676056,0.8059704342255202,1.0,37/124,20.30%,LEF1;TIAM1;RAC1;CALM1;ROR2;SFRP4;FZD4;AP2A2;FZD6;NFATC1;CTNNB1;ARHGEF19;PLCB3;PSMD13;PSMF1;RHOA;AP2M1;PSMB10;VANGL2;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PPP3CA;PSME1;CCDC88C;TNRC6C;PSMB3;DVL2;PRICKLE2;PPP3R1;ARRB2;PSMD5;AP2B1;AGO3
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.37557490857809783,0.9358167810776158,0.5504032258064516,0.8862990331122682,1.0,2/17,1.17%,RBPJ;NOTCH2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.2896420457159053,0.9356235347734071,0.5659722222222222,0.8859455282899956,1.0,15/66,15.04%,APPL2;PLCB1;UBE2E2;ANXA1;PLK5;DLG1;KANK2;PTEN;RBL2;MYO16;CDC73;PKD2;INO80;CDK4;HYAL1
prerank,regulation of ATP metabolic process (GO:1903578),0.2947774567355817,0.9355051947504848,0.570446735395189,0.8854249939868805,1.0,1/54,0.08%,PRKAG2
prerank,positive regulation of neuron projection development (GO:0010976),0.27443393729671695,0.9351265526837823,0.5652173913043478,0.8855452334539872,1.0,10/85,7.10%,PTK7;EPHA3;BMP7;CAMK1D;DPYSL3;AVIL;NDNF;PLK5;PTN;ARHGAP35
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.40246073327657705,-0.9351036606801855,0.5598455598455598,0.8084372322293581,1.0,7/11,39.29%,STAT3;CANX;JAK1;STAT1;IL12RB2;IL6ST;IL12A
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2810507576702346,0.9348319714020923,0.5627009646302251,0.8854368291749315,1.0,9/76,7.56%,SASH1;C1QTNF3;BMP7;NFAT5;SPHK1;UACA;DLG1;NLRC3;CCL19
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.33831068843943246,0.9346364735173548,0.5448028673835126,0.8851067247064808,1.0,4/27,4.96%,SLC22A2;SLC6A9;SLC1A3;SLC25A18
prerank,positive regulation of dendrite development (GO:1900006),-0.39956168012459986,-0.9346080905832901,0.5375,0.8089822316376942,1.0,4/10,6.74%,BMP5;DAB2IP;ZDHHC15;LRP8
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.2100124665034277,-0.9345671631839826,0.6781609195402298,0.80848919358057,1.0,58/241,20.78%,HSPA8;NOVA2;HNRNPK;SRSF2;PABPC1;SRSF1;HNRNPU;PPWD1;HNRNPA3;YBX1;PPIE;SF3B1;SF3B2;CPSF7;PHF5A;SFPQ;RBM14;DDX5;SRSF5;DDX39B;CPSF3;HNRNPH2;SRSF9;CWC15;RALY;USP39;RBM8A;POLR2C;XAB2;RNPS1;SNRPC;SRSF6;PRPF40B;FUS;SF3B5;HNRNPA0;SYMPK;CLP1;POLR2G;PRPF4;CPSF2;SPEN;GTF2F2;CSTF2T;ESS2;PCBP1;PCF11;CSTF2;MTREX;HNRNPUL1;YTHDC1;RBM17;PTBP1;CTNNBL1;RBM22;SNIP1;MAGOH;METTL3
prerank,methylguanosine-cap decapping (GO:0110156),-0.4053289456956956,-0.9345416598646364,0.5711610486891385,0.8079622249041775,1.0,7/10,35.40%,PATL1;DCPS;EDC3;EDC4;PNRC2;PATL2;DCP1A
prerank,female gamete generation (GO:0007292),0.335118232514302,0.9345338788935622,0.5324427480916031,0.8845293765657117,1.0,4/29,5.91%,DIAPH2;HORMAD1;DMC1;PTN
prerank,positive regulation of inflammatory response (GO:0050729),-0.2434845813310969,-0.934448743173642,0.5925925925925926,0.8075737426774001,1.0,16/86,14.36%,IL33;ETS1;LBP;NFKBIA;RPS19;GPR4;VAMP8;PDE2A;PDCD4;APP;GRN;FEM1A;IFI35;CD81;NFKBIZ;CD47
prerank,autophagy of mitochondrion (GO:0000422),0.31548306313245755,0.9340223406801924,0.5504424778761062,0.8849497979354711,1.0,9/38,15.63%,PRKN;WIPI1;BNIP3;ATG14;FUNDC2;FUNDC1;ATG9A;AMBRA1;ATG3
prerank,positive regulation of protein maturation (GO:1903319),0.41656368038867575,0.9339227600052125,0.5308641975308642,0.8844249760990918,1.0,2/11,4.05%,TFR2;CCBE1
prerank,regulation of defense response (GO:0031347),0.2811159647720312,0.9336421695569422,0.5625,0.884269069339397,1.0,9/76,7.98%,ADAMTS12;APPL2;ANXA1;LACC1;UFL1;CASP12;SETD6;DAGLB;RNF135
prerank,regulation of stem cell differentiation (GO:2000736),-0.24362799990402692,-0.9335137640580532,0.6109589041095891,0.8091601242485045,1.0,21/89,15.86%,LMO2;RUNX1;JAG1;CBFB;NOTCH1;HES1;GATA2;HNRNPU;PSMD13;PSMF1;PSMB10;PSMB6;TAL1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;TCF3
prerank,regulation of neuron apoptotic process (GO:0043523),0.26870698829259665,0.9335088404303146,0.5618892508143323,0.8837978377340187,1.0,9/96,5.04%,EPHA7;PRKN;SNX6;BCL2;NDNF;PCSK9;SRPK2;KDM2B;CPEB4
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.25280598105594965,-0.9331480647663473,0.6212121212121212,0.8094135739044743,1.0,17/70,15.86%,LMO2;RUNX1;CBFB;GATA2;PSMD13;PSMF1;PSMB10;PSMB6;TAL1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;TCF3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.3451428928310382,0.932590828212202,0.5540796963946869,0.8852020193313043,1.0,6/27,10.77%,PID1;GRB10;PRKCZ;PRKCB;TNS2;RPS6KB1
prerank,response to hydrogen peroxide (GO:0042542),-0.2746528276654497,-0.9325113752907119,0.5950226244343891,0.8103668368849486,1.0,9/45,10.10%,MAP3K5;FYN;RPS3;NET1;RHOB;SOD1;PDCD10;STK25;PLEKHA1
prerank,positive regulation of immune effector process (GO:0002699),-0.31168062142599273,-0.932456464436123,0.5895372233400402,0.8099029107228894,1.0,6/27,13.69%,PTPRJ;LBP;RPS19;PTPRC;XBP1;CD81
prerank,establishment of vesicle localization (GO:0051650),-0.34812817310140176,-0.9317084985450002,0.5742971887550201,0.8110244772332341,1.0,4/18,7.68%,RAB27A;LIMK2;SYNJ1;DNM2
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2855932777849301,0.9316234413319837,0.5589660743134087,0.886712434753042,1.0,15/67,15.63%,DCDC2;ODAD3;FER;PLD1;TBC1D9B;SDCCAG8;CAPZB;EPHA2;FXR1;CYLD;TBC1D19;IFT140;CDKL5;TBC1D17;ATG3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.32248268681733333,-0.9315081449909469,0.5503080082135524,0.8108448043071673,1.0,8/22,18.52%,UBB;EDEM3;RPS27A;UBC;TRIM13;MAN1A2;UBA52;RNF5
prerank,mitotic metaphase plate congression (GO:0007080),-0.2694502188498313,-0.9313146281578761,0.6148325358851675,0.8107293836541033,1.0,18/51,26.80%,CHMP5;CHMP2B;PINX1;CUL3;RMDN1;BOD1;CHMP1B;CHMP1A;CHMP3;KIFC1;CHMP7;PDCD6IP;NDC80;KIF14;SPDL1;CHMP4C;CDCA8;CEP55
prerank,positive regulation of neuron differentiation (GO:0045666),-0.2851387198122211,-0.9311650315079106,0.5690072639225182,0.8104895284357444,1.0,11/40,15.86%,MEF2C;NGF;NRCAM;MMD2;RHOA;BMP2;HEYL;REST;ARHGEF2;BRINP2;TCF3
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.39154818012905207,0.9310062673222742,0.5061224489795918,0.887375837697638,1.0,4/13,10.82%,KCNA5;ANK2;GJA1;SCN3B
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.23172707750226706,0.9307060089862347,0.6340819022457067,0.8873304667589245,1.0,64/327,16.70%,RORA;EFEMP1;ARNT2;DENND4A;ATXN1;TULP3;ESRRG;MYBL1;NR1I2;SOX6;PPARGC1B;NFYB;IGF2;SSBP2;NCOA2;SOX1;PERM1;TCF7L1;ZMIZ1;ZFP37;SUFU;THAP1;WWC1;WWC2;GPBP1;UBE2L3;GPBP1L1;MTF2;ZKSCAN5;POLR2A;NFIA;ZNF628;BRCA2;MITF;KAT6B;NFYC;NSD1;NUP107;ABL1;ASCC2;ZBTB11;ZBTB38;MYB;RNF14;SOX13;RNF20;PSPC1;NONO;FOXK2;CLOCK;UBE2V1;CREBBP;NLK;PCGF1;SOX12;SMARCA2;PATZ1;ZNHIT3;FZD7;PML;PHF1;IGSF1;REXO4;BACH1
prerank,positive regulation of cellular process (GO:0048522),0.22082134434233966,0.9306658815595029,0.6850763807285546,0.8866425927060566,1.0,77/565,12.90%,IL31RA;IGF1;BMP6;COLEC12;IL34;FGFR2;FGFR4;EFNB2;TPM1;MEIS1;RHOD;BCL2;CAMK1D;CCN2;PARD3;DKK1;SCX;PDGFRB;FER;CTSH;IGF2;PDPN;EPHA4;SRPK2;ITGAX;IL13RA1;TULP1;ASH2L;PDGFRA;SPHK1;PRKAA2;PDGFD;UFL1;IGF1R;FGF1;PTN;TET1;TTK;ECHDC3;ADRA1D;CDC123;IL6;FOLR2;PRKCA;PTEN;PRKAA1;CSF1;BIRC5;LYAR;GRK5;RPRD1B;COX17;NUPR1;SIRPA;MDM2;IER5;AXIN2;CST7;PHIP;FGF9;TNFSF13;HDAC1;FLCN;TFAP2B;FXR1;ERBB2;TGFA;KLHL22;PRODH;HSF1;PRKD2;AR;AREG;ADNP2;S100A9;GDNF;INO80
prerank,positive regulation of lipid kinase activity (GO:0090218),0.33609510132864484,0.9305285481036158,0.5308411214953271,0.8861819600839345,1.0,7/29,8.90%,KIT;PDGFRB;EPHA8;PDGFRA;CCL19;ATG14;PIK3R4
prerank,cellular response to misfolded protein (GO:0071218),-0.3393609463882735,-0.9300148234744685,0.5546038543897216,0.8125019003829922,1.0,7/20,21.92%,ATXN3;BAG6;CUL3;DERL1;AUP1;RNF5;VCP
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.2659392863513077,-0.9299579266901634,0.5742092457420924,0.812037630746161,1.0,20/57,23.72%,MEF2C;DLG2;PTK2B;MINK1;DLGAP1;APP;CACNG3;GRIN1;RELN;CACNG2;LYNX1;CAMK2B;GRIA2;CNIH3;NPTXR;NEFL;NPTX1;SHISA6;MAPK8IP2;SHANK1
prerank,mRNA metabolic process (GO:0016071),-0.24012659707369544,-0.9296201989331779,0.6135135135135135,0.8122104155500149,1.0,30/90,28.92%,PPARGC1A;SRSF2;SRSF1;SF3B2;SFPQ;DDX5;SRSF5;SSB;CPSF3;KIN;SRSF9;CPSF6;USP39;PRPF18;HNRNPA0;RIDA;RNASE4;PCF11;PTBP1;AGO3;METTL3;SNRPG;HSPA1B;NUDT16;ERN1;RNH1;DIS3L2;AURKAIP1;LSM11;SRSF7
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2873381478675271,0.92960177280865,0.5593803786574871,0.8875814310975992,1.0,14/63,14.03%,LEPR;TIMP3;BCL2;ATRAID;NUPR1;APOC1;GOLGA2;RIC1;WASHC1;RUBCN;KLHL22;PTPN3;FOXK2;PLIN5
prerank,double-strand break repair (GO:0006302),0.25341938427600774,0.9294724863548994,0.5805515239477503,0.887100412132391,1.0,25/158,11.35%,EYA1;RAD51B;BAZ1B;RAD51AP2;RNF138;HUS1B;RAD51C;TDP2;XRCC5;BLM;XRCC4;HELQ;KDM2A;AUNIP;BRCA2;POLM;ZSWIM7;MDC1;NHEJ1;PRKDC;DCLRE1A;PARP9;SMARCA5;DCLRE1B;ZFYVE26
prerank,in utero embryonic development (GO:0001701),0.35218029450382937,0.9293901403845284,0.5599250936329588,0.88653959920314,1.0,3/25,3.44%,ARNT2;FGFR2;IGF2
prerank,dendrite self-avoidance (GO:0070593),-0.3506600992086829,-0.9293587710533944,0.5681818181818182,0.8122366394102396,1.0,8/16,27.65%,BSG;ROBO4;CNTN6;NPTN;DSCAML1;VSTM2L;CNTN2;EMB
prerank,fluid transport (GO:0042044),-0.3801959327056381,-0.9293372077687021,0.5594149908592322,0.811697622530596,1.0,3/12,11.74%,AQP4;AQP11;SLC26A6
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3303693786746336,0.9293192085796069,0.5524475524475524,0.8859078038320961,1.0,5/30,8.30%,ROBO1;LPAR1;AKAP13;ABRA;F2RL2
prerank,blood vessel endothelial cell migration (GO:0043534),0.353787875517713,0.9292200689205603,0.54296875,0.885395887477086,1.0,2/22,1.19%,ROBO1;EFNB2
prerank,mitochondrial translational elongation (GO:0070125),-0.2404820938384894,-0.9290244240838644,0.6236559139784946,0.8118049834708634,1.0,28/88,29.09%,GFM1;MRPL32;MRPL33;MRPS14;MRPL38;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;MRPS35;MRPS28;MRPL13;MRPL35;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;TUFM;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14;AURKAIP1;CHCHD1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.2884285022273331,0.928762109272504,0.5672913117546848,0.8856953126205609,1.0,13/64,14.65%,ACSL1;GSTM2;PLA2G10;ACOT4;ACADL;CPT2;EPHX2;DAGLB;ACOT1;PLA2G4B;PLA2G4C;ACOX1;HACL1
prerank,positive regulation of viral process (GO:0048524),0.2864073482611351,0.9286945068613157,0.5570469798657718,0.8850838337805276,1.0,10/60,10.30%,PPARA;POLR2D;SRPK2;HACD3;POLR2A;RSF1;CCNT1;GTF2F1;PKN2;AXL
prerank,cellular response to oxygen-containing compound (GO:1901701),0.23452694712102237,0.9280667932788217,0.6241699867197875,0.8857937711406084,1.0,25/291,7.32%,RORA;ROCK2;PTK7;EPHA3;WNT6;PID1;SLC5A5;TPM1;DAPK1;CXCL13;FER;CRHBP;PDGFRA;MAPK9;CPEB4;CACTIN;AANAT;SSTR2;SLC38A9;IL6;NCOA3;PDCD1LG2;WNT5B;FOLR1;MMP9
prerank,natural killer cell activation (GO:0030101),-0.32922849255703046,-0.9279865691665232,0.5711462450592886,0.8136330490634478,1.0,10/23,29.89%,PTPRC;BAG6;PIK3CD;RABL3;CASP8;ULBP1;TOX;SNX27;PRDX1;RASGRP1
prerank,negative regulation of neuron differentiation (GO:0045665),-0.33080159401323567,-0.9277024645077392,0.5758196721311475,0.8136874980049417,1.0,9/22,23.10%,B2M;HES1;CALR;GSK3B;REST;DISP3;SOX2;DLL1;HEY1
prerank,negative regulation of cell projection organization (GO:0031345),0.3010810389602975,0.926642351365299,0.5704099821746881,0.8882944012152144,1.0,6/48,7.48%,EFNB2;LPAR1;DPYSL3;EPHA4;PTPN9;PTEN
prerank,regulation of mRNA catabolic process (GO:0061013),-0.23245202659998834,-0.9262312324958708,0.6126373626373627,0.8164708724869242,1.0,36/121,23.00%,PRR5L;HSPA8;VIM;UBB;HSPB1;PABPC1;YWHAB;RPS27A;UBC;PUM2;PSMD13;SET;PSMF1;EIF4G1;ZFP36L1;PSMB10;YTHDF3;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;UBA52;PSMB3;SERBP1;ZC3H12A;PSMD5;PCBP4;PRKCD;AKT1;FMR1;RBM24;PSMD9;PSMB4
prerank,action potential (GO:0001508),0.3117304504933328,0.9260844631977646,0.5670840787119857,0.8888384949083759,1.0,2/44,1.48%,SCN7A;DMD
prerank,glucose metabolic process (GO:0006006),-0.26069189978021295,-0.9260297068183798,0.5734265734265734,0.81631728583813,1.0,10/58,14.05%,APOD;PPARGC1A;PPARD;LRP5;HECTD4;GAPDH;ATF4;SLC39A14;TPI1;ALDOA
prerank,cellular response to calcium ion (GO:0071277),0.2836014974767069,0.9257141317523382,0.5901639344262295,0.8889190884609738,1.0,10/67,10.68%,ADGRV1;ADCY1;CRHBP;SYT11;SYT12;PRKAA2;PRKAA1;CAMK2D;CPNE4;NEUROD2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.3260609010769286,-0.9256568544908632,0.5780590717299579,0.816595731849503,1.0,8/21,19.74%,CTNNB1;VEGFA;NES;DISC1;CX3CR1;DISP3;TOX;DLL4
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3147934573285789,0.9250870088206532,0.5758683729433273,0.8895984108071494,1.0,9/41,13.77%,ACSL1;GSTM2;PLA2G10;PTGR1;DAGLB;FADS3;PLA2G4B;PLA2G4C;ACOX1
prerank,global genome nucleotide-excision repair (GO:0070911),-0.31015075643312867,-0.9244856837986125,0.5672268907563025,0.8187362712815893,1.0,7/26,17.98%,UBB;RPS27A;UBC;DDB1;RBX1;UBA52;CETN2
prerank,protein insertion into membrane (GO:0051205),-0.3013408814019277,-0.9243501097918793,0.5883575883575883,0.8184490142152288,1.0,13/32,32.24%,REEP1;STX1A;APP;CCDC47;SEC61G;GET4;VAPA;OTOF;RTP4;WDR83OS;STX5;SEC61B;UBE2J2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.35646798988812894,0.9240709435589695,0.5705765407554672,0.8911023026407469,1.0,5/20,14.05%,NR2F2;PTEN;CDK5RAP1;LATS1;CDKN1C
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.206523457252862,-0.9240001960217957,0.7208333333333333,0.8186571455311639,1.0,64/264,20.78%,HSPA8;NOVA2;HNRNPK;SRSF2;PABPC1;SRSF1;HNRNPU;PPWD1;HNRNPA3;YBX1;PPIE;SF3B1;SF3B2;CPSF7;PHF5A;SFPQ;RBM14;DDX5;DDX20;SRSF5;DDX39B;CPSF3;HNRNPH2;SRSF9;CLNS1A;CWC15;RALY;USP39;RBM8A;POLR2C;STRAP;XAB2;RNPS1;SNRPC;SRSF6;PRPF40B;SRPK1;FUS;SF3B5;HNRNPA0;SYMPK;CLP1;POLR2G;PRPF4;CPSF2;SPEN;DCPS;GTF2F2;CSTF2T;ESS2;PCBP1;PCF11;CSTF2;DDX17;MTREX;HNRNPUL1;YTHDC1;RBM17;PTBP1;CTNNBL1;RBM22;SNIP1;MAGOH;METTL3
prerank,regulation of primary metabolic process (GO:0080090),0.26018820460000874,0.9229950361068421,0.6031007751937985,0.8928494067528286,1.0,18/126,11.41%,ROCK2;FGFR4;PPARA;TBL1XR1;NFYB;NCOA2;OAZ3;PSME4;PSMA2;PSMA3;CHD9;PMVK;PSMD8;NFYC;MED1;PSMD3;FDPS;RXRA
prerank,regulation of myotube differentiation (GO:0010830),-0.31212678757119006,-0.9229748464139825,0.5665236051502146,0.8204517872553587,1.0,7/24,13.46%,NOTCH1;CCN3;HDAC5;PIEZO1;XBP1;ATP11A;SMYD1
prerank,response to organonitrogen compound (GO:0010243),-0.2828021580014803,-0.9228563058174982,0.6119733924611973,0.8201144857556382,1.0,16/38,27.14%,MTOR;DERL1;CCDC47;UBXN6;IRAK3;ERLEC1;NR1H4;GLRA3;RNF5;IRF5;VCP;BRSK2;GLRA1;MEAK7;TRPM2;SYVN1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.37871303567477754,0.9225772114893398,0.548728813559322,0.8930223384528475,1.0,4/16,5.26%,PDGFRB;FER;PDGFRA;PDGFD
prerank,actomyosin structure organization (GO:0031032),0.28232915973933653,0.9223516143695351,0.560064935064935,0.8927545268134619,1.0,9/75,6.42%,ROCK2;TPM1;SORBS1;CSRP3;FRMD6;TNNT2;EPB41L5;FAM171A1;MYO18A
prerank,steroid catabolic process (GO:0006706),-0.39125899623125854,-0.922188765536543,0.5708812260536399,0.8210682777666818,1.0,3/10,17.70%,SPP1;YWHAH;HSD11B1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.3286327136642931,-0.9218078755212423,0.574,0.8213645263190112,1.0,5/20,11.71%,PPIA;PPWD1;PPIE;PPIB;NKTR
prerank,lipoprotein localization (GO:0044872),0.40344311234361785,0.9216884450475054,0.5376569037656904,0.8935421000282122,1.0,3/11,8.41%,PRKCB;ZDHHC3;MIA3
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.3312485623167085,-0.9215736276554746,0.5903361344537815,0.8213223963112374,1.0,7/20,22.24%,ENTPD1;HSP90AB1;APP;PSTPIP1;NT5E;C3;CASP1
prerank,histone H4-K8 acetylation (GO:0043982),-0.3520995564252537,-0.921181479876361,0.5511811023622047,0.821007424250984,1.0,5/15,17.31%,ING4;OGT;JADE1;KANSL3;WDR5
prerank,histone H4-K5 acetylation (GO:0043981),-0.3520995564252537,-0.921181479876361,0.5511811023622047,0.821007424250984,1.0,5/15,17.31%,ING4;OGT;JADE1;KANSL3;WDR5
prerank,inflammatory response (GO:0006954),0.24218738976924753,0.9203071599002166,0.6364922206506365,0.8959201683375195,1.0,27/195,13.74%,ADCY1;BDKRB2;IL18;KIT;LOXL3;TPST1;CXCL13;ANXA1;ADM;CRHBP;PARP4;IL6;FOLR2;CCL19;PTGIR;IL17D;ITCH;CCL4;PTGER1;CDO1;MAPKAPK2;S100A9;NFATC4;TBK1;PLA2G4B;ADORA1;PLA2G4C
prerank,protein-containing complex assembly (GO:0065003),0.2352768090069302,0.9200835247924326,0.6503957783641161,0.8956575091835017,1.0,45/259,12.50%,TCF7L2;PLEKHA7;AFDN;DMD;KMT2A;FANCA;PARD3;PYGO1;ASH2L;SH3PXD2B;TEAD1;WASF1;TLE3;WASL;LRRK2;SNX9;TCF7L1;WDR19;PDCD6;CDC123;CAND1;F5;NOL3;BLM;FOLR1;WASF3;MCU;TLE1;MITF;PICALM;MDM2;GOLGA2;AXIN2;TUBGCP2;GSDMD;BCL9;HDAC1;LLGL1;DLG4;TGFA;CDC73;SAR1B;DNAJB12;HSF1;AREG
prerank,polyamine metabolic process (GO:0006595),-0.3793333669590227,-0.9199591177683761,0.5728744939271255,0.8232019298936941,1.0,8/13,37.43%,AMD1;HDAC6;SRM;DHPS;SMS;ODC1;HDAC10;OAZ2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.22296729187692954,0.9198255039086511,0.6782945736434108,0.8954793846283048,1.0,68/417,14.05%,TCF7L2;WNT4;RBPJ;NR2F2;BMP7;ATXN1;SNX6;DKK3;ARID5B;RUNX1T1;PRDM5;ZEB1;ZIC2;NR1I2;PLCB1;LOXL3;TSHZ3;JARID2;MIDEAS;VGLL4;PRICKLE1;HOXA7;FOXD1;ZHX2;CBY1;BEND5;L3MBTL2;ARID4A;IKZF4;DPF2;GLI3;SFMBT1;NIBAN2;BCOR;SALL1;XRCC5;BIRC5;WWP2;RSF1;ZMYND15;TLE1;KAT8;KAT6B;MDM2;MBTD1;SMURF2;SCMH1;L3MBTL3;ATOH8;HDAC1;TFAP2A;SMARCE1;TFAP2B;ZNF568;ZBTB38;MYB;CRY1;SOX13;CBFA2T2;PSPC1;NONO;FOXK2;SCML4;TFDP2;CLOCK;ZNF148;KDM5C;CDKN1C
prerank,regulation of osteoclast differentiation (GO:0045670),0.32715833468071787,0.919647851399644,0.5663716814159292,0.8951427892306005,1.0,4/33,8.62%,FBN1;LRRC17;CSF1;FSTL3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.23408016546279803,0.9191049490634764,0.6544980443285529,0.8956353943160194,1.0,71/260,19.11%,DCDC2;ASAP1;KIT;FGD4;RHOD;MYLK;INTU;AVIL;RAB3IP;ARL3;DYNC2H1;CDC14B;CCDC57;IFT80;PMP22;CC2D2A;ARMC9;WDR19;UBXN10;TTC8;WDPCP;KIF27;WDR35;NTN1;ARL6;CEP19;IQCB1;MTSS1;TEKT2;TCTN1;SCLT1;ATP6V0D1;PARVA;CEP89;BBS7;FBF1;OFD1;WDR11;IFT122;RAP2A;ACTN2;TTC39C;EXOC3;IFT140;CFAP298;STK26;CCDC65;WDR90;CEP164;CFAP70;CFAP410;ATP6V1D;EXOC7;EXOC1;DYNC2I1;CFAP20;SDCBP;SRGAP2;PDE6D;RAB11FIP3;RAP1B;ANO6;ARF4;RP2;TMEM237;BBS1;TRAF3IP1;MAP4K4;IFT81;TNIK;IFT46
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.2515365205681806,-0.9190762724870507,0.6230769230769231,0.8246201622669971,1.0,20/72,23.79%,ACER2;RPL26;SOX4;PLK2;PLAGL1;CHEK2;CNOT6L;ING4;SESN2;CDKN1B;BCL3;RPS27L;TNKS1BP1;PCBP4;TFAP4;GADD45A;CDKN1A;E2F7;RGCC;BAX
prerank,regulation of stem cell proliferation (GO:0072091),0.36547423105011084,0.9190733450411607,0.5833333333333334,0.8949537628324297,1.0,3/17,6.36%,GJA1;ACE;FBLN1
prerank,negative regulation of phagocytosis (GO:0050765),-0.35017548730786796,-0.9187496859879655,0.5696465696465697,0.824789315025415,1.0,8/17,26.99%,RACK1;DYSF;APPL1;CD47;PIP4P2;CD300A;FCGR2B;SNX3
prerank,atrial septum morphogenesis (GO:0060413),-0.39149043246306064,-0.9187129879260945,0.5834862385321101,0.8242683411853204,1.0,4/10,9.37%,TGFB2;BMPR2;SOX4;HEY2
prerank,regulation of collagen biosynthetic process (GO:0032965),0.35624734943564373,0.9183911520141264,0.5424430641821946,0.8957585822511229,1.0,3/19,6.76%,WNT4;SCX;IL6
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.38719026862809297,0.9183092876151352,0.5536062378167641,0.8951916914980251,1.0,4/14,13.77%,EHHADH;ECI2;AMACR;ACOX1
prerank,negative regulation of cellular component organization (GO:0051129),0.27414652081860835,0.9180303820463773,0.5953947368421053,0.8950693656338772,1.0,13/74,12.83%,BMP6;EPHA3;SYT11;WASL;PRKCZ;SNX33;XRCC5;RUBCN;RTEL1;HSF1;AR;PACSIN3;RAPGEF3
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.24644768529591016,0.9179245421326092,0.6221198156682027,0.8945492699181168,1.0,20/152,11.66%,ADCY5;ADCY1;LGR4;ADGRL1;LPAR1;GNAS;ADM;ABCA1;LPAR2;CACNA1D;GNAQ;ADRA1D;PTH2R;GRK5;PTGIR;GLP1R;PTGER1;ADRB3;AKAP12;ADGRB3
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.3182748377450322,-0.9176271249641504,0.5929978118161926,0.8262217026962531,1.0,7/23,24.17%,GAS6;NR1H4;LAPTM5;CD274;ZC3H12A;INHA;VSIR
prerank,brain morphogenesis (GO:0048854),-0.38568858228390757,-0.9172028042719972,0.5991735537190083,0.8265959248730933,1.0,1/12,0.48%,SHANK3
prerank,protein polyubiquitination (GO:0000209),0.22705127109637716,0.9170992693826797,0.6617647058823529,0.895664289019306,1.0,66/297,17.95%,SASH1;PRKN;PELI2;BCL2;SPSB1;UBE2E2;TRIM5;NEDD4;RNF213;FBXW4;DDB2;ANAPC13;RNF217;PSME4;PSMA2;FBXO44;UBE2L3;PSMA3;NPEPPS;UBR2;RNF152;SPOP;TTC3;TRIM56;RNF135;SIAH2;WWP2;AMFR;RNF216;RC3H2;UBE4A;FBXL17;NHLRC1;FBXO6;MDM2;PSMD8;ITCH;KBTBD7;SMURF2;PSMD3;RBBP6;FBXO4;FBXO38;RNF14;RNF20;FBXO11;CDC26;IFI27;UBE2V1;UBE2A;CHFR;BIRC2;TRIM62;PPIL2;SKP2;UBE2H;HECTD1;HERC6;TRIM69;ANAPC2;UBE2E1;NHLRC3;PELI3;DTX3L;UBE4B;FBXW10
prerank,cellular response to alcohol (GO:0097306),0.30166309540117675,0.9166836024339767,0.5721561969439728,0.8958963060062215,1.0,3/42,3.75%,ADCY5;ADCY1;GRAMD1C
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.30493386081044216,0.9164837193429186,0.5792079207920792,0.8955932895610254,1.0,3/46,3.54%,TCF7L2;ZIC1;NEDD4
prerank,glycoprotein metabolic process (GO:0009100),0.29083553012237884,0.9164268597744594,0.5711775043936731,0.8949820452684791,1.0,7/53,7.36%,ADAMTS9;LARGE1;PRKCSH;GAL3ST2;MAN1C1;FBXO44;GANC
prerank,positive regulation of integrin activation (GO:0033625),0.4017428476639682,0.916222639664788,0.549266247379455,0.8947123880490548,1.0,3/11,6.16%,CXCL13;FERMT1;CDH17
prerank,glycerophospholipid catabolic process (GO:0046475),-0.3103410773329405,-0.9157644235993029,0.6048387096774194,0.8292789853697808,1.0,6/27,15.14%,GPCPD1;SMPD4;GDPD1;GDPD3;PNPLA6;PLA2G4A
prerank,positive regulation of translational initiation (GO:0045948),0.3692669354837468,0.9156959558712722,0.5612648221343873,0.8951786411677063,1.0,6/18,16.40%,POLR2D;CDC123;YTHDF2;RPS6KB1;BOLL;LARP1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3161559376248158,0.9155711930910858,0.5784671532846716,0.8946905019747305,1.0,6/36,8.45%,AFDN;VAMP5;MACF1;OPTN;GGA2;BLZF1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.309743277278803,0.9155605963237112,0.5749128919860628,0.8939594679496315,1.0,5/41,7.56%,ITPR1;SLC8A3;SLC8A1;CACNA2D1;CCL19
prerank,cellular response to interleukin-6 (GO:0071354),-0.3089467791331105,-0.9146221073789271,0.5886214442013129,0.8312759092440226,1.0,13/26,24.71%,ST3GAL6;CBL;SBNO2;ST18;PTGIS;STAT3;SPI1;JAK1;CEBPA;RELA;STAT1;SELPLG;PTPRT
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.41639581960212846,0.9146120917102669,0.5551020408163265,0.8953710778098632,1.0,4/10,15.67%,KMT2A;RAPGEF3;SMARCB1;SMAD4
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.4003905134907033,0.9140711129037253,0.5560165975103735,0.8958526872645411,1.0,1/12,1.28%,BMP7
prerank,ovarian follicle development (GO:0001541),-0.36517529445844554,-0.9136403519388414,0.5816733067729084,0.8329603523203568,1.0,8/13,23.02%,SOD1;VEGFA;EIF2B5;EIF2B2;INHA;FOXL2;ANG;CEBPB
prerank,hexose metabolic process (GO:0019318),-0.2793379194497562,-0.9134253701154442,0.588495575221239,0.8328469455174436,1.0,15/39,30.91%,APOD;PPARD;HECTD4;HK1;FUCA2;ALDOA;ALDOC;GALT;AKR1A1;FUOM;SLC37A4;GALM;DCXR;GDPGP1;PMM1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.24211498842887041,-0.9130604402077493,0.6588541666666666,0.83311255448239,1.0,27/80,22.24%,MAP3K5;THBS1;GAS6;KLF4;NGF;CTSD;TNFSF10;NOD1;CD44;VEGFA;SOX7;NDUFA13;RPS6KA1;GPER1;REST;MT3;BCAP31;CARD16;RAF1;ARL6IP1;SOX2;FOXL2;AKT1;ACVR1C;CYCS;CDKN2D;CASP1
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.2997112185562861,-0.9129623536933622,0.6129032258064516,0.8327198669915253,1.0,8/29,22.30%,PABPC1;HNRNPU;YBX1;FUS;TENT5A;FMR1;SLC11A1;RBM24
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.31307988551388033,-0.9128712022737995,0.5867237687366167,0.8323421382928359,1.0,4/24,3.91%,ACVRL1;DACH1;RPS3;BMPR2
prerank,negative regulation of bone remodeling (GO:0046851),-0.3832204546238269,-0.9124460758099687,0.6041275797373359,0.8326858638250719,1.0,8/11,37.12%,UBASH3B;GPR137B;GPR137;GREM1;TNFAIP3;CALCA;P2RX7;TMEM119
prerank,ubiquinone biosynthetic process (GO:0006744),0.36911432395371613,0.9124415144851025,0.564755838641189,0.8988290960368686,1.0,5/15,11.44%,FDXR;COQ10A;NDUFA9;COQ8B;COQ6
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.2506096114731888,-0.9122805772021729,0.6266318537859008,0.8324708290347558,1.0,13/70,15.40%,TGFB2;DAB2IP;NGF;BLOC1S2;TGFB1;DCC;BCL2L1;GSK3B;TNFRSF1B;APPL1;CASP8AP2;FAS;CASP8
prerank,primary neural tube formation (GO:0014020),0.32967356345035775,0.9118226012366817,0.5695970695970696,0.8994845973788935,1.0,6/30,11.24%,LMO4;PRICKLE1;MTHFR;LRP2;COBL;IFT122
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3341856978020089,0.911604055700682,0.5597722960151803,0.8992084138272942,1.0,8/25,18.20%,PRPSAP2;AMPD3;ADSL;GMPS;SHMT1;ADK;APRT;GMPR2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.289016020481092,0.9113984918730149,0.5848056537102474,0.8989107195863646,1.0,5/56,4.81%,PLCB1;UBE2E2;ANXA1;RAD51B;RAD51C
prerank,monoacylglycerol metabolic process (GO:0046462),-0.3644662162968463,-0.9109222115540203,0.5697896749521989,0.8350079417110235,1.0,4/13,21.23%,MGLL;DGAT1;PLA2G4A;ABHD6
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.26803776447131245,-0.9109131838933414,0.6304347826086957,0.8344342639675246,1.0,17/49,28.42%,CAV1;SGMS1;RACK1;BCL2L1;RTKN2;NDUFA13;HERPUD1;BBC3;BCAP31;PLAUR;PINK1;NOC2L;BMF;BAX;URI1;FIS1;BID
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3675342788320951,0.9103528397342475,0.5918367346938775,0.9005328849389785,1.0,1/17,0.39%,ROCK2
prerank,cellular response to cAMP (GO:0071320),-0.2965653081157645,-0.9090512942559393,0.5911949685534591,0.8380151549775703,1.0,10/30,17.87%,RAP1A;IGFBP5;AHR;PDE2A;KCNQ1;ZFP36L1;SLC26A6;HCN1;CFTR;HCN2
prerank,response to purine-containing compound (GO:0014074),-0.3402806892257155,-0.9090212016097904,0.6181818181818182,0.837494306191175,1.0,10/17,34.88%,ABCC9;TRPC3;RYR2;VGF;DGKQ;STAT1;TRPM2;P2RY1;P2RX7;RYR1
prerank,RNA transport (GO:0050658),-0.24507621401794746,-0.9090146249837413,0.6213592233009708,0.8369097376312618,1.0,36/71,35.96%,RBFOX1;SRSF2;RFTN1;TGFBR2;SRSF1;YBX1;SRSF5;DDX39B;ZFP36L1;SRSF9;RBM8A;RNPS1;SRSF6;RTRAF;CKAP5;THOC3;MAGOH;FMR1;POM121;THOC6;EIF4E;THOC2;NUP153;EIF4A3;KIF5C;SRSF7;ALYREF;ATXN2;ZFP36;ZC3H11A;DHX38;U2AF1L4;CHTOP;HNRNPA1;SRSF3;NCBP2
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.26277006508445755,-0.9089365785035763,0.6357466063348416,0.8364826668899537,1.0,13/50,15.80%,PSMD13;PSMF1;OAZ1;PSMB10;PSMB6;AZIN1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.25965761883130345,-0.9089305166447079,0.6225961538461539,0.835907596297183,1.0,12/55,15.39%,CAV1;DAB2IP;RPS3;RACK1;TNFSF10;TPD52L1;BCL2L1;PAK2;GPER1;BBC3;FAS;BCAP31
prerank,positive regulation of lipid localization (GO:1905954),0.40813995539806225,0.9084531936228135,0.5699588477366255,0.904068556888419,1.0,5/11,22.07%,PLA2G10;IKBKE;PLIN5;HILPDA;NFKB1
prerank,P-body assembly (GO:0033962),-0.37202111896258117,-0.9082518943770718,0.5826923076923077,0.8368826847144837,1.0,7/12,35.30%,PATL1;LIMD1;EDC3;ATXN2;PATL2;DYNC1H1;RC3H1
prerank,regulation of receptor recycling (GO:0001919),-0.34458003983811797,-0.9081848803228532,0.5809128630705395,0.8364557495758767,1.0,4/16,10.75%,NSF;AP1AR;ECE1;LAMTOR1
prerank,negative regulation of cell cycle (GO:0045786),-0.24309403348647918,-0.9079859602373589,0.6508728179551122,0.8363069703341037,1.0,26/73,22.87%,PPP1R13B;RHOB;TGFB1;PDCD4;NR4A1;APC;CDK6;CDKN1B;BTG3;BMP2;HHEX;MEN1;GPER1;NLRP2B;BRINP2;DUSP1;ZBTB17;CAMK2N1;INHA;TFAP4;CHMP1A;BMP4;BTG1;GMNC;SIPA1;CEBPA
prerank,establishment of melanosome localization (GO:0032401),0.3596180578202858,0.9075260869508489,0.5981308411214953,0.905468243979069,1.0,5/19,14.65%,SHROOM2;ARL6;GPR143;BBS7;RAB11B
prerank,histone mRNA catabolic process (GO:0071044),0.376130146537491,0.9075204658462663,0.5823529411764706,0.9047305248700489,1.0,9/15,23.34%,TENT2;TUT1;DCP2;ERI1;TUT4;LSM1;XRN1;TUT7;EXOSC4
prerank,type I interferon signaling pathway (GO:0060337),0.3040590333460675,0.9074352593134213,0.5893805309734513,0.9034110963112958,1.0,5/41,5.33%,SP100;IFIT3;IFIT2;RNASEL;IRF8
prerank,cellular response to type I interferon (GO:0071357),0.3040590333460675,0.9074352593134213,0.5893805309734513,0.9034110963112958,1.0,5/41,5.33%,SP100;IFIT3;IFIT2;RNASEL;IRF8
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.2989134344278544,0.9073858864701299,0.6013864818024264,0.9027748851355722,1.0,4/40,5.48%,PID1;BCL2;SPART;LRRK2
prerank,regulation of ruffle assembly (GO:1900027),0.346832765549792,0.9072736955221314,0.5711538461538461,0.9022827531546752,1.0,1/23,0.20%,ARHGAP24
prerank,B cell homeostasis (GO:0001782),-0.4006623969938152,-0.9072191231996005,0.601113172541744,0.8374484899878178,1.0,6/10,22.29%,MEF2C;DOCK10;CAMLG;PPP2R3C;NCKAP1L;TNFAIP3
prerank,embryonic hemopoiesis (GO:0035162),-0.3816654680213906,-0.9069932582722436,0.6055226824457594,0.8373538574782957,1.0,5/12,11.47%,KITLG;KDR;TGFBR2;ATF4;TAL1
prerank,protein localization to lysosome (GO:0061462),-0.3043861481995866,-0.906918077570404,0.5921052631578947,0.836945998336975,1.0,15/28,30.21%,SH3BP4;SNX16;RTN4;HGS;CD81;NCOA4;M6PR;LAPTM5;ATP13A2;LAMTOR4;RAB7A;SCARB2;SORL1;RNF128;ZFYVE16
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.3320422100476024,0.9064834280032424,0.5719626168224299,0.9033339662052278,1.0,7/27,15.06%,PLA2G10;ETNK2;NAPEPLD;SLC27A1;PISD;CHKA;NAAA
prerank,regulation of telomere maintenance (GO:0032204),0.33799604152985774,0.906116779978444,0.6029411764705882,0.9034072836502801,1.0,11/26,22.11%,HDAC8;YLPM1;XRCC5;USP7;RTEL1;MRE11;PML;RAD50;NBN;TERF2;SMG1
prerank,regulation of JNK cascade (GO:0046328),0.262566563024245,0.9060670247154143,0.6410256410256411,0.9027731981270702,1.0,15/101,12.05%,TGFBR3;PRKN;MTURN;CCN2;PLCB1;MBIP;DUSP10;IGF1R;SH3RF1;CCL19;SIRPA;ITCH;SH3RF2;RAP2A;CYLD
prerank,neutral amino acid transport (GO:0015804),0.3351802263278697,0.9060123132291292,0.5930232558139535,0.9021589244892347,1.0,7/28,12.29%,SLC38A3;SLC6A9;LLGL2;SLC43A1;SLC1A5;SLC36A2;SLC38A2
prerank,nucleotide-excision repair (GO:0006289),-0.2294103189476126,-0.9046558540761965,0.6657223796033994,0.841333062868163,1.0,34/101,27.55%,ATXN3;UBB;UVSSA;COPS7A;RPS27A;UBC;PPIE;DDB1;RBX1;RPA1;OGG1;ERCC8;POLR2C;XAB2;UBA52;COPS8;POLR2G;POLK;POLA1;COPS6;CETN2;LIG4;POLE;POLD3;POLB;POLD1;GTF2H2;POLR2L;HMGN1;XPA;POLL;ERCC5;LIG3;RFC5
prerank,phospholipid dephosphorylation (GO:0046839),0.3031781797478269,0.9041966837158135,0.5768500948766604,0.9056091382844155,1.0,6/37,7.48%,PLPP3;MTMR3;SYNJ2;EPHX2;SGPP1;PTEN
prerank,rRNA transcription (GO:0009303),-0.34218598305740366,-0.9038747176553017,0.60546875,0.8424646380259071,1.0,8/17,23.04%,CAVIN1;BRF1;GTF3C1;SPIN1;ANG;SIRT7;GTF3C2;GTF3C4
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.4151053886038697,0.9038046422996321,0.5925925925925926,0.905817377648943,1.0,1/10,1.37%,PRKN
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.2814745074725123,-0.9033577124556847,0.6380090497737556,0.8430860874727666,1.0,20/35,40.80%,SMUG1;RPA1;OGG1;NEIL1;POLE;POLD3;POLB;NTHL1;POLD1;POLL;LIG3;RFC5;RPA3;FEN1;RPA2;XRCC1;RFC2;POLG;UNG;PCNA
prerank,cellular response to interleukin-7 (GO:0098761),-0.3376234289304869,-0.9032803652778238,0.5655577299412916,0.8420908933654867,1.0,11/17,34.94%,SOCS2;STAT3;CISH;JAK3;JAK1;SOCS1;CRLF2;IL2RG;TSLP;IL7;IL7R
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.3376234289304869,-0.9032803652778238,0.5655577299412916,0.8420908933654867,1.0,11/17,34.94%,SOCS2;STAT3;CISH;JAK3;JAK1;SOCS1;CRLF2;IL2RG;TSLP;IL7;IL7R
prerank,protein catabolic process (GO:0030163),0.2804750522092431,0.9031269919230163,0.5929054054054054,0.9065737983278511,1.0,13/59,14.74%,ADAMTS9;PRKN;CLPX;TPP1;FBXO44;LAMP2;SIAH2;FBXO6;CUL4B;NGLY1;RAB12;TRIM24;HTRA2
prerank,synaptic vesicle exocytosis (GO:0016079),0.30065227328956545,0.9029965791712757,0.6104129263913824,0.9061288868560821,1.0,1/40,0.06%,UNC13C
prerank,regulation of T cell proliferation (GO:0042129),-0.2527451458713539,-0.9023122112265113,0.6472081218274112,0.8436631551779586,1.0,14/61,23.85%,TFRC;SLC7A1;NCK1;PTPRC;TNFRSF21;TNFRSF1B;NCK2;CD274;IL15;JAK3;NCKAP1L;SDC4;CEBPB;CD80
prerank,regulation of phosphate metabolic process (GO:0019220),-0.34603521497622014,-0.9022171050858966,0.5817490494296578,0.843290657467309,1.0,7/16,28.31%,IKBKB;RAD17;SMG5;TIGAR;PSEN1;SMG6;BARD1
prerank,epithelial cell migration (GO:0010631),-0.27897394181296015,-0.9019185683219105,0.631578947368421,0.8433789955807829,1.0,16/37,24.36%,NOS3;FAP;PLXND1;PXN;KANK1;RHOA;DPP4;SCG2;CDH13;PKN3;CYP1B1;ADGRA2;PLEKHG5;PRKX;PTP4A3;STAT1
prerank,regulation of protein processing (GO:0070613),-0.32046059576833724,-0.901662111774026,0.6045548654244306,0.8433799297308754,1.0,3/21,5.68%,RUNX1;SERPINE2;NKD2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.34992045218705936,-0.9015909399226364,0.6,0.8429416283021063,1.0,10/15,44.58%,RYR2;SRPRB;SEC61G;ZFAND2B;SRP14;SPCS3;RAB10;SEC61A1;SPCS1;SRPRA
prerank,cardiac muscle cell differentiation (GO:0055007),-0.3262600504970792,-0.9013460301013375,0.5909090909090909,0.842898112217696,1.0,5/21,10.79%,MEF2C;CXADR;MYH11;VEGFA;BMP2
prerank,sphingoid metabolic process (GO:0046519),0.40452957312643356,0.9009509772726145,0.5815899581589958,0.9100544442370397,1.0,5/12,15.06%,PLPP3;SPHK1;SGPP1;PLPP2;NAAA
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3774947346632317,0.9004890564941596,0.5687103594080338,0.9103762493016124,1.0,5/14,16.87%,LHPP;ADSL;GMPS;ADK;PFAS
prerank,pentose-phosphate shunt (GO:0006098),0.3979222443326051,0.9003235282188485,0.5755102040816327,0.9099844863915614,1.0,4/11,11.22%,RPE;H6PD;RBKS;DERA
prerank,cGMP biosynthetic process (GO:0006182),-0.38860159768595137,-0.8995768858847508,0.585635359116022,0.846230990905721,1.0,2/10,4.49%,GUCY1B1;GUCY1A1
prerank,regulation of interferon-gamma production (GO:0032649),-0.24087052075228343,-0.899343941898914,0.6356382978723404,0.8461342613438255,1.0,24/71,30.53%,PDE4D;SLC7A5;GAS6;IL1R1;CYRIB;ISG15;HSPD1;CD47;NR1H4;LAPTM5;CD274;ZC3H12A;INHA;TRIM27;TXK;SLC11A1;CCR2;VSIR;IL12RB2;TLR7;TLR4;RASGRP1;FADD;ZFPM1
prerank,inhibitory synapse assembly (GO:1904862),-0.38274916927517477,-0.8993382070515897,0.6122448979591837,0.8455526524986143,1.0,6/11,43.50%,GABRB3;GABRG2;FGF13;GABRB2;LGI2;NPAS4
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.40322095713527584,0.8993269363313264,0.577639751552795,0.9114557138974382,1.0,2/10,4.71%,BMP7;ARHGAP12
prerank,response to cholesterol (GO:0070723),-0.33856636330669326,-0.8991984954153454,0.5988142292490118,0.845253737676833,1.0,4/17,9.08%,TGFBR2;TGFB1;PTCH1;GRAMD1A
prerank,cytosolic calcium ion transport (GO:0060401),0.3250617887100196,0.8991810343911187,0.5880281690140845,0.9110741308653109,1.0,6/28,10.46%,JPH1;SLC8A1;MAIP1;CACNA2D1;MCU;MICU1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.3611354597134218,-0.8990821264463924,0.6106719367588933,0.8449568064003738,1.0,5/13,25.17%,EPS8L2;EPS8;PLEKHM1;P2RY12;HRAS
prerank,negative regulation of protein transport (GO:0051224),-0.3042313601953957,-0.8990700802151381,0.6114649681528662,0.844390534855812,1.0,11/25,35.14%,CSK;RHBDF2;NDFIP2;RSAD2;CYP51A1;NDFIP1;SNX3;PPM1F;HMGCR;PKDCC;DRD3
prerank,hyaluronan catabolic process (GO:0030214),-0.3347062862862742,-0.8984568095551481,0.5748373101952278,0.8451892997719129,1.0,6/18,8.91%,TGFB1;CD44;CEMIP2;CHP1;HEXB;HEXA
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3858706136633293,0.8981960898148884,0.5887265135699373,0.9125338420243261,1.0,1/12,1.07%,PPARA
prerank,protein autoprocessing (GO:0016540),0.3641464153482744,0.8980056607360796,0.5777777777777777,0.912230798104903,1.0,4/17,14.90%,PCSK9;MYRFL;HTRA2;OMA1
prerank,GPI anchor biosynthetic process (GO:0006506),0.320367554695968,0.897903799767885,0.5942028985507246,0.9117135921980403,1.0,6/30,12.89%,PIGU;PIGG;PIGV;PIGX;PIGC;PIGQ
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.4009504078678268,0.8978350576820981,0.5747368421052632,0.9111007578794043,1.0,1/11,3.14%,NOS1AP
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.34004316122493994,-0.8978072415485995,0.6163265306122448,0.8460822069157047,1.0,4/17,10.40%,TMSB4X;KLF4;ARRB1;BCL3
prerank,regulation of actin filament-based movement (GO:1903115),0.4071297211481105,0.8977538058795334,0.5792811839323467,0.9105312016143399,1.0,2/10,3.96%,PDPN;ANK2
prerank,vesicle transport along microtubule (GO:0047496),-0.3111500888144696,-0.8974709779355265,0.6020408163265306,0.8462427606024012,1.0,10/23,32.71%,KIF1A;RAB1A;KIF13A;NDE1;BICDL1;KIF3B;HAP1;DYNC1I1;KIF5B;DYNC1H1
prerank,regulation of glycogen metabolic process (GO:0070873),0.3966534639996507,0.8974698030611358,0.561822125813449,0.910401961069937,1.0,2/12,10.38%,PPP1R3G;PPP1R3F
prerank,regulation of centriole replication (GO:0046599),0.3642508948668627,0.8973778625718133,0.5752032520325203,0.909872413505084,1.0,2/18,2.87%,SPICE1;ALMS1
prerank,regulation of phosphorylation (GO:0042325),-0.2205845424186842,-0.8973522816983489,0.7115384615384616,0.8458822382842993,1.0,36/120,22.01%,FN1;FNIP2;ITGA6;THBS1;PTK2;HSPB1;CORO1C;IKBKB;CCDC88A;APP;EMP2;ZBTB7A;SESN2;NLRC5;CDKN1B;OGT;KCTD20;RAD17;CADM4;NUP37;CCDC88C;MIF;NUP54;NUP85;PSEN1;INHA;PRKRIP1;NOP53;ANG;NUP133;BMP4;NCKAP1L;POM121;EIF6;CDKN1A;CDKN2D
prerank,maintenance of protein localization in organelle (GO:0072595),-0.32196589512074403,-0.8972574455057066,0.5973782771535581,0.8455120895154583,1.0,9/19,23.68%,HK1;HNRNPU;ARL2BP;HSPA5;BCL3;PINK1;AKT1;SKP1;CHCHD10
prerank,mitochondrial transport (GO:0006839),-0.26037262620678,-0.895789429430537,0.6746203904555315,0.8481806776591658,1.0,24/53,30.53%,HSP90AA1;FBXO7;TOMM20;BCL2L1;ABCB10;TOMM22;TMEM14C;TIMM9;TIMM10B;TIMM13;BCAP31;TIMM22;SLC25A4;TOMM7;MFN2;BCS1L;SPG7;FLVCR1;FIS1;TIMM44;TSPO;AIP;TOMM34;PMAIP1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.35231016556329836,-0.8957697819301929,0.5983935742971888,0.8476437107674355,1.0,8/14,31.30%,CPSF7;CPSF6;CPSF2;CSTF2T;CSTF2;ERN1;CPSF4L;CPSF1
prerank,regulation of RNA splicing (GO:0043484),-0.24127436307731398,-0.8955805217749258,0.6675257731958762,0.847480714280791,1.0,26/69,25.95%,MBNL1;AHNAK2;HNRNPK;AHNAK;QKI;LARP7;HNRNPH2;KHDRBS3;SRPK1;GRSF1;FUS;RPS26;TMBIM6;YTHDC1;HNRNPLL;PTBP1;RBM22;TRA2B;RBM20;FAM50A;FASTK;HNRNPF;MBNL2;ZPR1;PRX;ERN1
prerank,positive regulation of myelination (GO:0031643),0.3934404024416459,0.8953375626018679,0.6136363636363636,0.9135897498196117,1.0,4/11,13.78%,PARD3;ITGAX;CST7;DICER1
prerank,negative regulation of protein processing (GO:0010955),-0.3709370223183096,-0.8953310712257665,0.6374269005847953,0.8474282795336423,1.0,2/12,3.49%,THBS1;SERPINE2
prerank,secretory granule organization (GO:0033363),0.41032100283851963,0.895306954906233,0.5819672131147541,0.9129106312984022,1.0,3/10,10.95%,DTNBP1;ABCA1;F2RL3
prerank,negative regulation of interleukin-6 production (GO:0032715),0.33361672438957,0.8952681836163766,0.6048689138576779,0.9122599518685125,1.0,7/27,15.71%,C1QTNF3;SYT11;NLRC3;SIRPA;NLRP12;CX3CL1;CD200R1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.3878829300715367,-0.8938942824276174,0.625,0.8499972714872458,1.0,4/10,21.48%,FAS;MAP2K2;GREM1;MAPK3
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3420685412857484,0.8935583493135878,0.6051660516605166,0.9154393262832285,1.0,4/22,12.25%,AEBP1;AKAP13;ABL1;GBA2
prerank,cellular response to virus (GO:0098586),-0.2878374531326755,-0.8933068734247,0.6395604395604395,0.8506818455572033,1.0,12/30,26.70%,HSP90AA1;ARF1;CHUK;IFIH1;GBF1;ZC3H12A;EIF5A;FMR1;MAPK11;BAX;VWCE;CXCL10
prerank,axonal transport (GO:0098930),-0.27271202080089646,-0.8931610330802785,0.6152173913043478,0.8504156171237551,1.0,13/36,28.08%,AP3S1;BLOC1S2;SOD1;AP3M2;KIF1A;TMEM108;KIF3B;NEFL;DCTN1;KIF4A;HAP1;KIF1B;SNAPIN
prerank,negative regulation of immune system process (GO:0002683),0.36905074202699467,0.8927693961076745,0.5904572564612326,0.9164325586147295,1.0,4/16,9.75%,HOXA7;FCRLB;PDCD1;IL17D
prerank,phosphatidylserine metabolic process (GO:0006658),0.31155017449995887,0.8927486597662809,0.6220183486238532,0.9157334458926812,1.0,8/32,18.17%,OSBPL8;PLA2G10;SLC27A1;PLA2G4B;PLA2G12A;OSBPL10;ABHD12;ABHD16A
prerank,dephosphorylation (GO:0016311),0.2424288314648201,0.8922686862679963,0.6941529235382309,0.9160947165284314,1.0,17/147,7.48%,PTPN13;PXYLP1;PLPP3;LHPP;PPM1M;PTPN4;DUSP10;PPM1E;CDC14B;PTPRA;MTMR3;PTPN9;EPHX2;SGPP1;ACP3;PTPRD;PTEN
prerank,presynapse organization (GO:0099172),0.4130232643144761,0.8920825793450242,0.579175704989154,0.9157471169173627,1.0,1/10,2.23%,NLGN2
prerank,engulfment of apoptotic cell (GO:0043652),-0.3509792185067656,-0.89125513347074,0.6254826254826255,0.8539635793267688,1.0,2/15,1.92%,THBS1;RAC1
prerank,piRNA metabolic process (GO:0034587),0.3526567014194194,0.8909165041004956,0.616600790513834,0.9175467066277,1.0,19/19,64.78%,MYBL1;DDX4;PIWIL4;TDRD9;TDRD12;PIWIL2;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MAEL;FKBP6;EXD1;TDRKH;TEX15
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.34050005061678396,-0.8908696892929795,0.6139630390143738,0.8541972017594582,1.0,9/16,33.54%,SMCHD1;UBQLN4;POLQ;SHLD3;RMI2;CGAS;RIF1;SHLD2;HELB
prerank,lysosome organization (GO:0007040),0.3056521531432676,0.8908111918275826,0.6193078324225865,0.9170516310605958,1.0,6/36,6.91%,HOOK2;ABCA1;TPP1;LRRK2;ACP3;ATP10B
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.39535071995357063,0.8902080666668495,0.6122881355932204,0.9176931221852554,1.0,1/11,1.07%,PPARA
prerank,chromosome organization (GO:0051276),0.2555945131114362,0.8901473987055245,0.6634304207119741,0.9170902352781453,1.0,16/99,12.77%,TCF7L2;SATB1;TOP2B;HDAC8;DDB2;SOX1;MTHFR;SETD7;TCF7L1;MTF2;AXIN2;LATS1;ABL1;HDAC1;CUL4B;EZH1
prerank,positive regulation of lyase activity (GO:0051349),-0.34890801394118953,-0.8895019438915215,0.6052631578947368,0.8565730940185664,1.0,6/14,17.03%,NOS3;ISCU;CACNA1C;NOS1;NF1;ORAI1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3038334186121433,0.8892456177911754,0.6143667296786389,0.9183584043741798,1.0,7/38,14.27%,RORA;CACTIN;NLRC3;TLE1;MAPKBP1;NLRP12;NLRX1
prerank,mRNA 3'-end processing (GO:0031124),-0.23490343575425227,-0.8892254731695705,0.6616541353383458,0.8565579225998814,1.0,38/78,34.16%,SRSF2;PABPC1;SRSF1;APP;CPSF7;SRSF5;DDX39B;CPSF3;SRSF9;CPSF6;RBM8A;RNPS1;SRSF6;GRSF1;SYMPK;AHCYL1;CLP1;CPSF2;CSTF2T;PCF11;CSTF2;THOC3;MAGOH;THOC6;THOC2;EIF4A3;LSM11;SRSF7;ALYREF;CSTF1;CPSF4L;TENT4B;CPSF1;ZC3H11A;MTPAP;DHX38;U2AF1L4;CHTOP
prerank,regulation of trophoblast cell migration (GO:1901163),-0.3473471927350084,-0.8882056864883914,0.611764705882353,0.858168550917824,1.0,4/14,11.27%,ARHGDIB;CALR;VEGFA;YTHDF3
prerank,regulation of cellular protein localization (GO:1903827),-0.26421556647164784,-0.8878557613475019,0.6762114537444934,0.85835846847055,1.0,20/45,30.79%,HSP90AA1;HSP90AB1;CTNNB1;SPIDR;RALB;PTPN1;GPC1;RAB11FIP5;CCDC66;ATP13A2;GBF1;SUMO3;ABCA2;VCP;MAP1A;PPM1F;TRIM67;LCP1;EGF;SHH
prerank,regulation of humoral immune response (GO:0002920),0.2968562605128086,0.8876482503674042,0.6138433515482696,0.921141751324626,1.0,7/44,11.25%,PROS1;CXCL13;C2;CFH;VTN;C8B;C8G
prerank,development of primary male sexual characteristics (GO:0046546),0.3088741595949225,0.8874937326443207,0.5916515426497277,0.9207108528643719,1.0,3/34,5.73%,WNT4;KIT;LRP2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.32617048819659095,0.8874450930636391,0.6036363636363636,0.9200599773040977,1.0,1/25,0.34%,LEPROT
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.3373227919672931,-0.8873478886686152,0.61,0.8589308577690153,1.0,3/17,7.65%,FERMT2;PTPRC;HNRNPU
prerank,mitochondrial gene expression (GO:0140053),-0.2676034710775606,-0.8870884605072678,0.6769596199524941,0.858899449999536,1.0,10/42,25.00%,LARS2;TFB2M;NDUFA7;MRPS14;MRPS16;MRPL23;MRPS28;MRPS2;MRPS11;MRPL57
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3379739770051129,0.8870497546390426,0.5869120654396728,0.9201497737428188,1.0,3/21,8.73%,RAD51B;RAD51C;CDK1
prerank,negative regulation of cation channel activity (GO:2001258),0.33170651417741676,0.8868532484221133,0.5900383141762452,0.9198542312485543,1.0,8/26,19.43%,SLC6A9;GSTM2;MMP9;GNB5;PKD2;DRD2;GPR35;EPHB2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3334720953344314,-0.8865043077614022,0.6237623762376238,0.8595346345894103,1.0,6/18,14.23%,SHANK3;PTK2B;CACNG3;NRXN1;RELN;CACNG2
prerank,signal transduction in response to DNA damage (GO:0042770),-0.25909194050987183,-0.8863728290905192,0.7060301507537688,0.8592302577670045,1.0,17/49,30.01%,ACER2;TIPRL;CHEK2;SESN2;BCL3;DONSON;RAD17;USP28;RAD9A;ATR;GADD45A;DOT1L;E2F7;CHEK1;BID;USP10;NDRG1
prerank,osteoclast differentiation (GO:0030316),-0.3095101050629915,-0.8861330501409512,0.6303418803418803,0.8591317608408371,1.0,3/22,6.66%,FOXP1;SBNO2;TNFRSF11A
prerank,negative regulation of ion transport (GO:0043271),0.332101103486506,0.885961099241668,0.5938144329896907,0.9210666199007074,1.0,3/24,4.13%,WNK4;NEDD4;SYT11
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3135899176474712,0.8857240907408986,0.6188747731397459,0.9208341805107407,1.0,4/32,6.79%,AUTS2;AVIL;ABI2;ENPP2
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3448164912200657,0.8855146640616324,0.6137339055793991,0.9205526290028795,1.0,6/18,17.82%,PRKN;NOL3;NME5;NONO;HTRA2;TRAP1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3692434374188395,-0.8855085328621108,0.6037735849056604,0.8599085054661485,1.0,5/12,32.53%,GCLM;GGT1;CHAC2;MGST2;OPLAH
prerank,regulation of cation transmembrane transport (GO:1904062),0.318344227822314,0.8853131476086122,0.6153846153846154,0.9202497170696003,1.0,4/29,6.48%,KCNIP3;SNTA1;CACNA1D;DLG1
prerank,regulation of hemopoiesis (GO:1903706),-0.3732085139592266,-0.8850747492351062,0.6139359698681732,0.8602753625209224,1.0,2/10,2.22%,RUNX1;CBFB
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.23399573357195338,-0.884449839683676,0.7154471544715447,0.8610610044799822,1.0,32/80,29.31%,NSF;COPG1;ARF5;KIF26A;TMED2;LMAN2;RAB1A;BNIP1;PICK1;ARFGAP2;TMED10;TMED3;GBF1;SCYL1;TAPBP;KIF3B;PITPNB;RAB1B;KIF11;KIF15;TMEM115;TMED7;KIF4A;RAB6B;USE1;KLC2;KDELR3;COPA;KLC1;ARF3;KIF23;DNAJC28
prerank,monocyte chemotaxis (GO:0002548),0.31134254561193986,0.8842107252877787,0.6069469835466179,0.9218894662474194,1.0,5/32,10.07%,ANXA1;IL6;FOLR2;CCL19;CCL4
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.3237161488053517,-0.8831170856003328,0.6398390342052314,0.8633857420078638,1.0,2/18,3.32%,FTH1;DAB2IP
prerank,positive regulation of cellular respiration (GO:1901857),-0.3697799515842073,-0.8829684707152367,0.615819209039548,0.8631252210600416,1.0,8/11,40.37%,ISCU;PINK1;VCP;IFNAR1;PRELID1;PARK7;IFNLR1;IL4
prerank,microtubule polymerization (GO:0046785),0.31339026669458875,0.8827352056146436,0.6150793650793651,0.9243810761388571,1.0,10/29,20.29%,CCDC57;TUBGCP6;GOLGA2;TUBGCP2;RANBP9;TUBG1;AKAP9;TPX2;MAP7D3;CENPJ
prerank,nuclear export (GO:0051168),0.2639429748143443,0.8822117217681799,0.6632478632478632,0.9248084836103607,1.0,3/80,1.73%,RANBP3L;ATXN1;PHAX
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3485815341472383,-0.881955456253021,0.6411214953271028,0.8647096590211973,1.0,7/14,38.65%,TFRC;KMT5C;SHLD3;RIF1;SHLD2;KMT5B;CD226
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.27215938696137315,-0.8818732633962352,0.6666666666666666,0.8643030813102692,1.0,13/38,23.22%,PTPRJ;PPP2R5C;RACK1;PLEKHA1;XDH;GPER1;OTUD3;SH2B3;ARRB2;NOP53;AKT1;HYAL2;TRIB3
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.36229602113764875,-0.8817623530414069,0.6282527881040892,0.8639391520000411,1.0,6/12,34.75%,MCM4;GINS4;MCM5;MCM6;GINS2;CDC7
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.26318967520011205,-0.881755481454573,0.6867749419953596,0.8633684668080702,1.0,11/44,17.34%,THBS1;GAS6;KLF4;NGF;CD44;VEGFA;RPS6KA1;MT3;CARD16;RAF1;ARL6IP1
prerank,lipid droplet formation (GO:0140042),-0.38619416211598084,-0.881464708268708,0.6414342629482072,0.863409199717596,1.0,3/10,17.36%,CDS1;BSCL2;AUP1
prerank,negative regulation of cholesterol transport (GO:0032375),0.39349787300289274,0.8812807312423852,0.5773420479302832,0.9261086276282983,1.0,2/10,9.15%,PLA2G10;APOC1
prerank,endochondral bone morphogenesis (GO:0060350),-0.37048000652610086,-0.880853685252786,0.6318681318681318,0.864134178746321,1.0,2/11,3.91%,MEF2C;BMPR2
prerank,positive regulation of telomere maintenance (GO:0032206),-0.28633676997835183,-0.8805753669844578,0.6453744493392071,0.8641354093736034,1.0,4/31,10.52%,NEK7;GNL3;PPP1R10;MAP2K7
prerank,positive regulation of T cell activation (GO:0050870),-0.24253669730763763,-0.880297837592373,0.706766917293233,0.8641236726408833,1.0,17/62,24.03%,TFRC;SLC7A1;NCK1;PTPRC;CYRIB;XBP1;NCK2;HSPD1;CD81;CD47;CD274;IL15;JAK3;THY1;NCKAP1L;CD80;CCR2
prerank,positive regulation of transport (GO:0051050),-0.23135670418277482,-0.8801438338001767,0.7142857142857143,0.8638695828756429,1.0,37/85,29.77%,ACTB;GAS6;NEDD4L;RAB27A;GATA2;CALR;DOCK2;GSK3B;CHP1;HIP1R;C2CD5;LMAN2;CD47;SGK1;ACSL3;IL15;FMR1;NUMA1;SLC11A1;MLC1;NR1H3;DLL1;SPAG5;PLAA;CAPN10;FCGR2B;CHCHD10;BAX;SYNGR3;CHRM1;DOC2B;TREM2;BID;IL2RG;ABCA7;TUB;AHSG
prerank,actin crosslink formation (GO:0051764),0.3829718307601072,0.8800721473348807,0.5786163522012578,0.9280440203424078,1.0,3/12,6.46%,DPYSL3;BAIAP2;BAIAP2L2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.281372680043251,0.8800709891921114,0.6636851520572451,0.9272987279174187,1.0,13/51,15.67%,FBN1;SMAD6;SPART;LRP2;NBL1;CHRDL1;FSTL3;LEMD3;SMURF2;BMPR1A;FSTL1;SKI;SMAD4
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.3266688928888659,-0.8796451689443755,0.6338582677165354,0.8643470208923936,1.0,9/18,31.56%,APOD;GSK3B;CHP1;MDFIC;CTNNA1;OTUD7B;CABP1;SIN3A;MFHAS1
prerank,generation of neurons (GO:0048699),0.2326266779454892,0.8796053391663613,0.7119113573407202,0.9275770781547517,1.0,21/190,10.68%,DCDC2;AUTS2;WNT4;WNT6;ASCL2;IL1RAPL1;NDNF;PCSK9;ARTN;SDCCAG8;SH3RF1;PTPRD;WNT5B;EN1;RYK;YTHDF2;PAFAH1B1;TUBGCP2;IRX1;ATOH8;NEUROD2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.30723074418625773,0.8795555725700184,0.6252129471890971,0.9269308952166107,1.0,6/37,9.75%,APPL2;PPARA;IL6;NLRC3;SIRPA;IL17D
prerank,neutrophil chemotaxis (GO:0030593),-0.2517676714224483,-0.8791415892311849,0.6982097186700768,0.864804019109399,1.0,7/53,10.16%,BSG;TGFB2;PPIA;CXADR;EDN1;PPIB;PIK3CD
prerank,cell differentiation in hindbrain (GO:0021533),-0.37083528397696297,-0.8787037873714433,0.6441605839416058,0.8651736855620841,1.0,7/11,40.73%,KNDC1;GRID2;AGTPBP1;FAIM2;NOG;PROX1;OPHN1
prerank,proton transmembrane transport (GO:1902600),0.30046749966354447,0.8783709268410976,0.6104129263913824,0.9288298213482459,1.0,5/36,13.19%,ATP1A2;ATP6V0D1;ATP6V0E1;SLC36A2;DMAC2L
prerank,focal adhesion assembly (GO:0048041),-0.31537176507511383,-0.8774767582156799,0.652542372881356,0.8671261225427415,1.0,7/21,15.08%,THSD1;ACTN1;FERMT2;BCR;PEAK1;WHAMM;RCC2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.37214595640798254,0.8771687099748887,0.5876494023904383,0.9307502301978655,1.0,3/13,12.86%,ARID1B;ZMIZ1;ZMIZ2
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.22126821175160125,-0.8771593171881383,0.7374631268436578,0.8671929156402552,1.0,28/112,20.22%,PTPRJ;FOXP1;IL33;CD34;THBS1;GAS6;PLCG2;LBP;HSPB1;PTPRC;APP;STAT3;OAS2;ARHGEF2;CLU;IRAK3;IFNGR1;CD47;NR1H4;IFIH1;CX3CR1;MIF;ZC3H12A;PSEN1;TIRAP;TRIM27;TYROBP;FRMD8
prerank,endomembrane system organization (GO:0010256),-0.20545996320140097,-0.8768293735147992,0.7810457516339869,0.8673575367453982,1.0,61/178,28.37%,SPTBN1;ATP8B1;SYNE1;REEP3;CAV2;REEP5;LYSMD3;CHMP2B;VMP1;TMED5;ALS2CL;SMPD4;LEMD2;TMED2;SRGN;DYSF;TOR1B;LMAN2;LAMTOR1;USP50;RAB1A;NSFL1C;DNM1;VPS18;BNIP1;LMAN2L;TMED10;TMED3;HOOK1;ATL2;TLCD2;PRKD1;TRIP11;GBF1;VPS11;SEC16B;USP8;VPS51;SUN1;SPTSSB;ANK3;CTDNEP1;VAPA;EXOC8;CLASP2;TMED7;HUWE1;OTOF;SYP;RAB2A;SEC16A;SYNGR2;ANXA8L1;ANXA8;PI4K2B;RNF112;FBXW8;SEC31A;ATL3;RNF26;VPS33B
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.37347323932691856,0.8767921230106086,0.6021739130434782,0.9308526611901701,1.0,1/14,1.07%,PPARA
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.23132451782492064,-0.876712970252531,0.7253012048192771,0.8670212947430002,1.0,13/88,9.47%,CST3;DAB2IP;SERPINE2;RPS3;RACK1;CALR;IGFBP5;TOB1;BAG6;GAPDH;YBX1;EDN1;DNAJC1
prerank,positive regulation of ATPase activity (GO:0032781),0.29911682126197925,0.8766770469943943,0.6142857142857143,0.9303290789031589,1.0,3/41,2.80%,TPM1;ATP1B3;TNNT2
prerank,glucose import (GO:0046323),-0.3598727749184402,-0.8764961383738484,0.6452905811623246,0.8668932092504161,1.0,2/13,9.10%,SLC2A1;ZDHHC7
prerank,cellular response to DNA damage stimulus (GO:0006974),0.217709842352355,0.8764893653910494,0.776332899869961,0.9300035093470415,1.0,77/336,17.77%,STXBP4;BCL2;FANCA;UBE2E2;RAD51B;ATRIP;ASH2L;MAP2K6;BAZ1B;DDB2;PLK5;RAD51C;CTLA4;MRNIP;UFL1;INIP;PDS5B;PSME4;SETD7;PARP4;XRCC5;SLF1;BLM;NEK4;WDR48;CDK1;CHCHD6;UVRAG;BCL2L2;FBXO6;IRF3;UBA7;MBD4;PDS5A;ABL1;PRKDC;EPHA2;RTEL1;RBBP6;ZBTB38;IKBKE;MAPKAPK2;CUL4B;CRY1;LIG1;INO80;BOD1L1;MRE11;USP45;CIB1;FANCF;APEX1;BATF;MNAT1;CEP63;UBE2A;HTRA2;BABAM2;WRN;FANCC;BRSK1;RAD18;RAD51;LYN;NIPBL;PML;PHF1;MACROD1;ZDHHC16;REXO4;BACH1;TAOK3;RPAIN;TRRAP;XPC;DTX3L;TAOK2
prerank,mitochondrial translational termination (GO:0070126),-0.22646719952610242,-0.8764648776763523,0.7162162162162162,0.8663759340563822,1.0,28/88,29.09%,MRRF;MRPL32;MRPL33;MRPS14;MRPL38;ERAL1;MRPS16;MRPL50;MRPS5;MRPL23;MRPL24;MRPS35;MRPS28;MRPL13;MRPL35;MTRF1L;MRPL34;MRPS23;MRPS2;MRPS11;MRPS27;MRPL57;MRPL11;MRPS18C;MRPL18;MRPL14;AURKAIP1;CHCHD1
prerank,positive regulation of signaling (GO:0023056),-0.26562694581599544,-0.8760602637487789,0.6536796536796536,0.8666776801009379,1.0,16/37,29.52%,NSF;HOMER1;CLSTN2;EDN1;ECE1;KCTD13;PTPN23;CLSTN3;INPP5F;GRIK2;SOX11;CD80;VAMP3;CLSTN1;RIMS2;SYT1
prerank,negative regulation of coagulation (GO:0050819),0.367532400249345,0.8759956673319336,0.5970464135021097,0.9303299141451963,1.0,4/14,12.57%,TFPI;VTN;APOH;SERPINE1
prerank,protein localization to vacuole (GO:0072665),-0.3591974398732599,-0.8755863280592103,0.6528599605522682,0.8670940041155099,1.0,5/13,16.19%,SH3BP4;SH3GLB1;RTN4;CD81;ATP13A2
prerank,regulation of exit from mitosis (GO:0007096),-0.27410540994716814,-0.875508077173954,0.6808510638297872,0.8666721403544864,1.0,13/38,28.25%,UBB;BUB3;RPS27A;UBC;ANAPC16;UBA52;BUB1B;UBE2D1;ANAPC7;RGCC;KNTC1;CDC14A;MAD2L1BP
prerank,DNA-dependent DNA replication (GO:0006261),-0.21340918427286912,-0.875218037031802,0.7771428571428571,0.8666837299835224,1.0,58/128,36.86%,UBB;REV3L;RPS27A;UBC;WRNIP1;PSMD13;PSMF1;PSMB10;PSMB6;RPA1;PSME3;PSMB5;PSMC3;MCM4;PSMD12;PSMB8;TOPBP1;PSME1;UBA52;PSMB3;WDHD1;PRIM1;MCM8;POLA1;CDK2;POLE4;RECQL;PSMD5;POLE;POLD3;POLB;SIRT7;POLD1;PSMD9;PSMB4;GINS4;MCM5;PSMD10;MCM10;RFC5;POLE3;ORC1;TWNK;RPA3;MCM6;PSMA7;GMNN;DNA2;CDC6;GINS2;HELB;RPA2;CDC7;PSMC5;PSMC1;PSMC4;RFC2;CDC34
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.3136930166969189,-0.8750133746634757,0.616,0.8665254385988095,1.0,7/20,23.77%,HSP90AA1;CDC37;BIRC3;OGT;CASP8;PELI1;PDCD6IP
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.32938787994993823,0.8749718664568087,0.6232179226069247,0.931822594193094,1.0,4/24,7.80%,JARID2;RBBP4;RBBP7;MTF2
prerank,regulation of receptor internalization (GO:0002090),-0.27921162993300974,-0.8747558188549609,0.6752136752136753,0.8664616668967718,1.0,15/35,21.01%,SFRP4;RIN3;ARRB1;ARF1;VEGFA;CD63;ANKRD13A;PICK1;MKLN1;GREM1;ANKRD13B;ARRB2;INSR;FMR1;ATAD1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.23865223899313903,-0.8746117237832901,0.7004950495049505,0.8661785852155129,1.0,31/72,36.62%,UBB;RPS27A;UBC;DDB1;RBX1;RPA1;OGG1;UBA52;POLK;RNASE4;ZC3H12A;EDC3;POLD3;POLD1;GTF2H2;EDC4;XPA;ERCC5;RFC5;ERCC3;PNRC2;GTF2H5;RPA3;ISG20;DNA2;FEN1;RPA2;MEI4;DCP1A;RFC2;DNASE1L1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.304576851336921,0.8735573983062145,0.6496350364963503,0.9342217519989983,1.0,6/30,12.50%,DAB2;KLK2;NCOA2;HDAC1;RNF14;AR
prerank,high-density lipoprotein particle assembly (GO:0034380),0.3999140625788674,0.8735245229585474,0.6225596529284165,0.9335576926663175,1.0,2/10,13.55%,ABCA1;PRKACB
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.37369391073642716,0.8731480738945078,0.621676891615542,0.9336444159633795,1.0,5/13,16.02%,ATG10;UBA7;UBA3;DESI1;DESI2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.20935458782824115,0.8727669919282193,0.820125786163522,0.9337510544360798,1.0,76/497,14.05%,TCF7L2;WNT4;RBPJ;NR2F2;BMP7;IGF2BP1;DAPK1;ATXN1;SNX6;DKK3;ARID5B;RUNX1T1;PRDM5;ZEB1;ZIC2;NR1I2;PLCB1;LOXL3;TSHZ3;JARID2;MIDEAS;VGLL4;PRICKLE1;HOXA7;FOXD1;ZHX2;CBY1;BEND5;L3MBTL2;ARID4A;IKZF4;DPF2;GLI3;SFMBT1;NIBAN2;BCOR;TYMS;SALL1;XRCC5;BIRC5;WWP2;RSF1;ZMYND15;TLE1;KAT8;KAT6B;MDM2;MBTD1;SAMD4A;SMURF2;PDS5A;SCMH1;L3MBTL3;ATOH8;HDAC1;TFAP2A;SMARCE1;TFAP2B;FXR1;ZNF568;ZBTB38;MYB;CRY1;SOX13;CBFA2T2;PSPC1;SHMT1;TSPYL2;NONO;FOXK2;SCML4;TFDP2;CLOCK;ZNF148;KDM5C;CDKN1C
prerank,regulation of T cell activation (GO:0050863),-0.26199860786580237,-0.8727449210372058,0.6637362637362637,0.8694904993447792,1.0,24/42,43.82%,TNFRSF1B;CYRIB;DUSP3;HSPD1;CD47;LAPTM5;JAK3;THY1;METTL3;CCR2;CCL2;LAX1;IL4I1;PTPN22;GPNMB;PRELID1;CCL5;KAT2A;VTCN1;CRTAM;LCK;CCDC88B;TNFSF11;TNFSF9
prerank,mitochondrial membrane organization (GO:0007006),0.306715752978458,0.8726062938549963,0.6280373831775701,0.9333701895647761,1.0,7/32,11.49%,BCL2;SLC25A31;BNIP3;MAIP1;CHCHD6;MTX1;MTX2
prerank,negative regulation of biosynthetic process (GO:0009890),0.35415579825588206,0.8724009066017295,0.6094674556213018,0.9330893211970004,1.0,5/16,17.82%,PPARA;IL6;SLC30A10;ABCB7;TRAP1
prerank,negative regulation of T cell differentiation (GO:0045581),0.40027606030688295,0.8723893622023481,0.5925925925925926,0.932374495364003,1.0,3/10,13.31%,CTLA4;GLI3;LAG3
prerank,response to organic cyclic compound (GO:0014070),0.28177305594856705,0.8720838399500995,0.6557093425605537,0.9322669149835857,1.0,6/52,7.77%,FGFR4;IL18;ANXA1;STAT5B;LRRK2;STRN3
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.29273053280365013,-0.8717511172675123,0.6666666666666666,0.8709999717749705,1.0,8/27,14.55%,CSGALNACT1;CSPG4;BGN;CHST9;CHST11;XYLT1;VCAN;CHSY3
prerank,N-terminal protein amino acid modification (GO:0031365),0.36838907757882594,0.8717102851160408,0.5753968253968254,0.9323485419959027,1.0,3/14,12.99%,AANAT;NAA35;NAA60
prerank,digestive tract morphogenesis (GO:0048546),0.3714586465009791,0.8715854442873994,0.6245210727969349,0.93189046378122,1.0,3/14,10.11%,FGFR2;PDGFRA;BBS7
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.3232306203238732,-0.8715642150209977,0.6385542168674698,0.8708031908692474,1.0,4/17,12.45%,SLIT2;SFRP4;TMEM204;CASK
prerank,regulation of interleukin-17 production (GO:0032660),0.3067491367640001,0.8709544191770247,0.6282271944922547,0.9325555660716479,1.0,4/31,8.61%,IL18;SPHK1;IL6;SLAMF6
prerank,actin filament network formation (GO:0051639),-0.3615109316700118,-0.870766947998088,0.6453382084095064,0.8719300343706603,1.0,5/11,16.30%,CARMIL1;ACTN1;PLS3;FHOD3;SPIRE1
prerank,plasma membrane organization (GO:0007009),-0.24310076203836856,-0.8704153823366019,0.6864197530864198,0.8720484820091541,1.0,13/61,16.27%,SPTBN1;AHNAK2;NSF;FNBP1L;PACSIN2;CAVIN2;MYH9;DYSF;BIN1;WHAMM;ABCD2;TLCD2;STX2
prerank,pinocytosis (GO:0006907),-0.38306510268701033,-0.8699553349693085,0.651031894934334,0.8724363429016322,1.0,2/10,5.70%,CARMIL1;DOCK2
prerank,camera-type eye morphogenesis (GO:0048593),0.3961506999557709,0.8694278169053833,0.6323851203501094,0.9351553185913571,1.0,4/10,15.56%,SHROOM2;KDM2B;IFT122;SKI
prerank,defense response to bacterium (GO:0042742),0.251100853727171,0.8693254971184292,0.7138364779874213,0.9346477545073483,1.0,13/105,12.82%,COLEC12;GSDMA;LTF;CXCL13;SLAMF8;ANXA3;IL6;OPTN;GSDMD;PGLYRP3;MR1;SERPINE1;S100A9
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.30542488785082195,-0.8687042821910981,0.6194690265486725,0.8744813029821894,1.0,10/22,26.69%,CALM1;ATP1B1;VMP1;RYR2;CALM2;STAC3;JPH2;CALM3;HAP1;CASQ1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.2737778207377256,-0.8685097953430313,0.6938325991189427,0.874296343976472,1.0,9/33,21.04%,HSP90AA1;HSP90AB1;PINX1;RPA1;TERF2IP;TNKS1BP1;ANKRD28;CDK2;NHP2
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.2801752619733235,-0.8682237728216372,0.6689814814814815,0.8742735007388686,1.0,9/28,26.33%,SH3KBP1;CYRIB;HSPD1;CD47;TYROBP;THY1;NCKAP1L;CCR2;CCL2
prerank,respiratory electron transport chain (GO:0022904),-0.3439708798242285,-0.8681977083161788,0.6704545454545454,0.8737444418086827,1.0,3/14,10.86%,PPARGC1A;NDUFA5;GPD2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.2843259823479064,-0.8681512903444701,0.6703296703296703,0.8732557559222902,1.0,6/29,13.90%,CAV1;THBS1;TNFSF10;PAK2;GPER1;RET
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.3016800120146225,-0.8676684662337658,0.6756756756756757,0.873642746824011,1.0,10/23,25.31%,SYNJ1;MTM1;MTMR6;MTMR9;SACM1L;MTMR12;INPP5F;PIP4P2;MTMR1;TPTE
prerank,response to growth factor (GO:0070848),-0.26240212221191067,-0.8676428414351034,0.7133479212253829,0.8731166662241139,1.0,13/41,21.92%,ACVRL1;KLF4;RACK1;BMPR2;TGFBR2;CTNNB1;CPNE3;NOS1;ACVR1;SOX2;AKT1;ACVR1C;HDAC6
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.37032433856489944,0.867598428289486,0.6016427104722792,0.9376552813872637,1.0,3/12,9.66%,CDC14B;PTEN;GOLGA2
prerank,replication fork processing (GO:0031297),0.3005207247380573,0.8675513888526519,0.6503496503496503,0.9370166215432421,1.0,15/38,23.29%,BLM;BRCA2;ZGRF1;RTEL1;BOD1L1;PRIMPOL;MRE11;CENPX;WRN;RAD51;CDK9;SAMHD1;ETAA1;SMARCAL1;THOC1
prerank,regulation of presynapse assembly (GO:1905606),0.3450181718701947,0.8674176576199458,0.6412213740458015,0.9358231284188686,1.0,6/18,18.24%,GPC6;IL1RAPL1;PTPRD;GPC4;VPS35;SNCA
prerank,regulation of presynapse organization (GO:0099174),0.3450181718701947,0.8674176576199458,0.6412213740458015,0.9358231284188686,1.0,6/18,18.24%,GPC6;IL1RAPL1;PTPRD;GPC4;VPS35;SNCA
prerank,positive regulation of nervous system process (GO:0031646),0.3381634186602755,0.8672111222922342,0.6457925636007827,0.9355266911112573,1.0,3/18,3.91%,NLGN2;PARD3;ITGAX
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.30140652455016786,0.8671178221566403,0.6142857142857143,0.9349787649145261,1.0,9/35,16.28%,ACSS3;HMGCL;BDH1;GCDH;PAM;BDH2;AWAT2;HMGCLL1;HMGCS2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.36496532413434574,-0.8669838720221223,0.6613861386138614,0.8738938523914506,1.0,7/11,33.00%,BAG6;DERL1;AUP1;RNF5;VCP;UGGT1;RNF185
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.24937359686288796,-0.86671366815011,0.7095238095238096,0.8738780870295013,1.0,13/53,15.80%,PSMD13;PSMF1;OAZ1;PSMB10;PSMB6;AZIN1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3
prerank,regulation of cholesterol storage (GO:0010885),-0.3411307754272044,-0.8666168126793887,0.6761133603238867,0.8734938752595841,1.0,11/15,30.27%,SCARB1;PPARD;SREBF2;EHD1;NR1H2;ABCG1;NR1H3;TTC39B;TREM2;LPL;PPARG
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.2524002370498285,-0.8665599848380976,0.7139364303178484,0.8730199841717352,1.0,18/50,24.60%,ACTN4;RPS3;NOD1;LIMS1;PDCD4;APP;RHOA;RTKN2;IFI35;TERF2IP;LAPTM5;NR3C2;IRAK1;PTP4A3;RELA;AGER;LRRC19;TRIM44
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.2714746174905003,-0.8664797684315544,0.6993318485523385,0.8726070611117315,1.0,16/39,23.89%,RAB3C;MIA2;TANGO6;COPG1;OLFM2;RAB3B;SCG2;CANX;TMEM167A;MTTP;PREB;TVP23A;RAB8A;NECAB3;RAB8B;RAB3A
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.35036185836700234,0.8662029787987431,0.6097560975609756,0.9361840984446107,1.0,8/16,20.56%,BLM;SSBP1;WRN;MCM2;RAD51;PURA;MCM7;RECQL5
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.3390142482059145,0.8660106756938238,0.6390532544378699,0.935837905283242,1.0,4/19,16.26%,CHRNE;SLC5A7;NQO1;CHRNB2
prerank,melanosome localization (GO:0032400),0.3352543841503634,0.8656400500929241,0.6579925650557621,0.9359257842718145,1.0,5/21,14.65%,SHROOM2;ARL6;GPR143;BBS7;RAB11B
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.36288122407954787,0.8653492401267154,0.630057803468208,0.935777176283291,1.0,3/16,6.51%,IGF1R;MTRF1;BNIP3
prerank,positive regulation of potassium ion transport (GO:0043268),-0.2738221290494537,-0.8647209852928935,0.6955503512880562,0.8756821777102775,1.0,8/38,13.92%,KCNJ2;KCNMA1;FHL1;FLNA;KCNQ1;KCNMB4;KCNN2;KCNJ15
prerank,cytosolic transport (GO:0016482),-0.21602452068107064,-0.8645300149096409,0.7815126050420168,0.8755053358808067,1.0,30/108,22.72%,MYO1D;HEATR5A;MON2;VPS13A;VPS13C;VTI1B;STX6;EMP2;LAMP1;BET1L;SNX16;EVI5;PTPN23;TBC1D10A;LMTK2;EHD3;PIK3C3;HOOK1;LAPTM5;GBF1;SNX1;VPS51;TBC1D10B;SYS1;TRIM27;SNX2;DCTN1;SPAG9;CLN5;AP2A1
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.3210730457505681,-0.8644510150183176,0.6619718309859155,0.8750841493824061,1.0,10/19,35.89%,CHUK;HSPD1;IFIH1;IRF5;STAT1;TLR7;TLR4;DHX9;MAVS;TLR8
prerank,water transport (GO:0006833),-0.3527778127853358,-0.8638243107400159,0.6566037735849056,0.8757816024205441,1.0,3/12,15.43%,AQP4;AQP11;CFTR
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.21223506361601843,0.8636806424733258,0.8025806451612904,0.9384959043678919,1.0,71/366,17.39%,RORA;EFEMP1;ARNT2;DENND4A;ATXN1;TULP3;ESRRG;MYBL1;NR1I2;SOX6;PPARGC1B;NFYB;IGF2;SSBP2;NCOA2;SOX1;PERM1;TCF7L1;ZFP37;SUFU;THAP1;WWC1;WWC2;GPBP1;UBE2L3;GPBP1L1;MTF2;ZKSCAN5;POLR2A;NFIA;ZNF628;BRCA2;MITF;KAT6B;NFYC;NSD1;NUP107;ABL1;ASCC2;ZBTB11;RBBP6;ZBTB38;MYB;RNF14;SOX13;RNF20;PSPC1;NONO;FOXK2;ESCO1;CLOCK;UBE2V1;CREBBP;NLK;PCGF1;SOX12;SMARCA2;ORC3;PATZ1;ZNHIT3;FZD7;PML;PHF1;TCOF1;IGSF1;REXO4;BACH1;OBI1;TSC1;TRRAP;CTR9
prerank,negative regulation of neurogenesis (GO:0050768),0.29787281845209207,0.863454168612413,0.6279491833030852,0.9382243583410508,1.0,5/34,7.48%,APPL2;LRP4;PTN;IL6;PTEN
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.33336644367832974,0.8632307510918356,0.6187624750499002,0.9379750567593957,1.0,6/20,16.25%,TNRC6B;TNRC6A;AGO2;MOV10;CNOT8;CNOT7
prerank,negative regulation of autophagosome assembly (GO:1902902),0.37057501062320536,0.8631879467652002,0.6276150627615062,0.9373238483276375,1.0,4/13,12.88%,LRRK2;NUPR1;TMEM39A;FEZ1
prerank,protein N-linked glycosylation (GO:0006487),-0.23878819812453694,-0.8631062570252671,0.7493917274939172,0.8766644751032048,1.0,27/66,31.22%,ST6GAL1;FUT8;MAGT1;STT3B;KRTCAP2;SLC39A8;MCFD2;RPN1;MGAT1;ALG11;ST3GAL1;TMEM165;DDOST;MGAT5;ALG5;ALG14;MGAT2;ALG1;ALG8;DPM1;UBE2J1;DOLPP1;MGAT5B;ALG3;PMM1;DPAGT1;UGGT1
prerank,response to alcohol (GO:0097305),0.3078125530890706,0.8630629840933938,0.6018518518518519,0.9368683228854237,1.0,3/27,8.52%,TGFBR3;CCL19;PMVK
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2385692698884589,0.8628418736452684,0.7226386806596702,0.9366445378595473,1.0,26/129,16.71%,NINL;PLCB1;ALMS1;PHLDA1;CDK7;CCDC57;HAUS4;CEP152;SDCCAG8;OPTN;CDK1;PAFAH1B1;FBXL17;LATS1;OFD1;HAUS1;SFI1;CEP57;MNAT1;CEP63;CEP164;BRSK1;SKP2;CDKN2B;BACH1;PPP1R12B
prerank,L-serine metabolic process (GO:0006563),0.3951360114726346,0.8626248903877372,0.6308316430020284,0.9363797031020586,1.0,3/10,13.02%,CBS;SRR;SHMT1
prerank,calcineurin-mediated signaling (GO:0097720),-0.3879763747761861,-0.8624714825514534,0.6527514231499051,0.8768133514949555,1.0,5/10,19.74%,NFATC2;NFATC1;PPP3CA;PPP3R1;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3879763747761861,-0.8624714825514534,0.6527514231499051,0.8768133514949555,1.0,5/10,19.74%,NFATC2;NFATC1;PPP3CA;PPP3R1;NFATC3
prerank,nuclear membrane disassembly (GO:0051081),0.35455390676912646,0.8623153170910538,0.6258205689277899,0.936319308043513,1.0,4/14,10.07%,PRKCB;PRKCA;CDK1;AKAP8L
prerank,chemical homeostasis (GO:0048878),-0.24142292041655167,-0.8615580369698879,0.7400990099009901,0.8781287150136823,1.0,14/61,17.52%,SLC4A10;NEDD4L;WNK3;ACOX3;AQP4;AQP11;SLC4A8;SLC4A2;NR1D2;TLCD2;VGF;ATP13A2;WNK2;CLN8
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.33745353545738843,-0.8613727679886739,0.65748031496063,0.8779458890886088,1.0,6/14,20.61%,NOS3;EDN1;ECE1;ACE2;AGTR1;ENPEP
prerank,RNA catabolic process (GO:0006401),-0.2527967723573524,-0.8609977633561484,0.6997635933806147,0.8781244048075625,1.0,21/46,34.45%,RIDA;RNASE3;MTREX;SUPV3L1;AGO3;METTL3;HSPA1B;ZPR1;NUDT16;ERN1;RNH1;RNASEH2C;HNRNPD;DIS3L2;RNASEH2B;ZFP36;ISG20;DNA2;HSPA1A;FEN1;ZC3H12D
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3656627259491806,0.8608379570144541,0.6198830409356725,0.938732049869161,1.0,1/13,0.85%,RBPJ
prerank,membrane depolarization (GO:0051899),0.3045605648297819,0.8605736180935221,0.6383363471971067,0.9385866155013411,1.0,2/32,4.86%,SCN7A;CACNB4
prerank,GPI anchor metabolic process (GO:0006505),0.3165406976225176,0.8600970655848513,0.640074211502783,0.9388198312397305,1.0,5/26,12.89%,PIGU;PIGG;PIGV;PIGC;PIGQ
prerank,Notch signaling pathway (GO:0007219),0.270272459204666,0.8596512852411842,0.6866438356164384,0.9390219311766093,1.0,14/59,14.11%,RBPJ;NOTCH2;GMDS;SUSD5;MAML3;MAML1;WWC1;TRAF7;ITCH;DTX1;MAML2;PSENEN;SNAI1;CREBBP
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.2375623518127341,-0.8595691332559822,0.7524271844660194,0.8803658006787849,1.0,26/69,29.88%,STT3B;TRIM25;HSP90B1;BAG6;DERL1;HSPA5;HERPUD1;TRIM13;ERLIN2;DNAJC10;WFS1;AUP1;RNF5;DNAJB9;FBXO17;TMEM129;VCP;RNF103-CHMP3;UBE2J1;YOD1;SYVN1;FBXO2;RHBDD2;STUB1;FOXRED2;SEC61B
prerank,synaptonemal complex organization (GO:0070193),0.350766926567989,0.8593632467632348,0.6190476190476191,0.9381962537805744,1.0,2/15,6.34%,HORMAD1;TEX11
prerank,synaptonemal complex assembly (GO:0007130),0.350766926567989,0.8593632467632348,0.6190476190476191,0.9381962537805744,1.0,2/15,6.34%,HORMAD1;TEX11
prerank,regulation of filopodium assembly (GO:0051489),0.2914129308353931,0.85887628057314,0.6552346570397112,0.9385050574796789,1.0,7/38,11.29%,DOCK11;DPYSL3;RIPOR2;WASL;CAPZB;PIK3R1;FXR1
prerank,histone H2A acetylation (GO:0043968),0.34774354965653587,0.8588534161332957,0.6582809224318659,0.9378162866592069,1.0,1/16,1.41%,BRD8
prerank,cell cycle G2/M phase transition (GO:0044839),0.23732912267473427,0.8587638363311877,0.7238805970149254,0.9372935910809156,1.0,26/130,16.71%,NINL;PLCB1;ALMS1;PHLDA1;CDK7;CCDC57;HAUS4;CEP152;SDCCAG8;OPTN;CDK1;PAFAH1B1;FBXL17;AKAP8L;LATS1;OFD1;HAUS1;SFI1;CEP57;MNAT1;CEP63;CEP164;BRSK1;SKP2;CDKN2B;PPP1R12B
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.2695458238559935,-0.8586404957140041,0.6751152073732719,0.8816287792073241,1.0,7/33,14.03%,GLS;GCLM;KYAT1;DDAH1;SLC39A8;ALDH18A1;SIRT4
prerank,protein-containing complex subunit organization (GO:0043933),-0.21628957565378987,-0.8584540671764435,0.7948717948717948,0.8814182761247293,1.0,31/109,24.36%,SLC2A1;OCLN;LIN7A;PPARGC1A;PTK2B;REPS2;HES1;WIPF1;CAPZA2;SKAP2;ADD2;CARD10;IL1RAP;APC;CD2AP;ST13;CD74;ELOB;TRAF1;FAS;CD40;NUP54;TAPBP;TFAP4;NUP133;NCKAP1L;KPNA3;CAPZA1;CHCHD10;SHANK1;SPG7
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.3379447623121177,-0.858280527555155,0.6259842519685039,0.8812036230995561,1.0,5/14,16.12%,SEMA7A;PLCG2;CD74;CAMK4;LAPTM5
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.2978013113843617,0.8581729336550188,0.6407407407407407,0.9378333508429497,1.0,11/36,16.14%,TCF7L2;PLCB1;TNRC6B;TNRC6A;PDE6G;AGO2;FZD2;MAP3K7;NLK;MOV10;GNG2
prerank,response to gamma radiation (GO:0010332),-0.2937084676110355,-0.8569385396041871,0.6861924686192469,0.8833190660678841,1.0,10/24,25.32%,RPL26;CRYAB;MEN1;TRIM13;ATR;LIG4;TLK2;TMEM109;HRAS;TSPYL5
prerank,positive regulation of leukocyte migration (GO:0002687),0.31208184514944487,0.8567927016660214,0.6279926335174953,0.9399795073720918,1.0,4/27,8.41%,PTN;IL6;CSF1;MIA3
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.33206890710266135,0.8567119012325198,0.6126482213438735,0.9394223155953995,1.0,4/20,10.08%,LHPP;AMPD3;ADSL;GMPS
prerank,interstrand cross-link repair (GO:0036297),0.27748872106995937,0.8560983903889448,0.6725352112676056,0.9399807026122827,1.0,16/53,17.87%,FANCA;ATRIP;RAD51AP2;WDR48;FANCI;DCLRE1A;DCLRE1B;FANCB;FANCF;FANCE;FAAP100;CENPX;FANCC;RAD51;ERCC6L2;FAAP24
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3375407873057203,-0.8559714908399131,0.6647058823529411,0.8846114045158103,1.0,5/14,19.02%,CEPT1;LPIN3;ETNK1;LPIN1;ETNPPL
prerank,positive regulation of rRNA processing (GO:2000234),-0.3733250349077087,-0.8557940478812294,0.6482889733840305,0.8843847594795297,1.0,3/10,21.07%,BUD23;UTP15;SIRT7
prerank,transcription by RNA polymerase III (GO:0006383),-0.28808729661667404,-0.855464356209016,0.680672268907563,0.8844631412000857,1.0,12/27,25.43%,IVNS1ABP;BRF1;SNAPC1;ZC3H8;SNAPC4;CRCP;GTF3C1;RO60;GTF3C2;GTF3C4;POLR2L;SNAPC2
prerank,early endosome to late endosome transport (GO:0045022),-0.310762303705542,-0.85535444810264,0.6526946107784432,0.8841096379230438,1.0,6/20,14.88%,EMP2;SNX16;PTPN23;LMTK2;PIK3C3;HOOK1
prerank,mesoderm formation (GO:0001707),-0.3254279321470713,-0.8551813184719413,0.6897233201581028,0.8838933264898539,1.0,3/17,3.91%,ITGB1;ITGB4;BMPR2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3161311598271685,-0.8550959537394153,0.6819085487077535,0.8834723442668643,1.0,6/18,18.52%,UBB;RPS27A;UBC;TRIM13;UBA52;RNF5
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.37471463916839093,-0.8550959398638448,0.6706114398422091,0.8828918762351515,1.0,3/10,7.71%,KDR;RACK1;MYOC
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.32849736382585365,-0.8549971636441965,0.6565656565656566,0.8825095201304469,1.0,11/16,46.13%,ACACA;FASN;SCD5;ACLY;SCD;HSD17B8;MLYCD;SLC25A1;PPT2;DIP2A;ACSS1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2878148932029778,0.8549327636587898,0.6732142857142858,0.9417276883165282,1.0,4/42,10.07%,OXSR1;CXCL13;CCL19;CCL4
prerank,negative regulation of hydrolase activity (GO:0051346),-0.25384458294708384,-0.8548325876230318,0.7418604651162791,0.8822618341692433,1.0,13/49,16.46%,LRCH1;CST3;F11R;DAB2IP;SH3BP4;CHP1;TMED2;NOS1;SLC39A14;ZCCHC9;RCC2;ATP5IF1;NEIL1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.2266681100342041,-0.8547478898716421,0.745,0.8818547488681052,1.0,25/76,23.48%,RNF144B;CBFA2T3;PTK2;RNF144A;RACK1;TRIB2;NKD2;SOCS5;GSK3B;ZYG11B;RBX1;CLU;ELOB;ARIH2;COP1;LAPTM5;RNF19B;NOP53;ARIH1;VCP;RNF19A;USP5;CEBPA;TRIB3;HSPA1B
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.31608941559848946,0.8547423891011904,0.6471698113207547,0.94142200681047,1.0,4/28,6.89%,ADCY1;EPHA4;PTN;ARC
prerank,C21-steroid hormone metabolic process (GO:0008207),0.33262048022533475,0.8547063402830181,0.6496945010183299,0.9407684705382492,1.0,3/20,12.49%,FDXR;HSD17B10;AKR1B1
prerank,protein destabilization (GO:0031648),-0.2728426206972045,-0.854483846108948,0.6917808219178082,0.8817828123012721,1.0,6/32,9.18%,GSN;FBXL3;SOX17;CUL3;DERL1;SERF2
prerank,carboxylic acid catabolic process (GO:0046395),0.38142960945755144,0.854304031793915,0.6152304609218436,0.9409213836805229,1.0,3/12,14.33%,ACOT4;RENBP;NPL
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3019886113059354,0.8542437849847768,0.6574074074074074,0.9403390703767671,1.0,2/32,1.89%,CEMIP;PDPK1
prerank,protein K48-linked ubiquitination (GO:0070936),0.27384294787465463,0.8542235509522735,0.6850921273031826,0.939661615675013,1.0,15/54,17.61%,PRKN;UBE2E2;RNF152;TTC3;AMFR;RNF216;ITCH;KBTBD7;FBXO38;IFI27;UBE2A;SKP2;UBE2H;UBE2E1;DTX3L
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.28859536513773476,0.8537012452482772,0.6719298245614035,0.9400400867523547,1.0,9/41,13.05%,IL34;EPHA4;ACE;DLG4;TGFA;AREG;DLG3;GPRC5B;DOK7
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.2403941151226066,-0.8535175814256364,0.7336448598130841,0.8830953843155563,1.0,34/63,42.61%,RPL26;SOX4;PLK2;PLAGL1;CHEK2;CNOT6L;FBXO31;CDKN1B;RPS27L;TNKS1BP1;CDK2;PCBP4;GADD45A;CDKN1A;E2F7;RGCC;BAX;RFWD3;SFN;PIDD1;AURKA;E2F8;RPA2;CCND1;CNOT1;CNOT9;PLK3;CRADD;CCNB1;PRMT1;PCNA;CDC25C;TFDP1;TRIAP1
prerank,mitochondrion disassembly (GO:0061726),0.2973666505757784,0.8530647274715482,0.6857670979667283,0.940671149768116,1.0,8/34,15.63%,PRKN;WIPI1;BNIP3;FUNDC2;FUNDC1;ATG9A;AMBRA1;ATG3
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3177468693112535,0.8530385147970404,0.6356589147286822,0.9400108511833639,1.0,1/25,0.20%,ARHGAP24
prerank,positive regulation of cyclase activity (GO:0031281),-0.3348697672506793,-0.8530059607158883,0.681214421252372,0.8835316738405152,1.0,7/14,21.48%,NOS3;MAPK8;CACNA1C;NOS1;NF1;ORAI1;MAPK3
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.23048353598714633,-0.8529742397139635,0.7595238095238095,0.8830093624625301,1.0,19/69,19.13%,MEF2C;PPARGC1A;PTK2B;NGF;LGMN;SOD1;FOXQ1;SIX1;GRN;SET;MSH2;MT3;SIX4;CX3CR1;WFS1;PRKCG;TYRO3;LIG4;PINK1
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.29873266434049456,-0.8525580758218395,0.7034764826175869,0.8832238614461394,1.0,7/22,18.27%,RASSF2;CALM1;PDGFC;VEGFA;TNKS1BP1;CALM2;GREM1
prerank,outer dynein arm assembly (GO:0036158),0.36473210162256814,0.8525099946416986,0.6430062630480167,0.9403420376595579,1.0,3/15,14.99%,ODAD3;ODAD1;ODAD2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.39445412177324574,0.8522785494999958,0.6409185803757829,0.9401358751871902,1.0,1/10,1.00%,FGFR2
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.3253682669775182,0.8520754277999106,0.6438095238095238,0.9398619420524772,1.0,2/22,4.46%,SASH1;SPHK1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.3618954578595629,-0.851746886742107,0.6711538461538461,0.8836323273765221,1.0,4/10,32.70%,RACK1;PRKCD;SPHK2;NSMAF
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.3618954578595629,-0.851746886742107,0.6711538461538461,0.8836323273765221,1.0,4/10,32.70%,RACK1;PRKCD;SPHK2;NSMAF
prerank,neuron remodeling (GO:0016322),-0.37278395243170437,-0.8516178560692649,0.6648550724637681,0.8833277834765637,1.0,6/10,25.70%,SCARF1;ANKS1A;APP;C1QA;C3;RND1
prerank,protein glycosylation (GO:0006486),0.23928451521706018,0.8512442674997058,0.7455089820359282,0.940963532140777,1.0,14/125,8.48%,B3GALT1;ST3GAL3;GALNTL5;GALNT18;LARGE1;B3GNT5;ST3GAL5;B4GALT1;ALG6;MAN1C1;TET1;ALG2;ALG9;GFPT2
prerank,smooth muscle tissue development (GO:0048745),-0.37046507986249,-0.8509902611335338,0.6858846918489065,0.8839239156189701,1.0,5/10,20.48%,ENG;STRA6;PTCH1;NF1;BMP4
prerank,granulocyte chemotaxis (GO:0071621),-0.24045530359410724,-0.8508920164115744,0.7525,0.8835336855874499,1.0,11/55,17.86%,BSG;TGFB2;PPIA;CXADR;EDN1;PPIB;PIK3CD;SCG2;PIP5K1C;GBF1;CCL13
prerank,cGMP-mediated signaling (GO:0019934),0.36273707693612767,0.8507451836825979,0.6285140562248996,0.9412737542773577,1.0,1/13,0.87%,IRAG1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.27893132697391787,0.8506919034567755,0.6805054151624549,0.9406702227930871,1.0,6/44,10.80%,ROCK2;TNRC6B;TNRC6A;YTHDF2;AGO2;METTL14
prerank,neuron differentiation (GO:0030182),-0.20182139266870636,-0.8505409935577106,0.8873239436619719,0.8836524390847379,1.0,21/165,10.77%,MEF2C;PBX3;TGFB2;RUNX1;ACSL4;WNT9A;TENM2;FZD4;VSX1;SOX4;CTNNB1;MET;ATP8A2;TENM4;VEGFA;WNT16;RUNX2;DDIT4;LHX6;XBP1;IER2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3680363123343263,0.8502508644466403,0.6412825651302605,0.9408794068852094,1.0,1/12,2.36%,INSIG2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.34518023380115337,0.849726606164844,0.6352941176470588,0.941208853165529,1.0,3/16,7.40%,PDE6G;ACP3;PRKCA
prerank,epidermal cell differentiation (GO:0009913),-0.2637173960356569,-0.8490240134476421,0.6981981981981982,0.8860565982873194,1.0,9/41,20.64%,CLIC4;JAG1;CTNNB1;BCR;WNT16;GLI1;ADAM9;DSP;USH2A
prerank,maintenance of protein location in nucleus (GO:0051457),-0.30975423608442837,-0.8488957299617208,0.6843177189409368,0.8857260411687348,1.0,8/20,23.68%,SYNE1;HNRNPU;ARL2BP;BCL3;RANGAP1;SUN1;SKP1;CHCHD10
prerank,apical protein localization (GO:0045176),0.3926230379414495,0.8488361598484536,0.6228448275862069,0.9422764774020335,1.0,2/10,2.90%,SHROOM3;SHROOM2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.3420462354881792,-0.8486528921128141,0.6766467065868264,0.8856289643249989,1.0,5/13,18.46%,CPSF7;CPSF6;CPSF2;CSTF2T;CSTF2
prerank,neurogenesis (GO:0022008),0.28294402541204544,0.848640588776548,0.6512027491408935,0.9419565416873573,1.0,6/43,7.93%,LPAR1;FAT4;ANXA1;PCSK9;DAGLB;RYK
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.34747883537389124,-0.8484358173454769,0.6813819577735125,0.8854819510738299,1.0,4/12,16.76%,RPL26;CD44;CD74;MIF
prerank,regulation of cation channel activity (GO:2001257),0.2490962110521723,0.8482042561807842,0.7233009708737864,0.9421388221572023,1.0,17/89,12.85%,JPH1;DAPK1;DMD;NLGN2;CRHBP;ANK2;CACNB4;CACNG7;DLG1;MMP9;CAMK2D;DLG4;SELENON;SHISA9;ACTN2;GRIA4;DLG3
prerank,regulation of centrosome duplication (GO:0010824),-0.27487467276154676,-0.848102140816036,0.7108695652173913,0.8855055206344546,1.0,19/30,35.78%,CHMP5;CHMP2B;PLK2;CEP295NL;CCNF;CHMP1B;CHMP1A;GEN1;CHMP3;PDCD6IP;CEP295;CHMP4C;VPS4B;CEP131;NPM1;STIL;TMEM67;PKHD1;XRCC3
prerank,regulation of response to oxidative stress (GO:1902882),0.38155451572064775,0.848044422357177,0.6591836734693878,0.9417511726041826,1.0,1/11,1.37%,PRKN
prerank,regulation of calcium ion transport (GO:0051924),0.2683990415499049,0.8480415028956131,0.7019400352733686,0.9410412789645561,1.0,9/54,12.63%,STIM1;BCL2;MYLK;ANK2;CACNA1D;CACNA2D1;CCL4;PKD2;PACSIN3
prerank,mitotic recombination (GO:0006312),0.34994370881576925,0.8473832458013455,0.6438923395445134,0.9417114705218501,1.0,6/15,23.61%,DMC1;TEP1;RAD51;TPRKB;RAD50;RAD52
prerank,regulation of gluconeogenesis (GO:0006111),0.3026065965572569,0.8473641814095246,0.6455223880597015,0.9410462968544815,1.0,7/27,17.99%,C1QTNF3;SIK1;USP7;CRY1;GCK;NNMT;C1QTNF12
prerank,rRNA 3'-end processing (GO:0031125),0.39060337525833,0.847078877326803,0.6493775933609959,0.9409364398916581,1.0,5/10,18.60%,ERI3;ERI2;EXOSC8;ERI1;EXOSC3
prerank,Golgi to lysosome transport (GO:0090160),-0.3554092512868534,-0.8467272072077376,0.6821561338289963,0.8875956249990755,1.0,3/11,16.12%,LAMP1;EHD3;LAPTM5
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.24718209914196956,-0.8466212716229675,0.7206572769953051,0.887235452171363,1.0,17/47,26.68%,SPOCK2;SERPINE2;SERPINI1;SERPINF1;SERPINB9;GAPDH;BIN1;MT3;SPOCK1;TIMP2;SERPINA2;AKT1;SPOCK3;SORL1;TIMP1;ANXA8L1;ANXA8
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.35046439364962545,-0.8459433530386307,0.6685934489402697,0.8879930824269421,1.0,2/12,2.34%,LY6E;GSN
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3252732632509656,0.8450180021949691,0.6563706563706564,0.9444406522950708,1.0,2/22,2.73%,APPL2;LTF
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.27922040434431783,0.8450045948304231,0.6942003514938488,0.9437599657718069,1.0,7/43,12.50%,ERRFI1;SNX6;STAM2;TGFA;CHMP6;PTPN3;AREG
prerank,response to tumor necrosis factor (GO:0034612),0.24643825452100632,0.8448891297174241,0.7362637362637363,0.9432895708856207,1.0,11/91,11.11%,ADAMTS12;PID1;CRHBP;SPHK1;ZFAND6;CACTIN;ADAMTS7;CCL19;CCL4;GSDME;JAK2
prerank,regulation of p38MAPK cascade (GO:1900744),0.2895327027600153,0.8445283087244171,0.648936170212766,0.9433385779172637,1.0,4/35,6.48%,SASH1;DUSP10;SPHK1;DLG1
prerank,positive regulation of cell death (GO:0010942),0.26752386323291705,0.8443901321491956,0.7104377104377104,0.9428977025572146,1.0,9/59,11.69%,SLC6A13;EFNB2;DKK1;LRRK2;BNIP3;PICALM;AXIN2;EIF2S1;PRODH
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3337773702319722,-0.8443861665149737,0.6717850287907869,0.890549041515191,1.0,5/14,33.63%,ADRB2;PRKAR1A;ATP2B4;PKIG;PRKAR2B
prerank,positive regulation of defense response (GO:0031349),-0.21942184945213994,-0.8437100225931058,0.7914285714285715,0.891216821036982,1.0,12/89,11.15%,MEF2C;IL33;ETS1;NFKBIA;GPR4;PDE2A;PDCD4;APP;GRN;GBP5;FEM1A;IFI35
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.34793851275869725,-0.8435673852358849,0.6712062256809338,0.8909115749999941,1.0,7/11,51.81%,NFKBIZ;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.28987227034588364,-0.8429936761413254,0.6818181818181818,0.8914288462815193,1.0,9/25,21.92%,ATXN3;BAG6;CUL3;ZYG11B;DERL1;AUP1;RNF5;VCP;HDAC6
prerank,positive regulation of calcium ion import (GO:0090280),0.3687946823751222,0.8428649595946781,0.6391304347826087,0.9453656577961382,1.0,1/12,2.95%,PDGFRB
prerank,positive regulation of DNA replication (GO:0045740),-0.32134361162245706,-0.8422800138780595,0.6764091858037579,0.8922426366793559,1.0,3/16,12.22%,BCAR3;FAF1;GLI1
prerank,plasma membrane tubulation (GO:0097320),-0.34252546880707097,-0.8421534552120061,0.6782077393075356,0.8919056016841673,1.0,4/13,12.15%,FNBP1L;PACSIN2;CAVIN2;WHAMM
prerank,mRNA processing (GO:0006397),-0.1865957276333561,-0.8419107278299977,0.9306122448979591,0.8917923245205874,1.0,89/287,29.46%,HSPA8;NOVA2;HNRNPK;PPARGC1A;SRSF2;PABPC1;SRSF1;HNRNPU;PPWD1;HNRNPA3;YBX1;PPIE;SF3B1;SF3B2;CPSF7;PHF5A;SFPQ;RBM14;DDX5;SRSF5;DDX39B;CPSF3;KIN;HNRNPH2;SRSF9;CPSF6;CWC15;RALY;USP39;RBM8A;POLR2C;XAB2;PRPF18;RNPS1;SNRPC;SRSF6;PRPF40B;FUS;SF3B5;HNRNPA0;SYMPK;CLP1;POLR2G;PRPF4;CPSF2;SPEN;GTF2F2;CSTF2T;ESS2;PCBP1;PCF11;CSTF2;MTREX;HNRNPUL1;YTHDC1;THOC3;RBM17;PTBP1;CTNNBL1;RBM22;SNIP1;MAGOH;METTL3;TRA2B;CMTR2;THOC6;SNRPG;GTF2H2;SNRNP35;RBM4B;POLR2L;HNRNPF;HNRNPM;USP49;THOC2;ERN1;PUF60;HNRNPD;LSM8;RBM6;EIF4A3;TFIP11;AURKAIP1;SRSF7;ALYREF;ZCRB1;BUD31;ERCC3;CSTF1
prerank,keratinocyte differentiation (GO:0030216),-0.27928671483932177,-0.841770988376343,0.6652173913043479,0.891479771798536,1.0,4/29,8.27%,CLIC4;JAG1;BCR;WNT16
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3450105570304881,0.841644386936371,0.6558704453441295,0.9471660624756439,1.0,2/14,5.48%,PRKN;LRRK2
prerank,RNA polyadenylation (GO:0043631),-0.2822951381410652,-0.8413947515185595,0.7241379310344828,0.8910406578645002,1.0,9/26,18.37%,PABPC1;APP;CPSF3;GRSF1;SYMPK;AHCYL1;CLP1;CPSF2;PCF11
prerank,mRNA polyadenylation (GO:0006378),-0.2822951381410652,-0.8413947515185595,0.7241379310344828,0.8910406578645002,1.0,9/26,18.37%,PABPC1;APP;CPSF3;GRSF1;SYMPK;AHCYL1;CLP1;CPSF2;PCF11
prerank,sensory perception of chemical stimulus (GO:0007606),-0.32549028159608484,-0.8413339531779214,0.6955645161290323,0.8905775786570896,1.0,3/15,10.93%,GNAL;ADCY3;SYT10
prerank,regulation of mitotic cell cycle (GO:0007346),-0.19797787811188144,-0.8413030813228,0.8938356164383562,0.8900598023063468,1.0,46/171,23.55%,NEK7;IQGAP1;TTC28;CAV2;CDK11B;LGMN;BUB3;TGFB1;HNRNPU;APP;PSMD13;PSMF1;DDB1;PSMB10;CDKN1B;BTG3;PSMB6;DUSP3;TAL1;PSME3;PSMB5;PSMC3;TMEM8B;PSMD12;PSMB8;CUL1;BRINP2;PSME1;ANAPC16;PSMB3;GBF1;BUB1B;UBE2D1;PSMD5;TFAP4;SKP1;L3MBTL1;BTG1;TTL;ANAPC7;PSMD9;PSMB4;MKI67;EIF4E;AFAP1L2;NEK11
prerank,reverse cholesterol transport (GO:0043691),0.3619624853444342,0.8411839502276417,0.6787878787878788,0.9474055936921973,1.0,3/13,8.39%,ABCA1;LIPC;ABCA5
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.28979117575799374,-0.8410528535306344,0.7037815126050421,0.8899639348191957,1.0,9/24,26.70%,SLIT2;LGMN;CCN3;CXCL12;DUSP1;GREM1;CCR2;CREB3;CXCL10
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.2932014826320506,-0.8408100700392893,0.7057613168724279,0.8898459584118201,1.0,10/22,30.92%,MVB12B;UBAP1;PTPN23;MVB12A;UBAP1L;PLAA;VPS36;TOM1L1;VPS28;VPS4B
prerank,protein localization to organelle (GO:0033365),-0.20303566959052408,-0.8405476419413234,0.8477011494252874,0.8897646850937725,1.0,38/133,21.68%,RPL11;DNAJA1;PACSIN2;STX1A;CALR;EHD1;SIX1;APP;YBX1;LAMP1;CCDC47;ZBTB7A;TSPAN17;TOR1B;TMEM30A;SSB;ISG15;GBP5;HHEX;RPA1;TOLLIP;CEP68;RIPOR1;BBS9;LMNA;COL1A1;SEC61G;SIX4;GBF1;BICD1;AUP1;SYS1;IFT20;GET4;CTDNEP1;BMP4;FAM83H;VAPA
prerank,response to lipid (GO:0033993),0.2442654450078987,0.8402416340738429,0.7632398753894081,0.9485957361169093,1.0,8/105,3.68%,FGFR4;PPARA;RBP4;SMAD6;FER;CTSH;ANXA1;STAT5B
prerank,aminoglycan metabolic process (GO:0006022),0.38060455664004145,0.8398597026435957,0.627254509018036,0.9486270216166126,1.0,3/10,9.85%,GAL3ST3;XYLT2;B3GALT6
prerank,regulation of interferon-beta production (GO:0032648),0.27766354725103676,0.8398133581674292,0.7036363636363636,0.948001818440593,1.0,10/46,13.89%,CACTIN;NLRC3;POLR3G;TRIM56;RNF135;RNF216;SIRPA;IRF3;TBK1;POLR3C
prerank,response to chemokine (GO:1990868),0.36272725608821726,0.8397196743767865,0.6520076481835564,0.9474787793985827,1.0,2/13,3.63%,OXSR1;RIPOR2
prerank,ERAD pathway (GO:0036503),-0.22149568426621183,-0.8396126852301458,0.8087855297157622,0.8909283434744358,1.0,32/83,29.88%,ATXN3;STT3B;TRIM25;HSP90B1;BAG6;DERL1;CCDC47;UBXN6;HSPA5;HERPUD1;ERLEC1;TRIM13;ERLIN2;DNAJC10;WFS1;AUP1;RNF5;DNAJB9;GET4;FBXO17;TMEM129;VCP;RNF103-CHMP3;BRSK2;UBE2J1;YOD1;SYVN1;FBXO2;RHBDD2;STUB1;FOXRED2;SEC61B
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.32576749213764267,-0.8395323892396828,0.6789883268482491,0.8899413848756903,1.0,3/15,6.82%,AP3S1;BLOC1S2;AP3M2
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.32576749213764267,-0.8395323892396828,0.6789883268482491,0.8899413848756903,1.0,3/15,6.82%,AP3S1;BLOC1S2;AP3M2
prerank,establishment of mitotic spindle localization (GO:0040001),-0.2752986911733443,-0.8394452790494729,0.7097457627118644,0.8895228414493818,1.0,14/28,36.01%,ITGB1;NSFL1C;INSC;NDE1;NUMA1;DCTN1;CLASP2;NDC80;SPDL1;PLK1;ESPL1;PKHD1;CLASP1;NUSAP1
prerank,peroxisomal membrane transport (GO:0015919),-0.27930716318525317,-0.8393158470546445,0.6884531590413944,0.8891912768005489,1.0,12/27,29.55%,ABCD3;ABCD2;PEX1;PEX11B;ABCD4;PEX5;ATAD1;PEX10;RAB8B;PEX16;FIS1;PEX13
prerank,response to interferon-beta (GO:0035456),-0.2959768919659297,-0.8391862337246291,0.7029126213592233,0.8888708451724001,1.0,6/22,24.36%,AIM2;NDUFA13;SHFL;BST2;IFITM3;STAT1
prerank,regulation of viral life cycle (GO:1903900),-0.30220383145486746,-0.8390308022438625,0.6959847036328872,0.8885993405863027,1.0,6/21,19.83%,PPIA;TRIM14;TRIM25;HS3ST5;TYRO3;TRIM27
prerank,regulation of mRNA stability (GO:0043488),-0.20263622950931193,-0.8389483484081307,0.8403614457831325,0.8881927045815188,1.0,42/145,23.00%,HSPA8;VIM;UBB;HSPB1;PABPC1;YWHAB;RPS27A;UBC;PUM2;HNRNPU;YBX1;PSMD13;SET;PSMF1;EIF4G1;ZFP36L1;PSMB10;YTHDF3;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;FUS;TENT5A;PSME1;UBA52;RIDA;PSMB3;SERBP1;FASTKD3;PSMD5;PCBP4;PRKCD;AKT1;METTL3;FMR1;SLC11A1;RBM24;PSMD9;PSMB4
prerank,ether lipid biosynthetic process (GO:0008611),-0.36394885735294236,-0.8385263206190824,0.6708407871198568,0.8884136638736777,1.0,5/10,29.82%,FAR1;PLA2G4A;AGPS;DHRS7B;CHPT1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.3280372532198009,-0.8384116580393788,0.7064579256360078,0.8880439833259807,1.0,9/14,39.62%,RPS3;CD81;RELA;CARD11;KCNN4;TRAT1;CD226;TESPA1;LCK
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.28479889337063624,-0.8383574680757442,0.7309322033898306,0.8875929305866945,1.0,11/26,39.78%,CUL3;DUSP1;ANAPC7;NSMCE2;PLK1;DLGAP5;CDC6;ESPL1;UBE2C;ANAPC4;CCNB1
prerank,pseudouridine synthesis (GO:0001522),-0.3371684224309569,-0.8380833529204117,0.6833667334669339,0.887525091827687,1.0,7/13,29.60%,TRUB2;NHP2;PUS7;PUSL1;RPUSD2;NOP10;PUS1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.3587058623525833,-0.837938014445916,0.7051282051282052,0.8872085685197967,1.0,4/10,29.85%,DLGAP1;NPTXR;NPTX1;CACNG5
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.31120517624671673,0.8376625388778529,0.676950998185118,0.9509182703623664,1.0,5/27,8.58%,CTPS1;CTPS2;NUDT13;TYMS;TXNRD1
prerank,regulation of synapse maturation (GO:0090128),-0.3630556458182997,-0.837523823892867,0.6843137254901961,0.8874124033762814,1.0,5/10,15.07%,DAB2IP;ARHGEF15;NRXN1;RELN;CAMK2B
prerank,morphogenesis of an epithelium (GO:0002009),0.31361337429884784,0.8370238500000637,0.6771653543307087,0.9514349065260849,1.0,3/25,4.95%,FGFR2;ARHGAP12;KDM2B
prerank,regulation of chemotaxis (GO:0050920),0.301634914719473,0.8369648699539952,0.7145557655954632,0.9508451602248359,1.0,4/30,7.56%,EFNB2;PDGFRB;PDGFRA;CCL19
prerank,protein maturation (GO:0051604),-0.2177383122484189,-0.8367431338013102,0.7864864864864864,0.8883109426807732,1.0,24/95,24.16%,ADAM10;F3;CPD;PCSK2;GALNT2;PTCH1;SRGN;TSPAN17;ECE1;FURIN;OGT;CPXM2;HSPD1;DNAJB11;NAA40;GLRX3;PCSK1;ADAMTS3;PSEN1;PCSK5;TYSND1;ISCA1;NNAT;NAA16
prerank,modulation by host of symbiont process (GO:0051851),-0.27283016282624095,-0.8365182689642706,0.7015250544662309,0.8881513051468561,1.0,5/31,15.75%,LEF1;TARDBP;JUN;REST;CX3CR1
prerank,tRNA 5'-end processing (GO:0099116),-0.3241466295906478,-0.8361727069650652,0.683991683991684,0.8882570249354937,1.0,8/15,28.40%,SSB;POP5;POP4;RPP21;RPP30;TRMT10C;PRORP;POP7
prerank,regulation of mRNA metabolic process (GO:1903311),-0.35474292503579796,-0.8357698338163876,0.699047619047619,0.8884398393614708,1.0,7/11,33.25%,CDK11B;SRPK1;SAFB2;SLTM;SRPK3;DHX9;IWS1
prerank,regulation of mast cell degranulation (GO:0043304),0.3530047026688825,0.8355765507867859,0.6666666666666666,0.9529132926161011,1.0,5/14,20.04%,FER;GAB2;LYN;CD84;LGALS9
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.34176464298684994,0.8352837501927819,0.6447638603696099,0.9527838659645521,1.0,5/16,12.83%,FOXD1;FGF1;SALL1;PKD2;GDNF
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.34832056487949314,-0.8351296272839908,0.6786427145708582,0.8890883330100516,1.0,5/11,32.03%,TASOR;SETDB2;SIRT6;DNMT1;PPHLN1
prerank,histone ubiquitination (GO:0016574),0.3207230930401039,0.8349438627212105,0.6815533980582524,0.9527580933252002,1.0,9/21,22.88%,UBR2;CDC73;RNF20;UBE2A;CTR9;UBE2E1;DTX3L;PAF1;WAC
prerank,positive regulation of actin nucleation (GO:0051127),0.3672242515463204,0.8346240428555748,0.6615720524017468,0.9526994643145802,1.0,4/11,13.05%,ABI2;WASF1;WASF3;FCHSD2
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.31691871434913926,0.8345970980000679,0.6923076923076923,0.9520425491018516,1.0,4/22,10.14%,NR2F2;PTEN;CDK5RAP1;LATS1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.25612235530867095,0.8344001543093649,0.7259380097879282,0.9517345097550552,1.0,1/66,0.03%,IGF1
prerank,ether lipid metabolic process (GO:0046485),0.3387888914072672,0.8339040706737457,0.6844262295081968,0.9519989586232976,1.0,2/14,8.84%,AGMO;PAFAH1B1
prerank,lytic vacuole organization (GO:0080171),0.2948787297317146,0.8339016827308239,0.7064220183486238,0.9512958379890741,1.0,5/32,6.74%,HOOK2;ABCA1;TPP1;LRRK2;ACP3
prerank,negative regulation of immune effector process (GO:0002698),-0.33163912831745385,-0.8338689589401386,0.7131931166347992,0.8908738628626177,1.0,5/13,14.36%,RPS19;CD55;GRN;APPL1;CD47
prerank,magnesium ion transport (GO:0015693),0.3548887720797613,0.8337722566935174,0.6257668711656442,0.9508365469896477,1.0,2/12,4.49%,SLC41A1;MMGT1
prerank,peptidyl-lysine methylation (GO:0018022),0.30373320817750965,0.8332580055731375,0.6897880539499036,0.9511598867694704,1.0,7/26,19.76%,SETD6;SETD7;EEF1AKMT1;SMYD3;N6AMT1;SETD2;SETD4
prerank,protein acylation (GO:0043543),-0.2605482147280432,-0.8329303993053799,0.727069351230425,0.89206027683042,1.0,9/38,12.48%,ZDHHC14;ZDHHC15;FOXO1;ZDHHC2;ZDHHC7;ING4;PORCN;HHAT;SELENOK
prerank,chromatin assembly (GO:0031497),0.2800603643960635,0.8328176078731032,0.6983842010771992,0.9513518508548141,1.0,11/38,22.10%,RBBP4;RSF1;KAT6B;SMARCA5;NAP1L3;EZH1;NAA60;NAP1L1;PAF1;ANP32B;SOX9
prerank,early endosome to Golgi transport (GO:0034498),-0.3525207376257042,-0.8328176011033027,0.6918714555765595,0.8917130042436965,1.0,5/11,34.13%,EHD3;SNX1;SNX2;STX5;RBSN
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.33280480321144496,-0.8327330845616048,0.6866537717601547,0.8913061368019973,1.0,5/13,18.58%,RPL26;SPRED2;DDX5;EEF1E1;ATR
prerank,negative regulation of innate immune response (GO:0045824),-0.2632393113527799,-0.8318788762516264,0.7438752783964365,0.8922811021714777,1.0,8/34,12.95%,RPS19;SUSD4;GRN;A2M;NLRC5;ISG15;YTHDF3;IRAK3
prerank,transcription preinitiation complex assembly (GO:0070897),-0.34786478356294126,-0.8316246807542343,0.6878612716763006,0.8921918149565055,1.0,8/12,52.74%,TAF11;POLR1E;TAF1B;TAF7;TBP;TAF7L;BDP1;DR1
prerank,microtubule anchoring (GO:0034453),-0.33914200477794804,-0.8314794968531125,0.671875,0.8918939769271038,1.0,7/12,35.23%,BICD1;CLASP2;CAMSAP3;SAXO2;PCM1;BCCIP;CLASP1
prerank,negative regulation of autophagy (GO:0010507),0.26154596977037403,0.8314189249842243,0.70578231292517,0.953449457604118,1.0,10/54,13.20%,LEPR;BCL2;LRRK2;NUPR1;GOLGA2;WASHC1;RUBCN;KLHL22;LZTS1;FOXK2
prerank,regulation of protein localization to cell surface (GO:2000008),0.29052704974028576,0.8312496738900177,0.7065026362038664,0.9530806234058868,1.0,3/33,5.58%,LEPROT;GPD1L;SNX33
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.33654349510652853,-0.8308507944423664,0.6782273603082851,0.8925003876080052,1.0,5/12,21.67%,PTPN14;TGFB1;BMP4;SIRT7;UHMK1
prerank,neuromuscular process (GO:0050905),-0.31920890753451014,-0.8306658346424687,0.688622754491018,0.8923062266892018,1.0,4/16,10.74%,GCH1;STRA6;NRXN1;KCNA1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.307587838559033,-0.8304693527337371,0.7047244094488189,0.8921137175304198,1.0,8/18,33.20%,MCM4;POLA1;POLE;POLD3;GINS4;LIG3;POLE3;GINS2
prerank,cellular response to estradiol stimulus (GO:0071392),0.32980427868942264,0.8303528454556782,0.7013487475915221,0.9541576560903359,1.0,3/18,6.88%,CRHBP;SSTR2;NCOA3
prerank,endothelial tube morphogenesis (GO:0061154),-0.3601844034072509,-0.8302013850058593,0.6795366795366795,0.8920213007610265,1.0,5/10,14.38%,ACVRL1;RHOB;CTNNB1;RHOA;CSNK2B
prerank,neuron apoptotic process (GO:0051402),-0.29810153417734137,-0.8300690766134776,0.7257731958762886,0.8916837483826489,1.0,7/19,18.89%,CIT;TNFRSF21;GAPDH;APP;FAS;CDK5;LIG4
prerank,nucleotide biosynthetic process (GO:0009165),0.3268260204462869,0.8299097808116659,0.6984126984126984,0.9543022222832082,1.0,3/18,5.98%,PRPSAP2;NMNAT2;ADSL
prerank,organelle assembly (GO:0070925),0.20567731731354932,0.8297795644731816,0.8846641318124208,0.9538650426609829,1.0,94/385,19.40%,DCDC2;ASAP1;INTU;AVIL;TP53INP2;RAB3IP;ARL3;SH3PXD2B;RAB19;DYNC2H1;CDC14B;MAPRE2;CCDC57;IFT80;HAUS4;WIPI1;CC2D2A;ARMC9;WDR19;UBXN10;TTC8;WDPCP;KIF27;WDR35;ARL6;CEP19;UBXN2B;IQCB1;ATG14;VTA1;TUBGCP6;YTHDF2;RAB32;TEKT2;TCTN1;SCLT1;ATP6V0D1;STAM2;GOLGA2;TUBGCP2;PARVA;CEP89;BBS7;FBF1;OFD1;WDR11;HAUS1;IFT122;ATG9A;EIF2S1;CHMP6;VPS37A;VPS37C;TTC39C;EXOC3;INO80;IFT140;PLA2G4C;CFAP298;CCDC65;WDR90;LMOD1;CEP63;RAB43;CEP164;CFAP70;CFAP410;ATP6V1D;AMBRA1;ATG3;MIS12;RUFY4;EXOC7;EXOC1;DYNC2I1;IRGM;CDS2;VPS37D;CFAP20;ATG16L2;PDE6D;RAB11FIP3;NCOR1;ARF4;RP2;TMEM237;BBS1;TRAF3IP1;IFT81;IFT46;LSM3;DDX3X;LSM14A;BBS2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.24121335373013486,-0.8295530118429176,0.7893569844789357,0.8920460968821983,1.0,24/52,28.73%,PPP1R13B;SREBF2;SH3GLB1;NMT1;YWHAB;MAPK8;YWHAG;BBC3;ARIH2;CASP8;VPS11;YWHAQ;YWHAH;PINK1;PPP3R1;TOMM7;HUWE1;MICALL2;YWHAZ;RNF31;PPP3CC;ABLIM3;BID;SFN
prerank,histone H4 acetylation (GO:0043967),-0.2416447738799033,-0.8294438991553379,0.7701149425287356,0.8916752644503049,1.0,11/47,17.31%,LEF1;MORF4L1;APBB1;ING4;OGT;NAA40;JADE1;KANSL3;RUVBL1;PER1;WDR5
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.2523718354807171,0.8292433528686584,0.7219343696027634,0.9542456428117304,1.0,9/71,9.50%,ADAMTS12;PRKN;CLPX;CTSH;ADAMTS7;FBXO44;FBXL17;YME1L1;MDM2
prerank,regulation of dephosphorylation (GO:0035303),-0.32172679273364413,-0.8290415387143831,0.7108910891089109,0.891840068831653,1.0,6/15,27.76%,PPP1R16B;MTMR9;PPP1R16A;SMG5;MTMR1;SMG6
prerank,regulation of lamellipodium organization (GO:1902743),0.3491157394867721,0.8286248824497556,0.6659574468085107,0.9547346405708177,1.0,4/14,11.05%,FER;PDPN;CAPZB;EPHA2
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.3384849928512157,-0.8284266370008699,0.6963249516441006,0.8924028139563649,1.0,8/13,40.31%,BLOC1S2;RHOT1;BMF;BAX;PMAIP1;BNIP3L;BAD;RHOT2
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.21757311075779878,-0.8282803004050584,0.8521505376344086,0.892117919353863,1.0,27/91,25.20%,HIP1;NSF;SCARB1;STON2;RAB3C;PACSIN2;PTPRC;HIP1R;BET1L;RAB3B;PTPN1;CDH13;CPLX2;MAP2K2;SYT7;INPP5F;RIT2;MAPK3;RAB8A;MBTPS1;CHMP3;RAB8B;RAB3A;LGI3;CPLX1;HAP1;RAB5B
prerank,negative regulation of GTPase activity (GO:0034260),0.3159450248252109,0.8281356246955676,0.7055335968379447,0.9549978561802445,1.0,3/22,5.48%,GMIP;CPEB2;LRRK2
prerank,negative regulation of immune response (GO:0050777),0.223287356908444,0.8281265953828169,0.8052325581395349,0.9543073676149845,1.0,17/154,11.47%,ADCY5;ADCY1;FER;ADM;FCRLB;CACTIN;PDCD1;IL6;PTH2R;NLRC3;LYAR;PTGIR;GLP1R;ITCH;ADRB3;ENPP3;PCBP2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.2696975903863548,-0.8281058248032661,0.7268817204301076,0.8918879884350593,1.0,15/29,34.04%,UBB;RPS27A;UBC;DDB1;RBX1;RPA1;UBA52;CETN2;GTF2H2;XPA;ERCC5;ERCC3;GTF2H5;RPA3;RPA2
prerank,regulation of acute inflammatory response (GO:0002673),0.33888086415876406,0.8280782241097635,0.703187250996016,0.9537100416751513,1.0,18/18,66.15%,IL6;OSMR;ADAM8;KLKB1;PTGES;F12;DNASE1L3;C2CD4A;C2CD4B;PLA2G2D;DNASE1;FFAR2;OSM;CREB3L3;GSTP1;IL4;IL6ST;NLRP3
prerank,organelle disassembly (GO:1903008),0.2866927657551593,0.8279721783640974,0.7148080438756855,0.9532169340298237,1.0,6/33,10.75%,PLK5;UFL1;CDK1;RETREG1;GOLGA2;TEX264
prerank,positive regulation of endopeptidase activity (GO:0010950),0.30872313293620024,0.8276733935233489,0.6936416184971098,0.9530945781632141,1.0,2/26,3.71%,ROCK2;EPHA4
prerank,positive regulation of mitochondrial fission (GO:0090141),0.32453815709527256,0.8272496897233725,0.6767068273092369,0.9531959747341495,1.0,3/18,7.85%,PRKN;BNIP3;MCU
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.28659270982231005,-0.8267851986125337,0.7355555555555555,0.893614558970597,1.0,9/25,24.36%,ETS1;ABCB10;STAT3;TAL1;ANKRD54;NCKAP1L;MAPK11;HSPA1B;STAT1
prerank,modification-dependent protein catabolic process (GO:0019941),0.21639996328236466,0.8264828371808693,0.8367346938775511,0.9539859550763962,1.0,29/193,12.80%,ASB2;RNF43;PRKN;SPSB1;NEDD4;RNF213;FBXW4;RNF217;ZNRF3;TRPC4AP;UBE2L3;TTC3;SIAH2;AMFR;BIRC6;RC3H2;UBE4A;MDM2;ITCH;RNF149;SMURF2;PSMD3;RBBP6;KLHL15;RNF14;RNF20;FBXO11;RCHY1;CDC26
prerank,histone H3 acetylation (GO:0043966),-0.24929157737516183,-0.8264633588356869,0.7790178571428571,0.8935986365245354,1.0,9/40,19.25%,LEF1;ING4;YEATS2;BRPF1;KAT14;JADE1;PER1;WDR5;SPI1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.30014894294427225,-0.8264026042982375,0.7021696252465484,0.8931390137302245,1.0,3/19,5.71%,FBXO7;SREBF2;CAMKK2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.24296198643423061,-0.8263041301131248,0.7834821428571429,0.892744910650688,1.0,16/48,22.36%,SLIT2;GAS6;PTPRC;NLRC5;ISG15;YTHDF3;IRAK3;NLRP2B;NR1H2;CARD16;SIGIRR;SH2B3;PADI2;METTL3;NR1H3;TRAIP
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.32810413145448625,-0.8261790637530263,0.7229862475442044,0.892427370899584,1.0,6/15,22.19%,SCARB1;MFSD2A;NR1H2;CTDNEP1;NR1H3;C3
prerank,NAD biosynthetic process (GO:0009435),0.3176260822059593,0.8256628305384571,0.65748031496063,0.954863281485579,1.0,8/20,17.83%,NMNAT2;NADSYN1;PARP10;PARP9;NMNAT1;NUDT12;QPRT;NNMT
prerank,alanine transport (GO:0032328),-0.35957549020994406,-0.8256167899111133,0.6959706959706959,0.8929011511945447,1.0,4/10,16.40%,SLC6A6;SLC36A1;SLC1A4;SLC36A4
prerank,peptidyl-serine phosphorylation (GO:0018105),0.22408878313709304,0.8255164398226815,0.8072463768115942,0.9544562762816403,1.0,29/153,14.45%,ROCK2;PDPK1;CAMK1D;DMPK;SRPK2;MAPK9;RICTOR;LRRK2;PRKCZ;PRKCB;TTK;PRKCA;PKN2;CDK1;CAMK2D;CLSPN;VRK2;LATS1;PRKDC;RPS6KB1;IKBKE;MAPKAPK2;HIPK3;PRKD2;TBK1;MAPK1;MORC3;NLK;PRKCI
prerank,histone H3 deacetylation (GO:0070932),-0.3186783561826385,-0.8254143410096985,0.7072243346007605,0.8926884644189148,1.0,8/15,29.50%,SFPQ;PER1;SIRT7;HDAC9;SMARCAD1;SIRT6;HDAC3;PER2
prerank,regulation of stem cell population maintenance (GO:2000036),0.3305302004377542,0.8245450445702004,0.6706349206349206,0.9556412871601949,1.0,3/18,11.86%,PTN;NCOA3;CNOT2
prerank,response to glucocorticoid (GO:0051384),-0.2812762568460993,-0.8241844473510236,0.7410358565737052,0.8943227131397067,1.0,5/26,12.32%,SLIT2;FAM107A;HNRNPU;ZFP36L1;REST
prerank,response to organophosphorus (GO:0046683),-0.31150649844557887,-0.823922908401043,0.6968503937007874,0.8942507261328346,1.0,2/16,1.90%,ABCC9;TRPC3
prerank,motile cilium assembly (GO:0044458),0.35928181304538886,0.8235664091245569,0.6570247933884298,0.9568594919567707,1.0,12/12,64.10%,DNAAF3;RSPH9;E2F4;MCIDAS;BBOF1;BBS5;SPATA6;ZMYND10;DNAAF1;RSPH6A;CCDC39;CCDC40
prerank,receptor clustering (GO:0043113),0.2968171913491312,0.8232886687898837,0.6991304347826087,0.956709414386102,1.0,8/27,13.66%,LRP4;PTN;DLG1;DNAJA3;MUSK;DLG4;DLG3;MAGI2
prerank,aminoglycan catabolic process (GO:0006026),0.2987088489420642,0.8231572875633748,0.7094474153297683,0.9562515781342061,1.0,4/28,7.97%,SDC2;GPC6;GPC3;CTBS
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.34328772852741035,-0.8230654018606683,0.7061068702290076,0.8952029379791452,1.0,5/11,20.19%,MAP3K5;PDCD10;STK25;CYP1B1;PRKCD
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.2955247222947479,-0.823000402712663,0.705050505050505,0.8947397379136037,1.0,5/20,14.97%,DCC;BCL2L1;GSK3B;APPL1;FAS
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.32038774830203554,-0.8227793659749443,0.6890595009596929,0.894572429905809,1.0,5/14,19.88%,TARDBP;YBX3;HNRNPA0;TIRAP;MYD88
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2736290703872527,-0.8220396057714903,0.77079107505071,0.8953205875122676,1.0,6/29,11.27%,HSP90AB1;CDC37;NLRC5;ISG15;PTPN1;YTHDF3
prerank,protein localization to chromosome (GO:0034502),0.28401303951574436,0.8218463769968812,0.7082601054481547,0.9580078659283097,1.0,6/34,7.25%,MRNIP;TPP1;ACD;XRCC5;SLF1;XRCC4
prerank,positive regulation of viral genome replication (GO:0045070),0.2961750892589221,0.8215996278877136,0.7013232514177694,0.9577777681943933,1.0,5/29,8.59%,PPARA;SRPK2;TOP2B;HACD3;PKN2
prerank,regulation of protein neddylation (GO:2000434),-0.3606975555923749,-0.8214628705217906,0.7156133828996283,0.8957006908678513,1.0,5/10,14.54%,RPL11;RPL5;COPS9;DCUN1D1;DCUN1D2
prerank,neurotransmitter transport (GO:0006836),0.24896698839067735,0.8212498324595412,0.7487179487179487,0.9577942434484491,1.0,3/73,2.16%,ATP1A2;SLC22A2;SLC1A3
prerank,regulation of BMP signaling pathway (GO:0030510),0.24522160448702113,0.8212410623671391,0.7579831932773109,0.9571105780818209,1.0,17/73,15.67%,RBPJ;SMAD6;FOXD1;SPART;SULF1;ITGA3;LRP2;NBL1;FSTL3;LEMD3;SMURF2;TFAP2B;BMPR1A;FSTL1;CDH5;SKI;SMAD4
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.31753474006901033,-0.8212190142880096,0.7142857142857143,0.8956128581381194,1.0,5/16,22.08%,SCARB1;MFSD2A;NR1H2;CTDNEP1;NR1H3
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.3437323169294885,0.8209301438952987,0.685370741482966,0.957012771908189,1.0,1/14,1.22%,IL18
prerank,response to axon injury (GO:0048678),-0.3082891377040653,-0.8201560806009947,0.71484375,0.8969356677909257,1.0,9/18,29.17%,APOD;RTN4RL1;SOD1;TYROBP;SARM1;P2RY12;GAP43;TREM2;MAPK8IP3
prerank,positive regulation of natural killer cell activation (GO:0032816),0.3546442650757748,0.8196760166596467,0.648870636550308,0.9587817705297589,1.0,1/13,1.22%,IL18
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2358976962302176,0.8196071044072306,0.778125,0.9582134550604673,1.0,12/104,10.44%,KSR1;SLC8A3;LTF;SLC8A1;CDK7;BLM;CCNT2;CCNT1;SYAP1;UVRAG;SLC27A1;ABL1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.33477882506042345,0.819551261581807,0.6739562624254473,0.9576132532889469,1.0,2/18,3.94%,PRKN;CRHBP
prerank,regulation of chromosome organization (GO:0033044),0.31153050958683615,0.8193845932727849,0.7,0.9572473197736171,1.0,3/22,7.05%,HDAC8;YLPM1;XRCC5
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.29253491236294843,-0.8185896882779452,0.7267080745341615,0.8990610701911087,1.0,4/22,10.85%,KLF4;MBP;CD44;GCNT2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.2780222086522909,0.8183228684256268,0.7077205882352942,0.9586053155992532,1.0,10/37,18.05%,PRKN;PCSK9;OPTN;TFAP2A;DLG4;PLIN5;SDCBP;EDNRB;TRAP1;NCOR1
prerank,regulation of cytoplasmic transport (GO:1903649),0.3647685549536829,0.8182951159270369,0.6785009861932939,0.9579689244559978,1.0,3/11,13.41%,LRRK2;USP7;MAPK1
prerank,regulation of immunoglobulin production (GO:0002637),0.3051771286514263,0.8181986024920406,0.7063339731285988,0.957448269302425,1.0,2/23,6.76%,RBP4;IL6
prerank,substrate-dependent cell migration (GO:0006929),-0.32507633363112926,-0.8181648527150124,0.7190569744597249,0.899231615191997,1.0,4/14,10.61%,SHTN1;ANKS1A;PTPRC;CD2AP
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.361605434369863,0.8181312693051883,0.6825726141078838,0.956880129195742,1.0,3/11,13.90%,PRKN;P4HB;STK26
prerank,positive regulation of organelle organization (GO:0010638),-0.2579768877897087,-0.8177894455960233,0.7447698744769874,0.8993009390011977,1.0,8/32,18.89%,PPARGC1A;SYNJ1;GSK3B;C2CD5;SORBS3;ADRB2;SMCR8;LIG4
prerank,lipid homeostasis (GO:0055088),0.2591561811862175,0.8176334099983672,0.7516891891891891,0.9571453086785837,1.0,6/57,7.55%,ZBTB20;ABCA1;RBP1;PRKAA2;THADA;PRKAA1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.3232767954804296,0.8174760595043706,0.7,0.9567643767616947,1.0,3/18,13.45%,PPARA;MIA3;PAG1
prerank,negative regulation of developmental growth (GO:0048640),-0.26825003276946857,-0.8174746322891432,0.7571428571428571,0.8992678466870884,1.0,12/30,27.61%,DCC;PTCH1;RTN4;CDKN1B;SEMA3G;CDKL3;MT3;RTN4R;CDKN1A;FGFR3;ULK2;FGF13
prerank,negative regulation of phosphatase activity (GO:0010923),-0.28071653942774305,-0.8173897765594094,0.7343096234309623,0.8988685687325302,1.0,8/25,16.65%,TGFB2;SEMA4D;TIPRL;GSK3B;CHP1;ZCCHC9;MASTL;BOD1
prerank,regulation of chemokine production (GO:0032642),-0.25227440779357035,-0.8170734806779503,0.7517899761336515,0.8988578826756016,1.0,16/36,35.47%,FOXP1;IL33;APP;CD74;CSF1R;SIGIRR;ACKR1;AGER;SNAI2;TLR7;TREM2;TLR4;LPL;TSLP;IL7;ADAM17
prerank,calcium import into the mitochondrion (GO:0036444),0.3728373427336147,0.8166178096176286,0.6597077244258872,0.9577044394154262,1.0,3/10,10.46%,MAIP1;MCU;MICU1
prerank,regulation of hippo signaling (GO:0035330),0.3296602524502109,0.8161615797494701,0.6987951807228916,0.9578306503034926,1.0,4/17,10.50%,VGLL4;WWC1;WWC2;SCHIP1
prerank,iron ion transport (GO:0006826),0.2730378622092892,0.8160969156502558,0.7477797513321492,0.9572701296141525,1.0,8/47,10.02%,CP;HEPH;LTF;TFR2;REP15;ATP6V0D1;ATP6V0E1;STEAP3
prerank,regulation of mitochondrial fission (GO:0090140),0.3004519143185185,0.8153088147290519,0.7142857142857143,0.9580935600946403,1.0,4/24,7.85%,PRKN;LRRK2;BNIP3;MCU
prerank,regulation of peptide hormone secretion (GO:0090276),0.24852144088680053,0.8151488726169124,0.7664,0.957697102469369,1.0,8/67,7.58%,ITPR1;KCNA5;TFR2;CRHBP;CACNA1D;IL6;PRKCA;RAPGEF4
prerank,positive regulation of JUN kinase activity (GO:0043507),0.3110207449924033,0.8150772491568554,0.6897880539499036,0.9571482585319369,1.0,2/23,2.62%,SASH1;DKK1
prerank,positive regulation of peptidase activity (GO:0010952),-0.2944075117004361,-0.814929132068266,0.7090163934426229,0.9019611211599777,1.0,7/20,24.17%,GRN;NDUFA13;PSME3;PSME1;PINK1;VCP;VSIR
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3144036947601155,0.8148197541923625,0.697265625,0.9569376337547267,1.0,4/18,7.50%,PDPN;IL6;SMAD3;DDR2
prerank,arachidonic acid metabolic process (GO:0019369),-0.2558218941920684,-0.8147271788396695,0.791231732776618,0.9017457634224704,1.0,8/35,15.18%,MGLL;GPX4;PTGIS;PTGS2;PTGDS;ALOX12;PLA2G4A;CYP1B1
prerank,amide biosynthetic process (GO:0043604),0.26899798488897475,0.8147071178238833,0.726148409893993,0.9564768486285873,1.0,9/47,12.14%,DMD;PM20D1;CERS6;CERS5;AANAT;ASL;CERS1;PAM;SLC25A2
prerank,DNA recombination (GO:0006310),0.27871964094916085,0.8135722877053542,0.7202797202797203,0.9579459114883899,1.0,9/37,17.09%,RAD51B;RAD51C;DMC1;BLM;RTEL1;MRE11;WRN;RAD51;RPAIN
prerank,cellular lipid catabolic process (GO:0044242),0.30005759927932507,0.8134573607083179,0.7113207547169811,0.9574714926047057,1.0,3/27,6.79%,CEL;ACADL;ENPP2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.346096812327346,0.8131664404135982,0.6837944664031621,0.9573439025857584,1.0,3/13,7.35%,SZT2;SESN1;RNF152
prerank,response to exogenous dsRNA (GO:0043330),0.3264759805654935,0.8129500376965572,0.693359375,0.957080974941187,1.0,1/18,0.45%,COLEC12
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.271825687243497,-0.8128385099234107,0.7637969094922737,0.9044525650315456,1.0,3/29,6.25%,NSF;VTI1B;COPG1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3278743975199149,0.812405284191349,0.7015810276679841,0.9574974759679437,1.0,8/17,21.34%,AKAP13;ADRA1D;ADRB3;DRD2;ADCY9;ADRA2A;GPR101;RAPGEF2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2909740386920019,0.8123524805311481,0.7285974499089253,0.9569119643650298,1.0,15/29,24.97%,EXOSC8;DCP2;LSM5;CNOT8;CNOT7;EXOSC3;LSM3;LSM1;LSM4;DDX6;EXOSC4;DCP1B;LSM6;DIS3;NT5C3B
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.23892022956406758,0.8120796890243163,0.7903225806451613,0.9567297598495801,1.0,14/83,14.72%,NINL;ALMS1;HAUS4;CEP152;SDCCAG8;CDK1;PAFAH1B1;NEK10;OFD1;HAUS1;SFI1;CEP57;CEP63;CEP164
prerank,response to ionizing radiation (GO:0010212),0.2482336798626221,0.8116543266452945,0.7812018489984591,0.9568663437678729,1.0,14/70,16.10%,EYA1;ANXA1;MRNIP;INIP;BLM;XRCC4;PRKAA1;NHEJ1;INO80;CLOCK;BABAM2;BRSK1;SWI5;RAD51
prerank,muscle cell migration (GO:0014812),0.3777638526749677,0.8114825745618216,0.6708595387840671,0.9564979530876777,1.0,2/10,4.87%,MEGF10;DDR1
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.2762163524669866,-0.8113564086529685,0.7327935222672065,0.9064361667111426,1.0,8/23,26.10%,ITGB1;NSFL1C;INSC;NDE1;NUMA1;DCTN1;NDC80;SPDL1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.30586652784417023,0.8113098379613379,0.7,0.9561615743421786,1.0,9/22,25.29%,CCNT2;CCNT1;CDC73;ELL;TCERG1;SUPT4H1;THOC1;BRD4;CDK13
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.34110034752709667,0.8112852062900631,0.6877637130801688,0.9555251661576151,1.0,5/15,16.47%,FSTL3;LEMD3;MAGI2;SKI;IGSF1
prerank,defense response to virus (GO:0051607),0.23398596121578563,0.8112582503961483,0.8108108108108109,0.9548915901521942,1.0,11/100,7.98%,BCL2;PLA2G10;IFIT3;IFIT2;RNASEL;TRIM5;ZDHHC1;BNIP3;IL6;TRIM56;RNF135
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.35822565261907324,-0.8109862929365325,0.7145557655954632,0.9065199860724542,1.0,3/10,8.71%,IQSEC1;MTOR;FGF7
prerank,regulation of inclusion body assembly (GO:0090083),0.3596323527846045,0.8108138573967781,0.6556701030927835,0.9550219437071599,1.0,1/11,2.45%,SNCAIP
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.22761821027201004,-0.8107601136751929,0.8232445520581114,0.9063690890555385,1.0,18/59,23.41%,DAB2IP;UBB;NFKBIA;IKBKB;RPS27A;UBC;BIRC3;NKIRAS1;CHUK;BCL3;TBKBP1;TAB3;UBA52;SHARPIN;AKT1;RBCK1;FAIM;RELA
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.34516113080033767,0.8105600544430153,0.6868250539956804,0.9548349440116739,1.0,3/12,8.73%,PRKCB;PRKCA;CDK1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.3536692467917417,0.8103797476414116,0.6639004149377593,0.9544919802673258,1.0,2/12,5.98%,PRPSAP2;ADSL
prerank,water-soluble vitamin metabolic process (GO:0006767),0.25025905785621044,0.8099561526316917,0.7652173913043478,0.9545993059456745,1.0,22/68,23.60%,PCCA;MCCC2;TCN2;MTHFR;FOLR2;SLC19A2;SLC19A1;FLAD1;SHMT1;THTPA;MTHFS;MMAB;NNMT;DHFR;MTHFD2;PDXK;LMBRD1;TCN1;BTD;SLC52A1;FPGS;HLCS
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.33499760474974954,-0.8091194107623276,0.7142857142857143,0.9086366378225028,1.0,3/12,11.74%,FOXP1;ZBTB7A;HEYL
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.2901650060206957,-0.808883126420975,0.7329192546583851,0.9084894348388288,1.0,4/19,14.08%,SLC26A2;PAPSS2;BPNT2;SLC35B2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.21903410418706326,0.8083441137347585,0.8577712609970675,0.9569462188939095,1.0,26/158,15.54%,WLS;PRKN;PELI2;LPAR1;LTF;ECM1;TRIM5;AKAP13;GJA1;PRKCB;CXXC5;CCL19;SLC20A1;GOLT1B;IKBKE;CFLAR;GPRC5B;TBK1;MAP3K7;UNC5CL;UBE2V1;MTDH;BIRC2;TRIM62;CX3CL1;TMEM9B
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.37073540282874007,0.8072201663707017,0.6915113871635611,0.9583409986588789,1.0,3/10,9.87%,EPHA4;ATRAID;RIC1
prerank,negative regulation of transferase activity (GO:0051348),-0.26566699974080227,-0.80691049306444,0.7838983050847458,0.9111951577221232,1.0,5/28,11.31%,PINX1;GSK3B;HNRNPU;CDKN1B;MEN1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.3457523202722178,-0.8067997874769924,0.7544910179640718,0.910815958921029,1.0,4/11,21.07%,MTOR;PIH1D1;NOP53;SIRT7
prerank,regulation of endopeptidase activity (GO:0052548),-0.22770109953932283,-0.8066449745117031,0.8288508557457213,0.9105058160139926,1.0,15/59,18.57%,SPOCK2;SERPINE2;SERPINI1;SERPINF1;SERPINB9;GAPDH;BIRC3;FURIN;PSME3;PSMB8;SPOCK1;PSME1;ATP13A2;TIMP2;SERPINA2
prerank,response to interleukin-6 (GO:0070741),-0.3555582741428739,-0.806500847567951,0.7397003745318352,0.9101987955805553,1.0,3/10,8.87%,ST3GAL6;SBNO2;PTGIS
prerank,negative regulation of transmembrane transport (GO:0034763),0.36966722320751355,0.806115341816622,0.6727688787185355,0.9597254998940191,1.0,2/10,5.87%,OAZ3;PRKCB
prerank,regulation of cell projection organization (GO:0031344),0.3534652270751705,0.8055088707483429,0.6991525423728814,0.960175256105981,1.0,5/13,15.33%,MACF1;NTNG2;CCL19;MYO9A;MOV10
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.28684645806957904,-0.8052791815463951,0.7698744769874477,0.9116596122466677,1.0,12/22,33.35%,DUSP16;PPP1CA;DUSP8;DUSP1;PPM1A;DUSP6;DUSP4;DUSP18;PPM1F;PPP2CA;DUSP7;PDP1
prerank,V(D)J recombination (GO:0033151),0.3676808205378691,0.8050628116950344,0.7109704641350211,0.9603400206868882,1.0,3/11,12.75%,XRCC4;PRKDC;LIG1
prerank,sulfur compound catabolic process (GO:0044273),0.2711305330611373,0.8050531828388466,0.7578947368421053,0.9596801250978242,1.0,4/38,5.37%,FMOD;OGN;OMD;PRELP
prerank,organophosphate catabolic process (GO:0046434),0.35593220338983045,0.8049608808421682,0.6778242677824268,0.9591809656819299,1.0,11/11,64.43%,ENPP2;ABHD12;PLBD2;PNLIPRP2;APOA2;LIPG;ANGPTL3;PON1;PDXP;NUDT15;PLBD1
prerank,positive regulation of type I interferon production (GO:0032481),-0.21716968623457442,-0.8046718494227164,0.8663366336633663,0.9121094756709871,1.0,22/73,26.74%,LRRFIP1;HSP90AA1;G3BP1;CTNNB1;GAPDH;CHUK;ISG15;CRCP;OAS2;HSPD1;IFIH1;IRAK1;IRF5;MYD88;POLR3D;NFKB2;RELA;POLR2L;POLR3F;STAT1;CGAS;TLR7
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.26916113376618217,-0.8046236238734531,0.7789473684210526,0.9116302972036006,1.0,12/28,23.41%,UBB;NOD1;RPS27A;UBC;TAB3;AAMP;CASP8;UBA52;IRAK1;TNFAIP3;OTULIN;RELA
prerank,positive regulation of receptor internalization (GO:0002092),-0.279583230556095,-0.8045025797171781,0.7620967741935484,0.911274790054333,1.0,10/22,21.01%,SFRP4;ARRB1;VEGFA;CD63;PICK1;GREM1;ARRB2;INSR;FMR1;ATAD1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.32168159662134893,0.8043283918256473,0.7142857142857143,0.9596769152083204,1.0,4/18,10.71%,DKK1;SOX6;FRS2;HDAC1
prerank,regulation of NMDA receptor activity (GO:2000310),0.283548995342999,0.8041732737829239,0.7297297297297297,0.9593119737984321,1.0,8/32,12.85%,DAPK1;SLC6A9;CRHBP;DLG1;DLG4;ACTN2;GRIA4;DLG3
prerank,regulation of leukocyte activation (GO:0002694),-0.30954810493019813,-0.8041368441774187,0.7509293680297398,0.9113297495333256,1.0,5/14,16.76%,CD200;GPR137B;GPER1;CD74;MIF
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.3657476004359186,0.8041300929881617,0.6938775510204082,0.9587137509611416,1.0,1/11,1.00%,FGFR2
prerank,response to glucose (GO:0009749),0.26615728672666955,0.8040916998538038,0.75,0.9581005001649455,1.0,6/46,7.95%,TCF7L2;ZBTB20;PRKAA2;IGF1R;PRKAA1;SLC30A8
prerank,histone deacetylation (GO:0016575),0.2642532655262973,0.8027766498106587,0.7473684210526316,0.9598481605049893,1.0,4/43,4.20%,PRDM5;TBL1XR1;MIDEAS;HDAC8
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.2934760627968672,-0.8022790770786662,0.7577639751552795,0.9138897704445177,1.0,9/18,34.09%,EDN1;RFK;AGTR1;PDP2;POR;AGT;NOD2;PDP1;PARK7
prerank,nucleic acid metabolic process (GO:0090304),-0.21561730013867583,-0.8021673177375639,0.8671679197994987,0.9135151056664634,1.0,23/69,26.46%,HNRNPK;RBFOX2;HNRNPU;HNRNPA3;HNRNPH2;DDX54;POLR2C;TOPBP1;HNRNPA0;NT5E;POLR2G;GTF2F2;PCBP1;PTBP1;DDX24;METTL3;WDR74;DUSP11;POLR2L;HNRNPF;HNRNPM;HNRNPD;LSM8
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.30612441643661537,-0.8019978402103307,0.7348927875243665,0.9132473113581967,1.0,9/16,26.47%,RYR2;HSPA5;BCAP31;GBF1;SEC16B;VAPA;PPP1R15A;SEC16A;UBAC2
prerank,positive regulation of TORC1 signaling (GO:1904263),0.33375872081019425,0.8019205255724589,0.696652719665272,0.9607387618526971,1.0,9/16,22.74%,GPR137C;FLCN;KLHL22;SIK3;TELO2;LARS1;CLEC16A;LAMTOR5;RRAGD
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2576360919318267,-0.8017843015831657,0.7700650759219089,0.9130398350511357,1.0,10/31,25.91%,ATXN3;OTUD7A;ZRANB1;USP50;OTUD1;USP8;OTUD7B;TNFAIP3;USP33;YOD1
prerank,glucan catabolic process (GO:0009251),0.3306112411942496,0.8015818098469667,0.6817248459958932,0.9607113943241994,1.0,2/15,4.59%,PHKB;MGAM
prerank,nucleic acid-templated transcription (GO:0097659),0.2666505150248478,0.8014933036944112,0.7473684210526316,0.9601864622537566,1.0,5/42,10.93%,POLR2D;SCX;THAP1;POLR2A;DTX1
prerank,detection of calcium ion (GO:0005513),-0.3240855428412488,-0.8013693141998778,0.736328125,0.9131841639918271,1.0,5/13,15.59%,CALM1;RYR2;KCNMB4;KCNIP2;CALM2
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.3003323427520478,0.8012774658741775,0.7242718446601941,0.9599267105855591,1.0,3/25,5.24%,RBPJ;FOXD1;SULF1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.24236749561828513,0.801186068022822,0.7960526315789473,0.9594157106927859,1.0,18/73,18.71%,JARID2;IGF2;RBBP4;BAZ1B;RBBP7;MTF2;PRMT7;SMARCA5;TAF1A;POLR1F;POLR1A;CGGBP1;TAF1D;PHF1;PHF2;POLR1G;HDAC4;GLMN
prerank,cellular response to oxygen levels (GO:0071453),0.3637541914501338,0.8008162923626612,0.6936542669584245,0.9594152501896738,1.0,3/10,9.31%,CPEB4;TMEM199;ATP6V0D1
prerank,negative regulation of macroautophagy (GO:0016242),0.29544645919625717,0.8007898739549777,0.7348927875243665,0.9587916904105622,1.0,11/26,22.11%,LRRK2;NUPR1;RUBCN;TMEM39A;LZTS1;FEZ1;TSC1;PIK3CA;CLEC16A;TSC2;SMG1
prerank,regulation of T cell differentiation (GO:0045580),-0.25723444354708175,-0.8007569648846716,0.7982832618025751,0.913623141356132,1.0,7/33,15.70%,RUNX1;CBFB;NFATC2;SOD1;XBP1;TCF7;CAMK4
prerank,positive regulation of telomere capping (GO:1904355),-0.30202290524701125,-0.8007525518100904,0.750996015936255,0.913072176405431,1.0,2/17,10.52%,NEK7;MAP2K7
prerank,negative regulation of viral process (GO:0048525),-0.22345606273059931,-0.800327975643386,0.8040201005025126,0.9132230227150848,1.0,20/57,24.36%,PPIA;TRIM14;LARP7;ISG15;OAS2;RSAD2;SHFL;SRPK1;TRIM13;IFIH1;FAM111A;N4BP1;BST2;MID2;TRIM27;IFITM3;UBP1;CHMP3;BANF1;STAT1
prerank,DNA double-strand break processing (GO:0000729),0.3203454191680076,0.7999723834674337,0.6928838951310862,0.9596117917113973,1.0,7/18,23.61%,RNF138;BLM;MRE11;KAT5;RAD50;NBN;RAD52
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.34465169629835496,0.799855567981499,0.7178423236514523,0.9591617034587642,1.0,1/14,0.98%,PPP2R2B
prerank,renal absorption (GO:0070293),0.3700349449959928,0.7998024225737229,0.7066381156316917,0.9585824689383535,1.0,1/10,1.20%,WNK4
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.3247022715729235,-0.7995684837776622,0.72552783109405,0.9139058476237496,1.0,4/12,20.87%,STMN2;STMN1;TUBB4A;MAPRE1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.2788648375182437,0.7995333889498907,0.7758620689655172,0.9583735851138718,1.0,3/34,6.76%,RBP4;LACC1;IL6
prerank,cellular response to hydrogen peroxide (GO:0070301),0.2803886958612211,0.7990376099899941,0.7403314917127072,0.958605993092732,1.0,5/33,10.44%,OSER1;ANXA1;IL6;SIRPA;ABL1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.34962523481916996,0.7983580467970333,0.6869747899159664,0.9591165736440082,1.0,3/13,8.14%,ALG6;ALG2;ALG9
prerank,hyaluronan metabolic process (GO:0030212),-0.2800716002352519,-0.7983577449114941,0.7379912663755459,0.9152793004631424,1.0,6/23,8.91%,TGFB1;CD44;CEMIP2;CHP1;HEXB;HEXA
prerank,regulation of cytokinesis (GO:0032465),-0.21196519244218473,-0.7978137444000818,0.8413597733711048,0.91561792151834,1.0,16/78,17.98%,PKP4;CALM1;SH3GLB1;CIT;PLK2;BCL2L1;CUL3;RHOA;GIT1;PIK3C3;KIF13A;CALM2;PRKCE;KLHL9;ENTR1;CETN2
prerank,quinone biosynthetic process (GO:1901663),0.3270783252484491,0.797590937686779,0.6997885835095138,0.9597866384738647,1.0,4/14,11.44%,FDXR;COQ10A;COQ8B;COQ6
prerank,base-excision repair (GO:0006284),-0.2297797284916922,-0.7973495804333396,0.8051643192488263,0.9158360533146622,1.0,23/48,34.77%,SMUG1;RPA1;OGG1;POLQ;NEIL1;NEIL3;POLE;POLD3;POLB;NTHL1;POLD1;HUWE1;XPA;POLL;ERCC5;LIG3;RFC5;NEIL2;RPA3;DNA2;FEN1;RPA2;XRCC1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.31108254858115575,0.7973356834204335,0.7240663900414938,0.9595806365071532,1.0,3/18,6.98%,ANXA1;SSTR2;UBE2L3
prerank,membrane lipid metabolic process (GO:0006643),-0.2823455980430674,-0.7968178579960286,0.7379032258064516,0.9161284998898719,1.0,4/22,9.70%,ST3GAL6;SERINC1;B4GALT4;CERK
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.28251318956915444,0.7964986437498176,0.7223230490018149,0.96036926743164,1.0,13/30,20.59%,VAMP5;MACF1;KRT18;OPTN;GGA2;BLZF1;GOLPH3L;RAB26;PREPL;BBS1;GOLGA4;BBS2;RAB34
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.30224447605517035,-0.7958971091020939,0.7473233404710921,0.9170697175447808,1.0,13/15,49.81%,CD55;NKAP;CCR2;SHH;SYK;IL12A;IL23A;EBI3;IHH;IL23R;PNP;HSPH1;IL12B
prerank,regulation of innate immune response (GO:0045088),0.24848122473278236,0.7957751500539414,0.8003533568904594,0.9609900417583728,1.0,7/57,8.18%,APPL2;RNASEL;CACTIN;NLRC3;POLR3G;RNF135;LYAR
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.2647885277873921,-0.7954713152321239,0.7806451612903226,0.9171992174593816,1.0,7/28,19.28%,DAB2IP;NGF;BLOC1S2;CASP8AP2;CASP8;SPI1;TNFRSF10B
prerank,regulation of exosomal secretion (GO:1903541),0.3091913558362965,0.7950840229036286,0.7121771217712177,0.9616155903678137,1.0,1/19,1.37%,PRKN
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.2524467144326733,-0.794589410496898,0.8117154811715481,0.9180235966137638,1.0,9/32,20.17%,RPS19;PGLYRP1;DEFA6;GAPDH;RPL30;ROMO1;RNASE3;CCL13;ANG
prerank,long-chain fatty acid import into cell (GO:0044539),0.3697179080000277,0.794388860582085,0.6861924686192469,0.9622039587065501,1.0,3/10,10.77%,ACSL1;SLC27A1;RPS6KB1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.29837169506733574,-0.7943608300644085,0.7722772277227723,0.9178087745911414,1.0,8/17,28.73%,BCL2L1;CLU;BBC3;TIMM50;BAX;FIS1;BID;SFN
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.3493996672810203,0.7943160440244417,0.6838709677419355,0.9616541618587074,1.0,4/10,16.74%,STAT5B;JAK2;LYN;GHR
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.26170301379623506,-0.7942305593668589,0.7884187082405345,0.9174563197737562,1.0,11/31,29.63%,TOMM20;HSPD1;ROMO1;PEX1;PEX5;PEX10;TIMM50;PEX16;TIMM44;CHCHD4;DNLZ
prerank,nucleotide metabolic process (GO:0009117),0.293898496044154,0.7940308111814164,0.7295238095238096,0.961484606325417,1.0,5/23,11.84%,FHIT;CTPS2;NMNAT2;ENPP3;NMNAT1
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.2508912394246272,-0.7937511437861047,0.8264840182648402,0.9176663370902275,1.0,13/33,31.30%,CPSF7;CPSF3;SYMPK;CLP1;CPSF2;CSTF2T;PCF11;CSTF2;MAZ;SNRPG;LSM11;CSTF1;CPSF1
prerank,regulation of interleukin-13 production (GO:0032656),0.34206339068139624,0.7933640232538556,0.7008196721311475,0.9619687593107652,1.0,2/13,5.49%,IL18;PRKCZ
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.26917782352302577,-0.7932959578677884,0.7883817427385892,0.9178234406395623,1.0,7/25,19.26%,RAC1;RIN3;APP;ANKRD13A;ABCA2;ANKRD13B;PSEN1
prerank,cellular response to radiation (GO:0071478),-0.24298032589027768,-0.7928868224824484,0.7949308755760369,0.917904785795555,1.0,9/40,21.71%,NET1;RHOB;EEF1D;SPIDR;TNKS1BP1;RAD9A;LIG4;GADD45A;CDKN1A
prerank,cellular polysaccharide catabolic process (GO:0044247),0.31997734236843245,0.7928763685147606,0.704,0.9621556972873595,1.0,2/16,4.59%,PHKB;MGAM
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3222984404815372,-0.7926572528401762,0.7466918714555766,0.9177351883549791,1.0,3/12,13.03%,ELOVL5;FADS2;ELOVL1
prerank,modulation by host of viral genome replication (GO:0044827),0.34285404461496083,0.7923939593023274,0.7071129707112971,0.9623093110853487,1.0,1/13,1.37%,PRKN
prerank,response to cAMP (GO:0051591),0.26754965204231823,0.7921716703768459,0.7657657657657657,0.9620493731024531,1.0,4/37,5.21%,SLC5A5;DUOX2;CRHBP;AANAT
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.3003761785544323,0.7921128938444169,0.7132075471698113,0.9614814069300704,1.0,5/23,8.68%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.24594248948340464,0.7918336653124702,0.7928692699490663,0.9613076938164753,1.0,12/60,16.40%,FGFR4;SMOC2;PDGFRB;ACD;XRCC5;CCT6A;FBXO4;PRKD2;MAPK1;TCP1;PARN;HGF
prerank,microtubule-based transport (GO:0099111),-0.3267260948843041,-0.7910279917629512,0.7514450867052023,0.9197849687280948,1.0,6/13,36.45%,SPAG17;DNAAF2;DYNC1I1;CABYR;CCDC40;DNAAF4
prerank,positive regulation of double-strand break repair (GO:2000781),0.27067746280053934,0.7909979050088647,0.7553571428571428,0.9621259197589049,1.0,8/39,13.58%,MRNIP;SLF1;WDR48;SPIRE2;ARID2;PRKDC;PARP9;FANCB
prerank,mammary gland development (GO:0030879),0.3031042668156611,0.7907709823465416,0.7111111111111111,0.9618450664550801,1.0,5/21,14.38%,WNT4;ARHGAP35;APLN;JAK2;GLI2
prerank,dorsal/ventral pattern formation (GO:0009953),-0.2787329846803307,-0.7905211068909314,0.7855670103092783,0.9200091134353917,1.0,5/20,19.22%,ACVRL1;PTCH1;ACVR1;GREM1;DSCAML1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.19378056721320258,-0.7901741687035263,0.9351351351351351,0.9200061553096881,1.0,35/117,28.60%,PLCG2;RAMP2;FYN;ADCY4;PLK2;RHBDF2;MYH9;RAMP1;ADCY7;PTHLH;CYSLTR1;ADCY3;FURIN;CYSLTR2;ADRB2;PRKAR1A;CD81;IAPP;CALCRL;VIPR2;MC5R;YES1;GPR27;HRH2;TSHR;GGT1;GLP2R;NPSR1;ADCYAP1;GNB1;TREM2;GPR20;KARS1;CALCA;CD163
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.3255587126342726,0.7900978270777447,0.7355212355212355,0.9623368595081587,1.0,1/15,1.27%,STXBP4
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.2860257691728607,-0.79008537100753,0.7505154639175258,0.9196083322642623,1.0,4/20,12.75%,PDE4D;ADRA1B;ADRA1A;ADRB2
prerank,polyol biosynthetic process (GO:0046173),0.3241153053866668,0.7897673335575381,0.7322834645669292,0.9622487139976117,1.0,1/16,1.11%,CYP27A1
prerank,establishment of protein localization to organelle (GO:0072594),0.23798333466693075,0.7892437998059956,0.7993579454253612,0.9624795909062664,1.0,10/72,13.82%,APPL2;IPO13;HK2;PRICKLE1;LAMP2;NUTF2;NUP107;TNPO1;LAMP5;NXT2
prerank,cell differentiation in spinal cord (GO:0021515),0.3624264206014398,0.7890199033344402,0.728448275862069,0.9621967877177607,1.0,4/10,21.38%,SOX6;SOX13;MDGA1;DRAXIN
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.22735846285700126,-0.789014335257809,0.8277511961722488,0.9207525358903962,1.0,16/48,30.53%,PDE4D;SLC7A5;IL1R1;CYRIB;ISG15;HSPD1;TRIM27;TXK;SLC11A1;CCR2;IL12RB2;TLR7;TLR4;RASGRP1;FADD;ZFPM1
prerank,regulation of cytokine production (GO:0001817),0.21928927444251595,0.7888173015842428,0.8663729809104258,0.9619013627051659,1.0,11/126,7.89%,C1QTNF3;LGR4;IGF2BP1;PLA2R1;LTF;ANXA1;CCN4;SYT11;IRF8;IL6;TRIM56
prerank,negative regulation of T cell activation (GO:0050868),-0.24850650530002336,-0.7884603583820551,0.7868131868131868,0.9210702947323243,1.0,15/35,33.29%,TNFRSF21;CEACAM1;DUSP3;LAPTM5;CD274;JAK3;NCKAP1L;SDC4;FCGR2B;CEBPB;CD80;LAX1;IL4I1;PTPN22;GPNMB
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2597967556170035,0.7879853879423377,0.7522603978300181,0.9626898560200946,1.0,6/49,6.29%,KMT2A;MTURN;ASH2L;TNRC6B;TNRC6A;SETD1A
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.28021603639136416,-0.7879201058424843,0.7727272727272727,0.9208154956197014,1.0,10/21,34.04%,DDB1;RBX1;RPA1;GTF2H2;XPA;ERCC5;ERCC3;GTF2H5;RPA3;RPA2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.28021603639136416,-0.7879201058424843,0.7727272727272727,0.9208154956197014,1.0,10/21,34.04%,DDB1;RBX1;RPA1;GTF2H2;XPA;ERCC5;ERCC3;GTF2H5;RPA3;RPA2
prerank,positive regulation of sodium ion transport (GO:0010765),-0.32989028156955086,-0.7877475367352287,0.7359223300970874,0.9205169692405595,1.0,6/12,19.90%,WNK3;CNKSR3;NOS1;AHCYL1;SCN1B;ANK3
prerank,positive regulation of fat cell differentiation (GO:0045600),0.25455265759416623,0.7875328511553213,0.8081705150976909,0.9628047123310218,1.0,8/47,12.17%,BMP7;MEDAG;TMEM64;NAPEPLD;LMO3;SYAP1;ASXL2;SOX13
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.2637181486571314,0.78744547267762,0.7704918032786885,0.9623066763508586,1.0,4/44,3.96%,WNK4;ATP1B3;NOS1AP;ANK2
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2700513841379832,-0.7867429565057898,0.7622080679405521,0.9214474020259276,1.0,7/24,14.11%,FYN;KCNB1;CHP1;C2CD5;MIEF1;MIEF2;MTCL1
prerank,macromolecule catabolic process (GO:0009057),0.2938281381263686,0.7865580179024807,0.7467411545623837,0.9631816240578487,1.0,5/26,9.09%,CLPX;NEDD4;TPP1;PIK3R4;UVRAG
prerank,photoreceptor cell development (GO:0042461),0.32591291269743267,0.7860840493073894,0.7242718446601941,0.9633440679327033,1.0,2/14,4.12%,TULP1;ARL3
prerank,determination of bilateral symmetry (GO:0009855),0.3022982083765818,0.785681551305853,0.7448015122873346,0.9633551173020767,1.0,6/25,14.99%,ODAD3;DNAH11;ARL6;BBS7;PKD2;ODAD2
prerank,transport along microtubule (GO:0010970),-0.31749265568933854,-0.7856643930736925,0.7445109780439122,0.9225482048881559,1.0,5/13,31.37%,COPG1;APP;CAMSAP3;APBA1;DYNC1I1
prerank,cholesterol transport (GO:0030301),0.2624531026231991,0.7853570900728124,0.7859778597785978,0.963225565539716,1.0,7/45,10.19%,CEL;ABCA1;LIMA1;LIPC;ABCA5;APOC1;SOAT2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.23221137476917034,0.7844125575950956,0.8322683706070287,0.9641504805803194,1.0,21/80,18.84%,DENND2A;SNX6;PLEKHJ1;STX16;TMEM87A;RIC1;WASHC1;TMEM87B;VTI1A;SNX12;PHETA1;TRAPPC10;TBC1D17;RAB9A;VPS26A;PREPL;VPS54;VPS35;RHOBTB3;GOSR1;RAB29
prerank,positive regulation of axon extension (GO:0045773),-0.27496767026786617,-0.7840269251179747,0.7874493927125507,0.9244590798166197,1.0,4/22,11.59%,SEMA7A;SHTN1;VEGFA;DBNL
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.32507333414116324,0.7837112403423544,0.7328918322295805,0.964670190649315,1.0,3/15,6.98%,ANXA1;SSTR2;UBE2L3
prerank,superoxide metabolic process (GO:0006801),0.2803970506961737,0.7831361320411954,0.7504798464491362,0.9649535147029806,1.0,4/29,4.41%,SOD3;DUOX2;TAFA4;SH3PXD2B
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.27047169109704833,-0.782876612631668,0.7875751503006012,0.925683214009507,1.0,8/24,28.53%,TTLL7;VKORC1L1;VKORC1;TTLL8;CEP41;TTLL6;AGTPBP1;TTLL2
prerank,positive regulation of cell communication (GO:0010647),0.2809730055164552,0.7826024818132405,0.7406679764243614,0.965157126953541,1.0,1/28,0.46%,WLS
prerank,cellular response to superoxide (GO:0071451),-0.34755860019500195,-0.7825071961347047,0.7737226277372263,0.92570162027083,1.0,3/10,13.96%,NOS3;SOD1;MT3
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.30327565396982475,-0.7821402607058401,0.7706422018348624,0.9256865913411054,1.0,6/16,20.49%,SRSF1;PRPF39;CWC15;SNRPC;DCPS;RBM22
prerank,positive regulation of bone resorption (GO:0045780),-0.3335077682755018,-0.7819732477706214,0.7610789980732178,0.9253723772881028,1.0,3/11,16.00%,SPP1;TNFRSF11A;PLEKHM1
prerank,phosphate ion transmembrane transport (GO:0035435),0.3460020411382283,0.7815202540121886,0.7157894736842105,0.9663676280285824,1.0,3/12,9.59%,SLC20A2;SLC25A11;SLC20A1
prerank,protein-DNA complex assembly (GO:0065004),0.2194012979748486,0.7801807105217358,0.8733974358974359,0.9679185211324804,1.0,24/116,17.36%,TCF4;CDK7;DDB2;DMC1;PSME4;PSMA2;PSMA3;RSF1;KAT6B;PSMD8;SMARCA5;PSMD3;NAP1L3;CUL4B;ORC2;NAA60;MNAT1;RAD23B;ORC3;MCM2;RAD51;NAP1L1;ORC6;XPC
prerank,protein localization to synapse (GO:0035418),-0.31975141016963565,-0.7800663090830656,0.7655310621242485,0.9277070400640102,1.0,4/12,13.54%,ZDHHC15;NRXN1;PCLO;BSN
prerank,positive regulation of ion transport (GO:0043270),0.2528451836166607,0.7798482271256381,0.7992957746478874,0.9678337288929735,1.0,13/48,18.17%,GPD1L;MYLK;ANK2;CACNA1D;DLG1;CCL4;SCN3B;ACTN2;GDNF;CHRNB2;DRD2;ANO6;CAMK2A
prerank,protein localization to nucleus (GO:0034504),-0.19748455586969058,-0.7794918744084645,0.912568306010929,0.9280757382086285,1.0,29/102,21.43%,RPL11;PINX1;CALR;SIX1;HNRNPU;ZBTB7A;PPP1R10;APPL1;TOR1B;ARL2BP;BCL3;STAT3;HHEX;LMNA;COL1A1;SIX4;E2F3;NXT1;HEATR3;CSE1L;NUP85;FAM53C;NOP53;AKT1;SKP1;CTDNEP1;NUP133;BMP4;POM121
prerank,cholesterol efflux (GO:0033344),0.3085318242532298,0.7793764523281024,0.7392197125256673,0.9679317991834395,1.0,4/20,10.19%,ABCA1;ABCA5;APOC1;SOAT2
prerank,cellular response to gamma radiation (GO:0071480),-0.2916439959932457,-0.7792834304889987,0.7647058823529411,0.9278253279381408,1.0,7/17,25.32%,RPL26;CRYAB;ATR;TLK2;TMEM109;HRAS;TSPYL5
prerank,regulation of multicellular organismal development (GO:2000026),-0.2631889472372532,-0.7790463840509716,0.8089171974522293,0.9275998683369752,1.0,10/25,25.06%,SOX17;BAG6;SPAAR;OAS2;MYSM1;INSR;HPSE;GBX1;DUSP6;RAB14
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.22535637249066554,-0.7788108101400633,0.8726851851851852,0.9274139640248172,1.0,14/54,23.79%,RPL26;SOX4;PLK2;PLAGL1;CHEK2;CNOT6L;CDKN1B;TNKS1BP1;PCBP4;GADD45A;CDKN1A;E2F7;RGCC;BAX
prerank,apoptotic DNA fragmentation (GO:0006309),0.3201728471566788,0.7775355133866684,0.7292929292929293,0.9702965850241934,1.0,4/16,18.67%,CECR2;DICER1;DFFA;KPNB1
prerank,AMP metabolic process (GO:0046033),0.3405907151329225,0.7774886261575762,0.7404426559356136,0.969710008598145,1.0,2/13,5.98%,AMPD3;ADSL
prerank,ubiquinone metabolic process (GO:0006743),0.31286383283156377,0.7769600650200317,0.7422037422037422,0.9699100304095535,1.0,4/15,11.44%,FDXR;COQ10A;COQ8B;COQ6
prerank,regulation of axon guidance (GO:1902667),-0.3342139169498414,-0.7766030732075593,0.7593984962406015,0.9301137911231199,1.0,4/10,24.83%,VEGFA;ZSWIM6;ZSWIM8;TUBB2B
prerank,hexose transmembrane transport (GO:0008645),0.29525116128483253,0.7761683622310542,0.7595419847328244,0.9705647949088173,1.0,3/21,6.09%,SLC2A12;SLC45A3;SLC2A10
prerank,protein deacetylation (GO:0006476),-0.23396553882887489,-0.7761209683571872,0.825287356321839,0.930273119086098,1.0,14/41,23.56%,FLNA;HDAC5;MORF4L1;RBM14;SIN3B;SIRT4;BRMS1;HDAC11;SIRT7;HDAC7;HDAC9;HDAC6;RCOR3;SIRT6
prerank,regulation of transferase activity (GO:0051338),0.31683907122873217,0.775441980662905,0.7416974169741697,0.9710744358290992,1.0,4/17,10.38%,SLAMF8;PARP4;FEM1B;PPP1R3F
prerank,protein targeting (GO:0006605),-0.19447259703253889,-0.775435873983794,0.936046511627907,0.9307426656733495,1.0,44/118,32.09%,RASSF9;RPL11;FBXO7;TOMM20;ZDHHC14;ZDHHC15;CDC37;GOLGA7;AQP11;CACNG3;ZDHHC2;ZDHHC7;TOMM22;TIMM9;SRPRB;NACA;SEC61G;TIMM10B;TIMM13;BCAP31;ZFAND2B;PEX1;ZDHHC4;TIMM22;TOMM7;MFN2;ZDHHC20;ICMT;SRP14;PEX16;HAP1;RTP4;SEC63;SORL1;FIS1;TIMM44;TSPO;AIP;RABGEF1;TOMM34;ZDHHC18;SPCS3;NACAD;AP4B1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.344449807454333,0.7752309831166934,0.7226890756302521,0.9707429949633232,1.0,1/11,2.18%,BCL2
prerank,negative regulation of DNA replication (GO:0008156),-0.30747895653489377,-0.774940821001792,0.7729941291585127,0.9309366376946195,1.0,6/13,33.17%,RAD17;S100A11;ATR;GMNC;GMNN;CDC6
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3324503242950046,-0.7743758653651156,0.7466666666666667,0.9311987604701323,1.0,4/11,12.32%,FBXO7;RACK1;ATF4;REST
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3508264211203307,0.7742563110671894,0.7158119658119658,0.9717095750430546,1.0,2/10,8.77%,PXYLP1;XYLT2
prerank,protein complex oligomerization (GO:0051259),0.22833096293156074,0.7736168445116253,0.8509316770186336,0.9720929805915604,1.0,17/85,12.71%,UPB1;ALS2;RNF213;IKZF4;NOL3;ARC;BLM;MCU;RNF135;TMEM120B;YME1L1;GSDMD;MICU1;OXA1L;UGDH;PKD2;NINJ1
prerank,histone acetylation (GO:0016573),-0.20827833701562992,-0.7729809209815584,0.9024390243902439,0.9326780972017049,1.0,13/69,17.31%,LEF1;MORF4L1;APBB1;ING4;MRGBP;YEATS2;NAA40;BRPF1;KAT14;JADE1;RUVBL1;PER1;WDR5
prerank,Golgi organization (GO:0007030),0.2191629705880921,0.7726642032209138,0.8763866877971473,0.973090860776436,1.0,19/112,11.12%,TANGO2;OBSL1;DYNC2H1;PLK5;LRRK2;RAB30;FAM174B;MYO18A;OPTN;STX16;UBXN2B;DYM;BLZF1;CDK1;CUL7;TRAPPC8;GOLGA2;TJAP1;VTI1A
prerank,regulation of type I interferon production (GO:0032479),0.22800404829237036,0.7726509574956298,0.8603896103896104,0.9724507501194042,1.0,21/84,14.27%,IRF8;XRCC5;POLR3GL;POLR3G;TRIM56;RNF135;RNF216;ITCH;IRF3;UBA7;PRKDC;PCBP2;IKBKE;CYLD;TBK1;ZBP1;MRE11;DDX41;POLR3C;CREBBP;NLRX1
prerank,nuclear envelope organization (GO:0006998),-0.27636767150969943,-0.7726443776417851,0.7692307692307693,0.9326119632304047,1.0,6/20,20.44%,REEP3;LEMD2;TOR1B;TMEM43;SUN1;CTDNEP1
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.3276392353817271,-0.7724922440129468,0.7717601547388782,0.9322642540747729,1.0,5/11,30.96%,LARP7;FBL;EXOSC10;EXOSC5;TENT4B
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.261504014645177,-0.7722260481716368,0.8139013452914798,0.9321030695104506,1.0,11/25,30.36%,STMN2;STMN1;TPPP;STMN4;TPPP3;STMN3;CKAP5;KIF14;TRPV4;FGF13;NCKAP5L
prerank,lymphocyte chemotaxis (GO:0048247),-0.2432316689358222,-0.7713677421849863,0.8388520971302428,0.932743010289922,1.0,2/34,2.15%,SLC12A2;GAS6
prerank,tRNA transport (GO:0051031),-0.24368676164078817,-0.770992158425178,0.8351177730192719,0.9327537328379973,1.0,19/35,46.03%,TOMM20;YBX1;SSB;NUP37;NUP54;NUP85;NUP133;POM121;NUP153;NUP42;NOL6;NUP93;NUP35;RAN;SEH1L;NUP160;RAE1;TOMM20L;NUP210
prerank,aspartate family amino acid metabolic process (GO:0009066),0.3109549860688515,0.7707681052560709,0.756385068762279,0.9749194456350675,1.0,2/18,5.55%,MSRA;MTHFR
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.3182222935241046,-0.7707541135053637,0.7923387096774194,0.9325555205984039,1.0,9/12,54.33%,SLC11A1;CCR2;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,cytoplasmic microtubule organization (GO:0031122),0.24904639116587857,0.7704961630064616,0.8,0.9746974561076706,1.0,7/54,9.86%,FIGN;HOOK2;FIGNL2;KATNAL2;DLG1;TUBGCP6;TUBGCP2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.313901368517409,-0.7697828150241594,0.774390243902439,0.9334431630937042,1.0,4/13,15.17%,APOD;CHP1;RANGAP1;MDFIC
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.24552732330787838,0.7693142836526979,0.8006700167504187,0.9759607732858332,1.0,19/57,21.10%,HUS1B;CDC14B;MRNIP;BLM;CDK1;CLSPN;MDC1;PRKDC;RINT1;MRE11;BABAM2;BRSK1;TAOK3;TRIM39;TAOK2;UIMC1;RAD9B;NBN;STK33
prerank,RNA interference (GO:0016246),-0.2906194166062437,-0.7689894658433786,0.7813121272365805,0.9340273094782031,1.0,7/17,31.96%,CLP1;NRDE2;AGO3;TSN;TSNAX;DROSHA;DHX9
prerank,import into nucleus (GO:0051170),0.23590214946552582,0.768888248557805,0.8576214405360134,0.9760129489298034,1.0,17/73,22.00%,APPL2;IPO13;PRICKLE1;NUTF2;SMN1;NUP107;TNPO1;NXT2;RPAIN;IPO9;NUP214;KPNB1;GEMIN5;SNRPF;TSC2;TPR;RANBP17
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.18050930360158005,-0.7687337819056722,0.9695945945945946,0.9338069170580536,1.0,55/185,26.37%,HSP90AA1;UBB;PKD1;BUB3;RPS27A;UBC;CUL3;PSMD13;PSMF1;DDB1;APPL1;ZFP36L1;PSMB10;YWHAG;TUBB4B;DCTN3;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;CUL1;TUBA1A;PSME1;ODF2;ANAPC16;NDE1;UBA52;PSMB3;TUBB4A;ID2;CETN2;CDK2;BUB1B;UBE2D1;CKAP5;PSMD5;TFAP4;HAUS6;SKP1;MAPRE1;DCTN1;CEP41;ANAPC7;PSMD9;PSMB4;NEK11;RGCC;HMMR;KIF14;KNTC1;PSMD10;CDC14A;PCM1
prerank,synaptic membrane adhesion (GO:0099560),0.3298036837662993,0.7685474806303034,0.7327935222672065,0.9758987246323964,1.0,3/14,12.62%,GPC6;PTPRD;GPC4
prerank,fatty acid metabolic process (GO:0006631),0.217160114003006,0.7678989405906722,0.8945022288261516,0.9763033256547804,1.0,10/115,8.71%,PPARA;ACADSB;ACSL1;CEL;ACOT4;CPT2;ECHDC3;LIPH;LIPC;AASDH
prerank,DNA damage checkpoint signaling (GO:0000077),-0.2531395976277667,-0.7675299630304983,0.8257080610021786,0.934956082747761,1.0,9/28,24.74%,TIPRL;CHEK2;DONSON;RAD17;USP28;RAD9A;ATR;DOT1L;CHEK1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.24186475651752037,0.7671996056715299,0.8098471986417657,0.9767552735100181,1.0,3/55,2.95%,PID1;PRKN;PDGFRB
prerank,response to peptide (GO:1901652),0.2668443729934149,0.7657575699628953,0.7952468007312614,0.9784436908471321,1.0,4/33,7.32%,ANXA1;MMP2;STAT5B;MMP9
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2934449663322128,0.7657463657795245,0.7557692307692307,0.9778002222236615,1.0,3/22,5.10%,FANCA;DUSP10;CTLA4
prerank,regulation of viral transcription (GO:0046782),-0.23388208655760254,-0.765581255702587,0.8597285067873304,0.9371144393410951,1.0,13/39,20.75%,TRIM14;LARP7;POLR2C;NELFCD;TRIM13;MDFIC;POLR2G;GTF2F2;NELFE;MID2;TRIM27;IFITM3;UBP1
prerank,negative regulation of protein catabolic process (GO:0042177),0.25398081951694645,0.76516271294074,0.8130671506352087,0.9780530221138277,1.0,7/40,12.53%,TIMP3;AZIN2;BANP;ATRAID;RIC1;PTPN3;SNX12
prerank,regulation of defense response to virus (GO:0050688),0.32863905798818316,0.7647195471622478,0.7474747474747475,0.9780920600091062,1.0,5/14,19.04%,RNF216;ITCH;PCBP2;TRAF3IP1;ILRUN
prerank,protein ADP-ribosylation (GO:0006471),0.27447394242458933,0.7646646631531312,0.7890625,0.9775335012254021,1.0,12/28,25.61%,PARP4;PARP10;PARP12;PARP9;SIRT3;ARF4;TIPARP;PARP14;SIRT5;TNKS2;ART4;PARP2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.3192735716389573,-0.7639233781095397,0.7717996289424861,0.9388927543368096,1.0,5/11,24.03%,UAP1L1;UAP1;GNPDA1;AMDHD2;GNPDA2
prerank,regulation of neutrophil migration (GO:1902622),-0.32407061953933863,-0.763726310016642,0.7533206831119544,0.9386028556101946,1.0,4/10,20.80%,RAC1;RHOG;JAM3;NCKAP1L
prerank,cellular response to leucine (GO:0071233),-0.3344007292227801,-0.7635718707672046,0.7955390334572491,0.9377182776402528,1.0,3/10,9.55%,SESN3;MTOR;SESN2
prerank,response to leucine (GO:0043201),-0.3344007292227801,-0.7635718707672046,0.7955390334572491,0.9377182776402528,1.0,3/10,9.55%,SESN3;MTOR;SESN2
prerank,autophagosome assembly (GO:0000045),0.24586528660386858,0.7635148825553777,0.8076923076923077,0.9787001020657222,1.0,14/52,17.13%,TP53INP2;RAB19;WIPI1;UBXN2B;ATG14;TRAPPC8;ATG9A;STX17;RAB43;AMBRA1;ATG3;RUFY4;IRGM;ATG16L2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.2712397514284044,0.763480633292994,0.783068783068783,0.978099647852784,1.0,5/33,10.51%,MTURN;STAT5B;ARNT;MED1;PRKDC
prerank,positive regulation of protein deacetylation (GO:0090312),-0.2992706585970578,-0.7633919727206759,0.7738095238095238,0.9374026338399974,1.0,4/14,17.35%,APLNR;AKAP8;BRMS1;CTBP1
prerank,regulation of leukocyte migration (GO:0002685),0.3108421376356379,0.7633656692796886,0.7494780793319415,0.9776224021935074,1.0,3/16,8.41%,ANXA1;HOXA7;MIA3
prerank,regulation of myelination (GO:0031641),0.2792147230123469,0.7631866443832709,0.7857142857142857,0.97724582249021,1.0,6/25,13.78%,PARD3;ITGAX;PTN;CST7;TMEM98;DICER1
prerank,lipid droplet organization (GO:0034389),-0.26526844162512925,-0.763082782285382,0.8142857142857143,0.9372903341184587,1.0,4/22,17.36%,PPIA;CDS1;BSCL2;AUP1
prerank,histone deubiquitination (GO:0016578),0.29559259303915797,0.762806936746696,0.766798418972332,0.9771786596129937,1.0,5/18,21.27%,EPOP;USP7;TRRAP;UIMC1;USP21
prerank,UV-damage excision repair (GO:0070914),0.3336977485481628,0.7627605617308005,0.7420718816067653,0.9766061021198827,1.0,4/12,17.36%,DDB2;CUL4B;INO80;XPC
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.3319206127448016,-0.7627355502193219,0.8022813688212928,0.9366495074860606,1.0,6/10,29.53%,AP2A2;AP2M1;AP2B1;AP2A1;VLDLR;AP2S1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.3319206127448016,-0.7627355502193219,0.8022813688212928,0.9366495074860606,1.0,6/10,29.53%,AP2A2;AP2M1;AP2B1;AP2A1;VLDLR;AP2S1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.253058786710457,0.7625463373505604,0.8010471204188482,0.9762910924932683,1.0,8/45,12.19%,NCAM1;SP100;TRIM5;IRF8;CAMK2D;IRF3;JAK2;TRIM26
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.3034623366952215,-0.7624447027083978,0.7911877394636015,0.9359453066538088,1.0,4/15,15.77%,PABPC1;TOB1;ZFP36L1;TNRC6C
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.3034623366952215,-0.7624447027083978,0.7911877394636015,0.9359453066538088,1.0,4/15,15.77%,PABPC1;TOB1;ZFP36L1;TNRC6C
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.187965635628018,-0.7620532905078861,0.9540540540540541,0.9359114738357278,1.0,34/116,28.60%,PLCG2;RAMP2;FYN;ADCY4;PLK2;RHBDF2;MYH9;RAMP1;ADCY7;PTHLH;CYSLTR1;ADCY3;FURIN;CYSLTR2;ADRB2;PRKAR1A;IAPP;CALCRL;VIPR2;MC5R;YES1;GPR27;HRH2;TSHR;GGT1;FCGR2B;GLP2R;NPSR1;ADCYAP1;GNB1;TREM2;GPR20;CALCA;CD163
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.34702135378935073,0.7617458404035914,0.7537473233404711,0.9768917711894244,1.0,2/12,7.25%,METTL4;BLM
prerank,regulation of B cell differentiation (GO:0045577),-0.28429111454008993,-0.7616788952652053,0.7924901185770751,0.9358999357498873,1.0,6/17,20.80%,ZFP36L1;XBP1;ID2;INHA;PPP2R3C;NCKAP1L
prerank,protein sumoylation (GO:0016925),0.24602749834796128,0.760345773323312,0.8316151202749141,0.9784201185546633,1.0,4/49,10.15%,EYA1;NDC1;PIAS1;NUP107
prerank,regulation of complement activation (GO:0030449),0.2569881273141158,0.7598442470442578,0.7992895204262878,0.978539047207695,1.0,6/40,11.25%,PROS1;C2;CFH;VTN;C8B;C8G
prerank,non-motile cilium assembly (GO:1905515),0.2712469240203221,0.7587978899393302,0.7878228782287823,0.9795358698349043,1.0,6/30,11.24%,TTC8;TBC1D32;ARL13A;RPGRIP1L;CEP89;IFT122
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.33237076225983253,0.7587682888109717,0.7621052631578947,0.9782803460510181,1.0,2/11,7.48%,SYNJ2;PTEN
prerank,inositol phosphate dephosphorylation (GO:0046855),0.33237076225983253,0.7587682888109717,0.7621052631578947,0.9782803460510181,1.0,2/11,7.48%,SYNJ2;PTEN
prerank,regulation of embryonic development (GO:0045995),0.265347965361107,0.7586238538412833,0.8039927404718693,0.9778621374024278,1.0,7/34,11.91%,PLCB1;PHLDB2;NIBAN2;WDPCP;CDK1;CCSAP;RBM19
prerank,regulation of lymphocyte differentiation (GO:0045619),0.30098633974855826,0.7577441528215215,0.7354085603112841,0.9785708358779261,1.0,3/18,10.51%,SLAMF8;ABL1;PRKDC
prerank,protein polyglutamylation (GO:0018095),-0.3233569455886204,-0.7576340413473662,0.8105065666041276,0.940903342030465,1.0,4/11,28.53%,TTLL7;CEP41;TTLL6;TTLL2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.25726316019997725,-0.7575645828685951,0.8386411889596603,0.9404482383397357,1.0,8/25,29.16%,HNRNPU;LARP7;NELFCD;NELFE;RNF168;EAPP;EAF2;RNF8
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.2698323882202396,0.7575194932209186,0.8092592592592592,0.9782558064035201,1.0,8/31,19.99%,HSD17B1;FDXR;MOCS2;MOCS1;DHRS11;MOCS3;FDFT1;ALOX5
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.25728756971199007,-0.7564223598142692,0.8179959100204499,0.941420067906447,1.0,14/23,44.96%,PLK2;BUB1B;INTS3;CHEK1;CHMP4C;ZWINT;CDK5RAP3;BUB1;PLK3;WEE2;NABP1;AURKB;ZW10;PRCC
prerank,positive regulation of protein import (GO:1904591),-0.2492952360405015,-0.7563870801544388,0.8413461538461539,0.9409090334963851,1.0,11/30,24.55%,CDH1;FLNA;TGFB1;ARHGEF5;JUP;ZC3H12A;PSEN1;PRKCD;RBM22;HYAL2;ZPR1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.30604745045505216,0.756345028017172,0.743801652892562,0.9793784785187298,1.0,4/18,12.36%,PDPK1;IGF2;APLN;COL4A3
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.20373542684696283,-0.756053530415897,0.9263959390862944,0.9408293449882027,1.0,25/80,26.17%,CAV1;UBE3A;UBB;FAM107A;CUL3;RPS2;BIRC3;DERL1;RBX1;NDFIP2;DCUN1D1;DCUN1D2;WFS1;LAPTM5;SPRTN;UBE2D1;PINK1;NDFIP1;TRIB3;HUWE1;SPSB4;ARRDC3;PTTG1IP;TSPYL5;PSMD10
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.2193385278288864,-0.7559995573399335,0.8666666666666667,0.9403668677054179,1.0,19/49,27.99%,GSK3B;CRYAB;HSPA5;CLU;SVIP;NLRP2B;IAPP;RPL13A;RAF1;PPM1A;NOP53;PEX5;JAM3;HDAC6;SORL1;KIF14;THRA;TREM2;TFIP11
prerank,positive regulation of chromatin organization (GO:1905269),-0.30860335096987346,-0.7556766012758727,0.7461240310077519,0.9402269628872917,1.0,3/12,14.48%,H3-3A;TAL1;TERF2IP
prerank,regulation of protein targeting to membrane (GO:0090313),-0.253123069577213,-0.7555851385083674,0.8221258134490239,0.9398116332609949,1.0,9/28,19.90%,FYN;KCNB1;CHP1;C2CD5;MIEF1;MIEF2;MTCL1;GDI1;ANK3
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.3156343931050205,0.7555042076812258,0.7642436149312377,0.9800292425800632,1.0,1/14,0.72%,IL34
prerank,selective autophagy (GO:0061912),-0.21592002165359195,-0.7554906611578017,0.8905109489051095,0.9393902764166742,1.0,23/56,35.21%,VIM;UBB;DYNLL2;RPS27A;UBC;MAP1LC3B;WDFY3;CFTR;UBA52;AUP1;PEX5;HDAC6;RAB7A;ULK2;KLHL3;STBD1;DYNC1I1;DYNC1H1;ACBD5;PARK7;PCNT;UFC1;DYNLL1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.2903218178028063,0.7554057307593511,0.788235294117647,0.9795474262943026,1.0,6/22,16.36%,PHF8;LYAR;RASL11A;ERBB2;SMARCB1;NOL11
prerank,regulation of keratinocyte migration (GO:0051547),0.33240770583378276,0.7553427080658611,0.7569892473118279,0.9789899361307863,1.0,3/12,7.48%,MAPRE2;MMP9;PTEN
prerank,lipoprotein biosynthetic process (GO:0042158),0.34135535104180165,0.7553061777886405,0.7408207343412527,0.9783980320722448,1.0,2/11,5.75%,ATG10;WIPI1
prerank,striated muscle cell differentiation (GO:0051146),0.3082071716303402,0.7549836592521185,0.7695390781563126,0.9782409570040616,1.0,4/16,8.94%,CBY1;AKAP13;SIK1;KDM6B
prerank,leukotriene metabolic process (GO:0006691),-0.2713136171153954,-0.7546747614612832,0.8158995815899581,0.9399448835702666,1.0,10/19,37.39%,ALOX12;PLA2G4A;GGT1;LTA4H;PLA2G5;ALOX5AP;MGST2;DPEP1;ABCC1;GGT5
prerank,regulation of cell division (GO:0051302),0.2302662417118796,0.7544502694692314,0.8755980861244019,0.9784065826706758,1.0,20/72,19.42%,FGFR2;PLK5;FGF1;NCOA3;BLM;BIRC6;PIK3R4;UVRAG;FLCN;ZFYVE26;TXNIP;CIB1;MYO19;CSPP1;ORC6;SETD2;KLHL13;RAB11FIP3;PRPF40A;KIF18B
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.32364483083048934,-0.7543595067674783,0.779245283018868,0.9397970952995279,1.0,2/10,7.67%,DNAJA1;PDCD4
prerank,peptidyl-lysine modification (GO:0018205),0.21731000873099335,0.7542140339086216,0.8903436988543372,0.9781040293355115,1.0,8/99,10.15%,EYA1;LOXL1;LOXL3;SENP7;NDC1;PIAS1;EEF1AKMT1;NUP107
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.2757187238433473,0.7536849808292237,0.781431334622824,0.9782647729738,1.0,7/26,13.72%,DAB2;KANK2;STRN3;HDAC1;CRY1;CNOT2;CLOCK
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.3229449846328284,-0.7532756326112034,0.7728155339805826,0.9406595668059096,1.0,2/10,15.96%,KYAT1;QDPR
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.28658614972555796,0.7531366855443106,0.8073217726396917,0.9784728108107772,1.0,5/23,18.67%,CECR2;DICER1;DFFA;REXO4;KPNB1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.23841681702610687,0.7529162407973142,0.8593481989708405,0.9781690318334884,1.0,17/58,21.09%,XRCC5;XRCC4;KDM2A;UVRAG;POLM;MDC1;NHEJ1;PRKDC;DCLRE1A;DCLRE1B;MRE11;BABAM2;IFFO1;UIMC1;KAT5;RAD50;NBN
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.2728224990933734,-0.7528653732312637,0.8151093439363817,0.9406615957640225,1.0,6/20,16.43%,YWHAB;MET;RNF157;APLP1;STMN1;BICD1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.2218523597293071,-0.7527094739326355,0.8679245283018868,0.9403214745690059,1.0,12/47,18.27%,TGFB2;DAB2IP;MID1;PPIA;PDCD10;FOXO1;STK25;EPHB1;FAS;PER1;MAP2K2;GREM1
prerank,negative regulation of DNA recombination (GO:0045910),0.25055791131274374,0.7525268767496496,0.8200339558573854,0.9780945688042981,1.0,7/43,13.58%,POLR2D;ACD;BLM;POLR2A;RTEL1;KLHL15;FANCB
prerank,spindle assembly (GO:0051225),-0.20677185761650213,-0.7522841844530345,0.9122340425531915,0.9403314838248997,1.0,18/67,23.33%,NEK7;STARD9;RPS3;SMC1A;FLNA;CHEK2;RHOA;ARHGEF10;MZT1;TOGARAM1;WRAP73;KIF3B;KIF11;HAUS6;MAPRE1;NUMA1;KIFC1;CLASP2
prerank,glycerol metabolic process (GO:0006071),-0.334435152868183,-0.7521997634387365,0.7844990548204159,0.9399018098588574,1.0,3/10,18.36%,TPI1;PGP;COQ2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.27705370213911096,-0.7521395848724718,0.7891440501043842,0.9394382846813352,1.0,4/18,12.72%,RAP1A;GSK3B;SLC4A8;VPS18
prerank,RNA stabilization (GO:0043489),0.2614031873273424,0.7518798227349488,0.8148788927335641,0.9783835016192515,1.0,7/33,16.40%,PHAX;TRDMT1;AXIN2;TENT2;GDNF;PARN;LARP1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.31657688451057414,0.7518742827543093,0.7857142857142857,0.9777516735741876,1.0,4/15,16.96%,NLGN2;ZDHHC3;USP46;DRD2
prerank,positive regulation of cell growth (GO:0030307),0.21435164301437648,0.7508215285108812,0.8967642526964561,0.9786921075692714,1.0,4/96,4.46%,IGF1;BCL2;MACF1;SPHK1
prerank,regulation of DNA replication (GO:0006275),-0.22179733720350225,-0.7507529237870557,0.8997555012224939,0.9407332397443748,1.0,10/49,18.58%,BCAR3;ACVRL1;CCDC88A;FAF1;USP37;GLI1;RAD17;EHMT2;S100A11;ATR
prerank,regulation of sister chromatid cohesion (GO:0007063),0.3345388337645999,0.7506781149794494,0.7550200803212851,0.9782685190599731,1.0,2/12,9.79%,HDAC8;AXIN2
prerank,regulation of microtubule-based process (GO:0032886),0.25803752791750356,0.7498641480450505,0.8333333333333334,0.9788639502463395,1.0,9/36,14.78%,EPHA3;MACF1;PRKAA2;PHLDB2;PRKAA1;ERBB2;CYLD;BICD2;MEMO1
prerank,mRNA stabilization (GO:0048255),-0.23290787869846885,-0.7492165337437975,0.8589420654911839,0.9421632864061571,1.0,12/40,22.30%,TARDBP;PABPC1;YBX3;HNRNPU;YBX1;FUS;TENT5A;HNRNPA0;TIRAP;MYD88;SLC11A1;RBM24
prerank,snRNA metabolic process (GO:0016073),-0.28382154388791403,-0.7491601914905693,0.82,0.9416837293942799,1.0,6/17,23.40%,MEPCE;INTS11;INTS6;INTS1;MTREX;INTS3
prerank,response to interferon-gamma (GO:0034341),-0.20484355662796402,-0.7489924498474142,0.9275,0.941349567346856,1.0,18/67,22.40%,GCH1;GBP4;GAPDH;AQP4;GBP5;SLC26A6;CD74;SHFL;GBP3;CD47;RPL13A;CD40;CCL13;BST2;IFITM3;SLC11A1;CASP1;CIITA
prerank,sulfate transport (GO:0008272),0.3137983199974265,0.7484934582867615,0.7592592592592593,0.9802661020465714,1.0,3/14,10.43%,SLC13A4;SLC25A11;SLC13A1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.2530118725995444,-0.7467884123908216,0.8323108384458078,0.9436491905609531,1.0,13/25,36.89%,TNFSF10;GPER1;BBC3;PLAUR;PINK1;BIK;BMF;BAX;BID;PMAIP1;HRK;DNM1L;BAD
prerank,amino sugar biosynthetic process (GO:0046349),-0.30613059794738695,-0.746387596989304,0.8123827392120075,0.943604269535824,1.0,6/12,28.69%,UAP1L1;UAP1;GNPDA1;AMDHD2;GNPDA2;NANP
prerank,negative regulation of nervous system development (GO:0051961),0.30843953750497494,0.7462367310622733,0.7751479289940828,0.982969849708503,1.0,2/17,6.76%,APPL2;IL6
prerank,copper ion transport (GO:0006825),-0.3134083392830108,-0.7458227016396478,0.8190298507462687,0.9437672469551452,1.0,2/11,6.52%,ATOX1;SLC31A1
prerank,cellular response to UV (GO:0034644),-0.19928861157169014,-0.7455224161365925,0.9324675324675324,0.9436197365975022,1.0,25/76,28.21%,RPL26;CRIP1;DDB1;ATF4;MFAP4;COPS9;CARD16;POLK;USP28;N4BP1;ATR;PRKCD;NOC2L;MMP1;METTL3;FMR1;CDKN1A;BMF;POLD1;HYAL2;CHEK1;XPA;TIMP1;OPN3;TMEM161A
prerank,gene silencing by miRNA (GO:0035195),0.26072606934107434,0.7454318044298403,0.7881679389312977,0.9834778484048832,1.0,11/32,21.37%,ZC3H7B;TNRC6B;TNRC6A;AGO2;DICER1;MOV10;CNOT8;CNOT7;RBM4;XPO5;AGO1
prerank,acute-phase response (GO:0006953),-0.3063996705257648,-0.745365653929024,0.8065764023210832,0.9432815530750669,1.0,4/12,29.77%,LBP;SIGIRR;CEBPB;AHSG
prerank,mitotic sister chromatid cohesion (GO:0007064),0.30106354261792156,0.7452476401684179,0.7672583826429981,0.9830884753931183,1.0,6/16,21.83%,PDS5B;MAU2;PDS5A;NIPBL;DSCC1;NAA50
prerank,regulation of gene silencing by RNA (GO:0060966),0.23762656257536,0.7446005796267263,0.853448275862069,0.982719870203736,1.0,6/50,10.17%,POLR2D;TNRC6A;NDC1;POLR2A;NUP107;AGO2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.23762656257536,0.7446005796267263,0.853448275862069,0.982719870203736,1.0,6/50,10.17%,POLR2D;TNRC6A;NDC1;POLR2A;NUP107;AGO2
prerank,mitotic spindle assembly (GO:0090307),-0.22486640653690812,-0.7442340765667569,0.8800959232613909,0.9441113569656783,1.0,17/42,29.89%,SMC1A;FLNA;CHEK2;RHOA;ARHGEF10;MZT1;TOGARAM1;WRAP73;KIF3B;KIF11;KIFC1;CLASP2;KIF4A;KIFC2;SMC3;KIF23;ABRAXAS2
prerank,regulation of viral release from host cell (GO:1902186),-0.2595442149646901,-0.7437176126254954,0.8451882845188284,0.9442247225267812,1.0,6/21,22.28%,CHMP2B;TRIM25;DDB1;TRIM13;MID2;CHMP3
prerank,regulation of myoblast fusion (GO:1901739),0.32178852099135014,0.7436457376902118,0.7625272331154684,0.9835014844374513,1.0,2/11,12.18%,RIPOR2;CFLAR
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.24294634432884357,-0.7436415338080112,0.8662131519274376,0.9437760710781197,1.0,14/29,36.05%,LPCAT3;TMEM86B;LPCAT1;NR1H2;PLA2G4A;NR1H3;PLA2G4F;DBI;PLA2G5;MBOAT2;LPCAT4;PLBD1;PLAAT3;PLB1
prerank,cellular response to interferon-gamma (GO:0071346),0.21740475569201748,0.7435139226222454,0.8951612903225806,0.9830566643094407,1.0,12/88,12.19%,DAPK1;NCAM1;SP100;TRIM5;IRF8;CCL19;CAMK2D;SIRPA;IRF3;CCL4;JAK2;TRIM26
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.23816444126037925,-0.743228117999692,0.8318777292576419,0.9437312580360988,1.0,12/31,33.97%,PLCG2;HSPD1;LAPTM5;CD40;IRF5;TIRAP;MAPK11;AGER;TLR4;IL16;MDK;SYK
prerank,icosanoid metabolic process (GO:0006690),-0.2245484161730284,-0.7427716280135086,0.8959660297239915,0.9437675002471816,1.0,8/40,15.18%,MGLL;GPX4;PTGIS;PTGS2;PON2;ALOX12;PLA2G4A;CYP1B1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.2588876581444266,0.742763342322619,0.8278829604130808,0.9834997407617067,1.0,4/33,7.99%,IL34;ACIN1;PRKCA;CSF1
prerank,recombinational repair (GO:0000725),0.22757446136782195,0.7424316415108094,0.8794788273615635,0.983326808404769,1.0,16/77,16.10%,RAD51B;RAD51AP2;RNF138;HUS1B;RAD51C;BLM;HELQ;AUNIP;BRCA2;ZSWIM7;ZFYVE26;INO80;MRE11;WRN;SWI5;RAD51
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.26822890884747475,0.7413618535188589,0.8321033210332104,0.984211623722555,1.0,4/30,5.82%,ACSL1;HACD1;ACOT4;HACD3
prerank,negative regulation of receptor internalization (GO:0002091),-0.3059373177045289,-0.7412253971551631,0.8011472275334608,0.9451260001415007,1.0,7/12,40.90%,RIN3;ANKRD13A;ANKRD13B;ATXN2;WDR54;ANKRD13D;NECAB2
prerank,positive regulation of lipid storage (GO:0010884),-0.26472618268993214,-0.7411006038412017,0.8326086956521739,0.9447491404652056,1.0,3/21,5.98%,SCARB1;SREBF2;EHD1
prerank,positive regulation of transporter activity (GO:0032411),0.3261744222351525,0.7409650246054068,0.768762677484787,0.9841352217793055,1.0,1/13,1.68%,KMT2A
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.28948141001975297,-0.7408860515407696,0.8020408163265306,0.9444760400663369,1.0,10/16,45.47%,CLU;CYP51A1;IFNGR1;TREM2;HMGCR;ABCA7;LRP1;IL4;TNF;LRPAP1
prerank,endodermal cell fate commitment (GO:0001711),-0.3143901839116644,-0.7407541307075675,0.8015267175572519,0.9440826681012341,1.0,2/10,17.50%,SOX17;SOX2
prerank,negative regulation of JNK cascade (GO:0046329),0.26189226168762286,0.740606012576516,0.830155979202773,0.984023167453806,1.0,7/31,12.30%,PRKN;DUSP10;SIRPA;ITCH;SH3RF2;CYLD;HIPK3
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.258553658259705,0.7405870589053246,0.8105646630236795,0.983412815637936,1.0,10/33,16.35%,PLK5;DLG1;KANK2;PTEN;RBL2;MYO16;CDC73;PKD2;CDK4;CDKN2B
prerank,regulation of cellular response to stress (GO:0080135),0.20866408273006962,0.7405077192238445,0.9270516717325228,0.9828922282819883,1.0,19/115,14.11%,ROCK2;PRKN;CRHBP;NDC1;NEK4;AMFR;CAMK2D;NUPR1;HSPA1L;NUP107;ABL1;MLST8;AKT1S1;NPAS2;MAPKAPK2;SLC38A2;HSF1;MAPK1;CREBBP
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.24386886969517005,-0.7404647235026842,0.8702460850111857,0.943908983938763,1.0,11/27,28.40%,ZC3H12C;TRIR;CPSF3;RNASE4;RPP30;ZC3H12A;PCF11;NHP2;NUDT16;ERN1;POP7
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3201444693929898,-0.7403985013815082,0.7884615384615384,0.9434478360507661,1.0,3/10,23.45%,CALM1;FMR1;CALM3
prerank,regulation of B cell apoptotic process (GO:0002902),-0.30791784661761246,-0.74004657980609,0.797373358348968,0.9433643577998826,1.0,1/12,0.81%,FOXP1
prerank,DNA catabolic process (GO:0006308),0.32567482736974257,0.7395406040206558,0.7804878048780488,0.9836896330561731,1.0,11/11,67.45%,REXO4;DFFB;MUS81;DNASE1L3;SETMAR;DNASE1L2;DNASE1;FBH1;XRN2;DNASE1L1;ISG20
prerank,regulation of regulated secretory pathway (GO:1903305),0.2584658660509771,0.7393908041362188,0.8342749529190208,0.9832689195825841,1.0,4/34,5.48%,DTNBP1;SYT11;SYT12;LRRK2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.24178115742902,-0.7391856184943701,0.8504464285714286,0.9438946783443106,1.0,10/31,23.34%,KLF4;FHL1;FAM107A;APC;CDK6;JADE1;CDK2AP2;CDKN1A;CDKN2D;E2F7
prerank,nuclear pore complex assembly (GO:0051292),0.33556105644829864,0.738951047749101,0.7463312368972747,0.9832313995039984,1.0,2/10,10.15%,NDC1;NUP107
prerank,phospholipid metabolic process (GO:0006644),0.22532000750514794,0.7382907905002488,0.8885298869143781,0.9835331249535305,1.0,3/71,2.68%,AGPAT4;PLPP3;PLA2G10
prerank,regulation of neuroblast proliferation (GO:1902692),0.3073134049481596,0.7382401561942914,0.7607361963190185,0.9829843912599305,1.0,6/15,16.96%,LRRK2;PTN;DCT;CX3CL1;SMARCD3;DRD2
prerank,innate immune response in mucosa (GO:0002227),0.3456650030189871,0.738200980520124,0.7584745762711864,0.9824072153931321,1.0,1/10,2.73%,LTF
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.32129130431726516,-0.73725211429379,0.8139097744360902,0.9456997031909927,1.0,4/10,22.59%,MFSD2A;MTMR9;ABCA3;MTMR1
prerank,intracellular sterol transport (GO:0032366),0.31906248554768313,0.7370158205296,0.7829614604462475,0.9834506425785808,1.0,6/13,26.47%,ABCA1;SERAC1;RELCH;ARV1;OSBP;VPS4A
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.32839768865417307,0.7370000658312721,0.7709251101321586,0.9828389734912446,1.0,4/12,13.27%,APOC4;APOC1;SOAT2;P4HB
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.28135870572034377,0.7367608461820767,0.8165680473372781,0.9825277884511429,1.0,2/21,5.48%,PRKN;LRRK2
prerank,histone H4-K16 acetylation (GO:0043984),0.28830091362941657,0.736429814500601,0.8109161793372319,0.9823275004812873,1.0,3/19,10.66%,KMT2A;KAT8;KANSL1
prerank,cell junction maintenance (GO:0034331),0.30874492219455946,0.736176866802147,0.7620041753653445,0.9820478498226343,1.0,1/14,2.23%,NLGN2
prerank,regulation of histone deacetylation (GO:0031063),0.30715725495443125,0.735941515661465,0.7709611451942741,0.9817459087115482,1.0,4/13,16.18%,CAMK2D;AKAP8L;SAP30BP;NIPBL
prerank,regulation of synapse organization (GO:0050807),0.2689037530504229,0.7358968915149364,0.7921348314606742,0.9811721362706789,1.0,8/26,17.77%,IL1RAPL1;NEDD4;EPHA4;ABL1;CDKL5;GRIPAP1;CHRNB2;PDLIM5
prerank,regulation of cell aging (GO:0090342),-0.3122815718452798,-0.7357067984847178,0.8399209486166008,0.9470277308422748,1.0,3/11,16.76%,RSL1D1;LMNA;MIF
prerank,RNA splicing (GO:0008380),-0.19083187795938855,-0.7350320384198599,0.9536082474226805,0.9473110091384126,1.0,15/95,14.31%,MBNL1;PPARGC1A;TARDBP;IVNS1ABP;SRSF2;SF3B1;SF3B2;SFPQ;DDX39B;USP39;RBM8A;PRPF18;RNPS1;SRPK1;FUS
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.33118596569205727,0.7347991059076141,0.7616926503340757,0.9820637393301715,1.0,4/11,15.91%,ADM;GRK3;ADRB3;GRK2
prerank,neuromuscular synaptic transmission (GO:0007274),0.29399485134488096,0.7347488022289171,0.7894736842105263,0.981508471247063,1.0,5/18,16.98%,DTNA;FCHSD2;SLC5A7;CHRNB2;ERC2
prerank,defense response to symbiont (GO:0140546),0.2143656984804185,0.734149198449038,0.9104704097116844,0.9816768933949667,1.0,9/92,7.89%,BCL2;PLA2G10;IFIT3;IFIT2;RNASEL;TRIM5;BNIP3;IL6;TRIM56
prerank,mitotic spindle organization (GO:0007052),-0.17562816861583072,-0.733170429835943,0.9936507936507937,0.9489603066546124,1.0,63/153,35.23%,MAP4;SMC1A;CLIP1;FLNA;BUB3;PLK2;DYNLL2;EFHC2;CENPO;RPS27;CHEK2;RHOA;CENPK;ARHGEF10;MZT1;RANGAP1;NUP37;STMN1;TOGARAM1;RCC2;NDE1;RMDN1;WRAP73;CENPU;KIF3B;BUB1B;NUP85;CKAP5;KIF11;PPP1CC;NUP133;MAPRE1;B9D2;VCP;KIFC1;CLASP2;NDC80;KIF4A;KNL1;KIFC2;KNTC1;SPDL1;CDCA8;CEP126;SMC3;KIF23;ZWINT;ABRAXAS2;DYNC1I1;PLK1;BCCIP;NUDC;DLGAP5;DYNC1H1;AURKA;NEK9;TOGARAM2;STIL;PCNT;CDC20;BUB1;DYNLL1;CLASP1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.29737610365612926,-0.7331385363827413,0.8323699421965318,0.9484540876594573,1.0,8/13,44.25%,NUP54;KPNA4;KPNA3;RGPD1;KPNA2;NUP35;KPNA1;KPNA7
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.301428741760713,0.733114697364364,0.8074656188605108,0.9824170865319001,1.0,3/17,8.14%,ALG6;ALG2;ALG9
prerank,protein import (GO:0017038),0.2155088280264622,0.7316762649814929,0.9034810126582279,0.9837273697088771,1.0,11/84,13.82%,APPL2;IPO13;PXMP2;PRICKLE1;SNX33;LAMP2;NUTF2;NUP107;PXMP4;TNPO1;NXT2
prerank,cranial nerve development (GO:0021545),0.33050847457627114,0.7311197983883879,0.7671517671517671,0.9838778528797243,1.0,11/11,66.97%,SALL1;TFAP2A;CHRNB2;ATOH7;CHD7;ERBB3;ISL1;TIFAB;POU4F1;PAX2;TMEM126A
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.283294178300649,-0.7308393708681955,0.8580375782881002,0.9505887280855615,1.0,9/15,37.86%,APPL1;STAT3;GBP5;MYD88;TLR4;TLR6;NOD2;TICAM1;HIF1A
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.2920213562777738,0.7303394774532409,0.8012170385395537,0.9843482551899448,1.0,3/17,13.44%,PRKN;MDM2;SNAI1
prerank,protein-DNA complex disassembly (GO:0032986),-0.28406418768349634,-0.7300367271341809,0.8422174840085288,0.9509853327590642,1.0,3/16,10.76%,RPL23;SET;SMARCD1
prerank,glutathione metabolic process (GO:0006749),0.2548301381028431,0.7298473131022247,0.838475499092559,0.9843705307278073,1.0,3/38,5.01%,GSTM2;GSTT4;GSTT1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.29159563025271185,-0.729125489633769,0.8129770992366412,0.9515458368724203,1.0,10/13,34.94%,HES1;PTPRC;JAK3;MGAT5;DOT1L;CRLF2;PTPRT;EGF;TSLP;IL7R
prerank,negative regulation of catabolic process (GO:0009895),0.23495888911942392,0.7287194142299149,0.8883071553228621,0.9852762860646634,1.0,6/47,9.15%,PPARA;AZIN2;BANP;PRKAA1;NUPR1;APOC1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.24042513822199246,0.7287068492706675,0.847985347985348,0.9846624045935671,1.0,8/46,10.86%,TIMP3;DUSP10;FBLN1;DLG1;LMO3;PTEN;SIRPA;FLCN
prerank,regulation of myeloid cell differentiation (GO:0045637),0.22879319693316852,0.7285961689574822,0.8685121107266436,0.9841640008756771,1.0,14/62,16.12%,KMT2A;MEIS1;ASH2L;TNRC6B;TNRC6A;PRKCB;SETD1A;HDAC1;KMT2B;CDC73;CREBBP;MEIS2;MOV10;LYN
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.2809779392906072,0.7282341147493427,0.8030592734225621,0.9840440722990823,1.0,1/20,1.22%,IL18
prerank,inositol phosphate catabolic process (GO:0071545),-0.3012106025267646,-0.7277002150383172,0.8195777351247601,0.952653228971307,1.0,2/12,5.66%,SYNJ1;NUDT3
prerank,cellular response to chemokine (GO:1990869),0.2415604474581713,0.7276770835594124,0.8695652173913043,0.9841631724785229,1.0,3/46,3.63%,OXSR1;CXCL13;RIPOR2
prerank,nucleosome disassembly (GO:0006337),0.3027603343088377,0.7272391376868977,0.8080614203454894,0.9834880257575951,1.0,5/14,16.33%,ARID2;SMARCE1;SMARCB1;SMARCC1;SMARCD3
prerank,chromatin disassembly (GO:0031498),0.3027603343088377,0.7272391376868977,0.8080614203454894,0.9834880257575951,1.0,5/14,16.33%,ARID2;SMARCE1;SMARCB1;SMARCC1;SMARCD3
prerank,regulation of immune effector process (GO:0002697),0.24577448687868592,0.726603127519765,0.8628158844765343,0.9836853849563302,1.0,6/41,11.25%,PROS1;C2;CFH;VTN;C8B;C8G
prerank,presynaptic endocytosis (GO:0140238),0.2697178241827644,0.7263892423459155,0.8161350844277674,0.9833382124558363,1.0,3/24,6.00%,CEL;NLGN2;SYNJ2
prerank,intracellular protein transport (GO:0006886),0.18205213552267174,0.7257994769087467,0.9880636604774535,0.9834900878088552,1.0,62/304,18.84%,RANBP3L;WLS;APPL2;IPO13;KIF13B;SNX6;ARFGAP3;PRICKLE1;RAB19;ACD;SNX9;ARL5A;TBC1D9B;MAIP1;PDCD6;ARL6;STX16;LAMP2;GGA2;SLU7;TBC1D4;RAB32;DNAJC27;NUTF2;RAB22A;RIC1;NUP107;WDR11;IFT27;STX8;OXA1L;SAR1B;TNPO1;TECPR2;STX17;NXT2;ARL4C;TRAK1;RAB43;ARL5B;AP3B1;TBC1D17;CCHCR1;TRAK2;DESI1;COPB2;COPZ2;VPS26A;RPAIN;IPO9;NUP214;VPS35;STX11;IFT22;USP6NL;TBC1D9;TBC1D15;FAM91A1;ARF4;AP4M1;KPNB1;RAB29
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.21477745383269925,-0.7251210925396233,0.89086859688196,0.9550510415646717,1.0,22/45,39.28%,PUM2;APP;GCNT2;PER1;ZC3H7A;EIF2A;NOLC1;YTHDC1;PUM3;EIF4E;PCIF1;RBM4B;DDX25;RPL10;ATXN2;METTL18;MATR3;RC3H1;MAPKAPK5;MTPN;TRIM71;ZC3H10
prerank,mitotic sister chromatid segregation (GO:0000070),-0.1846229344072153,-0.7250247537377873,0.961764705882353,0.9546066781374611,1.0,37/98,32.48%,SMC1A;CHMP5;CHMP2B;PINX1;CUL3;SET;CENPK;CSNK2B;BOD1;WRAP73;CHMP1B;CHMP1A;SMC4;KNSTRN;NCAPH;CHMP3;SPAG5;TEX14;NCAPD3;KIFC1;CHMP7;PDCD6IP;NDC80;REC8;KIF14;SPDL1;CHMP4C;DIS3L2;CDCA8;CEP55;KIF23;ZWINT;KMT5A;VPS4B;PLK1;NUDC;DLGAP5
prerank,histone methylation (GO:0016571),0.26607579755361954,0.7245537773807819,0.8379373848987108,0.9844605900346258,1.0,8/26,20.80%,SETD6;PRMT7;NSD1;SMYD3;CREBBP;N6AMT1;NSD3;CARM1
prerank,regulation of chromatin binding (GO:0035561),0.33201943592795247,0.7245039538838673,0.760914760914761,0.9839101583454012,1.0,4/10,24.43%,PARP9;DTX3L;KDM4D;MED25
prerank,lymphocyte migration (GO:0072676),-0.2249129539525369,-0.7243993510891636,0.89086859688196,0.9547640718729187,1.0,2/32,3.56%,MSN;S1PR1
prerank,negative regulation of cell division (GO:0051782),0.32947825200191044,0.7242675897375971,0.7950819672131147,0.9836083948282341,1.0,3/11,17.16%,BLM;TXNIP;ORC6
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.3252248562395914,0.7238530131556591,0.7674418604651163,0.9835021727057066,1.0,2/10,7.35%,NOS1AP;CACNA2D1
prerank,phospholipid homeostasis (GO:0055091),0.32211022699919695,0.7236588802210246,0.7794117647058824,0.9831627314170749,1.0,1/11,4.04%,ABCA1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.2951423857194913,-0.7235849358673797,0.8268839103869654,0.9551258246634203,1.0,8/13,29.56%,STX3;HSP90AB1;TMEM35A;TYROBP;MAP1A;TM9SF4;ABCA7;RANGRF
prerank,regulation of intracellular transport (GO:0032386),-0.22371543408223754,-0.7234820320714076,0.9090909090909091,0.9547082050460098,1.0,11/38,25.13%,REEP5;CRYAB;LAMP1;PTPN1;ATP13A2;INPP5F;NUMA1;MLC1;SPAG5;CAPN10;HAP1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.2607878303346667,-0.7232593088766137,0.8316221765913757,0.9533181255814538,1.0,11/20,35.17%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;PLK1;IK;CDC20;BUB1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.2607878303346667,-0.7232593088766137,0.8316221765913757,0.9533181255814538,1.0,11/20,35.17%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;PLK1;IK;CDC20;BUB1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.2607878303346667,-0.7232593088766137,0.8316221765913757,0.9533181255814538,1.0,11/20,35.17%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;PLK1;IK;CDC20;BUB1
prerank,heterocycle biosynthetic process (GO:0018130),-0.2874685809061946,-0.72314372564368,0.8257425742574257,0.9529050113629688,1.0,6/14,34.13%,GCH1;GPHN;LIAS;PYCR2;PYCR1;NFS1
prerank,regulation of viral genome replication (GO:0045069),0.2273627323474693,0.7229143613332968,0.9061976549413735,0.9835164800927502,1.0,7/56,9.82%,PPARA;LTF;RNASEL;SRPK2;HACD3;PKN2;PARP10
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.2552208967242925,-0.7225945796813675,0.8329938900203666,0.9529886779231626,1.0,11/21,35.17%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;PLK1;IK;CDC20;BUB1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3086642532594634,0.7219370799905402,0.8076923076923077,0.9841930907049784,1.0,2/13,11.32%,TPST1;SULT4A1
prerank,DNA packaging (GO:0006323),0.3009284422105669,0.7218914292272472,0.7864077669902912,0.9836220885295271,1.0,6/16,27.59%,RBBP4;BANF2;AIFM1;NAA10;TP53;KAT6A
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.24900249175998343,0.7214555419834981,0.8480138169257341,0.9835669684997153,1.0,7/36,12.05%,PRKN;DUSP10;DLG1;SIRPA;ITCH;SH3RF2;CYLD
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.23439827932918586,0.7210172640024168,0.8810344827586207,0.983499375309438,1.0,12/52,13.17%,TLN1;TATDN2;TPP1;WIPI1;EXTL1;CUL7;ATP6V0D1;FKBP14;SERP1;EDEM1;TSPYL2;PLA2G4B
prerank,antibacterial humoral response (GO:0019731),0.296162593694625,0.7203630460451632,0.805940594059406,0.9837127664918464,1.0,1/16,2.73%,LTF
prerank,establishment of spindle localization (GO:0051293),-0.28662471903798004,-0.7202598778198436,0.8372093023255814,0.9550993993730513,1.0,10/14,38.02%,MAP4;CFL1;CLASP2;TLE6;ZBED3;DYNC1H1;ESPL1;CLASP1;NUSAP1;NLRP5
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.2189459722524213,-0.7202533540513799,0.9229074889867841,0.9545652024098419,1.0,23/42,39.87%,SMCHD1;SPIDR;UBQLN4;ACTR2;FUS;TERF2IP;POLQ;PPP4R2;SIRT6;CHEK1;SHLD3;RMI2;CGAS;RIF1;SHLD2;PPP4C;HELB;RPA2;FIGNL1;WAS;WRAP53;RADX;TIMELESS
prerank,erythrocyte development (GO:0048821),-0.311725661522014,-0.7183160508026847,0.8273921200750469,0.9561689582554806,1.0,4/10,20.80%,ABCB10;ZBTB7A;SH2B3;NCKAP1L
prerank,positive regulation of reproductive process (GO:2000243),0.2594127387268298,0.7181847529525691,0.8507462686567164,0.9859171287577809,1.0,6/31,15.98%,PLA2G10;PLCB1;AGO2;SMURF2;TACR3;SYDE1
prerank,myeloid cell differentiation (GO:0030099),-0.21271621103393507,-0.7177869101026848,0.9302325581395349,0.9562114300850354,1.0,16/47,26.33%,RUNX1;RPS19;RPS14;KMT2E;IKZF1;TAL1;ATP5IF1;SPI1;INHA;JAK3;TIRAP;HSPA9;PRKX;CEBPA;FLVCR1;EPO
prerank,establishment of spindle orientation (GO:0051294),0.2530113557929384,0.7177041264378967,0.8549618320610687,0.985922724276899,1.0,5/28,11.34%,LLGL2;GJA1;UBXN2B;PAFAH1B1;LLGL1
prerank,dendritic cell differentiation (GO:0097028),0.2771065281499731,0.7175615869180018,0.8169291338582677,0.9854807500244456,1.0,7/22,16.12%,IRF8;CCL19;BATF2;AXL;BATF;PRTN3;LYN
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.287841839806259,0.7175384107531548,0.8215686274509804,0.9848909982178633,1.0,4/18,11.42%,PHF8;LYAR;RASL11A;ERBB2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2517728113764638,0.7171363111600416,0.8738229755178908,0.98475637223368,1.0,2/34,5.06%,LGR4;CACTIN
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.2872522825863022,0.7155610875177085,0.7996031746031746,0.9861102129066786,1.0,4/17,13.05%,ABI2;WASF1;WASF3;FCHSD2
prerank,positive regulation of transmembrane transport (GO:0034764),0.3049536944697949,0.7154844475662342,0.7952755905511811,0.9855841453082664,1.0,2/13,6.46%,ACSL1;AZIN2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.26683108520119336,-0.715397757775317,0.8568548387096774,0.9582347590406596,1.0,7/18,33.16%,GSK3B;HIP1R;SLC35F6;CHCHD10;BAX;BID;HSPA1A
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.28611726661035697,-0.7152975259950856,0.8406374501992032,0.9577946343015675,1.0,3/14,19.43%,ADAM10;PSEN1;ABCG1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.29927579263182214,-0.7144103144364803,0.8483685220729367,0.9582213835201133,1.0,6/13,35.30%,PRR5L;ZC3H12A;GTPBP1;ZC3HAV1;CNOT1;RC3H1
prerank,neuron projection fasciculation (GO:0106030),0.3266194036186013,0.7140769181185292,0.8012820512820513,0.9867809948146791,1.0,2/10,7.10%,EPHA4;ARHGAP35
prerank,negative regulation of dephosphorylation (GO:0035305),-0.2654207570528486,-0.7138400800691024,0.8582834331337326,0.9583004136574561,1.0,9/18,31.56%,PPP1R16B;YWHAB;CHP1;ZCCHC9;PPP1R15A;URI1;PPP1R35;ARPP19;MFHAS1
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.2633456166183802,-0.7137026219431527,0.8491735537190083,0.9579063446964639,1.0,6/17,21.96%,SMUG1;OGG1;TERF2IP;NEIL1;NEIL3;NTHL1
prerank,macrophage migration (GO:1905517),0.3069451413679619,0.7132866841434864,0.8230616302186878,0.9871134863681215,1.0,3/13,17.65%,TAFA4;CKLF;EDNRB
prerank,cellular response to interferon-beta (GO:0035458),-0.28642651170996114,-0.7128067720731077,0.8355640535372849,0.9583102777252143,1.0,7/14,43.21%,AIM2;NDUFA13;STAT1;IFITM2;CDC34;UBE2G2;IRF1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.2684961468558503,0.7126411620419609,0.8301158301158301,0.98728815860112,1.0,5/20,16.26%,PLCB1;GNAQ;LY6G6D;GRK2;CHRNB2
prerank,endosome organization (GO:0007032),0.23776670103955602,0.7126190634901949,0.8593481989708405,0.9867004313688468,1.0,11/41,16.49%,HOOK2;ALS2;SNX33;PLEKHJ1;RAB22A;ARFGEF2;PLEKHF1;EEA1;PHETA1;WASHC4;PI4K2A
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.27609905543996993,0.7124978415122835,0.8283433133732535,0.9862412408958358,1.0,4/20,12.45%,SMOC2;SULF1;APLN;PRKD2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.28626237982361874,-0.7118436517049922,0.8574108818011257,0.9587930263720689,1.0,5/13,24.03%,UAP1L1;UAP1;GNPDA1;AMDHD2;GNPDA2
prerank,protein localization to microtubule organizing center (GO:1905508),-0.2733365939571228,-0.7114764994877062,0.8674463937621832,0.9586407958043397,1.0,5/15,33.74%,CEP83;SPAG5;PCM1;CEP131;STIL
prerank,histone H4 deacetylation (GO:0070933),0.32518744894829665,0.7111895475778469,0.7863436123348018,0.9872643839113804,1.0,2/10,10.71%,HDAC8;HDAC1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.21693522193794676,0.7101323839156294,0.9207920792079208,0.9879383447574169,1.0,15/68,17.07%,CDK7;SSU72;MTERF2;POLR2A;SMN1;TAF1A;POLR1F;POLR1A;TAF1D;WDR33;MNAT1;FIP1L1;CSTF3;POLR1G;CPSF4
prerank,regulation of sensory perception of pain (GO:0051930),-0.29328315906377944,-0.7097879664905549,0.8301886792452831,0.9598599560056992,1.0,2/11,5.09%,MGLL;CCN3
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.22024983149632196,-0.7096545368111892,0.9155844155844156,0.9594560688422594,1.0,15/36,35.47%,SHANK3;ITGB1;EDN1;RELN;ADRB2;GREM1;HDAC6;CCR2;CCL2;BTC;BUD31;EGF;PARK7;NCF1;ADAM17
prerank,DNA dealkylation (GO:0035510),0.3249816875588879,0.7092506864270273,0.7943107221006565,0.9877444063601402,1.0,4/10,24.76%,ASCC2;MPG;ASCC1;ALKBH3
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3249816875588879,0.7092506864270273,0.7943107221006565,0.9877444063601402,1.0,4/10,24.76%,ASCC2;MPG;ASCC1;ALKBH3
prerank,protein kinase A signaling (GO:0010737),0.31435650975622725,0.7091934974949695,0.8029978586723768,0.9871963700737619,1.0,2/12,13.55%,RAB13;PRKACB
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.32870240271914514,0.7088059866216609,0.7958333333333333,0.9870405524441856,1.0,1/10,2.89%,SP100
prerank,regulation of cytoplasmic translation (GO:2000765),-0.28386211194290983,-0.7083772995442165,0.8574144486692015,0.9602911214339611,1.0,8/14,31.96%,PKM;YBX3;CPEB1;FMR1;RBM24;CNBP;CPEB3;DHX9
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.28812815385195295,-0.7075783786774096,0.8273244781783681,0.9605599806926579,1.0,4/12,23.22%,WDTC1;CEACAM1;ERLIN2;TRIB3
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.3260737274721819,0.7066364683482146,0.8167006109979633,0.9878377574610383,1.0,4/10,23.16%,BLM;WRN;NBN;SMARCAL1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.3260737274721819,0.7066364683482146,0.8167006109979633,0.9878377574610383,1.0,4/10,23.16%,BLM;WRN;NBN;SMARCAL1
prerank,t-circle formation (GO:0090656),0.3260737274721819,0.7066364683482146,0.8167006109979633,0.9878377574610383,1.0,4/10,23.16%,BLM;WRN;NBN;SMARCAL1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.2569293665848876,-0.7060102708981879,0.859538784067086,0.9616298603650887,1.0,7/18,24.36%,CBL;ST18;STAT3;SPI1;JAK1;CEBPA;STAT1
prerank,defense response to protozoan (GO:0042832),-0.29243504946676985,-0.705904963125044,0.8596837944664032,0.9612070868012839,1.0,4/12,21.22%,GBP4;CD40;MYD88;SLC11A1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.280313030661933,-0.7057424271135573,0.8521560574948666,0.9608254973305896,1.0,5/13,21.96%,SMUG1;NT5C;OGG1;NEIL1;NTHL1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.21154506289553604,0.7056538545628683,0.9441707717569786,0.9884001004279919,1.0,22/76,19.54%,ANGPT1;PRICKLE1;SPHK1;LRRK2;UBE2L3;RWDD3;WDR48;FANCI;PIAS1;FBXO4;MYCBP2;CRY1;RCHY1;CENPX;BIRC2;AXIN1;TRAF6;HDAC4;TBC1D7;PIAS3;XIAP;DCUN1D5
prerank,positive regulation of TOR signaling (GO:0032008),0.24212481649584527,0.7044129276988748,0.8745583038869258,0.9892958933571738,1.0,14/40,20.64%,FNIP1;RICTOR;SLC38A9;GPR137C;MLST8;FLCN;KLHL22;SIK3;TELO2;LARS1;MIOS;PIK3CA;CLEC16A;LAMTOR5
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.2267086488689501,0.7037055498066108,0.9008547008547009,0.9895058453597262,1.0,6/51,8.79%,IL34;PTN;IL6;CSF1;MOSPD2;VEGFB
prerank,negative regulation of T cell proliferation (GO:0042130),-0.23439638519552655,-0.703586661111844,0.8910675381263616,0.9624812054924845,1.0,12/28,39.58%,TNFRSF21;PRKAR1A;CD274;SDC4;CEBPB;CD80;IL4I1;GPNMB;RC3H1;VTCN1;ARG1;CRTAM
prerank,negative regulation of double-strand break repair (GO:2000780),-0.22979270202154645,-0.703393646668147,0.9070796460176991,0.9621374920515097,1.0,12/30,33.54%,SMCHD1;OGG1;UBQLN4;OTUB1;POLQ;SHLD3;RMI2;CGAS;TFIP11;RIF1;SHLD2;HELB
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.3159576804402173,0.7030051227472166,0.8112033195020747,0.9896628111892697,1.0,2/11,9.10%,ANXA1;RC3H2
prerank,cellular component maintenance (GO:0043954),0.30914658380718496,0.7029396467849943,0.7966101694915254,0.9891334680731474,1.0,2/12,5.54%,IGF1R;ITGA3
prerank,serine family amino acid biosynthetic process (GO:0009070),0.30817815012696304,0.7029293979920447,0.816247582205029,0.9885353187795982,1.0,2/12,8.27%,CBS;SRR
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.25780634247747136,-0.7018298878359743,0.8851063829787233,0.9631622283992393,1.0,8/18,26.99%,MSN;PTPN23;VPS11;MAP2K2;MAPK3;CHMP3;EZR;SNX3
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.26740059397984056,0.7014970873764914,0.83399209486166,0.9895956382449614,1.0,8/20,22.18%,MEIS1;CDC73;CIB1;MEIS2;CTR9;LDB1;PAF1;HOXA5
prerank,protein alkylation (GO:0008213),-0.2490075124462963,-0.7014205519052046,0.8448979591836735,0.9630247383707778,1.0,11/22,43.49%,PCMT1;PRMT8;PRMT3;ETFBKMT;ETF1;FAM98B;FAM98A;PRMT1;VCPKMT;METTL21C;METTL21A
prerank,double-strand break repair via homologous recombination (GO:0000724),0.2066286871276021,0.70096132481959,0.9467741935483871,0.9896217933671853,1.0,19/95,16.18%,RAD51B;RAD51AP2;RNF138;HUS1B;RAD51C;BLM;HELQ;AUNIP;BRCA2;ZSWIM7;ZFYVE26;INO80;MRE11;FANCB;WRN;MCM2;SWI5;RAD51;NIPBL
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.25820242710632646,-0.7008667771879022,0.8895238095238095,0.9630123139027928,1.0,9/18,44.78%,ADAM10;PSEN1;ABCG1;ACHE;ADAM17;CLN3;LDLRAP1;NSG1;PSEN2
prerank,necroptotic process (GO:0070266),0.28954474097331245,0.6994143589846409,0.8524271844660194,0.9908601695677965,1.0,16/16,71.07%,CYLD;CD14;PGAM5;ITPK1;TRPM7;FASLG;LY96;IPMK;RIPK3;TLR3;MLKL;TICAM2;DNM1L;RIPK1;TICAM1;TLR4
prerank,mitochondrial protein processing (GO:0034982),0.30520049839542884,0.6990848796581275,0.8284424379232506,0.9906278956602038,1.0,3/11,16.89%,YME1L1;OMA1;IMMP1L
prerank,regulation of TORC1 signaling (GO:1903432),0.24225440788550986,0.6983049068010875,0.8727598566308243,0.9908733964882128,1.0,12/33,20.64%,SZT2;SESN1;RNF152;GPR137C;FLCN;KLHL22;SIK3;TELO2;LARS1;CLEC16A;KPTN;LAMTOR5
prerank,protein import into peroxisome membrane (GO:0045046),-0.2443751216553442,-0.6979693496435372,0.9,0.9653756479338251,1.0,9/22,29.55%,ABCD3;ABCD2;PEX11B;PEX5;ATAD1;RAB8B;PEX16;FIS1;PEX13
prerank,positive regulation of macrophage migration (GO:1905523),0.2770828316843046,0.6979619883735081,0.8656126482213439,0.9906441929706855,1.0,1/19,0.72%,IL34
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.31270752471120067,0.6977581307907247,0.8264642082429501,0.9902830815600581,1.0,4/10,21.84%,SLC45A3;SNCA;IRS2;IRS1
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.2451795721607835,-0.6976662824757436,0.8813905930470347,0.9651572980358293,1.0,4/21,19.26%,ADAM10;MYH9;ADAM9;PSEN1
prerank,regulation of cell cycle process (GO:0010564),0.2001609682911193,0.697412748231088,0.9631901840490797,0.9900651185078121,1.0,25/104,18.80%,OBSL1;HORMAD1;PLK5;CCDC8;CUL9;RPRD1B;BIRC6;YTHDF2;CUL7;PIK3R4;UVRAG;SND1;FLCN;MAD1L1;ZFYVE26;TXLNG;MYO19;CDKN2B;IHO1;SETD2;KLHL13;RAB11FIP3;USP19;PRPF40A;SFRP1
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.2542065791542289,-0.697075009997546,0.8830409356725146,0.9651655273025403,1.0,7/20,24.15%,SREBF2;LPCAT3;NR1H4;ABCA2;MBTPS1;TTC39B;DGKQ
prerank,myeloid cell development (GO:0061515),0.2831974352522153,0.6959844817907866,0.8390151515151515,0.9910819177501489,1.0,3/18,10.06%,KIT;LYAR;MED1
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.23224720948333544,-0.6958941848182864,0.9071925754060325,0.9658262021336342,1.0,10/28,24.55%,CDH1;FLNA;TGFB1;JUP;ZC3H12A;PSEN1;PRKCD;RBM22;HYAL2;ZPR1
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.2623443031334136,-0.695315241440738,0.8565891472868217,0.9658564708388866,1.0,6/17,22.08%,FURIN;NR1H2;PCSK5;ANGPTL4;HDAC9;NR1H3
prerank,T cell differentiation in thymus (GO:0033077),-0.27335736095706015,-0.695297265050873,0.8670634920634921,0.965340798217458,1.0,4/14,18.89%,PTPRC;ZFP36L1;RABL3;LIG4
prerank,endocytic recycling (GO:0032456),-0.20121764673485437,-0.6952924886032585,0.9396135265700483,0.9648107688412,1.0,15/50,26.99%,EHD4;DENND1B;EHD1;STX6;PTPN23;LMTK2;EHD3;ANKRD50;ENTR1;VPS51;RAB7A;SNX27;RAB14;MICALL2;SNX3
prerank,cellular response to catecholamine stimulus (GO:0071870),0.2666651861986333,0.6941465481043252,0.8491295938104448,0.9925083312285559,1.0,7/23,19.93%,PRKN;LRRK2;ABL1;MAPK1;GNG2;SNCA;SLC9A1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.22650608767623348,-0.6937789994354472,0.9067245119305857,0.9656641654636398,1.0,8/28,21.03%,PTK2;DAB2IP;CLU;PSMC3;ATP5IF1;LAPTM5;FMR1;CTSC
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.25885132395398674,0.6934485124614228,0.8552123552123552,0.9926510523641714,1.0,3/25,9.92%,B3GALT1;HAS1;NDST2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.23528084242231379,-0.6930206971351028,0.8898678414096917,0.9658293079122924,1.0,3/24,3.96%,PTK2B;NOTCH1;HES1
prerank,tryptophan catabolic process (GO:0006569),-0.2880927932365438,-0.6928284146933859,0.8752436647173489,0.9654756586465059,1.0,4/11,32.08%,KYAT1;KMO;IL4I1;HAAO
prerank,negative regulation of bone mineralization (GO:0030502),0.29509566394693765,0.6917695222201863,0.8109243697478992,0.9938940185604246,1.0,2/13,6.35%,ECM1;BCOR
prerank,somite development (GO:0061053),-0.29378923083650976,-0.6914509436443349,0.8815533980582524,0.9662651893058956,1.0,2/11,7.46%,MEOX2;PTCH1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.26773514456874686,-0.6898072844419887,0.8470824949698189,0.9672430645420897,1.0,9/16,47.12%,TUBB4B;ULBP1;CORO1A;KIF5B;RAET1E;SLAMF7;PLEKHM2;KLRK1;LYST
prerank,RNA modification (GO:0009451),-0.19876927497490343,-0.6892177068284755,0.9625935162094763,0.9672079270253549,1.0,22/54,32.59%,ADARB1;ADAR;SSB;MEPCE;QTRT1;TSR3;NSUN4;MRM2;THUMPD1;METTL3;ELP5;METTL1;AARS2;PUS7;ADAT2;CDKAL1;QTRT2;NOP10;RBM15;JMJD6;NSUN5;CTU1
prerank,lipoprotein transport (GO:0042953),0.31281208119634873,0.6891650188869105,0.8326086956521739,0.9960718147740569,1.0,2/10,8.41%,PRKCB;MIA3
prerank,regulation of DNA recombination (GO:0000018),-0.22392699201417043,-0.6888730211608621,0.9208791208791208,0.9669794790677559,1.0,15/32,34.94%,SPIDR;MSH2;TERF2IP;PPP4R2;SMARCAD1;SIRT6;CHEK1;ALYREF;ZCWPW1;SHLD2;PPP4C;KPNA2;RPA2;FIGNL1;IL7R
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.31301625991678156,0.6885613129206445,0.8069815195071869,0.9961237707102438,1.0,1/11,2.89%,SP100
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.26712806940167333,-0.6883503838696108,0.8533057851239669,0.9669141776763741,1.0,5/15,21.92%,ZC3H12A;GSTO2;ATF3;MKNK2;VCP
prerank,determination of left/right symmetry (GO:0007368),0.23955791969660925,0.6879662753924507,0.8743455497382199,0.9961384761921571,1.0,7/37,14.99%,ODAD3;DNAH11;ARL6;BBS7;OFD1;PKD2;ODAD2
prerank,DNA conformation change (GO:0071103),0.27867736256345355,0.6873003999025556,0.8360655737704918,0.9962252717938059,1.0,3/17,14.11%,TOP2B;ABL1;TOP1MT
prerank,ureteric bud morphogenesis (GO:0060675),-0.2591348403099855,-0.6863333569873713,0.871031746031746,0.968244845535061,1.0,8/16,34.32%,SIX1;NPNT;BMP2;BMP4;PAX8;FGF2;SHH;PAX2
prerank,regulation of mitochondrion organization (GO:0010821),0.2195160563859665,0.6847277190376319,0.9068541300527241,0.9983907251043292,1.0,9/47,17.24%,PID1;PRKN;LRRK2;FLCN;PISD;HTRA2;OMA1;MYO19;VPS35
prerank,ruffle organization (GO:0031529),0.2855883761617442,0.684683956735843,0.8491735537190083,0.9978261904606035,1.0,2/16,7.18%,TPM1;LIMA1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.26571668550629474,0.6843786158392878,0.8717434869739479,0.9975353023062689,1.0,1/22,1.28%,BMP7
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.2608499066175694,0.6841811059961413,0.8849206349206349,0.9971180625717618,1.0,2/21,4.78%,PPP4R4;PTPA
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.22357915440096565,0.6839355188622287,0.916083916083916,0.9967428085581869,1.0,12/48,18.27%,BAZ1B;ARID1B;ZMIZ1;SMARCA5;TAF1A;POLR1F;POLR1A;ZMIZ2;TAF1D;PHF2;POLR1G;ATAD2B
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.24215138550746967,-0.6836312112605252,0.8920570264765784,0.9701160036881699,1.0,9/19,39.21%,CORO2B;CHP1;PTP4A3;CEP295;TREM2;CCT3;CCT4;WRAP53;CCT2
prerank,GTP metabolic process (GO:0046039),-0.26291234979440226,-0.6835775860222528,0.8695652173913043,0.9696236584900851,1.0,3/15,13.98%,ENTPD7;IMPDH1;IMPDH2
prerank,negative regulation of synaptic transmission (GO:0050805),-0.23310015312278667,-0.6825397043263877,0.9059304703476483,0.9699958161519386,1.0,5/23,13.07%,PLK2;ARF1;SLC24A2;SLC30A1;PICK1
prerank,negative regulation of viral genome replication (GO:0045071),0.2286562841132623,0.6803723045087616,0.927461139896373,0.999849067925747,1.0,3/40,3.90%,LTF;RNASEL;SRPK2
prerank,indolalkylamine catabolic process (GO:0046218),-0.2904642422612346,-0.6795652131225967,0.888045540796964,0.9720716704381751,1.0,4/10,32.08%,KYAT1;KMO;IL4I1;HAAO
prerank,organophosphate biosynthetic process (GO:0090407),0.2357398821599835,0.6783764948860153,0.8875,1.0,1.0,11/37,21.25%,AGPAT4;MOCS2;PPIP5K2;ITPKA;MOCS1;GK;MOCS3;GK5;PIP5K1A;IP6K2;PCYT2
prerank,embryonic axis specification (GO:0000578),0.28641162793409736,0.6776748576806935,0.845703125,1.0,1.0,5/15,20.61%,SMAD6;COBL;HOXD8;CXXC4;SMAD2
prerank,intracellular cholesterol transport (GO:0032367),0.28179805593239293,0.6773969019976982,0.8466019417475729,1.0,1.0,3/15,17.13%,ABCA1;SERAC1;RELCH
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.2579665511315423,-0.6768039145397413,0.9078694817658349,0.9739612716874231,1.0,5/15,36.30%,PTTG1;ANAPC7;PLK1;CDC6;UBE2C
prerank,cell-cell junction maintenance (GO:0045217),0.29729121461969665,0.6759353636174779,0.8110403397027601,1.0,1.0,1/11,2.23%,NLGN2
prerank,regulation of lipid storage (GO:0010883),0.25747045641786187,0.6748264998679954,0.8838095238095238,1.0,1.0,4/22,14.03%,PLA2G10;IL6;IKBKE;PLIN5
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.2720701500912812,-0.674630737770132,0.8616600790513834,0.975224410330854,1.0,7/13,32.23%,ETS1;RHOA;IRAK1;FUT9;RELA;ITGB2;MDK
prerank,tRNA modification (GO:0006400),0.2131323645018203,0.6745202608894205,0.9429037520391517,1.0,1.0,14/62,18.43%,TRMT9B;PUS3;THADA;LCMT2;TRDMT1;OSGEP;WDR4;MTO1;THUMPD3;DUS2;DTWD1;TYW5;TPRKB;MOCS3
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2182442104491213,0.6737414878099601,0.9351535836177475,1.0,1.0,8/45,14.62%,BMP7;TOM1L2;SMAD3;TRIM35;PTPN3;GAS1;CDKN1C;CHFR
prerank,autophagosome organization (GO:1905037),0.21734130978330587,0.6735127467007733,0.9196581196581196,1.0,1.0,12/50,17.13%,TP53INP2;RAB19;WIPI1;UBXN2B;ATG14;ATG9A;RAB43;AMBRA1;ATG3;RUFY4;IRGM;ATG16L2
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.26260770298312397,-0.6734721746364651,0.8939096267190569,0.9756259536387195,1.0,2/14,5.06%,CMPK1;ME1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.23425921538669714,-0.6723287577951077,0.8938428874734607,0.9760640314781209,1.0,14/23,36.09%,SIX1;VEGFA;PIK3CD;SIX4;BMP4;PAX8;SIRT6;FGF2;EGF;AGT;MDK;NOG;PAX2;LIF
prerank,axoneme assembly (GO:0035082),0.236540841933332,0.6723080857796018,0.8985239852398524,1.0,1.0,6/31,14.90%,DNAI4;SPAG1;CFAP74;TTC12;CCDC65;DNAAF3
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.30289476806431836,0.6715342525148914,0.8236607142857143,1.0,1.0,1/10,6.02%,PDE6G
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.23602897546660098,-0.6713134572202228,0.9206008583690987,0.9764036899871756,1.0,10/24,34.29%,HSP90AA1;AIM2;ZC3H12A;STAT1;TRIM44;CGAS;SIN3A;MAVS;PTPN22;PQBP1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.23910875999171607,0.6712010549779429,0.9321100917431193,1.0,1.0,15/31,24.97%,EXOSC8;DCP2;LSM5;CNOT8;CNOT7;EXOSC3;LSM3;LSM1;LSM4;DDX6;EXOSC4;DCP1B;LSM6;DIS3;NT5C3B
prerank,regulation of spindle organization (GO:0090224),-0.24878484151743893,-0.670988027589785,0.8911290322580645,0.9761033529148614,1.0,8/18,46.31%,GNAI1;NUMA1;DCTN1;DYNC1H1;PSRC1;SENP6;RAE1;PARP3
prerank,synaptic vesicle recycling (GO:0036465),0.2353951829833328,0.670782712221765,0.8990990990990991,1.0,1.0,3/31,6.00%,CEL;NLGN2;SYNJ2
prerank,positive regulation of protein sumoylation (GO:0033235),0.304626934694324,0.6707508106537129,0.8208333333333333,1.0,1.0,4/10,19.01%,RWDD3;PIAS1;HDAC4;PIAS3
prerank,programmed necrotic cell death (GO:0097300),0.2706776361238462,0.6706868364808688,0.8919925512104283,1.0,1.0,18/18,72.96%,CYLD;CD14;PGAM5;ITPK1;TRPM7;FASLG;PPIF;LY96;IPMK;RIPK3;TLR3;MLKL;TICAM2;DNM1L;RIPK1;TICAM1;TLR4;ALKBH7
prerank,termination of RNA polymerase I transcription (GO:0006363),0.2382105576198205,0.6704856423769057,0.8994614003590664,1.0,1.0,7/30,16.97%,CDK7;TAF1A;POLR1F;POLR1A;TAF1D;MNAT1;POLR1G
prerank,regulation of RNA export from nucleus (GO:0046831),-0.28274937809332623,-0.6700168852811595,0.8705179282868526,0.9764186200343545,1.0,6/11,35.96%,CPSF6;NRDE2;NUP153;DHX9;IWS1;NCBP2
prerank,mitotic cell cycle phase transition (GO:0044772),0.17609120199843234,0.6698214526303721,0.9944444444444445,1.0,1.0,24/204,12.45%,NINL;PLCB1;ALMS1;PHLDA1;CDK7;CCDC57;EIF4EBP1;HAUS4;CEP152;NASP;PHF8;SDCCAG8;OPTN;CDK1;PAFAH1B1;FBXL17;LATS1;OFD1;HAUS1;RPS6KB1;SFI1;CUL4B;CCNE1;CEP57
prerank,acyl-CoA metabolic process (GO:0006637),0.22961607717392496,0.6688253618619484,0.9169675090252708,1.0,1.0,2/35,4.01%,SUCLG2;ACOT4
prerank,regulation of lymphocyte activation (GO:0051249),0.2850775315462364,0.668488197747074,0.8410041841004184,1.0,1.0,12/12,71.51%,PAG1;LAT;SIT1;CD4;CD19;LCK;CRTAM;KAT2A;CCL5;THEMIS2;IKZF3;DCAF15
prerank,regulation of response to stress (GO:0080134),-0.2899731100970696,-0.6680302755925176,0.8762088974854932,0.9774905248777099,1.0,2/10,9.74%,CORO2B;EIF4G1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.2840343457315296,-0.6674265587227108,0.8996062992125984,0.9774414555834159,1.0,6/11,37.75%,PLCG2;CDH13;TREM2;P2RX5;P2RX3;TRAT1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.2899153577089045,0.6674162139947605,0.8729508196721312,1.0,1.0,5/13,22.24%,LRRK2;RHOQ;RAB23;AK4;AK3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.2913496444171941,0.6671056939262592,0.8617234468937875,1.0,1.0,2/13,8.90%,IRAK2;PIK3R4
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.25929579821934734,0.6669252168914487,0.8752436647173489,1.0,1.0,7/19,21.01%,GFPT2;PMM2;RENBP;UGDH;PGM3;MPI;GMPPB
prerank,Golgi inheritance (GO:0048313),0.28786728804234424,0.6668589119776611,0.8583877995642701,0.9997552048671131,1.0,3/11,9.66%,PLK5;CDK1;GOLGA2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.23866044040184414,-0.6667646547681134,0.8994082840236687,0.9774434237114735,1.0,10/19,37.49%,AQP4;CFAP53;SPAG17;RFX3;DNAAF2;ODAD4;CABYR;CCDC40;DNAAF4;CCDC39
prerank,regulation of lipid kinase activity (GO:0043550),0.30079394402226434,0.6666658369270176,0.8272138228941684,0.9993369411680687,1.0,2/11,10.73%,RBL2;PIK3R1
prerank,negative regulation of protein depolymerization (GO:1901880),0.2485371764169974,0.6663151806300747,0.9138576779026217,0.9990760317947099,1.0,2/24,7.18%,PLEKHH2;LIMA1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.23295611955115664,0.6643887381683702,0.9101123595505618,1.0,1.0,5/30,11.27%,INSIG2;PMVK;ACAA2;ACAT2;FDPS
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.24797997956070278,0.6642109993920735,0.878731343283582,0.9998557526479931,1.0,2/23,6.76%,KIT;IL6
prerank,regulation of response to biotic stimulus (GO:0002831),0.24260787640969333,0.663249137429316,0.8814531548757171,1.0,1.0,2/28,3.24%,APPL2;TRIM5
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.2476161772965232,-0.6629575131965887,0.9012345679012346,0.9797844293528285,1.0,1/17,1.62%,SLC7A5
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.2837389293220921,-0.6623282835736555,0.8660194174757282,0.9786495154061373,1.0,3/11,29.33%,PPCDC;PANK2;PANK3
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.2837389293220921,-0.6623282835736555,0.8660194174757282,0.9786495154061373,1.0,3/11,29.33%,PPCDC;PANK2;PANK3
prerank,coenzyme A biosynthetic process (GO:0015937),-0.2837389293220921,-0.6623282835736555,0.8660194174757282,0.9786495154061373,1.0,3/11,29.33%,PPCDC;PANK2;PANK3
prerank,positive regulation of mRNA processing (GO:0050685),-0.2381789254434215,-0.6617403773969442,0.8956158663883089,0.9785773068428328,1.0,12/21,48.33%,RBMXL1;TRA2B;PRDX6;DAZAP1;CELF4;NCBP2;CELF3;LEO1;SF3B4;RBM3;TRA2A;NCBP1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.2471515025491957,-0.6610046117172699,0.9092702169625246,0.9785749726808866,1.0,4/18,15.65%,AGRN;CHRM3;GNA11;RGS10
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.2488075747683736,-0.6608425160584743,0.90625,0.9781651130720058,1.0,7/17,35.25%,LGMN;CXCL12;CCR2;CREB3;CXCL10;CXCL17;CCL5
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.28141338508032093,0.6603205485050072,0.8394004282655246,1.0,1.0,3/13,10.17%,TNRC6B;TNRC6A;AGO2
prerank,purine-containing compound salvage (GO:0043101),0.28632719740147006,0.6601788218680625,0.852882703777336,1.0,1.0,4/12,18.20%,AMPD3;ADK;APRT;GMPR2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.2237916050132502,-0.6601771333463062,0.9243697478991597,0.9781452715769933,1.0,7/27,19.97%,BHLHE40;FBXL3;PPP1CA;PER1;ID2;PPP1CB;PPP1CC
prerank,regulation of axon regeneration (GO:0048679),-0.2771790363372314,-0.6601083042531625,0.8853383458646616,0.977659079920252,1.0,5/12,21.35%,SCARF1;RTN4RL1;GRN;INPP5F;RTN4R
prerank,regulation of autophagosome maturation (GO:1901096),0.2804921933831615,0.6600892284983438,0.8473118279569892,1.0,1.0,7/13,25.43%,UVRAG;RUBCN;TMEM39A;IRGM;CLEC16A;FYCO1;PHF23
prerank,RNA methylation (GO:0001510),-0.18666627994661744,-0.6598613509744129,0.9851116625310173,0.9773096506644553,1.0,15/60,23.62%,TFB2M;TRMT61B;MEPCE;BUD23;FBL;ALKBH8;NSUN4;TRMT44;MRM2;TRMT12;METTL3;TYW3;TRMT10C;METTL1;PCIF1
prerank,gluconeogenesis (GO:0006094),0.22354796305138697,0.6588579169488077,0.9243856332703214,1.0,1.0,6/39,14.13%,RBP4;SLC25A11;CRY1;ENO2;PFKFB1;GPI
prerank,positive regulation of chemokine production (GO:0032722),-0.193506288540711,-0.6584803980839741,0.9739952718676123,0.9778056272159533,1.0,16/44,35.47%,IL33;MBP;APP;CD74;CSF1R;TIRAP;AGER;ADCYAP1;TLR7;TLR4;LPL;MAVS;TSLP;IL7;SYK;ADAM17
prerank,regulation of protein sumoylation (GO:0033233),0.26495291905123153,0.6583071454880116,0.8616600790513834,1.0,1.0,3/17,8.19%,ZMIZ1;RWDD3;PIAS1
prerank,natural killer cell mediated immunity (GO:0002228),-0.26094125383606603,-0.6563006344346458,0.8997995991983968,0.9788972596083563,1.0,9/15,47.12%,TUBB4B;ULBP1;KIF5B;RAET1E;SLAMF7;PLEKHM2;KLRD1;KLRK1;LYST
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.24944388119057964,-0.6541860256449119,0.9081419624217119,0.979940737973344,1.0,4/14,18.46%,RTCB;RTRAF;CLP1;CSTF2
prerank,protein import into nucleus (GO:0006606),0.2003616452982455,0.6538160402459425,0.9524590163934427,1.0,1.0,11/66,17.22%,APPL2;IPO13;PRICKLE1;NUTF2;NUP107;TNPO1;NXT2;CBLB;RPAIN;IPO9;NUP214
prerank,insulin secretion (GO:0030073),0.25526679429503757,0.6526672343386043,0.8825831702544031,1.0,1.0,5/19,17.49%,ANXA1;SLC30A8;RAB11FIP2;RAB11B;CYB5R4
prerank,eye photoreceptor cell development (GO:0042462),-0.25151790349628367,-0.652056715691504,0.8947368421052632,0.9808843279172107,1.0,4/15,20.04%,RP1;VEGFA;RORB;THY1
prerank,homologous chromosome segregation (GO:0045143),0.252211201159956,0.65129467257249,0.9090909090909091,1.0,1.0,2/20,8.73%,TERB2;MAJIN
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.29697872603400427,0.6510780694125816,0.8604651162790697,1.0,1.0,4/10,20.50%,TGFA;AREG;HBEGF;ADRA2A
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.2871939736346514,0.6486700506711381,0.8615071283095723,1.0,1.0,11/11,71.30%,CCT6A;TCP1;DKC1;CCT5;CCT7;CCT8;TERF1;CCT2;WRAP53;CCT4;CCT3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.17648746423301595,0.6485628457590261,0.9911373707533235,1.0,1.0,17/146,11.40%,NINL;ALMS1;RAD51B;RAD51C;HAUS4;CEP152;PSME4;PSMA2;SDCCAG8;PSMA3;CDK1;PAFAH1B1;PSMD8;OFD1;HAUS1;PSMD3;SFI1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.21499981887166597,-0.648426985515717,0.9454926624737946,0.982866243354122,1.0,8/29,20.78%,PUM2;ADAR;DGCR8;LIN28B;ZC3H7A;AGO3;SNIP1;METTL3
prerank,protein lipidation (GO:0006497),0.20519506970302612,0.6479426503615994,0.9672413793103448,1.0,1.0,9/59,12.89%,PIGU;ZDHHC1;ATG10;PIGG;WIPI1;ZDHHC3;PIGV;PIGC;PIGQ
prerank,regulation of integrin activation (GO:0033623),0.2710186597358666,0.6477650999700995,0.8857142857142857,1.0,1.0,2/15,4.14%,CXCL13;FERMT1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.2802248262410267,0.6466562014718675,0.8621359223300971,1.0,1.0,2/12,7.55%,CLCN2;H6PD
prerank,positive regulation of secretion (GO:0051047),-0.2703341730017132,-0.6459379041711929,0.9013035381750466,0.9840635586371191,1.0,2/11,17.75%,XBP1;ACSL3
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.2805396490158774,0.6454401370413356,0.8765957446808511,1.0,1.0,1/12,1.72%,UST
prerank,kinetochore organization (GO:0051383),-0.26352837962177345,-0.6440719237820817,0.9037328094302554,0.9848074013283779,1.0,10/13,53.80%,NDC80;DLGAP5;CENPW;CENPT;CENPF;CDT1;CENPC;CENPH;NUF2;CENPA
prerank,protein processing (GO:0016485),0.18370835491900928,0.6426344448881334,0.9784615384615385,1.0,1.0,5/102,4.11%,AEBP1;KLK2;CTSH;PCSK9;MYRFL
prerank,coenzyme A metabolic process (GO:0015936),-0.25307023085640873,-0.6425815541235353,0.9025844930417495,0.9853150453665839,1.0,4/14,29.33%,PPCDC;ACLY;PANK2;PANK3
prerank,fatty acid transport (GO:0015908),0.2552890345445884,0.6424337180495269,0.8959183673469387,1.0,1.0,2/17,9.87%,ACSL1;SLC27A1
prerank,regulation of lipid catabolic process (GO:0050994),0.25633682143417624,0.6412122950879456,0.8841463414634146,1.0,1.0,5/19,20.88%,PRKAA1;APOC1;ADRA2A;LONP2;RARRES2
prerank,positive regulation of T cell differentiation (GO:0045582),-0.1993115870816792,-0.640706471286784,0.953810623556582,0.9860270023129998,1.0,18/36,40.86%,LEF1;SOX4;XBP1;NKAP;NCKAP1L;SOCS1;VSIR;IL4I1;SHH;VNN1;MDK;IL7;ZAP70;GATA3;TESPA1;IL12RB1;IL4;BCL6
prerank,sensory perception of taste (GO:0050909),0.29527336639256807,0.6404811519125587,0.8556263269639066,1.0,1.0,10/10,70.49%,ASIC3;TAS1R2;PKD2L1;ASIC2;TAS1R3;GNAT3;PKD1L3;TAS1R1;CD36;ASIC1
prerank,axonal transport of mitochondrion (GO:0019896),-0.2673807368950686,-0.640426832984421,0.9056603773584906,0.9856731001700637,1.0,3/11,25.13%,ACTR10;NEFL;HAP1
prerank,regulation of defense response to virus by host (GO:0050691),-0.21188721130607424,-0.6403811516973503,0.9580573951434879,0.9851574474557102,1.0,13/30,35.50%,HSP90AA1;AIM2;ZC3H12A;TNFAIP3;STAT1;TRIM44;CGAS;SIN3A;DHX9;MAVS;PTPN22;PQBP1;IFNLR1
prerank,positive regulation of RNA splicing (GO:0033120),-0.21002335254358068,-0.6402363477683983,0.9665178571428571,0.9847157920398621,1.0,11/29,33.16%,RBMXL1;HNRNPLL;RBM22;TRA2B;RBM20;ZPR1;PRDX6;ERN1;DAZAP1;CELF4;HSPA1A
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.1819558401148525,-0.6401665921676101,0.984304932735426,0.9842230561164605,1.0,24/53,40.93%,CHRM3;HTR2A;HRH1;CALCRL;MC5R;NPY1R;HRH2;TSHR;NPY;HTR2C;CCL2;CHRM1;AGT;HTR1A;HTR1B;HTR1F;OPRM1;HRH3;CHRM5;CCR1;HTR6;CNR2;HTR1D;SSTR1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.1891048048554596,-0.6401515303518991,0.9855072463768116,0.9836975106229273,1.0,11/50,22.31%,ACTB;HSP90AB1;CDC37;CDKN1B;CCNF;CAMK2N1;CCNG2;GADD45A;CDKN1A;CDKN2D;CCNB2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.2859353007540981,0.6393699660455285,0.8967032967032967,1.0,1.0,5/10,21.34%,CCL19;AXL;LYN;LGALS9;RAPGEF2
prerank,negative regulation of intracellular protein transport (GO:0090317),0.24444458204559952,0.6391417129028019,0.9212121212121213,1.0,1.0,3/22,6.47%,SP100;LRRK2;SUFU
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.25457375292871864,0.6383275104640964,0.900990099009901,1.0,1.0,1/17,3.14%,NOS1AP
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.26954148476289347,-0.6379356626659375,0.8948374760994264,0.9846049557298491,1.0,1/11,2.15%,GAS6
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.2501810431769121,0.6375072806104526,0.9012345679012346,1.0,1.0,4/18,12.75%,COX19;COX17;OXA1L;COX20
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.23991828969272722,0.6371693164911516,0.9103053435114504,1.0,1.0,2/23,6.13%,GSTM2;EPHX2
prerank,prostanoid metabolic process (GO:0006692),0.2739185187217945,0.6351668411138022,0.8493449781659389,1.0,1.0,3/13,18.79%,PTGR1;ACOX1;PTGR2
prerank,protein localization to condensed chromosome (GO:1903083),0.2746307466721836,0.6350373179141643,0.8775933609958506,1.0,1.0,3/12,15.70%,TTK;CDK1;MIS12
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.24492038725639287,0.634995294683999,0.9361702127659575,1.0,1.0,4/21,13.88%,MITF;MED1;MED13;SRF
prerank,DNA duplex unwinding (GO:0032508),0.2075679516260831,0.6344978330900132,0.9506172839506173,1.0,1.0,17/50,21.09%,ANXA1;DDB2;BLM;SSBP1;RTEL1;CUL4B;MRE11;RAD23B;WRN;MCM2;RAD51;XPC;PURA;MCM7;RECQL5;RAD50;NBN
prerank,positive regulation of growth (GO:0045927),0.19361767225458185,0.6343446922196438,0.9836867862969005,1.0,1.0,17/64,20.46%,BCL2;PLCB1;SPHK1;ERBB2;KLHL22;ADNP2;S100A9;INO80;CIB1;HYAL1;N6AMT1;SDCBP;SFRP1;DDX3X;TAF9B;USP47;DERL2
prerank,sister chromatid segregation (GO:0000819),0.2238561427262501,0.6341214987608393,0.9247706422018349,1.0,1.0,11/31,20.36%,TOP2B;LATS1;NSL1;KLHL22;DSN1;INO80;MIS12;TUBG1;KIF18A;KIF18B;NCAPG2
prerank,replicative senescence (GO:0090399),-0.2588690532554746,-0.6329886065713795,0.9018036072144289,0.987206498441186,1.0,5/12,24.74%,WNT16;CHEK2;ROMO1;ATR;CHEK1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.24691450652610003,-0.6328563407091953,0.9173553719008265,0.9867625081824024,1.0,5/14,33.64%,CMPK1;AK5;NME2;ITPA;DCTPP1
prerank,regulation of protein acetylation (GO:1901983),-0.25848489246249784,-0.6311561809450642,0.9163498098859315,0.9872518264901525,1.0,3/12,24.08%,GSK3B;TERF2IP;CEP295
prerank,DNA strand elongation (GO:0022616),0.2521009930281591,0.6307612840905965,0.8864097363083164,1.0,1.0,8/18,23.19%,DCLRE1B;MRE11;POLD2;MCM7;RAD50;GINS3;NBN;RFC4
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.287175946268282,0.6307153308802292,0.8801652892561983,1.0,1.0,10/10,71.30%,CCT6A;TCP1;DKC1;CCT5;CCT7;CCT8;CCT2;WRAP53;CCT4;CCT3
prerank,glycogen catabolic process (GO:0005980),0.2600676535199421,0.6304631898888063,0.890495867768595,1.0,1.0,1/15,1.70%,PHKB
prerank,cholesterol biosynthetic process (GO:0006695),0.21962845704410697,0.6301778816634367,0.9410681399631676,1.0,1.0,5/31,11.27%,INSIG2;PMVK;ACAA2;ACAT2;FDPS
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.2260050654559415,0.6298306677255882,0.936046511627907,1.0,1.0,7/28,18.39%,MRNIP;AUNIP;PRKDC;PARP9;HSF1;DTX3L;KDM4D
prerank,DNA integrity checkpoint signaling (GO:0031570),0.22246404987894003,0.629648324406975,0.931095406360424,1.0,1.0,10/36,21.09%,ATRIP;HUS1B;CLSPN;FBXO6;CLOCK;CEP63;BRIP1;RAD9B;MAP3K20;NBN
prerank,defense response to fungus (GO:0050832),-0.23340463710119352,-0.6282863746387205,0.9366053169734151,0.9884316951369294,1.0,3/17,15.75%,PLCG2;GAPDH;CX3CR1
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.26410195613783527,-0.6280395677380096,0.9207920792079208,0.9875026364072242,1.0,2/11,10.34%,LARP7;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.26410195613783527,-0.6280395677380096,0.9207920792079208,0.9875026364072242,1.0,2/11,10.34%,LARP7;MEPCE
prerank,tRNA methylation (GO:0030488),0.22086769207997362,0.6275145411330153,0.9548736462093863,1.0,1.0,7/34,17.60%,HSD17B10;THADA;LCMT2;TRDMT1;MTO1;THUMPD3;TRMT1L
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.2464765957607034,0.6261205601293557,0.9171483622350675,1.0,1.0,6/19,18.61%,AMPD3;TYMS;ADK;APRT;GMPR2;POLD2
prerank,mucosal immune response (GO:0002385),0.2651030089504895,0.6257517919927774,0.8921001926782274,1.0,1.0,1/15,2.73%,LTF
prerank,epithelial cell development (GO:0002064),-0.2203703926722713,-0.6252161969724732,0.941972920696325,0.9886508789566332,1.0,2/20,6.95%,SIPA1L3;ACTA2
prerank,regulation of telomere capping (GO:1904353),-0.220860954207438,-0.6251841364541562,0.9445628997867804,0.9881411827269196,1.0,1/23,0.72%,NEK7
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.23958112156066735,0.6245234831675058,0.9243027888446215,1.0,1.0,3/22,7.12%,PSME4;PSMA2;PSMA3
prerank,heterochromatin assembly (GO:0031507),-0.23298404527282507,-0.6244714176080484,0.9455252918287937,0.9880149339306666,1.0,4/20,19.01%,SMCHD1;H3-3A;BAHD1;NRDE2
prerank,cobalamin metabolic process (GO:0009235),0.2507927491607096,0.6244219788735894,0.8904665314401623,1.0,1.0,4/17,21.30%,TCN2;MMAB;LMBRD1;TCN1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.2290573042090888,0.6243817403568934,0.9083820662768031,1.0,1.0,1/26,1.07%,PPARA
prerank,dermatan sulfate metabolic process (GO:0030205),0.2665795044506225,0.6233502364206845,0.8914893617021277,1.0,1.0,1/13,1.72%,UST
prerank,mRNA methylation (GO:0080009),-0.24043584220126935,-0.62311198103337,0.9338677354709419,0.9882594588499323,1.0,4/15,23.62%,TRMT61B;METTL3;TRMT10C;PCIF1
prerank,photoperiodism (GO:0009648),-0.20803517293225682,-0.6220954556116786,0.9537815126050421,0.9883236211412986,1.0,7/28,19.97%,BHLHE40;FBXL3;PPP1CA;PER1;ID2;PPP1CB;PPP1CC
prerank,transcription by RNA polymerase I (GO:0006360),0.21862533493794953,0.6211547805927785,0.9509090909090909,1.0,1.0,8/34,16.97%,CDK7;TAF1A;POLR1F;POLR1A;TAF1D;MNAT1;TCOF1;POLR1G
prerank,phasic smooth muscle contraction (GO:0014821),-0.2727220533877657,-0.620582369066737,0.912,0.9886628343342619,1.0,2/10,13.78%,EDN1;PTGER3
prerank,cardiolipin metabolic process (GO:0032048),-0.25746894794783665,-0.6199150301361127,0.9204081632653062,0.9885119073180371,1.0,2/13,15.14%,CRLS1;PLA2G4A
prerank,membrane lipid catabolic process (GO:0046466),-0.26708621470836047,-0.6195822174485017,0.9142300194931774,0.9881518676746575,1.0,2/10,15.18%,SGPL1;CYP1B1
prerank,glucan biosynthetic process (GO:0009250),0.2647500722757611,0.619069650961221,0.8789237668161435,1.0,1.0,2/12,9.46%,GYS1;NHLRC1
prerank,glycogen biosynthetic process (GO:0005978),0.2647500722757611,0.619069650961221,0.8789237668161435,1.0,1.0,2/12,9.46%,GYS1;NHLRC1
prerank,regulation of pH (GO:0006885),0.27634931269539975,0.6184582192166336,0.895397489539749,1.0,1.0,1/11,3.68%,LACC1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.2619431468066956,-0.6179896442237186,0.9384328358208955,0.9885254862646635,1.0,2/11,16.90%,CTNNB1;NR4A2
prerank,DNA modification (GO:0006304),-0.21318266398948654,-0.617881555232287,0.9517819706498952,0.9880480856206696,1.0,6/22,21.96%,SMUG1;OGG1;TERF2IP;NEIL1;NEIL3;NTHL1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.2600095637411008,0.6178564728405094,0.9105691056910569,1.0,1.0,3/15,15.19%,FAH;AADAT;GSTZ1
prerank,cellular response to light stimulus (GO:0071482),-0.1685235699307491,-0.6176961231532264,0.9929245283018868,0.9876072217813929,1.0,23/66,36.28%,RPL26;ATF4;COPS9;POLK;USP28;N4BP1;ATR;PRKCD;NOC2L;METTL3;FMR1;BMF;POLD1;GNB1;OPN3;TMEM161A;GPR52;SAG;NPM1;YY1;CDC25A;CASP9;PTPRK
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.26929582523954676,-0.6171419365742921,0.908411214953271,0.9873666558985564,1.0,3/10,23.62%,PIH1D1;RUVBL1;PIH1D2
prerank,cellular response to hydroxyurea (GO:0072711),-0.26552616521152494,-0.6160317779311635,0.91,0.9874322213985629,1.0,3/10,21.98%,SPIDR;FMR1;RTF2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.17117042899204513,0.6158309949852215,0.9969418960244648,1.0,1.0,16/125,12.78%,EML4;KIF2A;ITGB3BP;PTPA;CENPI;TTK;BIRC5;PAFAH1B1;SKA2;NUP107;NSL1;MAD1L1;CENPQ;DSN1;DCTN6;SUN2
prerank,regulation of mRNA polyadenylation (GO:1900363),0.24686774708430875,0.6139270037003698,0.9178356713426854,1.0,1.0,7/17,19.37%,CCNT1;HSF1;RNF20;ZC3H14;CTR9;NUDT21;CDK9
prerank,rRNA methylation (GO:0031167),-0.21426177124669754,-0.6137279832283931,0.95625,0.9881361089383542,1.0,6/22,23.15%,TFB2M;BUD23;FBL;NSUN4;MRM2;MRM3
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.1848902359661309,0.6131598283335753,0.9852459016393442,1.0,1.0,12/78,14.18%,NR2F2;CDK7;BLM;PTEN;CCNT2;CCNT1;CDK5RAP1;LATS1;CCNE1;PKD2;CDKN1C;MNAT1
prerank,extracellular transport (GO:0006858),0.2595372386308965,0.612986371469799,0.9028925619834711,1.0,1.0,2/13,11.67%,WWP2;SPA17
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.26691150372250316,-0.612635814306653,0.943609022556391,0.9882089799562999,1.0,1/10,6.01%,CTNNB1
prerank,androgen metabolic process (GO:0008209),0.24506056385227104,0.6126221801388907,0.9324577861163227,1.0,1.0,2/18,10.06%,HSD17B10;MED1
prerank,membrane protein proteolysis (GO:0033619),-0.19020614677578285,-0.6120570106518897,0.9599109131403119,0.9879877684542662,1.0,8/37,23.41%,ADAM10;TGFB1;MYH9;RET;ADAM9;PSEN1;MBTPS1;RELA
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.24096664404522872,0.6096389391621057,0.9452054794520548,1.0,1.0,4/19,15.55%,HNRNPC;ACD;DCP2;STN1
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.25920877741778425,-0.6093498887411135,0.9230769230769231,0.9888206930351117,1.0,8/11,50.44%,ZFP36L1;AHCYL1;BARD1;NCBP2;LEO1;PAPOLA;NCBP1;ZC3H3
prerank,alpha-amino acid metabolic process (GO:1901605),0.20040967803417678,0.6092480700690325,0.9753521126760564,1.0,1.0,7/45,14.79%,CBS;MTHFR;SRR;RIMKLB;KYAT3;AADAT;ASPA
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.24971511933373666,0.6092091082479276,0.9016064257028112,1.0,1.0,3/15,13.43%,HUS1B;MDC1;MRE11
prerank,cellular response to interleukin-2 (GO:0071352),-0.25808750207877174,-0.6091898012998922,0.9128014842300557,0.987854032309735,1.0,6/11,33.97%,PTK2B;JAK3;JAK1;IL2RA;IL2RG;SYK
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.25808750207877174,-0.6091898012998922,0.9128014842300557,0.987854032309735,1.0,6/11,33.97%,PTK2B;JAK3;JAK1;IL2RA;IL2RG;SYK
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.22406893786866566,0.6090994351723196,0.9568480300187617,1.0,1.0,6/27,18.86%,LPAR1;F2RL2;F2RL3;GPR157;DRD2;GPR35
prerank,eosinophil chemotaxis (GO:0048245),-0.2384327393171569,-0.607756903298286,0.9271255060728745,0.9875218590439157,1.0,10/14,50.77%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil migration (GO:0072677),-0.2384327393171569,-0.607756903298286,0.9271255060728745,0.9875218590439157,1.0,10/14,50.77%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,peptide hormone secretion (GO:0030072),0.2229120189633697,0.6077233559738585,0.9541984732824428,1.0,1.0,3/26,7.95%,ANXA1;IL6;SLC30A8
prerank,covalent chromatin modification (GO:0016569),0.2536760365335129,0.6058455741873673,0.8930131004366813,1.0,1.0,2/14,10.71%,UFL1;HDAC1
prerank,neuromuscular process controlling balance (GO:0050885),0.2648316416961556,0.6057550593045264,0.9116465863453815,1.0,1.0,2/12,8.84%,TPP1;PAFAH1B1
prerank,negative regulation of hormone secretion (GO:0046888),0.2744973223495851,0.605587711216116,0.8909853249475891,1.0,1.0,3/10,17.68%,GJA1;IL11;RAB11FIP3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.2526878257842886,0.6046865509680376,0.904862579281184,1.0,1.0,3/15,10.17%,TNRC6B;TNRC6A;AGO2
prerank,regulation of lysosomal lumen pH (GO:0035751),0.26175363943377705,0.6045760243003723,0.9298969072164949,1.0,1.0,2/12,9.02%,LRRK2;TMEM199
prerank,neuron fate commitment (GO:0048663),0.2520433756940555,0.6043571660865058,0.9211045364891519,1.0,1.0,1/14,3.21%,EPOP
prerank,tRNA processing (GO:0008033),0.19050608605812694,0.6042724511307492,0.9778830963665087,1.0,1.0,13/61,17.07%,TRMT9B;PUS3;TSEN34;TRNT1;LCMT2;TRDMT1;ZBTB8OS;WDR4;FARS2;TSEN2;DTWD1;TYW5;CPSF4
prerank,spliceosomal snRNP assembly (GO:0000387),0.20810975997401537,0.6036488176551607,0.9620938628158845,1.0,1.0,9/38,19.86%,PRMT7;SMN1;PRPF3;COIL;USP4;PRPF6;GEMIN5;LSM4;SNRPF
prerank,positive regulation of cytokinesis (GO:0032467),0.21106714072067934,0.6035637091931954,0.9610169491525423,1.0,1.0,3/32,8.59%,CXCR5;CDC14B;PKN2
prerank,melanosome transport (GO:0032402),0.24427008244809184,0.6035318107847016,0.9238095238095239,1.0,1.0,4/18,14.65%,ARL6;GPR143;BBS7;RAB11B
prerank,pigment granule transport (GO:0051904),0.24427008244809184,0.6035318107847016,0.9238095238095239,1.0,1.0,4/18,14.65%,ARL6;GPR143;BBS7;RAB11B
prerank,protein targeting to membrane (GO:0006612),0.177956696593931,0.6033416338095108,0.986863711001642,1.0,1.0,16/83,17.77%,PARD3;RAB3IP;PXMP2;ZDHHC1;ARL6;ZDHHC3;MICALL1;PXMP4;VPS37A;VPS37C;PRKCI;ATG3;VPS37D;SDCBP;SGTA;TAOK2
prerank,amyloid-beta metabolic process (GO:0050435),0.24199230607650274,0.6028205980809094,0.937625754527163,1.0,1.0,4/16,16.61%,ACE;PSENEN;NAT8;BACE1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.18397750751254488,0.6018116428532946,0.9798657718120806,1.0,1.0,7/62,11.29%,POLR2D;TNRC6A;NDC1;POLR2A;NUP107;AGO2;FXR1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.2151710377521771,-0.6012865635692686,0.9486166007905138,0.9901284895476162,1.0,6/20,21.75%,PUM2;ZC3H7A;AGO3;SNIP1;TSN;TSNAX
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2082539436731805,0.6008933570447623,0.9529837251356239,1.0,1.0,8/35,15.46%,ACD;XRCC5;CCT6A;RTEL1;FBXO4;MAPK1;TCP1;PARN
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.24903549079224763,-0.5993773406994557,0.9405940594059405,0.9904946808544605,1.0,4/12,23.80%,IREB2;SIRT4;ACLY;IDH3A
prerank,negative regulation of B cell proliferation (GO:0030889),-0.25730476474176545,-0.5992598108623433,0.93,0.9900191996757216,1.0,4/11,22.88%,TNFRSF21;TYROBP;CD300A;FCGR2B
prerank,tryptophan metabolic process (GO:0006568),-0.2512999340997851,-0.5980448737053982,0.9500959692898272,0.9900352578408846,1.0,4/11,32.08%,KYAT1;KMO;IL4I1;HAAO
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.2622251840402319,-0.5975072556192973,0.9246031746031746,0.9897594572533623,1.0,7/10,50.24%,NFKBIZ;ZC3H12A;SMAD7;RC3H1;IL4;FOXP3;TBX21
prerank,DNA replication (GO:0006260),0.17140050760357378,0.597390811345436,0.9923896499238964,1.0,1.0,29/105,21.09%,RBMS1;ATRIP;BAZ1A;BLM;NT5M;CDK1;CLSPN;REV1;RFC1;ORC2;CDK2AP1;MRE11;TOP1MT;WRN;ORC3;MCM2;NAP1L1;BRIP1;RNASEH2A;RPAIN;ORC6;POLD2;MCM7;POLG2;RAD9B;KAT5;RECQL5;RAD50;NBN
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.22227008217122973,-0.5973542069023786,0.9358178053830227,0.9892952474588997,1.0,4/15,18.46%,RTCB;RTRAF;CLP1;CSTF2
prerank,autophagy of nucleus (GO:0044804),0.2505320260795941,0.597188455665121,0.9314516129032258,1.0,1.0,3/16,15.63%,WIPI1;ATG9A;ATG3
prerank,regulation of interferon-alpha production (GO:0032647),-0.20976057359043715,-0.5968127016591561,0.976,0.9890094253345669,1.0,9/23,32.19%,CHUK;HSPD1;IFIH1;IRF5;STAT1;TLR7;TLR4;DHX9;MAVS
prerank,ncRNA export from nucleus (GO:0097064),0.20564667787595978,0.5962978405330532,0.9722222222222222,1.0,1.0,3/36,10.15%,PHAX;NDC1;NUP107
prerank,microtubule depolymerization (GO:0007019),0.2364123707252242,0.5962737421758063,0.9450757575757576,1.0,1.0,1/17,1.96%,KIF2A
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.23310449919380077,-0.59552350622379,0.9562043795620438,0.9890521510619228,1.0,2/14,9.27%,PPARGC1A;DDB1
prerank,RNA biosynthetic process (GO:0032774),0.212298005897461,0.5937324461631245,0.9562043795620438,1.0,1.0,4/31,10.63%,POLR2A;RSF1;SMN1;SMARCA5
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2429386255891014,0.5929310137845701,0.922920892494929,1.0,1.0,1/16,4.05%,TOP2B
prerank,snRNA processing (GO:0016180),-0.2256903842513054,-0.5928624775616914,0.9388145315487572,0.9897676105710671,1.0,5/16,23.40%,INTS6L;INTS11;INTS6;INTS1;INTS3
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.2244587895800311,-0.5917170143391094,0.9479768786127167,0.9897593967755965,1.0,2/16,7.28%,TNFRSF1B;AHR
prerank,response to hydroxyurea (GO:0072710),-0.24988466317408473,-0.5910860779860555,0.9371196754563894,0.989514306863685,1.0,3/11,21.98%,SPIDR;FMR1;RTF2
prerank,mitotic nuclear division (GO:0140014),0.18064027645014674,0.5905400196798068,0.9866666666666667,1.0,1.0,18/71,20.68%,SPICE1;KIF2A;KLHDC8B;GOLGA2;OFD1;NSL1;KLHL22;DSN1;INO80;MIS12;TUBG1;KIF18A;KPNB1;LSM14A;KIF18B;TPX2;NCAPG2;SPAST
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.22800186226846747,-0.5898520107057885,0.9510763209393346,0.9895240377455611,1.0,3/15,11.27%,NLRC5;ISG15;YTHDF3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.2231378132348601,0.5891384325132283,0.9556451612903226,1.0,1.0,7/21,18.62%,SAMD4A;CNOT2;PARN;CNOT8;CNOT7;CNOT10;TUT4
prerank,respiratory chain complex IV assembly (GO:0008535),-0.20958379638362934,-0.5883097077330607,0.9649122807017544,0.9896695704350164,1.0,9/21,29.04%,SMIM20;COA6;FASTKD3;BCS1L;COA3;COA8;COX15;COX16;COA5
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.1942034109993862,-0.588011886069653,0.9755102040816327,0.9892725811097174,1.0,14/29,40.09%,RPS2;FEM1A;DCUN1D1;DCUN1D2;PINK1;TRIB3;ARRDC3;SMAD7;PLK1;PARK7;DCUN1D3;FBXW7;DCUN1D4;LIMK1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.21376610649408864,0.5876009887075232,0.9539347408829175,1.0,1.0,2/27,4.13%,SYT11;SYT12
prerank,positive regulation of immunoglobulin production (GO:0002639),0.21061336069469844,0.5852212002886812,0.9598393574297188,1.0,1.0,2/31,6.76%,RBP4;IL6
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.20845578671419046,0.5849971684852989,0.9631675874769797,1.0,1.0,7/32,16.97%,CDK7;TAF1A;POLR1F;POLR1A;TAF1D;MNAT1;POLR1G
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.22131154227004912,0.5847853972175563,0.9565217391304348,1.0,1.0,4/23,15.33%,PLA2G10;PLA2G4B;PLA2G4C;PLA2G12A
prerank,positive regulation of organelle assembly (GO:1902117),0.19624228473016406,0.5842036250549287,0.9679595278246206,1.0,1.0,8/44,17.06%,ASAP1;ARHGAP35;STX18;CROCC;CNOT2;RAB3GAP1;CEP120;SDCBP
prerank,ncRNA 3'-end processing (GO:0043628),0.24903676466586094,0.5837616812206865,0.9294871794871795,1.0,1.0,4/14,17.80%,TRNT1;INTS8;ERI1;INTS14
prerank,mitochondrial transcription (GO:0006390),0.26836656575494805,0.5832065948736153,0.9103869653767821,1.0,1.0,4/10,23.82%,MTERF2;MRPL12;POLRMT;TFB1M
prerank,ncRNA metabolic process (GO:0034660),0.19837644988763273,0.582913573087439,0.9810246679316889,1.0,1.0,11/37,21.92%,DTD2;AGO2;DICER1;NIFK;PARN;DTD1;TUT4;DDX4;XPO5;PIWIL4;TUT7
prerank,purine ribonucleotide metabolic process (GO:0009150),0.1769776574055409,0.5807003456328924,0.9950738916256158,1.0,1.0,18/68,23.62%,TPST1;AMPD3;ACOT4;LRRK2;EPHA2;SULT4A1;ACOT1;RHOQ;GMPR2;ACBD6;ACOT11;BPNT1;RAB23;ACOT13;AK4;AK3;ACOT6;ACAT1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.21680367926548452,0.5800844234143625,0.9507874015748031,1.0,1.0,4/24,15.55%,HNRNPC;ACD;DCP2;STN1
prerank,tRNA wobble uridine modification (GO:0002098),0.24738242738746752,0.5800652821971016,0.9410526315789474,1.0,1.0,3/14,18.43%,TRMT9B;MTO1;MOCS3
prerank,regulation of oxidative phosphorylation (GO:0002082),0.23189638477910246,0.5799194114374222,0.9364161849710982,1.0,1.0,6/16,22.23%,NUPR1;COX7A2L;PDE12;COX7A2;ATP7A;AK4
prerank,zymogen activation (GO:0031638),0.2013640371665463,0.5788824167675857,0.966542750929368,1.0,1.0,2/39,3.31%,KLK2;CTSH
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.17943355476548445,-0.5760840244183243,0.988558352402746,0.9936569808839651,1.0,17/35,42.43%,CDH11;ATP2C1;CDH13;PCDHB14;CDH12;SELP;CDH10;CDH8;PCDHB5;PCDHB9;PCDHB13;PCDHB3;CDH7;CDH20;PCDHB4;CDH19;DCHS1
prerank,nuclear transport (GO:0051169),0.23596603875446792,0.5755191810325854,0.9310344827586207,1.0,1.0,4/16,18.97%,NUTF2;NXT2;PSIP1;RSRC1
prerank,negative regulation of telomere maintenance (GO:0032205),-0.22464288463178017,-0.5748910839545273,0.9679358717434869,0.9936035070700383,1.0,2/15,14.48%,PINX1;TERF2IP
prerank,placenta development (GO:0001890),0.2500110259176729,0.574774833421398,0.9339019189765458,1.0,1.0,2/12,8.85%,ASCL2;CUL7
prerank,mRNA modification (GO:0016556),0.2227987261851657,0.574489085210681,0.9431372549019608,1.0,1.0,3/22,10.80%,PUS3;METTL8;METTL14
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.22423670490242223,0.574450550227767,0.9525773195876288,1.0,1.0,7/19,23.07%,POLR3G;ICE2;AR;POLR3C;ELL;NAB2;ICE1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.2431276615073198,-0.5727519378843332,0.9605263157894737,0.9938383011807516,1.0,5/11,40.37%,XBP1;CIITA;TAF7;PF4;IL4
prerank,tetrapyrrole metabolic process (GO:0033013),0.22741121365942543,0.5726255991977967,0.9392712550607287,1.0,1.0,1/18,3.74%,TCN2
prerank,gastrulation (GO:0007369),0.23762518448680375,0.5725624708560438,0.9275929549902152,1.0,1.0,6/15,25.92%,GPC3;UGDH;SMAD2;LMBRD1;NPHP3;MKKS
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.22343109322580762,-0.5714420069955023,0.9506172839506173,0.9938072648553276,1.0,5/14,33.20%,RAB1A;SEC23A;SEC31A;SEC23B;SEC31B
prerank,miRNA metabolic process (GO:0010586),0.21761568665080022,0.5705682309135764,0.968944099378882,1.0,1.0,7/20,21.92%,SND1;AGO2;DICER1;PARN;TUT4;XPO5;TUT7
prerank,smoothened signaling pathway (GO:0007224),-0.18524497451113894,-0.569679178778212,0.9887640449438202,0.9939778548961308,1.0,9/32,23.92%,PTCH1;DISP2;GLI1;STK36;PTCHD1;DISP3;TTBK2;PTCH2;TCTN3
prerank,peptidyl-lysine acetylation (GO:0018394),0.2581031311491636,0.5693941443604597,0.9426751592356688,1.0,1.0,4/10,20.51%,ESCO1;CREBBP;KAT2B;KAT5
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.2554300062774638,0.5682214091808232,0.9094567404426559,1.0,1.0,11/11,74.47%,TAS1R2;PKD2L1;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;PKD1L3;RTP3;LPO;RTP4
prerank,tRNA export from nucleus (GO:0006409),-0.1808835894403432,-0.5648486683961066,0.9872068230277186,0.9946421200108645,1.0,16/32,46.03%,SSB;NUP37;NUP54;NUP85;NUP133;POM121;NUP153;NUP42;NOL6;NUP93;NUP35;RAN;SEH1L;NUP160;RAE1;NUP210
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.1808835894403432,-0.5648486683961066,0.9872068230277186,0.9946421200108645,1.0,16/32,46.03%,SSB;NUP37;NUP54;NUP85;NUP133;POM121;NUP153;NUP42;NOL6;NUP93;NUP35;RAN;SEH1L;NUP160;RAE1;NUP210
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.2592859362480948,0.5642588136476943,0.9242105263157895,1.0,1.0,4/10,20.95%,CDC73;HSF1;NUDT21;PAF1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.24460061224055396,0.5630481255725092,0.9327731092436975,1.0,1.0,2/12,9.35%,HUS1B;CLSPN
prerank,defense response to Gram-negative bacterium (GO:0050829),0.18879923411291466,0.5620292124150715,0.9739292364990689,1.0,1.0,6/42,12.57%,LTF;IL6;OPTN;GSDMD;MR1;SERPINE1
prerank,regulation of endocytic recycling (GO:2001135),-0.23907252359722395,-0.560764903274118,0.9723865877712031,0.9954524160837042,1.0,6/11,41.67%,EHD1;INPP5F;SORL1;EIPR1;EHD2;PLA2G3
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.21880612258306703,-0.5605450457199617,0.9791231732776617,0.9950153242487744,1.0,4/15,25.12%,RACK1;ORMDL2;PRKCD;SPHK2
prerank,regulation of cholesterol transport (GO:0032374),0.22337434473053708,0.5605295479508902,0.9595959595959596,1.0,1.0,3/20,9.15%,ABCA13;ABCA5;APOC1
prerank,apoptotic nuclear changes (GO:0030262),0.21171509154080764,0.5599188154023265,0.972972972972973,1.0,1.0,4/24,14.92%,ACIN1;CECR2;DICER1;DFFA
prerank,protein localization to centrosome (GO:0071539),-0.21049417420227626,-0.5570647456807366,0.969939879759519,0.9956158414662586,1.0,5/17,33.74%,CEP83;SPAG5;PCM1;CEP131;STIL
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.25065136795050835,0.5568095223880489,0.9288617886178862,1.0,1.0,1/11,2.58%,GSTM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.25065136795050835,0.5568095223880489,0.9288617886178862,1.0,1.0,1/11,2.58%,GSTM2
prerank,sensory perception of pain (GO:0019233),-0.1977342584525365,-0.5566880640445845,0.9738955823293173,0.9952162511926117,1.0,9/21,37.06%,TRPA1;CCR2;CCL2;ALOXE3;P2RX7;NIPSNAP1;KCNA2;PROK2;OPRM1
prerank,regulation of biosynthetic process (GO:0009889),0.25122410546139373,0.5565862262154296,0.9224137931034483,1.0,1.0,11/11,74.89%,SNCA;ALOX5;PIKFYVE;PCK1;UCP1;MID1IP1;CCN6;GSTP1;SLC25A33;THRSP;SPHK2
prerank,cell proliferation in forebrain (GO:0021846),0.2582386541962212,0.5565579799457631,0.9385245901639344,1.0,1.0,10/10,74.19%,CEP120;AKNA;DOCK7;NUMBL;NUMB;WNT3A;HOOK3;WNT7A;PCM1;KIF14
prerank,mitochondrial RNA metabolic process (GO:0000959),0.23124922813193197,0.5553366311605533,0.9389763779527559,1.0,1.0,4/14,23.82%,MTERF2;MRPL12;POLRMT;TFB1M
prerank,production of siRNA involved in RNA interference (GO:0030422),0.24545797605844696,0.5549524440637168,0.9297520661157025,1.0,1.0,2/10,13.78%,AGO2;DICER1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.21581049318557452,0.5516566054348326,0.953307392996109,1.0,1.0,6/18,20.23%,CCT6A;DCP2;TCP1;PARN;SHQ1;RUVBL2
prerank,tRNA wobble base modification (GO:0002097),0.23640926426692646,0.551516419828577,0.9621052631578947,1.0,1.0,3/14,18.43%,TRMT9B;MTO1;MOCS3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.2190110692726894,-0.547846962310642,0.9681908548707754,0.9972885340316382,1.0,9/13,54.50%,DUSP1;GEN1;NDC80;XRCC3;CCNB1;PCID2;DYNC1LI1;LCMT1;USP44
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.19322744568251954,0.5475006936576177,0.974757281553398,1.0,1.0,4/31,9.66%,CDC14B;UBE2L3;PTEN;GOLGA2
prerank,cell cycle G1/S phase transition (GO:0044843),0.17207091791492868,0.5471841679839402,0.9898819561551433,1.0,1.0,10/61,14.82%,CDK7;EIF4EBP1;NASP;PHF8;LATS1;RPS6KB1;CUL4B;CCNE1;MNAT1;CDK4
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.216983239415447,-0.5468630406766491,0.9657258064516129,0.9970533171608742,1.0,1/13,2.90%,RPS15
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.2294383165658728,-0.5459342209725799,0.9598540145985401,0.9962613628289796,1.0,4/11,21.52%,NOTCH4;TNRC6C;AGO3;EIF6
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.2294383165658728,-0.5459342209725799,0.9598540145985401,0.9962613628289796,1.0,4/11,21.52%,NOTCH4;TNRC6C;AGO3;EIF6
prerank,response to light stimulus (GO:0009416),0.1710564979803658,0.5456958568210278,0.9863481228668942,1.0,1.0,12/55,17.79%,DDB2;AANAT;REV1;DCT;CRY1;PRIMPOL;CLOCK;UBE2A;GPR88;BRSK1;DRD2;UBE4B
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.23902266012798562,-0.5445926181776091,0.966542750929368,0.9961075809542941,1.0,1/10,3.24%,PDE8A
prerank,neuropeptide signaling pathway (GO:0007218),-0.15387904562889454,-0.5440024709542174,1.0,0.9957571638658652,1.0,12/58,25.74%,SORCS2;CYSLTR1;CYSLTR2;NXPH2;GPR149;GLRA3;SORCS1;NPY;PNOC;SORL1;ADCYAP1;GLRA1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.2499277871021709,0.5420021660175539,0.9525773195876288,1.0,1.0,1/10,2.73%,LTF
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.1941970043287924,0.5401353252117201,0.981549815498155,1.0,1.0,3/31,6.94%,CTLA4;LST1;PDCD1LG2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.18994847978258356,0.5399430805516812,0.972875226039783,1.0,1.0,7/32,15.46%,ACD;XRCC5;CCT6A;FBXO4;MAPK1;TCP1;PARN
prerank,regulation of microtubule-based movement (GO:0060632),-0.22636120926888612,-0.5384015391195401,0.9588785046728971,0.9967211450993588,1.0,4/11,29.62%,LAMP1;HDAC6;HAP1;DYNLT2B
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.22223782879948956,0.5355710993272913,0.957169459962756,1.0,1.0,3/15,15.24%,ZC3H12B;DICER1;NYNRIN
prerank,snRNA 3'-end processing (GO:0034472),0.21293913086561625,0.5339959541809619,0.9693877551020408,1.0,1.0,5/19,18.60%,INTS8;EXOSC8;TUT1;INTS14;EXOSC3
prerank,dendritic cell migration (GO:0036336),-0.20151802482619868,-0.5338921880480263,0.9738955823293173,0.9973396407706795,1.0,7/16,39.72%,EPS8;TRPM4;CCR2;TRPM2;CCL5;PIK3CG;CCR1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.18077222516071462,0.5331843588383304,0.9907063197026023,1.0,1.0,7/40,14.01%,NEK4;FEM1B;ABL1;FXR1;NPAS2;CRY1;UBE2V1
prerank,pre-miRNA processing (GO:0031054),0.2218717638710832,0.5319541167823735,0.9613821138211383,1.0,1.0,5/14,21.92%,AGO2;DICER1;TUT4;AGO1;TUT7
prerank,protein targeting to peroxisome (GO:0006625),0.189229791539203,0.5317410450411816,0.985239852398524,1.0,1.0,5/29,15.19%,PXMP2;ZFAND6;PXMP4;HACL1;PEX7
prerank,regulation of mast cell activation (GO:0033003),0.24003515159123723,0.5306369161106365,0.952808988764045,1.0,1.0,10/10,76.01%,NECTIN2;LYN;CD84;CD300LF;PLSCR1;HAVCR1;CD226;TSLP;MILR1;CRLF2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.18278337401027162,0.5284005588244888,0.983957219251337,1.0,1.0,5/36,13.36%,PRKN;CSF1;AXL;PARP9;ZBP1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.15659043326927408,0.527642392113035,1.0,1.0,1.0,18/83,19.75%,CDK7;EIF4EBP1;NASP;PHF8;TYMS;LATS1;RPS6KB1;CUL4B;CCNE1;TFDP2;MNAT1;CDK15;CDK4;BACH1;NPAT;CAMK2A;DHFR;CCNE2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.1933471661334339,-0.5274347546306596,0.9653767820773931,0.9983651243174285,1.0,10/19,40.37%,GAS6;XBP1;PPP2R3C;NCKAP1L;MDK;IL7;SYK;ZAP70;GATA3;IL4
prerank,dopaminergic neuron differentiation (GO:0071542),-0.1949800465062948,-0.5270770787404926,0.9876796714579056,0.9979210491048759,1.0,7/19,36.00%,CTNNB1;VEGFA;NR4A2;LMX1A;SHH;MANF;LMX1B
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.23566497210562268,0.5258348173558525,0.9422310756972112,1.0,1.0,2/10,12.90%,SSBP1;INO80
prerank,chromosome condensation (GO:0030261),0.18166566559690883,0.5251819617920704,0.9946714031971581,1.0,1.0,9/36,20.36%,ACIN1;PHF8;CDK1;AKAP8L;BANF2;MCPH1;AIFM1;SMC2;NCAPG2
prerank,mesenchymal to epithelial transition (GO:0060231),0.2391847820879908,0.523861233853714,0.9545454545454546,1.0,1.0,2/10,15.68%,SALL1;FZD7
prerank,regulation of rRNA processing (GO:2000232),0.21551134998373947,0.5236737789105825,0.9648033126293996,1.0,1.0,5/16,19.95%,YTHDF2;DIMT1;SHQ1;RIOK1;KAT2B
prerank,mitochondrion distribution (GO:0048311),0.2271751684738968,0.5226814790113806,0.9415322580645161,1.0,1.0,3/12,15.35%,LRRK2;TRAK1;TRAK2
prerank,regulation of platelet activation (GO:0010543),-0.18301390710182242,-0.5219458781933901,0.9900398406374502,0.9985367707520247,1.0,1/21,0.98%,NOS3
prerank,positive regulation of interferon-beta production (GO:0032728),0.18156794305974278,0.5216231395164869,0.9893617021276596,1.0,1.0,6/33,13.89%,POLR3G;TRIM56;RNF135;IRF3;TBK1;POLR3C
prerank,positive regulation of chromosome organization (GO:2001252),-0.2060984203160734,-0.519082172226645,0.9791666666666666,0.9986511537286095,1.0,4/15,23.56%,GNL3;PPP1R10;LIG4;SIRT6
prerank,autophagy of peroxisome (GO:0030242),-0.2117615354835105,-0.5171135523611345,0.982421875,0.9985324677119266,1.0,3/12,20.38%,MAP1LC3B;PIK3C3;PEX5
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.22638257710220147,0.5145444720691069,0.9576271186440678,1.0,1.0,2/12,10.51%,PLK5;PRKDC
prerank,regulation of double-strand break repair (GO:2000779),-0.1584683529818232,-0.5140025665778629,0.9977924944812362,0.9986221634646806,1.0,15/39,34.12%,SPIDR;ACTR2;OTUB1;TERF2IP;SPIRE1;PPP4R2;SIRT7;SIRT6;CHEK1;ZCWPW1;SHLD2;PPP4C;MGMT;RPA2;FIGNL1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.20341404939231889,0.5139941449323102,0.9837728194726166,1.0,1.0,3/17,14.03%,PRKAA1;APOC1;PLIN5
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.20410144194272095,-0.5130634871158298,0.978021978021978,0.9982796817746199,1.0,5/13,40.37%,LAMP1;SPHK2;ITGB2;SYK;IL4
prerank,DNA alkylation (GO:0006305),-0.19078828377803317,-0.5117757502011636,0.9897330595482546,0.9974883226637696,1.0,7/19,41.07%,KMT2E;EHMT2;DNMT1;HELLS;TEX15;SPOCD1;DNMT3B
prerank,DNA methylation or demethylation (GO:0044728),-0.19078828377803317,-0.5117757502011636,0.9897330595482546,0.9974883226637696,1.0,7/19,41.07%,KMT2E;EHMT2;DNMT1;HELLS;TEX15;SPOCD1;DNMT3B
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.1655895435544168,0.5104805212024043,0.996551724137931,1.0,1.0,10/51,15.55%,HNRNPC;ACD;XRCC5;CCT6A;FBXO4;DCP2;MAPK1;TCP1;PARN;STN1
prerank,long-term memory (GO:0007616),0.2028626060063834,0.5084294724997162,0.9824561403508771,1.0,1.0,5/19,20.44%,ARC;NFATC4;SLC2A4;CALB1;RASGRF1
prerank,mRNA catabolic process (GO:0006402),0.16624875121861044,0.5081987110257367,0.9949664429530202,1.0,1.0,15/44,23.70%,YTHDF2;NBDY;DHX34;DCP2;NUDT12;LSM5;CNOT10;TUT4;PDE12;AGO1;XRN1;TUT7;THRAP3;EXOSC4;LSM6
prerank,protein methylation (GO:0006479),0.1724099429510621,0.5068007144993852,0.996415770609319,1.0,1.0,4/40,9.91%,CAMKMT;PRMT7;EEF1AKMT1;NSD1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.22142316864834938,0.5067515320704056,0.9494736842105264,1.0,1.0,2/12,12.49%,FDXR;AKR1B1
prerank,peptidyl-amino acid modification (GO:0018193),-0.21906973824618667,-0.5064946841159074,0.9833024118738405,0.9979496544668467,1.0,10/10,78.11%,FKBP10;PDF;APOA1;METAP1D;APOA2;METAP1;METAP2;TTLL4;FKBP7;ATP7A
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.18341964284573836,0.5050503288468216,0.9826254826254827,1.0,1.0,6/25,23.29%,CCNT2;CCNT1;ELL;LDB1;SUPT4H1;THOC1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.20337318603582985,-0.5022001130351642,0.982,0.9981753678425129,1.0,10/12,52.59%,GNL3;CCT3;GNL3L;CCT4;WRAP53;CCT2;CCT8;CCT7;CCT5;DKC1
prerank,primary miRNA processing (GO:0031053),-0.21636927476279622,-0.5020689421756527,0.9774859287054409,0.9976829743782791,1.0,4/10,30.37%,DGCR8;METTL3;SMAD1;DROSHA
prerank,DNA replication checkpoint signaling (GO:0000076),0.2047491765534542,0.5012477849157334,0.9653179190751445,1.0,1.0,2/16,9.35%,HUS1B;CLSPN
prerank,protein localization to kinetochore (GO:0034501),0.21233460349056357,0.49950365330818836,0.9578059071729957,1.0,1.0,3/14,15.70%,TTK;CDK1;MIS12
prerank,cellular response to pH (GO:0071467),-0.1867648051082172,-0.4988160193939117,0.9938398357289527,0.9977354829033968,1.0,4/17,29.52%,CHP1;RAB11FIP5;MCOLN1;ASIC1
prerank,histone mRNA metabolic process (GO:0008334),0.18011631350934182,0.49874497939790174,0.9869646182495344,1.0,1.0,10/27,23.34%,TENT2;TUT1;DCP2;ERI1;TUT4;LSM1;SNRPF;XRN1;TUT7;EXOSC4
prerank,regulation of DNA damage checkpoint (GO:2000001),0.22240273765673124,0.49850961275905886,0.960352422907489,1.0,1.0,4/10,23.29%,FEM1B;CRY1;ETAA1;THOC1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.2100545019076002,0.4984819451251124,0.9633401221995926,0.9997203307361348,1.0,1/14,5.66%,DDX60
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.2058510793269725,-0.49828273581754007,0.9868667917448405,0.9973009224175828,1.0,7/12,45.42%,RMDN1;BOD1;NDC80;KIF2C;SEH1L;CDT1;CENPC
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.20157745651168205,0.4977123803392924,0.9726890756302521,0.9993367552964878,1.0,2/17,8.73%,TTK;CDK1
prerank,rRNA catabolic process (GO:0016075),-0.19302215400717854,-0.4976790362535352,0.9853556485355649,0.9968895225602006,1.0,8/16,40.49%,TRIR;PELO;EXOSC10;EXOSC5;DEDD2;EXOSC2;ERN2;EXOSC9
prerank,acetyl-CoA metabolic process (GO:0006084),-0.19196279525030893,-0.4962573369884619,0.9829545454545454,0.9965862112753587,1.0,3/15,19.50%,ACACA;HMGCS1;ACLY
prerank,regulation of DNA metabolic process (GO:0051052),-0.1458911202215619,-0.4956869869353817,0.9977876106194691,0.996151764417868,1.0,17/44,34.94%,WDR70;WRNIP1;TERF2IP;UBE2V2;SMG5;SIRT7;SMARCAD1;HNRNPD;TOM1L1;SMG6;ALYREF;SUB1;PIF1;HELB;KPNA2;TICRR;IL7R
prerank,nuclear pore organization (GO:0006999),0.2092608612452032,0.4954403392374755,0.9749478079331941,0.9992789276478313,1.0,2/14,10.15%,NDC1;NUP107
prerank,fibrinolysis (GO:0042730),0.2132919806977353,0.4941958745318558,0.9772727272727273,0.998966227711215,1.0,12/13,59.72%,SERPINE1;PLAU;HRG;PLG;SERPINF2;FGG;PLAT;KRT1;F2;GP1BA;CPB2;SERPINB2
prerank,positive regulation of DNA recombination (GO:0045911),0.18369065236664295,0.4938895325145672,0.9866920152091255,0.9984762134653901,1.0,3/27,8.47%,MRNIP;WDR48;ARID2
prerank,ncRNA catabolic process (GO:0034661),-0.1673150937953496,-0.4936720256481677,0.9888143176733781,0.9959241455337219,1.0,14/28,41.78%,TRIR;LIN28B;MTREX;EXOSC10;NUDT16;DIS3L2;EXOSC5;TENT4B;NUDT16L1;DEDD2;EXOSC2;ERN2;EXOSC9;ZCCHC8
prerank,protein import into mitochondrial matrix (GO:0030150),-0.18512035571902807,-0.4925773218118094,0.9876288659793815,0.9955811367726495,1.0,5/18,29.63%,TOMM20;ROMO1;TIMM50;TIMM44;DNLZ
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.20328815578784293,0.4862188467422059,0.9936974789915967,0.9994505070142755,1.0,1/15,3.63%,RIPOR2
prerank,mitochondrial genome maintenance (GO:0000002),-0.20716561227322416,-0.48424254946904427,0.9894736842105263,0.996280906131926,1.0,3/11,28.06%,TOP3A;SLC25A4;MEF2A
prerank,mitotic DNA replication (GO:1902969),-0.20766424798207025,-0.4822425092867901,0.983177570093458,0.9960350009858145,1.0,2/10,17.40%,MCM4;POLA1
prerank,regulation of lipase activity (GO:0060191),0.20663318881571452,0.4807875318551024,0.98,0.999901275069141,1.0,4/13,18.24%,LIPC;PLIN5;LMF1;SNCA
prerank,vitamin D metabolic process (GO:0042359),-0.18892965729691535,-0.47769900431440365,0.982824427480916,0.996093921121549,1.0,1/13,4.63%,LGMN
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.15215419723373785,-0.47700493517596104,1.0,0.9956703597627141,1.0,14/32,42.58%,CDK17;POLA1;ID2;CDK5;E2F7;ZPR1;ORC1;CDC6;ESRRB;RRM2;PCNA;CDK18;TFDP1;CDC45
prerank,DNA methylation (GO:0006306),-0.16396591784462433,-0.47136347705832843,0.9959432048681541,0.9958348826219444,1.0,6/23,27.18%,KMT2E;PICK1;EHMT2;ZFP57;DNMT1;HELLS
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.18361769375578307,-0.4697165109844253,0.9921104536489151,0.995497620884088,1.0,2/14,13.78%,PTGS2;PTGER3
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.17799662769263885,-0.46930481135845187,0.9939879759519038,0.9950148180663637,1.0,1/16,5.20%,PINX1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.19890751553964958,0.4671005597388854,0.980806142034549,1.0,1.0,14/14,80.13%,CSF1;TRAF6;POU4F2;IFNG;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;ATP6AP1;TYROBP
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.20797633971209367,0.46635499218079135,0.9779116465863453,1.0,1.0,2/12,15.27%,TET1;ATF7IP
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.20005276431991176,0.46368347841415986,0.9842209072978304,1.0,1.0,3/13,18.69%,PRPF3;USP4;PRPF6
prerank,peptidyl-methionine modification (GO:0018206),0.2016447987946513,0.46217921686588803,0.981404958677686,1.0,1.0,12/12,79.85%,NAA60;NAA20;NAA15;METAP2;NAA25;METAP1;APOA2;METAP1D;APOA1;PDF;NAA16;NAA30
prerank,dendritic cell chemotaxis (GO:0002407),0.18754316569347654,0.45134982424856396,0.9874476987447699,1.0,1.0,14/14,81.26%,CCL19;CCR6;GPR183;HMGB1;CXCR4;CCR7;CXCR2;CCR5;CCR1;PIK3CG;CCL5;TRPM2;CCR2;TRPM4
prerank,cilium-dependent cell motility (GO:0060285),0.16876121581600656,0.44340844244516503,0.9959758551307847,1.0,1.0,3/22,14.00%,DNAH2;TEKT2;CCDC65
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.1999168953735515,0.4417541634968677,0.9814432989690721,1.0,1.0,4/11,21.14%,PRKCA;LYN;RDX;PRKCQ
prerank,mismatch repair (GO:0006298),0.16138404098962036,0.4362470315721187,0.988950276243094,1.0,1.0,7/27,18.61%,ABL1;LIG1;MLH1;RNASEH2A;SETD2;XPC;POLD2
prerank,mitotic chromosome condensation (GO:0007076),0.15933044421327147,0.43501111386237407,0.9944341372912802,1.0,1.0,6/26,20.36%,PHF8;CDK1;AKAP8L;MCPH1;SMC2;NCAPG2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.15368140656073045,0.4308220572734137,1.0,1.0,1.0,7/29,23.62%,ACOT4;ACOT1;ACBD6;ACOT11;ACOT13;ACOT6;ACAT1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.15368140656073045,0.4308220572734137,1.0,1.0,1.0,7/29,23.62%,ACOT4;ACOT1;ACBD6;ACOT11;ACOT13;ACOT6;ACAT1
prerank,regulation of chromosome segregation (GO:0051983),0.17846872750466306,0.43063561741707235,0.987603305785124,0.9998121847179156,1.0,3/16,17.09%,HORMAD1;RAD18;IHO1
prerank,activin receptor signaling pathway (GO:0032924),0.17547715308640677,0.4257559343311935,0.9979591836734694,0.9996786279670465,1.0,1/15,7.08%,SMAD3
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.19039970624076052,0.4243286492594135,0.998019801980198,0.9992517134836384,1.0,1/11,7.25%,BLM
prerank,glycine metabolic process (GO:0006544),-0.173491681316379,-0.42054707579609674,0.9980430528375733,0.998150695196263,1.0,3/12,28.72%,RIDA;GCAT;GLDC
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.1887593733035799,0.41054531821179685,0.9940357852882704,0.9997082547598477,1.0,1/10,6.94%,PDCD1LG2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.13940248555670862,0.402528497045229,0.9982788296041308,0.9996326252711439,1.0,11/40,23.29%,BLM;RTEL1;BOD1L1;PRIMPOL;CENPX;WRN;RAD51;CDK9;ETAA1;SMARCAL1;THOC1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.1615628007061647,0.39604539916608744,0.9979716024340771,0.9994211555252688,1.0,5/16,22.01%,PRKDC;PARP9;DTX3L;KDM4D;SHLD1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.1626271505713927,0.38881098993879143,1.0,0.99921040922562,1.0,15/15,83.75%,CCT6A;TCP1;SHQ1;RUVBL2;DKC1;CCT5;CCT7;NAF1;CCT8;CCT2;CCT4;NOP10;CCT3;NHP2;RUVBL1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.1578803380985396,0.34794238789907256,1.0,0.9996777816422117,1.0,3/11,20.88%,PPIP5K2;ITPKA;IP6K2
